0001144204-15-048466.txt : 20150812 0001144204-15-048466.hdr.sgml : 20150812 20150812145456 ACCESSION NUMBER: 0001144204-15-048466 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20150630 FILED AS OF DATE: 20150812 DATE AS OF CHANGE: 20150812 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EKSO BIONICS HOLDINGS, INC. CENTRAL INDEX KEY: 0001549084 STANDARD INDUSTRIAL CLASSIFICATION: GENERAL INDUSTRIAL MACHINERY & EQUIPMENT, NEC [3569] IRS NUMBER: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-55442 FILM NUMBER: 151046678 BUSINESS ADDRESS: STREET 1: 1414 HARBOUR WAY SOUTH STREET 2: SUITE 1201 CITY: RICHMOND STATE: CA ZIP: 94804 BUSINESS PHONE: 510-984-1761 MAIL ADDRESS: STREET 1: 1414 HARBOUR WAY SOUTH STREET 2: SUITE 1201 CITY: RICHMOND STATE: CA ZIP: 94804 FORMER COMPANY: FORMER CONFORMED NAME: PN Med Group Inc DATE OF NAME CHANGE: 20120503 10-Q 1 v417064_10q.htm FORM 10-Q

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 10-Q

  

 

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2015

 

or

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ______ to ______

 

Commission File Number: 333-181229

 

 

  

Ekso Bionics Holdings, Inc.

(Exact name of registrant as specified in its charter)

    

 

 

Nevada   99-0367049

(State or other jurisdiction of

incorporation or organization)

  

(I.R.S. Employer

Identification No.)

 

1414 Harbour Way South, Suite 1201

Richmond, CA

   94804
(Address of principal executive offices)   (Zip Code)

 

(203) 723-3576

(Registrant’s telephone number, including area code)

  

 

  

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

 

Indicate by check mark whether the registrant has submitted electronically and posted to its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ¨   Accelerated filer ¨
     
Non-accelerated filer x   Smaller reporting company ¨
(Do not check if a smaller reporting company)    

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

 

The number of shares of registrant’s common stock outstanding as of August 3, 2015 was: 102,139,765

  

 1 
 

 

Ekso Bionics Holdings, Inc.

 

Quarterly Report on Form 10-Q

 

Table of Contents

 

    Page No.
  PART I. FINANCIAL INFORMATION  
     
Item 1. Financial Statements 3
     
  Condensed Consolidated Balance Sheets as of June 30, 2015 (unaudited) and December 31, 2014 3
     
  Condensed Consolidated Statements of Operations for the Three Months and Six Months Ended June 30, 2015 and 2014 (unaudited) 4
     
  Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2015 and 2014 (unaudited) 5
     
  Notes to Condensed Consolidated Financial Statements (unaudited) 6
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 19
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk 29
     
Item 4. Controls and Procedures 29
     
  PART II. OTHER INFORMATION  
     
Item 1. Legal Proceedings 30
     
Item 1A.  Risk Factors 30
     
Item 6. Exhibits 31
     
  Signatures 32

  

 2 
 

 

PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

Ekso Bionics Holdings, Inc.

Condensed Consolidated Balance Sheets

(in thousands, except share and par value amounts)

 

  

June 30,

2015

  

December 31,

2014

 
   (Unaudited)   (Note 2) 
Assets          
Current assets:          
Cash  $16,251   $25,190 
Accounts receivable, net   2,394    1,549 
Inventories, net   1,188    622 
Prepaid expenses and other current assets   473    388 
Deferred cost of revenue, current   1,876    1,551 
Total current assets   22,182    29,300 
Property and equipment, net   2,154    2,102 
Deferred cost of revenue, non-current   2,515    2,017 
Other assets   55    55 
Total assets  $26,906   $33,474 
           
Liabilities and Stockholders' Equity          
Current liabilities:          
Notes payable, current  $43   $41 
Accounts payable   2,306    783 
Accrued liabilities   1,976    2,378 
Deferred revenues, current   4,032    3,412 
Total current liabilities   8,357    6,614 
Deferred revenues, non-current   4,492    3,895 
Notes payable, non-current   53    77 
Deferred rent   69    88 
Total liabilities   12,971    10,674 
Commitments and contingencies (Note 12)          
Stockholders' equity:          
Convertible Preferred stock, $0.001 par value; 10,000,000 shares authorized at June 30, 2015 and December 31, 2014; none issued and outstanding at June 30, 2015 and December 31, 2014, respectively   —    — 
Common stock, $0.001 par value; 500,000,000 shares authorized at June 30, 2015 and December 31, 2014; 102,123,767 and 101,621,358, shares issued and outstanding at June 30, 2015 and December 31, 2014, respectively   102    102 
Additional paid-in capital   95,394    94,499 
Accumulated deficit   (81,561)   (71,801)
Total stockholders' equity   13,935    22,800 
Total liabilities and stockholders' equity  $26,906   $33,474 

 

See Accompanying Notes to Unaudited Condensed Consolidated Financial Statements

 

 3 
 

 

 Ekso Bionics Holdings, Inc.

Condensed Consolidated Statements of Operations

(in thousands, except share and per share amounts)

(unaudited)

 

   Three months ended   Six months ended 
   June 30,   June 30, 
   2015   2014   2015   2014 
                 
Revenue                    
                     
Medical devices  $1,048   $690   $2,033   $1,217 
Engineering services   1,066    507    1,770    1,042 
Total revenue   2,114    1,197    3,803    2,259 
Cost of revenue                    
Cost of medical devices   970    502    1,768    832 
Cost of engineering services   642    650    1,130    902 
Total cost of revenue   1,612    1,152    2,898    1,734 
                     
Gross profit   502    45    905    525 
                     
Operating expenses                    
Sales and marketing   2,523    1,849    4,374    3,380 
Research and development   1,742    699    2,725    1,468 
General and administrative   1,872    1,809    3,534    3,880 
Total operating expenses   6,137    4,357    10,633    8,728 
Loss from operations   (5,635)   (4,312)   (9,728)   (8,203)
Other income (expense)                    
Interest expense   (3)   (3)   (6)   (430)
Gain (loss) on warrant liability   -    60,458    -    (16,979)
Interest income   3    2    7    3 
Other expense, net   (10)   (17)   (33)   (29)
Total other income (expense), net   (10)   60,440    (32)   (17,435)
Net income (loss)  $(5,645)  $56,128   $(9,760)  $(25,638)
Basic net income (loss) per share  $(0.06)  $0.72   $(0.10)  $(0.35)
Weighted-average shares used in computing basic per share amounts   102,094,158    78,497,558    101,944,359    72,688,073 
 Diluted net income (loss) per share  $(0.06)  $(0.05)  $(0.10)  $(0.35)
Weighted-average shares used in computing diluted per share amounts   102,094,158    94,772,411    101,944,359    72,688,073 

  

See Accompanying Notes to the Unaudited Condensed Consolidated Financial Statements

  

 4 
 

 

Ekso Bionics Holdings, Inc.

Condensed Consolidated Statements of Cash Flows

(in thousands)

(unaudited)

 

  

Six months 

ended June 30,

 
   2015   2014 
         
Operating activities:          
Net loss  $(9,760)  $(25,638)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization   419    333 
Inventory allowance expense   —    21 
Amortization of deferred rent   (19)   (18)
Amortization of debt discounts   —    198 
Stock-based compensation expense   791    693 
Loss on increase in fair value of warrant liability   —    16,979 
Changes in operating assets and liabilities:          
Accounts receivable   (845)   (944)
Inventories   (478)   (573)
Prepaid expense and other assets   (85)   (47)
Deferred cost of revenue   (823)   (917)
Accounts payable   1,523    (272)
Accrued liabilities   (402)   (166)
Deferred revenues   1,217    1,746 
Net cash used in operating activities   (8,462)   (8,605)
Investing activities:          
Acquisition of property and equipment, net   (559)   (675)
Net cash used in investing activities   (559)   (675)
Financing activities:          
Principal payments on notes payable   (22)   (2,544)
           
Proceeds from exercise of stock options   56    23 
Proceeds from exercise of common stock warrants   48    — 
           
Proceeds from issuance of common stock, net of issuance costs   —    21,961 
Net cash provided by financing activities   82    19,440 
           
Net increase (decrease) in cash   (8,939)   10,160 
Cash at beginning of the period   25,190    805 
Cash at end of the period  $16,251   $10,965 

 

See Accompanying Notes to Unaudited Condensed Consolidated Financial Statements

 

 5 
 

  

Ekso Bionics Holdings, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

(in thousands, except share and per share amounts)

(unaudited)

 

1. Organization

 

Description of Business and Liquidity

 

On January 15, 2014, a wholly-owned subsidiary of Ekso Bionics Holdings, Inc. named Ekso Acquisition Corp, merged with and into Ekso Bionics, Inc. (the “Merger”). Ekso Bionics, Inc. was the surviving corporation and became a wholly-owned subsidiary of Ekso Bionics Holdings, Inc. As a result of this transaction, Ekso Bionics Holdings, Inc. discontinued its pre-merger operations, acquired the business of Ekso Bionics, Inc. and continues the operations of Ekso Bionics, Inc. as a publicly traded company. See Note 3, The Merger, Offering and Other Related Transactions. Ekso Bionics, Inc. was incorporated in January 2005 in the State of Delaware. We are currently headquartered in Richmond, California.

 

As used in these notes to the condensed consolidated financial statements, the term “the Company” refers to Ekso Bionics Holdings, Inc. (formerly known as PN Med Group, Inc.) and its direct and indirect wholly-owned subsidiaries, including Ekso Bionics, Inc. and Ekso Bionics Ltd., after giving effect to the Merger; the term “Holdings” refers to the business of Ekso Bionics Holdings, Inc. prior to the Merger, and the term “Ekso Bionics” refers to Ekso Bionics, Inc. prior to the Merger. Unless otherwise indicated, all dollar amounts included in these notes to the financial statements are in thousands.

 

We are a leading developer and manufacturer of human bionic exoskeletons. We were founded after the Robotics and Human Engineering Laboratory at the University of California, Berkeley had a breakthrough in demonstrating human exoskeletons that are more energy efficient than previously thought possible.

 

We are pioneering the field of human exoskeletons to augment human strength, endurance and mobility. We design, develop and sell wearable robots, or “human exoskeletons,” that have applications in healthcare, industrial, military, and consumer markets. Our exoskeleton systems are strapped over the user’s clothing, enabling individuals with neurological conditions affecting gait (e.g., stroke or spinal cord injury) to walk again, permitting soldiers to carry heavy loads for long distances while mitigating lower back, knee, and ankle injuries, and allowing industrial workers to increase productivity and quality of work, for extended periods.

 

Our current medical device product, the Ekso GT, is a wearable bionic suit that provides individuals with stroke, spinal cord injuries and other lower-extremity paralysis or weakness the ability to stand and walk over ground with a full weight-bearing, reciprocal gait using a cane, crutches or a walker under the supervision of a physical therapist. Walking is achieved by the shifting of the user’s body to activate sensors in the device that initiate steps. Battery-powered motors drive the legs, replacing deficient neuromuscular function. First-time users can expect to walk with aid from the device the first time they put on the Ekso exoskeleton (after passing an assessment), while an experienced user can transfer to or from their wheelchair and don or remove the Ekso in less than five minutes.

 

Our engineering services division, Ekso Labs, is an exoskeleton laboratory that continually integrates emerging technologies into new product applications and expands on such technologies with our partners. Ekso Labs also develops intellectual property through research grants from government organizations, including the United States Special Operations Command and the Department of Defense.

 

 6 

  

Ekso Bionics Holdings, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

(in thousands, except share and per share amounts)

(unaudited)

 

Liquidity

 

Largely as a result of significant research and development activities related to the creation of our advanced technology and commercialization of this technology into our medical device business, we have incurred significant operating losses and negative cash flows from operations since inception. The Company has also recorded significant non-cash losses associated with revaluation of certain securities, which have also contributed significantly to our accumulated deficits. As of June 30, 2015, we had an accumulated deficit of $81,561.

 

The Company’s cash as of June 30, 2015, was $16,251 compared to $25,190 at December 31, 2014. During the six months ended June 30, 2015, the Company used $8,462 of cash in operations compared to $8,605 for the six months ended June 30, 2014.

 

Based upon our current six-month average monthly net use of cash of approximately $1,500 and assuming increases in current revenue and gross profit, offset by incremental net use of cash for increased sales and marketing and research and development, and a potential increase in rental activity for our medical device business, the Company believes it has sufficient resources to meet its financial obligations into the second quarter of 2016.

 

Our actual capital requirements may vary significantly and will depend on many factors. For example, we plan to continue to increase our investments (i) in our clinical, sales and marketing initiatives to accelerate adoption of the Ekso robotic exoskeleton in the rehabilitation market, (ii) in our research, development and commercialization activities with respect to an Ekso robotic exoskeleton for home use, and/or (iii) in the development and commercialization of able-bodied exoskeletons for industrial use. Consequently, the Company will require significant additional financing in the future, which we intend to raise through corporate collaborations, public or private equity offerings, debt financings or warrant solicitations within the next two to four quarters. Sales of additional equity securities by us could result in the dilution of the interests of existing stockholders. When we need additional financing, there can be no assurance that it will be available when required in sufficient amounts, on acceptable terms or at all. In the event that the necessary additional financing is not obtained, we may be required to reduce our discretionary overhead costs substantially, including research and development, general and administrative and sales and marketing expenses or otherwise curtail operations.

 

2. Basis of Presentation and Summary of Significant Accounting Policies and Estimates

 

There have been no material changes to our significant accounting policies as compared to those described in our Annual Report on Form 10-K for the year ended December 31, 2014.

 

Basis of Presentation

 

These unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”), for the presentation of interim financial information. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed, or omitted, pursuant to such rules and regulations. The condensed consolidated balance sheet at December 31, 2014, has been derived from the audited consolidated financial statements at that date but does not include all disclosures required for the annual financial statements and should be read in conjunction with our audited consolidated financial statements and notes thereto included as part of our Annual Report on Form 10-K for the year ended December 31, 2014.

 

In management’s opinion, the condensed consolidated financial statements reflect all adjustments (including reclassifications and normal recurring adjustments) necessary to present fairly the financial position at June 30, 2015, and results of operations and cash flows for all periods presented. The interim results presented are not necessarily indicative of results that can be expected for a full year. The condensed consolidated financial statements include the accounts of the Company and our wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.

 

 7 

  

Ekso Bionics Holdings, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

(in thousands, except share and per share amounts)

(unaudited)

  

Use of Estimates

 

The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet, and the reported amounts of revenues and expenses during the reporting period. For the Company, these estimates include, but are not limited to: revenue recognition, deferred revenue and the deferral of the associated costs, useful lives assigned to long-lived assets, realizability of

deferred tax assets, the valuation of options and warrants, and contingencies. Actual results could differ from those estimates.

 

Concentration of Credit Risk and Other Risks and Uncertainties

 

Financial instruments that potentially subject us to concentrations of credit risk consist principally of cash and accounts receivable. We maintain our cash accounts in excess of federally insured limits. However, we believe we are not exposed to significant credit risk due to the financial position of the depository institutions in which these deposits are held.  We extend credit to customers in the normal course of business and perform ongoing credit evaluations of our customers. Concentrations of credit risk with respect to accounts receivable exist to the full extent of amounts presented in the consolidated financial statements. We do not require collateral from our customers to secure accounts receivable.

 

Accounts receivable are derived from the sale of products shipped and services performed for customers located in the U.S. and throughout the world. Invoices are aged based on contractual terms with the customer. We review accounts receivable for collectability and provide an allowance for credit losses, as needed. We have not experienced any material losses related to accounts receivable as of June 30, 2015 and December 31, 2014. Many of the sales contracts with customers outside of the U.S. are settled in a foreign currency other than the U.S. dollar. We do not enter into any foreign currency hedging agreements and are susceptible to gains and losses from foreign currency fluctuations. To date, we have not experienced significant gains or losses upon settling foreign currency denominated accounts receivable.

 

As of June 30, 2015, we had two customers with accounts receivable balances totaling 10% or more of our total accounts receivable (26% and 10%), compared with two customers as of December 31, 2014 (22% and 11%).

 

In the three months ended June 30, 2015, we had one customer with sales comprising of 10% or more of our total customer sales (32%), compared with two customers in the three months ended June 30, 2014 (15% and 12%). In the six months ended June 30, 2015, we had two customers with sales comprising of 10% or more of our total customer sales (27%, and 11%), compared with one customer in the six months ended June 30, 2014 (17%).

 

Common Stock Warrants

 

We accounted for the common stock warrants issued in connection with our Merger and related private placement offering (see Note 3, The Merger, Offering and Other Related Transactions) in accordance with the guidance in Accounting Standards Codification (“ASC”) 815-40. Under ASC 815-40, the warrants did not meet the criteria for equity treatment and were recorded as a liability. The warrants initially had an anti-dilution clause that allowed for a decrease in the exercise price of the warrants if the Company issued additional shares of common stock without consideration or for consideration per share less than the exercise price of such warrants. Accordingly, we classified the warrant instruments as liabilities at their fair value at the date of issuance and re-measured the warrants at each balance sheet date. Changes in the fair value were recognized as a gain (loss) on warrant liability in our Condensed Consolidated Statement of Operations. These warrants were amended in November 2014 to remove the price-based anti-dilution provision, among other things. Accordingly, the warrants are no longer recorded as a liability.

 

 8 

  

Ekso Bionics Holdings, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

(in thousands, except share and per share amounts)

(unaudited)

 

Recent Accounting Pronouncements

 

In July 2015, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) 2015-11 Simplifying the Measurement of Inventory. Under ASU 2015-11, inventory is to be measured at the lower of cost and net realizable value (“NRV”). NRV is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.

 

The updated guidance is effective for annual reporting periods beginning on or after December 15, 2016, and interim periods therein. Early adoption is permitted. Management is in the process of assessing the impact of ASU 2015-11 on the Company’s consolidated financial statements.

  

3. The Merger, Offering and Other Related Transactions

 

Holdings was incorporated in the State of Nevada on January 30, 2012, as a distributor of medical supplies and equipment to municipalities, hospitals, pharmacies, care centers, and clinics in Chile. At the time of the Merger, Holdings was a “shell company” as defined in Rule 12b-2 of the Exchange Act. Holdings’ fiscal year end was previously March 31 but was changed to December 31 in connection with the Merger.

 

On January 15, 2014, Holdings and a newly formed wholly-owned subsidiary of Holdings, Ekso Acquisition Corp, (“Acquisition Sub”) entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”) with Ekso Bionics. Under the Merger Agreement, Acquisition Sub merged with and into Ekso Bionics, with Ekso Bionics remaining as the surviving corporation and with the stockholders of Ekso Bionics exchanging all of their common stock, convertible preferred stock (“preferred stock”) and warrants to purchase preferred stock issued and outstanding immediately prior to the closing of the Merger into an aggregate of 42,615,556 shares of Holdings’ common stock and warrants to purchase 621,361 shares of common stock. In addition, options to purchase 4,989,111 shares of common stock of Ekso Bionics were converted into options to purchase 7,602,408 shares of common stock of Holdings. These shares are in addition to 5,280,368 outstanding shares of Holdings common stock held by certain pre-Merger stockholders of Holdings, consisting of 4,500,600 shares held by such stockholders prior to the Merger and an additional 779,768 shares issued to such stockholders pursuant to a provision in the Merger Agreement requiring us to issue a number of shares of common stock such that the aggregate ownership of the pre-Merger stockholders (not including any shares of common stock purchased by them in the private placement offering described below) was approximately 6.8% of the outstanding common stock of the Company following the Merger and private placement offering.

 

Upon the closing of the Merger, under the terms of a split-off agreement and a general release agreement, Holdings transferred all of its pre-Merger operating assets and liabilities to a newly formed wholly-owned special-purpose subsidiary (“Split-Off Subsidiary”), and transferred all of the outstanding shares of capital stock of Split-Off Subsidiary to two individuals who were the pre-Merger majority stockholders of Holdings and Holdings’ former officers and sole director (the “Split-Off”), in consideration of and in exchange for (a) the surrender and cancellation of all shares of Holdings’ common stock held by such individuals (which were cancelled and resumed the status of authorized but unissued shares of our common stock) and (b) certain representations, covenants and indemnities.

 

Accounting for Reverse Merger

 

Ekso Bionics, as the accounting acquirer, recorded the Merger as the issuance of stock for the net monetary assets of Holdings accompanied by a recapitalization. This accounting was identical to that resulting from a reverse merger, except that no goodwill or intangible assets were recorded. In filings with the SEC subsequent to the Merger, including this filing, the historical financial statements of Holdings before the Merger have been replaced with the historical financial statements of Ekso Bionics before the Merger. The Merger is intended to be treated as a tax-free exchange under Section 368(a) of the Internal Revenue Code of 1986, as amended.

 

 9 

  

Ekso Bionics Holdings, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

(in thousands, except share and per share amounts)

(unaudited)

 

Retroactive Conversion of all Share and Per Share Amounts

 

In accordance with reverse merger accounting guidance, amounts for Ekso Bionics’ historical (pre-merger) common stock, preferred stock and warrants and options to purchase common stock, including share and per share amounts, have been retroactively adjusted using their respective exchange ratios in these financial statements unless otherwise disclosed. The conversion ratios were 1.5238, 1.6290, 1.9548 and 1.9548 for one with respect to shares of Ekso Bionic’s common stock, Series A preferred stock, Series A-2 preferred stock and Series B preferred stock, respectively.

 

Repayment of 2013 Bridge Note

 

In November 2013, in anticipation of the Merger and related private placement offering, Ekso Bionics completed a private placement to accredited investors of $5,000 of its senior subordinated secured convertible notes (“2013 Bridge Notes”). Upon the closing of the Merger and the private placement offering described below, the $5,000 in outstanding principal and $83 of accrued interest of the 2013 Bridge Notes automatically converted into 5,000,000 Units (as defined below), and investors in the 2013 Bridge Notes received warrants to purchase 2,500,000 shares of common stock at an exercise price of $1.00 per share for a term of three years (“Bridge Warrants”). The Bridge Warrants had weighted average anti-dilution protection, subject to customary exceptions.

 

Private Placement Offering

 

Concurrently with the closing of the Merger and in contemplation of the Merger, the Company held a closing of a private placement offering (“PPO”) in which it sold 20,580,000 units (“Units”) at a purchase price of $1.00 per Unit, with each Unit consisting of one share of common stock plus a warrant to purchase an additional share of common stock of the Company at $2.00 per share with a five year term (“PPO Warrants”). Included in the initial Unit sales were 5,000,000 Units that were issued upon conversion of the 2013 Bridge Notes mentioned above. Between January 29, 2014 and February 6, 2014, the Company issued an additional 9,720,000 Units in subsequent closings of the PPO. As a result of issuing a total of 30,300,000 Units, (a) the Company received gross proceeds of $25,300, (b) $5,083 of debt and accrued interest attributable to the 2013 Bridge Notes was settled with the issuance of 5,000,000 Units, (c) $2,553 of our Senior Note Payable (as defined below) was paid in full, and (d) we incurred offering costs of $3,338.

 

Investors in the Units have weighted average anti-dilution protection with respect to the shares of common stock included in the Units if within 24 months after the final closing of the PPO the Company issues additional shares of common stock or common stock equivalents (subject to customary exceptions, including but not limited to issuances of awards under the Company’s 2014 Equity Incentive Plan) for consideration per share less than $1.00. The PPO warrants also had weighted average anti-dilution protection, subject to customary exceptions.

 

In connection with the conversion of the 2013 Bridge Notes and the PPO, the placement agent for the PPO and its sub-agents were paid an aggregate commission of $3,030 and were issued warrants to purchase an aggregate of 3,030,000 shares of common stock with a term of five years and an exercise price of $1.00 per share (“Agent Warrants”). The Agent Warrants had weighted average anti-dilution protection, subject to customary exceptions.

 

Offer to Amend and Exercise

 

In November 2014, the Company consummated an offer to amend and exercise its PPO Warrants at a temporarily reduced exercise price (“Offer to Amend and Exercise”). Pursuant to the Offer to Amend and Exercise, an aggregate of 22,755,500 PPO Warrants were exercised by their holders and were also amended to reduce the exercise price from $2.00 to $1.00 per share of common stock, and to restrict the ability of the holder of shares issuable upon exercise of the amended warrants to sell, make any short sale of, loan, grant any option for the purchase of, or otherwise dispose of any of such shares without the prior written consent of the Company for a period of 50 days after the expiration date of the Offer to Amend and Exercise.

 

 10 

  

Ekso Bionics Holdings, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

(in thousands, except share and per share amounts)

(unaudited)

 

In connection with the Offer to Amend and Exercise, the holders of a majority of the then outstanding PPO Warrants, Bridge Warrants, and Agent Warrants approved an amendment to remove the price-based anti-dilution provisions in those warrants (see Note 9, Warrants).

 

2014 Equity Incentive Plan

 

Before the Merger, the Board of Directors adopted, and the stockholders approved, the 2014 Equity Incentive Plan (“2014 Plan”), which provides for the issuance of incentive awards constituting up to 14,410,000 shares of common stock to officers, key employees, consultants and directors. In connection with the Merger, options to purchase Ekso Bionics common stock outstanding immediately prior to the Merger were converted into options to purchase an aggregate of 7,602,408 shares of Holdings issued under the 2014 Plan.

 

On the closing of the Merger, the Board granted to officers and directors options to purchase an aggregate of 2,300,000 shares of common stock under the 2014 Plan.

 

Subsequent to the Merger, on June 10, 2015, the Board submitted to the stockholders and the stockholders approved and ratified an amendment of the 2014 Plan to increase the maximum number of shares of common stock that may be issued under the 2014 Plan by 11,590,000 shares to 26,000,000 shares. As of June 30, 2015, there were 11,767,633 shares available for future awards.

 

4. Deferred Revenues

 

In connection with our medical device sales and research services, we often receive cash payments before our earnings process is complete. In these instances, we record the payments as customer deposits until a device is shipped to the customer, or as customer advances in the case of research services until the earnings process is achieved.

 

Revenue from our Ekso medical device sales is deferred and recognized over the maintenance period. Accordingly, at the time of shipment to the customer the amount billed is recorded as deferred revenue. Also, at the time of shipment, the related inventory is reclassified to deferred cost of revenue where it is amortized to cost of revenue over the same period as the related revenue.

 

Deferred revenues and deferred cost of revenues consist of the following:

 

   June 30,   December 31, 
   2015   2014 
Customer deposits and advances  $353   $105 
Deferred Ekso medical device revenues   6,048    5,327 
Deferred service and leasing revenues   2,123    1,875 
Customer advances and deferred revenues   8,524    7,307 
Less current portion   (4,032)   (3,412)
Customer advances and deferred revenues, non-current  $4,492   $3,895 
Deferred Ekso medical device costs  $4,391   $3,568 
Less current portion   (1,876)   (1,551)
Deferred cost of revenue, non-current  $2,515   $2,017 

  

 11 

  

Ekso Bionics Holdings, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

(in thousands, except share and per share amounts)

(unaudited)

 

5. Accrued Liabilities

 

Accrued liabilities consist of the following:

 

   June 30,   December 31, 
   2015   2014 
Salaries, benefits and related expenses  $1,516   $1,847 
Professional fees   273    184 
Warranty expense   91    126 
Taxes   42    46 
Royalties   -    50 
Travel   48    76 
All other   6    49 
Total  $1,976   $2,378 

  

6. Notes Payable

 

In 2012, the Company entered into a note agreement in connection with its lease agreement for our Richmond, California facility. The note, for an aggregate principal of $200, with an interest rate of 7%, minimum monthly payments of $4, and a May 31, 2017, maturity, was used to fund leasehold improvements. In addition, the Company has a long-term capital lease obligation of $11 (see Note 7, Operating and Capital Leases).

 

Future obligations under these debt instruments as of June 30, 2015 are as follows:

 

   Leasehold         
   Improvement   Capital     
   Note   Lease   Total 
2015 (remainder)  $24   $3   $27 
2016   48    5    53 
2017   19    4    23 
Total minimum payments   91    12    103 
Less: interest   (6)   (1)   (7)
Present value minimum payments   85    11    96 
Less: current portion   (43)   -    (43)
Long-term portion of notes payable  $42   $11   $53 

 

 12 

  

Ekso Bionics Holdings, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

(in thousands, except share and per share amounts)

(unaudited)

  

7. Operating and Capital Leases

 

On November 29, 2011, the Company entered into an operating lease agreement for its headquarters and manufacturing facility in Richmond, California. The lease term commenced in March 2012 and expires in May 2017. The lease provides the Company with one option to renew for five additional years. The Company also leases nominal office equipment.

 

Future minimum operating lease payments are as follows as of June 30, 2015:

 

2015 (remainder of year)  $188 
2016   375 
2017   157 
Total  $720 

  

The Company also has a capital lease for the purchase of machinery and equipment with a balance of $11 and $13 as of June 30, 2015, and December 31, 2014, respectively, which is classified as a component of Notes payable, non-current (see Note 6, Notes Payable).

 

Rent expense under the Company’s operating leases was $86 and $86 for the three month periods ended June 30, 2015, and 2014, respectively and was $172 and $171 for the six month period ended June 30, 2015, and 2014, respectively.

 

8. Capitalization and Equity Structure

 

The Company’s authorized capital stock at June 30, 2015, consisted of 500,000,000 shares of common stock and 10,000,000 shares of preferred stock. At June 30, 2015, 102,123,767 shares of common stock were issued and outstanding, and no shares of preferred stock were issued and outstanding.

 

9. Warrants

 

As discussed in Note 3, The Merger, Offering and Other Related Transactions, the Company issued during the Merger and PPO, warrants to purchase a total of 36,055,000 shares of common stock of which 30,300,000 were at an exercise price of $2.00 per share, and the balance at $1.00 per share. These warrants contained “weighted average” anti-dilution protection in the event that we issued common stock or securities convertible into or exercisable for shares of common stock at a price lower than the subject warrant’s exercise price, subject to certain customary exceptions, as well as customary provisions for adjustment in the event of stock splits, subdivision or combination, mergers, etc.

 

Due to the market price of the Company’s common stock price exceeding the exercise price of the then outstanding warrants, the Company recorded a non-cash charge of $77,437 during the period ended March 31, 2014. As the market price of our common stock declined during the three months ended June 30, 2014, but still exceeded the exercise price of outstanding warrants, the Company recorded a non-cash benefit of $60,458 for the period.

 

 13 

  

Ekso Bionics Holdings, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

(in thousands, except share and per share amounts)

(unaudited)

   

The factors utilized in re-valuing the warrants were as follows as of June 30, 2014:

 

Dividend yield –
Risk-free interest rate 0.69% - 1.45%
Share price at final valuation 1.47
Expected term (in years) 2.55- 4.55
Volatility 70-75%
Periodic rate 0.18% - 0.66%
Periods in the model 10

  

These warrants were amended in November 2014 to remove the price-based anti-dilution provision, among other things. Accordingly, the warrants are no longer recorded as a liability.

 

Warrant activity for the six month period ended June 30, 2015 is as follows:

 

   Balance   Exercise   Term      Balance 
Name  December 31, 2014   Price   (Years)  Exercised   June 30, 2015 
Placement agent warrants   3,030,000   $1.00   5   (48,700)   2,981,300 
Bridge warrants   2,600,000   $1.00   3        2,600,000 
PPO warrants   7,544,500   $2.00   5        7,544,500 
Pre-Merger/PPO warrants   621,361   $1.38   various        621,361 
Total   13,795,861            (48,700)   13,747,161 

 

10. Stock-based Compensation Plans and Awards

 

In January 2014, and prior to the Merger, the Board of Directors and a majority of the stockholders adopted the 2014 Plan that allowed for the issuance of 14,410,000 shares of common stock. Options previously issued under the Ekso Bionics 2007 Equity Incentive Plan were converted into options to purchase an aggregate of 7,602,408 shares of the Company’s common stock under the 2014 Plan. On June 10, 2015, the 2014 Plan was amended and restated by the stockholders to increase the maximum number of shares by 11,590,000 shares to an aggregate of 26,00,000 shares of common stock available for issuance under the 2014 Plan. As of June 30, 2015, there were 11,767,633 shares available for future awards.

 

Under the terms of the 2014 Plan, the Board of Directors may award stock, options, or similar rights having either a fixed or variable price related to the fair market value of the shares and with an exercise or conversion privilege related to the passage of time, the occurrence of one or more events, or the satisfaction of performance criteria or other conditions, or any other security with the value derived from the value of the shares. Such awards include stock options, restricted stock, restricted stock units, stock appreciation rights and dividend equivalent rights.

 

 14 

  

Ekso Bionics Holdings, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

(in thousands, except share and per share amounts)

(unaudited)

 

The Board of Directors may grant stock options under the 2014 Plan at a price of not less than 100% of the fair market value of our common stock on the date the option is granted. Incentive stock options granted to employees who, on the date of grant, own stock representing more than 10% of the voting power of all of our classes of stock, are granted at an exercise price of not less than 110% of the fair market value of our common stock. The maximum term of incentive stock options granted to employees who, on the date of grant, own stock possessing more than 10% of the voting power of all our classes of stock, may not exceed five years. The maximum term of an incentive stock option granted to any other participant may not exceed ten years. Subject to the limitations discussed above, the Board of Directors determines the term and exercise or purchase price of other awards granted under the 2014 Plan. The Board of Directors also determines the terms and conditions of awards, including the vesting schedule and any forfeiture provisions. Options granted under the 2014 Plan may vest upon the passage of time, generally four years, or upon the attainment of certain performance criteria established by the Board of Directors. We may from time to time grant options to purchase common stock to non-employees for advisory and consulting services. Pursuant to ASC 505-50, Equity-Based Payments to Non-Employees, we periodically re-measure the fair value of these stock options using the Black-Scholes option pricing model and recognize expense ratably over the vesting period of each stock option award. Upon exercise of an option, it is the Company’s policy to issue new shares of common stock.

 

The following table summarizes information about the Company’s stock options outstanding at June 30, 2015, and activity during the six-month period then ended:

 

           Weighted-     
           Average     
       Weighted-   Remaining   Aggregate 
   Stock   Average   Contractual   Intrinsic 
   Awards   Exercise Price   Life (Years)   Value 
Balance as of December 31, 2014   10,791,081   $0.79           
Options granted   3,184,000   $1.40           
Options exercised   (697,356)  $0.55           
Options forfeited   (40,507)  $0.57           
Options cancelled   (10,126)  $1.74           
Balance as of June 30, 2015   13,227,092   $0.96    7.86   $4,197 
Vested and expected to vest at June 30, 2015   12,118,042   $0.92    7.71   $4,131 
Exercisable as of  June 30, 2015   5,970,959   $0.60    6.23   $3,451 

 

Of the 697,356 shares exercised, 535,404 were on a cashless basis for which the Company did not receive any proceeds, but instead withheld 243,647 shares from the option holders exercising such award to cover the exercise amount.

 

As of June 30, 2015, total unrecognized compensation cost related to unvested stock options was $5,386. This amount is expected to be recognized as stock-based compensation expense in the Company’s Condensed Consolidated Statements of Operations over the remaining weighted average vesting period of 3.09 years.

 

 15 

  

Ekso Bionics Holdings, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

(in thousands, except share and per share amounts)

(unaudited)

 

The per-share fair value of each stock option was determined on the date of grant using the Black-Scholes option pricing model using the following assumptions:

 

  Three months ended June 30,   Six months ended June 30,
  2015   2014   2015   2014
               
Dividend yield —   —   —   —
Risk-free interest rate 1.44% - 2.34%   1.90% - 2.61%   1.41% - 2.34%   1.74% - 2.67%
Expected term (in years) 6-10   6-8   6-10   6-10
Volatility 73% - 74%   66%   73% - 74%   66%

 

Total stock-based compensation expense related to options granted to employees and non-employees was included in the Condensed Consolidated Statements of Operations as follows:

 

   Three months ended June 30,   Six months ended June 30, 
   2015   2014   2015   2014 
Sales and marketing  $161   $150   $292   $251 
Research and development   108    21    162    90 
General and administrative   174    155    337    352 
   $443   $326   $791   $693 

 

11. Income Taxes

 

There were no material changes to the unrecognized tax benefits in the three months ended June 30, 2015, and the Company does not expect significant changes to unrecognized tax benefits through the end of the fiscal year. Because of the Company’s history of tax losses, all years remain open to tax audit.

 

12. Commitments and Contingencies

 

Contingencies

 

In the normal course of business, the Company is subject to various legal matters. In the opinion of management, the resolution of such matters will not have a material adverse effect on the Company’s condensed consolidated financial statements.

 

Material Contracts

 

The Company enters into various license, research collaboration and development agreements which provide for payments to the Company for government grants, fees, cost reimbursements typically with a markup, technology transfer and license fees, and royalty payments on sales.

 

The Company has two license agreements to maintain exclusive rights to patents. The Company is also required to pay 1% of net sales of products sold to entities other than the U.S. government. In the event of a sublicense, the Company will owe 21% of license fees and must pass through 1% of the sub-licensee’s net sales of products sold to entities other than the U.S. government. The license agreements also stipulate minimum annual royalties, starting in 2015 and for future years, of $50 per year.

 

 16 

  

Ekso Bionics Holdings, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

(in thousands, except share and per share amounts)

(unaudited)

 

U.S. Food and Drug Administration Clearance

 

The Company’s Ekso GT robotic exoskeleton has been marketed in the United States as a Class I 510(k) exempt Powered Exercise Equipment device since February 2012. On June 26, 2014, the U.S. Food and Drug Administration (“FDA”) announced the creation of a new product classification for Powered Exoskeleton devices. On October 21, 2014, the FDA published the summary for the reclassified Powered Exoskeleton and informed us in writing of the agency’s belief that this new product classification applied to the Ekso GT device. This new product classification was designated as being Class II, which requires the clearance of a 510(k) notice. Consequently, the FDA requested that we file a 510(k) notice to obtain this clearance. Per the FDA’s request, we filed our 510(k) notice on December 24, 2014, and this submission is currently under review by the FDA. The Company intends to continue marketing the Ekso robotic exoskeleton under its current Class I registration and listing with its current indications for use until 510(k) clearance is either granted or denied by the FDA or the Company is otherwise notified by the FDA to cease such activities. The Company believes that in situations where the class of a product has been elevated by the FDA, manufacturers are normally granted enforcement discretion by the FDA and given ample time to seek clearance at the new class level. Nonetheless, the FDA may not agree with our decision to continue marketing the device until a 510(k) notice is cleared. From the time of our submission to the date of this report, the FDA has not indicated or notified the Company that it disagrees with this decision. If the FDA disagrees with our decision, we may be required to cease marketing or to recall the products until we obtain clearance or approval, and we may be subject to regulatory fines or penalties.

 

13. Net Income (Loss) Per Share

 

The following table sets forth the computation of basic and diluted net income (loss) per share:

 

   Three months ended June 30,   Six months ended June 30, 
   2015   2014   2015   2014 
Numerator:               
Net income (loss)                    
Basic  $(5,645)  $56,128   $(9,760)  $(25,638)
Adjustment for change in fair value of warrant liability   -    (60,458)   -    - 
Diluted  $(5,645)  $(4,330)  $(9,760)  $(25,638)
                     
Denominator:                    
Weighted-average common shares outstanding used in computing basic and diluted net income (loss) per share                    
Basic   102,094,158    78,497,558    101,944,359    72,688,073 
Dilutive effect of warrants   -    9,593,643    -    - 
Dilutive effect of stock options   -    6,681,210    -    - 
Diluted   102,094,158    94,772,411    101,944,359    72,688,073 
Net income (loss) per share, basic   (0.06)  $0.72    (0.10)   (0.35)
Net loss per share, diluted   (0.06)  $(0.05)   (0.10)   (0.35)

 

The following table sets forth potential shares of common stock that are not included in the calculation of diluted net loss per share because to do so would be anti-dilutive as of the end of each period presented:

 

   Three months ended June 30,   Six months ended June 30, 
   2015   2014   2015   2014 
Options to purchase common stock   13,227,092    -    13,227,092    7,073,652 
Warrants to purchase common stock   13,747,161    -    13,747,161    14,546,085 
Total common stock equivalents   26,974,253    -    26,974,253    21,619,737 

  

 17 

  

Ekso Bionics Holdings, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

(in thousands, except share and per share amounts)

(unaudited)

 

14. Segment Disclosures

 

The Company has two reportable segments, Engineering Services and Medical. Engineering Services generates revenue principally from collaborative research and development service arrangements, technology license agreements, and government grants where the Company uses its robotics domain knowledge in bionic exoskeletons

to bid on and procure contracts and grants from entities such as such as the National Science Foundation and the Defense Advanced Research Projects Agency. The Medical segment designs, engineers, and manufactures exoskeletons for applications in the medical and military markets.

 

The Company evaluates performance and allocates resources based on segment gross profit margin. The reportable segments are each managed separately because they serve distinct markets, and one segment provides a service and the other manufactures and distributes a unique product. The Company does not consider net assets as a segment measure and, accordingly, assets are not allocated.

 

Segment reporting information is as follows:

 

   Engineering   Medical     
   Services   Devices   Total 
Three months ended June 30, 2015               
Revenue  $1,066   $1,048   $2,114 
Cost of revenue   642    970    1,612 
Gross profit  $424   $78   $502 
                
Three months ended June 30, 2014               
Revenue  $507   $690   $1,197 
Cost of revenue   650    502    1,152 
Gross profit (loss)  $(143)  $188   $45 
                
Six months ended June 30, 2015               
Revenue  $1,770   $2,033   $3,803 
Cost of revenue   1,130    1,768    2,898 
Gross profit  $640   $265   $905 
                
Six months ended June 30, 2014               
Revenue  $1,042   $1,217   $2,259 
Cost of revenue   902    832    1,734 
Gross profit  $140   $385   $525 

 

Geographic information for revenue based on location of customer is as follows:

 

   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2015   2014   2015   2014 
                 
North America  $1,622   $941   $2,894   $1,831 
Europe, Middle East, Asia   492    256    909    428 
   $2,114   $1,197   $3,803   $2,259 

 

 18 

 

  

Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

You should read the following discussion of our financial condition and results of operation in conjunction with the condensed consolidated financial statements and the notes thereto included elsewhere in this Quarterly Report on Form 10-Q and on our Annual Report on Form 10-K for the year ended December 31, 2014.

 

This Quarterly Report on Form 10-Q contains forward-looking statements, such as statements of our plans, objectives, expectations and intentions. Any statements that are not statements of historical fact are forward-looking statements. Terms such as “may,” “might,” “would,” “should,” “could,” “project,” “estimate,” “pro-forma,” “predict,” “potential,” “strategy,” “anticipate,” “attempt,” “develop,” “plan,” “help,” “believe,” “continue,” “intend,” “expect,” “future,” and terms of similar import (including the negative of any of the foregoing) may be intended to identify forward-looking statements.

 

The following factors, among others, including those described in the section titled “Risk Factors” included in our Annual Report on Form 10-K for the year ended December 31, 2014, could cause our future results to differ materially from those expressed in the forward-looking information:

 

·the anticipated timing, cost and progress of the development and commercialization of new products or services, and improvements to our existing products, and related impacts on our profitability and cash position;
·our ability to effectively market and sell our products and expand our business, both in unit sales and product diversification;
·our ability to obtain or maintain regulatory approval to market the Company’s medical devices;
·our ability to achieve broad customer adoption of our products and services;
·existing or increased competition;
·rapid changes in technological solutions available to our markets;
·volatility with our business, including long and variable sales cycles, which could have a negative impact on our results of operations for any given quarter;
·our ability to obtain or maintain patent protection for the Company’s intellectual property;
·the scope, validity and enforceability of our and third party intellectual property rights;
·significant government regulation of medical devices and the healthcare industry;
·our customers’ ability to get third party reimbursement for our products and services associated with them;
·our failure to implement our business plan or strategies;
·our ability to retain or attract key employees;
·our ability to obtain adequate financing to fund operations and to develop or enhance our technology;
·stock volatility or illiquidity;
·our ability to maintain adequate internal controls over financial reporting; and
·overall economic and market conditions.

 

Although we believe that the assumptions underlying the forward-looking statements and forward-looking information contained herein are reasonable, any of the assumptions could be inaccurate, and therefore such statements and information included in this Quarterly Report on Form 10-Q may not prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements and forward-looking information included herein, the inclusion of such statements and information should not be regarded as a representation by us or any other person that the results or conditions described in such statements and information or that our objectives and plans will be achieved. Such forward-looking statements speak only as of the date of this report. Except as required by law, we undertake no obligation to update any forward-looking statements to reflect events or circumstances after the date of such statements.

 

 19 

 

 

Overview

 

The Company designs, develops and sells wearable bionic devices or “human exoskeletons” that have applications in healthcare, industrial, military, and consumer markets. Our exoskeletons systems are strapped over the user’s clothing and augment human strength, endurance and mobility. These robotic or mechanical systems serve multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. We or our partners have sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (e.g., stroke or spinal cord injury) to rehabilitate and to walk again; (b) allow industrial workers to perform heavy duty work for extended periods; and (c) permit soldiers to carry heavy loads for long distances while mitigating lower back, knee, and ankle injuries. To-date, we have shipped approximately 145 of our devices to over 100 rehabilitation centers, distributors, and individual users for rehabilitation.

 

In our efforts to develop exoskeleton technology, we have established an extensive intellectual property portfolio that includes, in the United States alone and as of July 1, 2015, 12 patents that have been granted, 21 patent applications that are currently pending (meaning a complete patent application has been filed with the applicable patent authority and additional action is pending), and nine provisional patent applications that have been filed (meaning we have filed a short form application to establish an early filing date in anticipation of completion and submission of a complete application). All but three of the patents and pending patent applications are either solely owned by us or exclusively licensed to us. Many of these patents have also been filed internationally as appropriate for their respective subject matter. Our patent portfolio includes product and method type claims, since the devices that we produce and the processes performed by those devices are patentable. Our patents encompass technologies relevant to our devices, including medical exoskeletons, commercial exoskeletons, actuators, and strength-enhancing exoskeletons. The earliest priority date reaches back to 2003, and new applications continue to be filed.

 

Our long-term goal is to have one million people stand and walk in an Ekso exoskeleton by February 2022. Our first step to achieving that goal was for us to focus on selling our medical exoskeletons to rehabilitation centers and hospitals in the United States and Europe. We began that journey with the February 2012 sale of the Ekso, an exoskeleton for complete spinal cord injuries (“SCI”). We have since expanded that effort with the July 2013 launch of our Variable Assist software and the December 2013 release of our next generation Ekso hardware platform, Ekso GT. The Variable Assist software enables users with any amount of lower extremity strength to contribute their own power for either leg to achieve self-initiated walking. The Ekso GT builds on the experience of the Ekso and incorporates the Variable Assist, allowing us to expand our sales and marketing efforts beyond SCI-focused centers to centers supporting stroke and related neurological patients.

The Ekso GT is a wearable bionic suit that provides individuals with stroke, spinal cord injuries and other lower-extremity paralysis or weakness the ability to stand and walk over ground with a full weight-bearing, reciprocal gait using a cane, crutches or a walker under the supervision of a physical therapist. Walking is achieved by the shifting of the user’s body to activate sensors in the device that initiate steps. Battery-powered motors drive the legs, replacing deficient neuromuscular function. First-time users can expect to walk with aid from the device the first time they put on the Ekso exoskeleton (after passing an assessment), while an experienced user can transfer to or from their wheelchair and don or remove the Ekso in less than five minutes.

 

Most recently, we further upgraded our technology with the announcement in June 2015 of SmartAssist and the ability of the Ekso GT to integrate functional electrical stimulation (“FES”).  Our SmartAssist software is the next generation software after Variable Assist, both improving on its core functionality and adding new features. The SmartAssist software allows therapists to utilize Ekso GT across a broader continuum of care so that patients can use the device earlier for the pre ambulatory exercises and later during therapy to assist only as needed for each leg. The addition to the Ekso GT of FES integration offers the potential to combine the benefits of these two leading technologies into a single product offering.

 

 20 

 

 

Ekso Labs, our engineering services division, is focused on technology development and future applications. It is an exoskeleton laboratory that integrates emerging technologies into new product applications and expands on it for our partners. To date, the majority of our Ekso Labs revenue has been in the form of research grants from government organizations including United States Special Operations Command, the Defense Advanced Research Projects Agency, the National Institute of Health and the National Science Foundation. These projects fund research and development on new exoskeleton systems, providing the Company with new intellectual property and exoskeleton designs that have the potential for commercialization.

 

In addition to furthering exoskeleton technology for our current medical applications, Ekso Labs’ research and development work may have potential use in future, able-bodied models of the Ekso human exoskeleton. Many of the research projects funded by grants are focused on researching future medical applications and capabilities not yet ready for commercial development. Other projects, often funded by commercial partners or the U.S. military, focus on able-bodied human exoskeleton applications. One such development project was the Human Universal Load Carrier (“HULC”), a robotic exoskeleton designed for Lockheed Martin Corporation, with potential military applications to augment strength and endurance, allowing users to carry up to 200 pounds over long distances and rough terrain.

 

Most recently, industrial models that we are developing are intended to increase an individual’s workload, endurance and productivity. Specifically, we recently announced one initiative in this area with our intention to commercialize a passive, unpowered exoskeleton that allows industrial workers to increase productivity and quality of work and potentially helps industrial employers to reduce workmen’s compensation issues and lower their insurance costs.  We are currently assessing interest of potential customers, including major North American and European construction companies, major tool manufacturers, and have prototypes being tested in the field. 

 

As we continue to develop, commercialize and market our various exoskeleton technologies, we may seek to establish new strategic relationships with third parties.  Potential relationships may be in the form of technology or product development agreements, sales or distribution agreements, or license agreements.

 

Regulatory Plans

 

The U.S. government regulates the medical device industry through various agencies, including but not limited to, the U.S. Food and Drug Administration (“FDA”), which administers the federal Food, Drug and Cosmetic Act.

 

The FDA classifies medical devices into one of three classes (Class I, II or III) based on the degree of risk the FDA determines to be associated with a device and the extent of control deemed necessary to ensure the device’s safety and effectiveness. Devices requiring fewer controls because they are deemed to pose lower risk are placed in Class I or II. Class I devices are deemed to pose the least risk and are subject only to general controls applicable to all devices, such as requirements for device labeling, premarket notification, and adherence to the FDA’s current good manufacturing practice requirements, as reflected in its Quality System Regulation (“QSR”). Class II devices are intermediate risk devices that are subject to general controls and may also be subject to special controls such as performance standards, product-specific guidance documents, special labeling requirements, patient registries or post-market surveillance. Class III devices are those for which insufficient information exists to assure safety and effectiveness solely through general or special controls, and include life-sustaining, life-supporting, or implantable devices, and devices not “substantially equivalent” to a device that is already legally marketed. Most Class I devices, and some Class II devices are exempted by regulation from the 510(k) clearance requirement and can be marketed without prior authorization from FDA. Class I and Class II devices that have not been so exempted are eligible for marketing through the 510(k) clearance pathway. By contrast, devices placed in Class III generally require premarket approval, or PMA, prior to commercial marketing.

 

To obtain 510(k) clearance for a medical device, an applicant must submit a premarket notification to the FDA demonstrating that the device is “substantially equivalent” to a predicate device legally marketed in the United States. A device is substantially equivalent if, with respect to the predicate device, it has the same intended use and (i) the same technological characteristics, or (ii) has different technological characteristics and the information submitted demonstrates that the device is as safe and effective as a legally marketed device and does not raise different questions of safety or effectiveness.

 

 21 

 

 

While we believe that the Company’s Ekso GT robotic exoskeleton has been appropriately marketed as a Class I 510(k) exempt Powered Exercise Equipment device since February 2012, on June 26, 2014, the FDA announced the creation of a new product classification for Powered Exoskeleton devices. On October 21, 2014, the FDA published the summary for the reclassified Powered Exoskeleton. This new product classification was designated as being Class II, which requires the clearance of a 510(k) notice.

 

On October 21, 2014, concurrent with the FDA’s publication of the reclassification of Powered Exoskeleton devices, the FDA issued us an Untitled Letter which informed us in writing of the agency’s belief that this new product classification applied to our Ekso GT device. We filed a 510(k) notice for the Ekso robotic exoskeleton on December 24, 2014, and this submission is currently under review by the FDA. The Company intends to continue marketing the Ekso robotic exoskeleton under its current Class I registration and listing with its current indications for use until 510(k) clearance is either granted or denied by the FDA or the Company is otherwise notified by the FDA to cease from such activities. The Company believes that in situations where the class of a product has been elevated by the FDA, manufacturers are normally granted enforcement discretion by the FDA and given ample time to seek clearance at the new class level. Nonetheless, the FDA may not agree with our decision to continue marketing the device until a 510(k) notice is cleared. If the FDA disagrees with our decision, we may be required to cease marketing or to recall our products until we obtain clearance or approval, and we may be subject to regulatory fines or penalties.

 

Critical Accounting Policies and Estimates

 

Our discussion and analysis of our financial condition and results of operations is based upon our condensed consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these condensed consolidated financial statements requires us to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, and the related disclosure of contingent assets and liabilities. We base our estimates on historical experience and on various other assumptions that we believe are reasonable under the circumstances. Our estimates form the basis for our judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates.

 

An accounting policy is considered to be critical if it requires an accounting estimate to be made based on assumptions about matters that are highly uncertain at the time the estimate is made, and if different estimates that reasonably could have been used, or changes in the accounting estimate that are reasonably likely to occur, could materially impact the condensed consolidated financial statements. We believe that our critical accounting policies reflect the more significant estimates and assumptions used in the preparation of the condensed consolidated financial statements.

 

For the six month period ended June 30, 2015, there have been no material changes to our critical accounting policies and estimates as compared to those described in our Annual Report on Form 10-K for the year ended December 31, 2014, under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Critical Accounting Policies, Estimates and Judgments.”

  

 22 

 

 

Results of Operations

 

The following table present our results of operations for the periods indicated (in thousands):

 

   Three months ended June 30,
   2015   2014   Change   % Change
Revenue:                  
Medical devices  $1,048   $690    358   52%
Engineering services   1,066    507    559   110%
Total revenue   2,114    1,197    917   77%
                   
Cost of revenue:                  
Cost of medical devices   970    502    468   93%
Cost of engineering services   642    650    (8)  (1%)
Total cost of revenue   1,612    1,152    460   40%
                   
Gross profit   502    45    457   1016%
                   
Operating expenses:                  
Sales and marketing   2,523    1,849    674   36%
Research and development   1,742    699    1,043   149%
General and administrative   1,872    1,809    63   3%
Total operating expenses   6,137    4,357    1,780   41%
                   
Loss from operations   (5,635)   (4,312)   (1,323)  (31%)
                   
Other income (expense):                  
Interest expense   (3)   (3)   -   0%
Gain (loss) on warrant liability   -    60,458    (60,458)  (100%)
Interest income   3    2    1   50%
Other expense, net   (10)   (17)   7   (41%)
Total other income (expense), net   (10)   60,440    (60,450)  (100%)
                   
Net income ( loss)  $(5,645)  $56,128    (61,773)  (110%)

  

 23 

 

  

The following table present our results of operations for the periods indicated (in thousands):

 

   Six months ended June 30,
   2015   2014   Change   % Change
Revenue:                  
Medical devices  $2,033   $1,217    816   67%
Engineering services   1,770    1,042    728   70%
Total revenue   3,803    2,259    1,544   68%
                   
Cost of revenue:                  
Cost of medical devices   1,768    832    936   113%
Cost of engineering services   1,130    902    228   25%
Total cost of revenue   2,898    1,734    1,164   67%
                   
Gross profit   905    525    380   72%
                   
Operating expenses:                  
Sales and marketing   4,374    3,380    994   29%
Research and development   2,725    1,468    1,257   86%
General and administrative   3,534    3,880    (346)  (9%)
Total operating expenses   10,633    8,728    1,905   22%
                   
Loss from operations   (9,728)   (8,203)   (1,525)  (19%)
                   
Other income (expense):                  
Interest expense   (6)   (430)   424   99%
Loss on warrant liability   -    (16,979)   16,979   100%
Interest income   7    3    4   133%
Other expense, net   (33)   (29)   (4)  (14%)
Total other expense, net   (32)   (17,435)   17,403   100%
                   
Net loss  $(9,760)  $(25,638)   15,878   62%

  

 24 

 

 

Revenue:

 

For the three months ended June 30, 2015

 

Medical device revenue increased $0.4 million, or 52%, as compared to the three months ended June 30, 2014, primarily due to the near doubling of the number of medical device sales being recognized to revenue during the three months ended June 30, 2015, as compared to the same period in the prior year. Engineering services revenue increased by $0.6 million, or 110%, as compared to the three months ended June 30, 2014, primarily due to an overall increase in Ekso Labs projects period over period.

 

For the six months ended June 30, 2015

 

Medical device revenue increased $0.8 million, or 67%, as compared to the six months ended June 30, 2014, primarily due to the more than doubling of the number of medical device sales being recognized to revenue during the six months ended June 30, 2015, as compared to the same period in the prior year. Engineering services revenue increased by $0.7 million, or 70%, as compared to the six months ended June 30, 2014, primarily due to an overall increase in Ekso Labs projects period over period.

 

Gross Profit:

 

For the three months and six months ended June 30, 2015

 

Our gross profit for the three and six months ended June 30, 2015, increased over the prior year’s period by $457,000 and $380,000, respectively, and overall gross margins increased by 20 percentage points for the three months and were relatively flat for the six months ended June 30, 2015, as compared to the three and six months ended June 30, 2014, respectively.

 

The increase in medical device cost of revenue as compared to the three and six months ended June 30, 2015 exceeded the increase in associated revenue during the same periods, resulting in lower margins on medical devices, primarily due to increased levels of service expenses, which we recognize on an as-incurred basis. This increase in service expenses is a result of enhancements we are making to our fleet in order to implement numerous technological improvements we have developed subsequent to many of our units being placed into service. The Company expects this level of increased cost associated with enhancing our fleet to continue for the next quarter or two.

 

The drop in gross profit and margins for our medical devices was more than offset by improvements in gross profit and margins for our engineering services business during the three and six months ended June 30, 2015. The improvement in this segment was driven primarily by a better balance of higher margin projects compared to the prior year.

 

Operating Expenses:

 

For the three months ended June 30, 2015

 

Sales and marketing expenses increased $0.7 million, or 36%, as compared to the three months ended June 30, 2014, due to an increase in sales and marketing personnel and related resources, the greatest of which is an increase of $0.2 million in compensation related costs.

 

Research and development expenses increased $1.0 million, or 149%, as compared to the three months ended June 30, 2014, primarily due to an increase of $0.4 million in compensation related expenses as a result of increases in headcount and $0.2 million in development of our industrial business.

 

General and administrative expenses increased $0.1 million, or 3%, as compared to the three months ended June 30, 2014. The increase was primarily attributable to an increase in professional services fees primarily related to public company requirements and investor relations expenses.

 

 25 

 

 

For the six months ended June 30, 2015

 

Sales and marketing expenses increased $1.0 million, or 29%, as compared to the six months ended June 30, 2014, due to an increase in sales and marketing personnel and related resources, the greatest of which is an increase of $0.4 million in compensation related costs.

 

Research and development expenses increased $1.3 million, or 86%, as compared to the six months ended June 30, 2014, primarily due to an increase of $0.5 million in compensation related expenses as a result of increases in headcount and $0.3 million in expenses related to the development of our industrial business.

 

General and administrative expenses decreased $0.3 million, or 9%, as compared to the six months ended June 30, 2014. The decrease was primarily attributable to an overall $0.5 million decline in compensation costs. This decrease was offset by a $0.2 million increase in professional services fees primarily related to public company requirements and investor relations expenses.

 

Other Income (Expense), Net:

 

For the three months ended June 30, 2015

Total other income (expenses), net decreased $60.5 million, or 100%, as compared to the three months ended June 30, 2014. The decrease of $60.5 million was primarily attributable to a non-cash benefit in the 2014 period relating to outstanding warrants, with no comparable amount in the 2015 period. The 2014 benefit of $60.5 million was attributable to warrants issued in the private placement offering in first quarter of 2014, the value of which declined from March 31, 2014 to June 30, 2014. Due to the price-based anti-dilution provision in the warrants, the Company was required to classify the warrants as a liability and to adjust their fair value to market at each measurement period. In November 2014, the holders of a majority of the warrants approved an amendment to remove the price-based anti-dilution provisions in the warrants. As a result, the warrants are no longer recorded as a liability effective November 2014 because they met the criteria for equity treatment.

 

For the six months ended June 30, 2015

 

Total other expense, net for the six months ended June 30, 2015, reflected a decrease of $17.4 million as compared to the six months period ended June 30, 2014, primarily due to a $17.0 million non-cash charges in the 2014 period relating to outstanding warrants, with no comparable amount in the 2015 period. The $17.0 million of prior year warrant liability charges was attributable to warrants issued in the private placement offering in the first quarter of 2014. Interest expense decreased by $0.4 million during the six months ended June 30, 2015, as compared to the prior year periods due to the repayment of outstanding debt in January 2014.

  

Financial Condition, Liquidity and Capital Resources

 

Since the Company’s inception, we have devoted substantially all of our efforts toward the development of exoskeletons for the medical, military and industrial markets, toward the commercialization of our medical exoskeletons to rehabilitation centers and toward raising capital. Accordingly, we are considered to be in the early commercialization stage. We have financed our operations primarily through the issuance and sale of equity securities for cash consideration and convertible and promissory notes, as well as from government research grant awards and strategic collaboration payments.

 

Cash and Working Capital

 

Since the Company’s inception, we have incurred recurring net losses and negative cash flows from operations. We incurred net losses of $33.7 million for the year ended December 31, 2014, and $9.8 million for the six months ended June 30, 2015. In addition, our operating activities used $15.0 million for the year ended December 31, 2014, and $8.5 million for the six months ended June 30, 2015.

 

 26 

 

 

Liquidity and Capital Resources

 

Largely as a result of significant research and development activities related to the creation of our advanced technology and commercialization of this technology into our medical device business, we have incurred significant operating losses and negative cash flows from operations since inception. The Company has also recorded significant non-cash losses associated with revaluation of certain securities, which have also contributed significantly to our accumulated deficits. As of June 30, 2015, we had an accumulated deficit of $81.6 million.

 

The Company’s cash as of June 30, 2015, was $16.3 million compared to $25.2 million at December 31, 2014. During the six months ended June 30, 2015, the Company used $8.5 million of cash in operations compared to $8.6 million for the six months ended June 30, 2014.

 

Based upon our current six-month average monthly net use of cash of approximately $1.5 million and assuming increases in current revenue and gross profit, offset by incremental net use of cash for increased sales and marketing and research and development and a potential increase in rental activity for our medical device business, the Company believes it has sufficient resources to meet its financial obligations into the second quarter of 2016.

 

Our actual capital requirements may vary significantly and will depend on many factors. For example, we plan to continue to increase our investments (i) in our clinical, sales and marketing initiatives to accelerate adoption of the Ekso robotic exoskeleton in the rehabilitation market, (ii) in our research, development and commercialization activities with respect to an Ekso robotic exoskeleton for home use, and/or (iii) in the development and commercialization of able-bodied exoskeletons for industrial use. Consequently, the Company will require significant additional financing in the future, which we intend to raise through corporate collaborations, public or private equity offerings, debt financings or warrant solicitations within the next two to four quarters. Sales of additional equity securities by us could result in the dilution of the interests of existing stockholders. When we need additional financing, there can be no assurance that it will be available when required in sufficient amounts, on acceptable terms or at all. In the event that the necessary additional financing is not obtained, we may be required to reduce our discretionary overhead costs substantially, including research and development, general and administrative and sales and marketing expenses or otherwise curtail operations.

 

Cash and Cash Equivalents

 

The following table summarizes the sources and uses of cash for the periods stated (in thousands). The Company held no cash equivalents for any of the periods presented.

 

   Six Months Ended 
   June 30, 
   2015   2014 
         
Cash, beginning of period  $25,190   $805 
Net cash used in operating activities   (8,462)   (8,605)
Net cash used in investing activities   (559)   (675)
Net cash provided by financing activities   82    19,440 
Cash, end of period  $16,251   $10,965 

  

Net Cash Used in Operating Activities

 

Net cash used in operations for the six months ended June 30, 2015, was driven by our $9.8 million operating loss, offset by $1.2 million in non-cash charges related to depreciation and amortization, and stock compensation expense.

 

 27 

 

 

Net cash used in operations for the six months ended June 30, 2014, was driven by our $25.6 million operating loss, offset by $18.2 million in non-cash charges. Non-cash charges included $17.0 million that was attributable to warrants issued in the PPO. Due to an anti-dilution provision in the warrants, the Company was required to classify the warrants as a liability and to adjust their fair value to market at the end of each reporting period.

 

Net Cash Used in Investing Activities

 

Net cash used in investing activities of $0.6 million and $0.7 million for the six months ended June 30, 2015, and 2014, respectively, was primarily to acquire property and equipment, including expansion of our company-owned fleet of Ekso units used for demonstrations, loaners to current customers, and as rental units.

 

Net Cash Provided by Financing Activities

 

The net cash provided by financing activities for the six months ended June 30, 2015, of $0.1 million was primarily from the exercise of common stock warrants and options.

 

The net cash provided by financing activities for the six months ended June 30, 2014, of $19.4 million included a net $22.0 million from the PPO. The proceeds from the PPO were in turn used to retire $2.5 million of outstanding debt.

 

Contractual Obligations and Commitments

 

The following table summarizes our outstanding contractual obligations as of June 30, 2015, and the effect those obligations are expected to have on our liquidity and cash flows in future periods (in thousands):

 

   Payments Due By Period: 
       Less Than           After 
   Total   1 Year   1-3 Years   4-5 Years   5 Years 
Facility Operating  Lease  $720   $188   $532   $-   $- 
Leasehold Improvement Loans   91    24    67    -    - 
Capital lease   12    3    9    -    - 
Total  $823   $215   $608   $-   $- 

 

The table above reflects only payment obligations that are fixed and determinable.

 

 28 

 

 

Item 3. Quantitative and Qualitative Disclosure About Market Risk

 

We are exposed to market risks in the ordinary course of our business, including inflation risks.

 

We do not believe that inflation has had a material effect on our business, financial condition or results of operations. If our costs were to become subject to significant inflationary pressures, we may not be able to fully offset such higher costs through price increases. Our inability or failure to do so could harm our business, financial condition and results of operations.

 

In addition, we conduct business in foreign countries and have a United Kingdom based subsidiary. Accordingly, we are exposed to exchange rate risk. See Item 7A. Quantitative and Qualitative Disclosures About Market Risk in our Annual Report on Form 10-K for the year ended December 31, 2014. 

 

Item 4. Controls and Procedures

 

Disclosure Controls and Procedures.

 

Our management, with the participation of our principal executive officer and principal financial officer, conducted an evaluation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, (“Exchange Act”)) as of June 30, 2015, which are intended to provide reasonable assurance that information required to be disclosed in reports filed by us under the Exchange Act is recorded, processed, summarized and reported within the required time periods and is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

 

We previously reported a material weakness in internal control over financial reporting related to the timing of the implementation of certain policies, processes and procedures that we have put in place since the Merger, which was described in Item 9A of our Annual Report on Form 10-K for the year ended December 31, 2014. As of December 31, 2014, we considered the material weakness that resulted from the previously identified deficiencies in the aggregate to have been remediated. The Company has implemented policies, practices and procedures to remediate the previously identified material weakness and has begun the process of testing the controls it has put in place. However, many of these have not been operational for a sufficient period of time to be properly tested for their effectiveness over time, and therefore the Company cannot determine our controls to be effective in the aggregate. As a result, our management, with the participation of our principal executive officer and principal financial officer, concluded that our disclosure controls and procedures were not effective as of June 30, 2015.

It should be noted that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment and makes assumptions about the likelihood of future events. There can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote.  Management believes that the financial statements included in this Report fairly present in all material respects our financial condition, results of operations and cash flows for the periods presented.

 

Changes in Internal Control Over Financial Reporting

 

Except as noted in the preceding paragraphs, there were no changes in our internal control over financial reporting that occurred during the six months ended June 30, 2015, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

 29 

 

 

PART II. OTHER INFORMATION

 

Item 1.   Legal Proceedings

 

During the six months ended June 30, 2015, we were not a party to legal proceedings that could have a material affect on our consolidated financial position, results of operations or cash flows.

 

Item 1A. Risk Factors

 

An investment in our securities involves a risk of loss. You should carefully consider the information set forth in this Quarterly Report on Form 10-Q and in the section titled “Risk Factors” included in our Annual Report on Form 10-K for the year ended December 31, 2014. There have been no material changes to the Risk Factors described in our 2014 Annual Report on Form 10-K. 

  

 30 

 

 

Item 6. Exhibits

 

Exhibit
Number		   Description
     
31.1*   Certification of Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as amended.
     
31.2*   Certification of Chief Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as amended.
     
32.1*   Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
     
32.2*   Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
     
101*   The following financial statements from the Ekso Bionics Holdings, Inc. Quarterly Report on Form 10Q for the quarter ended June 30, 2015, formatted in Extensible Business Reporting Language (“XBRL”):

 

  · unaudited condensed consolidated balance sheets;
     
  · unaudited condensed consolidated statement of operations;
     
  · unaudited condensed consolidated statement of cash flows;
     
  · notes to unaudited condensed consolidated financial statements;

 

* Filed herewith 

 

 31 

 

  

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, Ekso Bionics Holdings, Inc. has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  EKSO BIONICS HOLDINGS, INC.
   
Date: August 12, 2015 By: /s/ Nathan Harding
    Nathan Harding
    Chief Executive Officer
     
Date: August 12, 2015 By: /s/ Max Scheder-Bieschin
    Max Scheder-Bieschin
    Chief Financial Officer
     
    (Duly Authorized Officer and Principal Financial and Accounting Officer)

 

 32 

 

 

 EX-31.1 2 v417064_ex31-1.htm EXHIBIT 31.1

Exhibit 31.1

 

CERTIFICATION

 

I, Nathan Harding, certify that:

 

(1)I have reviewed this Quarterly Report on Form 10-Q of Ekso Bionics Holdings, Inc.;

 

(2)Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

(3)Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;

 

(4)The company’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company’s internal control over financial reporting; and

 

(5)The company’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company’s auditors and the audit committee of the company’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the company’s internal control over financial reporting.

 

 

Date: August 12, 2015

  /s/ Nathan Harding
  Nathan Harding
  Principal Executive Officer

 

 

 

 EX-31.2 3 v417064_ex31-2.htm EXHIBIT 31.2

Exhibit 31.2

 

CERTIFICATION

 

I, Max Scheder-Bieschin, certify that:

 

(1)I have reviewed this Quarterly Report on Form 10-Q of Ekso Bionics Holdings, Inc.;

 

(2)Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

(3)Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;

 

(4)The company’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company’s internal control over financial reporting; and

 

(5)The company’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company’s auditors and the audit committee of the company’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the company’s internal control over financial reporting.

 

 

Date: August 12, 2015

  /s/ Max Scheder-Bieschin
  Max Scheder-Bieschin
  Principal Financial Officer

 

 

 EX-32.1 4 v417064_ex32-1.htm EXHIBIT 32.1

Exhibit 32.1

CERTIFICATION BY THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO

18 U.S.C. SECTION 1350

 

In connection with the Quarterly Report on Form 10-Q of Ekso Bionics Holdings, Inc. (the “Company”), for the quarterly period ended June 30, 2015 as filed with the Securities and Exchange Commission (the “Report”), I, Nathan Harding, Chief Executive Officer and principal executive officer, hereby certify as of the date hereof, solely for purposes of 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

(1)The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

  

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

 

 

Dated: August 12, 2015 

 

  /s/ Nathan Harding
  Nathan Harding
  Principal Executive Officer



 

 

 EX-32.2 5 v417064_ex32-2.htm EXHIBIT 32.2

Exhibit 32.2

CERTIFICATION BY THE PRINCIPAL FINANCIAL OFFICER PURSUANT TO

18 U.S.C. SECTION 1350

 

In connection with the Quarterly Report on Form 10-Q of Ekso Bionics Holdings, Inc. (the “Company”), for the quarterly period ended June 30, 2015 as filed with the Securities and Exchange Commission (the “Report”), I, Max Scheder-Bieschin, Chief Financial Officer and principal financial officer, hereby certify as of the date hereof, solely for purposes of 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

(1)The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

  

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

 

 

Dated: August 12, 2015

  

  /s/ Max Scheder-Bieschin
  Max Scheder-Bieschin
  Principal Financial Officer

 

 

 EX-101.INS 6 ekso-20150630.xml XBRL INSTANCE DOCUMENT 0001549084 2015-06-30 0001549084 2014-12-31 0001549084 2015-01-01 2015-06-30 0001549084 2014-01-01 2014-06-30 0001549084 2013-12-31 0001549084 2014-06-30 0001549084 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember ekso:CustomerConcentrationRiskOneMember 2015-01-01 2015-06-30 0001549084 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember ekso:CustomerConcentrationRiskOneMember 2014-01-01 2014-12-31 0001549084 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember ekso:CustomerConcentrationRiskTwoMember 2014-01-01 2014-12-31 0001549084 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember ekso:CustomerConcentrationRiskOneMember 2014-01-01 2014-06-30 0001549084 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember ekso:CustomerConcentrationRiskOneMember 2015-01-01 2015-06-30 0001549084 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember ekso:CustomerConcentrationRiskTwoMember 2015-01-01 2015-06-30 0001549084 us-gaap:CommonStockMember 2015-01-01 2015-06-30 0001549084 us-gaap:WarrantMember 2015-01-01 2015-06-30 0001549084 us-gaap:StockOptionMember 2015-01-01 2015-06-30 0001549084 ekso:SeriesAconvertiblePreferredStockMember 2015-01-01 2015-06-30 0001549084 ekso:SeriesAtwoConvertiblePreferredStockMember 2015-01-01 2015-06-30 0001549084 ekso:SeriesBconvertiblePreferredStockMember 2015-01-01 2015-06-30 0001549084 us-gaap:BridgeLoanMember 2013-11-30 0001549084 ekso:BridgeNoteWarrantsMember 2013-11-30 0001549084 ekso:BridgeNoteWarrantsMember 2013-11-01 2013-11-30 0001549084 2014-01-01 2014-01-14 0001549084 ekso:PrivatePlacementWarrantsMember 2015-06-30 0001549084 ekso:PrivatePlacementWarrantsMember 2015-01-01 2015-06-30 0001549084 2014-01-29 2014-02-06 0001549084 us-gaap:BridgeLoanMember 2015-01-01 2015-06-30 0001549084 us-gaap:BridgeLoanMember 2015-06-30 0001549084 ekso:BridgeNoteWarrantsMember 2015-06-30 0001549084 ekso:BridgeNoteWarrantsMember 2015-01-01 2015-06-30 0001549084 ekso:BridgeNotesPlacementAgentWarrantsMember 2015-06-30 0001549084 ekso:ConversionDateMember 2015-01-01 2015-06-30 0001549084 ekso:MergerDateMember 2015-01-01 2015-06-30 0001549084 ekso:PrivatePlacementWarrantsMember 2014-11-30 0001549084 us-gaap:SoftwareLicenseArrangementMember 2015-06-30 0001549084 us-gaap:SoftwareLicenseArrangementMember 2014-12-31 0001549084 us-gaap:NonsoftwareServiceSupportAndMaintenanceArrangementMember 2015-06-30 0001549084 us-gaap:NonsoftwareServiceSupportAndMaintenanceArrangementMember 2014-12-31 0001549084 us-gaap:SoftwareServiceSupportAndMaintenanceArrangementMember 2015-06-30 0001549084 us-gaap:SoftwareServiceSupportAndMaintenanceArrangementMember 2014-12-31 0001549084 us-gaap:CapitalLeaseObligationsMember 2015-06-30 0001549084 ekso:LeaseholdImprovementNoteMember 2015-06-30 0001549084 us-gaap:NotesPayableOtherPayablesMember 2015-06-30 0001549084 us-gaap:NotesPayableOtherPayablesMember 2015-01-01 2015-06-30 0001549084 2014-10-31 0001549084 us-gaap:WarrantMember 2014-10-31 0001549084 us-gaap:WarrantMember ekso:OfferToAmendAndExerciseMember 2014-10-31 0001549084 ekso:BridgeNotesPlacementAgentAndPrivatePlacementAgentWarrantsMember 2015-06-30 0001549084 ekso:BridgeNotesPlacementAgentAndPrivatePlacementAgentWarrantsMember 2014-12-31 0001549084 ekso:BridgeNotesPlacementAgentAndPrivatePlacementAgentWarrantsMember 2015-01-01 2015-06-30 0001549084 ekso:BridgeNoteWarrantsMember 2014-12-31 0001549084 ekso:PrivatePlacementWarrantsMember 2014-12-31 0001549084 ekso:EquityIncentivePlan2014Member 2015-06-30 0001549084 ekso:EquityIncentivePlan2014Member 2015-01-01 2015-06-30 0001549084 us-gaap:MinimumMember ekso:EquityIncentivePlan2014Member 2015-01-01 2015-06-30 0001549084 us-gaap:MinimumMember ekso:StockholdersMember ekso:EquityIncentivePlan2014Member 2015-01-01 2015-06-30 0001549084 us-gaap:MaximumMember ekso:StockholdersMember ekso:EquityIncentivePlan2014Member 2015-01-01 2015-06-30 0001549084 us-gaap:MaximumMember ekso:EquityIncentivePlan2014Member 2015-01-01 2015-06-30 0001549084 us-gaap:EmployeeStockOptionMember 2015-06-30 0001549084 us-gaap:EmployeeStockOptionMember 2015-01-01 2015-06-30 0001549084 ekso:EquityIncentivePlan2014Member 2014-12-31 0001549084 us-gaap:MinimumMember 2015-01-01 2015-06-30 0001549084 us-gaap:MaximumMember 2015-01-01 2015-06-30 0001549084 us-gaap:MinimumMember 2014-01-01 2014-06-30 0001549084 us-gaap:MaximumMember 2014-01-01 2014-06-30 0001549084 us-gaap:SellingAndMarketingExpenseMember 2015-01-01 2015-06-30 0001549084 us-gaap:SellingAndMarketingExpenseMember 2014-01-01 2014-06-30 0001549084 us-gaap:ResearchAndDevelopmentExpenseMember 2015-01-01 2015-06-30 0001549084 us-gaap:ResearchAndDevelopmentExpenseMember 2014-01-01 2014-06-30 0001549084 us-gaap:GeneralAndAdministrativeExpenseMember 2015-01-01 2015-06-30 0001549084 us-gaap:GeneralAndAdministrativeExpenseMember 2014-01-01 2014-06-30 0001549084 ekso:SalesRevenueGoodsNetExcludingGovernmentSalesMember us-gaap:RoyaltyAgreementTermsMember 2015-01-01 2015-06-30 0001549084 ekso:LicenseRevenueMember us-gaap:RoyaltyAgreementTermsMember 2015-01-01 2015-06-30 0001549084 ekso:SublicenseeSalesRevenueGoodsNetExcludingGovernmentSalesMember us-gaap:RoyaltyAgreementTermsMember 2015-01-01 2015-06-30 0001549084 us-gaap:EmployeeStockOptionMember 2015-01-01 2015-06-30 0001549084 us-gaap:EmployeeStockOptionMember 2014-01-01 2014-06-30 0001549084 us-gaap:WarrantMember 2015-01-01 2015-06-30 0001549084 us-gaap:WarrantMember 2014-01-01 2014-06-30 0001549084 ekso:EngineeringServicesMember 2015-01-01 2015-06-30 0001549084 ekso:MedicalDevicesMember 2015-01-01 2015-06-30 0001549084 ekso:EngineeringServicesMember 2014-01-01 2014-06-30 0001549084 ekso:MedicalDevicesMember 2014-01-01 2014-06-30 0001549084 us-gaap:NorthAmericaMember 2015-01-01 2015-06-30 0001549084 us-gaap:NorthAmericaMember 2014-01-01 2014-06-30 0001549084 ekso:OtherGeographicalMember 2015-01-01 2015-06-30 0001549084 ekso:OtherGeographicalMember 2014-01-01 2014-06-30 0001549084 us-gaap:RoyaltyAgreementTermsMember 2015-06-30 0001549084 ekso:PrivatePlacementWarrantsMember ekso:OfferToAmendAndExerciseMember 2014-11-30 0001549084 ekso:PrivatePlacementAgentWarrantsMember 2015-01-01 2015-06-30 0001549084 ekso:PreMergerAndPrivatePlacementWarrantsMember 2014-12-31 0001549084 ekso:PreMergerAndPrivatePlacementWarrantsMember 2015-06-30 0001549084 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember ekso:CustomerConcentrationRiskOneMember 2014-04-01 2014-06-30 0001549084 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember ekso:CustomerConcentrationRiskTwoMember 2014-04-01 2014-06-30 0001549084 2015-04-01 2015-06-30 0001549084 us-gaap:EmployeeStockOptionMember 2015-04-01 2015-06-30 0001549084 us-gaap:WarrantMember 2015-04-01 2015-06-30 0001549084 2014-04-01 2014-06-30 0001549084 us-gaap:EmployeeStockOptionMember 2014-04-01 2014-06-30 0001549084 us-gaap:WarrantMember 2014-04-01 2014-06-30 0001549084 ekso:EngineeringServicesMember 2015-04-01 2015-06-30 0001549084 ekso:MedicalDevicesMember 2015-04-01 2015-06-30 0001549084 ekso:EngineeringServicesMember 2014-04-01 2014-06-30 0001549084 ekso:MedicalDevicesMember 2014-04-01 2014-06-30 0001549084 us-gaap:NorthAmericaMember 2015-04-01 2015-06-30 0001549084 us-gaap:NorthAmericaMember 2014-04-01 2014-06-30 0001549084 ekso:OtherGeographicalMember 2015-04-01 2015-06-30 0001549084 ekso:OtherGeographicalMember 2014-04-01 2014-06-30 0001549084 us-gaap:MinimumMember 2015-04-01 2015-06-30 0001549084 us-gaap:MaximumMember 2015-04-01 2015-06-30 0001549084 us-gaap:MinimumMember 2014-04-01 2014-06-30 0001549084 us-gaap:MaximumMember 2014-04-01 2014-06-30 0001549084 us-gaap:SellingAndMarketingExpenseMember 2015-04-01 2015-06-30 0001549084 us-gaap:SellingAndMarketingExpenseMember 2014-04-01 2014-06-30 0001549084 us-gaap:ResearchAndDevelopmentExpenseMember 2015-04-01 2015-06-30 0001549084 us-gaap:ResearchAndDevelopmentExpenseMember 2014-04-01 2014-06-30 0001549084 us-gaap:GeneralAndAdministrativeExpenseMember 2015-04-01 2015-06-30 0001549084 us-gaap:GeneralAndAdministrativeExpenseMember 2014-04-01 2014-06-30 0001549084 2015-08-03 0001549084 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember ekso:CustomerConcentrationRiskTwoMember 2015-01-01 2015-06-30 0001549084 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember ekso:CustomerConcentrationRiskOneMember 2015-04-01 2015-06-30 0001549084 ekso:OfferToAmendAndExerciseMember 2014-01-01 2014-03-31 0001549084 ekso:OfferToAmendAndExerciseMember 2014-04-01 2014-06-30 0001549084 ekso:EquityIncentivePlan2014Member 2014-01-31 0001549084 ekso:EquityIncentivePlan2014Member 2015-06-09 2015-06-10 0001549084 us-gaap:WarrantMember 2014-01-01 2014-06-30 0001549084 us-gaap:WarrantMember us-gaap:MinimumMember 2014-01-01 2014-06-30 0001549084 us-gaap:WarrantMember us-gaap:MaximumMember 2014-01-01 2014-06-30 0001549084 us-gaap:WarrantMember 2014-06-30 iso4217:USD iso4217:USD xbrli:shares xbrli:shares xbrli:pure utr:Rate ekso:item 102139765 0.001 500000000 102123767 101621358 102000 102000 95394000 94499000 -81561000 -71801000 13935000 22800000 26906000 33474000 16251000 25190000 2394000 1549000 1188000 622000 473000 388000 1876000 1551000 22182000 29300000 2154000 2102000 2515000 2017000 55000 55000 26906000 33474000 43000 41000 2306000 783000 1976000 2378000 4032000 3412000 8357000 6614000 4492000 3895000 53000 77000 69000 88000 12971000 10674000 0.001 10000000 0 0.001 500000000 0 0 10000000 102123767 0 0.001 101621358 2033000 1217000 1770000 1042000 3803000 2259000 1768000 832000 1130000 902000 2898000 1734000 905000 525000 4374000 3380000 2725000 1468000 3534000 3880000 10633000 8728000 -9728000 -8203000 6000 430000 16979000 7000 3000 -33000 -29000 -32000 -17435000 -9760000 -25638000 -0.10 -0.35 101944359 72688073 419000 333000 21000 -19000 -18000 198000 791000 693000 845000 944000 478000 573000 85000 47000 823000 917000 1523000 -272000 -402000 -166000 1217000 1746000 -8462000 -8605000 559000 675000 -559000 -675000 22000 2544000 56000 23000 48000 21961000 82000 19440000 -8939000 10160000 805000 10965000 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b>2. Basis of Presentation and Summary of Significant Accounting Policies and Estimates</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;">There have been no material changes to our significant accounting policies as compared to those described in our Annual Report on Form 10-K for the year ended December 31, 2014.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;">&#160;</p> <div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b>Basis of Presentation</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">These unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#147;U.S. GAAP&#148;) and pursuant to the rules and regulations of the Securities and Exchange Commission (&#147;SEC&#148;), for the presentation of interim financial information. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed, or omitted, pursuant to such rules and regulations. The condensed consolidated balance sheet at December 31, 2014, has been derived from the audited consolidated financial statements at that date but does not include all disclosures required for the annual financial statements and should be read in conjunction with our audited consolidated financial statements and notes thereto included as part of our Annual Report on Form 10-K for the year ended December 31, 2014.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">In management's opinion, the condensed consolidated financial statements reflect all adjustments (including reclassifications and normal recurring adjustments) necessary to present fairly the financial position at June 30, 2015, and results of operations and cash flows for all periods presented. The interim results presented are not necessarily indicative of results that can be expected for a full year. The condensed consolidated financial statements include the accounts of the Company and our wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.</p> </div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b>&#160;</b></p> <div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b>Use of Estimates</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet, and the reported amounts of revenues and expenses during the reporting period. For the Company, these estimates include, but are not limited to: revenue recognition, deferred revenue and the deferral of the associated costs, useful lives assigned to long-lived assets, realizability of deferred tax assets, the valuation of options and warrants, and contingencies. Actual results could differ from those estimates.</p> </div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b>&#160;</b></p> <div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b>Concentration of Credit Risk and Other Risks and Uncertainties</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">Financial instruments that potentially subject us to concentrations of credit risk consist principally of cash and accounts receivable. We maintain our cash accounts in excess of federally insured limits. However, we believe we are not exposed to significant credit risk due to the financial position of the depository institutions in which these deposits are held. &#160;We extend credit to customers in the normal course of business and perform ongoing credit evaluations of our customers. Concentrations of credit risk with respect to accounts receivable exist to the full extent of amounts presented in the consolidated financial statements. We do not require collateral from our customers to secure accounts receivable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><br/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><!-- [if gte mso 9]><xml> <o:OfficeDocumentSettings> <o:AllowPNG></o:AllowPNG> </o:OfficeDocumentSettings> </xml><![endif]--> <!-- [if gte mso 9]><xml> <w:WordDocument> <w:View>Normal</w:View> <w:Zoom>0</w:Zoom> <w:TrackMoves></w:TrackMoves> <w:TrackFormatting></w:TrackFormatting> <w:DoNotShowPropertyChanges></w:DoNotShowPropertyChanges> <w:PunctuationKerning></w:PunctuationKerning> <w:ValidateAgainstSchemas></w:ValidateAgainstSchemas> <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid> <w:IgnoreMixedContent>false</w:IgnoreMixedContent> <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText> <w:DoNotPromoteQF></w:DoNotPromoteQF> <w:LidThemeOther>EN-US</w:LidThemeOther> <w:LidThemeAsian>X-NONE</w:LidThemeAsian> <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript> <w:Compatibility> <w:BreakWrappedTables></w:BreakWrappedTables> <w:SnapToGridInCell></w:SnapToGridInCell> <w:WrapTextWithPunct></w:WrapTextWithPunct> <w:UseAsianBreakRules></w:UseAsianBreakRules> <w:DontGrowAutofit></w:DontGrowAutofit> <w:SplitPgBreakAndParaMark></w:SplitPgBreakAndParaMark> <w:EnableOpenTypeKerning></w:EnableOpenTypeKerning> <w:DontFlipMirrorIndents></w:DontFlipMirrorIndents> <w:OverrideTableStyleHps></w:OverrideTableStyleHps> </w:Compatibility> <m:mathPr> <m:mathFont m:val="Cambria Math"></m:mathFont> <m:brkBin m:val="before"></m:brkBin> <m:brkBinSub m:val="&#45;-"></m:brkBinSub> <m:smallFrac m:val="off"></m:smallFrac> <m:dispDef></m:dispDef> <m:lMargin m:val="0"></m:lMargin> <m:rMargin m:val="0"></m:rMargin> <m:defJc m:val="centerGroup"></m:defJc> <m:wrapIndent m:val="1440"></m:wrapIndent> <m:intLim m:val="subSup"></m:intLim> <m:naryLim m:val="undOvr"></m:naryLim> </m:mathPr></w:WordDocument> </xml><![endif]--><!-- [if gte mso 9]><xml> <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="false" DefSemiHidden="false" DefQFormat="false" DefPriority="99" LatentStyleCount="371"> <w:LsdException Locked="false" Priority="0" QFormat="true" Name="Normal"></w:LsdException> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 1"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 2"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 3"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 4"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 5"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 6"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 7"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 8"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 9"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 6"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 7"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 8"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 9"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 1"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 2"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 3"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 4"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 5"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 6"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 7"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 8"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 9"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Normal Indent"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="footnote text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="annotation text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="header"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="footer"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index heading"></w:LsdException> <w:LsdException Locked="false" Priority="35" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="caption"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="table of figures"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="envelope address"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="envelope return"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="footnote reference"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="annotation reference"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="line number"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="page number"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="endnote reference"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="endnote text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="table of authorities"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="macro"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="toa heading"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Bullet"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Number"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Bullet 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Bullet 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Bullet 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Bullet 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Number 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Number 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Number 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Number 5"></w:LsdException> <w:LsdException Locked="false" Priority="10" QFormat="true" Name="Title"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Closing"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Signature"></w:LsdException> <w:LsdException Locked="false" Priority="1" SemiHidden="true" UnhideWhenUsed="true" Name="Default Paragraph Font"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text Indent"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Continue"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Continue 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Continue 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Continue 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Continue 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Message Header"></w:LsdException> <w:LsdException Locked="false" Priority="11" QFormat="true" Name="Subtitle"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Salutation"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Date"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text First Indent"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text First Indent 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Note Heading"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text Indent 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text Indent 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Block Text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Hyperlink"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="FollowedHyperlink"></w:LsdException> <w:LsdException Locked="false" Priority="22" QFormat="true" Name="Strong"></w:LsdException> <w:LsdException Locked="false" Priority="20" QFormat="true" Name="Emphasis"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Document Map"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Plain Text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="E-mail Signature"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Top of Form"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Bottom of Form"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Normal (Web)"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Acronym"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Address"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Cite"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Code"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Definition"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Keyboard"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Preformatted"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Sample"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Typewriter"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Variable"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Normal Table"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="annotation subject"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="No List"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Outline List 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Outline List 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Outline List 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Simple 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Simple 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Simple 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Classic 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Classic 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Classic 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Classic 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Colorful 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Colorful 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Colorful 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Columns 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Columns 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Columns 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Columns 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Columns 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 6"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 7"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 8"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 6"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 7"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 8"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table 3D effects 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table 3D effects 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table 3D effects 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Contemporary"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Elegant"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Professional"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Subtle 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Subtle 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Web 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Web 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Web 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Balloon Text"></w:LsdException> <w:LsdException Locked="false" Priority="39" Name="Table Grid"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Theme"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" Name="Placeholder Text"></w:LsdException> <w:LsdException Locked="false" Priority="1" QFormat="true" Name="No Spacing"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" Name="Revision"></w:LsdException> <w:LsdException Locked="false" Priority="34" QFormat="true" Name="List Paragraph"></w:LsdException> <w:LsdException Locked="false" Priority="29" QFormat="true" Name="Quote"></w:LsdException> <w:LsdException Locked="false" Priority="30" QFormat="true" Name="Intense Quote"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="19" QFormat="true" Name="Subtle Emphasis"></w:LsdException> <w:LsdException Locked="false" Priority="21" QFormat="true" Name="Intense Emphasis"></w:LsdException> <w:LsdException Locked="false" Priority="31" QFormat="true" Name="Subtle Reference"></w:LsdException> <w:LsdException Locked="false" Priority="32" QFormat="true" Name="Intense Reference"></w:LsdException> <w:LsdException Locked="false" Priority="33" QFormat="true" Name="Book Title"></w:LsdException> <w:LsdException Locked="false" Priority="37" SemiHidden="true" UnhideWhenUsed="true" Name="Bibliography"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="TOC Heading"></w:LsdException> <w:LsdException Locked="false" Priority="41" Name="Plain Table 1"></w:LsdException> <w:LsdException Locked="false" Priority="42" Name="Plain Table 2"></w:LsdException> <w:LsdException Locked="false" Priority="43" Name="Plain Table 3"></w:LsdException> <w:LsdException Locked="false" Priority="44" Name="Plain Table 4"></w:LsdException> <w:LsdException Locked="false" Priority="45" Name="Plain Table 5"></w:LsdException> <w:LsdException Locked="false" Priority="40" Name="Grid Table Light"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 6"></w:LsdException> </w:LatentStyles> </xml><![endif]--> <!-- [if gte mso 10]> <style> /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman",serif;} </style> <![endif]--></p> <p style="margin: 0in 0in 0.0001pt; text-align: justify; font-size: 12pt; font-family: 'Times New Roman', serif;"><font style="font-size: 10.0pt;">Accounts receivable are derived from the sale of products shipped and services performed for customers located in the U.S. and throughout the world. Invoices are aged based on contractual terms with the customer. We review accounts receivable for collectability and provide an allowance for credit losses, as needed. We have not experienced any material losses related to accounts receivable as of June 30, 2015 and December 31, 2014. Many of the sales contracts with customers outside of the U.S. are settled in a foreign currency other than the U.S. dollar. We do not enter into any foreign currency hedging agreements and are susceptible to gains and losses from foreign currency fluctuations. To date, we have not experienced significant gains or losses upon settling foreign currency denominated accounts receivable.</font></p> <p style="margin: 0in 0in 0.0001pt; text-align: justify; text-indent: 0.5in; font-size: 12pt; font-family: 'Times New Roman', serif;"><font style="font-size: 10.0pt;">&#160;</font></p> <p style="margin: 0in 0in 0.0001pt; text-align: justify; font-size: 12pt; font-family: 'Times New Roman', serif;"><font style="font-size: 10.0pt;">As of June 30, 2015, we had two customers with accounts receivable balances totaling 10% or more of our total accounts receivable (<font>26</font>% and <font>10</font>%), compared with two customers as of December 31, 2014 (<font>22</font>% and <font>11</font>%).</font></p> <p style="margin: 0in 0in 0.0001pt; text-align: justify; text-indent: 0.5in; font-size: 12pt; font-family: 'Times New Roman', serif;"><font style="font-size: 10.0pt;">&#160;</font></p> <p style="margin: 0in 0in 0.0001pt; text-align: justify; font-size: 12pt; font-family: 'Times New Roman', serif;"><font style="font-size: 10.0pt;">In the three months ended June 30, 2015, we had one customer with sales comprising of 10% or more of our total customer sales (<font>32</font>%), compared with two customers in the three months ended June 30, 2014&#160;(<font>15</font>% and <font>12</font>%). In the six months ended June 30, 2015, we had two customers with sales comprising of 10% or more of our total customer sales (<font>27</font>%, and <font>11</font>%), compared with one customer in the six months ended June 30, 2014 (<font>17</font>%).</font></p> </div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b>Common Stock Warrants</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><!-- [if gte mso 9]><xml> <o:OfficeDocumentSettings> <o:AllowPNG></o:AllowPNG> </o:OfficeDocumentSettings> </xml><![endif]--> <!-- [if gte mso 9]><xml> <w:WordDocument> <w:View>Normal</w:View> <w:Zoom>0</w:Zoom> <w:TrackMoves></w:TrackMoves> <w:TrackFormatting></w:TrackFormatting> <w:DoNotShowPropertyChanges></w:DoNotShowPropertyChanges> <w:PunctuationKerning></w:PunctuationKerning> <w:ValidateAgainstSchemas></w:ValidateAgainstSchemas> <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid> <w:IgnoreMixedContent>false</w:IgnoreMixedContent> <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText> <w:DoNotPromoteQF></w:DoNotPromoteQF> <w:LidThemeOther>EN-US</w:LidThemeOther> <w:LidThemeAsian>X-NONE</w:LidThemeAsian> <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript> <w:Compatibility> <w:BreakWrappedTables></w:BreakWrappedTables> <w:SnapToGridInCell></w:SnapToGridInCell> <w:WrapTextWithPunct></w:WrapTextWithPunct> <w:UseAsianBreakRules></w:UseAsianBreakRules> <w:DontGrowAutofit></w:DontGrowAutofit> <w:SplitPgBreakAndParaMark></w:SplitPgBreakAndParaMark> <w:EnableOpenTypeKerning></w:EnableOpenTypeKerning> <w:DontFlipMirrorIndents></w:DontFlipMirrorIndents> <w:OverrideTableStyleHps></w:OverrideTableStyleHps> </w:Compatibility> <m:mathPr> <m:mathFont m:val="Cambria Math"></m:mathFont> <m:brkBin m:val="before"></m:brkBin> <m:brkBinSub m:val="&#45;-"></m:brkBinSub> <m:smallFrac m:val="off"></m:smallFrac> <m:dispDef></m:dispDef> <m:lMargin m:val="0"></m:lMargin> <m:rMargin m:val="0"></m:rMargin> <m:defJc m:val="centerGroup"></m:defJc> <m:wrapIndent m:val="1440"></m:wrapIndent> <m:intLim m:val="subSup"></m:intLim> <m:naryLim m:val="undOvr"></m:naryLim> </m:mathPr></w:WordDocument> </xml><![endif]--><!-- [if gte mso 9]><xml> <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="false" DefSemiHidden="false" DefQFormat="false" DefPriority="99" LatentStyleCount="371"> <w:LsdException Locked="false" Priority="0" QFormat="true" Name="Normal"></w:LsdException> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 1"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 2"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 3"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 4"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 5"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 6"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 7"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 8"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 9"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 6"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 7"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 8"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 9"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 1"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 2"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 3"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 4"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 5"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 6"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 7"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 8"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 9"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Normal Indent"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="footnote text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="annotation text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="header"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="footer"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index heading"></w:LsdException> <w:LsdException Locked="false" Priority="35" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="caption"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="table of figures"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="envelope address"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="envelope return"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="footnote reference"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="annotation reference"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="line number"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="page number"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="endnote reference"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="endnote text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="table of authorities"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="macro"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="toa heading"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Bullet"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Number"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Bullet 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Bullet 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Bullet 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Bullet 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Number 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Number 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Number 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Number 5"></w:LsdException> <w:LsdException Locked="false" Priority="10" QFormat="true" Name="Title"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Closing"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Signature"></w:LsdException> <w:LsdException Locked="false" Priority="1" SemiHidden="true" UnhideWhenUsed="true" Name="Default Paragraph Font"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text Indent"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Continue"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Continue 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Continue 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Continue 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Continue 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Message Header"></w:LsdException> <w:LsdException Locked="false" Priority="11" QFormat="true" Name="Subtitle"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Salutation"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Date"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text First Indent"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text First Indent 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Note Heading"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text Indent 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text Indent 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Block Text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Hyperlink"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="FollowedHyperlink"></w:LsdException> <w:LsdException Locked="false" Priority="22" QFormat="true" Name="Strong"></w:LsdException> <w:LsdException Locked="false" Priority="20" QFormat="true" Name="Emphasis"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Document Map"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Plain Text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="E-mail Signature"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Top of Form"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Bottom of Form"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Normal (Web)"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Acronym"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Address"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Cite"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Code"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Definition"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Keyboard"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Preformatted"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Sample"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Typewriter"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Variable"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Normal Table"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="annotation subject"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="No List"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Outline List 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Outline List 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Outline List 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Simple 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Simple 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Simple 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Classic 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Classic 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Classic 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Classic 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Colorful 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Colorful 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Colorful 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Columns 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Columns 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Columns 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Columns 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Columns 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 6"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 7"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 8"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 6"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 7"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 8"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table 3D effects 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table 3D effects 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table 3D effects 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Contemporary"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Elegant"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Professional"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Subtle 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Subtle 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Web 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Web 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Web 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Balloon Text"></w:LsdException> <w:LsdException Locked="false" Priority="39" Name="Table Grid"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Theme"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" Name="Placeholder Text"></w:LsdException> <w:LsdException Locked="false" Priority="1" QFormat="true" Name="No Spacing"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" Name="Revision"></w:LsdException> <w:LsdException Locked="false" Priority="34" QFormat="true" Name="List Paragraph"></w:LsdException> <w:LsdException Locked="false" Priority="29" QFormat="true" Name="Quote"></w:LsdException> <w:LsdException Locked="false" Priority="30" QFormat="true" Name="Intense Quote"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="19" QFormat="true" Name="Subtle Emphasis"></w:LsdException> <w:LsdException Locked="false" Priority="21" QFormat="true" Name="Intense Emphasis"></w:LsdException> <w:LsdException Locked="false" Priority="31" QFormat="true" Name="Subtle Reference"></w:LsdException> <w:LsdException Locked="false" Priority="32" QFormat="true" Name="Intense Reference"></w:LsdException> <w:LsdException Locked="false" Priority="33" QFormat="true" Name="Book Title"></w:LsdException> <w:LsdException Locked="false" Priority="37" SemiHidden="true" UnhideWhenUsed="true" Name="Bibliography"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="TOC Heading"></w:LsdException> <w:LsdException Locked="false" Priority="41" Name="Plain Table 1"></w:LsdException> <w:LsdException Locked="false" Priority="42" Name="Plain Table 2"></w:LsdException> <w:LsdException Locked="false" Priority="43" Name="Plain Table 3"></w:LsdException> <w:LsdException Locked="false" Priority="44" Name="Plain Table 4"></w:LsdException> <w:LsdException Locked="false" Priority="45" Name="Plain Table 5"></w:LsdException> <w:LsdException Locked="false" Priority="40" Name="Grid Table Light"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 6"></w:LsdException> </w:LatentStyles> </xml><![endif]--> <!-- [if gte mso 10]> <style> /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman",serif;} </style> <![endif]--></p> <p style="margin: 0in 0in 0.0001pt; text-align: justify; font-size: 12pt; font-family: 'Times New Roman', serif;"><font style="font-size: 10.0pt;">We accounted for the common stock warrants issued in connection with our Merger and related private placement offering (see <i>Note 3, The Merger, Offering and Other Related Transactions) </i>in accordance with the guidance in Accounting Standards Codification (&#147;ASC&#148;) 815-40. Under ASC 815-40, the warrants did not meet the criteria for equity treatment and were recorded as a liability. The warrants initially had an anti-dilution clause that allowed for a decrease in the exercise price of the warrants if the Company issued additional shares of common stock without consideration or for consideration per share less than the exercise price of such warrants. Accordingly, we classified the warrant instruments as liabilities at their fair value at the date of issuance and re-measured the warrants at each balance sheet date. Changes in the fair value were recognized as a gain (loss) on warrant liability in our Condensed Consolidated Statement of Operations. These warrants were amended in November 2014 to remove the price-based anti-dilution provision, among other things. Accordingly, the warrants are no longer recorded as a liability.</font></p> </div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;">&#160;</p> <div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><b>Recent Accounting Pronouncements</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">In July 2015, the Financial Accounting Standards Board issued Accounting Standards Update (&#147;ASU&#148;) 2015-11 Simplifying the Measurement of Inventory. Under ASU 2015-11, inventory is to be measured at the lower of cost and net realizable value (&#147;NRV&#148;). NRV is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.<br/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><br/>The updated guidance is effective for annual reporting periods beginning on or after December 15, 2016, and interim periods therein. Early adoption is permitted. Management is in the process of assessing the impact of ASU 2015-11 on the Company's consolidated financial statements.</p> </div> </div> <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b>Use of Estimates</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet, and the reported amounts of revenues and expenses during the reporting period. For the Company, these estimates include, but are not limited to: revenue recognition, deferred revenue and the deferral of the associated costs, useful lives assigned to long-lived assets, realizability of deferred tax assets, the valuation of options and warrants, and contingencies. Actual results could differ from those estimates.</p> </div> <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b>Concentration of Credit Risk and Other Risks and Uncertainties</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">Financial instruments that potentially subject us to concentrations of credit risk consist principally of cash and accounts receivable. We maintain our cash accounts in excess of federally insured limits. However, we believe we are not exposed to significant credit risk due to the financial position of the depository institutions in which these deposits are held. &#160;We extend credit to customers in the normal course of business and perform ongoing credit evaluations of our customers. Concentrations of credit risk with respect to accounts receivable exist to the full extent of amounts presented in the consolidated financial statements. We do not require collateral from our customers to secure accounts receivable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><br/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><!-- [if gte mso 9]><xml> <o:OfficeDocumentSettings> <o:AllowPNG></o:AllowPNG> </o:OfficeDocumentSettings> </xml><![endif]--> <!-- [if gte mso 9]><xml> <w:WordDocument> <w:View>Normal</w:View> <w:Zoom>0</w:Zoom> <w:TrackMoves></w:TrackMoves> <w:TrackFormatting></w:TrackFormatting> <w:DoNotShowPropertyChanges></w:DoNotShowPropertyChanges> <w:PunctuationKerning></w:PunctuationKerning> <w:ValidateAgainstSchemas></w:ValidateAgainstSchemas> <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid> <w:IgnoreMixedContent>false</w:IgnoreMixedContent> <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText> <w:DoNotPromoteQF></w:DoNotPromoteQF> <w:LidThemeOther>EN-US</w:LidThemeOther> <w:LidThemeAsian>X-NONE</w:LidThemeAsian> <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript> <w:Compatibility> <w:BreakWrappedTables></w:BreakWrappedTables> <w:SnapToGridInCell></w:SnapToGridInCell> <w:WrapTextWithPunct></w:WrapTextWithPunct> <w:UseAsianBreakRules></w:UseAsianBreakRules> <w:DontGrowAutofit></w:DontGrowAutofit> <w:SplitPgBreakAndParaMark></w:SplitPgBreakAndParaMark> <w:EnableOpenTypeKerning></w:EnableOpenTypeKerning> <w:DontFlipMirrorIndents></w:DontFlipMirrorIndents> <w:OverrideTableStyleHps></w:OverrideTableStyleHps> </w:Compatibility> <m:mathPr> <m:mathFont m:val="Cambria Math"></m:mathFont> <m:brkBin m:val="before"></m:brkBin> <m:brkBinSub m:val="&#45;-"></m:brkBinSub> <m:smallFrac m:val="off"></m:smallFrac> <m:dispDef></m:dispDef> <m:lMargin m:val="0"></m:lMargin> <m:rMargin m:val="0"></m:rMargin> <m:defJc m:val="centerGroup"></m:defJc> <m:wrapIndent m:val="1440"></m:wrapIndent> <m:intLim m:val="subSup"></m:intLim> <m:naryLim m:val="undOvr"></m:naryLim> </m:mathPr></w:WordDocument> </xml><![endif]--><!-- [if gte mso 9]><xml> <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="false" DefSemiHidden="false" DefQFormat="false" DefPriority="99" LatentStyleCount="371"> <w:LsdException Locked="false" Priority="0" QFormat="true" Name="Normal"></w:LsdException> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 1"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 2"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 3"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 4"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 5"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 6"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 7"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 8"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 9"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 6"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 7"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 8"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 9"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 1"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 2"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 3"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 4"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 5"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 6"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 7"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 8"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 9"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Normal Indent"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="footnote text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="annotation text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="header"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="footer"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index heading"></w:LsdException> <w:LsdException Locked="false" Priority="35" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="caption"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="table of figures"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="envelope address"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="envelope return"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="footnote reference"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="annotation reference"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="line number"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="page number"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="endnote reference"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="endnote text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="table of authorities"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="macro"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="toa heading"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Bullet"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Number"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Bullet 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Bullet 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Bullet 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Bullet 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Number 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Number 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Number 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Number 5"></w:LsdException> <w:LsdException Locked="false" Priority="10" QFormat="true" Name="Title"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Closing"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Signature"></w:LsdException> <w:LsdException Locked="false" Priority="1" SemiHidden="true" UnhideWhenUsed="true" Name="Default Paragraph Font"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text Indent"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Continue"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Continue 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Continue 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Continue 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Continue 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Message Header"></w:LsdException> <w:LsdException Locked="false" Priority="11" QFormat="true" Name="Subtitle"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Salutation"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Date"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text First Indent"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text First Indent 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Note Heading"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text Indent 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text Indent 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Block Text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Hyperlink"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="FollowedHyperlink"></w:LsdException> <w:LsdException Locked="false" Priority="22" QFormat="true" Name="Strong"></w:LsdException> <w:LsdException Locked="false" Priority="20" QFormat="true" Name="Emphasis"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Document Map"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Plain Text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="E-mail Signature"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Top of Form"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Bottom of Form"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Normal (Web)"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Acronym"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Address"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Cite"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Code"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Definition"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Keyboard"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Preformatted"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Sample"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Typewriter"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Variable"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Normal Table"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="annotation subject"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="No List"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Outline List 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Outline List 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Outline List 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Simple 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Simple 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Simple 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Classic 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Classic 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Classic 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Classic 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Colorful 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Colorful 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Colorful 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Columns 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Columns 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Columns 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Columns 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Columns 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 6"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 7"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 8"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 6"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 7"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 8"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table 3D effects 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table 3D effects 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table 3D effects 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Contemporary"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Elegant"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Professional"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Subtle 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Subtle 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Web 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Web 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Web 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Balloon Text"></w:LsdException> <w:LsdException Locked="false" Priority="39" Name="Table Grid"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Theme"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" Name="Placeholder Text"></w:LsdException> <w:LsdException Locked="false" Priority="1" QFormat="true" Name="No Spacing"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" Name="Revision"></w:LsdException> <w:LsdException Locked="false" Priority="34" QFormat="true" Name="List Paragraph"></w:LsdException> <w:LsdException Locked="false" Priority="29" QFormat="true" Name="Quote"></w:LsdException> <w:LsdException Locked="false" Priority="30" QFormat="true" Name="Intense Quote"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="19" QFormat="true" Name="Subtle Emphasis"></w:LsdException> <w:LsdException Locked="false" Priority="21" QFormat="true" Name="Intense Emphasis"></w:LsdException> <w:LsdException Locked="false" Priority="31" QFormat="true" Name="Subtle Reference"></w:LsdException> <w:LsdException Locked="false" Priority="32" QFormat="true" Name="Intense Reference"></w:LsdException> <w:LsdException Locked="false" Priority="33" QFormat="true" Name="Book Title"></w:LsdException> <w:LsdException Locked="false" Priority="37" SemiHidden="true" UnhideWhenUsed="true" Name="Bibliography"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="TOC Heading"></w:LsdException> <w:LsdException Locked="false" Priority="41" Name="Plain Table 1"></w:LsdException> <w:LsdException Locked="false" Priority="42" Name="Plain Table 2"></w:LsdException> <w:LsdException Locked="false" Priority="43" Name="Plain Table 3"></w:LsdException> <w:LsdException Locked="false" Priority="44" Name="Plain Table 4"></w:LsdException> <w:LsdException Locked="false" Priority="45" Name="Plain Table 5"></w:LsdException> <w:LsdException Locked="false" Priority="40" Name="Grid Table Light"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 6"></w:LsdException> </w:LatentStyles> </xml><![endif]--> <!-- [if gte mso 10]> <style> /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman",serif;} </style> <![endif]--></p> <p style="margin: 0in 0in 0.0001pt; text-align: justify; font-size: 12pt; font-family: 'Times New Roman', serif;"><font style="font-size: 10.0pt;">Accounts receivable are derived from the sale of products shipped and services performed for customers located in the U.S. and throughout the world. Invoices are aged based on contractual terms with the customer. We review accounts receivable for collectability and provide an allowance for credit losses, as needed. We have not experienced any material losses related to accounts receivable as of June 30, 2015 and December 31, 2014. Many of the sales contracts with customers outside of the U.S. are settled in a foreign currency other than the U.S. dollar. We do not enter into any foreign currency hedging agreements and are susceptible to gains and losses from foreign currency fluctuations. To date, we have not experienced significant gains or losses upon settling foreign currency denominated accounts receivable.</font></p> <p style="margin: 0in 0in 0.0001pt; text-align: justify; text-indent: 0.5in; font-size: 12pt; font-family: 'Times New Roman', serif;"><font style="font-size: 10.0pt;">&#160;</font></p> <p style="margin: 0in 0in 0.0001pt; text-align: justify; font-size: 12pt; font-family: 'Times New Roman', serif;"><font style="font-size: 10.0pt;">As of June 30, 2015, we had two customers with accounts receivable balances totaling 10% or more of our total accounts receivable (<font>26</font>% and <font>10</font>%), compared with two customers as of December 31, 2014 (<font>22</font>% and <font>11</font>%).</font></p> <p style="margin: 0in 0in 0.0001pt; text-align: justify; text-indent: 0.5in; font-size: 12pt; font-family: 'Times New Roman', serif;"><font style="font-size: 10.0pt;">&#160;</font></p> <p style="margin: 0in 0in 0.0001pt; text-align: justify; font-size: 12pt; font-family: 'Times New Roman', serif;"><font style="font-size: 10.0pt;">In the three months ended June 30, 2015, we had one customer with sales comprising of 10% or more of our total customer sales (<font>32</font>%), compared with two customers in the three months ended June 30, 2014&#160;(<font>15</font>% and <font>12</font>%). In the six months ended June 30, 2015, we had two customers with sales comprising of 10% or more of our total customer sales (<font>27</font>%, and <font>11</font>%), compared with one customer in the six months ended June 30, 2014 (<font>17</font>%).</font></p> </div> 0.27 0.11 1.9548 5000000 83000 5000000 2500000 1.00 P3Y <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b>Common Stock Warrants</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><!-- [if gte mso 9]><xml> <o:OfficeDocumentSettings> <o:AllowPNG></o:AllowPNG> </o:OfficeDocumentSettings> </xml><![endif]--> <!-- [if gte mso 9]><xml> <w:WordDocument> <w:View>Normal</w:View> <w:Zoom>0</w:Zoom> <w:TrackMoves></w:TrackMoves> <w:TrackFormatting></w:TrackFormatting> <w:DoNotShowPropertyChanges></w:DoNotShowPropertyChanges> <w:PunctuationKerning></w:PunctuationKerning> <w:ValidateAgainstSchemas></w:ValidateAgainstSchemas> <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid> <w:IgnoreMixedContent>false</w:IgnoreMixedContent> <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText> <w:DoNotPromoteQF></w:DoNotPromoteQF> <w:LidThemeOther>EN-US</w:LidThemeOther> <w:LidThemeAsian>X-NONE</w:LidThemeAsian> <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript> <w:Compatibility> <w:BreakWrappedTables></w:BreakWrappedTables> <w:SnapToGridInCell></w:SnapToGridInCell> <w:WrapTextWithPunct></w:WrapTextWithPunct> <w:UseAsianBreakRules></w:UseAsianBreakRules> <w:DontGrowAutofit></w:DontGrowAutofit> <w:SplitPgBreakAndParaMark></w:SplitPgBreakAndParaMark> <w:EnableOpenTypeKerning></w:EnableOpenTypeKerning> <w:DontFlipMirrorIndents></w:DontFlipMirrorIndents> <w:OverrideTableStyleHps></w:OverrideTableStyleHps> </w:Compatibility> <m:mathPr> <m:mathFont m:val="Cambria Math"></m:mathFont> <m:brkBin m:val="before"></m:brkBin> <m:brkBinSub m:val="&#45;-"></m:brkBinSub> <m:smallFrac m:val="off"></m:smallFrac> <m:dispDef></m:dispDef> <m:lMargin m:val="0"></m:lMargin> <m:rMargin m:val="0"></m:rMargin> <m:defJc m:val="centerGroup"></m:defJc> <m:wrapIndent m:val="1440"></m:wrapIndent> <m:intLim m:val="subSup"></m:intLim> <m:naryLim m:val="undOvr"></m:naryLim> </m:mathPr></w:WordDocument> </xml><![endif]--><!-- [if gte mso 9]><xml> <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="false" DefSemiHidden="false" DefQFormat="false" DefPriority="99" LatentStyleCount="371"> <w:LsdException Locked="false" Priority="0" QFormat="true" Name="Normal"></w:LsdException> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 1"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 2"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 3"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 4"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 5"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 6"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 7"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 8"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 9"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 6"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 7"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 8"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 9"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 1"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 2"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 3"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 4"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 5"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 6"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 7"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 8"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 9"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Normal Indent"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="footnote text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="annotation text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="header"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="footer"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index heading"></w:LsdException> <w:LsdException Locked="false" Priority="35" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="caption"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="table of figures"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="envelope address"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="envelope return"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="footnote reference"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="annotation reference"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="line number"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="page number"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="endnote reference"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="endnote text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="table of authorities"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="macro"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="toa heading"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Bullet"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Number"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Bullet 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Bullet 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Bullet 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Bullet 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Number 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Number 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Number 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Number 5"></w:LsdException> <w:LsdException Locked="false" Priority="10" QFormat="true" Name="Title"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Closing"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Signature"></w:LsdException> <w:LsdException Locked="false" Priority="1" SemiHidden="true" UnhideWhenUsed="true" Name="Default Paragraph Font"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text Indent"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Continue"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Continue 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Continue 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Continue 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Continue 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Message Header"></w:LsdException> <w:LsdException Locked="false" Priority="11" QFormat="true" Name="Subtitle"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Salutation"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Date"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text First Indent"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text First Indent 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Note Heading"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text Indent 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text Indent 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Block Text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Hyperlink"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="FollowedHyperlink"></w:LsdException> <w:LsdException Locked="false" Priority="22" QFormat="true" Name="Strong"></w:LsdException> <w:LsdException Locked="false" Priority="20" QFormat="true" Name="Emphasis"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Document Map"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Plain Text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="E-mail Signature"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Top of Form"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Bottom of Form"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Normal (Web)"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Acronym"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Address"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Cite"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Code"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Definition"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Keyboard"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Preformatted"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Sample"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Typewriter"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Variable"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Normal Table"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="annotation subject"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="No List"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Outline List 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Outline List 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Outline List 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Simple 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Simple 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Simple 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Classic 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Classic 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Classic 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Classic 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Colorful 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Colorful 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Colorful 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Columns 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Columns 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Columns 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Columns 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Columns 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 6"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 7"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 8"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 6"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 7"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 8"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table 3D effects 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table 3D effects 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table 3D effects 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Contemporary"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Elegant"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Professional"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Subtle 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Subtle 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Web 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Web 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Web 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Balloon Text"></w:LsdException> <w:LsdException Locked="false" Priority="39" Name="Table Grid"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Theme"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" Name="Placeholder Text"></w:LsdException> <w:LsdException Locked="false" Priority="1" QFormat="true" Name="No Spacing"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" Name="Revision"></w:LsdException> <w:LsdException Locked="false" Priority="34" QFormat="true" Name="List Paragraph"></w:LsdException> <w:LsdException Locked="false" Priority="29" QFormat="true" Name="Quote"></w:LsdException> <w:LsdException Locked="false" Priority="30" QFormat="true" Name="Intense Quote"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="19" QFormat="true" Name="Subtle Emphasis"></w:LsdException> <w:LsdException Locked="false" Priority="21" QFormat="true" Name="Intense Emphasis"></w:LsdException> <w:LsdException Locked="false" Priority="31" QFormat="true" Name="Subtle Reference"></w:LsdException> <w:LsdException Locked="false" Priority="32" QFormat="true" Name="Intense Reference"></w:LsdException> <w:LsdException Locked="false" Priority="33" QFormat="true" Name="Book Title"></w:LsdException> <w:LsdException Locked="false" Priority="37" SemiHidden="true" UnhideWhenUsed="true" Name="Bibliography"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="TOC Heading"></w:LsdException> <w:LsdException Locked="false" Priority="41" Name="Plain Table 1"></w:LsdException> <w:LsdException Locked="false" Priority="42" Name="Plain Table 2"></w:LsdException> <w:LsdException Locked="false" Priority="43" Name="Plain Table 3"></w:LsdException> <w:LsdException Locked="false" Priority="44" Name="Plain Table 4"></w:LsdException> <w:LsdException Locked="false" Priority="45" Name="Plain Table 5"></w:LsdException> <w:LsdException Locked="false" Priority="40" Name="Grid Table Light"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 6"></w:LsdException> </w:LatentStyles> </xml><![endif]--> <!-- [if gte mso 10]> <style> /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman",serif;} </style> <![endif]--></p> <p style="margin: 0in 0in 0.0001pt; text-align: justify; font-size: 12pt; font-family: 'Times New Roman', serif;"><font style="font-size: 10.0pt;">We accounted for the common stock warrants issued in connection with our Merger and related private placement offering (see <i>Note 3, The Merger, Offering and Other Related Transactions) </i>in accordance with the guidance in Accounting Standards Codification (&#147;ASC&#148;) 815-40. Under ASC 815-40, the warrants did not meet the criteria for equity treatment and were recorded as a liability. The warrants initially had an anti-dilution clause that allowed for a decrease in the exercise price of the warrants if the Company issued additional shares of common stock without consideration or for consideration per share less than the exercise price of such warrants. Accordingly, we classified the warrant instruments as liabilities at their fair value at the date of issuance and re-measured the warrants at each balance sheet date. Changes in the fair value were recognized as a gain (loss) on warrant liability in our Condensed Consolidated Statement of Operations. These warrants were amended in November 2014 to remove the price-based anti-dilution provision, among other things. Accordingly, the warrants are no longer recorded as a liability.</font></p> </div> <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><b>Recent Accounting Pronouncements</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">In July 2015, the Financial Accounting Standards Board issued Accounting Standards Update (&#147;ASU&#148;) 2015-11 Simplifying the Measurement of Inventory. Under ASU 2015-11, inventory is to be measured at the lower of cost and net realizable value (&#147;NRV&#148;). NRV is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.<br/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><br/>The updated guidance is effective for annual reporting periods beginning on or after December 15, 2016, and interim periods therein. Early adoption is permitted. Management is in the process of assessing the impact of ASU 2015-11 on the Company's consolidated financial statements.</p> </div> 0.26 0.22 0.11 0.17 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b>Basis of Presentation</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">These unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#147;U.S. GAAP&#148;) and pursuant to the rules and regulations of the Securities and Exchange Commission (&#147;SEC&#148;), for the presentation of interim financial information. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed, or omitted, pursuant to such rules and regulations. The condensed consolidated balance sheet at December 31, 2014, has been derived from the audited consolidated financial statements at that date but does not include all disclosures required for the annual financial statements and should be read in conjunction with our audited consolidated financial statements and notes thereto included as part of our Annual Report on Form 10-K for the year ended December 31, 2014.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">In management's opinion, the condensed consolidated financial statements reflect all adjustments (including reclassifications and normal recurring adjustments) necessary to present fairly the financial position at June 30, 2015, and results of operations and cash flows for all periods presented. The interim results presented are not necessarily indicative of results that can be expected for a full year. The condensed consolidated financial statements include the accounts of the Company and our wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.</p> </div> 42615556 621361 4989111 7602408 5280368 4500600 779768 0.068 1.5238 1.6290 1.9548 20580000 1.00 1 2.00 9720000 30300000 25300000 5083000 2553000 3338000 3030000 3030000 1.00 P5Y 22755500 2.00 1.00 14410000 7602408 2300000 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in;"><b>3. The Merger, Offering and Other Related Transactions</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">Holdings was incorporated in the State of Nevada on January 30, 2012, as a distributor of medical supplies and equipment to municipalities, hospitals, pharmacies, care centers, and clinics in Chile. At the time of the Merger, Holdings was a &#147;shell company&#148; as defined in Rule 12b-2 of the Exchange Act. Holdings' fiscal year end was previously March 31&#160;but was changed to December 31 in connection with the Merger.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">On January 15, 2014, Holdings and a newly formed wholly-owned subsidiary of Holdings, Ekso Acquisition Corp, (&#147;Acquisition Sub&#148;) entered into an Agreement and Plan of Merger and Reorganization (the &#147;Merger Agreement&#148;) with Ekso Bionics. Under the Merger Agreement, Acquisition Sub merged with and into Ekso Bionics, with Ekso Bionics remaining as the surviving corporation and with the stockholders of Ekso Bionics exchanging all of their common stock, convertible preferred stock (&#147;preferred stock&#148;) and warrants to purchase preferred stock issued and outstanding immediately prior to the closing of the Merger into an aggregate of <font>42,615,556</font> shares of Holdings' common stock and warrants to purchase <font>621,361</font> shares of common stock. In addition, options to purchase <font>4,989,111</font> shares of common stock of Ekso Bionics were converted into options to purchase <font>7,602,408</font> shares of common stock of Holdings. These shares are in addition to <font>5,280,368</font> outstanding shares of Holdings common stock held by certain pre-Merger stockholders of Holdings, consisting of <font>4,500,600</font> shares held by such stockholders prior to the Merger and an additional <font>779,768</font> shares issued to such stockholders pursuant to a provision in the Merger Agreement requiring us to issue a number of shares of common stock such that the aggregate ownership of the pre-Merger stockholders (not including any shares of common stock purchased by them in the private placement offering described below) was approximately <font>6.8</font>% of the outstanding common stock of the Company following the Merger and private placement offering.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><br/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">Upon the closing of the Merger, under the terms of a split-off agreement and a general release agreement, Holdings transferred all of its pre-Merger operating assets and liabilities to a newly formed wholly-owned special-purpose subsidiary (&#147;Split-Off Subsidiary&#148;), and transferred all of the outstanding shares of capital stock of Split-Off Subsidiary to two individuals who were the pre-Merger majority stockholders of Holdings and Holdings' former officers and sole director (the &#147;Split-Off&#148;), in consideration of and in exchange for (a) the surrender and cancellation of all shares of Holdings' common stock held by such individuals (which were cancelled and resumed the status of authorized but unissued shares of our common stock) and (b) certain representations, covenants and indemnities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b>Accounting for Reverse Merger</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><!-- [if gte mso 9]><xml> <o:OfficeDocumentSettings> <o:AllowPNG></o:AllowPNG> </o:OfficeDocumentSettings> </xml><![endif]--> <!-- [if gte mso 9]><xml> <w:WordDocument> <w:View>Normal</w:View> <w:Zoom>0</w:Zoom> <w:TrackMoves></w:TrackMoves> <w:TrackFormatting></w:TrackFormatting> <w:DoNotShowPropertyChanges></w:DoNotShowPropertyChanges> <w:PunctuationKerning></w:PunctuationKerning> <w:ValidateAgainstSchemas></w:ValidateAgainstSchemas> <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid> <w:IgnoreMixedContent>false</w:IgnoreMixedContent> <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText> <w:DoNotPromoteQF></w:DoNotPromoteQF> <w:LidThemeOther>EN-US</w:LidThemeOther> <w:LidThemeAsian>X-NONE</w:LidThemeAsian> <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript> <w:Compatibility> <w:BreakWrappedTables></w:BreakWrappedTables> <w:SnapToGridInCell></w:SnapToGridInCell> <w:WrapTextWithPunct></w:WrapTextWithPunct> <w:UseAsianBreakRules></w:UseAsianBreakRules> <w:DontGrowAutofit></w:DontGrowAutofit> <w:SplitPgBreakAndParaMark></w:SplitPgBreakAndParaMark> <w:EnableOpenTypeKerning></w:EnableOpenTypeKerning> <w:DontFlipMirrorIndents></w:DontFlipMirrorIndents> <w:OverrideTableStyleHps></w:OverrideTableStyleHps> </w:Compatibility> <m:mathPr> <m:mathFont m:val="Cambria Math"></m:mathFont> <m:brkBin m:val="before"></m:brkBin> <m:brkBinSub m:val="&#45;-"></m:brkBinSub> <m:smallFrac m:val="off"></m:smallFrac> <m:dispDef></m:dispDef> <m:lMargin m:val="0"></m:lMargin> <m:rMargin m:val="0"></m:rMargin> <m:defJc m:val="centerGroup"></m:defJc> <m:wrapIndent m:val="1440"></m:wrapIndent> <m:intLim m:val="subSup"></m:intLim> <m:naryLim m:val="undOvr"></m:naryLim> </m:mathPr></w:WordDocument> </xml><![endif]--><!-- [if gte mso 9]><xml> <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="false" DefSemiHidden="false" DefQFormat="false" DefPriority="99" LatentStyleCount="371"> <w:LsdException Locked="false" Priority="0" QFormat="true" Name="Normal"></w:LsdException> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 1"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 2"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 3"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 4"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 5"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 6"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 7"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 8"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 9"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 6"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 7"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 8"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 9"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 1"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 2"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 3"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 4"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 5"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 6"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 7"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 8"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 9"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Normal Indent"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="footnote text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="annotation text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="header"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="footer"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index heading"></w:LsdException> <w:LsdException Locked="false" Priority="35" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="caption"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="table of figures"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="envelope address"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="envelope return"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="footnote reference"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="annotation reference"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="line number"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="page number"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="endnote reference"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="endnote text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="table of authorities"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="macro"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="toa heading"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Bullet"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Number"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Bullet 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Bullet 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Bullet 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Bullet 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Number 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Number 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Number 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Number 5"></w:LsdException> <w:LsdException Locked="false" Priority="10" QFormat="true" Name="Title"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Closing"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Signature"></w:LsdException> <w:LsdException Locked="false" Priority="1" SemiHidden="true" UnhideWhenUsed="true" Name="Default Paragraph Font"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text Indent"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Continue"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Continue 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Continue 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Continue 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Continue 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Message Header"></w:LsdException> <w:LsdException Locked="false" Priority="11" QFormat="true" Name="Subtitle"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Salutation"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Date"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text First Indent"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text First Indent 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Note Heading"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text Indent 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text Indent 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Block Text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Hyperlink"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="FollowedHyperlink"></w:LsdException> <w:LsdException Locked="false" Priority="22" QFormat="true" Name="Strong"></w:LsdException> <w:LsdException Locked="false" Priority="20" QFormat="true" Name="Emphasis"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Document Map"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Plain Text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="E-mail Signature"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Top of Form"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Bottom of Form"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Normal (Web)"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Acronym"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Address"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Cite"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Code"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Definition"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Keyboard"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Preformatted"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Sample"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Typewriter"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Variable"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Normal Table"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="annotation subject"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="No List"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Outline List 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Outline List 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Outline List 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Simple 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Simple 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Simple 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Classic 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Classic 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Classic 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Classic 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Colorful 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Colorful 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Colorful 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Columns 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Columns 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Columns 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Columns 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Columns 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 6"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 7"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 8"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 6"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 7"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 8"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table 3D effects 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table 3D effects 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table 3D effects 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Contemporary"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Elegant"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Professional"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Subtle 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Subtle 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Web 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Web 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Web 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Balloon Text"></w:LsdException> <w:LsdException Locked="false" Priority="39" Name="Table Grid"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Theme"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" Name="Placeholder Text"></w:LsdException> <w:LsdException Locked="false" Priority="1" QFormat="true" Name="No Spacing"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" Name="Revision"></w:LsdException> <w:LsdException Locked="false" Priority="34" QFormat="true" Name="List Paragraph"></w:LsdException> <w:LsdException Locked="false" Priority="29" QFormat="true" Name="Quote"></w:LsdException> <w:LsdException Locked="false" Priority="30" QFormat="true" Name="Intense Quote"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="19" QFormat="true" Name="Subtle Emphasis"></w:LsdException> <w:LsdException Locked="false" Priority="21" QFormat="true" Name="Intense Emphasis"></w:LsdException> <w:LsdException Locked="false" Priority="31" QFormat="true" Name="Subtle Reference"></w:LsdException> <w:LsdException Locked="false" Priority="32" QFormat="true" Name="Intense Reference"></w:LsdException> <w:LsdException Locked="false" Priority="33" QFormat="true" Name="Book Title"></w:LsdException> <w:LsdException Locked="false" Priority="37" SemiHidden="true" UnhideWhenUsed="true" Name="Bibliography"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="TOC Heading"></w:LsdException> <w:LsdException Locked="false" Priority="41" Name="Plain Table 1"></w:LsdException> <w:LsdException Locked="false" Priority="42" Name="Plain Table 2"></w:LsdException> <w:LsdException Locked="false" Priority="43" Name="Plain Table 3"></w:LsdException> <w:LsdException Locked="false" Priority="44" Name="Plain Table 4"></w:LsdException> <w:LsdException Locked="false" Priority="45" Name="Plain Table 5"></w:LsdException> <w:LsdException Locked="false" Priority="40" Name="Grid Table Light"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 6"></w:LsdException> </w:LatentStyles> </xml><![endif]--> <!-- [if gte mso 10]> <style> /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman",serif;} </style> <![endif]--></p> <p style="margin: 0in 0in 0.0001pt; text-align: justify; font-size: 12pt; font-family: 'Times New Roman', serif;"><font style="font-size: 10.0pt;">Ekso Bionics, as the accounting acquirer, recorded the Merger as the issuance of stock for the net monetary assets of Holdings accompanied by a recapitalization. This accounting was identical to that resulting from a reverse merger, except that no goodwill or intangible assets were recorded. In filings with the SEC subsequent to the Merger, including this filing, the historical financial statements of Holdings before the Merger have been replaced with the historical financial statements of Ekso Bionics before the Merger. The Merger is intended to be treated as a tax-free exchange under Section 368(a) of the Internal Revenue Code of 1986, as amended.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in;"><b>Retroactive Conversion of all Share and Per Share Amounts</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">In accordance with reverse merger accounting guidance, amounts for Ekso Bionics' historical (pre-merger) common stock, preferred stock and warrants and options to purchase common stock, including share and per share amounts, have been retroactively adjusted using their respective exchange ratios in these financial statements unless otherwise disclosed. The conversion ratios were <font>1.5238</font>, <font>1.6290</font>, <font>1.9548</font> and <font>1.9548</font> for one with respect to shares of Ekso Bionic's common stock, Series A preferred stock, Series A-2 preferred stock and Series B preferred stock, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b>Repayment of 2013 Bridge Note</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">In November 2013, in anticipation of the Merger and related private placement offering, Ekso Bionics completed a private placement to accredited investors of $<font>5,000</font> of its senior subordinated secured convertible notes (&#147;2013 Bridge Notes&#148;). Upon the closing of the Merger and the private placement offering described below, the $5,000 in outstanding principal and $<font>83</font> of accrued interest of the 2013 Bridge Notes automatically converted into <font>5,000,000</font> Units (as defined below), and investors in the 2013 Bridge Notes received warrants to purchase <font>2,500,000</font> shares of common stock at an exercise price of $<font>1.00</font> per share for a term of <font>three</font> years (&#147;Bridge Warrants&#148;). The Bridge Warrants had weighted average anti-dilution protection, subject to customary exceptions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b>Private Placement Offering</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">Concurrently with the closing of the Merger and in contemplation of the Merger, the Company held a closing of a private placement offering (&#147;PPO&#148;) in which it sold <font>20,580,000</font> units (&#147;Units&#148;) at a purchase price of $<font>1.00</font> per Unit, with each Unit consisting of <font>one</font> share of common stock plus a warrant to purchase an additional share of common stock of the Company at $<font>2.00</font> per share with a <font>five</font> year term (&#147;PPO Warrants&#148;). Included in the initial Unit sales were 5,000,000 Units that were issued upon conversion of the 2013 Bridge Notes mentioned above. Between January 29, 2014 and February 6, 2014, the Company issued an additional <font>9,720,000</font> Units in subsequent closings of the PPO. As a result of issuing a total of <font>30,300,000</font> Units, (a) the Company received gross proceeds of $<font>25,300</font>, (b) $<font>5,083</font> of debt and accrued interest attributable to the 2013 Bridge Notes was settled with the issuance of 5,000,000 Units, (c) $<font>2,553</font> of our Senior Note Payable (as defined below) was paid in full, and (d) we incurred offering costs of $<font>3,338</font>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><br/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">Investors in the Units have weighted average anti-dilution protection with respect to the shares of common stock included in the Units if within 24 months after the final closing of the PPO the Company issues additional shares of common stock or common stock equivalents (subject to customary exceptions, including but not limited to issuances of awards under the Company's 2014 Equity Incentive Plan) for consideration per share less than $1.00. The PPO warrants also had weighted average anti-dilution protection, subject to customary exceptions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">In connection with the conversion of the 2013 Bridge Notes and the PPO, the placement agent for the PPO and its sub-agents were paid an aggregate commission of $<font>3,030</font> and were issued warrants to purchase an aggregate of <font>3,030,000</font> shares of common stock with a term of <font>five</font> years and an exercise price of $<font>1.00</font>&#160;per share (&#147;Agent Warrants&#148;).&#160;The Agent Warrants had weighted average anti-dilution protection, subject to customary exceptions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b>Offer to Amend and Exercise</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">In November 2014, the Company consummated an offer to amend and exercise its PPO Warrants at a temporarily reduced exercise price (&#147;Offer to Amend and Exercise&#148;). Pursuant to the Offer to Amend and Exercise, an aggregate of <font>22,755,500</font> PPO Warrants were exercised by their holders and were also amended to reduce the exercise price from $<font>2.00</font> to $<font>1.00</font> per share of common stock, and to restrict the ability of the holder of shares issuable upon exercise of the amended warrants to sell, make any short sale of, loan, grant any option for the purchase of, or otherwise dispose of any of such shares without the prior written consent of the Company for a period of 50 days after the expiration date of the Offer to Amend and Exercise.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">In connection with the Offer to Amend and Exercise, the holders of a majority of the then outstanding PPO Warrants, Bridge Warrants, and Agent Warrants approved an amendment to remove the price-based anti-dilution provisions in those warrants (see Note 9,<i>&#160;Warrants</i>).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b>2014 Equity Incentive Plan</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">Before the Merger, the Board of Directors adopted, and the stockholders approved, the 2014 Equity Incentive Plan (&#147;2014 Plan&#148;), which provides for the issuance of incentive awards constituting up to <font>14,410,000</font> shares of common stock to officers, key employees, consultants and directors. In connection with the Merger, options to purchase Ekso Bionics common stock outstanding immediately prior to the Merger were converted into options to purchase an aggregate of <font>7,602,408</font> shares of Holdings issued under the 2014 Plan.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">On the closing of the Merger, the Board granted to officers and directors options to purchase an aggregate of <font>2,300,000</font> shares of common stock under the 2014 Plan.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><br/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">Subsequent to the Merger, on June 10, 2015, the Board submitted to the stockholders and the stockholders approved and ratified an amendment of the 2014 Plan to increase the maximum number of shares of common stock that may be issued under the 2014 Plan by <font>11,590,000</font> shares to <font>26,000,000</font> shares. As of June 30, 2015, there were <font>11,767,633</font> shares available for future awards.&#160;</p> </div> 1.00 1 1.00 1 1.00 1 1 1 353000 105000 6048000 5327000 2123000 1875000 8524000 7307000 4391000 3568000 126000 42000 46000 50000 48000 76000 6000 49000 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><b>4. Deferred Revenues</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><!-- [if gte mso 9]><xml> <o:OfficeDocumentSettings> <o:AllowPNG></o:AllowPNG> </o:OfficeDocumentSettings> </xml><![endif]--> <!-- [if gte mso 9]><xml> <w:WordDocument> <w:View>Normal</w:View> <w:Zoom>0</w:Zoom> <w:TrackMoves></w:TrackMoves> <w:TrackFormatting></w:TrackFormatting> <w:DoNotShowPropertyChanges></w:DoNotShowPropertyChanges> <w:PunctuationKerning></w:PunctuationKerning> <w:ValidateAgainstSchemas></w:ValidateAgainstSchemas> <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid> <w:IgnoreMixedContent>false</w:IgnoreMixedContent> <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText> <w:DoNotPromoteQF></w:DoNotPromoteQF> <w:LidThemeOther>EN-US</w:LidThemeOther> <w:LidThemeAsian>X-NONE</w:LidThemeAsian> <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript> <w:Compatibility> <w:BreakWrappedTables></w:BreakWrappedTables> <w:SnapToGridInCell></w:SnapToGridInCell> <w:WrapTextWithPunct></w:WrapTextWithPunct> <w:UseAsianBreakRules></w:UseAsianBreakRules> <w:DontGrowAutofit></w:DontGrowAutofit> <w:SplitPgBreakAndParaMark></w:SplitPgBreakAndParaMark> <w:EnableOpenTypeKerning></w:EnableOpenTypeKerning> <w:DontFlipMirrorIndents></w:DontFlipMirrorIndents> <w:OverrideTableStyleHps></w:OverrideTableStyleHps> </w:Compatibility> <m:mathPr> <m:mathFont m:val="Cambria Math"></m:mathFont> <m:brkBin m:val="before"></m:brkBin> <m:brkBinSub m:val="&#45;-"></m:brkBinSub> <m:smallFrac m:val="off"></m:smallFrac> <m:dispDef></m:dispDef> <m:lMargin m:val="0"></m:lMargin> <m:rMargin m:val="0"></m:rMargin> <m:defJc m:val="centerGroup"></m:defJc> <m:wrapIndent m:val="1440"></m:wrapIndent> <m:intLim m:val="subSup"></m:intLim> <m:naryLim m:val="undOvr"></m:naryLim> </m:mathPr></w:WordDocument> </xml><![endif]--><!-- [if gte mso 9]><xml> <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="false" DefSemiHidden="false" DefQFormat="false" DefPriority="99" LatentStyleCount="371"> <w:LsdException Locked="false" Priority="0" QFormat="true" Name="Normal"></w:LsdException> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 1"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 2"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 3"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 4"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 5"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 6"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 7"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 8"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 9"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 6"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 7"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 8"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 9"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 1"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 2"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 3"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 4"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 5"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 6"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 7"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 8"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 9"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Normal Indent"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="footnote text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="annotation text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="header"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="footer"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index heading"></w:LsdException> <w:LsdException Locked="false" Priority="35" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="caption"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="table of figures"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="envelope address"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="envelope return"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="footnote reference"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="annotation reference"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="line number"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="page number"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="endnote reference"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="endnote text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="table of authorities"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="macro"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="toa heading"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Bullet"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Number"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Bullet 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Bullet 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Bullet 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Bullet 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Number 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Number 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Number 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Number 5"></w:LsdException> <w:LsdException Locked="false" Priority="10" QFormat="true" Name="Title"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Closing"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Signature"></w:LsdException> <w:LsdException Locked="false" Priority="1" SemiHidden="true" UnhideWhenUsed="true" Name="Default Paragraph Font"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text Indent"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Continue"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Continue 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Continue 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Continue 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Continue 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Message Header"></w:LsdException> <w:LsdException Locked="false" Priority="11" QFormat="true" Name="Subtitle"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Salutation"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Date"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text First Indent"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text First Indent 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Note Heading"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text Indent 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text Indent 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Block Text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Hyperlink"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="FollowedHyperlink"></w:LsdException> <w:LsdException Locked="false" Priority="22" QFormat="true" Name="Strong"></w:LsdException> <w:LsdException Locked="false" Priority="20" QFormat="true" Name="Emphasis"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Document Map"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Plain Text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="E-mail Signature"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Top of Form"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Bottom of Form"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Normal (Web)"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Acronym"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Address"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Cite"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Code"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Definition"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Keyboard"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Preformatted"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Sample"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Typewriter"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Variable"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Normal Table"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="annotation subject"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="No List"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Outline List 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Outline List 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Outline List 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Simple 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Simple 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Simple 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Classic 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Classic 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Classic 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Classic 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Colorful 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Colorful 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Colorful 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Columns 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Columns 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Columns 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Columns 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Columns 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 6"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 7"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 8"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 6"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 7"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 8"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table 3D effects 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table 3D effects 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table 3D effects 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Contemporary"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Elegant"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Professional"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Subtle 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Subtle 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Web 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Web 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Web 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Balloon Text"></w:LsdException> <w:LsdException Locked="false" Priority="39" Name="Table Grid"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Theme"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" Name="Placeholder Text"></w:LsdException> <w:LsdException Locked="false" Priority="1" QFormat="true" Name="No Spacing"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" Name="Revision"></w:LsdException> <w:LsdException Locked="false" Priority="34" QFormat="true" Name="List Paragraph"></w:LsdException> <w:LsdException Locked="false" Priority="29" QFormat="true" Name="Quote"></w:LsdException> <w:LsdException Locked="false" Priority="30" QFormat="true" Name="Intense Quote"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="19" QFormat="true" Name="Subtle Emphasis"></w:LsdException> <w:LsdException Locked="false" Priority="21" QFormat="true" Name="Intense Emphasis"></w:LsdException> <w:LsdException Locked="false" Priority="31" QFormat="true" Name="Subtle Reference"></w:LsdException> <w:LsdException Locked="false" Priority="32" QFormat="true" Name="Intense Reference"></w:LsdException> <w:LsdException Locked="false" Priority="33" QFormat="true" Name="Book Title"></w:LsdException> <w:LsdException Locked="false" Priority="37" SemiHidden="true" UnhideWhenUsed="true" Name="Bibliography"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="TOC Heading"></w:LsdException> <w:LsdException Locked="false" Priority="41" Name="Plain Table 1"></w:LsdException> <w:LsdException Locked="false" Priority="42" Name="Plain Table 2"></w:LsdException> <w:LsdException Locked="false" Priority="43" Name="Plain Table 3"></w:LsdException> <w:LsdException Locked="false" Priority="44" Name="Plain Table 4"></w:LsdException> <w:LsdException Locked="false" Priority="45" Name="Plain Table 5"></w:LsdException> <w:LsdException Locked="false" Priority="40" Name="Grid Table Light"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 6"></w:LsdException> </w:LatentStyles> </xml><![endif]--> <!-- [if gte mso 10]> <style> /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman",serif;} </style> <![endif]--></p> <p style="margin: 0in 0in 0.0001pt; text-align: justify; font-size: 12pt; font-family: 'Times New Roman', serif;"><font style="font-size: 10.0pt;">In connection with our medical device sales and research services, we often receive cash payments before our earnings process is complete. In these instances, we record the payments as customer deposits until a device is shipped to the customer, or as customer advances in the case of research services until the earnings process is achieved.</font></p> <p style="margin: 0in 0in 0.0001pt; text-align: justify; font-size: 12pt; font-family: 'Times New Roman', serif;"><font style="font-size: 10.0pt;">&#160;</font></p> <p style="margin: 0in 0in 0.0001pt; text-align: justify; font-size: 12pt; font-family: 'Times New Roman', serif;"><font style="font-size: 10.0pt;">Revenue from our Ekso medical device sales is deferred and recognized over the maintenance period. Accordingly, at the time of shipment to the customer the amount billed is recorded as deferred revenue. Also, at the time of shipment, the related inventory is reclassified to deferred cost of revenue where it is amortized to cost of revenue over the same period as the related revenue.</font></p> <p style="margin: 0in 0in 0.0001pt; text-indent: 0.5in; font-size: 12pt; font-family: 'Times New Roman', serif;"><font style="font-size: 10.0pt;">&#160;</font></p> <p style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: 'Times New Roman', serif;"><font style="font-size: 10.0pt;">Deferred revenues and deferred cost of revenues consist of the following:</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;">&#160;</p> <div> <div style="display: block;"> <div class="CursorPointer"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; width: 90%; margin-left: 0.1px;"> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong> </strong></td> <td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><strong>June 30,</strong></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td> <td nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;" colspan="2"><strong>December 31,</strong><strong>&#160;</strong></td> <td nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px; width: 20px;" colspan="5"><strong>&#160;</strong><strong>&#160;</strong><strong>&#160;</strong><strong>&#160;</strong><strong>&#160;</strong></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong> </strong></td> <td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;"><strong>2015</strong></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td> <td nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" colspan="2"><strong>2014</strong><strong>&#160;</strong></td> <td nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px; width: 20px;" colspan="4"><strong>&#160;</strong><strong>&#160;</strong><strong>&#160;</strong><strong>&#160;</strong></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 70%; background-color: #cceeff;">Customer deposits and advances</td> <td style="font-family: 'times new roman'; padding: 0px; width: 1%; background-color: #cceeff;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 1%; background-color: #cceeff;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 12%; background-color: #cceeff;"><font> 353 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%; background-color: #cceeff;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 1%; background-color: #cceeff;">$</td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 12%; text-align: right; background-color: #cceeff;"><font>105</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%; text-align: right; background-color: #cceeff;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;">Deferred Ekso medical device revenues</td> <td style="font-family: 'Times New Roman';"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 6,048 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; text-align: right;"><font>5,327</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; text-align: right;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; background-color: #cceeff;">Deferred&#160;service and leasing revenues</td> <td style="font-family: 'times new roman'; padding: 0px; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; background-color: #cceeff;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; background-color: #cceeff;"><font> 2,123 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; background-color: #cceeff;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; text-align: right; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; background-color: #cceeff;"><font>1,875</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; text-align: right; background-color: #cceeff;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;">Customer advances and deferred revenues</td> <td style="font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 8,524 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; text-align: right;"><font>7,307</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; text-align: right;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; background-color: #cceeff;">Less current portion</td> <td style="font-family: 'times new roman'; padding: 0px; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; background-color: #cceeff;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; background-color: #cceeff;"><font> (4,032 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; background-color: #cceeff;">)</td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; background-color: #cceeff;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; text-align: right; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; background-color: #cceeff;"><font>(3,412</font></td> <td style="font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; text-align: left; background-color: #cceeff;">)</td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;">Customer advances and deferred revenues, non-current</td> <td style="font-family: 'times new roman'; padding: 0px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 4,492 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; text-align: right;"><font>3,895</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; text-align: right;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; background-color: #cceeff;">Deferred Ekso medical device costs</td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; background-color: #cceeff;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; background-color: #cceeff;"><font> 4,391 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman'; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; background-color: #cceeff;">$</td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; text-align: right; background-color: #cceeff;"><font>3,568</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; text-align: right; background-color: #cceeff;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;">Less current portion</td> <td style="font-family: 'times new roman'; padding: 0px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> (1,876 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap;">)</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; text-align: right;"><font>(1,551</font></td> <td style="font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; text-align: left;">)</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; background-color: #cceeff;">Deferred cost of revenue, non-current</td> <td style="font-family: 'times new roman'; padding: 0px; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; background-color: #cceeff;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; background-color: #cceeff;"><font> 2,515 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; background-color: #cceeff;">$</td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; text-align: right; border-bottom-color: #000000 !important; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; background-color: #cceeff;"><font>2,017</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; text-align: right; background-color: #cceeff;">&#160;</td> </tr> </table> </div> </div> </div> </div> <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <div style="display: block;"> <div class="CursorPointer"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; width: 90%; margin-left: 0.1px;"> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong> </strong></td> <td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><strong>June 30,</strong></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td> <td nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;" colspan="2"><strong>December 31,</strong><strong>&#160;</strong></td> <td nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px; width: 20px;" colspan="5"><strong>&#160;</strong><strong>&#160;</strong><strong>&#160;</strong><strong>&#160;</strong><strong>&#160;</strong></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong> </strong></td> <td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;"><strong>2015</strong></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td> <td nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" colspan="2"><strong>2014</strong><strong>&#160;</strong></td> <td nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px; width: 20px;" colspan="4"><strong>&#160;</strong><strong>&#160;</strong><strong>&#160;</strong><strong>&#160;</strong></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 70%; background-color: #cceeff;">Customer deposits and advances</td> <td style="font-family: 'times new roman'; padding: 0px; width: 1%; background-color: #cceeff;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 1%; background-color: #cceeff;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 12%; background-color: #cceeff;"><font> 353 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%; background-color: #cceeff;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 1%; background-color: #cceeff;">$</td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 12%; text-align: right; background-color: #cceeff;"><font>105</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%; text-align: right; background-color: #cceeff;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;">Deferred Ekso medical device revenues</td> <td style="font-family: 'Times New Roman';"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 6,048 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; text-align: right;"><font>5,327</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; text-align: right;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; background-color: #cceeff;">Deferred&#160;service and leasing revenues</td> <td style="font-family: 'times new roman'; padding: 0px; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; background-color: #cceeff;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; background-color: #cceeff;"><font> 2,123 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; background-color: #cceeff;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; text-align: right; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; background-color: #cceeff;"><font>1,875</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; text-align: right; background-color: #cceeff;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;">Customer advances and deferred revenues</td> <td style="font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 8,524 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; text-align: right;"><font>7,307</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; text-align: right;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; background-color: #cceeff;">Less current portion</td> <td style="font-family: 'times new roman'; padding: 0px; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; background-color: #cceeff;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; background-color: #cceeff;"><font> (4,032 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; background-color: #cceeff;">)</td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; background-color: #cceeff;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; text-align: right; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; background-color: #cceeff;"><font>(3,412</font></td> <td style="font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; text-align: left; background-color: #cceeff;">)</td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;">Customer advances and deferred revenues, non-current</td> <td style="font-family: 'times new roman'; padding: 0px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 4,492 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; text-align: right;"><font>3,895</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; text-align: right;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; background-color: #cceeff;">Deferred Ekso medical device costs</td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; background-color: #cceeff;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; background-color: #cceeff;"><font> 4,391 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman'; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; background-color: #cceeff;">$</td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; text-align: right; background-color: #cceeff;"><font>3,568</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; text-align: right; background-color: #cceeff;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;">Less current portion</td> <td style="font-family: 'times new roman'; padding: 0px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> (1,876 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap;">)</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; text-align: right;"><font>(1,551</font></td> <td style="font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; text-align: left;">)</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; background-color: #cceeff;">Deferred cost of revenue, non-current</td> <td style="font-family: 'times new roman'; padding: 0px; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; background-color: #cceeff;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; background-color: #cceeff;"><font> 2,515 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; background-color: #cceeff;">$</td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; text-align: right; border-bottom-color: #000000 !important; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; background-color: #cceeff;"><font>2,017</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; text-align: right; background-color: #cceeff;">&#160;</td> </tr> </table> </div> </div> </div> 1516000 1847000 273000 184000 91000 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><b>5. Accrued Liabilities</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">Accrued liabilities consist of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <div> <div style="display: block;"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; width: 90%; margin-left: 0.1px;"> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong> </strong></td> <td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><strong>June 30,</strong></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td> <td nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;" colspan="2"><strong>December 31,</strong></td> <td nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px; width: 20px;" colspan="4"><strong>&#160;</strong><strong>&#160;</strong><strong>&#160;</strong><strong>&#160;</strong></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong> </strong></td> <td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;"><strong>2015</strong></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td> <td nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" colspan="2"><strong>2014</strong></td> <td nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px; width: 20px;" colspan="5"><strong>&#160;</strong><strong>&#160;</strong><strong>&#160;</strong><strong>&#160;</strong><strong>&#160;</strong></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 70%; background-color: #cceeff;">Salaries,&#160;benefits&#160;and&#160;related&#160;expenses</td> <td style="font-family: 'times new roman'; padding: 0px; width: 1%; background-color: #cceeff;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 1%; background-color: #cceeff;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 12%; background-color: #cceeff;"><font> 1,516 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%; background-color: #cceeff;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 1%; background-color: #cceeff;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 12%; background-color: #cceeff;"><font>1,847</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%; background-color: #cceeff;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;">Professional fees</td> <td style="font-family: 'Times New Roman';"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 273 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>184</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; background-color: #cceeff;">Warranty expense</td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; background-color: #cceeff;"><font> 91 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman'; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; background-color: #cceeff;"><font>126</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';">Taxes</td> <td style="font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 42 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>46</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-family: 'Times New Roman'; background-color: #cceeff;">Royalties</td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; background-color: #cceeff;"><font> - </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman'; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; background-color: #cceeff;"><font>50</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';">Travel</td> <td style="font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 48 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>76</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-family: 'times new roman'; padding: 0px; background-color: #cceeff;">All other</td> <td style="font-family: 'times new roman'; padding: 0px; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; background-color: #cceeff;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; background-color: #cceeff;"><font> 6 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; background-color: #cceeff;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; background-color: #cceeff;"><font>49</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'times new roman'; padding: 0px;">Total</td> <td style="font-family: 'times new roman'; padding: 0px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 1,976 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>2,378</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;">&#160;</td> </tr> </table> </div> </div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> </div> <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <div style="display: block;"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; width: 90%; margin-left: 0.1px;"> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong> </strong></td> <td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><strong>June 30,</strong></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td> <td nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;" colspan="2"><strong>December 31,</strong></td> <td nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px; width: 20px;" colspan="4"><strong>&#160;</strong><strong>&#160;</strong><strong>&#160;</strong><strong>&#160;</strong></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong> </strong></td> <td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;"><strong>2015</strong></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td> <td nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" colspan="2"><strong>2014</strong></td> <td nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px; width: 20px;" colspan="5"><strong>&#160;</strong><strong>&#160;</strong><strong>&#160;</strong><strong>&#160;</strong><strong>&#160;</strong></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 70%; background-color: #cceeff;">Salaries,&#160;benefits&#160;and&#160;related&#160;expenses</td> <td style="font-family: 'times new roman'; padding: 0px; width: 1%; background-color: #cceeff;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 1%; background-color: #cceeff;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 12%; background-color: #cceeff;"><font> 1,516 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%; background-color: #cceeff;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 1%; background-color: #cceeff;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 12%; background-color: #cceeff;"><font>1,847</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%; background-color: #cceeff;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;">Professional fees</td> <td style="font-family: 'Times New Roman';"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 273 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>184</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; background-color: #cceeff;">Warranty expense</td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; background-color: #cceeff;"><font> 91 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman'; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; background-color: #cceeff;"><font>126</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';">Taxes</td> <td style="font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 42 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>46</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-family: 'Times New Roman'; background-color: #cceeff;">Royalties</td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; background-color: #cceeff;"><font> - </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman'; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; background-color: #cceeff;"><font>50</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';">Travel</td> <td style="font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 48 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>76</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-family: 'times new roman'; padding: 0px; background-color: #cceeff;">All other</td> <td style="font-family: 'times new roman'; padding: 0px; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; background-color: #cceeff;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; background-color: #cceeff;"><font> 6 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; background-color: #cceeff;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; background-color: #cceeff;"><font>49</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'times new roman'; padding: 0px;">Total</td> <td style="font-family: 'times new roman'; padding: 0px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 1,976 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>2,378</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;">&#160;</td> </tr> </table> </div> </div> 3000 24000 27000 5000 48000 53000 4000 19000 23000 12000 91000 103000 1000 6000 7000 11000 85000 96000 43000 11000 42000 200000 0.07 4000 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <div style="display: block;"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b>6. Notes Payable</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">In 2012, the Company entered into a note agreement in connection with its lease agreement for our Richmond, California facility. The note, for an aggregate principal of $<font>200</font>, with an interest rate of <font>7</font>%, minimum monthly payments of $<font>4</font>, and a May 31, 2017, maturity, was used to fund leasehold improvements. In addition, the Company has a long-term capital lease obligation of $11 (see Note 7, <em>Operating and Capital Leases</em>).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">Future obligations under these debt instruments as of June 30, 2015 are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <div class="CursorPointer"> <div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif;" width="100%"> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td nowrap="nowrap" style="width: 20px;">&#160;</td> <td nowrap="nowrap" style="width: 20px;">&#160;</td> <td nowrap="nowrap">&#160;</td> <td colspan="2" nowrap="nowrap" style="text-align: center;"><strong>Leasehold&#160;</strong></td> <td nowrap="nowrap"><strong>&#160;</strong></td> <td nowrap="nowrap"><strong>&#160;</strong></td> <td colspan="2" nowrap="nowrap" style="text-align: center;"><br/></td> <td nowrap="nowrap"><strong>&#160;</strong></td> <td nowrap="nowrap"><strong>&#160;</strong></td> <td colspan="2" nowrap="nowrap"><strong>&#160;</strong></td> <td nowrap="nowrap">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td nowrap="nowrap" style="width: 20px;">&#160;</td> <td nowrap="nowrap" style="width: 20px;">&#160;</td> <td nowrap="nowrap">&#160;</td> <td colspan="2" nowrap="nowrap" style="text-align: center;"><strong>Improvement</strong></td> <td nowrap="nowrap"><strong>&#160;</strong></td> <td nowrap="nowrap"><strong>&#160;</strong></td> <td colspan="2" nowrap="nowrap" style="text-align: center;"><strong>Capital</strong></td> <td nowrap="nowrap"><strong>&#160;</strong></td> <td nowrap="nowrap"><strong>&#160;</strong></td> <td colspan="2" nowrap="nowrap"><strong>&#160;</strong></td> <td nowrap="nowrap">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td nowrap="nowrap" style="padding-bottom: 1pt; width: 20px;">&#160;</td> <td nowrap="nowrap" style="padding-bottom: 1pt; width: 20px;">&#160;</td> <td nowrap="nowrap" style="padding-bottom: 1pt;">&#160;</td> <td colspan="2" nowrap="nowrap" style="text-align: center; border-bottom: Black 1pt solid !important;"><strong>Note</strong></td> <td nowrap="nowrap" style="padding-bottom: 1pt;"><strong>&#160;</strong></td> <td nowrap="nowrap" style="padding-bottom: 1pt;"><strong>&#160;</strong></td> <td colspan="2" nowrap="nowrap" style="text-align: center; border-bottom: Black 1pt solid !important;"><strong>Lease</strong></td> <td nowrap="nowrap" style="padding-bottom: 1pt;"><strong>&#160;</strong></td> <td nowrap="nowrap" style="padding-bottom: 1pt;"><strong>&#160;</strong></td> <td colspan="2" nowrap="nowrap" style="text-align: center; border-bottom: Black 1pt solid !important;"><strong>Total</strong></td> <td nowrap="nowrap" style="padding-bottom: 1pt;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 55%;">2015 (remainder)</td> <td style="width: 1px;"><br/></td> <td style="width: 1px;"></td> <td style="width: 1%;">&#160;</td> <td style="width: 1%; text-align: left;">$</td> <td style="width: 12%; text-align: right;"><font> 24 </font></td> <td style="width: 1%; text-align: left;">&#160;</td> <td style="width: 1%;">&#160;</td> <td style="width: 1%; text-align: left;">$</td> <td style="width: 12%; text-align: right;"><font>3 </font></td> <td style="width: 1%; text-align: left;">&#160;</td> <td style="width: 1%;">&#160;</td> <td style="width: 1%; text-align: left;">$</td> <td style="width: 12%; text-align: right;"><font> 27 </font></td> <td style="width: 1%; text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left;">2016</td> <td style="width: 20px;"><br/></td> <td style="width: 20px;"></td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;"><font> 48 </font></td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;"><font>5 </font></td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;"><font> 53 </font></td> <td style="text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; padding-bottom: 1pt;">2017</td> <td style="padding-bottom: 1pt; width: 20px;"><br/></td> <td style="padding-bottom: 1pt; width: 20px;"></td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: Black 1pt solid !important; text-align: left;">&#160;</td> <td style="border-bottom: Black 1pt solid !important; text-align: right;"><font> 19 </font></td> <td style="padding-bottom: 1pt; text-align: left;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: Black 1pt solid !important; text-align: left;">&#160;</td> <td style="border-bottom: Black 1pt solid !important; text-align: right;"><font>4 </font></td> <td style="padding-bottom: 1pt; text-align: left;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: Black 1pt solid !important; text-align: left;">&#160;</td> <td style="border-bottom: Black 1pt solid !important; text-align: right;"><font> 23 </font></td> <td style="padding-bottom: 1pt; text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left;">Total minimum payments</td> <td style="width: 20px;"><br/></td> <td style="width: 20px;"></td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;"><font> 91 </font></td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;"><font>12 </font></td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;"><font> 103 </font></td> <td style="text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; padding-bottom: 1pt;">Less: interest</td> <td style="padding-bottom: 1pt; width: 20px;"><br/></td> <td style="padding-bottom: 1pt; width: 20px;"><br/></td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: Black 1pt solid !important; text-align: left;">&#160;</td> <td style="border-bottom: Black 1pt solid !important; text-align: right;"><font> (6 </font></td> <td style="padding-bottom: 1pt; text-align: left;">)</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: Black 1pt solid !important; text-align: left;">&#160;</td> <td style="border-bottom: Black 1pt solid !important; text-align: right;"><font>(1 </font></td> <td style="padding-bottom: 1pt; text-align: left;">)</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: Black 1pt solid !important; text-align: left;">&#160;</td> <td style="border-bottom: Black 1pt solid !important; text-align: right;"><font> (7 </font></td> <td style="padding-bottom: 1pt; text-align: left;">)</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left;">Present&#160;value&#160;minimum payments</td> <td style="width: 20px;"><br/></td> <td style="width: 20px;"></td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;"><font> 85 </font></td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;"><font>11 </font></td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;"><font> 96 </font></td> <td style="text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; padding-bottom: 1pt;">Less: current portion</td> <td style="padding-bottom: 1pt; width: 20px;"><br/></td> <td style="padding-bottom: 1pt; width: 20px;"></td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: Black 1pt solid !important; text-align: left;">&#160;</td> <td style="border-bottom: Black 1pt solid !important; text-align: right;"><font> (43 </font></td> <td style="padding-bottom: 1pt; text-align: left;">)</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: Black 1pt solid !important; text-align: left;">&#160;</td> <td style="border-bottom: Black 1pt solid !important; text-align: right;"><font>- </font></td> <td style="padding-bottom: 1pt; text-align: left;"><br/></td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: Black 1pt solid !important; text-align: left;">&#160;</td> <td style="border-bottom: Black 1pt solid !important; text-align: right;"><font> (43 </font></td> <td style="padding-bottom: 1pt; text-align: left;">)</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left; padding-bottom: 2.5pt;">Long-term portion of notes payable</td> <td style="padding-bottom: 2.5pt; width: 20px;"><br/></td> <td style="padding-bottom: 2.5pt; width: 20px;"></td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: Black 2.5pt double !important; text-align: left;">$</td> <td style="border-bottom: Black 2.5pt double !important; text-align: right;"><font> 42 </font></td> <td style="padding-bottom: 2.5pt; text-align: left;">&#160;</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: Black 2.5pt double !important; text-align: left;">$</td> <td style="border-bottom: Black 2.5pt double !important; text-align: right;"><font>11 </font></td> <td style="padding-bottom: 2.5pt; text-align: left;">&#160;</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: Black 2.5pt double !important; text-align: left;">$</td> <td style="border-bottom: Black 2.5pt double !important; text-align: right;"><font> 53 </font></td> <td style="padding-bottom: 2.5pt; text-align: left;">&#160;</td> </tr> </table> </div> </div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><br/></p> </div> </div> 2600000 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif;" width="100%"> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td nowrap="nowrap" style="width: 20px;">&#160;</td> <td nowrap="nowrap" style="width: 20px;">&#160;</td> <td nowrap="nowrap">&#160;</td> <td colspan="2" nowrap="nowrap" style="text-align: center;"><strong>Leasehold&#160;</strong></td> <td nowrap="nowrap"><strong>&#160;</strong></td> <td nowrap="nowrap"><strong>&#160;</strong></td> <td colspan="2" nowrap="nowrap" style="text-align: center;"><br/></td> <td nowrap="nowrap"><strong>&#160;</strong></td> <td nowrap="nowrap"><strong>&#160;</strong></td> <td colspan="2" nowrap="nowrap"><strong>&#160;</strong></td> <td nowrap="nowrap">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td nowrap="nowrap" style="width: 20px;">&#160;</td> <td nowrap="nowrap" style="width: 20px;">&#160;</td> <td nowrap="nowrap">&#160;</td> <td colspan="2" nowrap="nowrap" style="text-align: center;"><strong>Improvement</strong></td> <td nowrap="nowrap"><strong>&#160;</strong></td> <td nowrap="nowrap"><strong>&#160;</strong></td> <td colspan="2" nowrap="nowrap" style="text-align: center;"><strong>Capital</strong></td> <td nowrap="nowrap"><strong>&#160;</strong></td> <td nowrap="nowrap"><strong>&#160;</strong></td> <td colspan="2" nowrap="nowrap"><strong>&#160;</strong></td> <td nowrap="nowrap">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td nowrap="nowrap" style="padding-bottom: 1pt; width: 20px;">&#160;</td> <td nowrap="nowrap" style="padding-bottom: 1pt; width: 20px;">&#160;</td> <td nowrap="nowrap" style="padding-bottom: 1pt;">&#160;</td> <td colspan="2" nowrap="nowrap" style="text-align: center; border-bottom: Black 1pt solid !important;"><strong>Note</strong></td> <td nowrap="nowrap" style="padding-bottom: 1pt;"><strong>&#160;</strong></td> <td nowrap="nowrap" style="padding-bottom: 1pt;"><strong>&#160;</strong></td> <td colspan="2" nowrap="nowrap" style="text-align: center; border-bottom: Black 1pt solid !important;"><strong>Lease</strong></td> <td nowrap="nowrap" style="padding-bottom: 1pt;"><strong>&#160;</strong></td> <td nowrap="nowrap" style="padding-bottom: 1pt;"><strong>&#160;</strong></td> <td colspan="2" nowrap="nowrap" style="text-align: center; border-bottom: Black 1pt solid !important;"><strong>Total</strong></td> <td nowrap="nowrap" style="padding-bottom: 1pt;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 55%;">2015 (remainder)</td> <td style="width: 1px;"><br/></td> <td style="width: 1px;"></td> <td style="width: 1%;">&#160;</td> <td style="width: 1%; text-align: left;">$</td> <td style="width: 12%; text-align: right;"><font> 24 </font></td> <td style="width: 1%; text-align: left;">&#160;</td> <td style="width: 1%;">&#160;</td> <td style="width: 1%; text-align: left;">$</td> <td style="width: 12%; text-align: right;"><font>3 </font></td> <td style="width: 1%; text-align: left;">&#160;</td> <td style="width: 1%;">&#160;</td> <td style="width: 1%; text-align: left;">$</td> <td style="width: 12%; text-align: right;"><font> 27 </font></td> <td style="width: 1%; text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left;">2016</td> <td style="width: 20px;"><br/></td> <td style="width: 20px;"></td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;"><font> 48 </font></td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;"><font>5 </font></td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;"><font> 53 </font></td> <td style="text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; padding-bottom: 1pt;">2017</td> <td style="padding-bottom: 1pt; width: 20px;"><br/></td> <td style="padding-bottom: 1pt; width: 20px;"></td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: Black 1pt solid !important; text-align: left;">&#160;</td> <td style="border-bottom: Black 1pt solid !important; text-align: right;"><font> 19 </font></td> <td style="padding-bottom: 1pt; text-align: left;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: Black 1pt solid !important; text-align: left;">&#160;</td> <td style="border-bottom: Black 1pt solid !important; text-align: right;"><font>4 </font></td> <td style="padding-bottom: 1pt; text-align: left;">&#160;</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: Black 1pt solid !important; text-align: left;">&#160;</td> <td style="border-bottom: Black 1pt solid !important; text-align: right;"><font> 23 </font></td> <td style="padding-bottom: 1pt; text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left;">Total minimum payments</td> <td style="width: 20px;"><br/></td> <td style="width: 20px;"></td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;"><font> 91 </font></td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;"><font>12 </font></td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;"><font> 103 </font></td> <td style="text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; padding-bottom: 1pt;">Less: interest</td> <td style="padding-bottom: 1pt; width: 20px;"><br/></td> <td style="padding-bottom: 1pt; width: 20px;"><br/></td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: Black 1pt solid !important; text-align: left;">&#160;</td> <td style="border-bottom: Black 1pt solid !important; text-align: right;"><font> (6 </font></td> <td style="padding-bottom: 1pt; text-align: left;">)</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: Black 1pt solid !important; text-align: left;">&#160;</td> <td style="border-bottom: Black 1pt solid !important; text-align: right;"><font>(1 </font></td> <td style="padding-bottom: 1pt; text-align: left;">)</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: Black 1pt solid !important; text-align: left;">&#160;</td> <td style="border-bottom: Black 1pt solid !important; text-align: right;"><font> (7 </font></td> <td style="padding-bottom: 1pt; text-align: left;">)</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left;">Present&#160;value&#160;minimum payments</td> <td style="width: 20px;"><br/></td> <td style="width: 20px;"></td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;"><font> 85 </font></td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;"><font>11 </font></td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;"><font> 96 </font></td> <td style="text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; padding-bottom: 1pt;">Less: current portion</td> <td style="padding-bottom: 1pt; width: 20px;"><br/></td> <td style="padding-bottom: 1pt; width: 20px;"></td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: Black 1pt solid !important; text-align: left;">&#160;</td> <td style="border-bottom: Black 1pt solid !important; text-align: right;"><font> (43 </font></td> <td style="padding-bottom: 1pt; text-align: left;">)</td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: Black 1pt solid !important; text-align: left;">&#160;</td> <td style="border-bottom: Black 1pt solid !important; text-align: right;"><font>- </font></td> <td style="padding-bottom: 1pt; text-align: left;"><br/></td> <td style="padding-bottom: 1pt;">&#160;</td> <td style="border-bottom: Black 1pt solid !important; text-align: left;">&#160;</td> <td style="border-bottom: Black 1pt solid !important; text-align: right;"><font> (43 </font></td> <td style="padding-bottom: 1pt; text-align: left;">)</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left; padding-bottom: 2.5pt;">Long-term portion of notes payable</td> <td style="padding-bottom: 2.5pt; width: 20px;"><br/></td> <td style="padding-bottom: 2.5pt; width: 20px;"></td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: Black 2.5pt double !important; text-align: left;">$</td> <td style="border-bottom: Black 2.5pt double !important; text-align: right;"><font> 42 </font></td> <td style="padding-bottom: 2.5pt; text-align: left;">&#160;</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: Black 2.5pt double !important; text-align: left;">$</td> <td style="border-bottom: Black 2.5pt double !important; text-align: right;"><font>11 </font></td> <td style="padding-bottom: 2.5pt; text-align: left;">&#160;</td> <td style="padding-bottom: 2.5pt;">&#160;</td> <td style="border-bottom: Black 2.5pt double !important; text-align: left;">$</td> <td style="border-bottom: Black 2.5pt double !important; text-align: right;"><font> 53 </font></td> <td style="padding-bottom: 2.5pt; text-align: left;">&#160;</td> </tr> </table> </div> P5Y 188000 375000 157000 720000 11000 13000 86000 86000 2017-05-31 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <div align="center"> <table style="border-collapse: collapse; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; width: 60%; margin-left: 0.100000001490116px; margin-right: 0.1px;" cellpadding="0" cellspacing="0"> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">Dividend yield</font></td> <td style="font-family: 'Times New Roman';" align="center"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;" align="center"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;" align="center"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px;" align="center" nowrap="nowrap"><br/></td> <td style="font-family: 'times new roman'; padding: 0px;" colspan="2" align="center" nowrap="nowrap"><font style="font-size: 10pt;"><font><font>&#150;</font><font>&#160;</font><font>&#160;</font>&#160;&#160;</font><font>&#160;</font></font></td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 70%;"><font style="font-size: 10pt;">Risk-free interest rate</font></td> <td style="font-family: 'Times New Roman'; width: 0%;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 0%;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px 5px; font-size: 10pt; white-space: nowrap; width: 0%;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px 0px 0px; font-size: 10pt; vertical-align: bottom; white-space: nowrap; width: 0%;" align="left"></td> <td style="font-family: 'times new roman'; padding: 0px; font-size: 10pt; vertical-align: bottom; white-space: nowrap; text-align: center; width: 15%;" align="right" nowrap="nowrap"><font style="font-size: 10pt;"><font>0.69</font>% - <font>1.45</font>%</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 0%;"><font style="font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">Share price at final valuation</font></td> <td style="font-family: 'times new roman'; padding: 0px;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; text-align: center;" align="right" nowrap="nowrap"><font><font style="font-size: 10pt;">1.47</font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">Expected term (in years)</font></td> <td style="font-family: 'Times New Roman';"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; font-size: 10pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="font-family: 'times new roman'; padding: 0px; font-size: 10pt; vertical-align: bottom; white-space: nowrap; text-align: center;" align="right" nowrap="nowrap"><font style="font-size: 10pt;"><font>2.55</font>- <font>4.55</font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-family: 'Times New Roman';"><font style="font-size: 10pt;">Volatility</font></td> <td style="font-family: 'Times New Roman';"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; text-align: center;" align="right" nowrap="nowrap"><font style="font-size: 10pt;"><font>70</font>-<font>75</font>%</font></td> <td style="text-align: left; padding: 0px; font-family: 'Times New Roman';"><font style="font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">Periodic rate</font></td> <td style="font-family: 'Times New Roman';"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; font-size: 10pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="font-family: 'times new roman'; padding: 0px; font-size: 10pt; vertical-align: bottom; white-space: nowrap; text-align: center;" align="right" nowrap="nowrap"><font style="font-size: 10pt;"><font>0.18</font>% - <font>0.66</font>%</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">Periods in the model</font></td> <td style="font-family: 'Times New Roman';"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; text-align: center;" align="right" nowrap="nowrap"><font><font style="font-size: 10pt;">10</font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> </tr> </table> </div> </div> 1.00 P3Y 2600000 7544500 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b>7. Operating and Capital Leases</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">On November 29, 2011, the Company entered into an operating lease agreement for its headquarters and manufacturing facility in Richmond, California. The lease term commenced in March 2012 and expires in May 2017. The lease provides the Company with one option to renew for <font>five</font> additional years. The Company also leases nominal office equipment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">Future minimum operating lease payments are as follows as of June 30, 2015:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <div class="CursorPointer"> <div> <div align="center"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; width: 50%; margin-left: 0.1px;"> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-family: 'times new roman'; padding: 0px; width: 83%;">2015&#160;(remainder&#160;of&#160;year)</td> <td style="font-family: 'times new roman'; padding: 0px; width: 1%;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 1%;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 14%;"><font>188</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;">2016</td> <td style="font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>375</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;">2017</td> <td style="font-family: 'times new roman'; padding: 0px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>157</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-family: 'times new roman'; padding: 0px;">Total</td> <td style="font-family: 'times new roman'; padding: 0px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>720</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;">&#160;</td> </tr> </table> </div> </div> </div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">The Company also has a capital lease for the purchase of machinery and equipment with a balance of $<font>11</font>&#160;and $<font>13</font> as of June 30, 2015, and December 31, 2014, respectively, which is classified as a component of Notes payable, non-current (see Note 6, <i>Notes Payable</i>).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">Rent expense under the Company's operating leases was $<font>86</font>&#160;and $<font>86</font>&#160;for the three&#160;month periods ended June 30, 2015, and 2014, respectively&#160;and was $<font>172</font> and $<font>171</font> for the six month period ended June 30, 2015, and 2014, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><br/></p> </div> <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <div align="center"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; width: 50%; margin-left: 0.1px;"> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-family: 'times new roman'; padding: 0px; width: 83%;">2015&#160;(remainder&#160;of&#160;year)</td> <td style="font-family: 'times new roman'; padding: 0px; width: 1%;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 1%;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 14%;"><font>188</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;">2016</td> <td style="font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>375</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;">2017</td> <td style="font-family: 'times new roman'; padding: 0px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>157</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-family: 'times new roman'; padding: 0px;">Total</td> <td style="font-family: 'times new roman'; padding: 0px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>720</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;">&#160;</td> </tr> </table> </div> </div> <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><b>9. Warrants</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">As discussed in <i>Note 3,</i> <i>The Merger, Offering and Other Related Transactions,</i> the Company issued during the Merger and PPO, warrants to purchase a total of <font>36,055,000</font> shares of common stock of which <font>30,300,000</font> were at an exercise price of $<font>2.00</font> per share, and the balance at $<font>1.00</font> per share. These warrants contained &#147;weighted average&#148; anti-dilution protection in the event that we issued common stock or securities convertible into or exercisable for shares of common stock at a price lower than the subject warrant's exercise price, subject to certain customary exceptions, as well as customary provisions for adjustment in the event of stock splits, subdivision or combination, mergers, etc.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><br/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">Due to the market price of the Company's common stock price exceeding the exercise price of the then outstanding warrants, the Company recorded a non-cash charge of $<font>77,437</font>&#160;during the period ended March 31, 2014. As the market price of our common stock declined during the three months ended June 30, 2014, but still exceeded the exercise price of outstanding warrants, the Company recorded a non-cash benefit of $<font>60,458</font> for the period.<br/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">The factors utilized in re-valuing the warrants were as follows as of June 30, 2014:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b>&#160;</b></p> <div> <div align="center"> <table style="border-collapse: collapse; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; width: 60%; margin-left: 0.100000001490116px; margin-right: 0.1px;" cellpadding="0" cellspacing="0"> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">Dividend yield</font></td> <td style="font-family: 'Times New Roman';" align="center"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;" align="center"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;" align="center"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px;" align="center" nowrap="nowrap"><br/></td> <td style="font-family: 'times new roman'; padding: 0px;" colspan="2" align="center" nowrap="nowrap"><font style="font-size: 10pt;"><font><font>&#150;</font><font>&#160;</font><font>&#160;</font>&#160;&#160;</font><font>&#160;</font></font></td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 70%;"><font style="font-size: 10pt;">Risk-free interest rate</font></td> <td style="font-family: 'Times New Roman'; width: 0%;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 0%;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px 5px; font-size: 10pt; white-space: nowrap; width: 0%;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px 0px 0px; font-size: 10pt; vertical-align: bottom; white-space: nowrap; width: 0%;" align="left"></td> <td style="font-family: 'times new roman'; padding: 0px; font-size: 10pt; vertical-align: bottom; white-space: nowrap; text-align: center; width: 15%;" align="right" nowrap="nowrap"><font style="font-size: 10pt;"><font>0.69</font>% - <font>1.45</font>%</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 0%;"><font style="font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">Share price at final valuation</font></td> <td style="font-family: 'times new roman'; padding: 0px;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; text-align: center;" align="right" nowrap="nowrap"><font><font style="font-size: 10pt;">1.47</font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">Expected term (in years)</font></td> <td style="font-family: 'Times New Roman';"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; font-size: 10pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="font-family: 'times new roman'; padding: 0px; font-size: 10pt; vertical-align: bottom; white-space: nowrap; text-align: center;" align="right" nowrap="nowrap"><font style="font-size: 10pt;"><font>2.55</font>- <font>4.55</font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-family: 'Times New Roman';"><font style="font-size: 10pt;">Volatility</font></td> <td style="font-family: 'Times New Roman';"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; text-align: center;" align="right" nowrap="nowrap"><font style="font-size: 10pt;"><font>70</font>-<font>75</font>%</font></td> <td style="text-align: left; padding: 0px; font-family: 'Times New Roman';"><font style="font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">Periodic rate</font></td> <td style="font-family: 'Times New Roman';"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px; font-size: 10pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; font-size: 10pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="font-family: 'times new roman'; padding: 0px; font-size: 10pt; vertical-align: bottom; white-space: nowrap; text-align: center;" align="right" nowrap="nowrap"><font style="font-size: 10pt;"><font>0.18</font>% - <font>0.66</font>%</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">Periods in the model</font></td> <td style="font-family: 'Times New Roman';"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; text-align: center;" align="right" nowrap="nowrap"><font><font style="font-size: 10pt;">10</font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> </tr> </table> </div> </div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">These warrants were amended in November 2014 to remove the price-based anti-dilution provision, among other things. Accordingly, the warrants are no longer recorded as a liability.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">Warrant activity for the six month period ended June 30, 2015 is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <div> <table style="border-collapse: collapse; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; width: 95%; margin-left: 0.1px;" cellpadding="0" cellspacing="0"> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" colspan="2" nowrap="nowrap"><strong>Balance</strong></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"><strong>&#160;</strong></td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" colspan="2" nowrap="nowrap"><strong>Exercise</strong></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"><strong>&#160;</strong></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"><strong>&#160;</strong></td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" colspan="2" nowrap="nowrap"><strong>Term</strong></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"><strong>&#160;</strong></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"><strong>&#160;</strong></td> <td style="font-family: 'Times New Roman';" colspan="2" nowrap="nowrap"><strong>&#160;</strong></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"><strong>&#160;</strong></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"><strong>&#160;</strong></td> <td style="text-align: center; padding: 0px;" colspan="2" nowrap="nowrap"><strong>Balance</strong><br/></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"><strong>&#160;</strong></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" nowrap="nowrap"><strong>Name</strong></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"></td> <td style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" colspan="2" nowrap="nowrap"><strong>December 31, 2014</strong></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><strong>&#160;</strong></td> <td style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" colspan="2" nowrap="nowrap"><strong>Price</strong></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><strong>&#160;</strong></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><strong>&#160;</strong></td> <td style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" colspan="2" nowrap="nowrap"><strong>(Years)</strong></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><strong>&#160;</strong></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><strong>&#160;</strong></td> <td style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" colspan="2" nowrap="nowrap"><strong>Exercised</strong></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><strong>&#160;</strong></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><strong>&#160;</strong></td> <td style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" colspan="2" nowrap="nowrap"><strong>June 30, 2015</strong></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><strong>&#160;</strong></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 35%;">Placement&#160;agent&#160;warrants</td> <td style="font-family: 'times new roman'; padding: 0px; width: 1%;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 1%;"></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 10%;"><font>3,030,000</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 1%;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 10%;"><font>1.00</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 10%; text-align: center;"><font>5</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 10%;"><font>(48,700</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 1%;">)</td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 10%;"><font>2,981,300</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;">Bridge warrants</td> <td style="font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>2,600,000</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>1.00</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; text-align: center;"><font>3</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>2,600,000</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;">PPO warrants</td> <td style="font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>7,544,500</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>2.00</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; text-align: center;"><font>5</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>7,544,500</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;">Pre-Merger/PPO warrants</td> <td style="font-family: 'times new roman'; padding: 0px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>621,361</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>1.38</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">various</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>621,361</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-family: 'times new roman'; padding: 0px;">Total</td> <td style="font-family: 'times new roman'; padding: 0px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>13,795,861</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>(48,700</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap;">)</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>13,747,161</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;">&#160;</td> </tr> </table> </div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;">&#160;</p> </div> <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <table style="border-collapse: collapse; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; width: 95%; margin-left: 0.1px;" cellpadding="0" cellspacing="0"> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" colspan="2" nowrap="nowrap"><strong>Balance</strong></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"><strong>&#160;</strong></td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" colspan="2" nowrap="nowrap"><strong>Exercise</strong></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"><strong>&#160;</strong></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"><strong>&#160;</strong></td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" colspan="2" nowrap="nowrap"><strong>Term</strong></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"><strong>&#160;</strong></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"><strong>&#160;</strong></td> <td style="font-family: 'Times New Roman';" colspan="2" nowrap="nowrap"><strong>&#160;</strong></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"><strong>&#160;</strong></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"><strong>&#160;</strong></td> <td style="text-align: center; padding: 0px;" colspan="2" nowrap="nowrap"><strong>Balance</strong><br/></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"><strong>&#160;</strong></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" nowrap="nowrap"><strong>Name</strong></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"></td> <td style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" colspan="2" nowrap="nowrap"><strong>December 31, 2014</strong></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><strong>&#160;</strong></td> <td style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" colspan="2" nowrap="nowrap"><strong>Price</strong></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><strong>&#160;</strong></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><strong>&#160;</strong></td> <td style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" colspan="2" nowrap="nowrap"><strong>(Years)</strong></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><strong>&#160;</strong></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><strong>&#160;</strong></td> <td style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" colspan="2" nowrap="nowrap"><strong>Exercised</strong></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><strong>&#160;</strong></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><strong>&#160;</strong></td> <td style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" colspan="2" nowrap="nowrap"><strong>June 30, 2015</strong></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><strong>&#160;</strong></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 35%;">Placement&#160;agent&#160;warrants</td> <td style="font-family: 'times new roman'; padding: 0px; width: 1%;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 1%;"></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 10%;"><font>3,030,000</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 1%;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 10%;"><font>1.00</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 10%; text-align: center;"><font>5</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 10%;"><font>(48,700</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 1%;">)</td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 10%;"><font>2,981,300</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;">Bridge warrants</td> <td style="font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>2,600,000</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>1.00</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; text-align: center;"><font>3</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>2,600,000</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;">PPO warrants</td> <td style="font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>7,544,500</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>2.00</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; text-align: center;"><font>5</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>7,544,500</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;">Pre-Merger/PPO warrants</td> <td style="font-family: 'times new roman'; padding: 0px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>621,361</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>1.38</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">various</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>621,361</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-family: 'times new roman'; padding: 0px;">Total</td> <td style="font-family: 'times new roman'; padding: 0px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>13,795,861</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>(48,700</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap;">)</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>13,747,161</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;">&#160;</td> </tr> </table> </div> 36055000 30300000 2.00 1.00 77437000 0.0069 0.0145 1.47 P2Y6M18D P4Y6M18D 0.70 0.0018 0.0066 10 3030000 1.00 P5Y 48700 2981300 P5Y 7544500 621361 1.38 621361 13795861 48700 13747161 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b>10. Stock-based Compensation Plans and Awards</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">In January 2014, and prior to the Merger, the Board of Directors and a majority of the stockholders adopted the 2014 Plan that allowed for the issuance of <font>14,410,000</font> shares of common stock. Options previously issued under the Ekso Bionics 2007 Equity Incentive Plan were converted into options to purchase an aggregate of <font>7,602,408</font> shares of the Company's common stock under the 2014 Plan.&#160;On June 10, 2015, the 2014 Plan was amended and restated by the stockholders to increase the maximum number of shares by <font>11,590,000</font> shares to an aggregate of <font>26,000,000</font> shares of common stock available for issuance under the 2014 Plan. As of June 30, 2015, there were <font>11,767,633</font> shares available for future awards.<br/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><br/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">Under the terms of the 2014 Plan, the Board of Directors may award stock, options, or similar rights having either a fixed or variable price related to the fair market value of the shares and with an exercise or conversion privilege related to the passage of time, the occurrence of one or more events, or the satisfaction of performance criteria or other conditions, or any other security with the value derived from the value of the shares. Such awards include stock options, restricted stock, restricted stock units, stock appreciation rights and dividend equivalent rights.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">The Board of Directors may grant stock options under the 2014 Plan at a price of not less than <font>100</font>% of the fair market value of our common stock on the date the option is granted. Incentive stock options granted to employees who, on the date of grant, own stock representing more than 10% of the voting power of all of our classes of stock, are granted at an exercise price of not less than <font>110</font>% of the fair market value of our common stock. The maximum term of incentive stock options granted to employees who, on the date of grant, own stock possessing more than 10% of the voting power of all our classes of stock, may not exceed <font>five</font> years. The maximum term of an incentive stock option granted to any other participant may not exceed <font>ten</font> years. Subject to the limitations discussed above, the Board of Directors determines the term and exercise or purchase price of other awards granted under the 2014 Plan. The Board of Directors also determines the terms and conditions of awards, including the vesting schedule and any forfeiture provisions. Options granted under the 2014 Plan may vest upon the passage of time, generally <font>four</font> years, or upon the attainment of certain performance criteria established by the Board of Directors. We may from time to time grant options to purchase common stock to non-employees for advisory and consulting services. Pursuant to ASC 505-50, <i>Equity-Based Payments to Non-Employees</i>, we periodically re-measure the fair value of these stock options using the Black-Scholes option pricing model and recognize expense ratably over the vesting period of each stock option award. Upon exercise of an option, it is the Company's policy to issue new shares of common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><br/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">The following table summarizes information about the Company's stock options outstanding at June 30, 2015, and activity during the&#160;six-month period then ended:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <div> <div style="display: block;"> <div class="CursorPointer"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; width: 100%;"> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="font-family: 'Times New Roman';" colspan="2" nowrap="nowrap"></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="font-family: 'Times New Roman';" colspan="2" nowrap="nowrap"></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap">&#160;</td> <td style="font-family: 'Times New Roman';" nowrap="nowrap">&#160;</td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" nowrap="nowrap" colspan="2">Weighted-&#160;</td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" nowrap="nowrap">&#160;</td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" nowrap="nowrap">&#160;</td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" nowrap="nowrap" colspan="2">&#160;&#160;</td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" nowrap="nowrap" colspan="12"><br/></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="font-family: 'Times New Roman';" colspan="2" nowrap="nowrap"></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="font-family: 'Times New Roman';" colspan="2" nowrap="nowrap"></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap">&#160;</td> <td style="font-family: 'Times New Roman';" nowrap="nowrap">&#160;</td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" nowrap="nowrap" colspan="2">Average&#160;</td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" nowrap="nowrap">&#160;</td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" nowrap="nowrap">&#160;</td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" nowrap="nowrap" colspan="2">&#160;&#160;</td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" nowrap="nowrap" colspan="12">&#160;&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="font-family: 'Times New Roman';" colspan="2" nowrap="nowrap"></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" colspan="2" nowrap="nowrap">Weighted-</td> <td style="font-family: 'Times New Roman';" nowrap="nowrap">&#160;</td> <td style="font-family: 'Times New Roman';" nowrap="nowrap">&#160;</td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" colspan="2" nowrap="nowrap">Remaining</td> <td style="font-family: 'Times New Roman';" nowrap="nowrap">&#160;</td> <td style="font-family: 'Times New Roman';" nowrap="nowrap">&#160;</td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" colspan="2" nowrap="nowrap">Aggregate</td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"><br/></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" colspan="2" nowrap="nowrap">Stock</td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" colspan="2" nowrap="nowrap">Average</td> <td style="font-family: 'Times New Roman';" nowrap="nowrap">&#160;</td> <td style="font-family: 'Times New Roman';" nowrap="nowrap">&#160;</td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" colspan="2" nowrap="nowrap">Contractual</td> <td style="font-family: 'Times New Roman';" nowrap="nowrap">&#160;</td> <td style="font-family: 'Times New Roman';" nowrap="nowrap">&#160;</td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" colspan="2" nowrap="nowrap">Intrinsic</td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"><br/></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';" nowrap="nowrap">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap">&#160;</td> <td style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" colspan="2" nowrap="nowrap">Awards</td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap">&#160;</td> <td style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" colspan="2" nowrap="nowrap">Exercise&#160;Price</td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap">&#160;</td> <td style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" colspan="2" nowrap="nowrap">Life&#160;(Years)</td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap">&#160;</td> <td style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" colspan="2" nowrap="nowrap">Value</td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><br/></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-family: 'times new roman'; padding: 0px; width: 48%;">Balance as of December 31, 2014</td> <td style="font-family: 'times new roman'; padding: 0px; width: 1%;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 1%;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 10%;"><font> 10,791,081 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 1%;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 10%;"><font> 0.79 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 10%;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 10%;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; text-indent: 10px;">Options granted</td> <td style="font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 3,184,000 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 1.40 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; text-indent: 10px;">Options exercised</td> <td style="font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> (697,356 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">)</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 0.55 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; text-indent: 10px;">Options forfeited</td> <td style="font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> (40,507 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">)</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 0.57 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; text-indent: 10px;">Options cancelled</td> <td style="font-family: 'times new roman'; padding: 0px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> (10,126 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px 0px 0px; white-space: nowrap;">)&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px 0px 0px; white-space: nowrap;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 1.74 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-family: 'times new roman'; padding: 0px;">Balance as of June 30, 2015</td> <td style="font-family: 'times new roman'; padding: 0px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 13,227,092 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 0.96 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 7.86 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 4,197 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;">Vested and expected to vest at June 30, 2015</td> <td style="font-family: 'times new roman'; padding: 0px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 12,118,042 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 0.92 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 7.71 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 4,131 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-family: 'times new roman'; padding: 0px;">Exercisable as of June 30, 2015</td> <td style="font-family: 'times new roman'; padding: 0px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 5,970,959 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 0.60 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 6.23 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 3,451 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> </tr> </table> </div> </div> </div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><font style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 13.3333330154419px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: inline !important; float: none;">Of the 697,356 shares exercised, <font>535,404</font>&#160;were on a cashless basis for which the Company did not receive any proceeds, but instead withheld <font>243,647</font> shares from the option holders exercising such award to cover the exercise amount.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><br/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">As of June 30, 2015, total unrecognized compensation cost related to unvested stock options was $<font>5,386</font>. This amount is expected to be recognized as stock-based compensation expense in the Company's Condensed Consolidated Statements of Operations over the remaining weighted average vesting period of <font>3.09</font>&#160;years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">The per-share fair value of each stock option was determined on the date of grant using the Black-Scholes option pricing model using the following assumptions:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <div> <div> <div class="CursorPointer"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; width: 100%; margin-left: 0.100000001490116px;"> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';" nowrap="nowrap" align="center"></td> <td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;"><strong>&#160;</strong></font></td> <td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;" colspan="6"><font style="font-size: 10pt;"><strong>Three months ended June 30,</strong></font><br/></td> <td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;"><strong> </strong></font></td> <td nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" colspan="8"><font style="font-size: 10pt;"><strong>Six months ended June 30,</strong></font></td> <td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;"><strong> </strong></font></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';" nowrap="nowrap" align="center"></td> <td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;"><strong>&#160;</strong></font></td> <td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;" colspan="2"><font style="font-size: 10pt;"><b>2015</b></font></td> <td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;"><strong>&#160;</strong></font></td> <td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;"><strong>&#160;</strong></font></td> <td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;" colspan="2"><font style="font-size: 10pt;"><strong>2014</strong></font><br/></td> <td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;"><strong> </strong></font></td> <td colspan="3" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;"><font style="font-size: 10pt;"><strong>2015</strong></font></td> <td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;"><strong> </strong></font></td> <td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"><br/></td> <td nowrap="nowrap" align="center" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" colspan="3"><font style="font-size: 10pt;"><strong>2014</strong></font></td> <td nowrap="nowrap" align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px;" colspan="7"><br/></td> </tr> <tr style="vertical-align: bottom;"> <td style="vertical-align: top; text-align: left;" nowrap="nowrap"></td> <td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" nowrap="nowrap" align="center"><font style="font-size: 10pt;">&#160;</font></td> <td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" nowrap="nowrap" align="center"><font style="font-size: 10pt;">&#160;</font></td> <td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" nowrap="nowrap" align="center"><font style="font-size: 10pt;">&#160;</font></td> <td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" nowrap="nowrap" align="center"><font style="font-size: 10pt;">&#160;</font></td> <td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" nowrap="nowrap" align="center"><font style="font-size: 10pt;">&#160;</font></td> <td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" nowrap="nowrap" align="center"><font style="font-size: 10pt;">&#160;</font></td> <td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" nowrap="nowrap" align="center"><br/></td> <td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" nowrap="nowrap" align="center"><font style="font-size: 10pt;">&#160;</font></td> <td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" colspan="3" nowrap="nowrap"><font style="font-size: 10pt;">&#160;</font></td> <td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" nowrap="nowrap" align="center"></td> <td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" nowrap="nowrap" align="center"><font style="font-size: 10pt;">&#160;</font></td> <td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" nowrap="nowrap" align="center" colspan="3"><font style="font-size: 10pt;">&#160;&#160;&#160;</font></td> <td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" nowrap="nowrap" align="center"><br/></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">Dividend yield</font></td> <td style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: center;"><font><font style="font-size: 10pt;">&#151;</font></font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: center;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: center;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: center;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: center;"><font><font style="font-size: 10pt;">&#151;</font></font></td> <td style="font-family: 'times new roman'; padding: 0px;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"></td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; text-align: center;" align="right" colspan="2"><font><font style="font-size: 10pt;">&#151;</font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; text-align: center;" align="right" colspan="2"><font><font style="font-size: 10pt;">&#151;</font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">Risk-free interest rate</font></td> <td style="font-family: 'Times New Roman';"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman';"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: center;"><font style="font-size: 10pt;"><font>1.44</font>% -&#160;<font>2.34</font>%&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: center;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: center;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: center;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: center;"><font style="font-size: 10pt;"><font>1.90</font>% -&#160;<font>2.61</font>%</font></td> <td style="font-family: 'Times New Roman';"><br/></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; font-size: 10pt; vertical-align: bottom; white-space: nowrap; text-align: center;" nowrap="nowrap" align="right" colspan="2"><font style="font-size: 10pt;"><font>1.41</font>% - <font>2.34</font>%</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman';"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; font-size: 10pt; vertical-align: bottom; white-space: nowrap; text-align: center;" nowrap="nowrap" align="right" colspan="2"><font style="font-size: 10pt;"><font>1.74</font>% - <font>2.67</font>%</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">Expected term (in years)</font></td> <td style="font-family: 'Times New Roman';"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman';"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: center;"><font style="font-size: 10pt;"><font>6</font>-<font>10</font>&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: center;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: center;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: center;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: center;"><font style="font-size: 10pt;"><font>6</font>-<font>8</font></font></td> <td style="font-family: 'Times New Roman';"><br/></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; font-size: 10pt; vertical-align: bottom; white-space: nowrap; text-align: center;" align="right" colspan="2"><font style="font-size: 10pt;"><font>6</font>-<font>10</font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman';"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; font-size: 10pt; vertical-align: bottom; white-space: nowrap; text-align: center;" align="right" colspan="2"><font style="font-size: 10pt;"><font>6</font>-<font>10</font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-family: 'Times New Roman';"><font style="font-size: 10pt;">Volatility</font></td> <td style="font-family: 'Times New Roman';"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman';"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: center;"><font style="font-size: 10pt;"><font>73</font>% - <font>74</font>%&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: center;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: center;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: center;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: center;"><font style="font-size: 10pt;"><font>66</font>%</font></td> <td style="font-family: 'Times New Roman';"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; text-align: center;" align="right" colspan="2"><font style="font-size: 10pt;"><font>73</font>% - <font>74</font>%</font></td> <td style="text-align: left; padding: 0px; font-family: 'Times New Roman';"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman';"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; text-align: center;" align="right" colspan="2"><font style="font-size: 10pt;"><font>66</font>%</font></td> <td style="text-align: left; padding: 0px; font-family: 'Times New Roman';"><font style="font-size: 10pt;">&#160;</font></td> </tr> </table> </div> </div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> </div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">Total stock-based compensation expense related to options granted to employees and non-employees was included in the Condensed Consolidated Statements of Operations as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <div> <div> <div class="CursorPointer"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; width: 90%; margin-left: 0.100000001490116px;"> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important; text-align: center;" nowrap="nowrap" colspan="6"><font style="font-size: 10pt;"><strong>Three months ended June 30,</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"></td> <td style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" colspan="6" nowrap="nowrap"><font style="font-size: 10pt;"><strong>Six months ended</strong></font> <font style="font-size: 10pt;"><strong>June 30</strong></font><font style="font-size: 10pt;"><strong>,</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important; text-align: center;" nowrap="nowrap" colspan="2"><font style="font-size: 10pt;"><strong>2015</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: center;" nowrap="nowrap"></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: center;" nowrap="nowrap"></td> <td style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important; text-align: center;" nowrap="nowrap" colspan="2"><font style="font-size: 10pt;"><strong>2014</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"></td> <td style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" colspan="2" nowrap="nowrap"><font style="font-size: 10pt;"><strong>2015</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" nowrap="nowrap" colspan="2"><font style="font-size: 10pt;"><strong>2014&#160;</strong></font></td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" nowrap="nowrap" colspan="5"><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">Sales and marketing</font></td> <td style="font-family: 'times new roman'; padding: 0px;"></td> <td style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">$</font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: right;"><font><font style="font-size: 10pt;"> 161 </font></font></td> <td style="font-family: 'times new roman'; padding: 0px;"></td> <td style="font-family: 'times new roman'; padding: 0px;"></td> <td style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">$</font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: right;"><font><font style="font-size: 10pt;"> 150 </font></font></td> <td style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap;"><font style="font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font><font style="font-size: 10pt;"> 292 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap;"><font style="font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font><font style="font-size: 10pt;"> 251 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">Research and development</font></td> <td style="font-family: 'Times New Roman';"></td> <td style="font-family: 'Times New Roman';"></td> <td style="font-family: 'Times New Roman'; text-align: right;"><font><font style="font-size: 10pt;"> 108 </font></font></td> <td style="font-family: 'Times New Roman';"></td> <td style="font-family: 'Times New Roman';"></td> <td style="font-family: 'Times New Roman';"></td> <td style="font-family: 'Times New Roman'; text-align: right;"><font><font style="font-size: 10pt;"> 21 </font></font></td> <td style="font-family: 'Times New Roman';"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman';"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font><font style="font-size: 10pt;"> 162 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font><font style="font-size: 10pt;"> 90 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">General and administrative</font></td> <td style="font-family: 'times new roman'; padding: 0px;"></td> <td style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"></td> <td style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important; text-align: right;"><font><font style="font-size: 10pt;"> 174 </font></font></td> <td style="font-family: 'times new roman'; padding: 0px;"></td> <td style="font-family: 'times new roman'; padding: 0px;"></td> <td style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"></td> <td style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important; text-align: right;"><font><font style="font-size: 10pt;"> 155 </font></font></td> <td style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font><font style="font-size: 10pt;"> 337 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font><font style="font-size: 10pt;"> 352 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px;"></td> <td style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">$</font></td> <td style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important; text-align: right;"><font><font style="font-size: 10pt;"> 443 </font></font><br/></td> <td style="font-family: 'times new roman'; padding: 0px;"></td> <td></td> <td style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">$</font></td> <td style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important; text-align: right;"><font><font style="font-size: 10pt;"> 326 </font></font></td> <td style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;"><font style="font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font><font style="font-size: 10pt;"> 791 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;"><font style="font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font><font style="font-size: 10pt;"> 693 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-size: 10pt;">&#160;</font></td> </tr> </table> </div> </div> </div> </div> P5Y P10Y P4Y <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <div style="display: block;"> <div class="CursorPointer"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; width: 100%;"> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="font-family: 'Times New Roman';" colspan="2" nowrap="nowrap"></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="font-family: 'Times New Roman';" colspan="2" nowrap="nowrap"></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap">&#160;</td> <td style="font-family: 'Times New Roman';" nowrap="nowrap">&#160;</td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" nowrap="nowrap" colspan="2">Weighted-&#160;</td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" nowrap="nowrap">&#160;</td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" nowrap="nowrap">&#160;</td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" nowrap="nowrap" colspan="2">&#160;&#160;</td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" nowrap="nowrap" colspan="12"><br/></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="font-family: 'Times New Roman';" colspan="2" nowrap="nowrap"></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="font-family: 'Times New Roman';" colspan="2" nowrap="nowrap"></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap">&#160;</td> <td style="font-family: 'Times New Roman';" nowrap="nowrap">&#160;</td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" nowrap="nowrap" colspan="2">Average&#160;</td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" nowrap="nowrap">&#160;</td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" nowrap="nowrap">&#160;</td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" nowrap="nowrap" colspan="2">&#160;&#160;</td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" nowrap="nowrap" colspan="12">&#160;&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="font-family: 'Times New Roman';" colspan="2" nowrap="nowrap"></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" colspan="2" nowrap="nowrap">Weighted-</td> <td style="font-family: 'Times New Roman';" nowrap="nowrap">&#160;</td> <td style="font-family: 'Times New Roman';" nowrap="nowrap">&#160;</td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" colspan="2" nowrap="nowrap">Remaining</td> <td style="font-family: 'Times New Roman';" nowrap="nowrap">&#160;</td> <td style="font-family: 'Times New Roman';" nowrap="nowrap">&#160;</td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" colspan="2" nowrap="nowrap">Aggregate</td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"><br/></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" colspan="2" nowrap="nowrap">Stock</td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" colspan="2" nowrap="nowrap">Average</td> <td style="font-family: 'Times New Roman';" nowrap="nowrap">&#160;</td> <td style="font-family: 'Times New Roman';" nowrap="nowrap">&#160;</td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" colspan="2" nowrap="nowrap">Contractual</td> <td style="font-family: 'Times New Roman';" nowrap="nowrap">&#160;</td> <td style="font-family: 'Times New Roman';" nowrap="nowrap">&#160;</td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" colspan="2" nowrap="nowrap">Intrinsic</td> <td style="font-family: 'Times New Roman';" nowrap="nowrap"><br/></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';" nowrap="nowrap">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap">&#160;</td> <td style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" colspan="2" nowrap="nowrap">Awards</td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap">&#160;</td> <td style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" colspan="2" nowrap="nowrap">Exercise&#160;Price</td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap">&#160;</td> <td style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" colspan="2" nowrap="nowrap">Life&#160;(Years)</td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap">&#160;</td> <td style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" colspan="2" nowrap="nowrap">Value</td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><br/></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-family: 'times new roman'; padding: 0px; width: 48%;">Balance as of December 31, 2014</td> <td style="font-family: 'times new roman'; padding: 0px; width: 1%;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 1%;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 10%;"><font> 10,791,081 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 1%;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 10%;"><font> 0.79 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 10%;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 10%;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; text-indent: 10px;">Options granted</td> <td style="font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 3,184,000 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 1.40 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; text-indent: 10px;">Options exercised</td> <td style="font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> (697,356 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">)</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 0.55 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; text-indent: 10px;">Options forfeited</td> <td style="font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> (40,507 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">)</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 0.57 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; text-indent: 10px;">Options cancelled</td> <td style="font-family: 'times new roman'; padding: 0px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> (10,126 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px 0px 0px; white-space: nowrap;">)&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px 0px 0px; white-space: nowrap;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 1.74 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-family: 'times new roman'; padding: 0px;">Balance as of June 30, 2015</td> <td style="font-family: 'times new roman'; padding: 0px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 13,227,092 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 0.96 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 7.86 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 4,197 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;">Vested and expected to vest at June 30, 2015</td> <td style="font-family: 'times new roman'; padding: 0px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 12,118,042 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 0.92 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 7.71 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 4,131 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-family: 'times new roman'; padding: 0px;">Exercisable as of June 30, 2015</td> <td style="font-family: 'times new roman'; padding: 0px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 5,970,959 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 0.60 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 6.23 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font> 3,451 </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td> </tr> </table> </div> </div> </div> <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <div> <div class="CursorPointer"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; width: 100%; margin-left: 0.100000001490116px;"> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';" nowrap="nowrap" align="center"></td> <td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;"><strong>&#160;</strong></font></td> <td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;" colspan="6"><font style="font-size: 10pt;"><strong>Three months ended June 30,</strong></font><br/></td> <td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;"><strong> </strong></font></td> <td nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" colspan="8"><font style="font-size: 10pt;"><strong>Six months ended June 30,</strong></font></td> <td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;"><strong> </strong></font></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';" nowrap="nowrap" align="center"></td> <td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;"><strong>&#160;</strong></font></td> <td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;" colspan="2"><font style="font-size: 10pt;"><b>2015</b></font></td> <td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;"><strong>&#160;</strong></font></td> <td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;"><strong>&#160;</strong></font></td> <td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;" colspan="2"><font style="font-size: 10pt;"><strong>2014</strong></font><br/></td> <td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;"><strong> </strong></font></td> <td colspan="3" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;"><font style="font-size: 10pt;"><strong>2015</strong></font></td> <td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;"><strong> </strong></font></td> <td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"><br/></td> <td nowrap="nowrap" align="center" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" colspan="3"><font style="font-size: 10pt;"><strong>2014</strong></font></td> <td nowrap="nowrap" align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px;" colspan="7"><br/></td> </tr> <tr style="vertical-align: bottom;"> <td style="vertical-align: top; text-align: left;" nowrap="nowrap"></td> <td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" nowrap="nowrap" align="center"><font style="font-size: 10pt;">&#160;</font></td> <td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" nowrap="nowrap" align="center"><font style="font-size: 10pt;">&#160;</font></td> <td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" nowrap="nowrap" align="center"><font style="font-size: 10pt;">&#160;</font></td> <td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" nowrap="nowrap" align="center"><font style="font-size: 10pt;">&#160;</font></td> <td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" nowrap="nowrap" align="center"><font style="font-size: 10pt;">&#160;</font></td> <td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" nowrap="nowrap" align="center"><font style="font-size: 10pt;">&#160;</font></td> <td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" nowrap="nowrap" align="center"><br/></td> <td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" nowrap="nowrap" align="center"><font style="font-size: 10pt;">&#160;</font></td> <td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" colspan="3" nowrap="nowrap"><font style="font-size: 10pt;">&#160;</font></td> <td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" nowrap="nowrap" align="center"></td> <td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" nowrap="nowrap" align="center"><font style="font-size: 10pt;">&#160;</font></td> <td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" nowrap="nowrap" align="center" colspan="3"><font style="font-size: 10pt;">&#160;&#160;&#160;</font></td> <td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" nowrap="nowrap" align="center"><br/></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">Dividend yield</font></td> <td style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: center;"><font><font style="font-size: 10pt;">&#151;</font></font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: center;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: center;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: center;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: center;"><font><font style="font-size: 10pt;">&#151;</font></font></td> <td style="font-family: 'times new roman'; padding: 0px;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"></td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; text-align: center;" align="right" colspan="2"><font><font style="font-size: 10pt;">&#151;</font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; text-align: center;" align="right" colspan="2"><font><font style="font-size: 10pt;">&#151;</font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">Risk-free interest rate</font></td> <td style="font-family: 'Times New Roman';"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman';"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: center;"><font style="font-size: 10pt;"><font>1.44</font>% -&#160;<font>2.34</font>%&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: center;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: center;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: center;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: center;"><font style="font-size: 10pt;"><font>1.90</font>% -&#160;<font>2.61</font>%</font></td> <td style="font-family: 'Times New Roman';"><br/></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; font-size: 10pt; vertical-align: bottom; white-space: nowrap; text-align: center;" nowrap="nowrap" align="right" colspan="2"><font style="font-size: 10pt;"><font>1.41</font>% - <font>2.34</font>%</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman';"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; font-size: 10pt; vertical-align: bottom; white-space: nowrap; text-align: center;" nowrap="nowrap" align="right" colspan="2"><font style="font-size: 10pt;"><font>1.74</font>% - <font>2.67</font>%</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">Expected term (in years)</font></td> <td style="font-family: 'Times New Roman';"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman';"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: center;"><font style="font-size: 10pt;"><font>6</font>-<font>10</font>&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: center;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: center;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: center;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: center;"><font style="font-size: 10pt;"><font>6</font>-<font>8</font></font></td> <td style="font-family: 'Times New Roman';"><br/></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; font-size: 10pt; vertical-align: bottom; white-space: nowrap; text-align: center;" align="right" colspan="2"><font style="font-size: 10pt;"><font>6</font>-<font>10</font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman';"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; font-size: 10pt; vertical-align: bottom; white-space: nowrap; text-align: center;" align="right" colspan="2"><font style="font-size: 10pt;"><font>6</font>-<font>10</font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-family: 'Times New Roman';"><font style="font-size: 10pt;">Volatility</font></td> <td style="font-family: 'Times New Roman';"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman';"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: center;"><font style="font-size: 10pt;"><font>73</font>% - <font>74</font>%&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: center;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: center;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: center;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: center;"><font style="font-size: 10pt;"><font>66</font>%</font></td> <td style="font-family: 'Times New Roman';"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; text-align: center;" align="right" colspan="2"><font style="font-size: 10pt;"><font>73</font>% - <font>74</font>%</font></td> <td style="text-align: left; padding: 0px; font-family: 'Times New Roman';"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman';"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; text-align: center;" align="right" colspan="2"><font style="font-size: 10pt;"><font>66</font>%</font></td> <td style="text-align: left; padding: 0px; font-family: 'Times New Roman';"><font style="font-size: 10pt;">&#160;</font></td> </tr> </table> </div> </div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> </div> <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <div> <div class="CursorPointer"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; width: 90%; margin-left: 0.100000001490116px;"> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important; text-align: center;" nowrap="nowrap" colspan="6"><font style="font-size: 10pt;"><strong>Three months ended June 30,</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"></td> <td style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" colspan="6" nowrap="nowrap"><font style="font-size: 10pt;"><strong>Six months ended</strong></font> <font style="font-size: 10pt;"><strong>June 30</strong></font><font style="font-size: 10pt;"><strong>,</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important; text-align: center;" nowrap="nowrap" colspan="2"><font style="font-size: 10pt;"><strong>2015</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: center;" nowrap="nowrap"></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: center;" nowrap="nowrap"></td> <td style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important; text-align: center;" nowrap="nowrap" colspan="2"><font style="font-size: 10pt;"><strong>2014</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"></td> <td style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" colspan="2" nowrap="nowrap"><font style="font-size: 10pt;"><strong>2015</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" nowrap="nowrap" colspan="2"><font style="font-size: 10pt;"><strong>2014&#160;</strong></font></td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" nowrap="nowrap" colspan="5"><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">Sales and marketing</font></td> <td style="font-family: 'times new roman'; padding: 0px;"></td> <td style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">$</font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: right;"><font><font style="font-size: 10pt;"> 161 </font></font></td> <td style="font-family: 'times new roman'; padding: 0px;"></td> <td style="font-family: 'times new roman'; padding: 0px;"></td> <td style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">$</font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: right;"><font><font style="font-size: 10pt;"> 150 </font></font></td> <td style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap;"><font style="font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font><font style="font-size: 10pt;"> 292 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap;"><font style="font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font><font style="font-size: 10pt;"> 251 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">Research and development</font></td> <td style="font-family: 'Times New Roman';"></td> <td style="font-family: 'Times New Roman';"></td> <td style="font-family: 'Times New Roman'; text-align: right;"><font><font style="font-size: 10pt;"> 108 </font></font></td> <td style="font-family: 'Times New Roman';"></td> <td style="font-family: 'Times New Roman';"></td> <td style="font-family: 'Times New Roman';"></td> <td style="font-family: 'Times New Roman'; text-align: right;"><font><font style="font-size: 10pt;"> 21 </font></font></td> <td style="font-family: 'Times New Roman';"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman';"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font><font style="font-size: 10pt;"> 162 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font><font style="font-size: 10pt;"> 90 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">General and administrative</font></td> <td style="font-family: 'times new roman'; padding: 0px;"></td> <td style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"></td> <td style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important; text-align: right;"><font><font style="font-size: 10pt;"> 174 </font></font></td> <td style="font-family: 'times new roman'; padding: 0px;"></td> <td style="font-family: 'times new roman'; padding: 0px;"></td> <td style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"></td> <td style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important; text-align: right;"><font><font style="font-size: 10pt;"> 155 </font></font></td> <td style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font><font style="font-size: 10pt;"> 337 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font><font style="font-size: 10pt;"> 352 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px;"></td> <td style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">$</font></td> <td style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important; text-align: right;"><font><font style="font-size: 10pt;"> 443 </font></font><br/></td> <td style="font-family: 'times new roman'; padding: 0px;"></td> <td></td> <td style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">$</font></td> <td style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important; text-align: right;"><font><font style="font-size: 10pt;"> 326 </font></font></td> <td style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;"><font style="font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font><font style="font-size: 10pt;"> 791 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;"><font style="font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font><font style="font-size: 10pt;"> 693 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-size: 10pt;">&#160;</font></td> </tr> </table> </div> </div> </div> 14410000 7602408 1.00 1.10 10791081 0.79 3184000 1.40 697356 0.55 40507 0.57 10126 1.74 13227092 0.96 P7Y10M10D 4197000 12118042 0.92 P7Y8M16D 4131000 5970959 0.60 P6Y2M23D 3451000 5386000 P3Y1M2D 0.0141 0.0234 0.0174 0.0267 P6Y P10Y P6Y P10Y 0.73 292000 251000 162000 90000 337000 352000 791000 693000 535404 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b>11. Income Taxes</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">There were <font>no</font> material changes to the unrecognized tax benefits in the three&#160;months ended June 30, 2015, and the Company does not expect significant changes to unrecognized tax benefits through the end of the fiscal year. Because of the Company's history of tax losses, all years remain open to tax audit.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> </div> 0.01 0.21 0.01 50000 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b>12. Commitments and Contingencies</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b>Contingencies</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">In the normal course of business, the Company is subject to various legal matters. In the opinion of management, the resolution of such matters will not have a material adverse effect on the Company's condensed consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b>Material Contracts</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">The Company enters into various license, research collaboration and development agreements which provide for payments to the Company for government grants, fees, cost reimbursements typically with a markup, technology transfer and license fees, and royalty payments on sales.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">The Company has two license agreements to maintain exclusive rights to patents. The Company is also required to pay <font>1</font>% of net sales of products sold to entities other than the U.S. government. In the event of a sublicense, the Company will owe <font>21</font>% of license fees and must pass through <font>1</font>% of the sub-licensee's net sales of products sold to entities other than the U.S. government.&#160;The license agreements also stipulate minimum annual royalties, starting in 2015 and for future years, of $<font>50</font>&#160;per year.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b>U.S. Food and Drug Administration Clearance</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">The Company's Ekso GT robotic exoskeleton has been marketed in the United States as a Class I 510(k) exempt Powered Exercise Equipment device since February 2012. On June 26, 2014, the&#160;U.S. Food and Drug Administration (&#147;FDA&#148;) announced the creation of a new product classification for Powered Exoskeleton devices. On October 21, 2014, the FDA published the summary for the reclassified Powered Exoskeleton and informed us in writing of the agency's belief that this new product classification applied to the Ekso GT device. This new product classification was designated as being Class II, which requires the clearance of a 510(k) notice. Consequently, the FDA requested that we file a 510(k) notice to obtain this clearance. Per the FDA's request, we filed our 510(k) notice on December 24, 2014, and this submission is currently under review by the FDA. The Company intends to continue marketing the Ekso robotic exoskeleton under its current Class I registration and listing with its current indications for use until 510(k) clearance is either granted or denied by the FDA or the Company is otherwise notified by the FDA to cease such activities. The Company believes that in situations where the class of a product has been elevated by the FDA, manufacturers are normally granted enforcement discretion by the FDA and given ample time to seek clearance at the new class level. Nonetheless, the FDA may not agree with our decision to continue marketing the device until a 510(k) notice is cleared. From the time of our submission to the date of this report, the FDA has not indicated or notified the Company that it disagrees with this decision. If the FDA disagrees with our decision, we may be required to cease marketing or to recall the products until we obtain clearance or approval, and we may be subject to regulatory fines or penalties.<br/></p> </div> 13227092 7073652 13747161 14546085 26974253 21619737 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><b>13. Net Income (Loss) Per Share</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><b>&#160;</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><font style="font-family: 'times new roman', times; font-size: 10pt;">The following table sets forth the computation of basic and diluted net income (loss) per share:</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><b>&#160;</b></font></p> <div> <div class="CursorPointer"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; width: 100%; margin-left: 0.100000001490116px;"> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td nowrap="nowrap" style="padding: 0px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important; text-align: center;" colspan="6"><font style="font-size: 10pt;"><strong>Three months ended June 30,</strong></font><br/></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong> </strong></font></td> <td colspan="6" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>Six months ended June 30,</strong></font></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong> </strong></font></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td nowrap="nowrap" style="padding: 0px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important; text-align: center;" colspan="2"><font style="font-size: 10pt;"><b>2015</b></font></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px; text-align: center;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px; text-align: center;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td nowrap="nowrap" style="padding: 0px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important; text-align: center;" colspan="2"><font style="font-size: 10pt;"><b>2014</b></font></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong> </strong></font></td> <td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>2015</strong></font></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong> </strong></font></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" colspan="2"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>2014</strong></font></td> <td nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><br/></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">Numerator:</font></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; background-color: #cceeff;"></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; background-color: #cceeff;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;&#160;</font></td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; text-indent: 10px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">Net income (loss)</font></td> <td style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px;"><br/></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: right;"><br/></td> <td style="font-family: 'times new roman'; padding: 0px;"></td> <td style="font-family: 'times new roman'; padding: 0px;"></td> <td style="font-family: 'times new roman'; padding: 0px;"><br/></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: right;"><br/></td> <td style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px;"><br/></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><br/></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;"><br/></td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><br/></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><br/></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><br/></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;"></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; padding: 0px; text-indent: 10px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">Basic</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">$</font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: right; width: 20px; background-color: #cceeff;"><font><font style="font-size: 10pt;"> (5,645 </font></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">)</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">$</font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: right; width: 20px; background-color: #cceeff;"><font><font style="font-size: 10pt;"> 56,128 </font></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; background-color: #cceeff;"><font><font style="font-size: 10pt;"> (9,760 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">)</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; background-color: #cceeff;"><font><font style="font-size: 10pt;"> (25,638 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">)</font></td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; text-indent: 10px; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">Adjustment for change in fair value of warrant liability&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: right; width: 20px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font><font style="font-size: 10pt;"> - </font></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: right; width: 20px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font><font style="font-size: 10pt;"> (60,458 </font></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-size: 10pt;">)</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font><font style="font-size: 10pt;"> - </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font><font style="font-size: 10pt;"> - </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; text-indent: 10px; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">Diluted&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">$</font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: right; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font><font style="font-size: 10pt;"> (5,645 </font></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">)</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 13.3333330154419px;">$</font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: right; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font><font style="font-size: 10pt;"> (4,330 </font></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">)</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font><font style="font-size: 10pt;"> (9,760 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">)</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font><font style="font-size: 10pt;"> (25,638 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">)</font></td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; text-indent: 10px; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: right; width: 20px;"><font style="font-size: 10pt;"> &#160; </font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: right; width: 20px;"><font style="font-size: 10pt;"> &#160; </font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px;"><font style="font-size: 10pt;"> &#160; </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px;"><font style="font-size: 10pt;"> &#160; </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">Denominator:</font></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"></td> <td style="font-family: 'Times New Roman'; text-align: right; background-color: #cceeff;"><font style="font-size: 10pt;"> &#160; </font></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"></td> <td style="font-family: 'Times New Roman'; text-align: right; background-color: #cceeff;"><font style="font-size: 10pt;"> &#160; </font></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;"><font style="font-size: 10pt;"> &#160; </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman'; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;"><font style="font-size: 10pt;"> &#160; </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; text-indent: 10px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">Weighted-average common shares outstanding used in computing basic and diluted net income (loss) per share</font></td> <td style="font-family: 'Times New Roman';"><br/></td> <td style="font-family: 'Times New Roman';"></td> <td style="font-family: 'Times New Roman'; text-align: right;"><br/></td> <td style="font-family: 'Times New Roman';"></td> <td style="font-family: 'Times New Roman';"></td> <td style="font-family: 'Times New Roman';"><br/></td> <td style="font-family: 'Times New Roman'; text-align: right;"><font style="font-size: 10pt;"> &#160; </font></td> <td style="font-family: 'Times New Roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font style="font-size: 10pt;"> &#160; </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font style="font-size: 10pt;"> &#160; </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; padding: 0px; text-indent: 10px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">Basic</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: right; width: 20px; background-color: #cceeff;"><font><font style="font-size: 10pt;"> 102,094,158 </font></font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: right; width: 20px; background-color: #cceeff;"><font><font style="font-size: 10pt;"> 78,497,558 </font></font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; background-color: #cceeff;"><font><font style="font-size: 10pt;"> 101,944,359 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; background-color: #cceeff;"><font><font style="font-size: 10pt;"> 72,688,073 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; text-indent: 10px; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">Dilutive effect of warrants&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: right; width: 20px;"><font><font style="font-size: 10pt;"> - </font></font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: right; width: 20px;"><font><font style="font-size: 10pt;"> 9,593,643 </font></font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px;"><font><font style="font-size: 10pt;"> - </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman'; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px;"><font><font style="font-size: 10pt;"> - </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; padding: 0px; text-indent: 10px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">Dilutive effect of stock options</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: right; width: 20px; background-color: #cceeff; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font><font style="font-size: 10pt;"> - </font></font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: right; width: 20px; background-color: #cceeff; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font><font style="font-size: 10pt;"> 6,681,210 </font></font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; width: 20px; background-color: #cceeff; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; background-color: #cceeff; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;"><font> - </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; width: 20px; background-color: #cceeff; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; background-color: #cceeff; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font><font style="font-size: 10pt;"> - </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: left; padding: 0px; text-indent: 10px; width: 20px;"><font style="font-size: 10pt;">Diluted</font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: right; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font><font style="font-size: 10pt;"> 102,094,158 </font></font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: right; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font><font style="font-size: 10pt;"> 94,772,411 </font></font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;"><font> 101,944,359 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman'; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font><font style="font-size: 10pt;"> 72,688,073 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; padding: 0px; text-indent: 10px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">Net income (loss) per share, basic</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: right; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font><font style="font-size: 10pt;"> (0.06 </font></font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">)</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: right; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font><font style="font-size: 10pt;"> 0.72 </font></font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;"><font> (0.10 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px 0px 0px; white-space: nowrap; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">)&#160;</font></td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font><font style="font-size: 10pt;"> (0.35 </font></font></td> <td style="text-align: left; padding: 0px 5px 0px 0px; white-space: nowrap; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">)</font></td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: left; padding: 0px; text-indent: 10px; width: 20px;"><font style="font-size: 10pt;">Net loss per share, diluted</font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: right; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font><font style="font-size: 10pt;"> (0.06 </font></font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-size: 10pt;">)</font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: right; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font><font style="font-size: 10pt;"> (0.05 </font></font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-size: 10pt;">)</font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;"> <font> (0.10 </font></font></td> <td style="text-align: left; padding: 0px 5px 0px 0px; white-space: nowrap; width: 20px;"><font><font style="font-size: 13.3333330154419px;">)</font></font></td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman'; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font><font style="font-size: 10pt;"> (0.35 </font></font></td> <td style="text-align: left; padding: 0px 5px 0px 0px; white-space: nowrap; width: 20px;"><font style="font-size: 10pt;">)</font></td> </tr> </table> </div> </div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><b>&#160;</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><font style="font-family: 'times new roman', times; font-size: 10pt;">The following table sets forth potential shares of common stock that are not included in the calculation of diluted net loss per share because to do so would be anti-dilutive as of the end of each period presented:</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><b>&#160;</b></font></p> <div> <div class="CursorPointer"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin-left: 0.100000001490116px;" width="100%"> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td nowrap="nowrap" style="padding-bottom: 1pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td nowrap="nowrap" style="padding-bottom: 1pt; font-family: 'times new roman'; text-align: center; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;" colspan="6"><font style="font-size: 10pt;"><strong>Three months ended June 30,</strong></font><br/></td> <td nowrap="nowrap" style="padding-bottom: 1pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td nowrap="nowrap" style="padding-bottom: 1pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong> </strong></font></td> <td colspan="6" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>Six months ended June 30,</strong></font></td> <td nowrap="nowrap" style="padding-bottom: 1pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td nowrap="nowrap" style="padding-bottom: 1pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td nowrap="nowrap" style="padding-bottom: 1pt; text-align: center; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;" colspan="2"><font><font style="font-size: 13.3333330154419px;"><b>2015</b></font></font></td> <td nowrap="nowrap" style="padding-bottom: 1pt; font-family: 'times new roman'; text-align: center;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td nowrap="nowrap" style="padding-bottom: 1pt; font-family: 'times new roman'; text-align: center;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td nowrap="nowrap" style="padding-bottom: 1pt; text-align: center; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;" colspan="2"><font><font style="font-size: 13.3333330154419px;"><b>2014</b></font></font></td> <td nowrap="nowrap" style="padding-bottom: 1pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td nowrap="nowrap" style="padding-bottom: 1pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong> </strong></font></td> <td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>2015</strong></font></td> <td nowrap="nowrap" style="padding-bottom: 1pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td nowrap="nowrap" style="padding-bottom: 1pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>2014</strong></font></td> <td nowrap="nowrap" style="padding-bottom: 1pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">Options to purchase common stock</font></td> <td style="font-family: 'times new roman'; text-align: right; background-color: #cceeff;">&#160;</td> <td style="font-family: 'times new roman'; text-align: right; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; text-align: right; background-color: #cceeff;"><font style="font-size: 10pt;"><font>13,227,092</font></font></td> <td style="font-family: 'times new roman'; text-align: right; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; text-align: right; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; text-align: right; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; text-align: right; background-color: #cceeff;"><font style="font-size: 10pt;"><font> - </font></font></td> <td style="font-family: 'times new roman'; text-align: right; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; background-color: #cceeff;"></td> <td style="text-align: left; font-family: 'times new roman'; background-color: #cceeff;"></td> <td style="text-align: right; font-family: 'times new roman'; vertical-align: bottom; white-space: nowrap; background-color: #cceeff;"><font><font style="font-family: 'times new roman', times; font-size: 10pt;"> 13,227,092 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; white-space: nowrap; padding-right: 5px; padding-left: 5px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; white-space: nowrap; padding-right: 5px; padding-left: 5px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; white-space: nowrap; padding-right: 5px; padding-left: 5px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; vertical-align: bottom; white-space: nowrap; background-color: #cceeff;"><font><font style="font-family: 'times new roman', times; font-size: 10pt;"> 7,073,652 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; white-space: nowrap; padding-right: 5px; padding-left: 5px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom;"> <td style="padding-bottom: 1pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;">Warrants to purchase common stock</font></td> <td style="padding-bottom: 1pt; font-family: 'times new roman'; text-align: right;">&#160;</td> <td style="padding-bottom: 1pt; font-family: 'times new roman'; text-align: right; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 1pt; font-family: 'times new roman'; text-align: right; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;"><font>13,747,161</font></font></td> <td style="padding-bottom: 1pt; font-family: 'times new roman'; text-align: right;"><font style="font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 1pt; font-family: 'times new roman'; text-align: right;"><font style="font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 1pt; font-family: 'times new roman'; text-align: right; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 1pt; font-family: 'times new roman'; text-align: right; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;"><font> - </font></font></td> <td style="padding-bottom: 1pt; font-family: 'times new roman'; text-align: right;"><font style="font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 1pt; font-family: 'times new roman';"></td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important;"></td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; vertical-align: bottom; white-space: nowrap;"><font><font style="font-family: 'times new roman', times; font-size: 10pt;"> 13,747,161 </font></font></td> <td style="padding-bottom: 1pt; text-align: left; font-family: 'times new roman'; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 1pt; font-family: 'times new roman'; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; vertical-align: bottom; white-space: nowrap;"><font><font style="font-family: 'times new roman', times; font-size: 10pt;"> 14,546,085 </font></font></td> <td style="padding-bottom: 1pt; text-align: left; font-family: 'times new roman'; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="padding-bottom: 1pt; width: 20px; background-color: #cceeff;"><font><font style="font-size: 13.3333330154419px;">Total common stock equivalents</font></font></td> <td style="padding-bottom: 1pt; font-family: 'times new roman'; text-align: right; width: 20px; background-color: #cceeff;">&#160;</td> <td style="padding-bottom: 1pt; font-family: 'times new roman'; text-align: right; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 1pt; font-family: 'times new roman'; text-align: right; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important; background-color: #cceeff;"><font style="font-size: 10pt;"><font><font style="font-family: 'times new roman', times; font-size: 10pt;"><font>26,974,253</font></font></font></font></td> <td style="padding-bottom: 1pt; font-family: 'times new roman'; text-align: right; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 1pt; font-family: 'times new roman'; text-align: right; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 1pt; font-family: 'times new roman'; text-align: right; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 1pt; font-family: 'times new roman'; text-align: right; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important; background-color: #cceeff;"><font style="font-size: 10pt;"><font><font style="font-size: 10pt;"><font>-</font></font></font></font></td> <td style="padding-bottom: 1pt; font-family: 'times new roman'; text-align: right; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 1pt; font-family: 'times new roman'; width: 20px; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important; background-color: #cceeff;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; vertical-align: bottom; white-space: nowrap; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important; background-color: #cceeff;"><font><font style="font-family: 'times new roman', times; font-size: 10pt;"><font><font style="font-family: 'times new roman', times; font-size: 10pt;"> 26,974,253</font></font></font></font></td> <td style="padding-bottom: 1pt; text-align: left; font-family: 'times new roman'; white-space: nowrap; padding-right: 5px; padding-left: 5px; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 1pt; font-family: 'times new roman'; white-space: nowrap; padding-right: 5px; padding-left: 5px; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; white-space: nowrap; padding-right: 5px; padding-left: 5px; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; vertical-align: bottom; white-space: nowrap; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important; background-color: #cceeff;"><font><font style="font-family: 'times new roman', times; font-size: 10pt;"><font><font style="font-family: 'times new roman', times; font-size: 10pt;"> 21,619,737</font></font></font></font></td> <td style="padding-bottom: 1pt; text-align: left; font-family: 'times new roman'; white-space: nowrap; padding-right: 5px; padding-left: 5px; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> </table> </div> </div> </div> 265000 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <div class="CursorPointer"> <table style="border-collapse: collapse; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; width: 100%; margin-left: 0.100000001490116px;" cellpadding="0" cellspacing="0"> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman'; width: 50%;" nowrap="nowrap"></td> <td style="font-family: 'times new roman'; padding: 0px; width: 2%;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: center; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important; width: 12%;" nowrap="nowrap" colspan="6"> <p style="margin: 0px;"><font style="font-size: 10pt;"><strong>Three Months&#160;</strong></font><strong>Ended</strong></p> <p style="margin: 0px;"><strong>June 30,</strong></p> </td> <td style="font-family: 'times new roman'; padding: 0px; width: 2%;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 2%;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong> </strong></font></td> <td colspan="6" style="text-align: center; font-family: 'times new roman'; padding: 0px; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; width: 12%;" nowrap="nowrap"> <p style="margin: 0px;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>Six Months Ended</strong></font></p> <p style="margin: 0px;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>June 30,</strong></font></p> </td> <td style="font-family: 'times new roman'; padding: 0px; width: 2%;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman'; width: 50%;" nowrap="nowrap"></td> <td style="font-family: 'times new roman'; padding: 0px; width: 0%;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: center; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important; width: 0%;" nowrap="nowrap" colspan="2"><font style="font-size: 10pt;"><strong>2015</strong></font><br/></td> <td style="font-family: 'times new roman'; padding: 0px; width: 0%;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 0%;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: center; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important; width: 0%;" nowrap="nowrap" colspan="2"><font style="font-size: 10pt;"><strong>2014</strong></font><br/></td> <td style="font-family: 'times new roman'; padding: 0px; width: 0%;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 0%;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong> </strong></font></td> <td colspan="2" style="font-family: 'times new roman'; padding: 0px; width: 0%; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; text-align: center;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>2015</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 0%; text-align: center;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 0%; text-align: center;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 0%; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; text-align: center;" colspan="2" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>2014</strong></font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 0%;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman'; width: 50%;" nowrap="nowrap">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; width: 0%;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: center; width: 20px;" nowrap="nowrap" colspan="2"><font style="font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: center; width: 20px;" nowrap="nowrap" colspan="2"><font style="font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px; text-align: center;" nowrap="nowrap" colspan="2"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px; text-align: center;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px; text-align: center;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px; text-align: center;" nowrap="nowrap" colspan="2"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 0%;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 50%;"><font style="font-family: 'times new roman', times; font-size: 10pt;">North&#160;America</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 0%;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; width: 0%;">$</td> <td style="font-family: 'times new roman'; padding: 0px; text-align: right; width: 0%;"><font style="font-size: 10pt;"><font> 1,622 </font></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 0%;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 0%;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 0%;"><font style="font-size: 10pt;">$</font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: right; width: 0%;"><font style="font-size: 10pt;"><font> 941 </font></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 0%;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; width: 0%;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 0%;"><font style="font-family: 'times new roman', times; font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 0%;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 2,894 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 0%;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 0%;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 0%;"><font style="font-family: 'times new roman', times; font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 0%;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 1,831 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 0%;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font><font style="font-size: 13.3333330154419px;">Europe, Middle East, Asia</font></font></td> <td style="font-family: 'times new roman'; padding: 0px;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"></td> <td style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important; text-align: right;"><font style="font-size: 10pt;"><font> 492 </font></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important; text-align: right;"><font style="font-size: 10pt;"><font> 256 </font></font></td> <td style="font-family: 'times new roman'; padding: 0px;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px;"></td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 909 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 428 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-family: 'times new roman'; padding: 0px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;">$</td> <td style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important; text-align: right;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 2,114 </font></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="padding: 0px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"> <p style="margin: 0px;"><font style="font-size: 10pt;">$</font></p> </td> <td style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important; text-align: right;"><font style="font-size: 10pt;"><font> 1,197 </font></font></td> <td style="font-family: 'times new roman'; padding: 0px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 3,803 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 2,259 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> </table> </div> </div> <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <div class="CursorPointer"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; width: 100%; margin-left: 0.100000001490116px;"> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td nowrap="nowrap" style="padding: 0px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important; text-align: center;" colspan="6"><font style="font-size: 10pt;"><strong>Three months ended June 30,</strong></font><br/></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong> </strong></font></td> <td colspan="6" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>Six months ended June 30,</strong></font></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong> </strong></font></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td nowrap="nowrap" style="padding: 0px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important; text-align: center;" colspan="2"><font style="font-size: 10pt;"><b>2015</b></font></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px; text-align: center;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px; text-align: center;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td nowrap="nowrap" style="padding: 0px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important; text-align: center;" colspan="2"><font style="font-size: 10pt;"><b>2014</b></font></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong> </strong></font></td> <td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>2015</strong></font></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong> </strong></font></td> <td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" colspan="2"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>2014</strong></font></td> <td nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><br/></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">Numerator:</font></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; background-color: #cceeff;"></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; background-color: #cceeff;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;&#160;</font></td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; text-indent: 10px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">Net income (loss)</font></td> <td style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px;"><br/></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: right;"><br/></td> <td style="font-family: 'times new roman'; padding: 0px;"></td> <td style="font-family: 'times new roman'; padding: 0px;"></td> <td style="font-family: 'times new roman'; padding: 0px;"><br/></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: right;"><br/></td> <td style="font-family: 'times new roman'; padding: 0px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px;"><br/></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><br/></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;"><br/></td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><br/></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><br/></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><br/></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;"></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; padding: 0px; text-indent: 10px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">Basic</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">$</font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: right; width: 20px; background-color: #cceeff;"><font><font style="font-size: 10pt;"> (5,645 </font></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">)</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">$</font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: right; width: 20px; background-color: #cceeff;"><font><font style="font-size: 10pt;"> 56,128 </font></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; background-color: #cceeff;"><font><font style="font-size: 10pt;"> (9,760 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">)</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; background-color: #cceeff;"><font><font style="font-size: 10pt;"> (25,638 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">)</font></td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; text-indent: 10px; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">Adjustment for change in fair value of warrant liability&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: right; width: 20px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font><font style="font-size: 10pt;"> - </font></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: right; width: 20px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font><font style="font-size: 10pt;"> (60,458 </font></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-size: 10pt;">)</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font><font style="font-size: 10pt;"> - </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font><font style="font-size: 10pt;"> - </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; text-indent: 10px; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">Diluted&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">$</font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: right; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font><font style="font-size: 10pt;"> (5,645 </font></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">)</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 13.3333330154419px;">$</font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: right; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font><font style="font-size: 10pt;"> (4,330 </font></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">)</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font><font style="font-size: 10pt;"> (9,760 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">)</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font><font style="font-size: 10pt;"> (25,638 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">)</font></td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; text-indent: 10px; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: right; width: 20px;"><font style="font-size: 10pt;"> &#160; </font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: right; width: 20px;"><font style="font-size: 10pt;"> &#160; </font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px;"><font style="font-size: 10pt;"> &#160; </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px;"><font style="font-size: 10pt;"> &#160; </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">Denominator:</font></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"></td> <td style="font-family: 'Times New Roman'; text-align: right; background-color: #cceeff;"><font style="font-size: 10pt;"> &#160; </font></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"></td> <td style="font-family: 'Times New Roman'; text-align: right; background-color: #cceeff;"><font style="font-size: 10pt;"> &#160; </font></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;"><font style="font-size: 10pt;"> &#160; </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman'; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;"><font style="font-size: 10pt;"> &#160; </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; text-indent: 10px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">Weighted-average common shares outstanding used in computing basic and diluted net income (loss) per share</font></td> <td style="font-family: 'Times New Roman';"><br/></td> <td style="font-family: 'Times New Roman';"></td> <td style="font-family: 'Times New Roman'; text-align: right;"><br/></td> <td style="font-family: 'Times New Roman';"></td> <td style="font-family: 'Times New Roman';"></td> <td style="font-family: 'Times New Roman';"><br/></td> <td style="font-family: 'Times New Roman'; text-align: right;"><font style="font-size: 10pt;"> &#160; </font></td> <td style="font-family: 'Times New Roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font style="font-size: 10pt;"> &#160; </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font style="font-size: 10pt;"> &#160; </font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; padding: 0px; text-indent: 10px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">Basic</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: right; width: 20px; background-color: #cceeff;"><font><font style="font-size: 10pt;"> 102,094,158 </font></font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: right; width: 20px; background-color: #cceeff;"><font><font style="font-size: 10pt;"> 78,497,558 </font></font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; background-color: #cceeff;"><font><font style="font-size: 10pt;"> 101,944,359 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; background-color: #cceeff;"><font><font style="font-size: 10pt;"> 72,688,073 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; text-indent: 10px; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">Dilutive effect of warrants&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: right; width: 20px;"><font><font style="font-size: 10pt;"> - </font></font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: right; width: 20px;"><font><font style="font-size: 10pt;"> 9,593,643 </font></font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px;"><font><font style="font-size: 10pt;"> - </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman'; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px;"><font><font style="font-size: 10pt;"> - </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; padding: 0px; text-indent: 10px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">Dilutive effect of stock options</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: right; width: 20px; background-color: #cceeff; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font><font style="font-size: 10pt;"> - </font></font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: right; width: 20px; background-color: #cceeff; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font><font style="font-size: 10pt;"> 6,681,210 </font></font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; width: 20px; background-color: #cceeff; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; background-color: #cceeff; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;"><font> - </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; width: 20px; background-color: #cceeff; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; background-color: #cceeff; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font><font style="font-size: 10pt;"> - </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: left; padding: 0px; text-indent: 10px; width: 20px;"><font style="font-size: 10pt;">Diluted</font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: right; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font><font style="font-size: 10pt;"> 102,094,158 </font></font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: right; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font><font style="font-size: 10pt;"> 94,772,411 </font></font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;"><font> 101,944,359 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman'; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font><font style="font-size: 10pt;"> 72,688,073 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; padding: 0px; text-indent: 10px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">Net income (loss) per share, basic</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: right; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font><font style="font-size: 10pt;"> (0.06 </font></font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">)</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: right; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font><font style="font-size: 10pt;"> 0.72 </font></font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;"><font> (0.10 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px 0px 0px; white-space: nowrap; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">)&#160;</font></td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font><font style="font-size: 10pt;"> (0.35 </font></font></td> <td style="text-align: left; padding: 0px 5px 0px 0px; white-space: nowrap; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">)</font></td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: left; padding: 0px; text-indent: 10px; width: 20px;"><font style="font-size: 10pt;">Net loss per share, diluted</font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: right; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font><font style="font-size: 10pt;"> (0.06 </font></font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-size: 10pt;">)</font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; text-align: right; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font><font style="font-size: 10pt;"> (0.05 </font></font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-size: 10pt;">)</font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;"> <font> (0.10 </font></font></td> <td style="text-align: left; padding: 0px 5px 0px 0px; white-space: nowrap; width: 20px;"><font><font style="font-size: 13.3333330154419px;">)</font></font></td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman'; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font><font style="font-size: 10pt;"> (0.35 </font></font></td> <td style="text-align: left; padding: 0px 5px 0px 0px; white-space: nowrap; width: 20px;"><font style="font-size: 10pt;">)</font></td> </tr> </table> </div> </div> <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <div class="CursorPointer"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin-left: 0.100000001490116px;" width="100%"> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td nowrap="nowrap" style="padding-bottom: 1pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td nowrap="nowrap" style="padding-bottom: 1pt; font-family: 'times new roman'; text-align: center; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;" colspan="6"><font style="font-size: 10pt;"><strong>Three months ended June 30,</strong></font><br/></td> <td nowrap="nowrap" style="padding-bottom: 1pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td nowrap="nowrap" style="padding-bottom: 1pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong> </strong></font></td> <td colspan="6" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>Six months ended June 30,</strong></font></td> <td nowrap="nowrap" style="padding-bottom: 1pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td nowrap="nowrap" style="padding-bottom: 1pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td nowrap="nowrap" style="padding-bottom: 1pt; text-align: center; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;" colspan="2"><font><font style="font-size: 13.3333330154419px;"><b>2015</b></font></font></td> <td nowrap="nowrap" style="padding-bottom: 1pt; font-family: 'times new roman'; text-align: center;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td nowrap="nowrap" style="padding-bottom: 1pt; font-family: 'times new roman'; text-align: center;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td nowrap="nowrap" style="padding-bottom: 1pt; text-align: center; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;" colspan="2"><font><font style="font-size: 13.3333330154419px;"><b>2014</b></font></font></td> <td nowrap="nowrap" style="padding-bottom: 1pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td nowrap="nowrap" style="padding-bottom: 1pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong> </strong></font></td> <td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>2015</strong></font></td> <td nowrap="nowrap" style="padding-bottom: 1pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td nowrap="nowrap" style="padding-bottom: 1pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>2014</strong></font></td> <td nowrap="nowrap" style="padding-bottom: 1pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">Options to purchase common stock</font></td> <td style="font-family: 'times new roman'; text-align: right; background-color: #cceeff;">&#160;</td> <td style="font-family: 'times new roman'; text-align: right; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; text-align: right; background-color: #cceeff;"><font style="font-size: 10pt;"><font>13,227,092</font></font></td> <td style="font-family: 'times new roman'; text-align: right; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; text-align: right; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; text-align: right; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; text-align: right; background-color: #cceeff;"><font style="font-size: 10pt;"><font> - </font></font></td> <td style="font-family: 'times new roman'; text-align: right; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; background-color: #cceeff;"></td> <td style="text-align: left; font-family: 'times new roman'; background-color: #cceeff;"></td> <td style="text-align: right; font-family: 'times new roman'; vertical-align: bottom; white-space: nowrap; background-color: #cceeff;"><font><font style="font-family: 'times new roman', times; font-size: 10pt;"> 13,227,092 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; white-space: nowrap; padding-right: 5px; padding-left: 5px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; white-space: nowrap; padding-right: 5px; padding-left: 5px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; white-space: nowrap; padding-right: 5px; padding-left: 5px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; vertical-align: bottom; white-space: nowrap; background-color: #cceeff;"><font><font style="font-family: 'times new roman', times; font-size: 10pt;"> 7,073,652 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; white-space: nowrap; padding-right: 5px; padding-left: 5px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom;"> <td style="padding-bottom: 1pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;">Warrants to purchase common stock</font></td> <td style="padding-bottom: 1pt; font-family: 'times new roman'; text-align: right;">&#160;</td> <td style="padding-bottom: 1pt; font-family: 'times new roman'; text-align: right; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 1pt; font-family: 'times new roman'; text-align: right; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;"><font>13,747,161</font></font></td> <td style="padding-bottom: 1pt; font-family: 'times new roman'; text-align: right;"><font style="font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 1pt; font-family: 'times new roman'; text-align: right;"><font style="font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 1pt; font-family: 'times new roman'; text-align: right; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 1pt; font-family: 'times new roman'; text-align: right; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;"><font> - </font></font></td> <td style="padding-bottom: 1pt; font-family: 'times new roman'; text-align: right;"><font style="font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 1pt; font-family: 'times new roman';"></td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important;"></td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; vertical-align: bottom; white-space: nowrap;"><font><font style="font-family: 'times new roman', times; font-size: 10pt;"> 13,747,161 </font></font></td> <td style="padding-bottom: 1pt; text-align: left; font-family: 'times new roman'; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 1pt; font-family: 'times new roman'; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; vertical-align: bottom; white-space: nowrap;"><font><font style="font-family: 'times new roman', times; font-size: 10pt;"> 14,546,085 </font></font></td> <td style="padding-bottom: 1pt; text-align: left; font-family: 'times new roman'; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="padding-bottom: 1pt; width: 20px; background-color: #cceeff;"><font><font style="font-size: 13.3333330154419px;">Total common stock equivalents</font></font></td> <td style="padding-bottom: 1pt; font-family: 'times new roman'; text-align: right; width: 20px; background-color: #cceeff;">&#160;</td> <td style="padding-bottom: 1pt; font-family: 'times new roman'; text-align: right; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 1pt; font-family: 'times new roman'; text-align: right; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important; background-color: #cceeff;"><font style="font-size: 10pt;"><font><font style="font-family: 'times new roman', times; font-size: 10pt;"><font>26,974,253</font></font></font></font></td> <td style="padding-bottom: 1pt; font-family: 'times new roman'; text-align: right; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 1pt; font-family: 'times new roman'; text-align: right; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 1pt; font-family: 'times new roman'; text-align: right; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 1pt; font-family: 'times new roman'; text-align: right; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important; background-color: #cceeff;"><font style="font-size: 10pt;"><font><font style="font-size: 10pt;"><font>-</font></font></font></font></td> <td style="padding-bottom: 1pt; font-family: 'times new roman'; text-align: right; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 1pt; font-family: 'times new roman'; width: 20px; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important; background-color: #cceeff;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; vertical-align: bottom; white-space: nowrap; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important; background-color: #cceeff;"><font><font style="font-family: 'times new roman', times; font-size: 10pt;"><font><font style="font-family: 'times new roman', times; font-size: 10pt;"> 26,974,253</font></font></font></font></td> <td style="padding-bottom: 1pt; text-align: left; font-family: 'times new roman'; white-space: nowrap; padding-right: 5px; padding-left: 5px; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 1pt; font-family: 'times new roman'; white-space: nowrap; padding-right: 5px; padding-left: 5px; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; white-space: nowrap; padding-right: 5px; padding-left: 5px; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; vertical-align: bottom; white-space: nowrap; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important; background-color: #cceeff;"><font><font style="font-family: 'times new roman', times; font-size: 10pt;"><font><font style="font-family: 'times new roman', times; font-size: 10pt;"> 21,619,737</font></font></font></font></td> <td style="padding-bottom: 1pt; text-align: left; font-family: 'times new roman'; white-space: nowrap; padding-right: 5px; padding-left: 5px; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> </table> </div> </div> 1770000 2033000 1130000 1768000 640000 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><b>14.</b> <b>Segment Disclosures</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><font style="font-family: 'times new roman', times; font-size: 10pt;">The Company has two reportable segments, Engineering Services and Medical. Engineering Services generates revenue principally from collaborative research and development service arrangements, technology license agreements, and government grants where the Company uses its robotics domain knowledge in bionic exoskeletons to bid on and procure contracts and grants from entities such as such as the National Science Foundation and the Defense Advanced Research Projects Agency. The Medical segment designs, engineers, and manufactures exoskeletons for applications in the medical and military markets.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><font style="font-family: 'times new roman', times; font-size: 10pt;">The Company evaluates performance and allocates resources based on segment gross profit margin. The reportable segments are each managed separately because they serve distinct markets, and one segment provides a service and the other manufactures and distributes a unique product. The Company does not consider net assets as a segment measure and, accordingly, assets are not allocated.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><font style="font-family: 'times new roman', times; font-size: 10pt;">Segment reporting information is as follows:</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></p> <div> <div class="CursorPointer"> <table style="border-collapse: collapse; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; width: 85%; margin-left: 0.1px;" cellpadding="0" cellspacing="0"> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong> </strong></font></td> <td colspan="2" style="text-align: center; font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>Engineering</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong> </strong></font></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" colspan="2" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>Medical</strong><strong>&#160;</strong></font></td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong> </strong></font></td> <td colspan="2" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>Services</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong> </strong></font></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td colspan="2" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>Devices</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td colspan="2" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>Total</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font><font style="font-size: 13.3333330154419px;">Three months ended June 30, 2015</font></font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-size: 10pt;"> Revenue </font></td> <td style="font-family: 'Times New Roman'; width: 20px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-size: 10pt;"><font> 1,066 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-size: 10pt;"><font> 1,048 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-size: 10pt;"><font> 2,114 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;"> Cost of revenue </font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;"><font> 642 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;"><font> 970 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;"><font> 1,612 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-size: 10pt;"> Gross profit</font></td> <td style="font-family: 'Times New Roman'; width: 20px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;"><font> 424 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;">$&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;"><font> 78 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;"><font> 502 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman'; width: 20px;"><font><font style="font-size: 13.3333330154419px;">Three months ended June 30, 2014</font></font></td> <td style="font-family: 'Times New Roman'; width: 20px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"></td> <td style="font-family: 'Times New Roman'; width: 20px;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"></td> <td style="font-family: 'Times New Roman'; width: 20px;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">Revenue&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;"> <font> 507 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;"> <font> 690 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;"> <font> 1,197 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">Cost of revenue&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;"> <font> 650 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"></td> <td style="font-family: 'Times New Roman'; width: 20px;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;"> <font> 502 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"></td> <td style="font-family: 'Times New Roman'; width: 20px;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;"> <font> 1,152 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">Gross profit (loss)</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;"> <font> (143 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;">)</td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;"> <font> 188 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;"> <font> 45 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"></td> <td style="font-family: 'Times New Roman'; width: 20px;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"></td> <td style="font-family: 'Times New Roman'; width: 20px;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">Six months ended June 30, 2015</font></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; background-color: #cceeff;"></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'times new roman'; padding: 0px; width: 55%; text-indent: 10px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">Revenue</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 1%;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 1%;"><font style="font-family: 'times new roman', times; font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 12%;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 1,770 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 1%;"><font style="font-family: 'times new roman', times; font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 12%;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 2,033 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 1%;"><font style="font-family: 'times new roman', times; font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 12%;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 3,803 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-family: 'times new roman'; padding: 0px; text-indent: 10px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">Cost of revenue</font></td> <td style="font-family: 'times new roman'; padding: 0px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 1,130 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 1,768 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 2,898 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; text-indent: 10px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">Gross profit</font></td> <td style="font-family: 'times new roman'; padding: 0px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 2.8pt !important; border-bottom-style: double !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 2.8pt !important; border-bottom-style: double !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 640 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 2.8pt !important; border-bottom-style: double !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 2.8pt !important; border-bottom-style: double !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 265 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 2.8pt !important; border-bottom-style: double !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 2.8pt !important; border-bottom-style: double !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 905 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="vertical-align: top; text-align: left; font-family: 'Times New Roman'; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="vertical-align: top; text-align: left; font-family: 'Times New Roman'; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; vertical-align: top; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; vertical-align: top; white-space: nowrap; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; vertical-align: top; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="vertical-align: top; text-align: left; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman'; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; vertical-align: top; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; vertical-align: top; white-space: nowrap; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; vertical-align: top; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="vertical-align: top; text-align: left; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman'; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; vertical-align: top; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; vertical-align: top; white-space: nowrap; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; vertical-align: top; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;">Six months ended June 30, 2014</font></td> <td style="font-family: 'Times New Roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-family: 'times new roman'; padding: 0px; text-indent: 10px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">Revenue</font></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 1,042 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman'; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 1,217 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman'; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 2,259 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'times new roman'; padding: 0px; text-indent: 10px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">Cost of revenue</font></td> <td style="font-family: 'times new roman'; padding: 0px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 902 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 832 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 1,734 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; text-indent: 10px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">Gross profit</font></td> <td style="font-family: 'times new roman'; padding: 0px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 140 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 385 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 525 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> </table> </div> </div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><font style="font-family: 'times new roman', times; font-size: 10pt;">Geographic information for revenue based on location of customer is as follows:</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></p> <div> <div class="CursorPointer"> <table style="border-collapse: collapse; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; width: 100%; margin-left: 0.100000001490116px;" cellpadding="0" cellspacing="0"> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman'; width: 50%;" nowrap="nowrap"></td> <td style="font-family: 'times new roman'; padding: 0px; width: 2%;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: center; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important; width: 12%;" nowrap="nowrap" colspan="6"> <p style="margin: 0px;"><font style="font-size: 10pt;"><strong>Three Months&#160;</strong></font><strong>Ended</strong></p> <p style="margin: 0px;"><strong>June 30,</strong></p> </td> <td style="font-family: 'times new roman'; padding: 0px; width: 2%;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 2%;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong> </strong></font></td> <td colspan="6" style="text-align: center; font-family: 'times new roman'; padding: 0px; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; width: 12%;" nowrap="nowrap"> <p style="margin: 0px;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>Six Months Ended</strong></font></p> <p style="margin: 0px;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>June 30,</strong></font></p> </td> <td style="font-family: 'times new roman'; padding: 0px; width: 2%;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman'; width: 50%;" nowrap="nowrap"></td> <td style="font-family: 'times new roman'; padding: 0px; width: 0%;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: center; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important; width: 0%;" nowrap="nowrap" colspan="2"><font style="font-size: 10pt;"><strong>2015</strong></font><br/></td> <td style="font-family: 'times new roman'; padding: 0px; width: 0%;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 0%;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: center; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important; width: 0%;" nowrap="nowrap" colspan="2"><font style="font-size: 10pt;"><strong>2014</strong></font><br/></td> <td style="font-family: 'times new roman'; padding: 0px; width: 0%;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 0%;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong> </strong></font></td> <td colspan="2" style="font-family: 'times new roman'; padding: 0px; width: 0%; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; text-align: center;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>2015</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 0%; text-align: center;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 0%; text-align: center;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 0%; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; text-align: center;" colspan="2" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>2014</strong></font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 0%;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman'; width: 50%;" nowrap="nowrap">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; width: 0%;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: center; width: 20px;" nowrap="nowrap" colspan="2"><font style="font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: center; width: 20px;" nowrap="nowrap" colspan="2"><font style="font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px; text-align: center;" nowrap="nowrap" colspan="2"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px; text-align: center;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px; text-align: center;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px; text-align: center;" nowrap="nowrap" colspan="2"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 0%;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 50%;"><font style="font-family: 'times new roman', times; font-size: 10pt;">North&#160;America</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 0%;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; width: 0%;">$</td> <td style="font-family: 'times new roman'; padding: 0px; text-align: right; width: 0%;"><font style="font-size: 10pt;"><font> 1,622 </font></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 0%;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 0%;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 0%;"><font style="font-size: 10pt;">$</font></td> <td style="font-family: 'times new roman'; padding: 0px; text-align: right; width: 0%;"><font style="font-size: 10pt;"><font> 941 </font></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 0%;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; width: 0%;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 0%;"><font style="font-family: 'times new roman', times; font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 0%;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 2,894 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 0%;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 0%;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 0%;"><font style="font-family: 'times new roman', times; font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 0%;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 1,831 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 0%;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px;"><font><font style="font-size: 13.3333330154419px;">Europe, Middle East, Asia</font></font></td> <td style="font-family: 'times new roman'; padding: 0px;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"></td> <td style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important; text-align: right;"><font style="font-size: 10pt;"><font> 492 </font></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important; text-align: right;"><font style="font-size: 10pt;"><font> 256 </font></font></td> <td style="font-family: 'times new roman'; padding: 0px;">&#160;</td> <td style="font-family: 'times new roman'; padding: 0px;"></td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 909 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 428 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-family: 'times new roman'; padding: 0px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;">$</td> <td style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important; text-align: right;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 2,114 </font></font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="padding: 0px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"> <p style="margin: 0px;"><font style="font-size: 10pt;">$</font></p> </td> <td style="font-family: 'times new roman'; padding: 0px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important; text-align: right;"><font style="font-size: 10pt;"><font> 1,197 </font></font></td> <td style="font-family: 'times new roman'; padding: 0px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 3,803 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 2,259 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> </table> </div> </div> </div> <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <div class="CursorPointer"> <table style="border-collapse: collapse; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; width: 85%; margin-left: 0.1px;" cellpadding="0" cellspacing="0"> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong> </strong></font></td> <td colspan="2" style="text-align: center; font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>Engineering</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong> </strong></font></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" colspan="2" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>Medical</strong><strong>&#160;</strong></font></td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="text-align: center; font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';" nowrap="nowrap"></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong> </strong></font></td> <td colspan="2" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>Services</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong> </strong></font></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td colspan="2" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>Devices</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> <td colspan="2" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>Total</strong></font></td> <td style="font-family: 'times new roman'; padding: 0px;" nowrap="nowrap"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>&#160;</strong></font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font><font style="font-size: 13.3333330154419px;">Three months ended June 30, 2015</font></font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-size: 10pt;"> Revenue </font></td> <td style="font-family: 'Times New Roman'; width: 20px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-size: 10pt;"><font> 1,066 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-size: 10pt;"><font> 1,048 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-size: 10pt;"><font> 2,114 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;"> Cost of revenue </font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;"><font> 642 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;"><font> 970 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;"><font> 1,612 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-size: 10pt;"> Gross profit</font></td> <td style="font-family: 'Times New Roman'; width: 20px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;"><font> 424 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;">$&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;"><font> 78 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;"><font> 502 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman'; width: 20px;"><font><font style="font-size: 13.3333330154419px;">Three months ended June 30, 2014</font></font></td> <td style="font-family: 'Times New Roman'; width: 20px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"></td> <td style="font-family: 'Times New Roman'; width: 20px;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"></td> <td style="font-family: 'Times New Roman'; width: 20px;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">Revenue&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;"> <font> 507 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;"> <font> 690 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-size: 10pt;"> <font> 1,197 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">Cost of revenue&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;"> <font> 650 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"></td> <td style="font-family: 'Times New Roman'; width: 20px;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;"> <font> 502 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"></td> <td style="font-family: 'Times New Roman'; width: 20px;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; border-bottom-width: 1pt !important; border-bottom-style: solid !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;"> <font> 1,152 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">Gross profit (loss)</font></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;"> <font> (143 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;">)</td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;"> <font> 188 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"></td> <td style="font-family: 'Times New Roman'; width: 20px; background-color: #cceeff;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; border-bottom-color: #000000 !important;"><font style="font-size: 10pt;"> <font> 45 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman'; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; width: 20px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;">&#160;</td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"></td> <td style="font-family: 'Times New Roman'; width: 20px;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"></td> <td style="font-family: 'Times New Roman'; width: 20px;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; width: 20px;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; width: 20px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">Six months ended June 30, 2015</font></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; background-color: #cceeff;"></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'times new roman'; padding: 0px; width: 55%; text-indent: 10px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">Revenue</font></td> <td style="font-family: 'times new roman'; padding: 0px; width: 1%;"></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 1%;"><font style="font-family: 'times new roman', times; font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 12%;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 1,770 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 1%;"><font style="font-family: 'times new roman', times; font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 12%;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 2,033 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; width: 1%;"><font style="font-family: 'times new roman', times; font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; width: 12%;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 3,803 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; width: 1%;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-family: 'times new roman'; padding: 0px; text-indent: 10px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">Cost of revenue</font></td> <td style="font-family: 'times new roman'; padding: 0px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 1,130 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 1,768 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 2,898 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; text-indent: 10px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">Gross profit</font></td> <td style="font-family: 'times new roman'; padding: 0px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 2.8pt !important; border-bottom-style: double !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 2.8pt !important; border-bottom-style: double !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 640 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 2.8pt !important; border-bottom-style: double !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 2.8pt !important; border-bottom-style: double !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 265 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 2.8pt !important; border-bottom-style: double !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 2.8pt !important; border-bottom-style: double !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 905 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="vertical-align: top; text-align: left; font-family: 'Times New Roman'; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="vertical-align: top; text-align: left; font-family: 'Times New Roman'; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; vertical-align: top; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; vertical-align: top; white-space: nowrap; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; vertical-align: top; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="vertical-align: top; text-align: left; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman'; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; vertical-align: top; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; vertical-align: top; white-space: nowrap; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; vertical-align: top; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="vertical-align: top; text-align: left; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman'; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; vertical-align: top; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; vertical-align: top; white-space: nowrap; background-color: #cceeff;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; vertical-align: top; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'Times New Roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;">Six months ended June 30, 2014</font></td> <td style="font-family: 'Times New Roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;">&#160;</td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-family: 'times new roman'; padding: 0px; text-indent: 10px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">Revenue</font></td> <td style="font-family: 'Times New Roman'; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 1,042 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman'; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 1,217 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman'; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 2,259 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: 'times new roman'; padding: 0px; text-indent: 10px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">Cost of revenue</font></td> <td style="font-family: 'times new roman'; padding: 0px;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 902 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 832 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 1pt !important; border-bottom-style: solid !important;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 1,734 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-family: 'times new roman'; padding: 0px; text-indent: 10px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">Gross profit</font></td> <td style="font-family: 'times new roman'; padding: 0px; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 140 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 385 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 10px 0px 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">$</font></td> <td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap; border-bottom-color: #000000 !important; border-bottom-width: 2.8pt !important; border-bottom-style: double !important; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;"><font> 525 </font></font></td> <td style="text-align: left; font-family: 'times new roman'; padding: 0px 5px; white-space: nowrap; background-color: #cceeff;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> </tr> </table> </div> </div> 1042000 1217000 902000 832000 140000 385000 2894000 1831000 909000 428000 false --12-31 2015-06-30 Non-accelerated Filer EKSO BIONICS HOLDINGS, INC. 0001549084 2015 Q2 10-Q -5645000 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"><b>8. Capitalization and Equity Structure</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0;"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;">The Company's authorized capital stock at June 30, 2015, consisted of 500,000,000 shares of common stock and 10,000,000 shares of preferred stock. At June 30, 2015, 102,123,767 shares of common stock were issued and outstanding, and no shares of preferred stock were issued and outstanding.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;">&#160;</p> </div> 1500000 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><b>1. Organization</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in;"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><b>Description of Business and Liquidity</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">On January 15, 2014, a wholly-owned subsidiary of Ekso Bionics Holdings, Inc. named Ekso Acquisition Corp, merged with and into Ekso Bionics, Inc. (the &#147;Merger&#148;). Ekso Bionics, Inc. was the surviving corporation and became a wholly-owned subsidiary of Ekso Bionics Holdings, Inc. As a result of this transaction, Ekso Bionics Holdings, Inc. discontinued its pre-merger operations, acquired the business of Ekso Bionics, Inc. and continues the operations of Ekso Bionics, Inc. as a publicly traded company. See <i>Note 3, The Merger, Offering and Other Related Transactions. </i>Ekso Bionics, Inc. was incorporated in January 2005 in the State of Delaware. We are currently headquartered in Richmond, California.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">As used in these notes to the condensed consolidated financial statements, the term &#147;the Company&#148; refers to Ekso Bionics Holdings, Inc. (formerly known as PN Med Group, Inc.) and its direct and indirect wholly-owned subsidiaries, including Ekso Bionics, Inc. and Ekso Bionics Ltd., after giving effect to the Merger; the term &#147;Holdings&#148; refers to the business of Ekso Bionics Holdings, Inc. prior to the Merger, and the term &#147;Ekso Bionics&#148; refers to Ekso Bionics, Inc. prior to the Merger. Unless otherwise indicated, all dollar amounts included in these notes to the financial statements are in thousands.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">We are a leading developer and manufacturer of human bionic exoskeletons . We were founded after the Robotics and Human Engineering Laboratory at the University of California, Berkeley had a breakthrough in demonstrating human exoskeletons that are more energy efficient than previously thought possible.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">We are pioneering the field of human exoskeletons to augment human strength, endurance and mobility. We design, develop and sell wearable robots, or &#147;human exoskeletons,&#148; that have applications in healthcare, industrial, military, and consumer markets. Our exoskeleton systems are strapped over the user's clothing, enabling individuals with neurological conditions affecting gait (e.g., stroke or spinal cord injury) to walk again, permitting soldiers to carry heavy loads for long distances while mitigating lower back, knee, and ankle injuries, and allowing industrial workers to increase productivity and quality of work, for extended periods.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><font style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 13.3333330154419px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: inline !important; float: none;">Our current medical device product, the Ekso GT, is a wearable bionic suit that provides individuals with stroke, spinal cord injuries and other lower-extremity paralysis or weakness the ability to stand and walk over ground with a full weight-bearing, reciprocal gait using a cane, crutches or a walker under the supervision of a physical therapist. Walking is achieved by the shifting of the user's body to activate sensors in the device that initiate steps. Battery-powered motors drive the legs, replacing deficient neuromuscular function. First-time users can expect to walk with aid from the device the first time they put on the Ekso exoskeleton (after passing an assessment), while an experienced user can transfer to or from their wheelchair and don or remove the Ekso in less than five minutes.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><font style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 13.3333330154419px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: inline !important; float: none;"></font><br/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><font style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 13.3333330154419px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: inline !important; float: none;">Our engineering services division, Ekso Labs, is an exoskeleton laboratory that continually integrates emerging technologies into new product applications and expands on such technologies with our partners. Ekso Labs also develops intellectual property through research grants from government organizations, including the United States Special Operations Command and the Department of Defense.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b>Liquidity</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">Largely as a result of significant research and development activities related to the creation of our advanced technology and commercialization of this technology into our medical device business, we have incurred significant operating losses and negative cash flows from operations since inception. The Company has also recorded significant non-cash losses associated with revaluation of certain securities, which have also contributed significantly to our accumulated deficits.&#160;As of June 30, 2015, we had an accumulated deficit of $<font>81,561</font>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">The Company's cash as of June 30, 2015, was $<font>16,251</font>&#160;compared to $<font>25,190</font> at December 31, 2014. During the six months ended June 30, 2015, the Company used $<font>8,462</font>&#160;of cash in operations compared to $<font>8,605</font>&#160;for the six months ended June 30, 2014.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">Based upon our current six-month average monthly net use of cash of approximately $<font>1,500</font> and assuming increases in current revenue and gross profit, offset by incremental net use of cash for increased sales and marketing and research and development, and a potential increase in rental activity for our medical device business, the Company believes it has sufficient resources to meet its financial obligations into the second quarter of 2016.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><br/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><font style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 13.3333330154419px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: inline !important; float: none;">O</font>ur actual capital requirements may vary significantly and will depend on many factors. For example, we plan to continue to increase our investments (i) in our clinical, sales and marketing initiatives to accelerate adoption of the Ekso robotic exoskeleton in the rehabilitation market, (ii) in our research, development and commercialization activities with respect to an Ekso robotic exoskeleton for home use, and/or (iii) in the development and commercialization of able-bodied exoskeletons for industrial use. Consequently, the Company will require significant additional financing in the future, which we intend to raise through corporate collaborations, public or private equity offerings, debt financings or warrant solicitations within the next two to four quarters. Sales of additional equity securities by us could result in the dilution of the interests of existing stockholders. When we need additional financing , there can be no assurance that it will be available when required in sufficient amounts, on acceptable terms or at all. In the event that the necessary additional financing is not obtained, we may be required to reduce our discretionary overhead costs substantially, including research and development, general and administrative and sales and marketing expenses or otherwise curtail operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><br/></p> </div> 0.15 0.12 56128000 -9760000 -60458000 -5645000 -4330000 -9760000 102094158 78497558 9593643 6681210 102094158 94772411 101944359 -0.06 0.72 -0.06 -0.05 -0.10 -25638000 -25638000 72688073 -0.35 13227092 13747161 26974253 1066000 1048000 2114000 642000 970000 1612000 424000 78000 502000 507000 690000 1197000 650000 502000 1152000 -143000 188000 45000 1622000 941000 492000 256000 0.0144 0.0234 0.0190 0.0261 P6Y P10Y P6Y P8Y 0.74 0.66 0.66 161000 150000 108000 21000 174000 155000 443000 326000 1048000 690000 1066000 507000 970000 502000 642000 650000 2523000 1849000 1742000 699000 1872000 1809000 6137000 4357000 -5635000 -4312000 3000 3000 -60458000 3000 2000 -10000 -17000 -10000 60440000 -5645000 56128000 0.10 0.32 172000 171000 -60458 0.75 11590000 26000000 11767633 0.73 0.74 243647 EX-101.SCH 7 ekso-20150630.xsd XBRL TAXONOMY EXTENSION SCHEMA 001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 004 - Statement - Condensed Consolidated Statement of Operations link:presentationLink link:calculationLink link:definitionLink 005 - Statement - Condensed Consolidated Statement of Cash Flows link:presentationLink link:calculationLink link:definitionLink 101 - Disclosure - Organization link:presentationLink link:calculationLink link:definitionLink 102 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies and Estimates link:presentationLink link:calculationLink link:definitionLink 103 - Disclosure - The Merger, Offering and Other Related Transactions link:presentationLink link:calculationLink link:definitionLink 104 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 105 - Disclosure - Deferred Revenues link:presentationLink link:calculationLink link:definitionLink 106 - Disclosure - Accrued Liabilities link:presentationLink link:calculationLink link:definitionLink 107 - Disclosure - Notes Payable link:presentationLink link:calculationLink link:definitionLink 108 - Disclosure - Operating and Capital Leases link:presentationLink link:calculationLink link:definitionLink 110 - Disclosure - Warrants link:presentationLink link:calculationLink link:definitionLink 111 - Disclosure - Stock-based Compensation Plans and Awards link:presentationLink link:calculationLink link:definitionLink 112 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 113 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 114 - Disclosure - Net Income (Loss) Per Share link:presentationLink link:calculationLink link:definitionLink 115 - Disclosure - Segment Disclosures link:presentationLink link:calculationLink link:definitionLink 202 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies and Estimates (Policies) link:presentationLink link:calculationLink link:definitionLink 305 - Disclosure - Deferred Revenues (Tables) link:presentationLink link:calculationLink link:definitionLink 306 - Disclosure - Accrued Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 307 - Disclosure - Notes Payable (Tables) link:presentationLink link:calculationLink link:definitionLink 308 - Disclosure - Operating and Capital Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 310 - Disclosure - Warrants (Tables) link:presentationLink link:calculationLink link:definitionLink 311 - Disclosure - Stock-based Compensation Plans and Awards (Tables) link:presentationLink link:calculationLink link:definitionLink 314 - Disclosure - Net Income (Loss) Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 315 - Disclosure - Segment Disclosures (Tables) link:presentationLink link:calculationLink link:definitionLink 8000 - Disclosure - Senior Notes Payable link:presentationLink link:calculationLink link:definitionLink 8001 - Disclosure - Convertible Debt link:presentationLink link:calculationLink link:definitionLink 8002 - Disclosure - Senior Notes Payable (Details) link:presentationLink link:calculationLink link:definitionLink 8003 - Disclosure - Segment Disclosures (Schedule of Revenue by Major Customer) (Details) link:presentationLink link:calculationLink link:definitionLink 8004 - Statement - Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) link:presentationLink link:calculationLink link:definitionLink 8005 - Statement - Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 8006 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies and Estimates (Tables) link:presentationLink link:calculationLink link:definitionLink 8007 - Disclosure - Summary of Significant Accounting Policies and Estimates (Schedule of Basic and Diluted Net Income (Loss) Per Share) (Details) link:presentationLink link:calculationLink link:definitionLink 8008 - Disclosure - Summary of Significant Accounting Policies and Estimates (Schedule of Antidilutive Securities) (Details) link:presentationLink link:calculationLink link:definitionLink 8009 - Disclosure - Fair Value Measurements (Schedule of Financial Assets and Liabilities Measured at Fair Value) (Details) link:presentationLink link:calculationLink link:definitionLink 8010 - Disclosure - Fair Value Measurements (Summary of Changes in Unobservable Inputs) (Details) link:presentationLink link:calculationLink link:definitionLink 8011 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 8012 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 8013 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 8014 - Disclosure - Inventories (Schedule of Inventories) (Details) link:presentationLink link:calculationLink link:definitionLink 8015 - Disclosure - Property and Equipment, net link:presentationLink link:calculationLink link:definitionLink 8016 - Disclosure - Property and Equipment, net (Tables) link:presentationLink link:calculationLink link:definitionLink 8017 - Disclosure - Property and Equipment, net (Schedule of Property and Equipment, net) (Details) link:presentationLink link:calculationLink link:definitionLink 8018 - Disclosure - Debt Instruments (Senior Notes Payable and Warrants) (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 8019 - Disclosure - Employee Benefit Plan link:presentationLink link:calculationLink link:definitionLink 8020 - Disclosure - Employee Benefit Plan (Details) link:presentationLink link:calculationLink link:definitionLink 8021 - Disclosure - Employee Stock Options (Schedule of Shares Available for Grant) (Details) link:presentationLink link:calculationLink link:definitionLink 8022 - Disclosure - Employee Stock Options (Summary of Information About Stock Options Outstanding) (Details) link:presentationLink link:calculationLink link:definitionLink 8024 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 8025 - Disclosure - Income Taxes (Schedule of Domestic and Foreign Components of Pre-tax Loss) (Details) link:presentationLink link:calculationLink link:definitionLink 8026 - Disclosure - Income Taxes (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 8027 - Disclosure - Income Taxes (Schedule of Income Tax Expense (Benefit) Differed from Amounts Computed by Applying Statutory Federal Income Tax Rate to Pretax Income (Loss)) (Details) link:presentationLink link:calculationLink link:definitionLink 8028 - Disclosure - Income Taxes (Schedule of Tax Effects of Temporary Differences and Related Deferred Tax Assets and Liabilities) (Details) link:presentationLink link:calculationLink link:definitionLink 8029 - Disclosure - Income Taxes (Schedule of Reconciliation of Beginning and Ending Amount of Unrecognized Tax Benefits) (Details) link:presentationLink link:calculationLink link:definitionLink 8030 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 8031 - Disclosure - Related Party Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 41001 - Disclosure - Warrants (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 8035 - Disclosure - Capitalization and Equity Structure (Common and Convertible Preferred Stock) (Details) link:presentationLink link:calculationLink link:definitionLink 8039 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 8040 - Disclosure - Subsequent Events (Details) link:presentationLink link:calculationLink link:definitionLink 40101 - Disclosure - Organization (Details) link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies and Estimates (Details) link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - The Merger, Offering and Other Related Transactions (Merger, Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40302 - Disclosure - The Merger, Offering and Other Related Transactions (Repayment of 2013 Bridge Note, Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40303 - Disclosure - The Merger, Offering and Other Related Transactions (Private Placement Offering and Offer to Amend and Exercise, Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40304 - Disclosure - The Merger, Offering and Other Related Transactions (2014 Equity Incentive Plan, Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - Deferred Revenues (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - Accrued Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - Notes Payable (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40702 - Disclosure - Notes Payable (Schedule of future obligations under debt instruments) (Details) link:presentationLink link:calculationLink link:definitionLink 40703 - Disclosure - Notes Payable (Schedule of future obligations under debt instruments) (Details) (Calc 2) link:presentationLink link:calculationLink link:definitionLink 40801 - Disclosure - Operating and Capital Leases (Details) link:presentationLink link:calculationLink link:definitionLink 8032 - Disclosure - Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 41002 - Disclosure - Warrants (Schedule of Assumption Used in Valuation) (Details) link:presentationLink link:calculationLink link:definitionLink 41003 - Disclosure - Warrants (Schedule of Warrants Outstanding) (Details) link:presentationLink link:calculationLink link:definitionLink 41101 - Disclosure - Stock-based Compensation Plans and Awards (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 41102 - Disclosure - Stock-based Compensation Plans and Awards (Summary of Stock Option Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 41103 - Disclosure - Stock-based Compensation Plans and Awards (Schedule of Fair Value Calculation Assumptions) (Details) link:presentationLink link:calculationLink link:definitionLink 41104 - Disclosure - Stock-based Compensation Plans and Awards (Schedule of Stock-based Compensation Expense) (Details) link:presentationLink link:calculationLink link:definitionLink 41301 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 41401 - Disclosure - Net Income (Loss) Per Share (Schedule of Basic and Diluted Net Income (Loss) Per Share) (Details) link:presentationLink link:calculationLink link:definitionLink 41402 - Disclosure - Net Income (Loss) Per Share (Schedule of Antidilutive Securities) (Details) link:presentationLink link:calculationLink link:definitionLink 41501 - Disclosure - Segment Disclosures (Schedule of Segment Reporting Information) (Details) link:presentationLink link:calculationLink link:definitionLink 41502 - Disclosure - Segment Disclosures (Schedule of Geographic Information) (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - Fair Value Measurements (Details) link:presentationLink link:calculationLink link:definitionLink 41201 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 109 - Disclosure - Capitalization and Equity Structure link:presentationLink link:calculationLink link:definitionLink 40901 - Disclosure - Capitalization and Equity Structure (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 ekso-20150630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 ekso-20150630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 ekso-20150630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Average Monthly Cash Burn. Average Monthly Cash Burn Average monthly net use of cash Reflects the percentage that revenues in the period from one specified customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer Customer Concentration Risk One [Member] Customer One [Member] Reflects the percentage that revenues in the period from one specified customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer Customer Concentration Risk Two [Member] Customer Two [Member] Number of shares of equity interests converted for shares issued or issuable to acquire entity. Business Acquisition Equity Interests Issued Or Issuable Number Of Shares Converted Shares converted in business acquisition Number of shares of stock previously held by shareholders issued during the period pursuant to acquisitions. Stock Issued During Period Shares Acquisitions Previously Held Previously held common stock issued for acquisition Number of shares of stock newly issued shareholders issued during the period pursuant to acquisitions. Stock Issued During Period Shares Acquisitions New Issues Number of newly issued common stock issued for acquisition Equity interest stated as a percentage of outstanding common stock owned. Equity Interest Equity interest percentage Conversion ratio for shares issued for the conversion of stock. Conversion Of Stock Conversion Ratio Conversion ratio Outstanding nonredeemable series A preferred stock that may be exchanged into common shares at the owner's option. Series Aconvertible Preferred Stock [Member] Series A [Member] Outstanding nonredeemable series A-2 preferred stock that may be exchanged into common shares at the owner's option. Series Atwo Convertible Preferred Stock [Member] Series A-2 [Member] Outstanding nonredeemable series B preferred stock that may be exchanged into common shares at the owner's option. Series Bconvertible Preferred Stock [Member] Series B [Member] Amendment Flag Term of a warrant or warrants. Class Of Warrant Or Right Expiration Period Warrant term Expiration period Warrants issued in connection with a bridge note. Bridge Note Warrants [Member] Bridge Warrants [Member] Bridge warrants [Member] Number of new equity units issued during the period. Equity Issued During Period Units New Issues Number of Units issued Equity Issued During Period Units New Issues Price Per Unit. Equity Issued During Period Units New Issues Price Per Unit Price per Unit Number of shares issued for each equity unit. Equity Units Shares Per Unit Shares attached to each Unit Warrants issued in connection with a private placement offering. Private Placement Warrants [Member] PPO Warrants [Member] Private Placement [Member] Warrants issued to the placement agent for bridge note financing. Bridge Notes Placement Agent Warrants [Member] Bridge Agent Warrants [Member] Conversion Date [Member]. Conversion Date [Member] Conversion [Member] Merger Date [Member]. Merger Date [Member] Merger [Member] Represents information pertaining to leasehold improvement note of the entity. Leasehold Improvement Note [Member] Leasehold Improvement Note [Member] Represents information pertaining to minimum monthly payments of debt. Debt Instrument Minimum Monthly Payments Minimum monthly payments Placement agent for private placement financing. Private Placement Agent Warrants [Member] PPO Agent Warrants [Member] Private Placement Agent [Member] Offer To Amend And Exercise [Member]. Offer To Amend And Exercise [Member] Offer to Amend and Exercise [Member] Income Taxes [Line Items] Income Taxes [Line Items] Income Taxes [Table] Income Taxes [Table] The acquisition of property and equipment with the use of an existing capital lease. Acquisition Of Property And Equipment With Capital Lease Acquisition of property and equipment with capital lease Current Fiscal Year End Date The acquisition of property and equipment with an existing note payable. Acquisition Of Property And Equipment With Note Payable Acquisition of property and equipment with note payable Amount of increase in the carrying amount of outstanding stock resulting from the issuance of warrants. Adjustments To Additional Paid In Capital Warrant Issued Adjustment Common stock warrants issued in connection with issuance of Series B convertible preferred stock Duration of an agreement with another party. Agreement Term Agreement term Bridge Note One [Member] Bridge Note One [Member] 2012 Tranche 1 Bridge Notes [Member] Bridge Notes One and Two [Member] Bridge Notes One And Two [Member] 2012 Bridge Notes [Member] Placement agent for bridge note financing. Bridge Notes Placement Agent [Member] Bridge Note Three [Member] Bridge Note Three [Member] 2013 Bridge Notes [Member] Bridge Note Two [Member] Bridge Note Two [Member] 2012 Tranche 2 Bridge Notes [Member] Date the warrants or rights expire, in CCYY-MM-DD format. Class Of Warrant Or Right Expiration Date Expiration date Date the warrants or rights were issued, in CCYY-MM-DD format. Class Of Warrant Or Right Issuance Date Date of issue Reflects the percentage that revenues in the period from one specified customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer Customer Concentration Risk Four [Member] Customer Four [Member] Document Period End Date Reflects the percentage that revenues in the period from one specified customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer Customer Concentration Risk Three [Member] Customer Three [Member] Defense Advanced Research Projects Agency [Member] Defense Advanced Research Projects Agency [Member] Document and Entity Information [Abstract] Document and Entity Information [Abstract] Operating segment that generates revenue principally from collaborative research and development service arrangements, technology license agreements, and government grants Engineering Services [Member] Award Date [Axis] The fair value of a warrant which accounts for an amount of revenue reduced during the period. Fair Value Of Warrant Accounted For As Reduction Of Revenue Fair value of warrant accounted for as a reduction of revenue Award Type [Axis] Person who previously held the highest ranking executive position, who had ultimate managerial responsibility for the entity and who reported to the board of directors. Former Chief Executive Officer [Member] Former CEO [Member] Award Date [Domain] Former Employees Group Two [Member] Former Employees Group Two [Member] Former Employees [Member] Former Employees [Member] Government entity that puts money, by purchase or expenditure, in something offering potential profitable returns, such as interest income or appreciation in value. Government Entity Investor [Member] Government Entity [Member] Revenue from the collection of fees associated with the sales of license rights. License Revenue [Member] License fees [Member] Lockheed Martin (Astrolink) [Member] Lockheed Martin (Astrolink) [Member] A single external customer with an investment interest. Major Customer [Member] Astrolink [Member] Lockheed [Member] Operating segement that designs, engineers, and manufactures exoskeletons for applications in the medical and military markets Medical Devices [Member] Limit as it relates to a certain voting power percentage. Minimum Voting Power Threshold [Member] 10% voting power [Member] National Science Foundation [Member] National Science Foundation [Member] Other geographic locations of customers not specified. Other Geographical [Member] All Other [Member] Europe, Middle East, Asia [Member] Placement agent for private placement financing. Private Placement Agent [Member] Related Party Transaction One [Member] Related Party Transaction One [Member] Related Party Transaction Three [Member] Related Party Transaction Three [Member] Related Party Transaction Two [Member] Related Party Transaction Two [Member] Recognition period for deferred revenue. Revenue Recognition Period Revenue recognition period A type of business combination that results in a new parent company. Reverse Merger [Member] Merger [Member] Percentage used to calculate royalty obligation using a specified benchmark. Royalty Percentage Royalty percentage Net sales revenue from goods sold, excluding revenue from government purchases. Sales Revenue Goods Net Excluding Government Sales [Member] Net sales [Member] Lender for senior debt financing. Senior Lender [Member] Sr. Note Holder [Member] The estimated forfeiture rate (a percentage of the outstanding options) to be forfeited or cancelled over the option's term. Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate Forfeiture rate Increase in shares available for grant due to the repurchase of shares during the period. Share Based Compensation Arrangement By Share Based Payment Award Shares Repurchased In Period Repurchased Net sales revenue of the sublicensee from goods sold, excluding revenue from government purchases. Sublicensee Sales Revenue Goods Net Excluding Government Sales [Member] Sub-licensee net sales [Member] United States Federal Government [Member] United States Federal Government [Member] U.S. Federal Government [Member] Represents the amount of principal payments, which is per unit increase in the purchase price, when the customer purchases eleven or more units. Amount of Principal Payments Per Unit Increase in Purchase Price Amount of principal payments which is per unit increase in the purchase price, when the customer purchases eleven or more units Value of shares issued for the conversion of convertible preferred stock during the period. Stock Issued During Period Value Conversion of Convertible Preferred Stock Conversion of preferred stock Number of common stock shares issued during the period for the conversion of convertible preferred stock. Stock Issued During Period Shares Conversion of Convertible Preferred Stock Conversion of preferred stock, shares Represents the value of stock issued as a result of the exercise of warrants. Stock Issued During Period Value Exercise of Warrants Issuance of common stock from exercise of warrants, net Represents the number of share warrants exercised during the current period. Stock Issued During Period Shares Warrants Exercised Issuance of common stock from exercise of warrants, net, shares Represents the amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with offering costs of warrant solicitation. Adjustments to Additional Paid in Capital Offering Costs of Warrant Solicitation Offering costs of warrant solicitation Represents the amount of conversion of bridge loan to common stock in noncash investing or financing activities. Conversion of Bridge Loan to Common Stock Conversion of bridge loan to common stock Represents the amount of conversion of preferred stock warrants to common stock warrants in noncash investing or financing activities. Conversion of Preferred Stock Warrants to Common Stock Warrants Conversion of preferred stock warrants to common stock warrants Conversion of Preferred Stock Warrants to Common Stock Warrants Represents information pertaining to Venture Lending & Leasing VI, Inc. Venture Lending and Leasing Vi Inc [Member] Lender [Member] Venture Lending and Leasing VI Inc [Member] Series A preferred stock that may be exchanged into common shares or other types of securities at the owner''s option. Convertible Seriesa Preferred Stock [Member] Series A convertible preferred stock [Member] Series B preferred stock that may be exchanged into common shares or other types of securities at the owner's option. Convertible Series B Preferred Stock [Member] Series B convertible preferred stock [Member] Represents information pertaining to number of tranches. Debt Instrument Number of Tranches Number of tranches Represents the fair value of the warrant carried under the fair value option. Warrant Fair Value Disclosure Fair value of the warrant The number of shares issued during the period upon the conversion of warrants. Stock Issued During Period Shares Conversion of Warrants Shares issued upon conversion of warrants Represents the additional warrant received in term of percentage to purchase a number of shares of entity common stock equal to the number of shares of entity common stock. Debt Instrument Additional Warrant Received Percentage Additional warrant received (as a percent) Tabular disclosure of the shares available for grant. Schedule of Share Based Compensation Arrangement by Share Based Payment Award Shares Available for Grant [Table Text Block] Schedule of shares available for grant Owners with a beneficial interest of more than 10 percent of the voting interests. Stockholders [Member] Stockholders [Member] Represents information pertaining to 2014 Plan. Equity Incentive Plan 2014 [Member] 2014 Plan [Member] Share Based Compensation Arrangement by Share Based Payment Award Options Aggregate Intrinsic Value [Abstract] Aggregate Intrinsic Value Gross number of shares conversion of prior plan during the period. Share Based Compensation Arrangement by Share Based Payment Award Number of Shares Conversion of Prior Plan Conversion of prior plan shares Gross number of share options (or share units) granted after merger during the period. Share Based Compensation Arrangement by Share Based Payment Award Options Grants in Period after Merger Grants made after Merger Represents information pertaining to options granted exercise price range, one. Exercise Price Range One [Member] $0.04 - $0.07 [Member] Represents information pertaining to options granted exercise price range, two. Exercise Price Range Two [Member] $0.39 - $1.00 [Member] Represents information pertaining to options granted exercise price range, three. Exercise Price Range Three [Member] $1.06 - $2.19 [Member] Entity Well-known Seasoned Issuer Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to unrealized gain/loss on warrant. Income Tax Reconciliation Unrealized Gain (Loss) on Warrant Unrealized Gain/Loss on warrant Entity Voluntary Filers Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to unrealized gain/loss on warrant. Effective Income Tax Rate Reconciliation Unrealized Gain (Loss) on Warrant Unrealized Gain/Loss on warrant Entity Current Reporting Status Amount of increase (decrease) in unrecognized tax benefits resulting from tax positions taken in prior period tax returns. Unrecognized Tax Benefits Increases (Decreases) Resulting from Prior Period Tax Positions Increase (decrease) of unrecognized tax benefits taken in prior years Entity Filer Category Amount of increase (decrease) in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return. Unrecognized Tax Benefits Increases (Decreases) Resulting from Current Period Tax Positions Increase (decrease) of unrecognized tax benefits taken in current year Entity Public Float Amount of increase (decrease) in unrecognized tax benefits resulting from settlements with taxing authorities. Unrecognized Tax Benefits Increases (Decreases) Resulting from Settlements With Taxing Authorities Increase (decrease) of unrecognized tax benefits related to settlements Entity Registrant Name Represents the amount of warrant solicitation costs incurred during the period. Warrant Solicitation Costs Warrant solicitation costs Entity Central Index Key Number of warrants or rights exercised. Class of Warrant or Right Exercised Merger/PPO Warrant Shares Exercised Warrants exercised Exercised Periodic rate assumption used in valuing an instrument. Fair Value Assumptions Periodic Rate Periodic rate Periods in the model assumption used in valuing an instrument. Fair Value Assumptions Periods in Model Periods in the model Tabular disclosure of warrants outstanding. Schedule of Warrants Outstanding [Table Text Block] Schedule of warrants activity Entity Common Stock, Shares Outstanding Number of warrants issued for each equity unit. Equity Units Warrants Per Unit Warrants attached to each Unit Warrants issued to the placement agent for bridge note and private placement financing. Bridge Notes Placement Agent and Private Placement Agent Warrants [Member] Placement agent warrants [Member] Warrants outstanding before a merger. Pre Merger Warrants [Member] Pre-Merger Warrants [Member] Transfer Of Warrant Liability To Equity. Transfer Of Warrant Liability To Equity Transfer of warrant liability to equity Additional Debt Incurred Prior To Business Combination. Additional Debt Incurred Prior To Business Combination Additional debt incurred prior to Merger Non Employee [Member]. Non Employee [Member] Non-employee [Member] Transfer Of Warrant Liability To Equity Upon Removal Of Antidilution Feature Transfer Of Warrant Liability To Equity Upon Removal Of Antidilution Feature Transfer to equity upon removal of anti-dilution feature Warrant Liability Transferred To Equity Upon Exercise. Warrant Liability Transferred To Equity Upon Exercise Warrant liability transferred to equity upon exercise Obligation To Issue Warrant Transferred To Equity. Obligation To Issue Warrant Transferred To Equity Obligation to issue a warrant transferred to equity Obligation to issue a warrant transferred to equity Adjustments To Additional Paid In Capital, Decrease Due To Unamortized Debt Discounts Transferred To Equity. Adjustments To Additional Paid In Capital, Decrease Due To Unamortized Debt Discounts Transferred To Equity Unamortized debt discounts transferred to equity Fourteen Employees [Member]. Fourteen Employees [Member] 14 employees [Member] Amount of increase (decrease) to additional paid in capital (APIC) resulting from the vesting of early exercised options. Adjustments To Additional Paid In Capital Vesting Of Early Exercised Options Vesting of early exercised options Adjustments To Additional Paid In Capital, Fair Value Of Warrant Obligation Transferred To Equity. Adjustments To Additional Paid In Capital, Fair Value Of Warrant Obligation Transferred To Equity Fair value of warrant obligation transferred to equity Adjustments To Additional Paid In Capital, Fair Value Of Warrant Liability Transferred To Equity Upon Removal Of Antidilution Clause. Adjustments To Additional Paid In Capital, Fair Value Of Warrant Liability Transferred To Equity Upon Removal Of Antidilution Clause Fair value of warrant liability transferred to equity upon removal of anti-dilution clause Value of shares of stock issued during the period that is attributable to a private placement offering. Stock Issued During Period, Value, Private Placement Offering PPO shares issued for cash Number of shares of stock issued during the period that is attributable to a private placement offering. Stock Issued During Period, Shares, Private Placement Offering PPO shares issued for cash, shares The value of stock issued during the period upon the conversion of debt as part of a private placement offering. Private Placement Offering, Stock Issued During Period, Value, Conversion Of Debt PPO shares issued upon conversion of 2013 Bridge Notes Document Fiscal Year Focus Number of shares issued during the period as a result of the conversion of debt as a part of a private public offering. Private Placement Offering, Stock Issued During Period, Shares, Conversion Of Debt PPO shares issued upon conversion of 2013 Bridge Notes, shares Document Fiscal Period Focus Warrants issued in connection with a private placement offering and warrants outstanding before a merger. Pre Merger and Private Placement Warrants [Member] Pre-Merger/PPO warrants [Member] Warrants And Rights Note Disclosure [Text Block]. Warrants And Rights Note Disclosure [Text Block] Warrants Number of share options (or share units) exercised during the current period on a cashless basis. Stock Issued During Period, Shares, Stock Options Exercised On Cashless Basis Options exercised on a cashless basis Shares withheld to cover the exercise price of the options exercised in a cashless exercise. Share-based Compensation Arrangement By Share-based Payment Award, Shares Withheld To Cover Exercise Amount Shares withheld to cover amount of cashless exercise Document Type Basis of Presentation and Summary of Significant Accounting Policies and Estimates [Abstract] Accounts Receivable [Member] Accounts receivable [Member] Accounts Payable, Current Accounts payable Accounts Receivable, Net, Current Accounts receivable, net Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Accrued Liabilities Accretion Expense Interest expense accrued to convertible notes UNITED STATES [Member] Unites States [Member] Accrued Royalties, Current Royalties Accrued Liabilities, Current Accrued liabilities Total Accrued Professional Fees, Current Professional fees Accrued Vacation, Current Travel Accrued Liabilities [Abstract] Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Accumulated depreciation and amortization Additional Paid in Capital Additional paid-in capital Additional Paid-in Capital [Member] Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt Additional paid-in capital adjustment for equity component Adjustments to Additional Paid in Capital, Share-based Compensation, Stock Options, Requisite Service Period Recognition Stock-based compensation expense Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Offering costs Adjustments to Additional Paid in Capital, Share-based Compensation, Other Long-term Incentive Plans, Requisite Service Period Recognition Compensation expense for options issued a non-employee Adjustments to Additional Paid in Capital, Warrant Issued Issuance of common stock warrants at fair value Advertising Costs, Policy [Policy Text Block] Advertising Costs Advertising Expense Advertising costs Allocated Share-based Compensation Expense Stock-based compensation expense Allowance for Doubtful Accounts Receivable, Current Accounts receivable, allowance Amortization of Debt Discount (Premium) Amortization of debt discounts Amortization of Deferred Charges Amortization of deferred rent Amortization of Financing Costs Amortization of notes payable offering costs Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities, Name [Domain] Antidilutive Securities [Axis] Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Antidilutive securities Asset Impairment Charges Impairment loss Assets [Abstract] Assets Assets, Fair Value Disclosure Fair value of assets Assets Total assets Assets, Current Total current assets Assets, Current [Abstract] Current assets: Basis of Accounting, Policy [Policy Text Block] Basis of Presentation Bridge Loan [Member] 2013 Bridge Notes [Member] Bridge Warrants [Member] Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Shares issued in business acquisition The Merger, Offering and Other Related Transactions [Abstract] Business Acquisition [Line Items] Business Acquisition [Line Items] Business Description and Basis of Presentation [Text Block] Organization Business Combination Disclosure [Text Block] The Merger, Offering and Other Related Transactions Counterparty Name [Axis] Capital Lease Obligations [Member] Capital Lease [Member] Capital Lease Obligations, Noncurrent Capital lease for purchase of machinery and equipment Capital Leases, Future Minimum Payments, Interest Included in Payments Less: interest Cash and Cash Equivalents, Policy [Policy Text Block] Cash and Cash Equivalents Cash and Cash Equivalents, at Carrying Value Cash at end of the period Cash at beginning of the period Cash Cash and Cash Equivalents, Period Increase (Decrease) Net increase (decrease) in cash Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Supplemental disclosure of non-cash activities: Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise price Exercise Price Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Number of shares called by each warrant Class of Stock [Line Items] Class of Warrant or Right [Domain] Class of Warrant or Right [Axis] Class of Warrant or Right, Number of Securities Called by Warrants or Rights Warrant Shares Issued Balance Number of shares called by warrants Number of shares Class of Warrant or Right [Line Items] Class of Stock [Domain] Class of Warrant or Right, Outstanding Balance Balance Balance Class of Warrant or Right [Table] Commitments and Contingencies Commitments and contingencies (Note 12) Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Commitments and Contingencies [Abstract] Common Stock, Value, Issued Common stock, $0.001 par value; 500,000,000 shares authorized at June 30, 2015 and December 31, 2014; 102,123,767 and 101,621,358, shares issued and outstanding at June 30, 2015 and December 31, 2014, respectively Common Stock, Shares, Issued Common stock, shares issued Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Par or Stated Value Per Share Common stock, par value per share Common Stock [Member] Series A [Member] Common stock [Member] Common Stock, Shares, Outstanding Common stock, shares outstanding Common stock Employee Benefit Plan [Abstract] Components of Deferred Tax Assets [Abstract] Deferred tax assets: Comprehensive Income, Policy [Policy Text Block] Comprehensive Income/(Loss) Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive loss Computer Equipment [Member] Computers and peripherals [Member] Concentration Risk Type [Domain] Concentration Risk Type [Axis] Concentration Risk, Credit Risk, Policy [Policy Text Block] Concentration of Credit Risk and Other Risks and Uncertainties Concentration Risk [Line Items] Concentration Risk Benchmark [Domain] Concentration Risk [Table] Concentration Risk, Percentage Concentration percentage Concentration Risk Benchmark [Axis] Consolidation, Policy [Policy Text Block] Principles of Consolidation Contractual Obligation, Due in Second Year 2015 2016 Contractual Obligation, Fiscal Year Maturity [Abstract] Future minimum annual royalties Contractual Obligation, Due in Next Twelve Months 2014 2016 Conversion of Stock, Amount Converted Conversion of convertible preferred stock to common stock Conversion of Stock, Shares Issued Conversion of stock, shares issued Convertible Preferred Stock, Terms of Conversion Terms of conversion Convertible Preferred Stock, Shares Issued upon Conversion Conversion of preferred stock Convertible Preferred Stock [Member] Convertible Debt [Member] Convertible Debt [Member] Convertible Debt, Fair Value Disclosures Convertible debt Fair value of convertible notes Cost of Goods and Services Sold Cost of revenue Total cost of revenue Cost of Services Cost of engineering services Cost of Goods and Services Sold [Abstract] Cost of revenue Cost of Goods Sold Cost of medical devices Customer Concentration Risk [Member] Customer [Member] Debt Instrument, Convertible, Number of Equity Instruments Number of shares issued Debt Instrument [Line Items] Repayment of 2013 Bridge Note [Line Items] Private Placement Offering [Line items] Debt Conversion, Original Debt, Amount Conversion of convertible notes into Series B convertible preferred stock Conversion of convertible debt Debt Conversion, Converted Instrument, Warrants or Options Issued Number of warrants issued for conversion of debt Warrants issued Debt Conversion, Converted Instrument, Shares Issued Shares issued Debt Instrument, Term Term Maturity term Notes Payable [Abstract] Debt Instrument, Convertible, Conversion Ratio Conversion discount Schedule of Long-term Debt Instruments [Table] Debt Conversion, Converted Instrument, Amount Common stock warrants issued in connection with Series B convertible preferred stock offering Debt conversion Debt Instrument, Basis Spread on Variable Rate Basis spread Debt Instrument, Date of First Required Payment Initial payment date Debt Instrument [Axis] Debt Disclosure [Text Block] Notes Payable Long-term Debt, Gross Outstanding principle Principal outstanding Debt Instrument, Convertible, Conversion Price Conversion price Conversion price (in dollars per share) Debt Instrument, Periodic Payment Periodic payment Debt Instrument, Unamortized Discount Unamortized debt discount Debt Instrument, Maturity Date Maturity date Debt Instrument, Frequency of Periodic Payment Periodic payment frequency Debt Instrument, Name [Domain] Debt Instrument, Face Amount Principal amount Debt Instrument, Interest Rate, Stated Percentage Stated interest rate Annual interest rate of note receivable Debt Instrument, Unamortized Discount (Premium), Net Unrealized appreciation Debt, Policy [Policy Text Block] Convertible Debt Instruments Debt Instrument, Interest Rate, Stated Percentage Rate Range, Minimum Minimum interest rate Deferred Tax Assets, Property, Plant and Equipment Depreciation and other Deferred Costs Deferred Ekso medical device costs Deferred Revenues [Abstract] Deferred Finance Costs, Noncurrent, Net Security issuance costs Deferred Compensation Share-based Arrangements, Liability, Current Liability due to early stock option exercise Deferred Costs, Noncurrent Deferred cost of revenue, non-current Deferred Costs, Current Deferred cost of revenue, current Less current portion Deferred Revenue Arrangement, by Type [Table] Deferred Rent Credit, Noncurrent Deferred rent Deferred Revenue Arrangement Type [Axis] Deferred Revenue [Domain] Deferred Revenue Disclosure [Text Block] Deferred Revenues Deferred Revenue Customer advances and deferred revenues Deferred Tax Assets, Net Net deferred tax asset Deferred Revenue, Current Deferred revenues, current Less current portion Deferred Revenue Arrangement [Line Items] Deferred Revenue, by Arrangement, Disclosure [Table Text Block] Schedule of Customer Deposits, Advances, Deferred Revenues, and Deferred Unit Costs Deferred Revenue, Noncurrent Deferred revenues, non-current Customer advances and deferred revenues, non-current Deferred Tax Assets, Net of Valuation Allowance Deferred tax asset Deferred Tax Assets, Operating Loss Carryforwards Net operating loss carryforwards Deferred Tax Assets, Tax Credit Carryforwards, Research Unused R&D tax credits Deferred Tax Assets, Valuation Allowance Less: Valuation allowance Defined Contribution Plan, Cost Recognized Employer contributions Depreciation Depreciation and amortization Derivative Financial Instruments, Liabilities [Member] Warrant Liability [Member] Derivative Liability Warrant liability Derivatives, Embedded Derivatives [Policy Text Block] Common Stock Warrants Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities Adjustment for change in fair value of warrant liability Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Stock-based Compensation Plans and Awards Stock-based Compensation Plans and Awards [Abstract] Domestic Tax Authority [Member] Federal [Member] Due to Related Parties, Current Amounts payable Due from Related Parties, Current Receivable Europe [Member] Europe [Member] Earnings Per Share, Policy [Policy Text Block] Net loss per share Earnings Per Share, Basic and Diluted Net loss per share, basic and diluted Basic and diluted net loss per share Earnings Per Share [Text Block] Net Income (Loss) Per Share Earnings Per Share, Basic Basic net income (loss) per share Net income (loss) per share, basic Earnings Per Share, Diluted Diluted net income (loss) per share Net loss per share, diluted Net Income (Loss) Per Share [Abstract] Effective Income Tax Rate Reconciliation, Other Adjustments Other Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent Foreign Effective Income Tax Rate Reconciliation, State and Local Income Taxes State tax, net of federal tax effect Effective Income Tax Rate Reconciliation, Nondeductible Expense Non-deductable expenses Effective Income Tax Rate Reconciliation, Tax Credit, Percent Tax credits Effective Income Tax Rate, Continuing Operations, Tax Rate Reconciliation [Abstract] Income tax expense (benefit) differed from the amounts computed by applying the statutory federal income tax rate to pretax income (loss), Percentage Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent R&D Credit Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance Change in valuation allowance Effective Income Tax Rate, Continuing Operations Total tax expense Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate Federal tax at statutory rate Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] Employee Stock Option [Member] Options to purchase common stock [Member] Stock options [Member] Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition Unrecognized compensation cost, period for recognition Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Stock Options Unrecognized compensation cost Employee-related Liabilities, Current Salaries, benefits and related expenses Revenue, Major Customer [Line Items] Equity Interest Issued or Issuable, Type [Domain] Equity Interest Type [Axis] Equity Component [Domain] Fair Value Assumptions, Expected Volatility Rate Volatility Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value Balance at December 31, 2014 Balance at December 31, 2013 Fair Value Assumptions, Expected Term Expected term Liability Class [Axis] Fair Value Assumptions, Expected Dividend Rate Dividend yield Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table] Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table Text Block] Schedule of assumption used in valuation Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances Fair value of warrants issued on Merger and subsequent PPO Fair Value Adjustment of Warrants Loss on increase in fair value of warrant liability Gain (loss) on warrant liability Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements Transfer to equity upon settlement at Merger Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value Assumptions, Risk Free Interest Rate Risk-free interest rate Fair Value, Measurements, Recurring [Member] Recurring [Member] Fair Value Measurements [Abstract] Measurement Frequency [Axis] Fair Value, Hierarchy [Axis] Fair Value by Liability Class [Domain] Fair Value Disclosures [Text Block] Fair Value Measurements Fair Value of Financial Instruments, Policy [Policy Text Block] Fair Value of Financial Instruments Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value, Measurement Frequency [Domain] Fair Value, Inputs, Level 3 [Member] Significant Unobservable Inputs Level 3 [Member] Fair Value, Inputs, Level 1 [Member] Quoted Prices in Active Markets for Identical Items Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Significant Other Observable Inputs Level 2 [Member] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Change in fair value of warrants issued on Merger and subsequent PPO Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Summary of Changes in Fair Value of Level 3 Liabilities Financial Liabilities Fair Value Disclosure Fair value of liabilities Total liabilities measured at estimated fair value Foreign Currency Transactions and Translations Policy [Policy Text Block] Foreign Currency Translation Gain (Loss) on Sale of Property Plant Equipment Loss on sale of property and equipment General and Administrative Expense General and administrative General and Administrative Expense [Member] General and Administrative [Member] Gross Profit Gross profit Impaired Financing Receivable, Policy [Policy Text Block] Warrants Issued in Connection with Financings Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Impairment of Long-Lived Assets Income Statement Location [Axis] Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest [Abstract] Domestic and foreign components of pre-tax loss Income (Loss) from Continuing Operations before Income Taxes, Domestic Domestic Condensed Consolidated Statement of Operations [Abstract] Income Taxes [Abstract] Income (Loss) from Continuing Operations before Income Taxes, Foreign Foreign Income Tax Authority [Axis] Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest Loss before income taxes Income Statement Location [Domain] Income Tax Reconciliation, Change in Deferred Tax Assets Valuation Allowance Change in valuation allowance Income Tax Expense (Benefit), Continuing Operations, Income Tax Reconciliation [Abstract] Income tax expense (benefit) differed from the amounts computed by applying the statutory federal income tax rate to pretax income (loss), Amount Income Tax Expense (Benefit) Total tax expense Income Tax Authority [Domain] Income Tax Disclosure [Text Block] Income Taxes Income Taxes Paid Cash paid for taxes Income Tax Reconciliation, Other Adjustments Other Income Tax, Policy [Policy Text Block] Income Taxes Income Tax Reconciliation, Income Tax Expense (Benefit), at Federal Statutory Income Tax Rate Federal tax at statutory rate Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount Foreign Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount R&D Credit Effective Income Tax Rate Reconciliation, Tax Credit, Amount Tax credits Income Tax Reconciliation, State and Local Income Taxes State tax, net of federal tax effect Income Tax Reconciliation, Nondeductible Expense Non-deductible expenses Increase (Decrease) in Accounts Receivable Accounts receivable Increase (Decrease) in Accounts Payable Accounts payable Increase (Decrease) in Accrued Liabilities Accrued liabilities Increase (Decrease) in Deferred Charges Deferred cost of revenue Increase (Decrease) in Deferred Revenue Deferred revenues Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Inventories Inventories Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expense and other assets Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants Dilutive effect of warrants Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Dilutive effect of stock options Interest Expense Interest expense Interest expense Interest Income, Other Interest income added to note receivable from stockholder Interest Payable, Current Debt and accrued interest Accrued interest Interest Paid Cash paid for interest Inventory, Policy [Policy Text Block] Inventories, net Inventory, Gross Subtotal Inventory Valuation Reserves Less: inventory reserve Inventory, Finished Goods, Gross Finished goods Inventory Disclosure [Text Block] Inventories Inventory, Net Inventories, net Inventory, net Inventory Write-down Inventory allowance expense Inventories [Abstract] Inventory, Work in Process, Gross Work in progress Inventory, Raw Materials, Gross Raw materials Investment Income, Interest Interest income Investor [Member] Investors [Member] Issuance of Stock and Warrants for Services or Claims Stock issued as compensation for consulting services Lessee Leasing Arrangements, Operating Leases, Renewal Term Option to renew Convertible Debt [Abstract] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Operating Leases, Rent Expense Rent expense Lease, Policy [Policy Text Block] Deferred Rent Lease Expiration Date Expiration date Leasehold improvements [Member] Leasehold improvement [Member] Leases of Lessee Disclosure [Text Block] Operating and Capital Leases Operating and Capital Leases [Abstract] Lender Concentration Risk [Member] Lender [Member] Liabilities, Current Total current liabilities Liabilities, Current [Abstract] Current liabilities: Liabilities Total liabilities Liabilities, Fair Value Adjustment Adjustment to record convertible note at fair value Liabilities and Equity [Abstract] Liabilities and Stockholders' Equity Liabilities, Fair Value Disclosure [Abstract] Liabilities: Liabilities and Equity Total liabilities and stockholders' equity Long-term Debt, Maturities, Repayments of Principal in Rolling Year Four 2018 Long-term Debt, Maturities, Repayments of Principal in Rolling Year Three 2017 Long-term Debt and Capital Lease Obligations, Repayments of Principal in Next Twelve Months 2015 Long-term Debt, Maturities, Repayments of Principal, Remainder of Fiscal Year 2015 (remainder) Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Three 2017 Long-term Debt and Capital Lease Obligations, Including Current Maturities [Abstract] Future obligations under debt instruments Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Two 2016 Long-term Debt, Maturities, Repayments of Principal in Rolling Year Two 2016 Long-term Debt and Capital Lease Obligations Total minimum payments Long-term Debt [Text Block] Senior Notes Payable Long-term Debt, Fiscal Year Maturity [Abstract] Repayments: Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months 2015 Notes Payable, Noncurrent Notes payable, non-current Long-term portion of notes payable Machinery and equipment [Member] Customer [Axis] Maximum [Member] Minimum [Member] North America [Member] North America [Member] Customer [Domain] Net Cash Provided by (Used in) Financing Activities [Abstract] Financing activities: Net Income (Loss) Available to Common Stockholders, Basic Net income (loss) Net loss used to compute net loss per share Basic Net Income (Loss) Available to Common Stockholders, Diluted Diluted Net Cash Provided by (Used in) Investing Activities, Continuing Operations Net cash used in investing activities Net Income (Loss) Available to Common Stockholders, Diluted [Abstract] Numerator: Net Cash Provided by (Used in) Operating Activities, Continuing Operations Cash used in operations Net cash used in operating activities Cash used in operations Net Income (Loss) Attributable to Parent Net loss Net income (loss) Net Cash Provided by (Used in) Investing Activities [Abstract] Investing activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Operating activities: Net Cash Provided by (Used in) Financing Activities, Continuing Operations Net cash provided by financing activities New Accounting Pronouncements, Policy [Policy Text Block] Recent Accounting Pronouncements Nonoperating Income (Expense) Other expense, net Nonsoftware Service, Support and Maintenance Arrangement [Member] Deferred Ekso medical device revenues [Member] Notes Payable, Other Payables [Member] Notes payable to landlord [Member] Other Notes Payable [Member] Notes Payable, Current Notes payable, current Less: current portion Less: current portion Notes Payable Current and long-term carrying amount Present value minimum payments Notes Receivable, Related Parties, Current Note receivable from stockholder Financing Receivable, Net Note receivable from a customer Office Equipment [Member] Furniture and office equipment [Member] Open Tax Year Open tax year Operating Expenses [Abstract] Operating expenses Operating Expenses Total operating expenses Operating Leases, Future Minimum Payments Due, Next Twelve Months 2015 Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] Future minimum operating lease payments: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year 2015 (remainder of year) Operating Leases, Future Minimum Payments, Due in Two Years 2016 Operating Income (Loss) Loss from operations Operating Leases, Future Minimum Payments Due Total Operating Leases, Future Minimum Payments, Due in Four Years 2018 Operating Loss Carryforwards, Expiration Date Net operating loss tax carryforwards, expiration Operating Loss Carryforwards Net operating loss tax carryforwards Operating Leases, Future Minimum Payments, Due in Three Years 2017 Organization [Abstract] Other Assets, Noncurrent Other assets Other Income and Expenses [Abstract] Other income (expense) Other Liabilities, Current Other All Other Other Nonoperating Income (Expense) Total other income (expense), net Prime Rate [Member] Products and Services [Domain] Payment of Financing and Stock Issuance Costs Payment of debt conversion and private placement commission Payments to Acquire Property, Plant, and Equipment Acquisition of property and equipment, net Payments to Acquire Notes Receivable Note receivable from stockholder Payments of Stock Issuance Costs Payment of offering costs Payments of Debt Issuance Costs Payment for private placement offering Pension and Other Postretirement Benefits Disclosure [Text Block] Employee Benefit Plan Plan Name [Axis] Plan Name [Domain] Preferred Stock, Par or Stated Value Per Share Convertible Preferred stock, par value per share Preferred Stock, Value, Issued Convertible Preferred stock, $0.001 par value; 10,000,000 shares authorized at June 30, 2015 and December 31, 2014; none issued and outstanding at June 30, 2015 and December 31, 2014, respectively Preferred Stock, Shares Issued Number of shares issued Convertible Preferred stock, shares issued Preferred Stock, Liquidation Preference Per Share Liquidation preference per share Preferred stock, liquidation preference per share Preferred Stock, Liquidation Preference, Value Aggregate liquidation preference Preferred Stock, Shares Authorized Number of shares authorized Convertible Preferred stock, shares authorized Preferred Stock, Shares Outstanding Number of shares outstanding Convertible Preferred stock, shares outstanding Preferred stock [Member] Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Private Placement [Member] Private Placement [Member] Proceeds from Warrant Exercises Proceeds from warrants, net of expenses Proceeds from exercise of common stock warrants Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants Proceeds from issuance of convertible preferred stock and warrants, net of issuance costs Proceeds from Convertible Debt Proceeds from issuance of 2012 Series B Convertible Bridge Notes Gross proceeds Proceeds from Issuance or Sale of Equity Proceeds from equity issuance Proceeds from Notes Payable Proceeds from issuance of notes payable and warrants, net of issuance costs Issuance of notes payable Proceeds from Issuance of Private Placement Proceeds from issuance of 2013 Series B Convertible Bridge Notes, net of issuance costs Proceeds from private placement Proceeds from Issuance of Convertible Preferred Stock Cash from issuance Proceeds from Issuance of Common Stock Proceeds from issuance of common stock, net of issuance costs Proceeds from Stock Options Exercised Proceeds from exercise of stock options Proceeds from Sale of Property, Plant, and Equipment Proceeds from sales of property and equipment Proceeds from Other Deposits Security deposits Products and Services [Axis] Product Warranty Accrual, Current Warranty expense Property, Plant and Equipment [Table Text Block] Schedule of Property and Equipment, net Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Other Types [Member] Other [Member] Property, Plant and Equipment, Policy [Policy Text Block] Property and Equipment Property and Equipment, net [Abstract] Property, Plant and Equipment, Useful Life Estimated life Property, Plant and Equipment, Type [Domain] Property, Plant and Equipment, Net Property and equipment, net Property and equipment, net Property, Plant and Equipment, Gross Property and equipment Property, Plant and Equipment [Line Items] Property, Plant and Equipment Disclosure [Text Block] Property and Equipment, net Range [Domain] Range [Axis] Receivables, Policy [Policy Text Block] Note Receivable Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Reconciliation of the beginning and ending amount of unrecognized tax benefits Related Party Transaction [Domain] Related Party Transactions Disclosure [Text Block] Related Party Transactions Related Party Transaction [Line Items] Related Party Transaction, Rate Interest rate Related Party Transaction, Amounts of Transaction Payments made Related Party Transaction, Date Due date Related Party Transaction [Axis] Related Party [Axis] Related Party [Domain] Related Party Transactions [Abstract] Repayments of Notes Payable Repayment of senior note Principal payments on notes payable Counterparty Name [Domain] Research and Development Expense Research and development Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Research Tax Credit Carryforward [Member] Research and Development [Member] Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Research and Development Arrangement, Contract to Perform for Others [Line Items] Research and Development Expense, Policy [Policy Text Block] Research and Development Research and Development Expense [Member] Research and Development [Member] Accumulated Deficit [Member] Retained Earnings (Accumulated Deficit) Accumulated deficit Accumulated deficit Revenue Recognition, Policy [Policy Text Block] Revenue and Cost of Revenue Recognition Revenue from Related Parties Revenue Revenue from External Customers by Geographic Areas [Table Text Block] Schedule of Geographic Information Revenues from External Customers and Long-Lived Assets [Line Items] Revenues [Abstract] Revenue Royalty Expense Royalty Royalty Agreement Terms [Member] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price Options Exercisable, Weighted Average Exercise Price (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Expected term Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Balance as of June 30, 2015 Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term Options Outstanding, Weighted-Average Remaining Contractual Life Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value Total fair value of shares vested Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent Percentage of fair market value Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Exercisable as of June 30, 2015 Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price Options Outstanding, Weighted Average Exercise Price (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term Vested and expected to vest at June 30, 2015 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares Vesting amount Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Expiration period Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Weighted average remaining contractual term of options exercisable Exercisable as of June 30, 2015 Revenue, Net Total revenue Revenue Sales Revenue, Services, Net Engineering services Sales Revenue, Goods, Net Medical devices Sales Revenue, Net [Member] Net sales [Member] Scenario, Unspecified [Domain] Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Schedule of Assets and Liabilities Measured at Fair Value Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of Antidilutive Securities Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Summary of Stock Option Activity Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] Schedule of domestic and foreign components of pre-tax loss Schedule of Revenues from External Customers and Long-Lived Assets [Table] Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule of Fair Value Calculation Assumptions Schedule of Maturities of Long-term Debt [Table Text Block] Schedule of future obligations under debt instruments Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Schedule of income tax expense (benefit) differed from the amounts computed by applying the statutory federal income tax rate to pretax income (loss) Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Schedule of tax effects of temporary differences and related deferred tax assets and liabilities Schedule of Accrued Liabilities [Table Text Block] Schedule of Accrued Liabilities Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] Schedule of Future Minimum Operating Lease Payments Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of basic and diluted net income (loss) per share Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block] Schedule of Revenue by Major Customer Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block] Schedule of reconciliation of the beginning and ending amount of unrecognized tax benefits Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Inventory, Current [Table Text Block] Schedule of Inventories Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Schedule of Revenue by Major Customers, by Reporting Segments [Table] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block] Allocation of Stock Option Compensation Expense Schedule of Property, Plant and Equipment [Table] Schedule of Related Party Transactions, by Related Party [Table] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table Text Block] Schedule of Segment Reporting Information Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table] Schedule of Stock by Class [Table] Schedule of Stock by Class [Table Text Block] Schedule of Issued and Outstanding Convertible Preferred Stock Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Schedule of Issued and outstanding warrants Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block] Summary of information about stock options outstanding Schedule of Research and Development Arrangement, Contract to Perform for Others [Table] Schedule of Share-based Goods and Nonemployee Services Transaction [Table] Security Deposit Security deposits Segment Disclosures [Abstract] Segment [Domain] Segment Reporting Information [Line Items] Segment Reporting Disclosure [Text Block] Segment Disclosures Segment, Geographical [Domain] Selling and Marketing Expense Sales and marketing Selling and Marketing Expense [Member] Sales and Marketing [Member] Senior Notes Payable [Abstract] Senior Notes [Member] Senior Notes Payable [Member] Series B [Member] Series A [Member] Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Vesting period Share-based Compensation Arrangement by Share-based Payment Award, Additional General Disclosures [Abstract] Shares Available for Grant Share-based Compensation Arrangement by Share-based Payment Award Accelerated Compensation Cost Vesting of early exercised stock options Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Options exercised Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Volatility, maximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Volatility, minimum Share-based Compensation Stock-based compensation expense Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward] Weighted-Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Options forfeited Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Risk-free interest rate, maximum Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Granted Options granted Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Award, Tranche One [Member] Upon signing memorandum [Member] Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized Additional shares authorized for grant Share-based Compensation Award, Tranche Two [Member] Upon becoming an employee [Member] Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Term Expected term Share Price Share price at final valuation Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Options cancelled Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Risk-free interest rate, minimum Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Options granted Exercise price Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Exercisable as of June 30, 2015 Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Dividend yield Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Options cancelled Options cancelled Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Options forfeited Options forfeited Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Exercisable as of June 30, 2015 Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Cancelled Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Weighted-Average Remaining Contractual Life (Years) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Ending balance Beginning balance Balance at the end of the year Total shares available Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Volatility Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Number of equity incentive shares authorized Shares authorized Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Risk-free interest rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract] Employees Assumptions used for calculation of fair value per share Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period Cancelled Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value Intrinsic value of the options exercised Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] Stock-based Compensation Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Vested and expected to vest at June 30, 2015 Share-based Compensation Arrangement by Share-based Payment Award, Plan Modification, Incremental Compensation Cost Incremental compensation cost Exercise Price Range [Axis] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Balance as of June 30, 2015 Equity Award [Domain] Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period Granted Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] Stock options outstanding , exercise price range [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Balance as of June 30, 2015 Balance as of December 31, 2014 Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Balance as of June 30, 2015 Balance as of December 31, 2014 Share-based Compensation Arrangement by Share-based Payment Award, Other Share Increase (Decrease) Cancelled Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Vested and expected to vest at June 30, 2015 Vested options Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Stock Awards Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted-average grant-date fair value of options granted Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Vested and expected to vest at June 30, 2015 Share-based Goods and Nonemployee Services Transaction, Modification of Terms, Incremental Compensation Cost Compensation expense from the modification of terms Share-based Goods and Nonemployee Services Transaction, Modification of Terms, Description and Terms Modification of terms Share-based Goods and Nonemployee Services Transaction, Supplier [Domain] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options Options Outstanding, Number of Shares Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Volatility Rate Volatility Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options Options Exercisable, Number of Shares Share-based Goods and Nonemployee Services Transaction, Valuation Method, Risk Free Interest Rate Risk-free interest rate Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Dividend Rate Dividend yield Share-based Goods and Nonemployee Services Transaction [Abstract] Share-based Goods and Nonemployee Services Transaction, Quantity of Securities Issued Securities issued for services Share-based Goods and Nonemployee Services Transaction [Line Items] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit Exercise price, maximum (in dollars per share) Supplier [Axis] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit Exercise price, minimum (in dollars per share) Shares Issued, Price Per Share Shares issued price per share Shares issued, price per share Shares, Outstanding Balance, shares Balance, shares Shipping and Handling Cost, Policy [Policy Text Block] Shipping Costs Short-term Debt [Text Block] Convertible Debt Short-term Debt, Type [Axis] Short-term Debt, Type [Domain] Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit Expected significant changes to unrecognized tax benefits Significant Accounting Policies [Text Block] Basis of Presentation and Summary of Significant Accounting Policies and Estimates Software License Arrangement [Member] Customer deposits and advances [Member] Software Service, Support and Maintenance Arrangement [Member] Deferred service and leasing revenues [Member] Software and Software Development Costs [Member] Computer software [Member] State and Local Jurisdiction [Member] State [Member] Statement [Line Items] Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) [Abstract] Condensed Consolidated Statements of Cash Flows [Abstract] Equity Components [Axis] Statement [Table] Scenario [Axis] Business Segments [Axis] Condensed Consolidated Balance Sheets [Abstract] Class of Stock [Axis] Geographical [Axis] Stock Issued During Period, Value, Acquisitions Issuance of shares to stockholders of Ekso Bionics Holdings Inc. Stock Issued During Period, Value, Issued for Services Shares issued to consultant Stock Issued During Period, Value, Stock Options Exercised Issuance of common stock upon exercise of options Stock Repurchased During Period, Value Common stock repurchased Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Issuance of common stock upon exercise of options, shares Options exercised Stock Issued During Period, Shares, Other Fair value of warrant liability transferred to equity upon net exercise, shares Stock Issued During Period, Value, New Issues Issuance of Series A-2/Series B convertible preferred stock at $2.10 per share issued in exchange for cash Stock Issued Preferred stock and common warrants issued to lender Preferred stock and common stock warrants issued to lender Stock Issued During Period, Value, Conversion of Convertible Securities Issuance of stock upon conversion of convertible debt and accrued interest Stock Issued During Period, Shares, New Issues Issuance of Series A-2/Series B convertible preferred stock at $2.10 per share issued in exchange for cash, shares New issues Stock Issued During Period, Shares, Conversion of Convertible Securities Issuance of stock upon conversion of convertible debt and accrued interest, shares Shares issued upon conversion of debt Equity Option [Member] Stock options [Member] Options [Member] Stock Issued During Period, Shares, Acquisitions Common stock issued for acquisition Issuance of shares to stockholders of Ekso Bionics Holdings Inc., shares Stock Granted, Value, Share-based Compensation, Gross Fair value of options granted to employees Stock Issued During Period, Value, Other Fair value of warrant liability transferred to equity upon net exercise Stock Repurchased During Period, Shares Common stock repurchased, shares Stock Issued During Period, Shares, Issued for Services Shares issued to consultant, shares Stockholders' Equity Note Disclosure [Text Block] Capitalization and Equity Structure Stockholders' Equity Attributable to Parent [Abstract] Stockholders' equity: Capitalization and Equity Structure [Abstract] Stockholders' Equity Attributable to Parent Balance Balance Stockholders' deficit Total stockholders' equity Stockholders' Equity Note, Spinoff Transaction Effect of merger and recapitalization of share amounts Subsequent Event Type [Axis] Subsequent Event [Line Items] Subsequent Events [Text Block] Subsequent Events Subsequent Events [Abstract] Subsequent Event Type [Domain] Subsequent Event [Table] Supplemental Cash Flow Information [Abstract] Supplementary cash flows disclosure: Tax Credit Carryforward [Axis] Tax Credit Carryforward, Name [Domain] Tax Credit Carryforward, Expiration Date Tax credit carryforwards, expiration Taxes Payable, Current Taxes Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests Convertible preferred stock issuable in series, $0.001 par value; 10,000,000 and 33,523,600 shares authorized at December 31, 2014 and December 31, 2013, respectively; none and 25,923,872 shares issued and outstanding at December 31, 2014 and December 31, 2013, respectively; liquidation preference of $1.07 per share at December 31, 2013 Tools, Dies and Molds [Member] Tools, molds, dies and jigs [Member] Transfer to Investments Transfer to property and equipment from inventory Transfer of property and equipment from inventory Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations Reductions to unrecognized tax benefits related lapsing statute of limitations Unrecognized Tax Benefits Balance at the end of the year Balance at the beginning of the year Unrecognized tax benefits Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Accrued interest and penalties related to uncertain tax positions Unrecognized Tax Benefits, Period Increase (Decrease) Change in unrecognized tax benefit Use of Estimates, Policy [Policy Text Block] Use of Estimates Vesting [Domain] Vesting [Axis] Variable Rate [Axis] Variable Rate [Domain] Warrant [Member] Warrants [Member] Warrants to purchase common stock [Member] Warrants [Abstract] Warrants and Rights Outstanding Fair value of warrants Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Denominator: Weighted-average common shares outstanding used in computing basic and diluted net income (loss) per share Weighted Average Number of Shares Outstanding, Basic Basic Weighted-average shares used in computing basic per share amounts Weighted Average Number of Shares Outstanding, Basic and Diluted Shares used to compute basic and diluted net loss per share Weighted Average Number of Shares Outstanding, Diluted Diluted Weighted-average shares used in computing diluted per share amounts EX-101.PRE 11 ekso-20150630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 12 R39.htm IDEA: XBRL DOCUMENT v3.2.0.727
Operating and Capital Leases (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Dec. 31, 2014
Operating and Capital Leases [Abstract]          
Expiration date     May 31, 2017    
Option to renew     5 years    
Future minimum operating lease payments:          
2015 (remainder of year) $ 188   $ 188    
2016 375   375    
2017 157   157    
Total 720   720    
Capital lease for purchase of machinery and equipment 11   11   $ 13
Rent expense $ 86 $ 86 $ 172 $ 171  
XML 13 R48.htm IDEA: XBRL DOCUMENT v3.2.0.727
Income Taxes (Details) - Jun. 30, 2015 - USD ($)
None in scaling factor is -9223372036854775296
Total
Income Taxes [Abstract]  
Change in unrecognized tax benefit  
Expected significant changes to unrecognized tax benefits  
EXCEL 14 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0````(``]W#$<71Q9N\@$``+8@```3````6T-O;G1E;G1?5'EP97-= M+GAM;,W:S4[C,!`'\%>IG[_Y"G.=G88X[+J4_+?&(MM3U;'VGD:SRWV@Y%Y6VOO!M#H9-[+M MV!UDG;O5RK34N?;!YBUURJ7I4XY7LSL=THVV.07;#6P*[#]Y7>+L8PI&'TAW ML2=*=JAC>AHH'JN_C[Q4OJ*5?AC2NPH_W[LZT#"MB;WQSZ6N=SE+S+\MJQR- M;ZIPN/%OG1E;AN;']6\[ROD_7LO!3=S:X2KH1W-08'NR,95C;;49CXWJT87- M#^5):%^A-!8Z??_3T*=@9-/AA$B\JP\!TH<$Z4.!]-&`]'$&TL=G MD#Z^@/3Q%:0/OD!I!$54CD(J1S&5HZ#*453E**QR%%QW8OG*\M"_V/Z'D4X$G1H>)%]2-F`Q+M*;V" M^GH`A3&^.R6:E((C-Z."N[_8_`)02P,$%`````@`#W<,1UWP<_ON`0``;"`` M`!H```!X;"]?K M'^G8E$/?Y?8PY,6?T['+J^G^NFI+&58AY$V;3DV^Z8?434]W_7AJRG0Y[L/0 M;%Z;?0I:U\LP7LZI'A\^SEX\;]?5^+R5:O&S&?>IK*O?_?B:VY1*#N>3W$P+ M3(_?AO2=Y?O=[K!)3_WFUREUY8N*\&^!*LP'Z7R04H)L/L@H03X?Y)2@.!\4 M*4'+^:`E)>AV/NB6$G0W'W1'";J?#[JG!$D-9*PY20AKCM8"N!:.UP+`%H[8 M`L@6CMD"T!:.V@+8%H[;`N`6CMP"Z!:.W0+P%H[>"O16CMX*]%;2MS;ZV.;H MK4!OY>BM0&_EZ*U`;^7HK4!OY>BM0&_EZ*U`;^7HK4!OY>AM0&_CZ&U`;^/H M;4!O(^V5H,T2CMX&]#:.W@;T-H[>!O0VCMX&]#:.W@;T-H[>!O0VCMX.]':. MW@[T=H[>#O1VCMX.]';27C?:[.;H[4!OY^CM0&_GZ.U`;^?H[4!OY^CM0&_G MZ!V!WI&C=P1Z1X[>$>@=.7I'H'?DZ!TO],YM,Z;M2QD/W3Y?N^:_X;#H`N]< MWH[I^BGGJ;#A0NLRK93"^7CU%_D\]6](^/1CP>,[4$L#!!0````(``]W#$L]2%:&W2BU,$^_7GML#*%C+@X7@A=;_/B>W/#O04 MMJY&1F=@K`1DBS11>$7&Z\;,VNPJ"%#,(.5X1A!%;V-M4F[IT4P#'<=2P$"+ M/`5E@W:K=1G`PH**(#K--DX;8:_8Y2;+$BFXE5J%#U(8C3JV[&XA(.D%GP$E M@SR/0>1&VF78JC!U4XD9"YY`G_8*8YX@5*@/8XGIZS3C:AE43T.IWO!/-M$# M;J'.VGY1>9]Q`Q%MNN5]8RPQOY849U)P^S.NIA#5L5]?KG/Q#`:+2,_;9RWZ M;%*PME>^@4=234=<&@Q[.4*QO&[, MN9%Q.69(CNU?55E2\ M>DHVJ[ZFOE`($:,5ZD1&)+.(W?*$*P'L"$[G$,[8TA>=^0A.U\EY,E.NY/ON M@&\Y2F0Z9B,#2,DJD67&QGF:2O,I'%8'+B'K6E.3CB2_Z:@#MP:FF*976P/L^D MY0D;`@G'[7(%6>6JTLS?O-#,V)I<.#DOW!CJ#;?#L=7B[;10:E&PE(2.E>L1 MZ0+=6;I70J?`)GRQZY0Z3:4M5(U58%H508(2.U,%EJW<-H<:\82-J$;E>'0? M&Z9ETPPDBD1C;G;X]0JGW=I/!*PY*2J()_NJP4_8DH4?ZM,',;WE]GOVUKU] M>6B1BLWV+=0W(==F`6L.P'*9[(!ZB]MQ%]<[%3KG1W#:1W#+(>9K1Q@=P-M;#F_+"+0`_QWW?^CGNYO=S?GY[47R38N^5P9J'SZ.Q M^S+T0>%M8\Z'$4]=_3Y9U+0,NO7&K:[^/7\=)R2WEQL&3 M,Q8<2O!7!U5K3[E=)%M$2PGQ?`N*^4FHT"&Y-DXQ#*';$,OXCFV`%%DV)PJ0 M"8:,'(&I[8E)50I.N0.&QG5XP7N\W;LZP@0G4(,"C9[DDYPDU8O>:=/HD@SZ MJ@R.:^9Q:81<2Q"W[5#V.Q4Z(SCE3W(0??OX]T\/,4.2KO+@95_5-,VDF<:Z M,'!.WI:/S_%L4JD],LTAJ+RDV%I8).?.K].[^]5#4A59/DNSFS0O5ODUG.SP;A=E%C#R-U&C8C+C9\1),!S)RU*HT?A(N:;.,+\ M_N,3.(X'=<)XV7;0-L8)7\7[-43'EQ-6MC&N/:5^1!>OJOH"4$L#!!0````( M``]W#$>97)PC$`8``)PG```3````>&PO=&AE;64O=&AE;64Q+GAM;.U:6W/: M.!1^[Z_0>&?V;0O&-H&VM!-S:7;;M)F$[4X?A1%8C6QY9)&$?[]'-A#+E@WM MDDVZFSP$+.G[SD5'Y^@X>?/N+F+HAHB4\GA@V2_;UKNW+][@5S(D$4$P&:>O M\,`*I4Q>M5II`,,X?+&A`T%116F]?(+3E'S/X%/F7/Z3H= M,H%N,!M8('_.;Z?D3EJ(X53"Q,!J9S]6:\?1TDB`@LE]E`6Z2?:CTQ4(,@T[ M.IU8SG9\]L3MGXS*VG0T;1K@X_%X.+;+THMP'`3@4;N>PIWT;+^D00FTHVG0 M9-CVVJZ1IJJ-4T_3]WW?ZYMHG`J-6T_3:W?=TXZ)QJW0>`V^\4^'PZZ)QJO0 M=.MI)B?]KFNDZ19H0D;CZWH2%;7E0-,@`%AP=M;,T@.67BGZ=90:V1V[W4%< M\%CN.8D1_L;%!-9ITAF6-$9RG9`%#@`WQ-%,4'RO0;:*X,*2TER0UL\IM5`: M")K(@?5'@B'%W*_]]9>[R:0S>IU].LYKE']IJP&G[;N;SY/\<^CDGZ>3UTU" MSG"\+`GQ^R-;88 MC'(CN]WV6'WV3T=N(]>IP+,BUY1&)$6?R"VZY!$XM4D-,A,_")V&F&I0'`*D M"3&6H8;XM,:L$>`3?;>^",C?C8CWJV^:/5>A6$G:A/@01AKBG'/F<]%L^P>E M1M'V5;SOX%^9PU"AR1 M&QT"9QNS1B&$:;OP'J\DCIJMPA$K0CYB&38:CFED)O816:I^JAS0^J!XR"@7Q MN1X^Y7IX"C>6QKQ0KH)[`?_1VC?"J_B"P#E_+GW/I>^Y]#VATK\>WZV22$KYI9+2,6 MD$N!LT$DN/R+RO`JQ`GH9%LE"0AMNZ5/U2I77Y:^Y*+@\6^3I MKZ%T/BS/^3Q?Y[3-"S-#MW)+ZK:4OK4F.$KTL@'37[ M]EUVY".E,%.70[@:0KX#;;J=W#HXGIB1N0K34I!OP_GIQ7@:XCG9!+E]F%=M MY]C1T?OGP5&PH^\\EAW'B/*B(>ZAAIC/PT.'>7M?F&>5QE`T%&ULK"0L1K=@ MN-?Q+!3@9&`MH`>#KU$"\E)58#%;Q@,KD*)\3(Q%Z'#GEUQ?X]&2X]NF9;5N MKREW&6TB4CG":9@39ZO*WF6QP54=SU5;\K"^:CVT%4[/_EFMR)\,$4X6"Q)( M8Y07IDJB\QE3ON>;G*YZ(G;ZEW?!8/+]<,E'#^4[YU_T74.N?O;= MX_INDSM(3)QYQ1$!=$4"(Y4U#VT%SU&\Z.9 MX!ZSAW.;>KC"1:S_6-8>^3+?.7#;.MX#7N83+$.D?L%]BHJ`$:MBOKJO3_DE MG#NT>_&!()O\UMND]MW@#'S4JUJE9"L1/TL'?!^2!F.,6_0T7X\48JVFL:W& MVC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5`Y3_;U`UH]@TT')$%7C&9MC:C MY$X*/-S^[PVPPL2.X>V+OP%02P,$%`````@`#W<,1W,VX!A,`@``>@H```T` M``!X;"]S='EL97,N>&ULS59;:]LP%/XK0AFCA1';*4UI:QM&(3#8RJ!YZ%N1 M;=D6Z.+)5U!$NE MJAO/J],2,U1/186Y7LF%9$CIJ2R\NI(89;79Q*@W\_VYQQ#A,`YYPQ9,U2`5 M#5<1O!@@X/;?B0Q'\.GLZY]&J-LOP(V3;Y.)_W1^NXN?V85S"!S'CRR"P?P2 M>B\GG?K^?F*SN$,^?R7Y_[AWJ*\,M==XB21!(#YH@1NG;PS`#V[CH_1KB0-K:+L!MGZH^19)%$ MT.]^+P^7C.QV,,+J\)79KQ/N MR/S8JCE"P@F28QK;IY4V_[S2WJ>F3E'MUV]4YG6-8:/[;/6>`05)0Z@BO)>` MS&OAWLBF6VUA[#N:,VO'EF-7%4KT0W`KBB;+<(X:JGZ3E5!V,8*C_=/(#^:# MUW*@B.!H_\(9:=BU53"^-N-_4$L#!!0````(``]W#$>70X=:;@0``#01```/ M````>&PO=V]R:V)O;VLN>&ULE9=13]PX%$;_BI4GD'9W)HD#+>I4*DQW%XD" MZJ#VV20>QB*)9VVG4'[]7B=#^<)<1>5IDDSNL7U]?&-_\"=J>--,2^2680]#_7:B=)6>H#=;(S_ MOOLC$95>JZX.-]39YW8729K)+#L:&/&U;T8_>`3&!T*5P?S0-^IVDD)]#*8UCB.9 MO1I*G_Z7*]'VR7F>8J':2GQN`U'$>3M,'J4F]H%>/J_ZAMV)H0MW7J5#JA!T M9MM*MUY7@JZ\K4U%6:G$J:I56VH!H`Q`V5M!.8!R`.6_#5H%^J$A`T@"2+X5 M5`"H`%"Q#[IR=ZHU3Z\S>P111_M1I\H;+^Q:7#OM::KZ\'Z^5EW3*``=`^AX M'T3.BR_:W6GWA[A:K[4C7WO.5=AHAU/T#D#O]D%+3<&.4O!5_]!MISV$OH?0 M]_NAG\K2=11Y853OK!D%IW.4;+X??FF#]N):_531<@@;75CA*W&_"9 MVAI:?.)"*S_N`,J934P9 M%5?!EO=_WJI!QH9*K1\Z)&/8XS@#:FC([4;&-" MK!E^R"75,H(\I(^3DZLKF6+=0SHR1/KO.]@--S1A3)Z6GSS:@4-Z,D7?"N=@U M1*&^&:,OXQT[.O0W8_S%CX(X6.J@3#TFH,+96Q7.4>$<%1F6(0I5S1N5IU&A+,-H3,$Y/HR2BT.F<<9I9[LSLY6AWSMC-KG<.A&[G MG-OC!7\9EUSH%6WMJXZNR+%U%SI$H=XYI_=D$5DB"CW/ M&<\GO[T2/9?HN60\?ZE'K]/T*NL2-9>,YB\DS-(G[[MF2]U$%&HN&`?0<(0L_.M"_'6#K)FU97\9#O^V;HE%S&DS_]#'MY6<3M7[S_ M8BMJ.Q[9Z73>U?49/;MJ+ZSJ#[8#^?FL__%_4$L#!!0````(``]W#$&PO=V]R:W-H965T&ULC57;CILP$/T5 MQ`($M#:FMA.V?U]?@&577LA+;`_GS)F)QS-Y MQ\6KK`A1P1NCC=R%E5+M-HID61&&Y1-O2:._7+A@6.FCN$:R%02?+8G1"`&0 M10S735CDUO8LBIS?%*T;\BP">6,,BW\'0GFW"V$X&%[J:Z6,(2KR:.2=:T8: M6?,F$.2R"_=P>X2Q@5C$[YIT=Y%P(3`Z&D5,8%ULN='`FE MQI-6_ML[?=*>YB>@GH!&`EK/$N*>$(\$F-A,760V MKV]8X2(7O`MDB\UMPZV&"^-$>PZD]:93DM:X-]9[`?+H;MST"#1!'!P"CHA( M^_8*H-!'1Y:.OA8X.D2\+!`/`O$T@]C2DV5Z,M"3*3VQ]/1C?%/$P2&R98'4 M*Y!:^FI&P"'6RP*95R"S],V,@$-`L*RP\BJL'!]^E$@MI'$2/21--F#]P%VL MO3IKY^13L6335'K(`]6R\4IL'#^92<5!$(#IL@@$7A5K-G_'S*4,F`<*"T*_ M2O\TYVIKP#Q071#Y5=S[A',%UF/0`Q4&8[^*>\9HIL:./08"!./-*OM\/=&D M_S$BKG8NR*#DMT:Y]C=:Q]FS1[9_OL.+O,57\@N+:]W(X,25[L*V95XX5T1' M`9YT3)6>CN.!DHLRVY7>"SJ`P``71$``!@```!X;"]W;W)KRBPV$-[5F(Z%E8?KJ3$VW]?2C-RY2P]X<66Z&>& M+RGRU=#;2]?_&$[&C,'/IFZ'Q\UI',\/83@\GTQ3#I^ZLVGM+\>N;\K1WO8O MX7#N37F8@YHZ1*62L"FK=K/;SFW?^MVV>QWKJC7?^F!X;9JR_W=OZN[RN('- MTO"]>CF-4T.XVX;7N$/5F':HNC;HS?%Q\QD>"JTF9";^JLQE6%T'D_BGKOLQ MW?QQ>-RH28.IS?,XI2CMUYLI3%U/F6S/_W#2__N<`M?72_:O\W"M_*=R,$57 M_UT=QI-5JS;!P1S+UWK\WEU^-SR&>$KXW-7#_!D\OPYCURPAFZ`I?])WU<[? M%_HE4QSF#D`.P&L`1&*`Y@#]+B`D9?.XOI1CN=OVW248SN7TM.'!XOV4Q&8. MACF;'=(P-WZ>6M]VB-OP; MXJ-UO*;X^%9B.B,M#8(02#"&^U2Q)()@@1J^TWM61 M.G6DI",7=!`"62H\OX*A>+64[BK)G$HR&HH2E&2\,2%#00I3N58>"S9W:LE) M"PA:"$&[&`4I"Z0\U@DHIY2YV6H11KQGQN[16!"S4`I2#S7@5D.VIH4UN6_O?%K()_4/B-RNR20O6G) M)IF))$]8&(^="&Z7!+(W+=DD,ZCEJ24JS3S>@^!V2E@\3A)##.2B1S&%.O6P M2W#[)9#1:=0PTR4BW/#!ISE'ML)W<:)9'>19)S,Q-)V8B;U,$UTFR;"AYMVSTPBK*N" M&9^7/;I-$Y%G7Z@*F0',4ZDL7#"5^)@FNHM4)-.,?)[RU31ORV0VN\0C@]OL M,.8ZRR.#VZ&0*[5,FE5V*(72G/X*W=?B]B=D[Y'\B9D\EJOM!;-[U:/>1K=# M(?E*+#D4,[]E$">"=Q0+ET*F/%YNZ'8I)&]Y?^:Y540,Z%Q+50QCB)E/J:G= M/J79@X2%L6?&4M&8].H M3W:0)U,>KC>U.8[396JO>SK]T\W8G9<_,Z[_J.S^`U!+`P04````"``/=PQ' MX0TY("8"``"7!P``&````'AL+W=O*O.I=0%D&?@ MYCM6#6U%Q=J`T],V?$*;`D$M,8K?%>W%9!QH^#UC[WKR\[@-H6:@-3U('4'4 MXTH+6M$B)&M&2Q@TY,,^J]8\>_LF20>;VX`'`[X9T'+6$`V&Z,X` M+)GIZP>1),\XZP/1$?VUT4;)N0Y1R8$P::HE88I/NGK-XR@#5YTS2/!$LK,2 M[%<4@^(S!*CUG1!XA(BF$-A"+!_[H]&_G/HCZX^_(JZ,I+5-6`E<0(C\JL*E M\K(LG2Q+RY)\726>LE@)@O;G%Q8>H9!E2)T-J&=8SNR3]UBYQJ;PL*R?+RD0D,]WNK"2&C[>)3^EE6CN9 MUI8)S3"MAPV)$8[29&9'%:,2)1A%D^_N94+0"67*B@K/4`V:[V#=I&XN,#E" M.W*FOP@_5ZT(]DRJT]@Z"WY7Y;%]7.V[[O00 MANW+7E=%>U^?]+'_SVO=5$77_VS>PO;4Z&(W&E5E2*,H#JOB<%QMUN/8]V:S MKM^[\G#4WYN@?:^JHOEWJ\OZ_+@B*SOPX_"V[X:!<+,.)[O=H=+']E`?@T:_ M/JZ>R$-.U8",Q-\'?6YGWX,A^.>Z_CG\^'/WN(J&&'2I7[K!1=%_?.A4E^7@ MJ9_Y%SC]G',PG'^WWK^-]G]J,]_:-`@ M!H#:1ZW`0,#]FG` M40,.!MQW!@$&XFJ&T&@?5RXKNF*S;NIST)Z*83^1AQYO!B>]YZ`=O?6+UHZ# M3\/HQR9FZ_!C\`,(G2%;0/@RDAF$3$38S^\,@JY<,]#1G"Y/D!HB%D@,-YWD M7YPLALELF&R^5LS8Q[?MN;7G20Y<0I*C"`DD&T"90]A4F`$(CI+8!\P M;-L:*(D\!)'(J6@<[B4A&VD+#(D))LI21&!Y`HJJ!$N4]249]U!&W,I,=Y'( MP[8%!MU:*4!<8+((9`*!?)*8O2:1P;H$A$GT^B6V5J##HE9*B.8<) M^:PP+0MS=TMBNI/$VB4P1&'%*9VH"%5F*"88FC*@E%?*W$V3F!XEL:X)3$P8 MDM@4*,X$UC>!ZD\5UP><2VD&Z]?2)VG2+DXBB.+#`P:,W&] M)%TL,2#(PY=_F6A9#76K,FT`*QSDQM-Z51P@E6SE)`97]6E`(CL\DI27B_]Y#Y M<^N4QOT91/K4%7>KIA(.[U@>I5\>/S&!)5)Z)5+^KT2ZW\$IO&%C+^'`>"42 MW'$I*2>(TVQRZI%(A24RG%U05KIY&Z^&V^"E?C]VYLYM&IVNGY_&2]JK\2UY M2(EC/",/N;E<_G2_69^*-_U7T;P=CFWP7'==78UWH*]UW>D^Z.B^E[#7Q6[Z M4>K7;O@JAWR8*V;SHZM/]L9\NK;?_`=02P,$%`````@`#W<,1T.VI,O(`P`` MV1$``!@```!X;"]W;W)KP9< M-@9:Z4A-1J/9PTJC.>R>Z<1)4`/.`.GT_OL%7*;3L^Z*]Q+`>57UGL'/'^NK M[E[ZDU)#\-;4;?\8GH;A_!!%_>ZDFK+_HL^J'?\YZ*XIA_&Q.T;]N5/E?@YJ MZ@CB6$9-6;7A9CVW_>@V:WT9ZJI5/[J@OS1-V?U3J%I?'T,6VH:?U?$T3`W1 M9ATM84>'MOLW^;Y8[TG\M>;77]=[4?3B/;.`SV MZE!>ZN&GOGY7J"&9$NYTW<^_P>[2#[JQ(6'0E&_F6K7S]6K^226&N0,``V`) M6.JX`S@&\/<`,2LUS&9=7\NAW*P[?0WZ8Q)#QZ`SI%"--O"3$ M&(A@^4=,5.4MDID1&2#60%2G58CQ>6>[D MD1L>5`T#8;E'#18[B\S-8XJ8^``+!*4Y([@@2/H,&,;<9-`38K(.@F2>YAZ5 MP#D<&&`E\$C!W60YIN!4SQG0*A,))0E1N1`>=-QNPP32$9\7*A"T$FE&T4%4 MDOJ\RL1-)T$ZA.X"0:N,[)S$Q:8C#VF85@L\H-Q@;5(#^\#<&M"[V,Q MI0G0`Q)J_K$HF?HH'N8/11YC&BP.U]@-['B*%; M(&@%Y"=C08G/S`!N]P-T/T;-#`A*B`7>%C'@,2N`V_D`78TEGYSG5U:E].*I_FPXK?V@CULS9G#>YK- M^EP>U9]E=ZS:/GC6P[B?GS??!ZT'-3*+OXS==E+E?GFHU6&8;M/QOC,G#^9A MT&=[D+*BO??#D3%7 M]Z"%>\`!3/C3HM7"A]1VS`T61)-(6C&>91^8%M+0JDRU9UN5.'HE#3Q;XD:M MA?U]`873B>9T+;S(KO>QP*J2;;Q&:C!.HB$6VA,]Y\=+$1$)\$/"Y'8QB=ZO MB*\Q^=:<:!8M@(+:1P41EAL\@5)1*#3^M6B^MXS$?;RJ?TF[#>ZOPL$3JI^R M\7TPFU'20"M&Y5]P^@K+%AZC8(W*I2^I1^=1KQ1*M'B;5VG2.LU_>+'0[A/X M0N`;X5.6C,^-DLW/PHNJM#@1-X@XN_P8X#:*!&7BDEIPZ%+Q'*NW*N=YR6Y1 M:,'P'>:R8#8$"^IW6W!ZC\X3G?^;?ECIA[W#P^+P/P2*5:#8"Q3WM[C'7%;, MX:\F;'>F&FR7KHXC-8[&ST>Z5;?;>>9I)N_PJAQ$!]^%[:1QY(H^3#:-H47T M$-IG#X^4].'];(F"UL?P8XCM?*7FQ..P/I#ME59_`%!+`P04````"``/=PQ' MW)-R59\!``"Q`P``&````'AL+W=OMC#O1SOO^R)BK.M#"/6`/)OQIT&KA0VI;YGH+HDXDK1C/ MLD>FA32T+%+MV98%#EY)`\^6N$%K8?]=0.%XHCNZ%%YDV_E88&7!5EXM-1@G MT1`+S8F>=\=+'A$)\%O"Z#8QB=ZOB*\Q^5F?:!8M@(+*1P41EAL\@5)1*#3^ M.VN^MXS$;;RH?T^[#>ZOPL$3JC^R]ETPFU%20R,&Y5]P_`'S%@Y1L$+ETI=4 M@_.H%PHE6KQ-JS1I':<_7[.9=I_`9P+_0&!3HV3SF_"B+"R.Q/4BSFYW#'`; M18(R<4DM.'2I>([56[GC><%N46C&\`WF,F-6!`OJ=UMP>H_.$YU_3M\O]/W6 MX7YV>/A<(%\$\JU`?G^+6\QEP3Q^:,(V9ZK!MNGJ.%+A8/QTI&MUO9UGGF;R M#B^+7K3P2]A6&D>NZ,-DTQ@:1`^A??9PH*0+[V=-%#0^AE]";*^^6! MK*^T_`]02P,$%`````@`#W<,1\[LS="A`0``L0,``!@```!X;"]W;W)K@K??=GC%7MJ"%N\$. M3/A3H]7"A]0VS'461)5(6C&>97=,"VEHD:?:LRUR[+V2!IXM<;W6POX[@<+A M0#=T+KS(IO6QP(J<+;Q*:C!.HB$6Z@,];O:G740DP*N$P:UB$KV?$=]C\KLZ MT"Q:``6ECPHB+!=X`J6B4&C\=]+\:AF)ZWA6_YEV&]R?A8,G5&^R\FTPFU%2 M02UZY5]P^`73%FZC8(G*I2\I>^=1SQ1*M/@85VG2.HQ_[K83[3J!3P2^$!ZR M9'QLE&S^$%X4N<6!N$[$V6WV`6ZC2%`F+JD%ARX5C[%Z*3;\/F>7*#1A^`IS MFC`+@@7UJRTXO4;GB8#<+[-8"N^M;7&-.,^;QOR9L M=:8:;).NCB,E]L:/1[I4E]MYY&DF7_`B[T0#?X1MI''DC#Y,-HVA1O00VF=WO&7-F"%NX&.S#A3XU6"Q]2VS#761!5(FG%>);=,2VD MH46>:D^VR+'W2AIXLL3U6@O[[P0*AP/=T+GP+)O6QP(K^I.R=1SU3 M*-'B;5RE2>LP_N$_)MIU`I\(?"%\SY+QL5&R^2"\*'*+`W&=B+/;[`/<1I&@ M3%Q2"PY=*AYC]5)LMEG.+E%HPO`5YC1A%@0+ZE=;<'J-SA.=?T[?SO3MVN%V MZ5)=;N>1IYF\PXN\ M$PW\%K:1QI$S^C#9-(8:T4-HG]W<4M*&][,D"FH?PV\AMN.5&A./W?Q`EE=: M_`=02P,$%`````@`#W<,1T"W^\>@`0``L0,``!D```!X;"]W;W)K&ULA5/;;MP@$/T5Q`<$W[:M5EY+NZFB]J%2E(?VF;7'-@HP M#N!U^O<%?(E5K907,S,^Y\R!@7)"\VI[`$?>E=3V1'OGAB-CMNY!+HI-#P;(@=E>+F[P4D3B>: MTK7P(KK>A0*K2K;Q&J%`6X&:&&A/])P>+T5`1,!O`9/=Q21XOR*^AN1G.7U*-UJ%8*)8J_SZO0<9WF/WFZT.X3LH60;81O230^ M-XHVOW/'J]+@1.S`P^S2HX>;(.*5B8UJWJ&-Q7.HWJHTSTMV"T(+)MMA+@MF M0S"O?K=%1N_1LTC//J?G*SW?.\P7A\7G`L4J4.P%BOM;W&,N*^;P7Q.V.U,% MIHM7QY(:1^WF(]VJV^T\9W$F'_"J''@'O[CIA+;DBLY/-HZA173@VRF#B2@`0`` ML0,``!D```!X;"]W;W)K&ULA5/;;N,@$/T5Q`<4 MAZ0718ZEI*NJ^[!2U8?VF=AC&Q48+^"X^_<+^%*KBM07,S,^Y\R!@7Q`^^%: M`$\^M3+N0%OONSUCKFQ!"W>#'9CPIT:KA0^I;9CK+(@JD;1B/,ONF!;2T")/ MM1=;Y-A[)0V\6.)ZK87]=P*%PX%NZ%QXE4WK8X$5.5MXE=1@G$1#+-0'>MSL M3[N(2(`W"8-;Q21Z/R-^Q.1W=:!9M``*2A\51%@N\`A*1:'0^.^D^=4R$M?Q MK/Z4=AON5?<7B&:0NW4;!$Y=*7E+WSJ&<*)5I\ MCJLT:1W&/WRF72?PB<`7PD.6C(^-DLU?PHLBMS@0UXDXN\T^P&T4">9K)%[S(.]'` M'V$;:1PYHP^336.H$3V$]MG-+25M>#]+HJ#V,;P/L1VOU)AX[.8'LKS2XC]0 M2P,$%`````@`#W<,1Y?[H>ZB`0``L0,``!D```!X;"]W;W)K&ULA5/;;N,@$/T5Q`<4QW%VV\BQE*1:[3ZL5/6A?2;VV$8%Q@4< M=_]^`5]J59'Z`C/#.6=F&,@'-&^V!7#D0TEM#[1UKMLS9LL6%+=WV('V)S4: MQ9UW3<-L9X!7D:0D2Y/D!U-<:%KD,?9DBAQ[)X6&)T-LKQ0W_TX@<3C0#9T# MSZ)I70BP(F<+KQ(*M!6HB8'Z0(^;_2D+B`AX$3#8E4U"[1?$M^#\J0XT"26` MA-(%!>ZW*YQ!RB#D$[]/FI\I`W%MS^J_8K>^^@NW<$;Y*BK7^F(32BJH>2_= M,PZ_86IA%P1+E#:NI.RM0S53*%'\8]R%COLPGF3)1+M-2"="NA#N(X&-B6*9 MC]SQ(CCI/7_ M9W$DU"Z8/[UMQB=]?V#,51UHX>ZP!Q/^-&BU\"&U+7.]!5$GDE:,9]DWIH4TM"Q2 M[<66!0Y>20,OEKA!:V'_G4'A>*0[NA1>9=OY6&!EP59>+348)]$0"\V1GG:' M+XAO,?E9'VD6+8""RD<%$98K/()242@T_CMK?K2,Q&V\ MJ#^EW0;W%^'@$=4?6?LNF,THJ:$1@_*O.#[#O(7[*%BA MIU6:M([3G_QAIMTF\)G`5\+W+!F?&B6;/X0796%Q)*X7<7:[0X#;*!*4B4MJ MP:%+Q5.L7LM=S@MVC4(SAF\PYQFS(EA0O]F"TUMTGNC\:_I^H>^W#O>SP_W7 M`ODBD&\%\MM;W&+."R;_U(1MSE2#;=/5<:3"P?CI2-?J>CM//,WD`UX6O6CA ME["M-(YV-Y2A`0``L0,``!D```!X;"]W;W)K&ULA5/;CML@$/T5Q`@NB3B2M&,^R1Z:%-+0L4NW%E@4.7DD#+Y:X06MA_UY`X7BB.[H4 M7F7;^5A@9<%67BTU&"?1$`O-B9YWQTL>$0GP2\+H-C&)WJ^(;S'Y49]H%BV` M@LI'!1&6&SR#4E$H-/XS:WZTC,1MO*A_2[L-[J_"P3.JW[+V73";45)#(P;E M7W'\#O,6#E&P0N72EU2#\Z@7"B5:O$^K-&D=IS\\FVGW"7PF\)7P)1'8U"C9 M_"J\*`N+(W&]B+/;'0/<1I&@3%Q2"PY=*IYC]5;N\D/!;E%HQO`-YC)C5@0+ MZG=;<'J/SA.=?T[?+_3]UN%^=OCXN4"^".1;@?S^%K>8RX)Y^J\)VYRI!MNF MJ^-(A8/QTY&NU?5VGGF:R0>\+'K1PD]A6VD&PO=V]R:W-H965T<.3"0#VC>;`O@ MR+N2VAYHZURW9\R6+2AN[[`#[?_4:!1W/C4-LYT!7D62DBQ-DA],<:%ID-_M3 M%A`1\"I@L*N8!.]GQ+>0_*T.-`D60$+I@@+WRP4>0,H@Y!O_GS2_6@;B.I[5 M?\?=>O=G;N$!Y3]1N=:;32BIH.:]="\X_(%I"[L@6**T\4O*WCI4,X42Q=_' M5>BX#N.?W7:B72>D$R%="/=)-#XVBC8?N>-%;G`@MN-A=IN]AYL@XI6)C6K> MH8W%8ZA>BDUVG[-+$)HPZ0ISFC`+@GGUJRU2>HV>1GIZF[Z=Z=NUP^WD\-=M M@6P6R-8"V?4MKC&G";-+OC5AJS-58)IX=2PIL==N/-*ENMS.8QIG\@4O\HXW M\,1-([0E9W1^LG$,-:(#WSZYVU'2^O>S)!)J%\*?/C;CE1H3A]W\0)976GP" M4$L#!!0````(``]W#$&PO=V]R:W-H965TWQ1@'$` MK]._+^!+K&JE],7,C,\YK^E/4?[N:]=YLPDE-31B ME.X%I^^P;.$0!"N4-GY)-5J':J50HL3[O/8ZKM/\A^<+[3Z!+P2^$3(>C<^- MHLUOPHFR,#@1.X@PN_3HX2:(>&5BHYIW:&/Q'*JW,CVD!;L%H07#=YC+@MD0 MS*O?;<'I/3J/=/XY/5OIV=YAMCC\#X%\%XQEQ63_=.$[&PO=V]R:W-H965T<.3!0C&C>;`?@ MR+N2VAYIYUQ_8,Q6'2AN[[`'[?\T:!1W/C4ML[T!7D>2DBQ+DGNFN-"T+&+M MQ90%#DX*#2^&V$$I;OZ?0>)XI"E="J^B[5PHL+)@*Z\6"K05J(F!YDA/Z>&< M!T0$_!$PVDU,@O<+XEM(?M5'F@0+(*%R08'[Y0J/(&40\HW_S9J?+0-Q&R_J M3W&WWOV%6WA$^5?4KO-F$TIJ:/@@W2N.SS!O81\$*Y0V?DDU6(=JH5"B^/NT M"AW7$BB\:E1M/F3.UX6!D=B>QYFEQX\W`01KTQL5/,. M;2R>0O5:ION\8-<@-&.R#>8\8U8$\^HW6V3T%CV+].Q[^FZA[[8.=[/#_?<" M^2*0;P7RVUO<8LX+YOY+$[8Y4P6FC5?'D@H'[:8C7:OK[3QE<2:?\++H>0N_ MN6F%MN2"SD\VCJ%!=.#;)W=[2CK_?M9$0N-"^,/'9KI24^*P7Q[(^DK+#U!+ M`P04````"``/=PQ'0L.DBZ(!``"Q`P``&0```'AL+W=O!E)2K(T26Z9XD+3/(NU-Y-GV#DI-+P98CNEN/D^@L1^3U=T*KR+ MNG&AP/*,S;Q2*-!6H"8&JCT]K';'34!$P%\!O5W$)'@_(7Z$Y*7O*==._8 M/\.XA6T0+%#:^"5%9QVJB4*)XE_#*G1<^^'/^F&D72:D(R&="?=)-#XTBC;_ M<,?SS&!/;,O#[%8[#S=!Q"L3&]6\0QN+AU`]YZOM7<;.06C$I`O,<<3,".;5 M+[9(Z25Z&NGI=?IZHJ^7#M>CP_OK`IM)8+,4V%S>XA)SG#`/_S5ABS-58.IX M=2PIL--N.-*Y.M_.0QIG\@O/LY;7\,I-+;0E)W1^LG$,%:(#WSZYV5+2^/(Z;4DH`$``+$# M```9````>&PO=V]R:W-H965T M!D0$O`@8["HFP?L%\2TDOZLC38(%D%"ZH,#]0O5:I/LD9]<@-&&R%>8\818$\^HW6V3T%CV+].S?],U,WZP=;B:'_]%_ M.PMLUP+;VUM<8\XSYKM+MCI3!::)5\>2$GOMQB-=JLOM/&5Q)E_P(N]X`W^X M:82VY(+.3S:.H49TX-LG=SM*6O]^ED1"[4)X[V,S7JDQ<=C-#V1YI<5?4$L# M!!0````(``]W#$>8]]YSVP$``$4%```9````>&PO=V]R:W-H965TP<3V5E703X/J<\UT4(!NY>)4-@$+OC';RZ#5*]0>,9=$`(_*!]]#I+Q47 MC"B]%#66O0!26A.C./#]&#/2=EZ>V=JSR#,^*-IV\"R0'!@CXN\9*!^/WLYS MA9>V;I0IX#S#BZ]L&72RY1T24!V]T^YP3HW""GZW,,K5')G>+YR_FL7/\NCY MI@6@4"B30/1PA4>@U`1I\-N<^8$TQO7KN+T3"(Z=_VE(UNEG?0R54 M9*#JA8\_8-Y"9`(+3J7]1<4@%6?.XB%&WJ>Q[>PX3E]2?[9M&X+9$'PRX`ED MV_Q.%,DSP4V+^N]U!RX4)T\UT<9OAJ@F9-L-*<9\VB MP#I]$Q%X6_;`VH/[]M#9PW6'X40/HOL!>Q>P7P?LYRWN_]_B6G-VFB]`HDU( M-`?$-R!.D]R'Q)N0>`Y(;T"9XD*/G1J.N9+=7DQ3H&])Q_R/.M)#;^(J-M.H@M7^K;9JU%Q MKD#C_8?(0XU^TY8%A4J9::+G8KKFTT+QWCU:R\N9_P-02P,$%`````@`#W<, M1P9BWX:B`0``L0,``!D```!X;"]W;W)K&ULC5/; M;J,P$/T5RQ]0$T+:*B)(25?5[L-*51_:9P<&L&I[J&U"]^]KFTO9*M+N"YX9 MSF7&EWQ`\V9;`$<^E-3V0%OGNCUCMFQ!<7N#'6C_IT:CN/.I:9CM#/`JDI1D M:9+<,L6%ID4>:T^FR+%W4FAX,L3V2G'SYP02AP/=T+GP+)K6A0(K^F>HZ>1GOZ;OIWI MVW6'V]%]^Q_^V2R0K06R:<3=WR.N,:<9<_O-A*WV5(%IXM6QI,1>NW%+E^IR M.X]I/),O>)%WO('?W#1"6W)&YT\V'D.-Z,#;)S<[2EK_?I9$0NU">.=C,UZI M,7'8S0]D>:7%)U!+`P04````"``/=PQ'OA8Y-J8!``"Q`P``&0```'AL+W=O M:>=#;&# M4MS\.8/$\4AW="F\B+9SH<#*@JV\6BC05J`F!IHC/>T.YSP@(N"7@-%N8A*\ M7Q!?0_*C/M(D6``)E0L*W"]7>`0I@Y!O_#9K?K0,Q&V\J'^+TWKW%V[A$>5O M4;O.FTTHJ:'A@W0O.'Z'>83[(%BAM/%+JL$Z5`N%$L7?IU7HN([3GRR=:;<) MZ4Q(5\)#$HU/C:+-)^YX61@UY.+O=P<--$/'*Q$8U[]#&XBE4K^5NOR_8 M-0C-F'2#.<^8%<&\^LT6*;U%3R,]_9R>+?1LZS";NF?YYP+Y(I!O!?)YQ(=_ M1]QBS@OFZW]-V&9/%9@V7AU+*ARTF[9TK:ZW\Q0/D7W`RZ+G+?SDIA7:D@LZ M?[+Q&!I$![Y]??SYI(:%P(]SXVTY6:$H?]\D#65UK^!5!+`P04```` M"``/=PQ'Y;;,FZ4!``"Q`P``&0```'AL+W=O:>=#;MS\/8/$\4A3NA1>1-NY4&!E MP59>+11H*U`3`\V1GM+#.0^("/@M8+2;F`3O%\37D/RLCS0)%D!"Y8("]\L5 M'D'*(.0;O\V:'RT#<1LOZD]Q6N_^PBT\HOPC:M=YLPDE-31\D.X%QQ\PC[`/ M@A5*&[^D&JQ#M5`H4?Q]6H6.ZSC]V>%@9' M8GL>SBX]>+@)(EZ9V*CF'=I8/(7JM4P?DH)=@]",R3:8\XQ9$S)A(: M%\)['YOI2DV)PWYY(.LK+?\!4$L#!!0````(``]W#$=KF>&$I`$``+$#```9 M````>&PO=V]R:W-H965T`5Y&D)$N3Y)XI+C0M\AA[,46. MO9-"PXLAME>*F_\GD#@(:IA5T0+%':N)*RMP[53*%$\?=Q%SKN MPWBR2R?:=4(Z$=*%)%WO('? MW#1"6W)&YR<;QU`C.O#ID[L=):W_/XLCH7;!_.%M,SZIT7'8S1]D^:7%!U!+ M`P04````"``/=PQ'"+>/8;(!```6!```&0```'AL+W=OX+A[ M^P'&KCM%RXV!P_>'#K@8E7XS'8!%[X)+<\2=M?V!$%-U(*AY4#U(M],H+:AU M2]T2TVN@=2`)3K(DV1%!F<1E$6HONBS48#F3\**1&82@^L\9N!J/.,5SX96U MG?4%4A9DX=5,@#1,2:2A.>)3>CAO/2(`?C(8S6J.?/:+4F]^\;T^XL1'``Z5 M]0K4#5=X!LZ]D#/^'34_+#UQ/9_5OX;3NO07:N!9\5^LMIT+FV!40T,';E_5 M^`WB$4+"2G$3OJ@:C%5BIF`DZ/LT,AG&<=K)TTB[3<@B(5L(^R0$GXQ"S"_4 MTK+0:D2FI[YWZ<'!M1=QRL@$-9?0A.+)5Z]ENM\5Y.J%(B9;8%;]"S0L_OTS4S?K!-N)O=\=U\@GP7RM4`>C_CX^8AKS'G&[.^;;&^:;*/` MTW],(N8I^<>$K!HG0+?A?AI4J4':J6]+=7D"IRPT_@->%CUMX0?5+9,&791U MUR?TNE'*@K-/'K88=>Z1+@L.C?731S?7T[V=%E;U\RMU#I2@/[3-KCR\*&`?P.OW[`L:.4UG9 M%\,,YS(C#^23D*^J!=#HG;->'7&K]7`@1)4M<*KNQ`"].:F%Y%2;4#9$#1)H MY4B1BU*SKX5DB-7).Y=\S,#$=<8B7Q$O7M-HF2)&3 ME5=U''K5B1Y)J(_X%![.F44XP.\.)K79(UO[18A7&_RLCCBP)0"#4EL%:I8K M/`)C5L@8OWG-#TM+W.X7]2?7K:G^0A4\"O:GJW1KB@TPJJ"F(],O8OH!OH74 M"I:"*?=%Y:BTX`L%(T[?Y[7KW3K-)VGL:?N$R!.BE?`M<(7/1J[,[U33(I=B M0FJ@]M^%!P.75L0H(^743(7*)4\V>RW"AS`G5ROD,=$&<_:8%4&,^JY%A/?H MD:-'M^GQ0H^W%<:S>_)P6R!9!)*M0.);C#ZWN,6<%TQ\VR3=-4F]0/*%R8)) M;YMDNR:9%\B^,%DP]_^9D,UT<)"-NP0*E6+L]3P<:W:]9Z?(3=<'O,@'VL`O M*INN5^@BM)E1-U"U$!J,?7"78M2:EV`-&-3:;N_-7LZ78PZT&):KOKXWQ3]0 M2P,$%`````@`#W<,1P:.I=:S`0``%@0``!D```!X;"]W;W)K&ULA53=;ILP%'X5RP]0`PE;&A&DI-/47DRJ>K%=.W``JS:'V29T M;S_;_)1647.#[A]JSS#'LK10O/FIA>*:[_G4#B<*`QG0LO MHFZL+[`\8PNO%`I:([`E&JH#/<;[4^H1`?!;P&!6<^*SGQ%?_>*I/-#(1P`) MA?4*W`T7>``IO9`S_CMIOEMZXGH^J_\,NW7IS]S``\H_HK2-"QM14D+%>VE? M<'B$:0LA88'2A"F-1S11*%'\;1]&&<1C?I+N)=IV03(1D(>RB$'PT"C%_ M<,OS3.-`3,=][^*]@VLOXI2)"6HNH0G%HZ]>\OA^E[&+%YHPR0ISFC`+@CGU MJQ8)O49/`CVY3=_,],TZX69T3W>W!;:SP'8ML)VV>/]QBVO,:<2X8WO;)+UJ MDDX"\1VW%AL9MOX?(KR/\#4$L#!!0` M```(``]W#$>EIVX=L0$``!8$```9````>&PO=V]R:W-H965TGY=EFV)4^MET`!:]"B[-`7?6]GM"3-6!H.9&]2#=2J.TH-:5NB6F MUT#K0!*N)Z/JL_A-VZ]&=JX%[QOZRVG0N;8%1#0P=NG]3X$Z8M MA(25XB9\4348J\1,P4C0US@R&<8QKF3I1+M.2"="NA#NDA`\&H68/ZBE9:'5 MB$Q/_=EM]@ZNO8A31B:HN80F-(^^>RG39%N0BQ>:,.D*SC%M>8TXS)OS?)KYKDD\#N"Y,9 M<_O)A*P.3H!NP_TTJ%*#M/'%GTM(7?5+=,&G16UEV?<-:- M4A:&ULC57+ MCJ,P$/P5Q`<,ML&0B0A27JO=PTJC.>R>G<0):``SMA-F_W[]@C`1(;E@NZFJ MKFZPG;:,?XB<4NE]564M%GXN93,/`K'/:47$"VMHK=X<&:^(5$M^"D3#*3D8 M4E4&"(`XJ$A1^UEJ8F\\2]E9ED5-W[@GSE5%^+\5+5F[\*'?!=Z+4RYU(,C2 MH.<=BHK6HF"UQ^EQX2_A?)MHA`'\*6@K!G-/>]\Q]J$7OPX+'V@+M*1[J16( M&BYT3I5KG?$4'7K/Q;'&2NS`+?.]`C.9?RG;4_ MJ2L!:\$]*X5Y>ONSD*SJ*+Y7D2\[%K496_LFFCG:.`$Y`NH)?9YQ0N@(X940 M31(B1XB>)6!'P#>$P-9N.K M,@1F:7#10@Z#!IB5Q<`>$2CUT13('Z,CF^)^@K5%Q/@^9.-$PON0K8.`U\=& MP\YH..Q%:.M$Z+%`U`E$0X'("&#PW61B(+5MAH7,(([A?=3&HA(X`T]T'8]Z MP;8;-SW%0R\6`F.$)[RL'0J\WGZ?;XZ[=/!UHOJM1GIUK:?=1'^T/ MXB72>_TFOH+SM3U/KS)9VI`3_4WXJ:B%MV-2G21FVQ\9DU3Y`B^JL%Q=(?VB MI$>IIXFNV)ZJ=B%9T]T1_465_0=02P,$%`````@`#W<,1[:)*;%L`@``5`D` M`!D```!X;"]W;W)K&ULE5;=CJ(P&'T5P@,,M/SH M&"11U.Q>;#*9B]WKJE7(`&7;*K-OOVUID=D486^D_3CG]/2D\C5I"?U@.<;< M^:S*FJW=G/-FY7GLE.,*L1?2X%J\N1!:(2ZF].JQAF)T5J2J]*#OQUZ%BMI- M$U5[HVE";KPL:OQ&'7:K*D3_;'%)VK4+7%-X+ZXYEP4O3;R>=RXJ7+."U`[% ME[6[`:L#""5$(7X6N&6#L2/-'PGYD)/OY[7K2P^XQ"D_%6<>2[<^JYSQA=T*_D[:;]AO8=("IY(R=2O M<[HQ3BI#<9T*?7;/HE;/MGNS]#7-3H":`'M"OXZ=$&A"\""$3PFA)H1S5X@T M(9J[0JP)\8,0J_"[L%34.\11FE#2.JQ!\@""E8!3*2*4':;41,I,%3>R>D\A M@(EWET(:`P>8;8>)PW'(KH.`<<3!+!3T&$^8M#J%KLT%[`3&E\@Z1!P]\3DI MLI\6.6B1&3L)S$["8>:!CB*<%@B-0#`4"+5`-"T061U$6B#^NLLA9F?8SZ:G\AV$#90?ZI M;\$J`Y;Z#JSV7;M_R*=)@Z[X!Z+7HF;.D7#1MU23N1#"L?#KOX@&EXLK3C\I M\87+X4*,:=?TNPDGC;G#]!>I]"]02P,$%`````@`#W<,1U<#&ULE59=;YLP%/TKB!]0\,48 MJ`A2TVK:'B95?=B>G<0)J(`9=I+NW\\V)J.2FS@O\0?GGG/OQ8>X///Q7=2, MR>"C:WNQ"FLIA\CQV5:CD>(C&,C.Y,4-=&$,QT#<>PZ.OY=LY:?5R$*YXVWYE!+O1%5972)VS4=ZT7# M^V!D^U7XA![70#3$('XU["P6\T`GO^'\72]^[%9AK'-@+=M*34'5<&+/K&TU MDU+^8TG_:^K`Y7QF_V;*5>EOJ&#/O/W=[&2MLHW#8,?V]-C*-W[^SFP-J2;< M\E:8WV![%))WC.?I21[;,'<`V`"X!!0F[TG'9/E"):W*D9\# M,5#][M"C0H^:0Q$'PI"I!(79?-*[IPJ@**.3)K(86%I/$%TRD^)TB,(LD M2Q$P!`CRVP3)3("7!(G-`'W.,C68?LIRPJ20QPGQ$,).(6R%X(K0A,&I.N.Q M1TM2IU!JA9(K0A,FRXK,IR#BU"%6!W_666+6,R:]+9(Y13)+0&X3Y,X#DEN" M[#9!X%*F[X/2.@MV&0<2GX`F4D5B]80]O M(K=OD#4.OO85L"!<#'/#,(>WR0P&T> MF,WCX7/XXD_K#O.`VSR0^%1K0=A'Q^T&PO=V]R M:W-H965T]\YP`M24O9.\\)$9"-"O/ MXX><5)B_T(;4\I\39146`B#R*ES4;IKHM5>6)O0BRJ(F MK\SAEZK"[%]&2MJN7>CV"V_%.1=JP4L3;X@[%A6I>4%KAY'3VMW`U0X&"M'$ MGX*T?#1VE/D]I>]J\NNX=H'R0$IR$$H"R\N5;$E9*B69^<.(?N54@>-QK_Y# MEROM[S$G6UK^+8XBEVZ!ZQS)"5]*\4;;G\34$"K!`RVY_G4.%RYHU8>X3H4_ MNVM1ZVO;_1,#$V8/0"8`#0%#'GN`;P+\N0&!"0B^`G2OO:X4W8@=%CA-&&T= MWF#U>,"5Q)D2DQZ%?3U"_$=M[8M+$TFIB:4S$MRG&3-8SRVEF^YV9-`*!U8E> MEA+1C(9":+WW$,Z_^1#979BW,GK0\\Q`X:R;#WU[(O/V1NA1H@Z*_0<586=]+G+G0"^UZ';S874X>S=('P=?>)HT M^$Q^8W8N:N[LJ9"'BCX!3I0*(CV`%^DHEU\'PZ0D)Z&&"SEFW7G9301M^N-_ M^`9)_P-02P,$%`````@`#W<,1V^=)#"6`P``UA(``!D```!X;"]W;W)K&ULE9C=(!`C/#`*;4JJC$[,56I?9B]YKH MJ%2`<0%C]NV7GQZ#I@?&&P7\NOLPS6G`Z5D6[^5!B,KZS-*\G-F'JCH^.DZY M.8@L+A_D4>3U+SM99'%5[Q9[ISP6(MZV05GJ4-?UG2Q.>936QUX%>R/U3-`6<^=2YQVR03>9G(W"K$;F8_D<<7 MYC=(2_Q.Q+GL;5N-^#U M.965S%2(;67Q9_>=Y.WWN?LE="$,#Z`00"\!Q!L,8!#`3`,\"/!,`S@$<-,` M'P)\TX```@+3@!`"PIL`IVM'V\Q57,7S:2'/5GF,FTN?&J.?LRISZ;.1Y,(&-IC%HKQ],Q2,5S/K(#A1,]$P.B)YXX8*K168GP] M\Z+$?)5RZD5#5XZJE6/]E:-0)!A/P%0"KY^`08+P6B5OF;Q;^HZ9!/7<<5T] MMX1<+@^'P:@#FR!]#YGY1 MI+&["<%EJ>'(#5+@TY'<,1X)/A\)##4>Z)NP`FAHB'Q#]$+P:4=@W/&;2=V' M5A=HHH1 M@@+?H`X^$,ADW*EK!=7-::QJ\&2!CP4*8R$P:!`E:(\I,>\QI;@*.M[C-4`& MYJ*XRRFX/`@-4GCXN7IWG"ON*LH-KF=J?)^G^(V>^@;C'B`8X@:U<(=2=;LV MTQ-N(@5Q M9M)=IGEW`->$`S>^%4`A&[C:@.%NC]*+P>^/S,.?#*\+J5L?-RF$NY2!2\.A M1U"`&&,&$X7A1F4&1ET!Q%WL84OH2#-P(``!T(```9````>&PO=V]R:W-H965T3JEYLUR0AL55L/"!Q]_8#C#-WHPG-10SX M^[\#X9!J9/Q5-(3(X*VCO5B%C93#8Q2)?4,Z+![80'KUYLAXAZ7J\E,D!D[P MP11U-(H!R*(.MWU85V;LF=<5.TO:]N29!^+<=9C_7A/*QE4(PWG@I3TU4@]$ M=15=ZPYM1WK1LC[@Y+@*G^#C%J8:8A`_6C**13O0YG>,O>K.M\,J!-H#H60O M-056CPO9$$HUDU+^94G_:NK"97MF_V+B*OL[+,B&T9_M03;*+0B#`SGB,Y4O M;/Q*;`;C<,^H,-_!_BPDZ^:2,.CPV_1L>_,91U:+R0!XE_4_X#;[ MY*3D3DNYM53>L#1A$E@@+Z'"*51,0N6-2.L)`V%:^D4JG4JE58(W(I56*<_R M+$GN*T'@E#+#6BOVH(#.106A_ZJ"L=M%[/$C6E">@1@!CRT`W=L5VOU:^DP: M;3[35U)!OFR_CZCZ#^`U!+`P04````"``/=PQ'P'8H]8`" M``"G"0``&0```'AL+W=O40^A*P.?=R?!T;9V?1 MO.\YV?5!31PB` M.&I8U89YUO<]=WDF3JJN6O[K M&M[*2K1!Q_>K\`DN"Y@8I"=^5_PL1_>!D=\(\6H:/W>K$!@'7O.M,BF8OKSQ M@M>UR:3?_-2'J/]5.E=H6A,&.[]FI5B_B_(.[ M,5"3<"MJV?\&VY-4HAE"PJ!A[_9:M?WU;)]0[,+\`<@%H$L`)),!V`7@3P&1 M->O']8TIEF>=.`?RR,QLPZ7&.Y-$9PYDGTT/2?:=3Z;W+4<+DD5O)I%CT(A9 M.^8V43@"7Y!("W@MT&"!QQ;(6=#["?"0@(P38)<@OI9,>J:UP[!,2A&Y#146 M2C!([JL0KPIQ*LGU6^A8Q3(/!&!TFRHU5BI[*84+$,P0LXH6(A3./TODKB54EF3)%E'F":Q!,N`T4IO"^3>F52 M.YR)XJ\M@BBD$RH.`G#&/W?A-5E8$P#N)X#`NX[[[ID+&4*O!(3^I7Q5$`=A MBB<*XB`(YL@@OPQR)9DQNQ#[2X*_4!+_C@+)G))8*`9D8JT7CJ(8S?B70/^> M`MU>`&;L2C#V%R7^0E'\:Q@F_J)<;?D#!!&>V/,=I9?Z9YUH]$D]L@/_Q;I# MU?TKT0BNLLX%$7NM2GIDNCYGME;A-]W]ESA&TH<1R.19>S6?X? M4$L#!!0````(``]W#$=^A)MZ)P(``$H'```9````>&PO=V]R:W-H965T]_V>+R1V,3+^*FI*9?#6M;W8A;64PQ8`<:AI1\0#&VBO MGIP8[XA42WX&8N"4'(VI:T$$80HZTO1A69B]9UX6["+;IJ?//!"7KB/\WQ-M MV;@+43AMO#3G6NH-4!;@YCLV'>U%P_J`T],N?$3;"D$M,8K?#1W%;!YH^#UC MKWKQ\[@+H6:@+3U('4'4<*45;5N=I"K_=:'O-;5Q/I_2OYMV%?Z>"%JQ]D]S ME+6BA6%PI"=R:>4+&W]0UT.B`P^L%>8S.%R$9-UD"8..O-FQZPVQ,\2?#,"2F;Z^$4G*@K,Q$`/1;QMME9SK$)4<").F6A)F\U'O M7LL8Q@6XZB"GB6::)ZN)[BLJIW@/`0I@D2*:*.(Y163\*,;K`?$4@.'X;E57@?)T"P44,LZV/!>CY M.IP(Y9GO;WF+RC:?<,#LU!O(F?XB_-ST(M@SJ0Y0<]J=&)-4I<`'U5^M+K;; MHJ4GJ:>9FG-[U-N%9,-T<]VNS_(_4$L#!!0````(``]W#$>1IML#H@$````$ M```9````>&PO=V]R:W-H965T/!VG%%B-D-(*BY4B-(]Z=76E#K6KTG9M1`NT`2G!19=DT$91*W39@]Z;91 M!\N9A">-S$$(JC\VP-6TQCF>!\]L/U@_(&U#3KR."9"&*8DT]&M\EZ\VM4<$ MP`N#R2QJY+-OE7KSS;]NC3,?`3CLK%>@;CG"/7#NA9SQ_Z3Y9>F)RWI6_Q-V MZ])OJ8%[Q5]99P<7-L.H@YX>N'U6TU](6P@)=XJ;\$6[@[%*S!2,!'V/*Y-A MG>*?VRS1SA.*1"B^""%W]`DI'ZBE;:/5A,Q(_='E*X?67L,)(Q/$7$`3AG=^ M>FS+/&_(T0LE3+'`;"*F*+,3ACC]LR;%;%(N38ID4EP6*&>!:BE0)H'R>\J; M@)$Q9<2XBW?9I#IK4B63ZKO)$K.9,?5ED_JL29T$KG_92<14/RS(XGA'NH=' MJO=,&K15UEV4<*R]4A:<0G958S2XYWAJ./36ES>NUO&&QL:J<7YOIT???@)0 M2P,$%`````@`#W<,1SD'_L_;`@``\`T``!D```!X;"]W;W)K&ULE5?!2%F?9O*B#$#IXJ\I:+<.#UL?[*%*;@ZBXNI-' M49LO.]E47)MFLX_4L1%\VP95901Q/(TJ7M3A:M'V/36KA3SILJC%4Q.H4U7Q MYN^C*.5Y&;*PZ_A9[`_:=D2K172)VQ:5J%4AZZ`1NV7XP.[726PA+>)7(;R*M2A+F\DP_\&D_SEM8/^]R_ZU':Z1 M_\R56,OR=['5!Z,V#H.MV/%3J7_*\S>!8\ALPHTL5?L;;$Y*RZH+"8.*O[EG M4;?/L_LRBS','P`8`)<`EHX&)!B0O`N(G+)V7%^XYJM%(\^!.G+[;[-[`V]L M$I,Y4&TV,R35=C[8WM=5PO)%]&H3(09ZF$>'@6'$&A')!1(9`5X5T*E(^BH` M5"=0,R0@J_Y]DG3,_\KF<#MK^>$`016/R^9R3C(XHR'W[G,Y+U$942:/S> M9Q3S(X@!@<;O?D:Q/X(F%$OX"P`;J`!7A1]!C$+CKP'L8Q$8WN'\YH4!\UXI M11!%*?B-"9TQ"?4.!C;C3Q@3_,8$BC$1!(2U#'YG`LF9B$HIP_%;$TC61%1O MS,,\?F\"Q9L(FE/6B-^;0/$F@B:4=>3W)E!V9P3-"'43_-X$R@8-'W?HX1.F MW\`)Q<`(2M\7SJAW-C_RO?C!FWU1J^!9:G/,;\_D.RFU,#GB.Z/\8*Y?ET8I M=MJ^YN:]<1<2U]#RV-VO+I>\U3]02P,$%`````@`#W<,1Y\L,&Z5`@``J`D` M`!D```!X;"]W;W)K&ULC9;+DJ(P%(9?A>(!&A)N M:B%5*EHSBZGJZL7,.FH4JH$X2=2>MY_<0%H#NI'D^)W__+D0DEX)_60%QMSY MJJN&S=V"\]/,\]BNP#5B;^2$&_'/@=`:<=&E1X^=*$9[E517'O3]V*M1V;A9 MJF+O-$O)F5=E@]^IP\YUC>B_):[(=>X"MPU\E,>"RX"7I5Z7MR]KW+"2-`[% MA[F[`+,-@!)1Q.\27UFO[4CS6T(^9>?G?N[ZT@.N\(Y+"20>%[S"52651.6_ M1O164R;VVZWZ1@U7V-\BAE>D^E/N>2'<^JZSQP=TKO@'N?[`9@R1%-R1BJE? M9W=FG-1MBNO4Z$L_RT8]K_J?.#1I]@1H$F"7T-6Q)P0F(;@EC%<(34+X:H7( M)$2O5HA-0GR7X.G)4E.=(XZRE)*KPTY(;D`P$SB5(D+984I-S#)3P86,7K(` M)JEWD4*&@3UFJ9DX'$9RC8".\(0!JPOHVBI`E0Z'"ZPT$4)+(6B;1`X(\4T0Q, MXN=%8NM4Q*;("[LBL;I,C,#=DB:*:?3.T0R83(:9_)$9-#)IC40]@<5$3X4/ MXN]5^M!20T$2#3/Y(S/H9&IU,FV=)"-.-`2B$29_9`:=`-^Z.BHL7Q5_Q(J! M$C@"Y19HV`RPFS'G6!",F3&G%!CS8F?Z^VG3,B\<$@#:[4)C-QS9V@::Q,/, MZ@4F-PQ(1MZC=0?=OZU>[ZM28WI4%P#F[,BYX?H0[*+=)6.A[AAW\268K8`E MGH/96E\A;O)9>D)'_`O18]DP9TNX^!:J#]>!$(Z%7_]-K%HAKDU=I\('+IN) M:%-]D=`=3D[MO:B[G&7_`5!+`P04````"``/=PQ'9)"*4/H!``!\!@``&0`` M`'AL+W=OQ%% MSB^*MAUY$9Z\,(;%GP.A?-C[H3\57MMSHTP!%#FX^:J6D4ZVO/,$J??^<[@K M,Z.P@I\M&>1L[AGV(^=O9O&]VON!02"4G)1)P'JXDI)0:H+TQK_'S'];&N-\ M/J5_M=UJ^B.6I.3T5UNI1L,&OE>1&E^H>N7#-S*V$)O`$Z?2/KW312K.)HOO M,?SNQK:SX^#>Q)-MV0!'`[P9PFC3@$8#NC,`1V;[^H(5+G+!!T_VV!QVN--R M84)TLB=MFFY)VN*SJ5X+A.(<7$W0J($SS<%IX+JB'!7H)@$:8)$"3A1H3@&M M/XP^$8"F@&@>@&Q`$GQDC*VD\R4+#(EC@EN,"6?9DK^ERE= M9$K=R6WL='"2K2.[5ZPR9(L,F6/(-ABRAPSW"L<`9A=%C\_D!Q;GMI/>D2M] MY]@+HN9<$9T0/.F\1G\*;@M*:F6FJ9X+=SNZA>+]=-??/CC%7U!+`P04```` M"``/=PQ'MUI\,Y$"``!]"0``&0```'AL+W=OS$S\;!>=R631KA5;MID`AD35\1T M8]#U.>>>JRLDY6?&W\2!4AE\U%4CIN%!RN,DBL3F0&LB'MF1-NJ?'>,UD6K( M]Y$XZ)OS/C%;L/`UA>`F\ ME/N#U(&HR*.6MRUKVHB2-0&GNVGX!"=KB#3$('Z6]"PZ[X$V_\K8FQY\WTY# MH#W0BFZDEB#J\4[GM*JTDLK\VXE>86D:7]D$7L2L%?^+R;:'4_T=J)I/']IP31V3ATF`VD*`.@'+H<"UPX($@"ZP%[OJ==[:E1&R>=$ MN)-H;B$90.GH'T==X,H"'V`VQN-!EC*OI,$8)'M1\ M&/L]N8UC2/NA_X.&__%%0_\G#=&`)>!`MT:CSLY?4[XWI[H(-NS42+L'M='V MYO`4ZY/C)CZ#DP7TQ)=PLK+W@JM\D1_)GOX@?%\V(GAE4IU7YG#9,2:I<@L> MU>YQ4'>A=E#1G=2O6+US>SNP`\F.E\M.>^,J_@)02P,$%`````@`#W<,1Y&? MIJXO`@``(@@``!D```!X;"]W;W)K&ULC9;?CJ,@ M%,9?Q?@`152T;:S)=#:;W8M-)G.Q>TTKK6907*!U]NT7$%V[(96;\L?O?+]# M/8#%P/B'J`F1P6=+.W$(:RG[/0#B7),6BPWK2:>>7!AOL51#?@6BYP17)JBE M((ZB#+2XZ<*R,'-OO"S83=*F(V\\$+>VQ?S/D5`V'$(83A/OS;66>@*4!9CC MJJ8EG6A8%W!R.80O<'^$N988Q<^&#&+1#W3R)\8^].![=0@CG0.AY"RU!5;- MG;P22K63(O^VIO^8.G#9G]R_FN6J]$]8D%=&?S65K%6V41A4Y()O5+ZSX1NQ M:T#:\,RH,+_!^28D:Z>0,&CQY]@VG6F'\R]PY(3MK M`)]`)DV\#H&1DV*FM47R!#.+//XQ"-TL:91)D')W9S[$Y#'B4,$V=Y MP,2_/J![L\'4HT(F$?(H9.C>;A!Y%,DLVGEPW%L.9CY58D691\G#W,W)?:K$ MBC+X'P7\D/S*]-)X(3D^HF,4#)1>INKOI\ MO,+&@63]="//GP7E7U!+`P04````"``/=PQ'R,4))1$#``!O#@``&0```'AL M+W=OP.2`.$,]DQL3Z<] M=":30WLFMFPS`>0B.4[_OI(0Q$[6]N820'Z[;W?U=B,51]F]J)T0.GAKZE9- MPYW6^_LH4JN=:$IU)_>B-;]L9->4VGQVVTCM.U&NG5%31S2.LZ@IJS:<%6[M ML9L5\J#KJA6/7:`.35-V_^:BEL=I2,)AX:G:[K1=B&9%--JMJT:TJI)MT(G- M-'P@]TL66XA#_*[$49V\!S;X9RE?[,?/]32,;0RB%BMM793F\2H6HJZM)\/\ MUSM]Y[2&I^^#]^\N71/^F6CC,%B+37FH]9,\_A`^A]0Z7,E: MN;_!ZJ"T;`:3,&C*M_Y9M>YY['_)N#>##:@WH*/!R`,;,&_`L`:)-TC>#1)7 MFCX55XAEJY-_#..C&>`^6\F1HHM_A@5U]G+*-%]&H=>0P] MP(=).=1I@[3]GGT&,+X),TS1,52D"GU3.D5IA[S+ M#)%1-F24<(+)B(-,W#,A=B\'=R_'[]X$C&""R-5C8A;'F**2&&1RRU;P_)R* MGU)Y$**@A,`L0W=_8$G..M>W-T?4G5"8AR+$Z$%8-1(&4S'$'GD0G>2$H;C@ M9B9#-^<(%RDH29+B-4G@!B28#O0@FL5(6<(M2/AM6"P0S%SP(O0,4'@S4#P:>(EP04'.4X#5'X8:F%)&Q M!_$T25)4QG!'4X88A0/H,F3Y"7(Y$+C=:7);7FO>OO0_V'EOOA>C?>,6?_`5!+ M`P04````"``/=PQ'`87(IM4"``"'#```&0```'AL+W=OE;5>Q`=CCO=)HC<'60E]IXZR MMI_L5%,)8Q^;?:*/C13;MJ@J$X)0GE2BJ./EO!U[:I9S=3)E44_0/I?TQ6.[WOV;ZU=V_Z+ MT'*ERM_%UAQLMRB.MG(G3J5Y5N?O$CQDCG"C2MW^CS8G;535E\11)=Z[:U&W MUW/W"4=0YB\@4$"&`DPG"U(H2(<"DDX64"B@'Q22SDH[$6MAQ'+>J'.DC\)M M#WQOX8TCL:CELE0)!?)TA[`CHF2(&`77:9M9BZ\]%A,*48V;_K2M2K1#LE M2JX39%ZO6;C7W-M!#NN*)[QVF"S-**+7=9A7AX$.F=!A,!MI3MEU'>[5X:"3 M7NJPL0X'/R&S-O.JS$#EPTX?8U8])F`?8^15:8?=ZO(`"NS='QB';Q!,_%V0 M@#CTH!RABSQ\0JX!&9X<[`\I3F%^\ZFV.A#+$:$H9!;],<44M-C$>@^@$)W, MKY,!Q>QK3X\`PCB;!4Z@/_D8HL\G5FL%((Q9SO(T#1#SQQ]#_CD.H.#^K(A;`+&/ M.LGH!'@4>_E3-/NBUM&+,O8PV9[\=DH9:4G0G?T^.-A?!<-#*7?&W3)[WW3G MY.[!J&-_[!]^>RS_`5!+`P04````"``/=PQ'0A2$_O$"``"I#```&0```'AL M+W=O"X>$Q5GV;^H@A(X^VJ93 MR_B@]?$A2=3F(-I*W&EWA^T74A6B^2R;UNWHE.U[*)> M[);Q(WU80VXE@^)G+4_UHI\22;7_56'TRU)(ZV8E>=&OTBS]^$[X%;PXUL MU/`:;4Y*RW;<$D=M]>&.=3<)1\TG:O2:2C)2TH*^CF)H23F>KV>QXSD-"DM M&"$!+7$4Q'U+<`/D-'=9F:<\^QR4H:#,@](;(*>Y8X23_'-.CG)RSV$W.$YS M1PF%@'X*E%-X#K_!<1J:`N1D,N'_DDJ45'I2=H/D-!0H+0@+(%&"HH9ER\IO ML+R(EZ8I7@:P*)I&ZC-?%@$6@)<+>"#+6;E.1.[SD%KQX-,4SZ/]U9V0?/;O M60`(SSUE>!ZO0,RWQ'D`"0\^Y7@@KTA\)`4$DN+)IQD>R2M2YH>7ATP/SS[- M\5!>D7+?4QD0?HJGGQ9X**](Q4@*B22>?EKBD9Q_QTL/"N@("!I'&*,?D!*@ M:*E`\?%/16LO8B&W+,!C#X`/?\X!SPFX!P.>>DCQT<\YJ><$?,3`\-$S;Y$& M6.!I!HZ//I]^2[R(T3(@S("'&3)\]K,[A!/7H&3R M%'JL]N)'U>_K3D6O4IL'VN'IE%L;%_+C%T<'\;[A<-&*G[6ENSGOW).TN MM#R.?PPN_TY6?P%02P,$%`````@`#W<,1W6E?$NA`@``TPH``!D```!X;"]W M;W)K&ULE9;?DIHP%,9?A>$!%A*"_P:94;'37G1F M9R_:ZZA1F`5B2=3MVS<)";)KB/1&R/%WOGSG&.$D-]J\LYP0[GU491$$;)^3"K,7>B:U^.9(FPISL6Q.`3LW!!]44E4&,`PG086+VD\3%7MMTH1> M>%G4Y+7QV*6JFOP&(+ M8HDHXE=!;JQW[TGS.TK?Y>+'8>F'T@,IR9Y+"2PN5[(A92F5Q,Y_M.A]3YG8 MOS?JWU2YPOX.,[*AY>_BP'/A-O2]`SGB2\G?Z.T[T34HAWM:,O7I[2^,T\JD M^%Z%/]IK4:OKK?UF%NHT>P+4";!+Z/:Q)T0Z(;HG(&<"T@EH[`ZQ3HB_[!"T MM:O.99CC-&GHS6-G+,\36`B\D2)"V6-*332-J>!*1J\I"E$27*609F"/6;?, MQ(%D+0(Z(A`&K"Z@;]L!JG0XO,&F)2:QP\-3D>V#R*#-R-B,^LV*=+-&""`C M@/H"2`E$:(1`;!6(M8/)YRK[S-HPTV%F8YC9,),99C[,;#4#PN<%3:P%3;0` MF4$C7_;S9"`E@?`0",?P8` M:'A0RL8H;2U06U;0>V-7I#FI68EY>WJI>?L.ZJ+=/+:"\HW_);X& MBPVPQ#,YOZD)X2Z?)F=\(C]QO;F:M=<'HV(V0WQZ;_`%!+`P04````"``/=PQ';DJ17X4"``!S"0`` M&0```'AL+W=O_9WX1VW%'VG>:8\RL MSZJLZ=;.&6LVCD-/.:X0?2$-KOF;"VDKQ/BTO3JT:3$ZRZ2J=(#KADZ%BMI. M8AE[;9.8W%A9U/BUM>BMJE#[>X]+TFUMS^X#;\4U9R+@)+$SY)V+"M>T(+75 MXLO6WGF;@P<%(HD?!>[HZ-D2Q1\)>1>3;^>M[8H:<(E/3$@@/GS@%)>E4.(K M_]*B]S5%XOBY5_\BV^7E'Q'%*2E_%F>6\VI=VSKC"[J5[(UT7['N(1"")U)2 M^6N=;I21JD^QK0I]JK&HY=BI-RM7IYD3@$X`0\*PCCD!Z@1X3_!G$WR=X"]= M(=`)P<,*CNI=.I,:$_C60*\0;"X048JP"V:04@TV=J2!41!C,U/!4Y_",R62;LRX1C MLZ`V"SX7\'L!?RS@*YM<]^\B(\G4R@O%^#Z<9E+%0!!.,YEBHK4WS1P4$ZX7 M-!08&PJT(_YS@=!H:;C&ULA9/+3L,P$$5_Q?('X-1-H51I)`I"L$"JNH"UVTP:"SL3;+L5%72`VUE5@3`^6:/LQ6FS14Q()W":V=S$GPOD?\#,%KL:9)L``* M#BX0A!_.\`A*!9!O_-4S?UL&X70^T)_C;KW[O;#PB.I#%J[R9A-*"BC%2;D= MMB_0;V$1@`=4-G[)X60=ZD%"B1:7;I1U'-MN99GTLNL"W@OX*+B-OKL^T>63 M<"+/#+;$-B)#"Q$>8-VIA\"-ESGO*[C)T#J*_ADYI-5\/GR5C# M//]J$SXTF4^;\`B8+?C_@/D`2*>`>>]R^3\@O0I(>\#]'P";G%DCCO`FS%'6 MENS1^=./9U4B.O",Y&9!2>7?^!@H*%V8WOFYZ:Z]"QPVPR,>_Z3\!U!+`P04 M````"``/=PQ'+N`V)N0!``#U!0``&0```'AL+W=O,R..IB`6F+'[]@N( MKMV0Z(W`\3N_[SLQ4HQ6,"P?^$!Z_:;A@F&E MC^(*Y"`(KFT3HP!%4088[OJP+&SM590%ORG:]>15!/+&&!9_*D+Y>`IA.!?> MNFNK3`&4!5CZZHZ17G:\#P1I3N$3/%80&8E5_.K(*%?[P(0_<_YN#C_J4QB9 M#(22BS((K)<[>2:4&I)V_G#0?YZF<;V?Z2]V7!W_C"5YYO1W5ZM6IXW"H"8- MOE'UQL?OQ,V0&N"%4VF?P>4F%6=S2Q@P_#FM76_7<7ISB%R;OP&Y!K0TY#;W MY&-3?L,*EX7@8R`';+X=/&JU,`P-#J2%Z8#2%I],]5XF<52`NP$Y#5IIJDF# M5AJ@^5X3-)O$:Q/D3.`V()X!J07T$R">$D0P^QHS7XFJ293N2)G,)LDZ9>)2 MHFU`ZATS=8!X&Y!Y$V0.D'R=T^@Y>#I0TRFQSO1?3K30=%!_F2W:YZ?NBD@Z`(``%L+```9````>&PO=V]R:W-H965T>)<>1]%7LJE?U+J/`\"N3OQ(I4S<>9E?><@JB)5 M]65U#.2YXNG>!!5Y@`!@09%FI;]:F+67:K40%Y5G)7^I/'DIBK3ZL^:YN"Y] MZ#<+/[+C2>F%8+4(VKA]5O!29J+T*GY8^L]POH58(X;XF?&K[)Q[NOA7(=[T MQ;?]T@>Z!I[SG=(2:7UXYQN>YUJISOS;B=YRZL#N>:/^Q=BMRW]-)=^(_%>V M5Z>Z6N![>WY(+[GZ(:Y?N?-`M>!.Y-+\>KN+5*)H0GRO2#_L,2O-\6KO1,"% M]0<@%X#:@#9/?P!V`?@60$8#B`L@4S-0%T`_90BL=].Y)%7I:E&)JR?/J7Z> MX+S&*RU2*WO2J-5-DV;Q6:^^KPB.%\&[%G(,ZC!KRS`RC"06@2T1U`7T5H'\ MO@S(A*/A!!M+,#I2PT.1[3\B@V7BIDS<;1:VS2+@L0!I!$A7@!B!*+RO,31( M:5MAD2?*"!VF-I:B#*)HF$J<5APR,$QM'84HP]%C8[37&'6=@?=Y:+=FRSPQ M0.B$/*PW#W-YT$@'V:0..HI@/-*;A$WJ(/NO#H:]SU;HG.''`E%O:R(G0(:W M8&T9"!"(":31R&99,HQ('-(Q,&DD85S73N-A4@QB*(X(3W`H3]N6#_@WVW>PZ:LGT.C4D8(@)' M_I5)*_IX`QTZ?0+G-E/[\'XSJR%GL`,L&%LXS`P"]$PE=S$X#"UO5%X MPB<"XGYSS4MXQP\E!",7KBL&L M;O2IGG3;BYP?E#X-]0[8V<]>*'%N1MEVGE[]!5!+`P04````"``/=PQ':24M MG4T"``#7!P``&0```'AL+W=O/UPTE)TTJ"P\! M$'HER2LW373MM4D3=A5%7M'7QN'7LB3-WPTM6+MRH=L5WO)+)E3!2Q.OYYWR MDE8\9Y73T//*7A1*`DB;Q]T M2XM"*R;40;ZS]3NT> M`B5X9`775^=XY8*5'<5U2O)I[GFE[ZUYLP"6-DY`EH!Z0M]GG.!;@G\CX*<$ M;`EX;H?`$H*[#I[9NTYN1P1)DX:U#J^)^I[@4L(;)2*5':[59&A<%]>J^I%B M'"?>AQ*R`;`PFQ(\A.P.!/<*3!D9=('>L`])T]+C!UB#"X(F'29']?R(/ M;?J=37\8EF_""L"T`.X$\%``6P'XU62@,97)PF!0&$<8!?YCX&XN<&^!,(1Q MY$?3WH-1[X'UCJ8%PM'TPOGI1:,.HAGI&0ST$8I`C)ZD-Q>X-\`(1'XX9^^+ M4>L+:]V?%HA'PXOGAP?!J`5=GHK/@J`?X4A^+T_RFXW<=T@Y!8R.67[14'/0CU&*F0S=\Q"L+H;H_TL3_\!4$L# M!!0````(``]W#$=Y!6&PO=V]R:W-H965T6Q/9.`.^VA,YD![?'FE=\`=VHDWW MS9ZU=2&ZQ_;@\5-+BYTRJBL/^W[DU479N.NE6GMNUTMV%E79T.?6X>>Z+MH_ M3[1BEY6+W'[AI3P:4:K2BIUGG^#Z*=/:3B^[]6_JG2[\%\+ M3C-6_2IWXMA%Z[O.CNZ+V.4;A1Q"*;AE%5>?SO;,!:M[$]>IBP]]+1MU MO>AO$A_,S`88#/!@,/@Q&P1@$'P:$*L!`0,RUT,(!N&-!T_GKBJ7%Z)8+UMV M2I%.V>%*K2L:5XN/SRDTYA0JA=B_=A*.<](( MBA">AC*`4&B!<@WA)$VFH0THQ0&YGU-DS"G2.1%+3AH)?5M*$?2+)2&-I+Z% MV8`K/*/M8F,Z,<01W1=(C(V?S&_\U!A!:FS\JX)J!/DV*$NAZK&EI"`4VUIR MTWLC^'Y*R#?FI);O=#XP$;&U20^%%J4<((0"6UI`I?Z!%<3NV>2:28#!B46*`<(WYYRK@8V0$%RVX3>Z/A7T_:@#M[/6!X?;]:?T")#AO5RH8[KTQTAU9U MPMPS)F@7K__0U??8O:X,#Q7="WD;R\+K`[Q^$.S4OX\,+T7KOU!+`P04```` M"``/=PQ'XW%QE0U^I1:[UC6B?W>X(MW&!G9?>"LO M!9<%)TV<@7>-O07K/7`E1"%^E;ACHV=+FC\0\BXG/TX;VY4> M<(6/7$H@,7S@#%>55!*=_QC16T])'#_WZM_4(H32CI+-8BN9_`6L"I%!'*%E-J M(C2FBEM9_4C]($J<#RED,'"$V6E,Z,]#<@T!`\(1!B9=0'NJ`U1T.-\@TX@P M>.#AJ;M6\'H[M5.:.CK\;THBX=9AW)M>'Z8QZJP\6V MA?+HO*OOP#H#$_5<7H3JJ+W)ITF++O@GHI>R8=:!<'%@J]/U3`C'PJ_[(@(N MQ%4]3"I\YO)Q)9/7EY>><-+V=_'PAR#]!U!+`P04````"``/=PQ'QBQ);74U M``#QY0``%````'AL+W-H87)E9%-T&UL[7WK;MS(E?#O]%,4!EZ, M#%#M9M_;20:097NBQ!>M96>P"/8'Q:Z6&+/)#B^2%>Q;3/!][^,GVW.I*A;) M(KNE<8)-(F#&DKKK>NK4N9]3O\GS0GS9QDG^V^^NBV+W_-FS/+R6VR`?ICN9 MP#>;--L&!?R973W+=YD,UOFUE,4V?C8>C>;/MD&4?"?*)/I+*4_3,BE^^]UT M/O[NA]_DT0^_*7YXF8;E5B:%")*U>)4447$GSA(>,TH3<2SRZR"3^6^>%3_\ MYAGVX7YS\39-BNL<^JSENOGM[\MD*"8C3XQ'_JSYY4EY-12CB?O+?>OYT\EE M7F1!6/QW9\^/=SO9_-(?'?]G:QW0>DT]7L?!5?/;31#GK6'4@C[(JPA7`5W? M!=MVJS]QWE(30\EUF4KL5K^+AU-/\YWM?[OV20N?N:EFH".%WQ,BA:6]0'//C5 MKURG>%IF67.^KJ&.C_WQ\<3O@,SK*):9.(5^5VG6`LN[-#D.PE!"&VBQYM9= M,$ZW6T"@BR(-/WOB@K!:O"^+O`!4BY(6`IRFX@CR',9^WO@[R MZQ;RAB%>YEQD,I3137`92T\DLFBV.TMN8.0TBV3N_/X\D[L@6@OY98>;S>G> MI<4U`#VLK:J]H8V$[]/`195)"(W%$2Y#^..GS6YTPZ_3>"VS_'O"HN*N?:=2N!A9$<$.!-P! MM+ MA0LOMY>`;?K2_QH!)464YWB^=,TJXG/@&!X`,M_)L(AN9-RBAHK"=6YB-OH6 MN_!'8\\?3[S%?$%-_)'OS<>^-YDM/3WLWW&3)^MUA)(`H`X2KF,@NF&PBP"5 M'%>IW)8Q4>VUW$1AU(&"N0-A]B(KK?V0GH?QD:/S`._(M2PBX)A/@:\\$<\Z M9*_#1NR6E'IQW^"+`$K,"[A7_Q9B/:0WX\]#>J9]#-V^'@?MT^YPP,8!_[W=S24.;@42P M)3FR)7%%<8FDX>^RAK4:?.\J#J%7J-6`YIW>'DZOJJL4H'30(8?#SG'';<'A MSV6NI,DB1;TI!4$26$FB.N"G^'N("].;3P^9\J7.D^(A.1C0"K2H+8X/??L6`J1 M`?@:<"J3T`MALPDBS4-AOKWW]?0Z`.$];T"5]"T"6I]RY5!W>S3=/4JNI>/> M3[?=JS:Y<'$O.KDVDN]#N9,0A,T\TH>].UQQ;JTI17V061CFA$\E&`"\GP^GN%EJ2E4;)/=U1 M1*-;V.A.T,,/30-$A^XSAC.XB4".$I=W8N.`5PMTM);\VU,BN0Z+#]%+ MT*`N)0@M"0X-2P,D1FHO4Y3\4+*<_$[4+L`"KDGSI)P*)(`A#YN8=^-TS3;>2`/9E?P M[6U4L`05`:&HC:8&.4(P??WY+3;/OO[MZ=#5Z#;("9QY"1+C#1Y$").D647^ M+V4(JWGX7DX`5*@$EW'!9Q?!C(#).2)3FGB]G8GDHZ$$-?`(+4V9/"8`9)8( M!Y!&*"'QPKUK7RM.$R1W0W$A MI2#[S<0#=B\%0]P3[S<;%L=Q1I;@/DA6X3]6`,@)1)I^02NX0$QFX%AQ=:&1 M/T);_E"WDE1^)8G`- M&S]_!QM:"]`*RAVW>LIH!Z>Q!IB'A<)"]8<;3]G=J&^W"B"8`=4)6L/H%'2[,FL?MW0K9[ MO*'XE,2T%$2)VXCD#U3QX%0]E*/$&B`(&KV21Q78.O'#A0@"Y5EJKJ3/H?A) MTH>!B&5`9Z`T+Q0<2%M+R@U@9)GAU=J(ZQ(^$9>T&6!*:?Y9QK+`*T)#W8*V M(C:P/EP7GQ&NY4-ZF18(5ASR=S2$K2:_"2Z1M)"\6%"'3PFHQOH@#,RKK2VSN(8I<,<@ M2H)0"JKDU1TB4!1&*+3#UPE2DYL(((27^AI'+L0.9$,TRAB`[0`$:OD,;1FO M*P#5ITQ%4%Z13L#?POI`+2^N/>1<949\EX"=LE1)DZQE'ET!'53GP;8X"6AP M"UHRRADB0Z@"1@$F??VY/:\'2$B[O0:E1P2[78S(1.0,`'4M@[BX#F$K>`'7 MH#9D@"O`1G`%0+\]31#S$FZ^TMH!7]Z7F3V+R.]R0"[&+(3[;@(UQK0Y<8N5T%4 M@/8ZO(+[#U.EGR5N/=]%"?7(\";\N/H, M*,"`"I+/L>3YB:;19ZC[J+TJ^(K;%.#(TQNY"(2J=/<,[(KPSZJ$N**$N[Q]-@QM MKPWKJ.9-(]`1E> MU[O3X:0E0C4K@%/EPVJM0%W@-\4<:";@#7"R):JF6E/6C#'3IM4KTA49P%=X MU1(V55F:34T@4[S8&+9R<;&3)%18IGBT].L[C!U>2EROMH&A`0'$U*&E%;T) M0.`!^`5U'0#Y701(C1:6K,,8;.F:T(:E9BT0`S75ZA@"+5C?!(1F!J9WBJ=M MMZA,`XVM+$FL?U0-Z>1PE`9AU0(C8+1DQ@K`*ME)8RV_LH&@U4T1R41>D9F: M5>D-F04;5F<8!(4!_&?'E_AC):[#?.K8T;"7K1MSDH\:1]93YGF*!CNM%()0 M$\2EV7$(&(+6Z%S"^@F@=$L!Y"POX#R([%ET2091:ZJ8J!S!N.U_9,4%)JBY M016\UD08VIVP_1.Q]+W9W+>WC+(#*?G.$>'3)\*?>^.9+\8SSU^-Q-*;SL?P M[WPT`Y**VE&YP_U:K#*/OAQOT2(Z(FQ25GGQ1PN5@=?C".BQE[$,,.0?=+=2,]%5>T&0M M2\JWGZ''V#%&?O3-YX-SS=2EN902K68"OR"Y*%2&4X57-EX'U<`[,W#.>G:F MKW^:D\0<`K8J*R2,I=FQ+E>@QHK_-'Q'TBB0J)QAV%;+%>UG/3# M@1L('TG9*I,`:&3!^O>AFKBU^QT:;#->+&XQ6Y,>P`S9VC(;'-%[=L6.+R2< M(=('H_HU2/31UY\_#2^&XL>3D_.O?V.U?%=F:.`S2G)6:G]<)J_P+FHS!WYY M84@"G^`7/ATB]%%.4A/,[A40D%E3A&`Z#`0%SVGH$NP%)G);/< M8\W(&]ET@12"52,^V"`GV4>S]%]ZH<59@A8-H/DX,S"7%!0:D@'O:5%#ZTY, M-BZ`9F!YW8XJV0F8=(S2\*8F\#'RXI?`CDA2KGH_!0X$HFF.U!6@H"X4^:#B MNX919Y(E2%=UH2[H@\<<2/E`[@@THC5)/*->,ROH"Z[',UZ3L M(T[IY49T&9.X#\O,:#*22O50F*;4.CRNWHOCA+[&94)7[393Q$L+ M2QR8E74;'H$$Q3%O,M1]]%@DREK&6(M&R#@"Y2(HM.-8KQ6)VN`32P\UGJ>H MD"5JRH.VB(V0&J+$W*!8ZL[F%C(CPFR#SP!E,S?)Y'E>;MG!I$Q?RE:*/("N MD5P;BR+*.TY?)4OAAFBP%TD%*A:=?7@6HD1JVS4J6!E070O1[D:M)7'D[KHT M%C?N1"R2T'>(Q,#&`$]912N`*+3QB#!J',;C9"WBN9Z4Y.NK)&)'Q+KA`37+ MYB\PO()W9PG!ZF&!18T,AW'1.09>JC9DT*B#".V)[P( MOIA6.$]-C%?>0V5`85^@L=U5H:3(;TDWU!O4G+Y\4"5VIAK/FP&'HK3W@-3BF>N;4Z. M`X)EXY%JT"!3H(T0T]<$H6(]:B=["2C;T%,Z'44NH5.,6B=>6=:[[:W0V2%7 MEFXTQ%+%*Z#-)T=K(5G%V8*OS$\*V(H;5JN(TS"P)7ND^4QP MR)23EDQ5;],,3_TLN4EI./+A7)&@B7B8)JR[!WSIT4.ES$D$/#4;P0A]'?+6 M>3*TLI3,2IHN$9ZPG9A4>1/>0VWYY-G^X*'PEDBX48R=Q$'573$60&2Z1@=4 M=@O+K.-:E,,4X(ZQ'HJW.+RZ63D%(&J@*&!48,?`5-R3:LU@1Y>&+(I8*1"X M1PFW6UD2PCME]B:KH^G%7CH;_1!Q,[8HX8):HUS+-9D.@ZM,6B(Q35_F9`G" MC4-W=&"Q\'Q4``ZC9[I,K;<&]1DQGT&M4OA"%2%M@0KGR`70NR'3E7D=B M`JN8"7\LQ@M)[*!F#L"W4)!!EK)BS1`=Q/OTMGBTXZ$S*.O/Y]@9"S#I!MZG`M10G&'GLIT"%,EO`TLX/O\Q(= M.EI+T3&)I(N5240BJC*M@W!-&3SPZ^XZ`#$LI(_1`2]"XA!:;`=4P%`)6.(I M.LV`AC*RD1].\2<-B=H.`_'U9]"LXEC'('W]&RX>3>P)[_E#&6,ZV>7Q6`]D M;'N@'@S-<-^#2$59K=J:0N-;81%OR3W/`N]EL+BB[;^Z+J;=:KCP? M>,?"FX_&WG2T%#-OO!S!MTOX%O,+YZ.16"Q6W@(^F0^7P'Z44]PYM6?%';`< M3A$'.="-XA@8;R7V*8179GYDUQ0>$E0H8JZ&=I@3+^)CT6&0;VMAD)WAYR1> M]UTN]O,>P[F@:FM?-K3]T^J!#B.FJL_)&6"X2WUQQ-"LT]/I8!N=V*ACH6%` MQ]!TMK=I/3#E.N5P,^5[T!O?!G].,U15FFA=HRL6I:/01A2!@/EFRL2=QE)% M,0)BJ2MN%D8;5;:_:"TK^PC?4GUE6"YA)0@0VPH(\%,=53P!3!9-J M<36)#Q5]C$`A%X0-BB.V#1`TU,CJQJ"U9ZOB7U$W+AG[JHQ8I-_`J?B.52L@ MS=B:F^_KT>53XZG)I.WO04Z6@K@4:.4%EB>W"6':T!;:$"285X<2C3JP.DE3 M9,OR@*D@WLRKW-[6Q5;M[0!WAI86FE$B@WU(#&K3=Z&%SRXC#>S`@0>&D M(O$H>T2YO2(2)]9HP:*0H92-6FQ9HTVB5A:0O1#WN55T`.U,.^6?24"92]/U M;83W@\@3$EG6;VF)=)AZP^2XV$0QLWI-MR]>G=*U!+E#)HWPUWH0!RR?>[/` M#7]C$DG8Y>6QP7,I4>FS(5Z9PCD825JLY("1:]RE-;HMZ*&@C.9Y4L]8`"\P MQH/]0@':18\WJ,>9"\>4]D*)&T"Q\?8I\D.I=`EYC]B,>YJRON^OEG.6\K8T MU1!:%%E*@2;8*J%(U.J>7G!6&$H'.!G]=:+L5&=M/V,="VPTNBHC:N<9,Q?B MK`V?[VV`'E5![D\;[+?),VO,E3BG=@%8C+8^1(4NN=E?*P?.JQV^`1)ZI,F+ M13%=2MF*,BO'O3HBHI;:()EWA"F7S4AHY7O0GJFP.A0U'ET7?S@;3Y;P8SY> MC>#':C9=ZA\?I$K8P6,$07,B7F31^DIINW!N[X!^D=B*7Q)]#_""@PAO&VCO MI4XWDAB4/H;HZ^C$YBZRH)$XB@E+*7.N)R""8$&#Y81_H3_&GJIU`#N$?]BB M<:Z&/3?#&ET)#;4<`1/?6:9`I[2D&!E:RR2LV0$!K^9K(\X4V(.Y=EA9&;[^ M?'[^'J5`8]>."@K-!>![LZ6U+;2_C/$7BNH#F6O,7X)Z-M&`F.&O"!F`#T!E M-A$3;P)X<&9@:(5)*%?>K4H(-3%`>-C'E/R)>]UE@!66TF*9L#G^TX@O-H-N M1.2K^:(-C0&?C:?:Y%2%QF\XHK9^#`"=&GR)/T.OJBY$QPK2.MLFE?0FB-DU MK3TMQC.`')&94C/N#\6"NG/,<%B6(&[)\%))ME6\%BIQXA65BD".42V"X"YT;@PLZ)B^532+DC9KBDE81=G0W9]XH\F(_R5\ MIYM`EX/N-FZ-RGRI6!V5)]B@:-/ZA>6X?K8^D8:K!@K,0";A$!>-&S"F270B M"Z0+H$R2YQ]H5HE2@.G"=BRXY3T+)&O8>2,JJ:>]U]+>QF-O,9M1/!Y1"`)) MQW'V#DR"2Z4G!)4*H8X>_D]JZHL-#T\CQ4\U[^L)84`%-(PCO&%H!Z8H&^5H MFU!F`IO*5VYA-`V$)\9(90M`91EAVB<`#E M#F$'6#WEJD66MOZ^5Q>O-DJAT$S::KK?VNS>)32UD-"PH8M.21RMBNA<\(US MH5H%D`..,C.LI0;A/K"S$`)D=!,U\:HB60ST6KH)?K,-OD3;:M!M M(,;JD<_S'5#?WWY':FEV([_[83H4[3$S-`H M5<:O3I*O$ZI17H6V,(0IV.:O=MX8!6R@.2&4)KRG%C`:U&WBN/&M=?7,3LF6 M0,J+N(S(+!+EE1TAR%O1/1@5EJ>=$W@J]B@.M)1N7$15O!^?P+JCP@+FM&`: M9D$0Y(H6W*/9T(`CQU1KAH,V>.@EF&6W"C6HU`GW(G(32Z-HQ295V6K/!\83 M:KO4!^1HQQL_.&UA(I?B43@%$@N(X$^`W,T&9E$N=#!+`7(Q13/K9+RH>B@4 M9+LE$"X.J50]J#R;\+WE8E8MQZR@MG'39^G-0`!?`,%>#-X@`NN$`(HC0U/^ M%&2LL7@JCB;`5^"70X>NU0>$G0-;6HU)$04$I@K/#GR-_(;K*,;[IKE+H:')?8CRC"]P:Q5$+\A=@ MYD40JYSR2YG(C49-?5=,&"'EM'=1]8A2; M;7DI'#X]!'3#64%"'3*"#R#J@3P!4F*5QBTV0:@RG3]><]XZYQ'4Q"L3Y<=Z MT!C%/#$55H4D.-M3Y3]X@]/GXG594(#J94SYNBB^&7F%`N(9:P)=L3$`/]9`#50 M.2HJYJ`US'*&`2>KN1JE3?PF`DLRTL_!&XQ/I;H&^GN`4JW*#=(LI'$^4BV@ M]SUUK%JG=)^V/5$!BV$_+KRW5>`5':[?A^AVZ2(7-I/Q2`;KOY1!5FCQO"J0 M0)9_A=?D;'<@/N,[#T[@I61$BL*"'NQ5Q_NHHYXIR)N^H8"9A=W?J$_VCEB@ M3:127EC#Q`Q4W`!9#M0-T?C1W'(ENB/&^B.K;`B`%$>7^Y9%2?`(MF M-)\M#/U;C$>US$9EVLDI@9L/D9=CDHNT`H;!%RAV)C)K5(+2Z>(ZR)R(!L98 M31HT[P,VUO3<9<)JP"17F8;+.?[G+^`R+EJUO$]K/B.V,+`R?`'$A@IH/*#+ M?>G[_=119\L87.YY4JMA9:LYR:JVL\O M",#SQ`2DZ=FL920W%K*751PZ%_50YKIZ^LSW>1W2W`8-I](DAC?L?5W&LBHK MP294E0Y6)2[##8?-\L5=++SI9"'F(V\Z6Q(DD,JB6:8$C920E;S0Q\CN](J, M38R.MI=Z39\/7J(#'O_&V`J`[L4#9/%>#$Q&LY7`+WI;,#N/MXP M7`^VWE<)&=!F,7BE\YR(PA_!,I$HYD_A$&8S,85_!G],T:E"G&(!4LULP&\1 M1*&>SU_BI'/UN5'4M^D:1$M_I')0&_ME_R5CD&7ZO;^9D3R2:#PK.+X9]?Z& M`EX#-Z=!4%:+S&KJ=5#52C0(KW/X[PQUSZ,O[!G12JXC))>T94LJTZ6@C<7[ M(T);?3K`-RO:(>'H'T/+]'_Q>>BNC9D&YPT[OMEG981_PI<)N-]TZ2W@-SA= M;[7T\<(-E$'8=!MCR)#=;5)]-*BY.!;>;$I!1B@K\@3F(Q3P5)#+LUHG';N$ M@T^6@(T91NGICQ7/]8&0KF;>$MI52\8/IPO/AP_[BF>>VL4ST=['HL\)&68? MW/&^%-,?#<7A@Y]5H86JZAYE+CC*>'79OBD8J^D*J%MBV3S>M+52FAUBJ16Z M;9NVG6;K?>93*W301)'5YNW<"%IOR8:N7?VI]O=A]:1H&V'5F`P]:N0;I8)J M$5U\T-.B+\CK,T*J@*/[V'13*[U!55(5-S'%4BU'J0DWI.(JNI)E9GO9T%T< MQ?*J-396E`F8*Z`QCK>9ABH%@>/M$VG"[]$"HHIBL>6LB/(-,T>2`3CMADM= MPL%BY@GE>M.&J[)3;#)-=(J'*I)A.=GWQ_ MAMV3A]BX;7W"5^6?1//XANS`)'L>@0' MLI.'$N72O%X7X%(G056R2GWE?>\QJ-)*\@H9U<$\]?3@T'FHY,`VE8X-%\M?`F M,[0IX"`@I.@V`/J-I#"`H^D(.-%"-UF8)E74X1$LQA_S*/YP,6TLOL[2@?^, MQPMO1-;2T7`U%XOA:K:BWO.1F`_'$S+(3F<^2-^$(AI$BJP9X'EB M-ID!&9^*\73BS:<+=]X3YP25B>7QJ-6E)C.N1?Y*"F`Q!$"C-VNC,V\"H)H, M1RM.,I?9,0=2U$M6RP#=.59_ZKZ6R$0H+4#%+NLT;:8$)HI+O`!9Z//Q10@\ M3VJ7*%$`;,#B:-6XNL%6WOGSP<>>;*L++?HUOZG,NJ(R\#9%]O]O_NN4W0'= M883A9(J18*@(@;`#G_GZLP5^.^^1VBE[#%1__8L_JHGO$P$CS.?5+]:#*SW% MQ^US3ANW%3Z2AC*R&IL<5Y^H;)9:J-&^:O2$CE;-+EN2?LCQ"/?Y.)YYH!)- M))S.2*JENSZ>^8.N]QX`P$LQAD.:C\5J-.A^[D'X`'`?5*H)*(J3V7@`=WU* M=W:,-&1!#I7YJFV;/.-'`\B&W_?=O254'YVZ5O^/Y.DCY0S4HWUO/YW:"?OW M:MQ7MWH\%/U]ZW^=[`>]40P4UB->FH2A&WS M).=GL9G8;!*8-;VZ89SFE%Y^::?8U`K75=F]M?`74A%VEF!DPQ>_L^KT72E# M"KJH/,TNHNTE'I+J?[=#]Z(.\0SH'F*%9JNVG:FVR"DAM`TU)'G+R)UU5RMP M3Y[[=C$ZS,G0`UC[HU(DJN*"_`*$*L?;JJ14C*8)"@;[QSHJJ=IVNF8W-KP3 M/M$"`<2#TJM?IRE+!"^S$@0NBR!@HE>,Q4U1VJA;.%4%5*Z86R]<7%5=8HHE M.XIJD2WC%!W\XDS,_-'1YZ?(_X''B7-5LM,(CMW^31UY]?OSSA'"I.K&4-U*Y_&-2J3M;K$!%256NN(*%>$J*5 MO0?=@.Q'OKTXF)?KG>?7.JE$%8/3>FXM",(U"8<6JXRCDBM;8*VQ*E0+;2XA MGAK5V=BP/DTY##U[HL*:E=*H#YRWI#(X>KJS3(2)\#J]X%)2T#0?^)D.63.% M=SC$3&,;05PA18(8)JDPAHH'T^8RA!X.P#(=;>L6`X!1(JWW)J'@DNX/;=S, M-*2<`S78][D>SM,#<J?J@ZA MZM["I(U+2^D9NG(+U]X_'1IZ9=D?IV9>KI64-&`=\X[T;[FG4/ M77-*:2E4O)$CEA0(JB."O2FKAI:R4@Q@T6D_^GSJ)82P5Y6$@/#<--KCQLE1 M14RK*DY:!Y.J&*.JWV#1S4C79U#10(Q/09[KX'E&4T.<`&@W7$C.S.W5BK-K M(ZPJC:W=X``O@+ZC/&#NUA%/%$M%/G9@I^*A\([Q.N, MD;=A.$$BX8O8B`8X)IH4D&<33ZB"[-8RY)K+W>BB"*8.;:MCLKX)&'#V6EM< M=(06E8VL<%D1@JKZ%$5HH3>[6B9"ETOCJ3K[>/SFE&T\X',C$-*>3!86!;/Q MKD#0V9BA&PWMW=-E52&5-K-C/*K`P99*S$:+8V6X5P5E&#H8AL@TPB)$F0H/ MU9G^U526G*:*%F+<&J:&4[T/4$HXB*55#0#?<%%2[=$;>F;+Y#W=H^F]9>D) MX%;/<$Z#D>0<*A/#CX]Z&9[(KXNQD6SO`V+?4FE]AQ7T$=S/!ZW7U0;\G-H3 M<33SYM,9F4UF<\\?+_$SS#$>T6='8_A^LA1/!]4;7YQ.P6E5^Y^JPM@.Y4W# M.(_C@7Y&K3;WT=2;3-24KME?ZH(ON)O6JVK:9=AZ[+'SL;<#CT.!"5W"H]74 M\V$3BZ4W72V\&?R*S[.NIK#RV4HLQMY\N?1&BPEOD)+/E(JPJ7PFQV+ES59H MJYE4P*BWK1M=CL4$OQ8P/Q3##IP+ZEU_M46/061H]%PA.:S MT7`QQC]\/`+X.8$#&NB'W^QN&GRZ(_Z<\4^[[[X;8VJR]8:"ZX)G3?L#$*FP MK!+%[".MKY<>#D(^C1&RP&52<:O+B5K.R!MMI",_<[(VEBQEFC7UP+[E/7V_ M)TG2-E<>VW\L\&R]^6P\^,E5T:`YAG:Y'=M_@$PVF\Z]T7(VT,]Q=N1Q@;ZP M6DR]\0PQU_H#1/6Y#W=VT@[QO)#\_,C+JN[K`4WN3;*G^.A1>QB7ULBL6.'@ ME7JER'X3YD)'H".%4$^N#MTMN&!"0:7#.'#:K@](KAE+-;^1W<7E33RI4IW;RBZSV9:.;HEU>NLE1A*A])KIUW#6*:K)]*82B.Y,Q5U/ZV#N4WA77O*5];HM3@#K MYO$=B$I$D*@1V[$P5IT*O&(BM"%O^&`&70RJ'03X6.B%,S#0::EG-Z%\02WL MG:QFI+/4(,<\4]4CHDYE$OVE-`)B'3"F`+1.O"2BK(N"\)2\"E7="L?W5!J[ MSK90K17QUQ!=5_>]JL9JN^H:(1OV[54X,S"W^"5;'U00;1]5IQ@-G7""L=2C M.8=R8Q8!QE3[F*30R*683\=BM1@)))+C@?V8,46R8H#N`GO/1N-]DT^MR=$; MAD9F3UB)@\@GN'4O6C+WE:MF$P'Q*@\PQ36`UVC/_M`Y]C@,&R6A!ZQC/5JWY M5P"`)=:^`_8T;<[MT]R3)_FOJT]>5JRCD%Z'`L\146 M3[R-UFL@'J\"--.'PGX?&=A,=W$FKO)#3Y1_/9A'W?/SZK\/BL MPC_KLPKMP(Y?\LK"MQWM\'RSX?'-!OGX9L/CFPU=;S:X8C-; M3S@\7__\8AVR:VCCSATV[1X$0(5+9GQFDH[ M+Y68Y&GG4^ZUJWAYBGNHC]&L)]#D?-BE>ZQO].]>W^@@E-Q?%^EAZ/6O6*3H M((!NNFKS-*OR'`3FQZH\W[@JST%GJ*K'O%7[J,9C6.L$SX-.\!=5C^FLPW'( M+BKSG0E,,PKS04O_9RX=T0>8JJ*#2I`]"!J/I1C^;Y1BZ,9]RR],^@.'NJ'Q M\O!3?DR!_K=.@>[E"AAZ3`>%MSU.YI[=:_ M8B'O[P;1?^K4WKZ4@4,D@WM%I;P?1,!TOP_&CW]6Q8H==#J/4;J/4;H'1.GV(:$5P7M?[/M7"]9]7WLL M]J4L@BC.D9M^NG@ICIX@.D48*@MJ(C`VQR,8X5!K.:TG-$XQ*D*SR2I\K258 M*E9+F!+?$=,LV2F`<17_B/!B:]_&YORGMZ3#.2J6U`ZYM6G=_SV^_1#PG1!X@,=2'.D.[U`* M0%GF:0U9YRWR.JSTY6,EM;86@KRQPT=<>].8XCNK5Y^;7L-51.\"HV MJGLGIXW'(]LW"33^96L'5:'GCM5?U(3_SE:\9/5@]N&KOL#0#X!,]Z68CX>K M-N!UO^-Q=\_5;#AM;UCU?-'9[T$7KO<=SLY[6#'+9UI5!+A]XHJ8_1S4[^4F M[](;^:'QQ%SGD51# M-R-$-O5RJQ0(>UFT;GFMI'?[VUU4,<$H;4%SPK:P%A=J/9W8M?YS\^0'1Q%V M^7(U&?HF*-GS:"IU[7L[\-OCZVMY.12CN1OI?A\``_*G[B]M7&Y]V;-)QM5H M#ZZJQTP)FQR#\T-=U*J#Y`5%$837;+^F[%E76^N5R0-:U^X@R*H1UV]IO[10 MJS/<1NSS:A3R15L7196-;L1,56]TMH:RG\KL0O.9^YXX^X)$U/?.9RO6 M>(:R\][!S`F'&YVWL8L_$-:[O'8G57$!)/EV.PT4@-9]HWWRN>M(%,15Z MV?6U(TKN`;:!^ABU3??JLX>%?36[N:*V'CAT+8*K0F_T MWM[>O9%\7;V=46GW1H$#8\G:_+H12M;!ADU$68LHNTKGFA"S5FL*-G/X.YF& MM^686F19![UNZN+,#AJOXVD>>OB5ND3_H8Y$Z[U%E:QJ>:W:2J'*#+%]07?N ML?80MOVQ=VWKK!5=UTD'3!BCL,,868?L9,9]07SW/DE+JUL[L!.?GL,`UE_] M"N/PW(*!>6:N`TOV/3;W?`^2F-#`+AA7C\4=\%!<6XNHWH/KF*#W-;7]4F05 MG-BO+[9AGW4+F*>Z7"@;GOI(E7YX24DX9TXECK6,CUK+.#E$RSBD#R@P>Y6* M"D`U'W,5IOE)>3G^J.,ENYG!%/[>.R%JNY5RWD+;*I[)ROH`+ONA*D<`6WV7 M)J8^@5PY_^04M_%6;I`TQ$@U6R& M@:TMKE4+CFI=:M9Z*Z.ZOP2*<]>"?A4UU>*43O="+0"VO4R_;=I\&WSI!0'& MZ[8Z30]<_L+IB<&0W&Z;<@WMS:?O*[FBCN[=F&N(@K[R*29[7UWWBS(J0+'+ M&MBV]W1%Y>ZYWTZT:(;H=ML&W3&WO?;XP\)F]UKQ^OAG.XX4&06Y5BG3"F-T MVH([4V+,U"/?#J71XW/OZK%ZY9NE`?3`S3$^]3XD<[_6GJZLR56V3)V&#@NO M\-5[?6/G%3BM&9KYU;4=&AG<2(M!KE7%B8Y[UU(?*C-!R^+![R:X-'?U.(OJ MH#7]?202*.D#C";GQD5&TGCSC;06T1DYJ9MC+1?V(W2_;(V^VV/;))`/''SD M/CK'Z-]P2_>X]_OBXOLUSNI9-*>>>6_+OPJ8=[ZJN"?^?2]-ZFI@`MN[&IBP M]OX5U0*?7/?[T"#V#A[4%;3>8C0ZOE0'O=13"_8VKQ(9[(0%.R&AQ>XU11P9 MN6#DE@M4PZ5I-W>VFZMV8]UN/'&V,YD653X%RZR_Y$+<*ZC?NAZMQ5D%DBA" MB?R/]2+15O1Q9TAUAS#J:972(;E-V_$G+LO@>E82\X=3MJ# M8#Z!Z\-%Z\.Y,XJH$HH[][Z8[.WH7O!BZNHX=Q/OI?OC!R)99S>5Y?`0@4R_ M*JDK1(LN+X$GZCD7'RH!B74*3BKO#T$Q:1%O35I$IV9EIT6\M-(B.GUM5H+$ M23U!HJM+[?VQ/NZE88D/>-"3)"$7ZN!GMK'.P/%J/)Y,%N/19+Z<31>+V7@U M;TEZ)I>@]JPAUM92%NE.%;%6=(F&R?G10_Z>`LE+.;W M-Q';SEC]=Y8 MKX1U+G[L['I17AZKLNF20D_[(=";P&-3CA5B2 M3=LJ1+MI?6QET8A_7!9-6^J#SLXEN[-F#FA:2YIQH4-_]HNK1T>^RX-QK2/9 MY9``@HZN6"R82[=2.:C3^E,UKX(,9=#^^> MSBR6@]-5'L+\>P?LA:+S;8EN]SX[BW4^S(,!X$Z5>,C.320!8=2K+R"JHG'D MU%3KPBM/;JPW5/SNA.N+]D:9U%(HNO;8G3S1[O$LSXL?_A=02P$"%`,4```` M"``/=PQ'%T<6;O(!``"V(```$P``````````````@`$`````6T-O;G1E;G1? M5'EP97-=+GAM;%!+`0(4`Q0````(``]W#$=(=07NQ0```"L"```+```````` M``````"``2,"``!?&UL4$L!`A0#%`````@`#W<,1U&9?VL_`0`` M:0,``!$``````````````(`!C@@``&1O8U!R;W!S+V-O&UL4$L!`A0# M%`````@`#W<,1YE&PO7 M0X=:;@0``#01```/``````````````"``;02``!X;"]W;W)K8F]O:RYX;6Q0 M2P$"%`,4````"``/=PQ'-@&AGT("``"/!P``&```````````````@`%/%P`` M>&PO=V]R:W-H965T&UL4$L!`A0#%`````@`#W<,1V_SXX>J M`P``71$``!@``````````````(`!QQD``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`#W<,1T.VI,O(`P``V1$``!@````````` M`````(`!`24``'AL+W=OWNC(IH0$``+$#```8``````````````"``?\H``!X;"]W;W)K&PO=V]R:W-H965T&UL4$L!`A0# M%`````@`#W<,1\[LS="A`0``L0,``!@``````````````(`!JRP``'AL+W=O M&PO=V]R:W-H965T7I@XD MH`$``+$#```9``````````````"``3`R``!X;"]W;W)K&UL4$L!`A0#%`````@`#W<,1Y?[H>ZB`0``L0,``!D````````````` M`(`!!S0``'AL+W=O&PO=V]R:W-H965T M4H0$``+$#```9```` M``````````"``;@W``!X;"]W;W)K&UL4$L!`A0# M%`````@`#W<,1P?^NN2C`0``L0,``!D``````````````(`!D#D``'AL+W=O M&PO=V]R:W-H965T&UL4$L!`A0#%`````@`#W<,1T+# MI(NB`0``L0,``!D``````````````(`!&3\``'AL+W=O&PO=V]R:W-H965T8]]YSVP$``$4%```9``````````````"``&UL4$L!`A0#%`````@`#W<,1P9BWX:B`0``L0,``!D` M`````````````(`!VT0``'AL+W=O&PO M=V]R:W-H965T&UL4$L!`A0#%`````@`#W<,1VN9X82D`0``L0,``!D``````````````(`! M;4H``'AL+W=O/8;(!```6!```&0``````````````@`%(3```>&PO=V]R:W-H965T&UL4$L!`A0#%``` M``@`#W<,1P:.I=:S`0``%@0``!D``````````````(`!)U```'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`#W<,1[:)*;%L M`@``5`D``!D``````````````(`!8U8``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`#W<,1V^=)#"6`P``UA(``!D````` M`````````(`!:EX``'AL+W=O&UL M4$L!`A0#%`````@`#W<,1WZ$FWHG`@``2@<``!D``````````````(`!7&<` M`'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@` M#W<,1Y\L,&Z5`@``J`D``!D``````````````(`!I6X``'AL+W=O&PO=V]R:W-H965TW6GPSD0(``'T)```9``````````````"``:)S``!X;"]W M;W)K&UL4$L!`A0#%`````@`#W<,1Y&?IJXO`@`` M(@@``!D``````````````(`!:G8``'AL+W=O```>&PO=V]R:W-H965T&UL4$L!`A0#%`````@`#W<,1T(4A/[Q`@``J0P``!D````````` M`````(`!)'\``'AL+W=O&PO=V]R:W-H M965T&UL4$L! M`A0#%`````@`#W<,1XRL:7.'`0``50,``!D``````````````(`!X(<``'AL M+W=OB0``>&PO=V]R:W-H965T?NBD@Z`(``%L+```9``````````````"` M`;F+``!X;"]W;W)K&UL4$L!`A0#%`````@`#W<, M1VDE+9U-`@``UP<``!D``````````````(`!V(X``'AL+W=O05G,QL#```@#0``&0`````` M````````@`%&PO=V]R:W-H965T&UL4$L!`A0#%`````@`#W<,1\8L26UU-0``\>4` M`!0``````````````(`!19<``'AL+W-H87)E9%-T&UL4$L%!@`` 0```^`#X`Y!```.S,```````` ` end XML 15 R46.htm IDEA: XBRL DOCUMENT v3.2.0.727
Stock-based Compensation Plans and Awards (Schedule of Fair Value Calculation Assumptions) (Details)
 3 Months Ended 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Assumptions used for calculation of fair value per share        
Dividend yield        
Risk-free interest rate, minimum 1.44% 1.90% 1.41% 1.74%
Risk-free interest rate, maximum 2.34% 2.61% 2.34% 2.67%
Volatility   66.00%   66.00%
Volatility, minimum 73.00%   73.00%  
Volatility, maximum 74.00%   74.00%  
Minimum [Member]        
Assumptions used for calculation of fair value per share        
Expected term 6 years 6 years 6 years 6 years
Maximum [Member]        
Assumptions used for calculation of fair value per share        
Expected term 10 years 8 years 10 years 10 years
XML 16 R33.htm IDEA: XBRL DOCUMENT v3.2.0.727
The Merger, Offering and Other Related Transactions (Private Placement Offering and Offer to Amend and Exercise, Narrative) (Details) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 6 Months Ended
Feb. 06, 2014
Jan. 14, 2014
Nov. 30, 2013
Jun. 30, 2015
Jun. 30, 2014
Nov. 30, 2014
Oct. 31, 2014
Private Placement Offering [Line items]              
Number of Units issued 9,720,000 20,580,000   30,300,000      
Price per Unit $ 1.00 $ 1.00   $ 1.00      
Shares attached to each Unit 1 1   1      
Warrants attached to each Unit 1 1   1      
Repayment of senior note       $ 22 $ 2,544    
Conversion price       $ 1.00      
Payment of debt conversion and private placement commission       $ 3,030      
Number of shares called by warrants       36,055,000     30,300,000
Bridge Warrants [Member]              
Private Placement Offering [Line items]              
Exercise price     $ 1.00 $ 1.00      
Expiration period     3 years 3 years      
PPO Warrants [Member]              
Private Placement Offering [Line items]              
Exercise price       $ 2.00   $ 2.00  
Expiration period       5 years      
Number of shares called by warrants           22,755,500  
PPO Warrants [Member] | Offer to Amend and Exercise [Member]              
Private Placement Offering [Line items]              
Exercise price           $ 1.00  
Bridge Agent Warrants [Member]              
Private Placement Offering [Line items]              
Exercise price       $ 1.00      
Number of shares called by warrants       3,030,000      
PPO Agent Warrants [Member]              
Private Placement Offering [Line items]              
Expiration period       5 years      
2013 Bridge Notes [Member]              
Private Placement Offering [Line items]              
Gross proceeds       $ 25,300      
Debt and accrued interest     $ 83 5,083      
Repayment of senior note       2,553      
Payment of offering costs       $ 3,338      
Number of shares called by warrants     5,000,000        
XML 17 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 18 R25.htm IDEA: XBRL DOCUMENT v3.2.0.727
Warrants (Tables)
 6 Months Ended
Jun. 30, 2015
Warrants [Abstract]  
Schedule of assumption used in valuation
Dividend yield    
–     
Risk-free interest rate     0.69% - 1.45%  
Share price at final valuation     1.47  
Expected term (in years)     2.55- 4.55  
Volatility       70-75%  
Periodic rate       0.18% - 0.66%  
Periods in the model       10  
Schedule of warrants activity
Balance   Exercise     Term           Balance
  
Name December 31, 2014   Price     (Years)     Exercised     June 30, 2015  
Placement agent warrants 3,030,000     $ 1.00       5       (48,700 )     2,981,300  
Bridge warrants     2,600,000     $ 1.00       3               2,600,000  
PPO warrants     7,544,500     $ 2.00       5               7,544,500  
Pre-Merger/PPO warrants     621,361     $ 1.38       various               621,361  
Total     13,795,861                       (48,700 )     13,747,161  
XML 19 R50.htm IDEA: XBRL DOCUMENT v3.2.0.727
Net Income (Loss) Per Share (Schedule of Basic and Diluted Net Income (Loss) Per Share) (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Numerator:        
Net income (loss) $ (5,645) $ 56,128 $ (9,760) $ (25,638)
Adjustment for change in fair value of warrant liability   (60,458)    
Diluted $ (5,645) $ (4,330) $ (9,760) $ (25,638)
Denominator: Weighted-average common shares outstanding used in computing basic and diluted net income (loss) per share        
Basic 102,094,158 78,497,558 101,944,359 72,688,073
Dilutive effect of warrants   9,593,643    
Dilutive effect of stock options   6,681,210    
Diluted 102,094,158 94,772,411 101,944,359 72,688,073
Net income (loss) per share, basic $ (0.06) $ 0.72 $ (0.10) $ (0.35)
Net loss per share, diluted $ (0.06) $ (0.05) $ (0.10) $ (0.35)
XML 20 R42.htm IDEA: XBRL DOCUMENT v3.2.0.727
Warrants (Schedule of Assumption Used in Valuation) (Details) - Jun. 30, 2014 - Warrants [Member]
item
$ / shares
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]  
Dividend yield  
Share price at final valuation $ 1.47
Periods in the model | item 10
Minimum [Member]  
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]  
Risk-free interest rate 0.69%
Expected term 2 years 6 months 18 days
Volatility 70.00%
Periodic rate 0.18%
Maximum [Member]  
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]  
Risk-free interest rate 1.45%
Expected term 4 years 6 months 18 days
Volatility 75.00%
Periodic rate 0.66%
XML 21 R37.htm IDEA: XBRL DOCUMENT v3.2.0.727
Notes Payable (Narrative) (Details) - Jun. 30, 2015 - Other Notes Payable [Member] - USD ($)
$ in Thousands
Total
Debt Instrument [Line Items]  
Principal outstanding $ 200
Stated interest rate 7.00%
Minimum monthly payments $ 4
XML 22 R52.htm IDEA: XBRL DOCUMENT v3.2.0.727
Segment Disclosures (Schedule of Segment Reporting Information) (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Segment Reporting Information [Line Items]        
Revenue $ 2,114 $ 1,197 $ 3,803 $ 2,259
Cost of revenue 1,612 1,152 2,898 1,734
Gross profit 502 45 905 525
Engineering Services [Member]        
Segment Reporting Information [Line Items]        
Revenue 1,066 507 1,770 1,042
Cost of revenue 642 650 1,130 902
Gross profit 424 (143) 640 140
Medical Devices [Member]        
Segment Reporting Information [Line Items]        
Revenue 1,048 690 2,033 1,217
Cost of revenue 970 502 1,768 832
Gross profit $ 78 $ 188 $ 265 $ 385
XML 23 R47.htm IDEA: XBRL DOCUMENT v3.2.0.727
Stock-based Compensation Plans and Awards (Schedule of Stock-based Compensation Expense) (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Stock-based compensation expense $ 443 $ 326 $ 791 $ 693
Sales and Marketing [Member]        
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Stock-based compensation expense 161 150 292 251
Research and Development [Member]        
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Stock-based compensation expense 108 21 162 90
General and Administrative [Member]        
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Stock-based compensation expense $ 174 $ 155 $ 337 $ 352
XML 24 R9.htm IDEA: XBRL DOCUMENT v3.2.0.727
Deferred Revenues
 6 Months Ended
Jun. 30, 2015
Deferred Revenues [Abstract]  
Deferred Revenues

4. Deferred Revenues

 

In connection with our medical device sales and research services, we often receive cash payments before our earnings process is complete. In these instances, we record the payments as customer deposits until a device is shipped to the customer, or as customer advances in the case of research services until the earnings process is achieved.

 

Revenue from our Ekso medical device sales is deferred and recognized over the maintenance period. Accordingly, at the time of shipment to the customer the amount billed is recorded as deferred revenue. Also, at the time of shipment, the related inventory is reclassified to deferred cost of revenue where it is amortized to cost of revenue over the same period as the related revenue.

 

Deferred revenues and deferred cost of revenues consist of the following:

 

June 30,     December 31,       
2015     2014        
Customer deposits and advances $ 353     $ 105  
Deferred Ekso medical device revenues   6,048       5,327  
Deferred service and leasing revenues     2,123       1,875  
Customer advances and deferred revenues     8,524       7,307  
Less current portion     (4,032 )     (3,412 )
Customer advances and deferred revenues, non-current   $ 4,492     $ 3,895  
Deferred Ekso medical device costs   $ 4,391     $ 3,568  
Less current portion     (1,876 )     (1,551 )
Deferred cost of revenue, non-current   $ 2,515     $ 2,017  
XML 25 R43.htm IDEA: XBRL DOCUMENT v3.2.0.727
Warrants (Schedule of Warrants Outstanding) (Details) - $ / shares
 1 Months Ended 6 Months Ended
Nov. 30, 2013
Jun. 30, 2015
Nov. 30, 2014
Class of Warrant or Right [Line Items]      
Balance   13,795,861  
Exercised   (48,700)  
Balance   13,747,161  
Placement agent warrants [Member]      
Class of Warrant or Right [Line Items]      
Balance   3,030,000  
Exercise price   $ 1.00  
Warrant term   5 years  
Exercised   (48,700)  
Balance   2,981,300  
Bridge warrants [Member]      
Class of Warrant or Right [Line Items]      
Balance   2,600,000  
Exercise price $ 1.00 $ 1.00  
Warrant term 3 years 3 years  
Balance   2,600,000  
PPO Warrants [Member]      
Class of Warrant or Right [Line Items]      
Balance   7,544,500  
Exercise price   $ 2.00 $ 2.00
Warrant term   5 years  
Balance   7,544,500  
Pre-Merger/PPO warrants [Member]      
Class of Warrant or Right [Line Items]      
Balance   621,361  
Exercise price   $ 1.38  
Balance   621,361  
XML 26 R29.htm IDEA: XBRL DOCUMENT v3.2.0.727
Organization (Details) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Dec. 31, 2014
Dec. 31, 2013
Organization [Abstract]        
Accumulated deficit $ 81,561   $ 71,801  
Cash 16,251 $ 10,965 $ 25,190 $ 805
Cash used in operations 8,462 $ 8,605    
Average monthly net use of cash $ 1,500      
XML 27 R28.htm IDEA: XBRL DOCUMENT v3.2.0.727
Segment Disclosures (Tables)
 6 Months Ended
Jun. 30, 2015
Segment Disclosures [Abstract]  
Schedule of Segment Reporting Information
Engineering   Medical           
Services   Devices     Total  
Three months ended June 30, 2015                      
Revenue   $ 1,066     $ 1,048     $ 2,114  
Cost of revenue     642       970       1,612  
Gross profit   $ 424     $  78     $ 502  
             
Three months ended June 30, 2014            
Revenue    $ 507 $ 690 $ 1,197  
Cost of revenue      650 502 1,152  
Gross profit (loss)   $ (143 ) $ 188 $ 45  
             
Six months ended June 30, 2015                    
Revenue $ 1,770     $ 2,033     $ 3,803  
Cost of revenue     1,130       1,768       2,898  
Gross profit   $ 640     $ 265     $ 905  
                         
Six months ended June 30, 2014                        
Revenue   $ 1,042     $ 1,217     $ 2,259  
Cost of revenue     902       832       1,734  
Gross profit   $ 140     $ 385     $ 525  
Schedule of Geographic Information
 

Three Months Ended

June 30,

  

Six Months Ended

June 30,

  
  2015
     2014
   2015     2014  
                         
North America   $ 1,622     $ 941   $ 2,894     $ 1,831  
Europe, Middle East, Asia   492       256     909       428  
    $ 2,114    

$

 1,197     $ 3,803     $ 2,259  
XML 28 R44.htm IDEA: XBRL DOCUMENT v3.2.0.727
Stock-based Compensation Plans and Awards (Narrative) (Details) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 10, 2015
Jun. 30, 2015
Jan. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of equity incentive shares authorized   14,410,000  
Stock options [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Options exercised on a cashless basis   535,404  
Shares withheld to cover amount of cashless exercise   243,647  
Unrecognized compensation cost   $ 5,386  
Unrecognized compensation cost, period for recognition   3 years 1 month 2 days  
Equity Incentive Plan 2014 [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of equity incentive shares authorized   26,000,000 14,410,000
Conversion of prior plan shares   7,602,408  
Vesting period   4 years  
Additional shares authorized for grant 11,590,000    
Total shares available   11,767,633  
Minimum [Member] | Equity Incentive Plan 2014 [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Percentage of fair market value   100.00%  
Minimum [Member] | Stockholders [Member] | Equity Incentive Plan 2014 [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Percentage of fair market value   110.00%  
Maximum [Member] | Equity Incentive Plan 2014 [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expiration period   10 years  
Maximum [Member] | Stockholders [Member] | Equity Incentive Plan 2014 [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expiration period   5 years  
XML 29 R30.htm IDEA: XBRL DOCUMENT v3.2.0.727
Basis of Presentation and Summary of Significant Accounting Policies and Estimates (Details) - Customer [Member]
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Dec. 31, 2014
Customer One [Member] | Accounts receivable [Member]          
Concentration Risk [Line Items]          
Concentration percentage     26.00%   22.00%
Customer One [Member] | Net sales [Member]          
Concentration Risk [Line Items]          
Concentration percentage 32.00% 15.00% 27.00% 17.00%  
Customer Two [Member] | Accounts receivable [Member]          
Concentration Risk [Line Items]          
Concentration percentage     10.00%   11.00%
Customer Two [Member] | Net sales [Member]          
Concentration Risk [Line Items]          
Concentration percentage   12.00% 11.00%    
XML 30 R31.htm IDEA: XBRL DOCUMENT v3.2.0.727
The Merger, Offering and Other Related Transactions (Merger, Narrative) (Details) - 6 months ended Jun. 30, 2015 - shares
Total
The Merger, Offering and Other Related Transactions [Abstract]  
Common stock issued for acquisition 5,280,368
Previously held common stock issued for acquisition 4,500,600
Number of newly issued common stock issued for acquisition 779,768
Equity interest percentage 6.80%
Common stock [Member]  
Business Acquisition [Line Items]  
Shares issued in business acquisition 42,615,556
Conversion ratio 152.38%
Warrants [Member]  
Business Acquisition [Line Items]  
Shares issued in business acquisition 621,361
Stock options [Member]  
Business Acquisition [Line Items]  
Shares issued in business acquisition 7,602,408
Shares converted in business acquisition 4,989,111
Series A [Member]  
Business Acquisition [Line Items]  
Conversion ratio 162.90%
Series A-2 [Member]  
Business Acquisition [Line Items]  
Conversion ratio 195.48%
Series B [Member]  
Business Acquisition [Line Items]  
Conversion ratio 195.48%
XML 31 R8.htm IDEA: XBRL DOCUMENT v3.2.0.727
The Merger, Offering and Other Related Transactions
 6 Months Ended
Jun. 30, 2015
The Merger, Offering and Other Related Transactions [Abstract]  
The Merger, Offering and Other Related Transactions

3. The Merger, Offering and Other Related Transactions

 

Holdings was incorporated in the State of Nevada on January 30, 2012, as a distributor of medical supplies and equipment to municipalities, hospitals, pharmacies, care centers, and clinics in Chile. At the time of the Merger, Holdings was a “shell company” as defined in Rule 12b-2 of the Exchange Act. Holdings' fiscal year end was previously March 31 but was changed to December 31 in connection with the Merger.

 

On January 15, 2014, Holdings and a newly formed wholly-owned subsidiary of Holdings, Ekso Acquisition Corp, (“Acquisition Sub”) entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”) with Ekso Bionics. Under the Merger Agreement, Acquisition Sub merged with and into Ekso Bionics, with Ekso Bionics remaining as the surviving corporation and with the stockholders of Ekso Bionics exchanging all of their common stock, convertible preferred stock (“preferred stock”) and warrants to purchase preferred stock issued and outstanding immediately prior to the closing of the Merger into an aggregate of 42,615,556 shares of Holdings' common stock and warrants to purchase 621,361 shares of common stock. In addition, options to purchase 4,989,111 shares of common stock of Ekso Bionics were converted into options to purchase 7,602,408 shares of common stock of Holdings. These shares are in addition to 5,280,368 outstanding shares of Holdings common stock held by certain pre-Merger stockholders of Holdings, consisting of 4,500,600 shares held by such stockholders prior to the Merger and an additional 779,768 shares issued to such stockholders pursuant to a provision in the Merger Agreement requiring us to issue a number of shares of common stock such that the aggregate ownership of the pre-Merger stockholders (not including any shares of common stock purchased by them in the private placement offering described below) was approximately 6.8% of the outstanding common stock of the Company following the Merger and private placement offering.


Upon the closing of the Merger, under the terms of a split-off agreement and a general release agreement, Holdings transferred all of its pre-Merger operating assets and liabilities to a newly formed wholly-owned special-purpose subsidiary (“Split-Off Subsidiary”), and transferred all of the outstanding shares of capital stock of Split-Off Subsidiary to two individuals who were the pre-Merger majority stockholders of Holdings and Holdings' former officers and sole director (the “Split-Off”), in consideration of and in exchange for (a) the surrender and cancellation of all shares of Holdings' common stock held by such individuals (which were cancelled and resumed the status of authorized but unissued shares of our common stock) and (b) certain representations, covenants and indemnities.

 

Accounting for Reverse Merger

 

Ekso Bionics, as the accounting acquirer, recorded the Merger as the issuance of stock for the net monetary assets of Holdings accompanied by a recapitalization. This accounting was identical to that resulting from a reverse merger, except that no goodwill or intangible assets were recorded. In filings with the SEC subsequent to the Merger, including this filing, the historical financial statements of Holdings before the Merger have been replaced with the historical financial statements of Ekso Bionics before the Merger. The Merger is intended to be treated as a tax-free exchange under Section 368(a) of the Internal Revenue Code of 1986, as amended.

 

Retroactive Conversion of all Share and Per Share Amounts

 

In accordance with reverse merger accounting guidance, amounts for Ekso Bionics' historical (pre-merger) common stock, preferred stock and warrants and options to purchase common stock, including share and per share amounts, have been retroactively adjusted using their respective exchange ratios in these financial statements unless otherwise disclosed. The conversion ratios were 1.5238, 1.6290, 1.9548 and 1.9548 for one with respect to shares of Ekso Bionic's common stock, Series A preferred stock, Series A-2 preferred stock and Series B preferred stock, respectively.

 

Repayment of 2013 Bridge Note

 

In November 2013, in anticipation of the Merger and related private placement offering, Ekso Bionics completed a private placement to accredited investors of $5,000 of its senior subordinated secured convertible notes (“2013 Bridge Notes”). Upon the closing of the Merger and the private placement offering described below, the $5,000 in outstanding principal and $83 of accrued interest of the 2013 Bridge Notes automatically converted into 5,000,000 Units (as defined below), and investors in the 2013 Bridge Notes received warrants to purchase 2,500,000 shares of common stock at an exercise price of $1.00 per share for a term of three years (“Bridge Warrants”). The Bridge Warrants had weighted average anti-dilution protection, subject to customary exceptions.

 

Private Placement Offering

 

Concurrently with the closing of the Merger and in contemplation of the Merger, the Company held a closing of a private placement offering (“PPO”) in which it sold 20,580,000 units (“Units”) at a purchase price of $1.00 per Unit, with each Unit consisting of one share of common stock plus a warrant to purchase an additional share of common stock of the Company at $2.00 per share with a five year term (“PPO Warrants”). Included in the initial Unit sales were 5,000,000 Units that were issued upon conversion of the 2013 Bridge Notes mentioned above. Between January 29, 2014 and February 6, 2014, the Company issued an additional 9,720,000 Units in subsequent closings of the PPO. As a result of issuing a total of 30,300,000 Units, (a) the Company received gross proceeds of $25,300, (b) $5,083 of debt and accrued interest attributable to the 2013 Bridge Notes was settled with the issuance of 5,000,000 Units, (c) $2,553 of our Senior Note Payable (as defined below) was paid in full, and (d) we incurred offering costs of $3,338.


Investors in the Units have weighted average anti-dilution protection with respect to the shares of common stock included in the Units if within 24 months after the final closing of the PPO the Company issues additional shares of common stock or common stock equivalents (subject to customary exceptions, including but not limited to issuances of awards under the Company's 2014 Equity Incentive Plan) for consideration per share less than $1.00. The PPO warrants also had weighted average anti-dilution protection, subject to customary exceptions.

 

In connection with the conversion of the 2013 Bridge Notes and the PPO, the placement agent for the PPO and its sub-agents were paid an aggregate commission of $3,030 and were issued warrants to purchase an aggregate of 3,030,000 shares of common stock with a term of five years and an exercise price of $1.00 per share (“Agent Warrants”). The Agent Warrants had weighted average anti-dilution protection, subject to customary exceptions.

 

Offer to Amend and Exercise

 

In November 2014, the Company consummated an offer to amend and exercise its PPO Warrants at a temporarily reduced exercise price (“Offer to Amend and Exercise”). Pursuant to the Offer to Amend and Exercise, an aggregate of 22,755,500 PPO Warrants were exercised by their holders and were also amended to reduce the exercise price from $2.00 to $1.00 per share of common stock, and to restrict the ability of the holder of shares issuable upon exercise of the amended warrants to sell, make any short sale of, loan, grant any option for the purchase of, or otherwise dispose of any of such shares without the prior written consent of the Company for a period of 50 days after the expiration date of the Offer to Amend and Exercise.

 

In connection with the Offer to Amend and Exercise, the holders of a majority of the then outstanding PPO Warrants, Bridge Warrants, and Agent Warrants approved an amendment to remove the price-based anti-dilution provisions in those warrants (see Note 9, Warrants).

 

2014 Equity Incentive Plan

 

Before the Merger, the Board of Directors adopted, and the stockholders approved, the 2014 Equity Incentive Plan (“2014 Plan”), which provides for the issuance of incentive awards constituting up to 14,410,000 shares of common stock to officers, key employees, consultants and directors. In connection with the Merger, options to purchase Ekso Bionics common stock outstanding immediately prior to the Merger were converted into options to purchase an aggregate of 7,602,408 shares of Holdings issued under the 2014 Plan.

 

On the closing of the Merger, the Board granted to officers and directors options to purchase an aggregate of 2,300,000 shares of common stock under the 2014 Plan.


Subsequent to the Merger, on June 10, 2015, the Board submitted to the stockholders and the stockholders approved and ratified an amendment of the 2014 Plan to increase the maximum number of shares of common stock that may be issued under the 2014 Plan by 11,590,000 shares to 26,000,000 shares. As of June 30, 2015, there were 11,767,633 shares available for future awards. 
XML 32 R32.htm IDEA: XBRL DOCUMENT v3.2.0.727
The Merger, Offering and Other Related Transactions (Repayment of 2013 Bridge Note, Narrative) (Details) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 6 Months Ended
Nov. 30, 2013
Jun. 30, 2015
Oct. 31, 2014
Repayment of 2013 Bridge Note [Line Items]      
Number of shares called by warrants   36,055,000 30,300,000
Bridge Warrants [Member]      
Repayment of 2013 Bridge Note [Line Items]      
Number of warrants issued for conversion of debt 2,500,000    
Exercise price $ 1.00 $ 1.00  
Expiration period 3 years 3 years  
2013 Bridge Notes [Member]      
Repayment of 2013 Bridge Note [Line Items]      
Principal amount $ 5,000    
Accrued interest $ 83 $ 5,083  
Number of shares called by warrants 5,000,000    
XML 33 R40.htm IDEA: XBRL DOCUMENT v3.2.0.727
Capitalization and Equity Structure (Details) - shares
Jun. 30, 2015
Dec. 31, 2014
Capitalization and Equity Structure [Abstract]    
Common stock, shares authorized 500,000,000 500,000,000
Convertible Preferred stock, shares authorized 10,000,000 10,000,000
Common stock, shares issued 102,123,767 101,621,358
Common stock, shares outstanding 102,123,767 101,621,358
Convertible Preferred stock, shares issued 0 0
Convertible Preferred stock, shares outstanding 0 0
XML 34 R53.htm IDEA: XBRL DOCUMENT v3.2.0.727
Segment Disclosures (Schedule of Geographic Information) (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Revenues from External Customers and Long-Lived Assets [Line Items]        
Revenue $ 2,114 $ 1,197 $ 3,803 $ 2,259
North America [Member]        
Revenues from External Customers and Long-Lived Assets [Line Items]        
Revenue 1,622 941 2,894 1,831
Europe, Middle East, Asia [Member]        
Revenues from External Customers and Long-Lived Assets [Line Items]        
Revenue $ 492 $ 256 $ 909 $ 428
XML 35 R2.htm IDEA: XBRL DOCUMENT v3.2.0.727
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2015
Dec. 31, 2014
Current assets:    
Cash $ 16,251 $ 25,190
Accounts receivable, net 2,394 1,549
Inventories, net 1,188 622
Prepaid expenses and other current assets 473 388
Deferred cost of revenue, current 1,876 1,551
Total current assets 22,182 29,300
Property and equipment, net 2,154 2,102
Deferred cost of revenue, non-current 2,515 2,017
Other assets 55 55
Total assets 26,906 33,474
Current liabilities:    
Notes payable, current 43 41
Accounts payable 2,306 783
Accrued liabilities 1,976 2,378
Deferred revenues, current 4,032 3,412
Total current liabilities 8,357 6,614
Deferred revenues, non-current 4,492 3,895
Notes payable, non-current 53 77
Deferred rent 69 88
Total liabilities $ 12,971 $ 10,674
Commitments and contingencies (Note 12)    
Stockholders' equity:    
Convertible Preferred stock, $0.001 par value; 10,000,000 shares authorized at June 30, 2015 and December 31, 2014; none issued and outstanding at June 30, 2015 and December 31, 2014, respectively    
Common stock, $0.001 par value; 500,000,000 shares authorized at June 30, 2015 and December 31, 2014; 102,123,767 and 101,621,358, shares issued and outstanding at June 30, 2015 and December 31, 2014, respectively $ 102 $ 102
Additional paid-in capital 95,394 94,499
Accumulated deficit (81,561) (71,801)
Total stockholders' equity 13,935 22,800
Total liabilities and stockholders' equity $ 26,906 $ 33,474
XML 36 R45.htm IDEA: XBRL DOCUMENT v3.2.0.727
Stock-based Compensation Plans and Awards (Summary of Stock Option Activity) (Details) - Jun. 30, 2015 - 2014 Plan [Member] - USD ($)
$ / shares in Units, $ in Thousands
Total
Stock Awards  
Balance as of December 31, 2014 10,791,081
Options granted 3,184,000
Options exercised (697,356)
Options forfeited (40,507)
Options cancelled (10,126)
Balance as of June 30, 2015 13,227,092
Vested and expected to vest at June 30, 2015 12,118,042
Exercisable as of June 30, 2015 5,970,959
Weighted-Average Exercise Price  
Balance as of December 31, 2014 $ 0.79
Options granted 1.40
Options exercised 0.55
Options forfeited 0.57
Options cancelled 1.74
Balance as of June 30, 2015 0.96
Vested and expected to vest at June 30, 2015 0.92
Exercisable as of June 30, 2015 $ 0.60
Weighted-Average Remaining Contractual Life (Years)  
Balance as of June 30, 2015 7 years 10 months 10 days
Vested and expected to vest at June 30, 2015 7 years 8 months 16 days
Exercisable as of June 30, 2015 6 years 2 months 23 days
Aggregate Intrinsic Value  
Balance as of June 30, 2015 $ 4,197
Vested and expected to vest at June 30, 2015 4,131
Exercisable as of June 30, 2015 $ 3,451
XML 37 R6.htm IDEA: XBRL DOCUMENT v3.2.0.727
Organization
 6 Months Ended
Jun. 30, 2015
Organization [Abstract]  
Organization

1. Organization

 

Description of Business and Liquidity

 

On January 15, 2014, a wholly-owned subsidiary of Ekso Bionics Holdings, Inc. named Ekso Acquisition Corp, merged with and into Ekso Bionics, Inc. (the “Merger”). Ekso Bionics, Inc. was the surviving corporation and became a wholly-owned subsidiary of Ekso Bionics Holdings, Inc. As a result of this transaction, Ekso Bionics Holdings, Inc. discontinued its pre-merger operations, acquired the business of Ekso Bionics, Inc. and continues the operations of Ekso Bionics, Inc. as a publicly traded company. See Note 3, The Merger, Offering and Other Related Transactions. Ekso Bionics, Inc. was incorporated in January 2005 in the State of Delaware. We are currently headquartered in Richmond, California.

 

As used in these notes to the condensed consolidated financial statements, the term “the Company” refers to Ekso Bionics Holdings, Inc. (formerly known as PN Med Group, Inc.) and its direct and indirect wholly-owned subsidiaries, including Ekso Bionics, Inc. and Ekso Bionics Ltd., after giving effect to the Merger; the term “Holdings” refers to the business of Ekso Bionics Holdings, Inc. prior to the Merger, and the term “Ekso Bionics” refers to Ekso Bionics, Inc. prior to the Merger. Unless otherwise indicated, all dollar amounts included in these notes to the financial statements are in thousands.

 

We are a leading developer and manufacturer of human bionic exoskeletons . We were founded after the Robotics and Human Engineering Laboratory at the University of California, Berkeley had a breakthrough in demonstrating human exoskeletons that are more energy efficient than previously thought possible.

 

We are pioneering the field of human exoskeletons to augment human strength, endurance and mobility. We design, develop and sell wearable robots, or “human exoskeletons,” that have applications in healthcare, industrial, military, and consumer markets. Our exoskeleton systems are strapped over the user's clothing, enabling individuals with neurological conditions affecting gait (e.g., stroke or spinal cord injury) to walk again, permitting soldiers to carry heavy loads for long distances while mitigating lower back, knee, and ankle injuries, and allowing industrial workers to increase productivity and quality of work, for extended periods.

 

Our current medical device product, the Ekso GT, is a wearable bionic suit that provides individuals with stroke, spinal cord injuries and other lower-extremity paralysis or weakness the ability to stand and walk over ground with a full weight-bearing, reciprocal gait using a cane, crutches or a walker under the supervision of a physical therapist. Walking is achieved by the shifting of the user's body to activate sensors in the device that initiate steps. Battery-powered motors drive the legs, replacing deficient neuromuscular function. First-time users can expect to walk with aid from the device the first time they put on the Ekso exoskeleton (after passing an assessment), while an experienced user can transfer to or from their wheelchair and don or remove the Ekso in less than five minutes.


Our engineering services division, Ekso Labs, is an exoskeleton laboratory that continually integrates emerging technologies into new product applications and expands on such technologies with our partners. Ekso Labs also develops intellectual property through research grants from government organizations, including the United States Special Operations Command and the Department of Defense.

 

Liquidity

 

Largely as a result of significant research and development activities related to the creation of our advanced technology and commercialization of this technology into our medical device business, we have incurred significant operating losses and negative cash flows from operations since inception. The Company has also recorded significant non-cash losses associated with revaluation of certain securities, which have also contributed significantly to our accumulated deficits. As of June 30, 2015, we had an accumulated deficit of $81,561.

 

The Company's cash as of June 30, 2015, was $16,251 compared to $25,190 at December 31, 2014. During the six months ended June 30, 2015, the Company used $8,462 of cash in operations compared to $8,605 for the six months ended June 30, 2014.

 

Based upon our current six-month average monthly net use of cash of approximately $1,500 and assuming increases in current revenue and gross profit, offset by incremental net use of cash for increased sales and marketing and research and development, and a potential increase in rental activity for our medical device business, the Company believes it has sufficient resources to meet its financial obligations into the second quarter of 2016.


Our actual capital requirements may vary significantly and will depend on many factors. For example, we plan to continue to increase our investments (i) in our clinical, sales and marketing initiatives to accelerate adoption of the Ekso robotic exoskeleton in the rehabilitation market, (ii) in our research, development and commercialization activities with respect to an Ekso robotic exoskeleton for home use, and/or (iii) in the development and commercialization of able-bodied exoskeletons for industrial use. Consequently, the Company will require significant additional financing in the future, which we intend to raise through corporate collaborations, public or private equity offerings, debt financings or warrant solicitations within the next two to four quarters. Sales of additional equity securities by us could result in the dilution of the interests of existing stockholders. When we need additional financing , there can be no assurance that it will be available when required in sufficient amounts, on acceptable terms or at all. In the event that the necessary additional financing is not obtained, we may be required to reduce our discretionary overhead costs substantially, including research and development, general and administrative and sales and marketing expenses or otherwise curtail operations.
XML 38 R35.htm IDEA: XBRL DOCUMENT v3.2.0.727
Deferred Revenues (Details) - USD ($)
$ in Thousands
Jun. 30, 2015
Dec. 31, 2014
Deferred Revenue Arrangement [Line Items]    
Customer advances and deferred revenues $ 8,524 $ 7,307
Less current portion (4,032) (3,412)
Customer advances and deferred revenues, non-current 4,492 3,895
Deferred Ekso medical device costs 4,391 3,568
Less current portion (1,876) (1,551)
Deferred cost of revenue, non-current 2,515 2,017
Customer deposits and advances [Member]    
Deferred Revenue Arrangement [Line Items]    
Customer advances and deferred revenues 353 105
Deferred Ekso medical device revenues [Member]    
Deferred Revenue Arrangement [Line Items]    
Customer advances and deferred revenues 6,048 5,327
Deferred service and leasing revenues [Member]    
Deferred Revenue Arrangement [Line Items]    
Customer advances and deferred revenues $ 2,123 $ 1,875
XML 39 R22.htm IDEA: XBRL DOCUMENT v3.2.0.727
Accrued Liabilities (Tables)
 6 Months Ended
Jun. 30, 2015
Accrued Liabilities [Abstract]  
Schedule of Accrued Liabilities
June 30,     December 31,       
2015     2014      
Salaries, benefits and related expenses $ 1,516     $ 1,847  
Professional fees   273       184  
Warranty expense     91       126  
Taxes     42       46  
Royalties     -       50  
Travel     48       76  
All other     6       49  
Total   $ 1,976     $ 2,378  
XML 40 R36.htm IDEA: XBRL DOCUMENT v3.2.0.727
Accrued Liabilities (Details) - USD ($)
$ in Thousands
Jun. 30, 2015
Dec. 31, 2014
Accrued Liabilities [Abstract]    
Salaries, benefits and related expenses $ 1,516 $ 1,847
Professional fees 273 184
Warranty expense 91 126
Taxes $ 42 46
Royalties   50
Travel $ 48 76
All Other 6 49
Total $ 1,976 $ 2,378
XML 41 R24.htm IDEA: XBRL DOCUMENT v3.2.0.727
Operating and Capital Leases (Tables)
 6 Months Ended
Jun. 30, 2015
Operating and Capital Leases [Abstract]  
Schedule of Future Minimum Operating Lease Payments
2015 (remainder of year)   $ 188  
2016     375  
2017     157  
Total   $ 720  
XML 42 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 43 R7.htm IDEA: XBRL DOCUMENT v3.2.0.727
Basis of Presentation and Summary of Significant Accounting Policies and Estimates
 6 Months Ended
Jun. 30, 2015
Basis of Presentation and Summary of Significant Accounting Policies and Estimates [Abstract]  
Basis of Presentation and Summary of Significant Accounting Policies and Estimates

2. Basis of Presentation and Summary of Significant Accounting Policies and Estimates

 

There have been no material changes to our significant accounting policies as compared to those described in our Annual Report on Form 10-K for the year ended December 31, 2014.

 

Basis of Presentation

 

These unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”), for the presentation of interim financial information. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed, or omitted, pursuant to such rules and regulations. The condensed consolidated balance sheet at December 31, 2014, has been derived from the audited consolidated financial statements at that date but does not include all disclosures required for the annual financial statements and should be read in conjunction with our audited consolidated financial statements and notes thereto included as part of our Annual Report on Form 10-K for the year ended December 31, 2014.

 

In management's opinion, the condensed consolidated financial statements reflect all adjustments (including reclassifications and normal recurring adjustments) necessary to present fairly the financial position at June 30, 2015, and results of operations and cash flows for all periods presented. The interim results presented are not necessarily indicative of results that can be expected for a full year. The condensed consolidated financial statements include the accounts of the Company and our wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.

 

Use of Estimates

 

The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet, and the reported amounts of revenues and expenses during the reporting period. For the Company, these estimates include, but are not limited to: revenue recognition, deferred revenue and the deferral of the associated costs, useful lives assigned to long-lived assets, realizability of deferred tax assets, the valuation of options and warrants, and contingencies. Actual results could differ from those estimates.

 

Concentration of Credit Risk and Other Risks and Uncertainties

 

Financial instruments that potentially subject us to concentrations of credit risk consist principally of cash and accounts receivable. We maintain our cash accounts in excess of federally insured limits. However, we believe we are not exposed to significant credit risk due to the financial position of the depository institutions in which these deposits are held.  We extend credit to customers in the normal course of business and perform ongoing credit evaluations of our customers. Concentrations of credit risk with respect to accounts receivable exist to the full extent of amounts presented in the consolidated financial statements. We do not require collateral from our customers to secure accounts receivable.


Accounts receivable are derived from the sale of products shipped and services performed for customers located in the U.S. and throughout the world. Invoices are aged based on contractual terms with the customer. We review accounts receivable for collectability and provide an allowance for credit losses, as needed. We have not experienced any material losses related to accounts receivable as of June 30, 2015 and December 31, 2014. Many of the sales contracts with customers outside of the U.S. are settled in a foreign currency other than the U.S. dollar. We do not enter into any foreign currency hedging agreements and are susceptible to gains and losses from foreign currency fluctuations. To date, we have not experienced significant gains or losses upon settling foreign currency denominated accounts receivable.

 

As of June 30, 2015, we had two customers with accounts receivable balances totaling 10% or more of our total accounts receivable (26% and 10%), compared with two customers as of December 31, 2014 (22% and 11%).

 

In the three months ended June 30, 2015, we had one customer with sales comprising of 10% or more of our total customer sales (32%), compared with two customers in the three months ended June 30, 2014 (15% and 12%). In the six months ended June 30, 2015, we had two customers with sales comprising of 10% or more of our total customer sales (27%, and 11%), compared with one customer in the six months ended June 30, 2014 (17%).

 

Common Stock Warrants

 

We accounted for the common stock warrants issued in connection with our Merger and related private placement offering (see Note 3, The Merger, Offering and Other Related Transactions) in accordance with the guidance in Accounting Standards Codification (“ASC”) 815-40. Under ASC 815-40, the warrants did not meet the criteria for equity treatment and were recorded as a liability. The warrants initially had an anti-dilution clause that allowed for a decrease in the exercise price of the warrants if the Company issued additional shares of common stock without consideration or for consideration per share less than the exercise price of such warrants. Accordingly, we classified the warrant instruments as liabilities at their fair value at the date of issuance and re-measured the warrants at each balance sheet date. Changes in the fair value were recognized as a gain (loss) on warrant liability in our Condensed Consolidated Statement of Operations. These warrants were amended in November 2014 to remove the price-based anti-dilution provision, among other things. Accordingly, the warrants are no longer recorded as a liability.

 

Recent Accounting Pronouncements

 

In July 2015, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) 2015-11 Simplifying the Measurement of Inventory. Under ASU 2015-11, inventory is to be measured at the lower of cost and net realizable value (“NRV”). NRV is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.


The updated guidance is effective for annual reporting periods beginning on or after December 15, 2016, and interim periods therein. Early adoption is permitted. Management is in the process of assessing the impact of ASU 2015-11 on the Company's consolidated financial statements.
XML 44 R3.htm IDEA: XBRL DOCUMENT v3.2.0.727
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Jun. 30, 2015
Dec. 31, 2014
Condensed Consolidated Balance Sheets [Abstract]    
Convertible Preferred stock, par value per share $ 0.001 $ 0.001
Convertible Preferred stock, shares authorized 10,000,000 10,000,000
Convertible Preferred stock, shares issued 0 0
Convertible Preferred stock, shares outstanding 0 0
Common stock, par value per share $ 0.001 $ 0.001
Common stock, shares authorized 500,000,000 500,000,000
Common stock, shares issued 102,123,767 101,621,358
Common stock, shares outstanding 102,123,767 101,621,358
XML 45 R17.htm IDEA: XBRL DOCUMENT v3.2.0.727
Commitments and Contingencies
 6 Months Ended
Jun. 30, 2015
Commitments and Contingencies [Abstract]  
Commitments and Contingencies

12. Commitments and Contingencies

 

Contingencies

 

In the normal course of business, the Company is subject to various legal matters. In the opinion of management, the resolution of such matters will not have a material adverse effect on the Company's condensed consolidated financial statements.

 

Material Contracts

 

The Company enters into various license, research collaboration and development agreements which provide for payments to the Company for government grants, fees, cost reimbursements typically with a markup, technology transfer and license fees, and royalty payments on sales.

 

The Company has two license agreements to maintain exclusive rights to patents. The Company is also required to pay 1% of net sales of products sold to entities other than the U.S. government. In the event of a sublicense, the Company will owe 21% of license fees and must pass through 1% of the sub-licensee's net sales of products sold to entities other than the U.S. government. The license agreements also stipulate minimum annual royalties, starting in 2015 and for future years, of $50 per year.

 

U.S. Food and Drug Administration Clearance

 

The Company's Ekso GT robotic exoskeleton has been marketed in the United States as a Class I 510(k) exempt Powered Exercise Equipment device since February 2012. On June 26, 2014, the U.S. Food and Drug Administration (“FDA”) announced the creation of a new product classification for Powered Exoskeleton devices. On October 21, 2014, the FDA published the summary for the reclassified Powered Exoskeleton and informed us in writing of the agency's belief that this new product classification applied to the Ekso GT device. This new product classification was designated as being Class II, which requires the clearance of a 510(k) notice. Consequently, the FDA requested that we file a 510(k) notice to obtain this clearance. Per the FDA's request, we filed our 510(k) notice on December 24, 2014, and this submission is currently under review by the FDA. The Company intends to continue marketing the Ekso robotic exoskeleton under its current Class I registration and listing with its current indications for use until 510(k) clearance is either granted or denied by the FDA or the Company is otherwise notified by the FDA to cease such activities. The Company believes that in situations where the class of a product has been elevated by the FDA, manufacturers are normally granted enforcement discretion by the FDA and given ample time to seek clearance at the new class level. Nonetheless, the FDA may not agree with our decision to continue marketing the device until a 510(k) notice is cleared. From the time of our submission to the date of this report, the FDA has not indicated or notified the Company that it disagrees with this decision. If the FDA disagrees with our decision, we may be required to cease marketing or to recall the products until we obtain clearance or approval, and we may be subject to regulatory fines or penalties.
ZIP 46 0001144204-15-048466-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001144204-15-048466-xbrl.zip M4$L#!!0````(`.1V#$>]X])L)AT!`/K<$``1`!P`96MS;RTR,#$U,#8S,"YX M;6Q55`D``XN6RU6+ELM5=7@+``$$)0X```0Y`0``[%U;JV@D7WTA?IMSI2^5,=Y)*LF?.JP*RK=V`O"5(XOGU1Q(&`\8&9#M&B>=A M=\:`UL>Z?%I:NO#A'\^^ISU"0A$./IX8I_J)!@,'NRB8?#R):`=0!Z$3C88@ M<(&'`_CQ9`[IR3\^_?4O'_ZKT[D@$(30U1[FVOT4:O]"00@F4/M.<#1[I]W@ M)TCBJY>WEW?:!2`/..AT^,//#\1#Y_R_&H,0T'-$<=WIZ M.N673S&9G)FZ;ITM[CA9/."AX->&N_GE!T!A#',W:!/6MT.[K1L8Q4)[0S`6"6/C(&]$&(65S@C_3RC\!? M%.>`\1\>F/<@AYXZV!>/Z'U+/V%6UK0/_)W.J4!["\>:>,?S<#YCCD21/_,X M=/';E,#QQQ/>6B=IXO29NB?:6=Q0[#`.#D+X'&K(_7AR,1C8YL".!:5WP"!$ MX7SQ6_HKU]6'WPUGQX43468FLA:09 M)`B[*_*%H<)/L4+['4M/&U]<:27Y:?'J&[4QU%731K=CF,R]]J,-0PEM ML#X>^=H^!$,MHP9.?)B^2GK!93">9QYR4/@3^@],J(O8?7&*N,@, MSB\P2SN"D("0_7R+Z*_/\\\L@L=B![!@P?C M5C^Q#]#K'L#B&Q2XRB5S?N=NP.$0F<0R+%H;%_1,^AD4:%H=(*?<5%@=U MQ/IA>@<\R&+T$081O()A&V)"P:YBCQE4[Q@3QY@XCBIR,=$_QL0Q)@Z<.[4K M)BQ=V9'VUS\C!O22O0^!-+RD-(+N->'_\D%#:8!@W\?!78B=FB'Q)AQ`V3%E MX.@`J0,H.TRX"YD2^-,7'J#T>BS, MF^G^[YA"(!VQ-WZ$)$3,*6X('$-"H'OL`?(^H&Q:7-,'PB=\<72#2C<8O&XW M^'RD@DH?,-2E@BDFX3TD_A?X$*YV_I\)UI&8!E#5>VV M"-E%9GY-;M%D&F9B-S;<%0[AXA;Z.@UXB%6,;\*`.;H5)FQ&MP6K[Y1N3356 M:^Y@GL/H&-W]J%#9\D55X-P0],C4=.,!1R0W!^>_/:Y;MDQE"Q%JF+'-2:=Y MB!K$+EC0M!NRH,FTN!\5'O/V-Q0OZ@[4VVGLE^KCCH,TQ0UX'*2]0;JU#C%( M>V&KTS0]'4U>^U##4G;$.'H"1#AV=I6+*&KS^_B%8]2F5E9V0%EFY9^03"`Y M6CAG866GKM4H&>3W:.^M\MU7=C3S93&'N%C=..)&F@B#E2P^P>.0Q37\@1S6 M3/;>5]G']I4=ZBANU#V>IF#UE1W^-#'J%0[HPJYWD#PRT]Y%LQDFX2AP?P+$ M=!+P`U?:8.Q]1O!`V5'/*S7V/B-[H.PI!#)TW79+[S6LE5WN_QHMO<^8/LC9 M1SNR]$-XR51!(E&0RF_A`#,4`N\'!!1>/WAH(G;UO,Y"U4&.7MJ;!<7(5MAM MBCWWTI\1_"BBC]%!QC_;)A/Z7I*)H6Z8RG9%&VJM!]T5^%*&4W:R:]>&:R([W5!RY[#!`E-\ M)H6Y'K-QR#T>LG;,5/>NJ;F;0X_?+*I\29G?O* MCA5?GYWW5A/@=GZ-W;A*=FYMQLN=XS6F"JU8W?92T:ULO4'%!1'[,J.I*SOS MQNP37`$_NW`I.::#G\"$'KD%`ZZ^UYA%L=:/AGLSW:5I*,NVMWS>*S^2_HD" MY$?^[D?21\^2\"QE:\XOZ5FWT.-?GKIAMIK?LVR``D=,!7Z>9Z]D3P'A1WWP MN2=(:B8.1T??LZ,KNVNQS-'!\]'1CXY>[NC*KG%^24<_>I:$9RF[T%ILW@O:!L1*%LJ4=H+6L8%ZA[#5?/14Q3U5V8I;#<:-'KS86>&1?-^.2W>5 M+3..6)LN\B*>&]Y!)R(H1)#&?@K=;P3[%]B?1:%P].OQ5T`"YKZ4^5[>P'%.O[[O*%N??(.^T[+!2U?9PN:+^,[Q.\U%?U&V!/I&_*5E_-)3MEB: M)NF?(XH"2.E=W!C-+D`+)NP2TTPP69SP=TQIEZ97MCY:Q_0_H8L:<<"1 MXU.3*UM_5N3&TP>'Z/'2];9:\EX>F.)`UBZI6P!J-H! M8/SYRY*C/%_Q08#,I*^X?VBQ2??5Y0][ACU4UZ18[/K5VN5<=U<."% MW-V6C'Q$3"A;R3S&Q`YCXOX)'V,BC@G3.D@):/N$N*D*]Y40"Q4>EUBILSRO M;;YS7&[5[N56+?.7OAH?"VMSCZ?N)VC>(%VWS7>4K7V]$;INF;^H^VU[]1;+ MM:RG5O=+]THMEFN;U97M(-0+^+9QO;(5=Z4"OFU65W8UC3I+)=O&\:]QU5S+ M3-ZV*%>VQ*O20LFVQ;FRM5F5C-ZR2!\JF\"W\BCOEH6TNJMB6GF4=]NLJ^SZ MCE;&;MN86=E-::V,W;995]EQM+IGL+>-OI4=5ZOK`FUC`67'V4H?P-XV(E!V MX*VT%[2,"VQEY\X5/WZ]96Q@*SN1KK@?M(@/;%T_3.VFN0KS^[N&'=U*&]_5 M_BZN#5O9T7#]O2,CQ\%1$-);Z$#T"!Z\/1SLWK:=-:IM9VG1YF01%LJ6$=KF MB$IO\3KLML<6)5`B)I2MJ[3^S(T=G/-C93;U[];LRM92E#-[F])D6]GBR8T' M@BO@P^R"TS\CAOU2L#L;$_$[N/H.>`@'"_$]',+!#-?5E:UWM-5PQ4ZYW]'M MQIVRL8NU)[0F]TC6FJ(%6V?A.M M&"7?]HS]*=7R+6.6-2U'(3GGEZ7:O0RAOZ9=,>Y`['J]AEV(SK^*\+O`OH\# M<=Y!K.[K*.0AQ;_"*83>@XEQHBW"YQ:.EQ-2&F]/_+(PE.9"!_G`HPSJU;>3 M3X9N,G8<]'L?SNH)C,$MB[#IG3>`7!-1&7'_!;P()D&5(#0+"`<#VQS8&839 M0"S"U$]UWI_KB?Z7PBM(J8,7TGD#J M2D+B1N4[_P8;(,62*N"4.%JO!--0KX/)Z#-7ZPTW8*KC9L+("9A^#9_*(NE8 M0CGKC"7:KB=Y4*6&K26/7!?QZ0+@W0#D7@878(9"X"4`AA*O;OVFR.YA2%``723TS]&CA/YD<>#_PL<\^PFY4-=0C^=H='K&SE8 MU1*E$18INX[>.@-CJ&^'4/C;%'LN)#3.+5-$=2AZQ:DMV^KE`*T*J`V@C(.K M5&*R._1&`'X@\("\^'B8P-T`IY)_R^#T;;V?@U,E3A)<)1&7@+.L[J"[!;@+ M0/FJ0/X/O_P(/,AWX8<7;,0Q9\Z7HTA#BIW[9B_OW[5D;@-3ALH92%O?%N;J M\I$K&%Y$A+`G4W0R/&^NT/P&21*89!A?C)7E,%T&C^PW3.;LAC2;E.%WPQ@. M0*["BD7(Q3=%($9\U&,J@2?AQL?2U"$4JA]0MLY2#\S(:X9!*%;M&G)A5H M?N!@PK^OF.7?%(@,J?;R7%;6?@,$4G0Z:(A@J:H@O&#_HG#5*#T9.NW;:TRR M*D<"D0RE%D::]1%E8BP%(%4V->V!L2YZJT7*<*:A]]<7_U9&^K%":LWL]>JP M9]VIO7JB-\%=-\'7*R/9>M-IQ0F^S0(W@1]/0M;KGVAG M]=NOQZ";V^>S5"B,CUL-V%@KX`=#P,#)NF,]@FSR'NOG'\NHL(X5*\RW=NZQ M62STR_BQJ/)]QD*-F>Y^)6/N8:J[3.?YV>Y^&8_6@55AV;*9[AIH9-<#2*"I M$6+],HYM&LKU>+(O/\6_#4_667S0KR3,+59$U&2`]>`JV7;'S-1@\4V_C*%E M:6G[U3>%4*O,;K=84U(6;]D-H=\Q=FFF*CLH)7"CJC1IY=/],@D-,)02M%F5 M41;*H\TP).?E9V&4$G*%*@PQ[%@#(R.D&9+2?+=*(7K7W`Y)%D$I_U;HPAKJ MZ]VBMN12.JYX=]/LV?4E\P+Z]5CXR!WVTK@[(J M'TKQWM!>:^R"G,9XI#AP8'6E\'PGF-(;@L?+]5E#&?:S]7SU*=-NM4`9DNN9 M-06N/]TOE2]#<5VK4%-8+Z;TY;*KT>I MFPL;]21)T63?'N0SZ8VR5A<1QG?$+I%H*T4D0Y"#@@'*130$(L6'$D"N<(#S M85+P2D.7H<..55S%L49,8S0R[-@Q;1DT8CE/#4A2A%D8&VV6)8=+BD6-0=6[+-5Y+K@RC=LQ>WQK6%;SRV5M`D;,$4(=+RZI\ M)L.AGQH9#*6"&F&IP[;KL5B]1EC^#=%D&D)W],B<9@*O(K['F0V&BP74`L9* M_ETM/.JB[&AWF=O:2XB-Y.\$>B5CET(?F'V6Q0ZLG2#_`F>$-2X.M5ON:I+A M[ZY17"&P;+F.3!F6M@I]QGJ9Z9+]?Q,4PB_X*2.Y'AEOSEXVM2]#JJ:QTC/G MFR\L6O,Q"=%_%A_63A?5,@>8+(<)1NEFJ$I2+=AUHR@I5%*4:PQWA>HA_(*H M6*5X0Z"/(G^);!=Y;0-Q4LFMO5D1*^(*)9P%&?,5V#[OG0M1*97=VGGG+9?1 M#(=,. M,:&PS(2X4;H'JK*C&10W@&T0)85*JH@[*(ZEMD"UV#65T%CI[JDE7!E6'U8Y M81T(NWT-J5I&<22]C]=8UW&5[L:J5+Q9Y2<;.Z\&Z&1Z$]NH4FA#=(7U_TMT M4K-TO4KE%>1)PY/I;SKFH+A/='MXA4T"RVWV4C66KEX#84'D-B"E2B]&OU@9 MW1YD80GY$J'4^HCB,HU*>=+PI!9-#+I5"MP(C^_A!G1Z0S`_0\K]//^=I4R7 M05H;'SDA>HRW*(AE;A'[;7$1!QGC2XTVAMV^6:RD;(%F/V\F-6(9]@L3R[M\ M,T8H8NWA/1XY?T:(P+5[2I=O(=-]]0IK4NK+W1ZO3(?6'_1V@G>-K>**>0// MD>GV.D6E;P=F/R\FU6$6K;/+%[MEB5]LZ^MQV7X5"@#PYK1/2%(I, M/VGV"J.T>F"8">TEI]R[2U0R?6,OW_542I,&)U55*YZ> M(0UN,5F8W+D,A-)MB)5#VN*A&>L%R4"JUUU5K3M?2A('EP8.O!YGENHNQ>VB M:M9`G$RW8!IVX9"P2H&U:/,;"MB#]6FS=%MB]1"R#FG6A+*?UY+I#8RXZK2G M-RL_V^E&G&!;S(_3]RC=*5F=PMI6OK]N(GL7J*667>I&8>YTUZC7G=U5NOX?GL M9?FP="T-AN(XWC[`"/O>.YQM?BH/$\%L";?^!_F*<:G[BD M&AYK-P12IK!X<@`$KG87^:S!.;^6T9.V5)26:$K<_I4)\`%+C7CK9P^)G+/9 MOE\I_A$%_'AQ=N-I#P6+UP3^[/U_L]C;/1#1_OT4$JA-P2/4'B`,M`!K7`$$ M`4]SIOS4>:J%6,,1T6A&@6"IP%FJ0,HF6\8[C9\[ M?KH?-:Q7,PN)E_7G4F=^:7_D(!N]<7-YP*`B1\S8'KF'L4Q?J#;CB17^ MQUH.I^P__!;M(6)_8*&Q,%&6QC27TR:!HLKDIG8$,3V6-\]>F4YQY+$W8DX% M@5`M@_5'%#C":D*WG&4;8&:-"#FXXU<$2_`7BCX#01"!TXTA-^"EI*[VL M\2W-/&02N$APC2M>E%$%$YH\(V*-I2,\&N#SC*EL$4A`&T=,-/?&C;Q0JOTD M5$4T+N;C$J[F"T-`,!?ORD/B:8H9%7;P4\!:H]$#12X"?`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`MC`^_O*7P=B;=/E@_6CS MB\>88<3JR5X%N@JM(?<_P]S!A3-63?K.KP>K4LX83M(G+TFG_&4XN*;[HVT] M77DN9GA)C.[:FZ!O2V#3W8RW=V5J=[#ZPTPH\2ZFE_#;>&IY6?EO'ZJ>^)7T`N M,HM+,&3S.WOEP7N@ABPN0V\K'%0U9I.XW7"][$ZL&9> MOF736*G8$[^,<<.GX*#55KQ-_UVLM)U1VEXK#6O(OX;THBO&;)!8;QFOQ[T$3E0B5@W?W1GZY8-6O+Z#+-"Q'"OT=5\?=8= MML_BA#G:NZ_X30R7"8*JL+6HJ=89":'$GJV/%"_7%O[,68R)\?9VAAFEP,P9 MY9'QMDJD.$<%V"KWQ=-,BCJ5HZA;.8IZE:.H7SF*!I6C:%@YBBXJ1]'H0(JV M)4*@8N3MZ\$VR'K\ZWV0]?G2>S M'[XZOV4_?'5>RG[XQ?HD8@%(Q`J^4.1P`R-^9B@4F9J`*S[9%HZ-GB>S"V=T MP9!B)O6];'7ZU#_0[9]0CE`H*US^Z1(_'NLSW%5:*#@S>2)I1JBF`79)X#9S M/;M8KH?&Q<:-,\R02QME'+F&< M?61U4:)VVK?A!]TUBO6CK@W+*7I>QY/G%-8GA_8TQM!=27C+IM0S7((;?V8V M7*%?,$MYU2 M+)>XQ5K-U4FRM&[[\`7WGN='*MPS^>EYR6Q# M-[\4BOK>PH,O3%.%'LT5F*Q?/E>XMJ7P$TTG;3'Q;K&<8^Z<8B<'?S,PN:'+ M0H'O##Q-6+C4OFLNJ&X054N:'57FX>9G\F`M,1R-$E`\^!O+=?&P7@GX_F?T M5Y_9^-OB.WXU`25^+H'C5R5\5N3`UWK!;I]`M;024-^RJ2[R#Q2/_3?V/+:H MK16/?&>R_<%\%A(L=O0$]#%+F`2T,4N7KA4@SN&MJ1@AB>@BV5X M`KH,AE_S[&N'[Z0^!+L,E@?89?*\V*BNCVT9EHVYE4H9\`"\E!$/P$L9/8Q7X\$=B8_Z$40>/`94@9!RY#Q#AP&?+%@4L3 MKF*/U,6`BSU7%P,N]G"=`"YAZ1$#+D./2UMVE+#3,`9/+&.WK$".@"Y#V#^S<2E=1MRR^EOP'@=J&):EY'MQ\O#QJLM7 M`C=Y(D'EN.%7]B`)HUK>I6VL^VB1^R6=J#S3.FA%.Q1GF1VTD^TK M^.@0:[R3;%R!C,4:[T;[)S7=6P2L49@@8]!+@5"7`V/07X%0L@**M3^0M:^0 M_N%*^THB,;'V+V3M*Z1_)&M?78Z18:B_;ZG]1:UZ#4/=#>.\JLW#L+,&H;8+ MW;7VU1H)N?G$*[1PWY=".978T1Q0)`8U!Y14RYH#5JJ)S0%+;FM5`:6Y(9_8 MHXYK$G6N6R_%_^#]"4\)J=NTF9:V\^^>=?`VJUBWTO:&?L"$W`XC:N%29L8< MQ$X^1>8`))\K,,JQ!KXPR;^VHF!Z!LXYW[^B8'H&SCG?N*1SU0AO%6"++1>"O$ MRC;>"H&RC;="6<@VWNJ6P5G&6R%*AO%6B++1>"O$VFB\%6)E&V^%0-G&6R%0 MMO%6")1MO!4"91OO7.-6.8!L--X*L;*-MT*@;..M4!:RC;>Z/,59QELA2H;Q M5HBRT7@KQ-IHO!5B91MOA4#9QELA4+;Q5@B4;;P5`F4;;W5`&<9;(*M+WY5EO!6B9!AOA2@;C;="K(W&6R%6MO%6")1MO!4" M91MOA4#9QELA4+;Q5@>48;P5@FPTW@JQLHVW0J!LXZU0%K*-M[H;,K*,MT*4 M#..M$&6C\5:(M=%X*\3*-MX*@;*-MT*@;..M$"C;>"L$RC;>ZH`RC+="D(W& M6R%6MO%6")1MO-4!M=-V,_A[J!5EHHIMGTC;+AKL:U".V,W*_`A=_*3H%H08 M8EK^L*"/.4!V4R#?6-87HB(Y<0QKN/.>;7ULZ!;?AW/H&8S]+HR2IVR^O5:4 MDS$BJA=:(S^K&=_7K6Z#0:\C:U_=-[!>5]:^NC!MKR=K7UTDH=>7M:_.V>V% M4QJWQ\'!,G`4U4$,)!!MU2!#"8A",;J0-*]0BD:2YM4)45\VR'V"3HPZC+8$ M8Q#FJ%"'TY'@#-7C9$FM^GU6G4X6PB]0K#MA%XAX'9"KW#8 MMA!Z=?'W;*%7B),I]`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`&%`W$=]`L0LF8UWKV)%RR83Z(BU M8+9##&L":J`1Z#,V]LOY_3FOZ,YMRYO-+<_ESY\LV]#.R0?ST>+-(25T!O7& MU(%_@\I.H!LVG;@>-8!G]L(A3[H[YY4#M'/RF4%W'G5@#)5TCU-F&0:;@)KH M!L@F)P4Z]JAK@&<2S*K^1,V)7]9FFNY"%QR'.0U"'6(RIC&-X\SI(R.FY1+V M%?JNXSD&9,DS64!_;1VH%/6``(-SP+6D1$&KP-R_>B;,"JT&Z;3:?4[56RBR M&#.;=-O\:>^>.LQU#3$<%/O(0.Z@ MFHWG,*!M*&M#!1H;+`T81@5K-4MTV(0.0@O8(2!HK94YTV9X\(C.;,;P+G6' M=XC#>PXWE-AQJ#ZCNBE>^KSB0K?6X-3P<-RYD3LG#Q;1@*$-\I0R"`Y4UJ?Z MA((."`082Q_`6X(H<28@A6M(&C.M!5H-',OUP3KG^HT*I5+9^4/=U-`L0MF^ M;A9B`/X?72R__Z_VH/5]+KTJPH2MJXXO%:!M3U9,';AVR+1O3`U4=P>DT:5< M)MJM/Z&\+$`TL'7+L\4[:?57`:5(3F>08.2?N&#'"[1;R0+?-D"!%S@A:KXQ M2Q`M+,.:'5@![6P";:^`UD)<*2'^(&PMS(<,/#XH,W?`PL(LDR+8EAE->$)J M@JE@`1Z7@R(,4I,JQ6%542LA2]W.3O*I;T5Y+QJB!%B[OTEP5ZE!]T#,??K7 M;3@E,0'*6-49)HEK;-:[568F!E+?HF[J38WVGZHT0AL#@*)#C=*]+< M$`\:Y)[+-`E5!_USN;[(5#)&0F$40/-C_./:6@`W8:4$RSWRF=HVN`0.IVJ< M:27V)6E#_W/N\NK23L$Y8F^MB8?.V3TX0Z`)3JS`%7K! M=Q]_#'F4?$3\9^GM[+72E9/[=/G9LK4`)/;X5_#R\:=8Q?I+[N"A7^:_+6N! M/UO^Z^"W__H!7.>&?B^?V.VF027OPP8!'*"CO(5]X'=^\F<+6@-<@!F)1&WO^QF;TRV>;XGJ=!WWBXR]_&8R]29,\.(U9.]"G05 M6D/N?X8)C@MGK)KTG5_O%T>:TUU-S&Z:V^" MOBV!37'M&#?4_A+O8GH)OXUW)G+L=LG,A^%>NE[O_[M([-A!!@?.!X*_&D9KY_Z/HA.RD5F<0F&;'YGKSQX MCW[LXA*T_/79-5V,;9V2&W@>A4&C!7Q?JW"O3<. MZHC)M-?_OKE>#XK%JCHP"QCOP1H'5:WI-%XG?!^KH^G.\BV;QDK%GOAEC!L^ M!0>MMN)M^N]BI>V,TO9::8U-_QK2.^%Q%9!8;QFOQ[T$ M3E0B5DTWW9_U15#%\<;W21CQ/E;!I/9SK(9G:K>/=KR&7R"2J;CL!#J_,G=O M<@QV\0OBX74,@XN8_KT+C\/`/CQ>3841O8FGS8B>ADDRHD?1YX'1Z(S$<*\Q M(("I0,3&MIV^-*3=;.-'Y6-,/.B#1EIFFSE3?3/>H8E(`HK4[9=219&ZS2RJ M*%*WTT`51>H^`ZNB2-U'0544'7K=MWJ*#KT'7#U%HP,IVBTE$P8LOQ9\5;'` M+/::8H%9[!7%`O-02[4/YJ&V:!_,0ZW-/IB'VI-],`^U&/M@'FH3]LN6)BAP MK8E"'VD_?'4>T7[XZOR?_?#5>3O[X:OS;?;#5^?)[(>OSF_9#U^=E[(??K$^ MB5@`$K&"+Q1Y:EFN:<&R&S\S%(I,3<#E<>SBL='S9';AC"X84LRD<\6)/KO] M`]W^">4(A;*"[Y'$3[U3?>;9[-`;N4I%'=)9Z7@,E,K<;@#],)GD]"X4,^=HY74"S8P M"SJQK6*[;%%%$\MNN+A#OW!`\L8S#%8"[L?B55A<)E$\9+%Q*@Y9;)B*0Q8; MI8K);AE#ZB.7,+(^<@D#[".7,,["5I0QSCYR">/L(YLBGU#)?@QA]^80?!G2V%&IX(>10*^Y:ZQ?8SLEGO==LIQ7+)22C8D'S$@(>:JYSV M[7VQ'8YPB[6:JY-D:=WVX0ONO8&G:0KW3'YZ7C+;T,U#$X'NAOK>PH,O3%.% M'LT5G;3K\>Y=VU+XB::3MIA0=,7@CI.#OQF8W-!EH<#^16A%2^V[YH+J!E&U MI-E191YN?B8/UA+#T2@!Q8._X7DY2L'W/Z._^LS&WQ;?\:L)*/%S"1R_*N&S M(@>^U@MV^P2JI96`&B7=*1[[;^QY;%%;*Q[YSL8#/'C0D96`?D_QZ%L)]A-F M_B>82@O^]L*Q?Z6VCM\3RS"<#X4#QS[1.][X-S8I=JK^:)'"ORC>>B[?%R#N MAR\/NM@%3`*ZV,6+R'QVKZ,M*9CA">AB&9Z`+H/AUP9U'/WPG=2'8)?!\@"[ M3)X7&]7UL8-\B:4,>`!>RH@'X*4,N65X"],IB^L5Z2FG'L8C^> M"&Q^)U,9@L:!RY`R#ER&B''@,N2+`YJ8L!%WNN+@9<[.$Z`5S"TB,& M7(8>E[;L*&&G80RX##WFP&7H,0V-66PS+3,@W/6[!72\,9N68$<`5V& ML']FXU*ZC+AE];?@/0Z8"-Y2\KTX>?AXU>4K@9L\D:!RW/`K>Y"$42WOTC;6 M?;3(_9).5)YI'<0N.,&;9^[G:L_,#MK)]A5\=(@UWDDVKD#&8HUWH_V3FNXM M`M8H3)`QZ*5`J,N!,>BO0"A9`<7:'\C:5TC_<*5])9&86/L7LO85TC^2M:\N MQ\@PU%]^)Y%2]1J&NAO&>56;AV%G#4)M%[IK[:LU$G+SJ?X*8)D=S0%%8E!S M0$FUK#E@I9K8'+#DME854)H;\HD]ZK@F4>>Z]5+\#]Z?\)20NDV;:6D[_^Y9 M!V^SBG4K;6_H!TS([3"B%BYE9LQ![.139`Y`\KDR!R#YI*D>2#)[Y@"2.HWF M@"6?3W,`DD^L.N:]XU`-E&&^%(!N-MT*L;..M$"C;>"N4A6SCK6X9G&6\%:)D&&^% M*!N-MT*LC<9;(5:V\58(E&V\%0)E&V^%0-G&6R%0MO'.-6Z5`\A&XZT0*]MX M*P3*-MX*92';>*O+4YQEO!6B9!AOA2@;C;="K(W&6R%6MO%6")1MO!4"91MO MA4#9QELA4+;Q5@>48;P5@FPTW@JQLHVW0J!LXZU0%K*-M[KT75G&6R%*AO%6 MB++1>"O$VFB\%6)E&V^%0-G&6R%0MO%6")1MO!4"91MO=4`9QELAR$;CK1`K MVW@K!,HVW@IE(=MXJ[LA(\MX*T3),-X*438:;X58&XVW0JQLXZT0*-MX*P3* M-MX*@;*-MT*@;..M#BC#>"L$V6B\%6)E&V^%0-G&6QU0.VTW@[^'6E$FJMCV MB;3MHL&^!N6(W:S,C]#%3XIN08@AIN4/"_J8`V0W!?*-97TA*I(3Q["&.^_9 MUL>&;O%].(>>P=COPBAYRN;;:T4Y&2.B>J$U\K.:\7W=ZC88]#JR]M5]`^MU M9>VK"]/V>K+VU442>GU9^^J`V"VK.1OO''`RA5X=SA9"KQ!L M.Z%7"+B=T"L)D"KU"G$RA+\1QSP%L.Z%7"+B=T"L)D"KU" MG$RA5X>SA=`K!-M.Z!4";B?T"H=M"Z%7%W_/%GJ%.)E"KQ`G4^C5X6PA]`K! MMA-ZA8#;";W"80N%GG_/RCOF&`/)8]D::SX/QSW6?!ZN2ZSYW&*.,8Q<8XXQ MG%QCCNM2FV?,,2Z^><8,<=,H<\CYI@I]'G$'-.%/H^8HTSH\X@Y MRH0^;]<0<4X4^CYAC MIM#G$7/,%/H\8H[I0I]'S%$F]'G$'&5"GT?,42;T><0<4X4^CYACIM#G$7/, M%/K-@/B'YI-\B]]2F8N M(PO'(NW6OZ.Z#K;%BW[W9\(;CMWTZ9`_?T=<)/C\QK'$)8F"_O^%AIJ\;M.$ MOEWZ>99%D;/O$:?IBO>V]32FIM9T]/^PRU;BU<0RUE[YC5K.W'JZ?&9._.G2 M9^KE:)1X3&W@RN69C[ND&FX];E+#O6SI)NF?]Y8N"?\*"MFTN:#V3#>QT-K# MYIA?XWMYWFJUVE$E>,-O:[Q\TC7KJ6G9RSF%RE/+=$4OVJWS%A;G3Z9TH1O/ MP!Q]P1SRD3V13]:"FF<-A]GZ]/O_\XKLDO/CK,Y]XWC'^ M3TBJR[ZZT'M]!F]_\QQ7GS['223MSBJ%Y)L5$K]I$$%C*)58/(".MR7ZRXM] M9H1.)I9GNDR#YFWBSAF96(L%J(?C@GZ0)VK;U'0=HCN.!X6`[(EEFFS"5>A) M=^?$\FQRP^P9LPF(!K&90;$Y&/I'^(,L,=LVOTW;FDZ!0G-&7CF,<4'7D8B/ M%I3J-C#EM]].@]P&1;'%6Z#*)I_\=A^`'H=R?.=;H6:\&:`,^V)KU)PP01GV M9N;IX@F\OQ)]Q7;O76B9VIJ#E_/J4WTBKO1\]?_H8OG]?[5[P^^O[J^#'Q?? M?TLNVOUFKW5.?C$Q;3B\])\T.$K()DW7B&FY9,&8*[AIXZVL.N7L9?_C@3(0 MUV;4Y2S![CTQFP'7D'3H'G4()89.Q[H!1<\Y5Z)!0"VGAO%,YA2*0H^A-TU- M-SQ._<2@GL,`ED++XDIX#DN)QB:`Z7`N(%7L*[,G.OR&40+>6--D+W3Q^]I: M+*GY'(P]:BGB4(,X<]!@!^LEI06X;GDNBHBC`Y\$4X$"I"+Y<`E--YB%IYWP0;307QG,#>(>==AP802`PU@?HJ./:_!9W!WD:<%0'JBD? M&1VHHO"O1VIXS']&-)18P,0>VX>26B%<8KQK:70\T%K#2T/,&AI MC']\8MR-B!FE.]LRX6]A+AU.RSAS1LFIUP>W+YW0..@'D_S5`_L%\M87PO$> M)FAS`E9-;I[?X#7B@062EOAER;4V8;I_B9MNQ&JVV^)J6:`$J[M\LN%*':C- M!_,1_K+LY\C(_Q+4;8"R^&^!%E24,;AF@5'PC0<:7%O81$>8=A/,`=A=0_\/ M=[:$_L<(_?CIUQBAYP1^\^;1#@+3%ERW'6882+(PB+X]X0I&@1I@B.UPFS7V M'-T$6]H0%A7M/=CJ,3!["43J$^X650H\&I=G&&75JV MN.::J^/8_BX704P7E!@J3H'>4ABZ:#IW_+N4=#!7?)(S30^$R&9(.><7`%H@ M'V,&@"8^$7,1G<*$##[S1%@^E$,8Y8'HNV[B;+T(*Z-A8[IY3MY1&SA)-4LL M'@`>BBQTO&;^G-Q0D\Z$(.FAR0; M<[]Q^'P9&OAIJ"5.8.J=\VS;&/SZRW>>TYQ1NKR\!S9S7\=T(TVZ`XP)3(MX M$\H;`V;Q'W[_.T+^$M3YQ6&WTW>^,$+?-+RA9=;N]\^00!R^3VSZ^NQZ.!QU M+MIG/_A6$PM^\TZ;4?O^ZJK=Z?;ZPXL1N+NM;Q(NJ?!FB<2=%5)0C)CA'[\( M)0I[FJ/UE;O[_*&.LSLTVCKOPQ*G/#/]P.67X?)*N'!3?VFP023]]0'HXP*= M%NZ%_W)^?TY^O+JZ`]T$_Q?]QD6D+V!*%_1+9.\!(APJF"NJ)CP]^`VV;0)^%1AJ8?6XT'/?.Z5.TA/$OQ/^G6\C4PBQ M&4P3G@_-OB[15X-5@6<'RK]JG\[)>W_=Y6L^GQ6=.$-T3U3@[!6\#LL4+&#:_=\`'"X81&^.30X/`(@+C'`:8 M5G2>'9`/CL0=MR8^UGSN-<+I37BIT&2(Z]*O82G$P=DOE";+'UR^`/+=0\'9 M<(30**$SZ0JS[GB&BT;1,W!,<7U(IK:U@*:M.+=2C6)D!I,F+6GNP*M&KTR( M_2?=^7*-+?T6V;W!BMB_1:1P=T6G">QU;@<-/,6*_0'EP#V"RU%^ZI8S< MU_B*D]NLI86Q/[%>=[SQ;VC`/.X\3N(,%]Z8X+B-'.<+9?`@P>&#EI>\/A:A MSEP81S%WHXLW8?HCC_:1S^"/XH!0?Z$H2@/F:'##_PSL#E@SRQ'6`(GGP: MT1A_PIUI8)KN>H(/0.737)_,?0OH%Q/+QCDSP%9&0_P90P7`7RV`1[;"P%@+ M9HV:LDG M*TLV5$`V#F[`),\P1$>X0QC,)##W.HQ'Y?R>;'8&40(TBX^3/\]")0-C9FCK MN:E,=(6/(IO@O"@3J+@*%>GL%[S$6`VUC_X=O/%#]#S":%W>3D'8V5MKPA7\ MGKDX1SFQ`E<8;[O[^&/8A^0CXC]+;V>O+P-R3#>$F1;00[N5H\^<:O M\];Z:+GW4E_.I7QA-]=CAGH@LN<56WVDIFP?A``(<7,(?]_?TJ^Q,O@F]K MNL8O[>2^`CY_]['YRWWP&6SUY4JE*T>G_+O9/YH?;S^^6ZD5OEVI=4DZY2_#P37='VWK MZ]C=+\W].6-;MN6_8%[@,X*]=+W?OU;\&U@!!@?./[I]*=EO'[J^^!K MKEQD%I=@R.9W]LJ#]_C];7$)6@Y+!+H8XT>@&W@>?3:.RL6JCNTO;V#2]RN. M&;@H+%Y%O%^K<.^-@SK"2>KUOV^NUX-BL:H.S`+&>[#&055K.HW7"=_'ZF"L M\"V;QDK%GOAEC!L^!0>MMN)M^N]BI>V,TO9::5A?_C6D%UTQ9H/$>LMX+5XF M5N<)U$B(0U"QW>LE<*(2L6K@3O^L+X(JX,+?)V'$^U@%C,C&:GBF=OMHQVOX M!2*9BLM.H/,K<_=&6DW`?J[&&),/&@#2%HFP#E3?9/PH8G; M`HK4[2]719&ZS;^J*%*W,U,51>JVS:FB2-TF*E44#2M'T47E*!H=2-%N*2PQ M\O8UAUMQ-V,>:N7VP3S4CNV#>:BEV@?S4%NT#^:AUF8?S$/MR3Z8AUJ,?3`/ MM0G[99<5%+C61*&/M!^^.H]H/WQU_L]^^.J\G?WPU?DV^^&K\V3VPU?GM^R' MK\Y+V0^_6)]$+`")6,$7BCRU+-?$'I[,+IS1!4.* MF72N.#%ZMW^@VS^A'*%05HC-@_CQ6)]Y-COT3H+=P)GYR`QKR7`'.F"7!&XS MU[.+Y7IH7&Q%UR3L;6'*(<#0349,#_=I%HJ[I+-2<)FIE3C<`7KALTEH7*CG MSM%*Z@4;F`6=V%:Q7;:HHHEE-UP\T5@X('GC&08K`?=C\2HL+M\J'K+8.!6' M+#9,Q2&+C5+%9+>,(?612QA9'[F$`?:12QAG82O*&&TOD MGE&%'LT5G;3KA.]=VU+XB::3MIA0="7SCI.#OQF8W-!EH<#^Q;%%2^V[YH+J M!E&UI-E191YN?B8/UA+#T2@!Q8._X7G,2L'W/Z._^LS&WQ;?\:L)*/%S"1R_ M*N&S(@>^U@MV^P2JI96`&B4I+![[;^QYC'F$BD>^L_$`#QYT9"6@WU,\^E:" M_829_XDGOBL>^U=JZ_@]L0S#^5`X<.P3O9]BH.!^D\*_*-YZ+M\7P&,AQ6Y# M3T`7NX!)0!>[>!&98GGV-%8PPQ/0Q3(\`5T&PZ]Y8LO#=U(?@ET&RP/L,GE> M;%37QP[R2Y@)AQQRX##WFP&7HMGT2Z'/<2X-\9;$8+WO(@D.]L:XKIP/$FC3)"&M[8+2N0(Z#+$/;/;%Q*EQ&W MK/X6O,Q"^'PIK[[N=HSLX-VLGT%'QUBC7>2C2N0L5CCW6C_I*9[BX`U"A-D#'HI M$.IR8`SZ*Q!*5D"Q]@>R]A72/UQI7TDD)M;^A:Q]A?2/9.VKRS$R#/67W^&H M5+V&H>Z&<5[5YF'868-0VX7N6OMJC83];!VZQBW4K; M&_H!$W([C*B%2YD92S)XY@*1.HSE@R>?3'(#D M$VL.LI`]PRKTU#)F6(4H&3.L0I2-,ZQ"K(TS;.ZKF1R`LHUW[NN;'("RC7?N M*Q[U0!G&6R'(1N.M$"O;>"L$RC;>"F4AVWBK6P9G&6^%*!G&6R'*1N.M$&NC M\5:(E6V\%0)E&V^%0-G&6R%0MO%6")1MO'.-6^4`LM%X*\3*-MX*@;*-MT)9 MR#;>ZO(49QEOA2@9QELARD;CK1!KH_%6B)5MO!4"91MOA4#9QELA4+;Q5@B4 M;;S5`648;X4@&XVW0JQLXZT0*-MX*Y2%;..M+GU7EO%6B))AO!6B;#3>"K$V M&F^%6-G&6R%0MO%6")1MO!4"91MOA4#9QEL=4(;Q5@BRT7@KQ,HVW@J!LHVW M0EG(-M[J;LC(,MX*43*,MT*4C<9;(=9&XZT0*]MX*P3*-MX*@;*-MT*@;..M M$"C;>*L#RC#>"D$V&F^%6-G&6R%0MO%6!]1.V\W@[Z%6E(DJMGTB;;MHL*]! M.6(W*_,C=/&3HEL08HAI^<."/N8`V4V!?&-97XB*Y,0QK.'.>[;UL:%;?!_. MH6:(W\K&9\7[>Z#0:]CJQ]==_`>EU9^^K"M+V> MK'UUD81>7]:^.F>W%TYIW!X'!\O`450',9!`M%6##"4@"L7H0M*\0BD:29I7 M)T1]V2#W"3HQZC#:$HQ!F*-"'4Y'@C-4CY,EM>KW6QCL'G$RA5X>SA=`K!-M.Z!4";B?T M"H=M"Z%7.-5G"KU"G$RAS]MU48^SA=`K!-M.Z!4";B?T"H=M"Z%7N(K)%'J% M.)E"KQ`G4^@+<=QS`-M.Z!4";B?T"H=M"Z%7N+3.%'J%.)E"KQ`G4^C5X6PA M]`K!MA-ZA8#;";W"8=M"Z-7%W[.%7B%.IM`KQ,D4>G4X6PB]0K#MA%XAX'9" MKW#80J'GW[/RCCG&0/)8ML::S\-QCS6?A^L2:SZWF&,,(]>88PPGUYCCNM3F M&7.,BV^>,<>X'.<9,<=4H<\CYI@I]'G$'#.% M/H^88[K0YQ%SE`E]'C%'F=#G$7.4"7T>,<=4H<\CYI@I]'G$'#.%?C,@/J'9I/\2Y^2F95'D M['O$:;KBO6T]C:FI-1W]/^RRE7@UL8RU5WZCEC.WGBZ?F1-_NO29>CD:)1Y3 M&[AR>>;C+JF&6X^;U'`O6[I)^N>]I4O"OX)"-FTNJ#W332RT]K`YYM?X7IZW M6JUV5`G>\-L:+Y]TS7IJ6O9R3J'RU#)=T8MVZ[R%Q?F3*5WHQC,P1U\PAWQD M3^23M:#F6<-AMC[]_O_\X0O'0/Q.#B$OL8S>+@DO_OK,)YYWC/\3DNJRKR[T M7I_!V]\\Q]6GSW$22;NS2B'Y9H7$;QI$T!A*)18/H.-MB?[R8B#)EF>Z#K'9 MA.F/7")@:(@&+3TRC4QM:T'<.2,.A3?6E"QM2_/P_@)GKB^74`*$`7$?]0D0 MLV0VWKV*%2V;3*`CUH+9#C&L":B!1J#/V-@OY_?GO*([MRUO-K<\ES]_LFQ# M.R+-X>4T!G4&U,'_@TJ.X%NV'3B>M0`GMD+ASSI[IQ7#M#.R6<&W7G4 M@3%4TCU.F648;`)JHAL@FYP4Z-BCK@&>23"K^A,U)WY9FVFZ"UUP'.8T"'6( MR9C&-(XSIX^,F)9+V%?HNX[G&)`ESV0!_;5UH%+4`P(,S@'7DA(%K0)S_^J9 M,"NT&J33:O].HPUS7$<%#L(P.Y@VHVGL.`MJ&L#15H;+`T8!@5K-4LT6$3.@@M8(>`H+56 MYDR;X<$C.K,9P[O4'=XA#N\YW%!BQZ'ZC.JF>.GSB@O=6H-3P\-QYT;NG#Q8 M1`.&-LA3RB`X4%F?ZA,*.B`08"Q]`&\)HL29@!2N(6G,M!9H-7`LUP?KG.LW M*I1*9>K6A^>[B38G^G MZ8_XZR_?>4YS1NGR\MHR<3%C\XGUD^Y\N>;^#O[UP^]_1\A?4@O>,1L?@(/6 M)KJ&][;,VGU83Z,[`FKTB4U?GUT/AZ/.J']&/%B>\"=WG@UK+8U-=%AV.*_/ M.F<_M,X[PPR"8CC[4'0AHVBPB:)V>Q>*V!?'PF*/(&-0YG9Z[\+:,GKP":M& M)(W62>JVAC&2H'R"I-[9#^WS4;]W\9?OMH)*\NDM&[L?3,>U/?3#WM,)NUK@ M)!82A&DKU@AJQWGTR_W;.#W-[MD/_1;_7\2F-)@D,7CNUV:.>T>?OG;Z=?J:V#1[BK?T)XTL?/9QC@:4,?$%83C/G&M8" M3'OS[)=S_().1&]G$[WW<]!V)T[RAX_O)>P[D*+U(8]D0OP%[FPT/%'U6QZR M<#XXCL>T2&\P*\=ZQT:;.];I2^1B+UJV&+%W7T$5=8?=V;!@#%^&3(EUIR?K MSD52KD"O>:=6K$'[?.,X;:(C;B;D]9>ZL"]`@VYI$=U]^3#\<-?]9V`,MFEP M53Q@>0]O'YGS#@1,@TDF]B@"'TALYT7[[`><2F`FP8+?O--FU+Z_NFIWNKW^ M\&*$@_]-PMT1GA*1N$K"^5GQSK`.>D=+EZR4;X@'#7+/'2P2^G$8+)([;Z$3 M-L8_KJT%3*R$FTP2#!*?%\>9#N.^),F\4Y7M9W=Y-8HX^G?PQH\^_RKSI[PIPAH^M'7X*%?YK\M:X$_6_[KX+?_^L&FDR\WUJ.(U/IED@_C)44B M!>SD:O'D&[_.6^NCY=[/@6VVM003^'P]I^8L@955Q&_ESC.#,,C?F&TFP>4O M`P:!G&#,Y(J'0]S[R9PM:!P]O8#?PCU]9!^F_[CY^8/YB&7Q%0^>^PW(WOM5 M/\Q,<*UO]*],X[>0BJ&+5Y:7\*M?&4_TV>&[NPZO[5EO)+!@?".#PPG+9 MW]^OLC_Q(OALH&O\/L);#(WA\W*^6W@L]!#$1\,_;\C@JM(;<_PQK'2Z'M7IH87)=U0^TN\B^DE_#;> MF`5V,;9V2&W@>?1&+RL6J MCNTO;V"1ZU<<,PR]QJN(]VL5[KUQ4$=,IKW^]\WU>E`L5M6!60W@D/ ML8/$>LMX+5XF5N<)U$B(0U"QW>LE<*(2L6JZZ?ZL+X(JCC>^3\*(][$*)K6? M8S4\4[M]M.,U_`*13,5E)]#YE;E[DV.PBU\0_]**7T3%Y]U[%QZ'WWCA\6I6 MI.A-/(-2]#3,EQ0]BKX4CV!!%,.]QO4N9H42>YQW^NB<=LF9_X$VQL2#OFVG M)3F;,]67I!Z:DRJ@2-W66544J=O7J(HB=9O.5%&D;D>0*HK4[0]11=&PR-]0*SV-OJ!>:AEFH?S$-MT3Z8AUJ;?3`/ MM2?[8!YJ,?;!/-0F[)S"&5TPI)A)YXIS/G?[![K]$\H1"F4%WRZ/NWZF^LS#3]I%@C/SD1G6 MDA&J:8!=$KC-7,\NENNA<;$598#?V\*40X"AFXR8?']'H;A+.BL%EYE:B<,= MH!<^FX3&A7KNW!)[>`HE8$$GME5LERVJ:&+9#1X6*ARPV3L4ABPU3<02QME'5A?U>GYG4]6QUUS:U=R7A+9M2SW`) M;OSA=S<1W-E2*!?>6-HS>2C:?0U1RX@_<6W"S8"ZZ14KY@GD,NQFB%V"Y0RQ M2["=(7:QL^0-&)D$>AL&_Q,%,Y-NN];CNE M6"XY"04;DH\8\%!SJ]^^O2^VPQ%NL59S=9(LK=L^?,&]-_`T3>&>R4_/2V8; MNGEH3NC=4-];>/"%::K0H[FBDW93ZKUK6PH_T732%A.*;IO=<7+P-P.3&[HL M%-B_$[-HJ7W77%#=(*J6-#NJS,/-S^3!6F(X&B6@>/`W/$53*?C^9_17G]GX MV^([?C4!)7XN@>-7)7Q6Y,#7>L%NGT"UM!)0H_QKQ6/_C3V/+6IKQ2/?V7B` M!P\ZLA+0[RD>?2O!?L+,_P13:<'?7CCVK]36\7MB&8;SH7#@V"=ZQQO_QB;% M3M4?+5+X%\5;S^7[`G@LI-AMZ`GH8AAB%R\B">:]CK:D8(8GH(ME>`*Z M#(;SG!7ZX3NI#\$N@^4!=ID\+S:JZV,'J7-+&?``O)01#\!+&7++\!:F4Q;7 M.79)3.?89?*\)#7CV,5^/!'8_'J^,@2-`Y<^`R]+C[ MEK#IE&%:^#*T.09?AD['X,MQ`DV7+9:63>WG$N#?&6Q&"][R()#O;&O*'$ST M>7#.FKU"&M[8+2N0(Z#+$/;/;%Q*EQ&WK/X6O,QNZ[P$K+[N=HSLX-VLGT%'QUB MC7>2C2N0L5CCW6C_I*9[BX`U"A-D8-YF*82Z'!B88CD!H60%%&M_(&M?(?W# ME?:51&)B[5_(VE=(_TC6OKH<(\-0?_GU=$K5:QCJ;ACG56T>AITU"+5=Z*ZU MK]9(R,VG^MO@978T!Q2)0O6 M2_$_>'_"4T+J-FVFI>W\NV<=O,TJUJVTO:%XI8;I,*(6+F5FS$'LY%-D#D#R MN3('(/FDJ1Y(,GOF`)(ZC>:`)9]/N:]O<@#*-MZYKWC4`V48;X4@&XVW0JQLXZT0*-MX M*Y2%;..M;AF<9;P5HF08;X4H&XVW0JR-QELA5K;Q5@B4;;P5`F4;;X5`V<9; M(5"V\"K&RC;="H&SC MK5`6LHVWNO1=6<9;(4J&\5:(LM%X*\3::+P58F4;;X5`V<9;(5"V\58(E&V\ M%0)E&V]U0!G&6R'(1N.M$"O;>"L$RC;>"F4AVWBKNR$CRW@K1,DPW@I1-AIO MA5@;C;="K&SCK1`HVW@K!,HVW@J!LHVW0J!LXZT.*,-X*P39:+P58F4;;X5` MV<9;'5`[;3>#OX=:42:JV/:)M.VBP;X&Y8C=K,R/T,5/BFY!B"&FY0\+^I@# M9#<%\HUE?2$JDA/'L(8[[]G6QX9N\7TXAY[!V._"*'G*YMMK13D9(Z)ZH37R MLYKQ?=WJ-ACT.K+VU7T#ZW5E[:L+T_9ZLO;511)Z?5G[ZIS=7CBE<7L<'"P# M1U$=Q$`"T58-,I2`*!2C"TGS"J5H)&E>G1#U98/<)^C$J,-H2S`&88X*=3@= M"X52?*?0*<3*%/F_713W. M%D*O$&P[H5<(N)W0*QRV+81>X2HF4^@5XF0*O4*<3*$OQ''/`6P[H5<(N)W0 M*QRV+81>X=(Z4^@5XF0*O4*<3*%7A[.%T"L$VT[H%0)N)_0*AVT+H5<7?\\6 M>H4XF4*O$"=3Z-7A;"'T"L&V$WJ%@-L)O<)A"X6>?\_*.^88`\ECV1IK/@_' M/=9\'JY+K/G<8HXQC%QCCC&<7&..ZU*;9\PQ+KYYQASCQCO/F*-,Z/.(.:8*?1XQQTRASR/F MF"GT><0<0< M94*?1\Q1)O1YQ!Q3A3Z/F&.FT.<1<\P4^CQBCNE"GT?,42;T><0<94*?1\Q1 M)O1YQ!Q3A3Z/F&.FT.<1<\P4^LV`^)RZ4/;>?3:8@\]__SO^XNO"""K_X5_, MU/3IOYO-L-X?FDWR+WU*9BXC"\KI\9D[\Z=)GZN5HE'A,;>#*Y9F/NZ0:;CUN4L.];.DFZ9_W MEBX)_PH*V;2YH/9,-['0VL/FF%_C>WG>:K7:425XPV]KO'S2->NI:=G+.87* M4\MT12_:K?,6%N=/IG2A&\_`''W!'/*1/9%/UH*:9PV'V?KT^__SAR\<`_$[ M.82\Q#)ZNR2\^.LSGWC>,?Y/2*K+OKK0>WT&;W_S'%>?/L=)).W.*H7DFQ42 MOVD006,HE5@\@(ZW)?K+BWUFA$XFEF>Z3(/F;>+.&9E8BP6HA^."?I`G:MO4 M=!VB.XX'A8#LB66:;,)5Z$EWY\3R;'+#[!FS"8@&L9E!L3D8^D?X@RPQVS:_ M3=N:3H%".8QQ0=>1B(\6E.HV,.6WWTZ#W`9%L<5;H,HFG_QV'X`>AW)\ MYUNA9KP9H`S[8FO4G#!!&?9FYNGB";R_$GW%=N]=:)G:FH.7\^I3?2*N]'SU M_^AB^?U_M7O#[Z_NKX,?%]]_2R[:_6:O=4Y^,3%M.+STGS0X2L@F3=>(:;ED MP9@KN&GCK:PZY>QE_^.!,A#79M3E+,'N/3&;`=>0=.@>=0@EAD['N@%%SSE7 MHD%`+:>&\4SF%(I"CZ$W34TW/$[]Q*">PP"60LOB2G@.2XG&)H#I<"X@5>PK MLR)0@SAST&`'ZR6E!;AN>2Z*B*,# MGP13@0*D(OEP"5SDK1"PC`[2G$:9XTWF(6GG?!!M-!?&1IP5`>J*1\9':BB\*]':GC,?T8TE%C`Q!YSJ1$2W5P`\SP[ M"<$;8A2(&U.#%W;F..K8QCFYA@[-F!,P/`85CO?,!(7T1WR&6_1?&98#,HV* MY?RP\7'B5',L<'\FYK0 MY8_6(UN,82@ZK7:/N!;0M8!'G&0^`,TQ1;"DG"UM2Z2N;4!;%FB3Q374G<.H MK(Y0DF&`;EK$@#I0/DWFN4ZCQ9)9T^\T_1%__>4[SVG.*%U>OF7&.@1.L:WD@P M:^/9QPG>G_+5_<2FK\^NA\-1YZ)]]@/2!"1AP6_>:3-JWU]=M3O=7G]X,0+S MWOHF88*%]282\RT,\LJ,@7708L-LN%*^(1XTR#TW^B2<6W#BC.:`,?[QB7%_ M)6;]DCWG;!UG3EV'$2+,Z*"EOGWIS,E!/YCDKQZP&@2[+Z3P/7@"Y@3,IWP> M>(/WE0>F3EKBER4W#XDYXI?X'(%8S79;W&$+E&!UE\]JW'H$^OG!?(2_+/LY MFDU^">HV0"O]MT`+:N08?,#`^OA6"BV[+8RO(^80$^P.&'A#_P_WZH2AB1'Z M\=.O,4+/"?SFS:/!!:8MN!%QF&$@R<+R^H:+:S(%:H`AML.-X]AS=!.,=D.8 M;IQ88%(8`[.70*0^X?XGIRV8(98&<[FYT'1G:3G4:'"J79S*EY8M[M/F>C^V MO\M%$-,%)8:*B[;J);L`@KHP5ENGE.WE$;.$DU2ZQ2`!Z*+'2\ MS_Z'<`N9X@@,!O(:I$"\Z\N4.Q!`<)7P>DS`D+C:Y?^/PB3F< M2::AECC!G.*<;S;"NQK6I%F&N0Q-E)BU/NG.ESMP`N`!]+4=F>`+B0D>P>+0 M`Z^(/[D#)3E#7P<$VG!>GW7.?FB==P81E5DX^U`TDE'4V4A1)S>*\)SY.D7= M312UV_E1U)91U-M(T7`?BM[@<>G;:4P2,R=U/,1^/)/Z!A.&?_#^H[[?@7>. M'.+AB/RF]PR2RICSA;/KF=2#A0K8LDGH+&\T<;"@`O,^9@R]6X;Q">X?KZXH M:>07P"P)C<#,YI`9,\'CQF49O&=+5]1%(_N+J8?NN1.?D'\YOS\G/UY=W<7] M!YP7EC#+>NCZP]2/+=@>(HAER,PSA%\?+-CNV<2S_44-E'CW=<)7'6C;%SJ_ M\"Z.>?\NOJ)MA`O^94Q8^.+'GYHB/NGFE)\:QUDZZ=Y/&,S>T-E8"4[*U+)< M$Q?V,.-/8%GCX7+1Y,$F`Q%OQA<8ZY`;-P19_@IHW1!#L6N/$=$WGST&4'UN:&A@XEN&Q!*.3 ML9P=:#9YL(/YW@LP.1Q8X`@,(/<]L,TK0=HG[C.A!X)9"$#WFW\+J7]FU"9B M8;K&XC4'Y-0L%ZQ6%J%K!RZ9M=1-[C"[Z9(I'1*;30WP5;FP4`TQQ/-78F30 M<,&RVP^93'QK(L81=1-?>K:(O$6UOX7U!7J8N`R`0?;M!8]I@#+S\$9("[CW MNK`"+BS`3$:ZK8:_"!-JYWB&6!=889B"OYE09TZFL+1QA)<-'0A\8Q\0'6#4 MU,`^!6V%K_WX@AN2JW-;H_&./O*U2U"'Z]J$FJ@-[.L26!;&RJ8>0*,T9MH% M*?<#5>7:**:*T%8'P33L*ZK$T]P"4]BTGDQ<>GEC1]=TH)AA`,4P1"L_#AQ_\D'+@C777O;%N*^Y-BVIQ7_'#Q_=G M/_0Z@W:_WX_Y^6HHR[>W/5EONYM[.^BTNX-V/GUE7QSKX`;!77\$KR#>U[ZL MK[TM1G9T,6KCXD0M8?D.[&#/S@X'K4ZO=9&O%-]CG%Z\>.NAG;_C-E94B`$Y M47]2(I\;^]/O7+2Z@UA_ML:.">/6=6#%\ZA;GF,\_\2,V&C(@@;;4-_KMUJ# M5LL7O3W)V*84P<7N#3B&;9O):@^9?[MU")4[X2XFJ?[TARG((U\GE1 MP:`U(F7ST3:,;2?(6T=8"0;BFN)V^EE\ZKNU/^&.K7?^QUQ.>_C2\=\Z493P M0C+)=#O=K3C9X9P\B(X#Q%8ROW0[_6];"]\%T\%7>QVFMJ&$Q[\[QJAJ(NR.:5[A8F>ZT; M!U*DTL2/9/-0=Y?)4I6)3ZF_U$4X2EBTB.ZUJ>FB`VP^^^&N_\_`*]JFP9Q$ M13;_=+>8?SJ=8;_?KZJL2*:K9*\*<`>4=`4F>8GX;.G9*!/[<`6.(&]P1Q=& M(YGI?.+9MO7@N[*?O,BPO7C5YFK]=. MVBSE1"KBP2W?D.'\R!G\P=?J'VW+<2(NR";K[A9!O;783PY4%L@&F8O0W2($ MUEEUZ')G0Q!C@^;'_D[QM^$WMK4=`YU6BG-1Y1T#.GZ_9]_U\Z[%-^XM<)\ZP<[)E=@UZ`(/ M@H]1P9`G>DA)M%?`F3/#(/[WIVC7`'9&P],F@@>?/#R=U1DW.T'#X1:$JXE[ M'C;_#9F"4E$C_,C+\99AK)3<4'LR)]UV-,SX"1P+B>8T9$GLL[#L'$+4KY/_ M7'P;R9F_J[`7&TN4`DI,]@2,Q5T9P#WYQ\9G'+6@6H.\`U^6Q"+!Y!H$OI'8 M[QI[>>^-XWM7N`ARJ8"1HB:YFMF,A6<<[@S*MY;$SHE\8I8]HZ;^'__D!0Y? MA.07#%N)0_'1YL2^@9H@Z\$^VD@"HHH-LD(TZ)Z-`B7V\Y@^Q?'F&NL(N"^> MZGQO)Q7;9F%^>-0?\4%@%H*M+Z$P\C,1P'@@C7\%3C3(A*+P%D'3A/KH=N(\ M10-E/`ABH+J`?48>B\,6L7%9>;6ZIRC==J,[:*&7Q!E"C[J*>'&8?J-S MT0*FK<#$96!];)+8<_SB-GX.-X.!:#5]>5C5@D M'0_`^'ZN1/,)\8Q9&FK&CRXE6#P<-8:K/?=Q?'T(=HXED6+[RFAT'"9P"U9M MD+]5"[OJ\?'F;:.-YBL6?LA)/JHG'N33F#,!KP;K,,-Z^E:X$4M@R%=^I@!L1D([SY.L M_E-`?5S85J4ZOG=F:N&IMNA813C$Z30F?($B#Q,4Z`[\LO3W]$MM<@.67<'L M"'/T0AP4(`XXGFX3V`1B%9^J:;"=%4]R\C.#-)I+0_WGFY#\^<.?OW2Q%2L0 M0W][%Y\Q'>;O78H?P^.ZD^&E+!ENKVJ"7"XMM&:1UQ+?T\I[`2L7G-K]]XE- MKN&.J22QJU(74PK*_>Q(`&40W,H\67QSV:.N>>"7(_7"SJ_HXX+^QL]`I]I" M3F/,549FH%&8ZA,LR;=N6@9NI;7!WP43M^(KA00F.NYO`HL=PYSZ[D[@>XCC M+*_HMX%#8S,N*&(WGCF!%4!4TS`V3]$)TQQGS:NGN8Z'./DL*%KV70WB\&G\;3D(VB^]KYA/.(S-IL(L. M5\4+DTOBR2\7P@5_[%@;#OTGAM_N`SOQ4EPSAYU< M+9Y\X]=Y:WVTW/LYL,W&B<-]]L]/QRIG%?%;NP&_AGCZR#]-_W/S\P7S$LOB*IQ;Q&Y"]]ZM^F)F6 MS6[TKQCFQ(L1W=7*\A)^]2OCB3X[G#/H_H@9!F.7JZUD%HP/!'!X8;GL[^]7 MV9]X$215T358;RP8CQCB\WD[O]XOCF`,)PE#<'$Z MY2_#P37='VWKZ1_F"HG*Q MJF/[RQOP6_R*8P8S-(M7$>_7*O"0EJ@C)M->__OF>CT,UT55'3R']1ZL<5`5 MO,UXG?!]K`Z>W7[+IK%2L2=^&>.&3\%!JZUXF_Z[6&D[H[2]5EICT[^&](J0 M-TBLMXS7XF5B=9Y`C80X!!7;O5X")RH1JZ:;[L_Z(J@"*X_[)(QX'ZN`)^1C M-6#!=?MHQVOX!2*9BLM.H/,K<_APKS18GD5_S[19@!"QZOWAD; MO8G?+QL]#6^3C1Y%>;3P*WX,]QI=3[PS5V2`WBDE5ROEXEH_?56,B0=E_DJ[ M`GK._"OI52(==&-O0)&ZQ,*J*%*7]5451>I2IXJB8>4H MNJ@<1:,#*=KM[G(,F7P]V`;N@WFHE=L'\U`[M@_FH99J'\Q#;=$^F(=:FWTP M#[4G^V`>:C'VP3S4)D16JKN#F1(4N-9$H8^T'[XZCV@_?'7^SW[XZKR=_?#5 M^3;[X:OS9/;#5^>W[(>OSDO9#[]8GT0L`(E8P1>*'&:XP<\,A2)3$W#%E[G" ML='S9';AC"X84LRDOI>M3I_Z![K]$\H1"F6%2.9H3FA<^"8]9DY861:F'`(,W63^[JA"<9=T5@HN,[42ASM` M+WPV"8V+O^$#=V,42L""3FRKV"Y;5-'$LALN7F51."!YXQD&*P'W8_$JS'&+ M#51QR&+C5!RRV#`5ARPV2A63W3*&U$_UF4E=SSZTIS&&[DK"6S:EGN$2 MW/@SL^ER3G!G2Z%<>&-IS^2A:/]UVRG%>IP\IW#/Y MZ7G);$,WOQ2*^MX2EPZJ0H_FBDXG;:YP;4OA)YI.VF+BW6(YQQ3IQ4X._F9@ MO)J#$SR5P_*J$SXH<^%HOV.T3J)96`FIT.W7QV']CSV.\U[%X MY#N;B1N17%8"^CW%HV\EV$^8^9_XC\\6]L M4NQ4_=$BA7]1O/5@"YV`9.`+G;QPJ5:W&;+"F9X`KI8AB>@ MRV`X3_2J'[Z3^A#L,E@>8)?)\V*CNCZV95CVU#/*&?``O)01#\!+&7++\!:F M4Q;7.79)3.?89?*\)#7CV,5^/!'8F/^A%$'CP&5(&0D1`RY#CTM;=I2PTS`&7(8><^`R])@#EZ'''+@, M/>Z^)6PZ91.W'/V_5P"_#N#S6C!6QX$\IUM39F# MF8(/SEFS5TC#&[ME!7($=!G"_IF-2^DRXI;5WX+W.%##L"PEWXN3AX]77;X2 MN,D3"2K'#;^R!TD8U?(N;6/=1XO<+^E$Y9G602O:H3B;N^1^KO;,[*"=;%_! M1X=8XYUDXPID+-9X-]H_J>G>(F"-P@09@UX*A+H<&(/^"H22%5"L_8&L?87T M#U?:5Q*)B;5_(6M?(?TC6?OJYFF""2Y5R*K&C.:!(#&H.**F6-0>L5!.;`Y;XDZUZV7XG_P_H2GA-1MVDQ+V_EWSSIXFU6L6VE[0_&>9]-A1"UP95J&GEC'#*D3) MF&$5HFR<815B;9QA"D$V&F^%6-G& M6R%0MO%6*`O9QEO=,CC+>"M$R3#>"E$V&F^%6!N-MT*L;..M$"C;>"L$RC;> M"H&RC;="H&SCG6O<*@>0C<9;(5:V\58(E&V\%"O$RC;>"H&RC;="H&SC MK1`HVW@K!,HVWNJ`,HRW0I"-QELA5K;Q5@B4;;P5RD*V\59W0T:6\5:(DF&\ M%:)L--X*L38:;X58V<9;(5"V\58(E&V\%0)E&V^%0-G&6QU0AO%6"++1>"O$ MRC;>"H&RC;LZV/#=WB^W`./8.QWX51\I3-M]>*/[NM5M,.AU9.VK^P;6Z\K:5Q>F[?5D[:N+)/3ZLO;5.;N]<$KC M]C@X6`:.HCJ(@02BK1ID*`%1*$87DN852M%(TKPZ(>K+!KE/T(E1A]&68`S" M'!7J<#H2G*%ZG"RI5;_/2BZ^.>!(Y3@''*E`J\?)D.PIPMA%XAV'9"KQ!P.Z%7.&Q;"+W"54RFT"O$R11ZA3B90E^(XYX#V'9" MKQ!P.Z%7.&Q;"+W"I76FT"O$R11ZA3B90J\.9PNA5PBVG=`K!-Q.Z!4.VQ9" MKR[^GBWT"G$RA5XA3J;0J\/90N@5@FTG]`H!MQ-ZA<,6"CW_GI5WS#$&DL>R M-=9\'HY[K/D\7)=8\[G%'&,8N<8<8SBYQAS7I3;/F&-,<=TH<\CYB@3^KR-=YXQ1YG0YQ%S3!7Z/&*. MF4*?1\PQ4^CSB#FF"WT>,4>9T.<1<0<,X4^ MCYACNM#G$7.4"7T>,4>9T.<1YXQQTRASR/FF"GT><0<0=VF"7V[]/,LBR)GWR-.TQ7O;>MI3$VMZ>C_ M89>MQ*N)9:R]\ANUG+GU=/G,G/C3I<_4R]$H\9C:P)7+,Q]W237<>MRDAGO9 MTDW2/^\M71+^%12R:7-![9EN8J&UA\TQO\;W\KS5:K6C2O"&W]9X^:1KUE/3 MLI=S"I6GENF*7K1;YRTLSI],Z4(WGH$Y^H(YY"-[(I^L!37/&@ZS]>GW_^_N8YKCY]CI-(VIU5 M"LDW*R1^TR""QE`JL7@`'6]+])<7>_<%I.L-<$>?.`U"'>+.&:&3B>69+AX; MH9/_\72;V0UBLXEE:TSC)6Z8/6-V4%YW'(^:$X87*#LN*!40:O,W)G/)PH)_ M4_L92CO,=;#03Y:!P^UPI,62FCJT.X82B$*7N@N<^`\?M'/R,->=.$5/`*KC M??+ZA!K$M0"'NE#/\0S^?FI;"][0([,=T!Y.:8,PKINBL&F1F65I3[IA$"!4 M-UUJSG14!I_$)V:SL,/GY(-)IKK!"7[2W3GOV?V[:[S^TV'_XZ$IX'0$?&E` MDQ/#X^=N7"1?U&[P(O#;!8U`XD%G@6TZ_.6X8"7PPO$D>\9XDRV+`8-?BA+A@X,,/D M#EG.?UTM4$,<3OXX?^8%'2F%>QP4M!+-@JUQT\.U(*GT<:LQ\W1>#F1-\(F; MJ+@Z?!/7GU=+FS5%*]\2,%%@PX1E:Q!X,V6V#7H@3!V.PA.U;8J-X@]K*>9A M4)JE9X-R`$'))B+KX(0#N01Z_5^"P$9"UT-I,,!*:L@'(,!SA(5ANHT&<,F$ MO(0:::,)137&,D"%U"IX)C@F8!R@B/VD0RE-=R:&Y:#A0W,PB:3/;X];QV!^ MP9%HG_<[W8N$YC96"@PZHU9F@5&_EVR!8(=]KDA:EIDC;WK M+/[%1`Z_`G='PP5;T)5O&YS.:+2$Q980`#XI`]L2FW'BLTR<@DZC+Z,@,HQQ M4TC`*:8F3!S,GN`4`/P3WOP?DP9XM;5HTD)##$XALQ=8+5[+G8.7F*SVS*B= M$!V_CY_]3B4$!^>@E?&">@K#"&L1EBP6'=>CIV^\[7K+M2N6U^[7HZ1!F\:C!E&'T"%P[53NE4" M79R(:_,,B0T75NB:+V*?R9P9:)9CC2OC%+V#(P1Q@30HZCORJM[H]$P'WH7:(GG0Q[Q7M"$S1/ MP;"NVREATY(C)3=4'[A7SV<#$17!@!S0SEGE4/"RA><IVKC.J('5>ER0W[.QS9\. MQ,.DZ/K82;;'V3-J##NI4QIT.18,\>7?"2@'EIV3*X='93!,PUT-P.,!)AAU M%Z!6!*C;:G139]`&P=!"G/IP7IS9%BQFP/A/&-/6W9Y.'YM=68B\&G^[YAQ) MW`2-C5W.R#5_@;HN."8>C[H&D:#UT<+`E<--GBUP:F* M1SE`-7"Y0`Q]P9PY*80+0'#^`&*,4%NS<>KT#7/<9#2P:O$?NOYC? M39.2^',G%&OD6DH.IW&L-_'$$Q2RQ,=X:8H()I__Q2A?'$QL1.9 M*SY5^1_(D!K184[A2I_YQ\\-BR!H8.NPSHI)$^XBI\`!EQ>5'3\7CW4#YV?? M^/OW*N.W8&$7^5R/#BE?V(04^\6#?L6-L%6,2\@%FZI7'_O44T^AQWQ]C7I>Z[)IHO)1O$ZN2M9(H/D:EI MD50)=Q'`?N.;2@*&PC_)`'!J.#"'[;RQ8'Z&LO]5M4!Q<@U(-K![3&J%CS>US M.'/XPMP(O/$4'J]\OND)QD� M6Y*5;R/@"_3:VWO14!O<`U`\&_CYA8%+N5@:UC-#]G(WPG##3^]:P!^^9T=F M9P*VRC[2KWYFBRV$8Z9%7RR8IH,U!\]#3!.)O3]BQE[Y-"1#RW(?AHU!J]/H MM2[2.!3N$`I"AN'2.1S&D[R0"-AZ'[\:&")>0"72XM#(TEK%J6J1,?T\'7FNJKDW@4 ME!#X9XYV M?>JYGAT8\?-TE?Y.TQ_QUU^^\YSFC-+EY1OS_\_G>$_"6H\Y:-W0\P3]@>CM%UM+$@VNUVA^Y6F^C:Z[,'.NNT^F?B M2]Q7]Q.;OCZ['@Y'G>'HC'_WXD]^N7][QVR^'>Z,:&RB+V#E]/JL<_8#KG$B M>K?&%B0SF!5O'$[_&H'#=0*[G?X.'-R3`CD?!3?6B+S81.3V M7$P@*.+A:-,@5X"'[98Z2 MM'H7"J`EEK@[;&5#][N=H0)HF8T=MK.A04!5#+7,'N3)[&#&WG5[0_D*KDE>7>VI7D3U[>;SU>X>X(:UP9U'.ZL7Z\2*;&5 M&XEL=P8)&K<$35+Z0+_"3"=V3ZQ1);&CFT>VDR!*TOX.!,CYR<`-=B;C%A>1/^OB:XYD6+HR0[N)'4DR M4B!VI$-F8S:SPK37A08)[YF(XVS_!3?PR5X9A/=U]_#%D5/*1W]9WV8WQ M(KL=!T^C^NGRLV5K`4R6\.&CV,BOVW92WP2MQH_S^9LP6-TY!>(&KDGCZR M#]-_W/S\P7S$XGS[#R8<\-N0O8]J?YB9ELUN]*_H;N%Q7'>UOKQ$U,*5\42? M'QNK\X@EVDF;YRUCMMR!A/]K6TY7G6E/=38S^ MVIMX7Y?`OKL9;Q>6"G?4IC?4_A+O]7^O#> MT)8+W6-\8'E*3A^6L;;2'T?"-9W*9*%[Q:7 M8!/G=W8"4SQ\#[21Q248"O`QZ&)LZY3

.6ZF'B)T8$IW+#0( MWZI_69@4K6,+/&D>J>B=AY'@H?#@)6G`8>C6:_-1_ M#W5U.,;'N]:L5#U]-<8!$W;MF(=.F+33.XC"_JP('DYA-'KD`RL,MB`>8M$< M"2DRZO:NYX_T3T+"`S7N<1?.K.*V`@'<"N1C,>9":R,NNL*QG0R_B=%]XWN* MTVH%-54ZSVP4QL%/E(\F53$0VU#D8WC/RP>P6]3U6[HJ/UW%Q=/GJ+#OU4#0 M-;"^X*@K2-G!ZSF$J4:XF@A?I'#3W+MVL1//*OD7^QT->Q5,Z*`6-3`P-KC6 MT0?20TL@3CJ'5T8FSR`DEAVY6QJ(2N1B_-TG9]##>]\,84\DQ0-,8^MOHML5 M#U`IU6L?HU*JTDZWI*!_5H0KI4JC`U42%+:,5"EM:3Z!2JD!U./4)JRL,DIE MHFO%2)6)J=/:="JE&MO)\%N[4MKZ]J0JI039*$REE!`?$4FC>PT,/L?Y[V\S MSF^2DGEX7N#524V:8*ND:DT4*ARF9T"B0JHQ$+VHH=0+6!T5\IE0P!H-\RF. M&H$%725Q0#%PA42E$;P^,BW*H%@2U=H9A#M$JB@^?W8G,!\WF,_.F`=WP9FA M?LK)7%/E?1T_QDN>+/$GO56:<*:\#S518&;3,R"1S&D,'&V&ZD`OQE1WHV`^ MN9P15U@S7@80(\UVM36BS75-@S$HYG):.X-0A\CE=DA_BOF*W/'7TX3Z6%/; MHX-]4BG<]6U>9.5?@?*T8W$#D[&]N"#\>?QKPJ15+2O@"7`GO&>"Q+XU$B:Z M?['CL8.Y3X.!H?36B!W.85I4T:6I_[V-DO(Y/GV\^\(7VRPN8I[?Y/F6VV]$ MA5(PD,I,"H*0F_T7AZ$[HUWP!&A0UWO,V,B44\([J:P2.TV:=,#'8.)TQN!0 M*M4K&DZN$\(YB;&?Q;PQ`2\O'-W#-:X\XB[-6%Z+.6-WB)=-&KV3&M6]BQ-^ M4W"PR:ZEHZ\ MD/C8`-3=$5)9]0\FU5&C:T1$XBX\-O,`ZEKC(]7("XRGQS[TMS:H#`Y+0V*, MNZ.0C6AUP=;1]WB]7;,?XH0MT]4JRG(FZ"07&G\\,PFV]\Z>2R8U=G[YU)SF M>/T]AAI`JX4.'$4?"PTRE%;_LC#CZ8XM\(/J(Q57^U-.?@H;+1 MZX>.EP^%#Q\T6]`TT9'SN_2/L4?.&I68(^>.2GJYJ^:I$!PY=RT=.64]-@!U MY"R5S7SDK$,D;KYKY@'4;/=(-7*V.SWVH3]R5AD&G\A>(STQ9I*F]*@54MX=C4),]@,F71HTC92E[7]7)3?7= M19VV?!+9C?B"$+L8W[F:&AS<1(EJ53\-)$-X%EY@U6H;X&)RP5/E9/5B)QG7 M]B%L?C[F%CL&>IF"M:'][-+'S_QNK]/J&^)IET>>=G$"KG8YAJM=!D\06F>W M&Q,#13ME0G#0#A!&"OV0"<"A>%>LM'O5"+EHW\-`"1:J%ZB!@_Y=JT'0OOU& MX_PCN(5?]"ZI*TZ7;Y*E*Z\>:^KA(R)BOXS*7F+T*7F3TIKDGA[B&)/]?`0X M!K\7>RDN^%%%6]/$3G[A[V&^&?N(64#W])&P`C3>;THCK9/G?I3FE_/M7 M:5Y\2E?QXNDK_UZ\+)7_KHVJ/IT[H=:M,Q"$?"R%"LJ..EW0Y23JJFDG%U96/VK?Z_Z,5D-S)3QE[.I`!K#V?LXM=%B`K4Y)P9J1#@K!K*JZL2 M0>W7XGLR<60,?W7(3#`]-G#U-\T*<7GW:WY;V&.1J7$G]J@;`\'39`E4;-'H M<$&=LNN5_/Q9R0-K)KYAWPA&".,K5B#,P26Z>%)U4N%G=!="8G2MJKZ^)!C[ M59H\\JR(Q14)XLLY>9`#)P_Q(4*<6VHS+D$UM#4R[JXM`EJ.[,#@V[T*7X@T M/8_9]H*)KX@MX32]70M4U,Y@QDG=QP83G>\$Q,CK=!W%B2M*#EO;<-*TQD'* MH2U(6-DIZ8&6NJ\.+]775!%S]*;MF%&ZAA4U52\'W&A\:43DQ/=)?!55VR)5_6K77(P]5VC%PL;3#(QWT60,R!9J0#\R#IOFH)9I5D5H*U+9N5 MPEDCG941<"^?-0HN6*5"'.BT5]+T(L)_R'CK\N+(2% M<7(O"]4QSZUU8:_.^IS.V!F:4!TL!<^XS#J]6,XDZB`?VC=D34N*=6<_%S*1 MCKL+&AC$(,1("%1<&#O$VU1#^7*U%"HO$_8R*?]4/B">%-5%'6+Z_.W8XCF;4;#`$X6@<4O>S:'+!N$W+5M&!U$]9JP[Y5K:B$*E?O MZ`+6SZ\Z0+5T5T"4AD?B!",7I<-=4TZT;O,B79,DW:2X*2"*:1,M'L?(R M/QGWM$<2<`1N.PQ$6_?-Z3TDJ6),YZR0*'>ZW?` M1B1?$]RYP$_R/G;5_2Y8W5/21*OO!():/__44LD0=]>QBY=,/>5,!CVHT=/? M$B08R0O8^!W/,E%IK7I*_*QX.?PK1W(9?^3)EFRX#0D%'=5FH*96Z]C@.8K1<,M-UL`PI65F4.Z+7( MN)(-9%2235B[#37P.CI&%[)>'M6!J;FW`IP47!$GMCCH'.R3T^HWA)EOY%JJ%B M>NE*;!QTT,#!["`!_/_CG3Q^\2%=+4OR??//;5P\V:X_]^FK0XFY+RQP7.P$ MQI)%I0>\C)+$GL8\7<7+2"RXW/61JS_:VQT_94VIL#H#6@[_6V+_S"K![(?7 M_"Y>Q,6/]*XP]_(Z/:0]G%:+WJ_2/W)T"M%WTR%=T M@0:\UBIPG*LT><&[*T"@>BGF=\7![GI\E_V8[$@9JWKW,$'4YE0&9':Z&@%I M=\4`.*R8012QTD2\;=-^9Y<^.B2J^\!"T607,!8UJCS`J)1P58?&_<>T]D0[ M>8`>;`Z.HT6;JJ\!;D[^%@!O7Z,R1[(![*"1#E%U(U@('6@&QDPCVP,D59?V M6$]^0@T.A^]+[_^J]ZIU>-G8X.'J]Q_`I;\L>!)E<>H2.E1M=0Y^V!;6SU5V M`+O[D0H/KS_H>=7\BV8D4+Y0/0(,[U\+A'8?`QZ,[A(`%B^W>9SP//_"[]>N MF96ICPXFZCZP<#'9!0P;C2H/^"@E7#6?LN9CFG@R>H`>5PZ.H\67JJ\!9T[^ M%J2B\#86RYSB:/5)K`2/T\2]LF#MJJ\P&+I"5QJL5H)7'$P:O2H/>D&Z"D1] M>C+[\L!Y0;KN8'<>4_W!U?4,=0BM"&,]PMUQ`Z#YU2K*\[J(Z1(Y=>UUN.VV MAP6KSAY@A"K4>,"RT_M*?B+W;,K:/I19O$,+K>-^!CQ9'2H`B'[A MZ7T6;1[B1;1R`9&NO0Y$W?:P(-+9`PPBA1H/$'5Z7[4_H0DA[8O60\CB&UH( M'?47[=.P!S[0Z$ M-S]KH>#GK-4%C8["KJK`5C5E55M6-;Y@LOD%:W>@`EQ/?U+@N)='=F'M)D:% MV,>!5Y:RV`^.;-[WG*7I9]XD7._KO\ MO!2:LYMD\9=3\W>'I8C8'A]X<:+>R.KCMVE6;RKK$^VT,CQ"GD(&.D=H[<8/ M?BK5PTBB*]$E#-9?WJ59LWMZ`M%0[V]>%&%S6Q^6Z,CRHPH2WC]ZF%1;``R# M[O6[Y9LI'3#?KHHHH7*L;`!O'Q05H?V=;'QL72:_NTA^V2-&&N5XQ$F-''2V M,-J/'R]UZH>1A5JJ2]RLFM1=V:XO?38Q^Z$7H[BXM`^G*.7Y\0HI=(P>3_56 M(,#D>""Z2-?K-*E&H6R[*?_*ZZ;BVW0SD4H+-CX&15TLA(2/OI_YI@3@0Y0K M3#9%6Y=^JNAJ[@?'%R[V`49/BSI'&C!*J:-CJXTR1!)"NI./J)'MX5Y*')OZ M:W!+P3,=(]=?*]],^+U8S.$8NZQZ`9RT/K-C'X^R?>/Y.Z9;B`%VS?`AI!OP MJF$_P`C.09#;$,XH"#-+=?@%J(,XL_[>Z:E);%7U>78;5:O.UAN>Y-71Y>UC M(&^?6+O=I^A)?GS]1Y25H:P6>K$;X>7B8J-*-R$BZ>>QKLFLN_<[YK(&@<[) M+$4DC3G@LYF!`:E>0[Z+>HKR#)?^@S]DP"AB]VB0N<3+-/T-00'-Y9^NFCIA M`X]S[#AX];3`<$DUD?U8/!A.EW/MZ).HUAWQN>'`PA$2T4;?0,!78HSS!57# M,I,432<`^T-?\8.YRL^\0"T%>()X7!\=/\7;JX5P5I'"O8WBC#W*<7Z9II4# MG4Q]67_0YO8Z=^+/<;97#INSVDEQFL\O650/:8-:X MC]>DG,[[?*;A=C+\IMZ".._HD]"'FH&\^+CR\*5L4S[^ZV>7_Z/^ZTNQIFMW M/MUF=SY=59R("O9OEW]Y_A/;B$.\!<$VB\%B4;2H;A.6JR`74?YP.B`8-!L] M%`94HMMS>Q`[?DSJ)M"H]H*N5^3QAN;SPSA"#B'/G8#@X>W/C4Z-\;*QF?JY M/R&++E>?CKDT63:5WWKLT%Y9N^+)DN!`U]$_?/C0XB$81=7GCN72VD?*<'B; M>GN)=R%4=#%Y2?7!_'S%HWYI\Q6"-4<9JZLS?_,X33[>M<[__<(79=>RO$!TWM!Y.AA@$-[)>F^./%) MW:VR_5+Z2/B_Y;75Y:K189-4HN7P>/)_` M;JE08!PTDAX;CE1&WMVR=\_"LJ:SSUSG2-4YC:4CS'F"%)>/13G-?4ZDO*QS M(K_YHH$%YB,AGK-&89QX_$E1H")S5]B(5>8)S9^"86+8/.I@5(RST&VO#KU: M8U,.AHS+/UT)%H]/CL6'K5(;[K$$*T.5B<"E(4^A/IE=X-&IYR\;(1-$+0^Y MJG#*'"=?(/)U:S^60BH1.0KWY+1IP'#\7!:Y3.2N!+!.-*'<-A@VA^7"HZ-S MG-S9;D:`G-K-*'2$7AX?9*5`IT#D&70N[C,-T`5/_ZOM,8=W@:LR>E4[59)^ MV`Z.4%3Z`5/I(_&.6#_HU=S[5WU([A9XW3M4`]#PNI6(:K?7@&0,S\#+[CI: M>KC(/W:K[.J]LS-R$K=LQ]--8'.2`\F(:49'3Q]7:>TJG9&3.$5G7R<)'D-U MX;__)0/Z_CZ%L?&.9-?;.T*Y"^JB`84TIR+69*X:,'B57QH^_+*!KAS/U#JD M;X]?0X*[<$`I[_`PK7KT*>8QHWV[T_/L804<(-\>IRQSH#%`!::C']*_+X?? MJ#&A>B0_9*EN3'C&R!.E0#V$@?' M*@-^#6!ZV,\*1Z+I([Q.'NNN^Z/%-,,]WLE_?00JV&C MZ2')+QGU"]=]S<$#5?=\DZ:4=E\)DR>:K#>K](F3"M-`FJ[Y^'#[B:,Y=K\;!II#CU-'C>HRF(_HM!(<6 MXE^0L=,W[/*!6HS]BHPOU*I%;I[B=1>!TLN4@#4*\+N+8&0/#7!11DLQA+.: MKLH@6-5$\]-!EV;T]]3PP4577ZT^[WTQL$6(SS2U0@C^C(?6\A$FK%6Z!TYX M=$4Z35W?[*?Z)G$]L,WK_.8Y;-[K-=71$>8YWT$#!>-/;:M-@(:#Y99@@I%P M=.Q?BFR[*,KVI^?9;H$. MV;>)A;?KV[S(HD7A',^..U@#V+X#$JB/+<(*42T]?="ZZZX.0M=%D<6WVR(2 M^V]+]_I4)D=)P;XUWVJ3D[C$W2DJ2S#'(D,I/H#$2ZYV`1H7ND< MCKE8;[IO=W;-N;3.&!*/SAATQAT:UK#QU1-37FD351#Y`,<;+"X`0?,:OQQH M(PN`;Q+7*=.NJCXN)/*>E]%*[`>9@X/TR&Q<7`1VX]&A:*\=1I63?"FBK.CE M)A[;B8X[SLI-G#;R^+M)=VL.F)N\&&4\)=7T_B13R+L+-_^+#N M\@+/77[VTS,5[NW>9E_\*1X\UC^\;74 M=_T]UBX%-;<^CEVZUC"X-ML"%)FT2AS`JNE[M?^"R6^8^(I]$U]2J?I:WG,7 M;DZ.T<&6NI<"2HZ>%`PW[^*$WQ1\[0B<3G,SXWM'ZSFU0TKJ)!4NY:8U7*,_"&:,8M0UP,;F\Y-C)YN=7]B$$ M@&=1&B3DM@4EEN86GH9>1&*Q!H>E_1:.Z#JK.)K:`A';R[8"R751B*:;'404 M%H)T!S"OTW44:ZO&MO;VH7;3'FNP?6@/VG![IZ;7@+ONK1MR5U_31)+BG;L, MNY5NXC#PKOHY#;TUGA4.36+-CR.0VDTM&*J:HL"G;04.TJ_>,FN4NSM2SU6Y,V MK]X=[#CV!H*3EZU0"'-5Z@(Z-UE7[89,M&2B*6NU)9@0^CF2`J]]/+$+82JYL<8TW;KXLN=\\*C*8/T=I<<7#LY8*L=B\\?'5M0T39 M@;*>6&O)T"'N@HE&Q.H2KI[AAC^M2SFA<-_;$8L&7PR,R#??-W$F8_#KJ-"5 M+SQZNB#SN"<>.M4V(B*TH[`G2H_DZ)&Z;\A$2\)8U?B+&UZ-SN:$V4,)CK@- MY:DH`RU7O2`N*P98PFD7E=,N6@WS"\9W;4_#8:T#*RR7#3V@XOFGZ$E4)%]M M,[$35A]@="V[`:7;$@J6.AO``H9"@1/:.OVNY(>L_O2"U9^309/V;:K08WGU M"JP<]U!B8SP_P:)KI9Y>#E/3,963)8=ZB`N?]O*1L'S)UYLTB[*G:IV^9/4X MN;^6>R)NDL5J*VX"_)1FLF36.FG@:_JA?.9I4I3/O[3J_B8I?8SGA;9RA:;H MF*T1%,&`&.T)`,4*#/L[=5.9KVW[8(U8EDE]X+M)+-:=.<> M")WAX:G+AMC8[5`IN$(%$Y\.3^#D"CAFAB",ZJ*(Y)&7703X-V6`K:XDDMO5 MY;'9DA7BA.4\B\7Q\?_VTU]^^NDYVT3U]4;_Q9[_=/'33_(_N>'PQ8N+?[]\ M)_E7*C@KWF"[Z^Y1E[\?R"E='Y9]GK^-,7%ZSLNN&+ M(G[DJZ?_8DF:<-GR\M\O_EK*_U__<=G(KT_W%E^FVR(ORK\(XNJO:Q673WA9 M57JJ9\+KBX3_[?E??OH/MBG[UGLHNSI>G'D2$KFS8LJP*6^:KO+7)8BOD^7[ M=+7,WTN_U>6MYM;'R:>N-4QD,-L"E`9JE3A0LZ;OE?SB@HFO)/7(+]FWZFLJ MLSV6-]V%NY-K=!"K[J6`70A?PDD5#+IZ.Y4L+U1NM1:?7K!EXUW_+[Z?JW/9 M`\)`]PI+S?5MD%_3FS(;RPNQ>$=;4#"U/:9E=5L8()GL`*)DC0H'["A[7C4? M"Z]H?4$$*L87VP6*@Q]T0*+JHX#(V&Z#P[Y:33W]1S)ORX,V65J.!(HGR;WB M2*^-:,;$6RU'3&*!>)H1.>0+PK?L%#S`N\".GE1+]SI]LAP/WZ;]/VKE>`'^UR3CB_0^$460K]'WESSA=W&1?^;+K3P1 MJ/R;N):L'"N^+9_JNVB3\X]WUYO-*EZ(`>67(BJV1?G1NW@=%[(PH4L/$#4= M)1#J##E<-T*[/,2DK[=/M:X1$5._Q0-G7,PZW\F_/O$HFY=K]8T% MSLX%5O;1R<>[=L2DL;^#778<[);?QTDBLI[YNIFM[C/8S:!N+-')Q[BVQ*2K MOX.].(J+[3Q[9EYEN\YDL%=U+S8)GE#>)(MTS)F'CU^4VH":ZC(;WA[B3?5,&K!,@/=R+D;$0CA-522'.' MEP^[\DL/8#@RD(MD9Y::!MK&K)O=:02M2QG\J#C M_&,&9H,%P"B0.U\>2H%R;XMNXNETG;YO!$5Q^[!14DPLO%VF8MKY&F6C MXSAWU`@&RTK-0)'J6+8#"`^[7/U:K?+8?5*&F'05+Y[8M_K_Y.X?T;S*+IQ, MK[R#EH/&"CC@NP8.CW=5^/J(8.)C+YFR)]B9T\L7@G+?;^5()4[NC:<(*ML< M,=]1&Q#O5NJ%X;UCT7:7/NQQ5?^3V*E^ZC?5<6?3"SWVY8.V75@$]5_G^2^@D6-7;T?FMPVFOK99:GPU\HNMO41:+ M=4R?RQA@W.4083SUV[/6T\A#]BS1ZOEM&TNE@ M]O[@N_J8Y; MFU[HL4&!)"KK:"AU4&I,]*LLEI<3.QR,E]WT8'0T]\T MX+1)T<+6VV$#POGC_A`^5PPKNMB`>]`%!ZT*JY`@>JBI!R[;`O9@%,O)JN]9 MJP%18*I\P(Y&O>=8(=CJZH"["(G?QO%]<&@8D;OC[KU7#W. M-6T'\+F@$X%_Y\(?YJR\C7\6I;-MN'IYN"KSO7 MO1\'`U#AQV$#2#@,X$%_*5`H@K+)@3M@5%TU`F`05`>EG+1?@T5.",^&FQ+TTHHT M9>AM`[1W7^Y)?I>NUGFJ+C=MW1DC[P^A4A,+@0SK3.:8R`@Z$VJP]-C0ZV19 MY[H]4D6[,(^5!/J,X^"F7M3C[/8^ M#*07ZD=%1&$T>D)J,04+3R)%_=**V>6[JV(VUU231!5I2D6D\<`T*-7%AQ/% M(E!M6B]8;+0!'!1R^N?LYRY+2$;V=.Q2D5;OJ,4BHQ7PWNY5 M,&J2SFF5C/"1TK-LA(>47>FH_6+>E7\K/VP^*O\HAQ.\_.3_`U!+`P04```` M"`#D=@Q'<.`NJ0V2``!7/0L`%0`<`&5K`L``00E#@``!#D!``#MO5EWY+:R+OC>:_5_;OW^Z+[Z(B M3I)OORG**%M%*<[0W[]]0<6W__/_^3__C__\O[[[[B)'48E6WSR^?//PA+[Y M(\G*:(.^^2W'^]W__HP)] M0WJ1%=5___[M4UGN_N/[[[]\^?+FZV.>OL'YYOL?WKY]__VA];=-<_K;57DD M:#?^V_?U+]M-$P'K)*,:QB?6J:#Q_[XF'3FU['?ZR_NJZ;M??_WU^^JWQZ;% MBM60\'SW_?_^='T?/Z%M=&J2?*+8YP7J)D9V"1+A/S3A6/\2Z*##IT8F"K M,P4N<&3:H0,3\TX]XAWE%NTBI-^I+A.KG=K9Z-3.RO#5O,BOHU66I+O"8!`9 MK"QV,++1M*6-+L1Q@>.U=B\.Y+:&\3,JK\@\(H-IGTM%E8L$F!OV`#LS3D%CIBT`DK'"+K3@Z>MSI=Z(FMM()DS[8Z$)"H%DB7*ZB?$6^^:G)!MR`DYWU"39:GF`; MW<[E:F&!DNNO3'(['=`?NI6=Q6V]$Z[?C2.]K:X8 M]L3J$<-C;+"=W^-B8=)`SRL2PM%@Q=;A8:E+1;3>&/:H86%OZ-;/L87CH8;+ M1)N5*B MQ]4ZBA^C8IV4>;E+#"?H;(86',XD0MJ)BU\*'.V39Z-MK(:!>6?6S]L"Q\G> M8'[:9F&I0VNR+-M&:P,;]=E8Z9A1=VQUPJ0/EKJ@'W5J8CLQ9Q6M8[PK#0-- MBXN-;KTSZ,P[6Y;)\6.$(KPO'\ULT^%CHVOZP*EH;73!Q")VK$`^;@:=J*DM M=$._"W8&PF`Z>UTI<@-^U(SL-$9@QW2E:6A,>B!I5,HDT,H>]MH%]$N*:,T^7=U MK2'*5O7!^7V9[^-R;VN/#"QE*K5&UL?.9I#!7I"5K2!]-_UBQ4N_Z,N'BV]? MS?FU%IZA#4T[N8X>$6`2S.*5YGF'%;WD\RN]Y//NIZJ370GMKNYR5)#I0(6K M:_*#CGCTM20SEM,F(16AV^5^]O^[K:.BH>J]'8%]]MHFCW/=7C>Y26Q>$G ME6;?O7W7W+WZ'\V/_W$X)B4=.BL*5!:?4=E3#]*TT5#_C/\J["47Y, M.B+_'(Q]]XY9T^+[797Z]%W\U-KS7N=X"QD@K*3F;:OKW_S'-USVWY3X&S%; MG*]0_O=OWWW[S>Z0XG5=6YVK;J5KB?("=7S*`7:.*M^A&&=QDB:512Z>HFR# MKK*!QG]$Z;X>[C3%7YK[ABRDV6/HPRMD[(XVN8695%*[^R>9:NKC'09%65SNYN#4`L< M>\@UXA@&HNT930?I1M*/'O!N:@^0[U4]1(]I/Y(*VW#VJ)HVWF"IVV<,WWR3 MH*/B2Y$AX->,]WN'0>N,1N('(N7L:\*;C3';]`)+KXV_PPM1"CJT'%[-L/[@ MPT[:V;Y\PGE2O@C&5]R8M^/5:^S_B(/45!UZ'M/#FHW.JOV:&PN`(&T/F0>' M`@>HLJJ($/`]@N)GEZBHKDV<1P5:7>#M#F5%,RPYW42MKHJ?OYS:W$8O]&=5 MB#O%N6QUFT;9YVB++O$V2C(.H,84U()V_93(]AM/81%;["QFKY@5-1B.JD2;/9!YTI4A7W(9Y)654[_WWV>%*LD MIK81`@M(U9];R:B"`IN:#0Q@)Q747B0&",$/VUV*7Q"J:D?=[*3@D[;OP4[0 MWCG@1IUV8W6;<6`Z1C?;$!=TSX-/+G,I+EVT`JD@>R%>+27E&QZRW1'5%2)7 MHG2_Q+.%WQU1CQCZ21C>V(UZ,.DW\A,5XI@D5%0%"NR8TF=O;YKVG]\/K'Q- M?C!!"GGU+(.U8[E+'.^K0)VM/F3$[B]7&;'HMH8->T-"F:Y]?`>C,_3.`L5O M-OCY^Q5*J&/^2/]!=?^QY8_D1_\X(SU9T=Y\3*--3TON[QMM&+]WNU&M-")8 MKB!KLQHB@_H?@[>UDRSHX%[LJ M;0H$OIA#DL)DF#AT^Q;E"5[Q`2%LUT(#IUUX4(`H;(H#CHQ3$OU$(*@[^B=* MT_^5X2_9/8H*G*'555'L!Q,RX7]P=O/= M/;41OT.;A'8N*^DF%'?0V91>92OT M]7\A?KCGM!O.`_KM0H6`6&%+7_Z^C`8$4R\0+O!VB[/J[*HZ!"MN]F7UHC29 MC?`1`2`:PD-(%"Q6X*:P!!RAP.,]VVSQD6K]\[_1N']VOE]WMZ[=AW>T[M7%[ M5Y'V0YB^PVG%T\F;]!SV2/1O+'(5$UW2.'`=W%EL\C`#3AL_W19*AHB"+N<'S;)_7OB`\<'7;@+Y)OB-+>WH#Y^_? MOAUG&EM7*+_*8M+GY!G1[M!%/G]:`R)HSW$D!-Z,-F>^HZ*O9.Q[:\%QO/V`^NFG])[;'2^E;<6X*I6/._KRGL^R;]=EJ ME=13B3KKHJEY\&]NX=H))-IR=8C$Q>4-1\EOUX>H`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`.:0%[G-&E4>>X]T6HMBJE':-2:%!,H`ZNYZL.137626+W.WDGY MK[6K?ME4P_OP%>5Q0HQQDUU$Q5.*BH+89O!]M,MT`+3"+-P21G6[P?5&2;3-[@ M.SJ:O%EZ['0C--%W=#1E`'[^\]1^;F=1^J&[)&"/R&.*1YP&:7M MW].[?9]Q^=^HO$,QWF2T,-;A=#&6D]20 MFUK#)L#\N@28CK7:,[2IXPI+]E3AI"M[B2+61B[LX-%5K(D9OX09,[0G54Z@#?]&%L<:W=]%'$S#083C<]T!6A'T>5PQ/S*7/YVG\=/ MY(>W>1+7E4>V.*N"(3$1O2!OV^G!`FVY/4#@XOAF8^2WZP.TTR`RZJ>>+6J4SWQ?U.+INN/BMX\+]3AX]RO[M'_XNDORJG$]V['MTSS^MAQY MR'_Q7J41\-MEAYT_'/F%ZZ8Z5JW^:+)=:TL(%]J61=BZ!L`4,6=_'6<<_'[% MA=E_W=SLL+UV>4AQ>:W)RBCY[?&6'E)\]R[@N;=Y>N'R!N,2%98W&-OQX(=0 M:TS;,MOR@.-K=?ZP)P)ZG__7]?'OY3T?WYZO$A&NLC)/LB*)JX-'V]ZO(=I6 M0%`2O<0(6^/F=]A0TNL0+=Z^LL4"O6ST":^2=1)7)%=9G%<$P[0EV_%"0[2M M>*$D>HD7ML;-[WBAI-?A"MXK"Q=-3*U66\>`^B=*-D\TY9&LDZ(-JGYY&97H MF.(TTDQ#LQ>6)QW*O5CBR0BCZ7=HT57Q4,\QS"AS3)@^Y3<+'T:0MN?EZ0_; M^^]C)N^.L[+M)3;3]0^-;C)SYH?=TUV?>[<9!ZO2<:C1(2QY;X>I84F8/E.; MQ9WS+S)] MX2<8!,'0`T/NE4#-/<1"?RY&U2KMI>G-^@'EV\)DLV9,H88?(%6AP;D:?6C\;Q>(,R^MS.%+5ZN/"2>>S=3 M@<-,\6@)'-U>FR"DW]M0)W9-DK)PH<]LPR[[ M;;`,'_6PH-K_(:,7/Z&;3/SVLP8'V"8]FX-SSV>/KGRO'&`0CM=V)`*VK-F2 MCH?@@4^I>*KR]IH,."CCU*?=*`LX5=QM,L`I8S?)(D[=69_WL1=](L36[7^( M>YRTO;SS8?W/[P=V(_/$O^K?,7_5L2GZ6J)L=4I$'%B5;OD\$LHD+M[$>%OW MH-K4*Q[C7105N,#1ZEOWQ:J;L[VSS29'FZA$WBS,G\AK7%.)%(*R6K MH2+#NZK<31.CZ>1=W<8J/207:+DJ@4B@LV`XJ2-8K%H`'KU>J)Y"7YM5#41Z MSF0#3F\,ZG(/9%'[X>L.Q>2?#YC^J&4OSBB-E`QEW!_+:5$&_7F=P"A1*!FT/?*+I,B M3G&QS^MB=$?+-,_?TH/58C`?+#B+6+M,>TYORM1=-+;]/F8_^EI_?[,7;>WQ M=[[%9@F9>'SKI:=AD<7&261:*Z0% MDCE'KYYPE,;W]'&5.=2G?_LVS&/"PV4%PM@PC: M)T(2`F]@P$E+5]%7`HI>NKF$L_UEH">/+9O-9AD.:O:(LE9W6+[MZG%DQW/7 MZWX6JJT)ZH"QK5EHB_&\'<2ZZ:=T*QN=]^96F+8RU4^+.[1KWGDX/N]B-=]# M*L5*BH=`BGL_G&2!9OQ,.72@;%C]]/,4BNO'XDW4X^#Y]-_UK[?%8=XZV"]?J;\@GEU:^J&XKDUY>H M_MOZD;E4DK7#)U9@:V\@5YYIT,9RNHEN#N\@VX(_X./W=]S"LV*M)9=^A'Z83JL%ON1+A?&'.'4_GLC#GV MMK](VI91^DQ9MLB\D]IEQOJ(\S5*2CIG9292U@U>I(@IMX# MV_%+I0=+Z'(\ZO.,6BKF>-77"5OW+<<(5G:EC_,"E5SZ$J0Y91"VR*)C[]I!J<=E7L^Y`%G&$74(#ZA[!BWQ*BYA:B!N.]!"F=*W5U MD+HOH[P,/4QQ*H^YC5YV.C5-6<`ETDT;Z:QB8Y;AS]1"352T^')K2&"_9KU] MXZ#H]:C/`D^CC_TTGN"!Y$$L#NC5:1TM7_4!YNDFS01UOE1D6IZ+260N0<-X MI(*(#Q*%YIT0#X^=-#Y^G.K.%D/8>'M+'6&+U^N/31#NSM,DZ+K&E<:/A)N^%#ZO%M\2<9\P$?: M?Q%:PN8;,UH6>-7A2O[2!="08SUN9;^#EH.;S0XN,<\;>(0>"FT:)OP]'`-# M^A,*_8EY2W";)+@M4L5$U-2 M\`%%LA5D<=-)/E+C'[VW5+2Y"\5437?&,I,0P$A?'^V2'%>2]0MQ#$E+"+`X M4L&&`*9JRE?]YU)1E%OD9?Q+9R.'`*:D)018'*E@0P!3->6$IWF%@-;BZ?.> M\)N06@SZGN_!J/7Y,>F=G;GD1H]5\X'$JSA__/[`3JNR0_JWS%_U4$. M^EJB;'4RYP`[]";X(Z%,XN)-C+=U1ZJWAA_Q+BIP$>TB0N[*T\_B&.^SDMH= MITF<2&^SR@EZGBLBL/=,\QUZ1MD>W:$8;[(JE8W_V+*L;?O)9'Y;Y]$%,!)8 M36-.$.`+.I8ZX`O0778;?@,F:5X;'!J@TR;58A8=".O?0AJBT_Z,=RSE;/*"^3@EB&3EDS[C.T_(;] M>,YH&`@.P;IJH4S$/>C5P%E1H/)JNXN2G#K,!9F:;1`O!5GB(>DCS3!X/Q%GU&)$(_1%\YX`)0]!`FI`@,9G#MC;`F M%!/TW=H+G,6(7BZA=KE+BK\>:(X)%VNBQ@.8L1L'AS"`SH;@8DLX)?@X0\B230-+E/0VQ5QF!+"K*NZA$]R7=-B#S1-KU:,-#C#J#'HI4&`2&+&W;&*%- M16K@E\P^XQ(59/V-DN(>]LWJ^`FM]BFB MBV2\(XN8E]LTRDIZW/&O?;*C/B3Z8JJ2][?XP>2!H5#3+D;8A,ML$/NK5_,R M(O$2T_O`X,G9@$(Z0VM1N--\7Y1D?IT/>O<)"4[B@51]"\BHG+L59%2QKADX M[B20V9FWRF3-:V%T_D+-_('"[B1/O%QJ MR3E!SA_@7/H?$/Y<9#J7(8_CZ0UWF MFE4#4RQG9E$:9?'3-LK_4ILK<PNF2K#D[88'1W#^7 MXPTE5M8>_)WJ2NP<4G`EA;TJCE*ZS*\2',@:7P@U8=O^>I?=-DB00?2V@#". M&/MUR'TP>W=/0/0IY*DKX%6V+X,T[PS(:;^)ISV8M"2>$>C1[>#EZ MFMI"CTDF7^WUR$+&CM@&-KVN)^?T(76&HT_1/W%^V`XI!,CA-^QAA=4P('1( M]=3&`XOS(?B^^9N/1N(YAM"9A,L1^/Y)1[+8K?H2/=A)^1QMT.8P$'H35->8@9BBD,G<[^29CKV45J=K9Q1`JYQ"0 M#R[6-0('#UR)QXQAB"1'&TJJL'KX@C5@-:`"P:I%-0=8\8Q@'U8M28XV3%1A M]1'OD"\` MURJJ#GO-RHT!B=7U6T_N0=S1RB3"CP6C10]ZG18.#UJ^)MO]5J@+L\W@>*73 MQKG+L.R/82IQO*#%L7M\TN'DP]E9DLF'E-6F/Z3=-MX/J4`EQ2'M%6L\.?,<]A5#PJ9H"/MKD`X7CQ))E._H0+[FJGDYT$Z`ONF,C)U! MZ)N+H7F3ZRGL?"W/\@G,S+R09=&:+1'](.!%0;;=4I!M8K5/17,N<%$65==> M'LAHGA.I?_%TAU'Q*QBQJ9Q[KW8Y(X`5;-4V8HLZ?&G@[ROXM.US'A5)<;/N MV>(%!D8UXAXFH<2!05/+)D8(A4H,>GOR(BJ>R/>5_D6_L<]12G=>83!5HNUG M]<)H`P.ICD7,BN#`!)YNYH<(T6$5*95@JDHN+_LUCX"J:1?;!<'$037,9]H& M20T7I/M)2?_%!:F40G8MHDT1'!2AVMNM&-86$W2J"=&L((JO*LV@85%.,H2< M@"0\S$'U-P6=0(ZCFM;VRMS!P"9HR2A<%SJTY-H:EZ+C+D+"K"U]B7(R=RW) MI*#XL'U$JQ5:M7[$!16$:(`O,5%P4%.P@2'JQ)*"KFW^(]*GD MZK]I93[@'J(QOSZ6]?F%AF]+EC/#O'XG@G[(HGY``:T:1\\VITI%*GN3NFQZ MH%=G$QC6#>UD!'%UV8<('^9;&J>W06[RRZ38X2)*;];7.-MA,U=`1KVL4(N7"9AV`M'8G@KZ,_2=*-D]4G6>41QOT>4^+&]VLJREG<;,O MBY)\NXGM&JTODR).<;'/ZZHQ$I^PR[SG(+:8!^8MH]C4R'5L]=4@/ONO1 M\D6??,UX+.5T1KJVHF@CB^)[%._SI"1=_/`U3O=D6#\2[Z,+Z7T]_&1NV;OC MT:DMU5];CB*DOP:U+"2P$#>JCK-]>$I4ZE[?N7\/CMW?LG=#2QNOX\AY.([%S"XXL*>_(=Y7F4 MB1]E9K;I3X6[;8*$DTA/"Q#JL0_Z36_#;\_Y"YN!H`[P!!)!'PI+$CUU$+OV MQ-H?:R5WL]+I3I5&:6>]G36!;7$M>8C#-GN[SG7->]3#::E@JVL%J?,8CX6T M'K$-?>1^I:.'_8_G`ARCCV9H6!*KYF5-[64S;^+-O&23)>LDIGG6@_Y)$T"4 MB/N;;T!BYQ%,<5--QR9FFV5`B?:6\.XB192Z#!#YGI@LB1Z3M`ZCV>JF?$)Y M^T?2F*'.8QA&5'BXF[K76"QNHQ?Z60-U^W1F59<=*:6U_4<1P@[YLX''TI-IW0U-#1K%9A@)A0.A0=?V/V1YW*$T*A4^W&`Z3D*.@"Y\>*H:QS92`?*# M3N'IVT`,54GK'D"YK<.')EA?"$8=/FCU#&4;Q.!>!/V\U$/T%1UV1L7P%;3L0979 M,GQ8R@U@&X),B?9>8W%YC%D'3%\#)A.3 MYX2H>/[R>X%65]G-#M%W+[/-65PFSZ#P-:*H?I0;191&,*R&F)K^[4_OWU:& MIS]IO^S3S/2:XV*T^HCSL^(.T4E@E5W7E+WJV=202V,N;2[NX]V86,*V[,N+ MC2-TGH90[4X?%LAO?GKWMT"?.J,?"T35:DH4"J90K&:,65*WV>P1#[30Q)#F M]^J$V;>_O@^SX-_9%N=E\N\FC9J^PDJS9*BO$BMOD_V6!V(H71_5]+IXP M_^YO/X6Y!=K5\/@6'"VB",,\FT0(^3[)*T6\T')>`+[?PQ/>?WW_#7X%EG&$UVZ/#AMQ;\+$YG'-?++:DBX=TU3>ASKE_BY*,&NDFNX_H9GOG[9OCPS<<[*L1]YP` M2OQJO$'+FH[<`MI7Y>/B7VO?R-"F2B1S_L`F<5)4-%:KCJTXKB!H.7A6D]'R MU8!<;B='B&9VK+4A_OX'^.LVOH&X>9KTSSPIT27^PIMW\QOR7H9M-7Q%")98 MR1F`A_TZ9(H'.A]O'?DSYF$<%,.(^@_22HA>#;J5K.<(Z;(^MJ+VSPIODOD5 MM=G/`?&2G(2-06\YO2*,@ZSE"-N\OITP'>A"D]KD8XJ_?"86(_^D7ZNBK!\. M.NYRGDQS*A,@22:RQ;;G(^9L[24)G<5D/54D]8[P8:'5?I;VSZ1\NHAV";T! M2]\,9^4(:3-IIPAI,'$>5*P!!%NR)">PF/;SF/BCT3]'%PI-\/X9EZC)3=>& M.X.',MH[/%XIV/EV]`+KG>XY*G;!@?H%)JKG1=7]\SQ9;<@$(LHZ[Q&QT*U` MU@8TB&Q^&%:WUMBP!?5(NQ+&Z$B]/?2GZNGA,*33?Q,L#IA^?LO\DLR)5&^00JOGA6=E6 M8T,7TJ%#79BI46IIB=YRSLK]SK8TP[3^<8E6[WAK<"A=?Y$MIYL5KG7M-2*R M%;K48!N^G^H3M&G&=$O'/-D0"Z7TI[6B/&B#Z0;Y:5*Z64);U5X30!O0I:!K M*'3U.WKL549,L:=K8!6$R\F%0!>1OP*\@ZTW.>Q%/;-7TL&;8[(S.D';(*KF M^A54>SY:P]6D[XS=9K,TPGX5I@"O!WINK51/<'<89G_@&N; M5$?]'/`)V_;+4K';SA*.$+M,@$M.-P(O`WB5Q3D]MKU$]=^MU)+F5%>2,J'. M8)#^"6?@D9D.+W'@T(8"/[<+P=WH]NIBM$OG)1 M*+_R__A*LM,>E.G`R/4GO6$LV"HE+]C&;#\U(=1D;::&O<)M*ICED$)@.R"= M(W+%]AD?O`/YQQ350&^F#[6$E2`!TTFAZU\I$MNXU2HR8@NTO/(A?WNCD%/M M^RSAH"2[7J`R'1BS_M0$'`NS2K7];&.V7Z/OE_E$VQ0 MRK?(R`CM"%8^2?4]G!+C[:)D=7##INS@H8;Q65$@[NZ@&3,IG&',9H=S#1N. M[`"P'@5>">$S*EFWVAA[LI+=1WU&/8_0812`^2XP?4%]3W[6H!%GO`!CAZFV M6=E,G0<<`X#AD6S+"4#J/6T'(M,>ZF=4^_#49G,&7M3%4.GA(]$:B:HF`BCZ MCQZ)*&:"<[A51@&Q4+SR72V_/IG$)#%"J^(C&;8F9?S#5Y3'2<%=Z$!(AB]S M"4CF@E*X7<:!J5"^[DTM3PZ4V\H=/+!_.Z?^'R*_J;/#LY6D+*(=I@*LZS"= MH3<8VW9T?]'I8=`OW+:5;_)ND\<4T0\'M>\*`%\AG0"^'+H9PA=BH='AR^F$;JZ\%_"]0[OC]B)@GBMK MW@,KO_E,,`JTQRC0Y,N>YSGJZ9Z+X3DJ@!'LP$_(*`#SF9^C*C+5-FM8YZ@0 M@,G/4?5LJQ9J!#T%G*.">ZC]B?3I&/4!5Z44<]1YR*-=25%RJ@IGP#EDA3"8 MB4]HVVP4_*OT)O#TOH&JU=1">A\02B9#]H!LKG@6VV<:%`_ZH+R1Y!EVVXNU MX9M+D%"MSD&T/I=QF`NXM:TV#LY5NN.HV+%]P%>9M)=HAXL$E''`;"\`!'V.#S>3^?:<(E/MH!G6]IRBGUBU[2B^8]I#[3FP M#]MSG2\"WSV&;89H;[>9#WBYFH^%Q;;`H.>Q]\0VJ'[._%!S339CA9`,:B^* M2)P^1D>6RO0ONEQ^)@MI,A4[(]C(\Q<"@^I)28X5E&@9S\H!:)W[)VBDL9E- M.!XJ$MVI6`\3>2Q*H_P!("$AP:L/F?.=O]'!^@_N`PVO&:X#JTP*6(TJ8#5@ M27?RTD_(WE8=["^&E)`K9@&"+X_%3%`,LM`H4.9)MC\##V1P++Y+:V'`S'IS MV%L*>W-)=12-BU48CIN.?/L;2.$.%#P;;IR!$LJ?Q7:MI8$RWH\W'"C(OGJ@ MZ_S];I=6EHG2@V6NLC7.MS5,)$M^->K^ZA]*'1R,]>QBB%VP4%>/95HKPH:W MZ"'Z2K.^$]X=$TZK8=FT;BOW2%-$#H:JS`,73%[ON*HKYX"G,"/@54:Z03[# M0C`-FPR0U&X2-HRXRMK$4%O(`4!O+"#H/[\?V/R:_*#^'?-7G?%`7TN4K4X7 MK`8C0A][?22425R\(7Y0=^.T)/JN@>Q?N\7E*A,DK2XEM7/L#NU8>O<;HGMJA+'&QW^]IF-^L/49Z1R=!1/6)% M=$6^4;PS*-OL>[YGC[VS(&2H0OU8WSC6[_*V:_H#;^?QTCI"\;CVYT1B6VIT MDI'L=#_H51+;!I^C+;K$VRC)E#QO2`9RJC:9,T-\V.Y2_()0ZS[P)[1]1#G' M`M+V/=4%[3V-$8S1Q.KZ*_GS263;3P6B@O:]INR7$&;,-CUH]=H$"2>1GA8@ MU&,?^%.-AA^N\Q[G>IPYF*C3\FE9 MN[.Z43]U[+>#&:1X#UK6O#_#X#9WMP??[`[<<'8'P-AY$-Q2'4=(?T??LA#G M$4@*+CR1A3G!AM>_SKF`Y7Y9C2LN]D;'&2=[*W[>?A=O^]6J/A:7_BT]YG&8 M[3MP%":0H6%)K)J5D.3DY(#^\+LX?G2X]U^]0"299+$;]1$ M[VAY\RX6Q^!8H@=O3=+AUG'+[OM3ZB75?;@'52MQL<^I54%(YK1EHF'0-AAP MB+74Q,J`:="[BX=GV>J'!>]2,=MP0.7+VU-P`"F\)"4'2_==J/=OWBF\V^P3+%H/ M0YXPSX&'L&T/)IRV`<`%HJ4R;#A,0Z^*Q*[VQ/^204B&M9$$)`'@24%G95B) M>0?]7D&S['YI:C7Q=IK9K?I;Q?U6`"JR>JLV83BCA$(_7;Q'Z@K:T]9+T/6><' M!2"!54-3QAS5$C[M>1`I.%@3,,4NMB#B3HN$L.'K#F4% M(M_YUC:<&)0*E(/]*@!E.)!4-X0N(D&2E)_<\@F.UTGTF*1)R\,DY\=R@A[X M1`3.]VF:=]-@.S3LQIR]F7YCY^X%&#C&UHQ09XY;\26Q=F;Z$HZ7H0/>`\SW MI,,#*_#A)6X_1!BO?7@@`VENBC.>D./VWZ_O`\7:!2;S=3(_(@YTB1[+CU&2 M5]L#IPOYO'-U!,N\4-^8@N=\X4)0*=;:"P+Z$([I^#/;T&3SE!,\U9S#)''=V*9A6JF\( M^'!DV'Y.'+!)"EH3,UL&!B.YMD8X8K(_S@"##T=GV:JJR_&$4Z)20<\URQ?X M3A.(G!^Z).0.5V_;;5*_C8HBQ/!JDU*,5BM"2A\\D'8&&,=6\@] M4RB\NW(3"`UZ)_@T+\K*"_)W4DJ3KR$DW&DJBR1H/"I8PR(@Q5)/.UP_O/ME M%DLF!5!RVHL73C.$H]@.HV!Q(/((Q)^"W(7KYN688+04';`?R8;0.' MGEQ_J[!CBCM"[I/Q\_G\2[63ZMGI#F MP]:*3'O-=;#F^G<^V(-891Q`;!Y1OVSM2/&0*FO;1R&P:-@+E MVMM$'5/::5H=ZIF%\K:@\D8@?.LO,`""+6$1AB*90=\0[!0K\A=/?ARBR.NS$=5>OO3^[>50O0G-5"NBF)/@LT^IQM'*$_PJKIX0R(1@4Z]9"P( M')\3O"_2E_]")P]H%+7!JC&`&2OG00`TU-BJQ3B!0M03&BK,>N!HMFV*XL_H M2]6LOP5OR$4+NRTN,X4MSTZ3(+8EW-&F`@>L]??XL/O.`B*[11MD_19A`4BH MGPDX^HQUI\V>U#`[O3ETT+X-\/.7UO]@#]RIL>$^80=E$PPJ+5E*$[KZTD]3 M>K>+.T@\%JWY5.A92T$8?7APU+2-*0[A8H/>*V-XV77_@4'.2DY$PEG)L4GL M32L8TIN<_EW5N][3UZQOUO7`-I5'$'-M9YUY>S)CD;DW+BX$"![9 MJA+_9_7M.(6RV">_UHAUQXJ$OJ%81;C3#^ZHI5BPA]*TT2RG"0NDBC8PP9Y< M5-#'PZ:N5?\6_F4R8"[_AFDQ#P;YHUI5TT5L]RGHN=M%&A5%$R4N\39*,EZR M!;=A/]V"T=#B#B690M/)\ZF\6_?L^1.B0\3Z5@C+")%3B. M-A1WVET$BG'D.V)PE5_PA3:^X,0,B$&(`T*9LBVT@0:1Y-2#BA5,#5?+>A`%.[D-"*M,OI>WX*:G> M^)SR*+(S5%7\#BJ2D[!J.HGPY72*ZG*SH[81@HO;CK63WVT7-+AD>EL$%T-4 MT(']SXB6^RV%L&*VZ4&JUR9H.(GTM0BEGIB@L^K%^I^_4`N`].7USG)M=.-1#O3@YW,\79Q(J]D.Q#MJ3; M__X$.DB:462$`8/WY!3UW=_I;B]R!<%:VIYW>WO8?A:P@]IC!)P)1/L4@*4& MP@JG"+);V'TAG:4A@WG?4,ZO7"SW+3Q1_O02T`,9U7,B_"^X&03$?GI$J>&"EH-JQ(R6 MP3F_7%]#3V<*X,UZIL^7:'9W;O*[9/-40A(G1!3L#`HVA<5$USQ9;1"M=MA( M*OAGCK*VG314;EOG,(>,!59367RDR))T2A'E2IA#2E%7=<&*4]H>XAZ>K#CE MN@P70X#(H`(RSJJ(+<6#B-J-](-]-^&'EK=+)VUM,1V:9=X/7W=)7HU6?>6# M%5*5"#N)T3!"Y[X@&RIL8`B.0W!$GA*C8:)TJTM[=%5AIL['1&T4[_/ZD8PH3='J_*6O MO@KLU;E"'$"%:_"NH&U"RTZATH^@,T"H@4ZW?XZ7RDXV.^E;Y[TTUQIXWP-C M?HP9FB:_D)S!EMGTW<"@!T$73>N:YF,4H[K"-VA],6PN7&"TFX>&3H#29N!C M"PAZI^.0`@!ZS%G/]T\X+^F32%0]29*GL&T_9XC=-A0@0535@Q&' MLP>[M(.>"<^\)*UE<&"?=;G(;1*.M`@22LE-+"E"6'BT?5\?8EWC2'QYA=>L MGP@P:.8?!OA7"R1*0H=_>)E@R'A&&2Z['?FKC"*TI+GXL$1>TER6-)N7\OK6H.JOW49 M9BD0^6V'<&.U#0Q44G6-H,/B?@#(FZDSR.40.2RK8"#AM.;`9-`Z1*"(53:' MRH#_$2S*MVO\7=HN=VN6NS7BNS5AYG\M=VM"4@% M<`I)V(CDD`0(0XCRQMCC"&D`]TN8>,MQC-"J^$@&H#6?H$;AP4U.T4>;B"(H ML(%5-\":2(9N!0Q/"K[)W? MAY>`F%,/K/[]E3T&U);3<3`^?W_>`UHE1;:+OC@L>G!!2["AG`QL^?(YVHK6 M4J*F@[>-64U=[HWM\_@I*M#9)D?U&U*]'@J_?\2 M$T-L;V<-*LZ#+RC_B3-V'A3_+3110XO7ETZ;X?5C]]$M\X7[X0)$C;)S@0E( MZ=XC^&.$3:P@OL[7$G>ZN`04X]>%DD&OS[7!):04@HM#&22X(%:P`"Z.F*!? ML;[`VRW.^+"3MAM,=`;M/(<45$,E``F8>K`U"`@WD*:#D_<``XJ"GEH`$(:, M'[U)T[T.[7YY5\0AN_HAC[+XB7WG%T;1_F;**)Q#&WJU24EUS>M-,AE^79AL M#LL_1DG^1Y3NT>G!5!9TY*W;L!&U#@8R8)4UX2+B[RC'C0.58Q9>]W)P?=WS ME`I_NNC$0I`VDS:P-)@$@S=3`VG"4$-LV"F_RU5-O^ZG!7)5TV*:GKL:OBC? M@J:W[8;B"KY5PY`P*%74UG6QFG7@B76]&W#$.U[H51#X4TEL$O&%Q1Y)N.@2 M*F_M6F)/2-#/-G95^SV+MC@ODW^3N0F9'8-!)Z`3(H])%R[\Y&:PA4&FI*"O MQ';U6]Z'DZ-M>1].YQ(8X%Z.K+G@^E>X]W*`2MNY^,6\EZ-F>[LNQ@67-AF/`J]U<0!;BQ0C71=RB#'S`\R^J]1UF"\VK]($PBXK;K MAXEA.\\@P!A<#-<3A("3B$Z`&++V*ZGU#])U,G.^1MFJ+I=TC:*"_.N/Y"J+ M^1FM"F3MHW`0F7/LJ%\)P-IFX6`+W(7CD3A(]+RN9G$_Z&MVR1M':0-M=+,N\FB1GE$4JY:B44"KLZ] M63SZRGE&4`,"LH*O]=..!+TXK`N4T^32D9(I[W&:Q$EM"58)05!;1B(EHVT@ M8`,JJP4A/F]'I5,YX*`9P,6:Y@(W/;Y.HL'\[-P[+E'UOC#M2?.%2P:WQ$!M!WO7S+;AX!.BK"[J.+SW!>&)=Y1; ME%)`)9C`[^7OW[X-_&6@XV6FL]4_]T595Y#GW`I2HNF!3D(3#OA4E-<%H42& MTX/BTE[`BMV`]GXB2G+,`0@/*NCBG'>PI>C.-?7W-5]G MC:NZJ,U9S-MBYA_:JE%V3AJ`E+XXC:@,D985U,L00<4XFCJ+P55^P=PC#"F^ MX,0,B$&(`T*9LBVT@0:1I'NO\=!R3/ZQZW`_*U4="F^UX.+?^^5MU69$`O&T+I/(:H96_0DHAV# MN[BCU_OR%Y![>B(:WET]-DUH@%,Q@1GH))(.WY(WRCMTWB#OE3PJJ(LP]<<% M59'%?&3PW9MP8]DKO&^LBRZ]>\>J"./>/[8S!W9YRTOX`M097DE*D9N<@R:F=8T]5 M3ZRSP\"!)%!V-PH(9%I!JKM;N7&$BCB*=\5R.7?\PR[.D26MH7C[-M"41YZN]2WC^O;Q[SMZ;507 MO7).4!B+.,T`SV!#60>V2/()X:%6DFUK>IV0-=6JLES]"Y3%_**R8$KA@3.' M,AS$JAM"%Z$@24&_-@'0L+J(HH_)#KDZ,!OR6:&399(1(=J(<_1"E?T"W/3# M$!&];O+[B"Z3F!49U`D%1;EYA"&A4M$,^GB4"SI]P\.\,\G4$5P3R9`+!*9A MUSRR8R"K``;4-")HGCJU?+D"M%P!6JX`+5>`/$;9<@5HN0*T7`'R?Q*P)-\& MEGP[>)QDR83R$28>94*Y@\O^L4#_VM,,HV?RQP.1)P*+N'4?*KS6P0$%I+8A M3'@RCDF9/__-!\L%DBOD,/Z2_CSAE'2DJ/?4:%:))-L'1C2(Q&(B#[`"TLIF M2H]8I&HFC\O7LQCQ0'P]4=9>'IR]>25'%F_%H5DITK`E20*SE7##67C>(7J< MCCZA?(-R_BI3T*R]I&0V\W%\.TM'9FL[3U#XO!UC0)_PH*%T]>P.(:SLPW] M(UOUPUSU^PCSF'\I M*;^4E'>"L6O835L)$01MUT9W;SE?`::D#U]W25[?M:A>0F5]`)0(V[$?2.BG M5PT'#AO80\7#K@?/10(E^I6&RNET7>A1!6@]"@#"CA0S@1;;`J-@ZBA*><,O M@`>:EO=')P"R3:MI0]RP$_-[D?1F7Q9EE*V2;*."<@89!-`=LKE@EV^+<6#: MD:>[9-M51L%6T,^=DP<<*O>?YR=.CYT:%?YJ MZ.=["C8P!J=8EJL[/'O`/Y"MY/5H.+A>>38;B!OIX\C,U+ M^3V_$&-2?0^(%5GQ/8<0$;X>VP,(Y*5925N'SXMMMSCC%U>6MAL\#39HYQSX MXO'!<"4Y:&?R[S[K->![^)*^]>:E(^'P`\I(BYN&`P+]BME2'`BK9+]S"X5J MND=7[\V$KQ"&/&E[]IR;U=Y=Z-L7)=ZB_`)G,1FN^C#B+BDD@1!&U0^+,BKG M_B$?4:QK!(Z[<"5V0J=,4M!W:ZZR9T3T8]<8$C?J`:S?*"P\"54T@4^?L:-3 M1CMHJ:4='8@MG='#&-O MBL6>MW)T6;-=N.6"U9:1LM+M+%EMTW%D^#`%74JX&Y1P-[TS`:_@#KLJX=/6 MWE+`';2[%W8!]]E7[(17;]>MURDOWBZJUNG^IE.^*YW?=5J>#%V>#'7X9*@G M9427)T-?P9.A4^^X+4^&OJ(G0\/28#1=)],D-$X=R78.&$](W#\22BS]:""3-8X+V8Q MI3X0(G5P,*@`\.A0S0,@?$.,`9&.M%/D'1\D7[`Z1/HT$("<:&8"#XX11@'' M298':9^<3EY+KD]#R6`?V.LQKE"?;8@3TKW[!Y1O60[!;-!&?Z^!KU`?&AT# M-%2#]O7@>F"/]^EV@,9M*"\FF9=[](!;ZI-I]<4^IV/"\0$Y00_](H*@P*5L M`0.P060%G:M"%/M(1D(1>5*2(?8$)*&B#VH%._@32#L@\$V8L8]CB+OAA7P% M"MBW_\Z/J_@Z`(3;P`+^A,+FN+MSML5[>N%ZW?J9&AA%'&#@9'.8$U@!-AH/ MO&SAH5>5X*T.E8,IHZ0'B&).^(27-;&`QTY5DZG?T+4%OF>4L:8J7.A)V@^` MQVT?*.Q@^EL!'5=4T"^]\8([_^8G@`+X??;C!BA$'T"H4T@4$TB$Q#E_BC=R M>EB$K3^\!7%^S)Y1C?K=1*+$C+!1.W];@"15PCAG/&HZ@Y`1>]D!R#AL"*O M"C+XD,_S&WY&>5;=9;]N\DAL-R^-0(*2#?WO'MI4UZJBI_0:I^2N0-L"BHJC6C$JW\92X^75]XI1`BV:S?% M=07K^I]F-WRZEVMD2/GVR'`;3WSK2J<[@+V3ZT$IQT'ZU@R-#R]1-I;=>W7N M?GS_LP]52,>VNWP;:^)A8';H."J,07%1PK)]7P)2OI+7GE>Z=+[30L(\"_G"JK/]$7PJ@WA8^^_NR#CCM-D18?]^-," MK[EWXJ)L-2R=<(G629R4RUWDY;KH5U:]%*9!C=!EQ*4\^A M-+73H5?Y/"M2#6#A^V=9`206OLH`R(!G?`Z/;DK2:[3Z$.59DFT*(6[$C0?' M-.S&X:`$I*XN.'C,3\G*[K?=!COTO/TVWE:^J*'%B\&K?^Z+LMJ!>,"U1_20JBVPU_BXVY%K?%M+-,-V<:`JYMVTX=W19Z<)AB M^`WR^RWGC6@*W7A@/1?O$9ZY;N'IXA/KQ"KQFX^ M!VB@9G$(&*TPJ]@-P2QQ#0I_]1J$M5\=.GU08Z4<6KDI_2`.&*4"AB!L^JJ#<(Y!#2/8L5Q MUG*0;AP?9'X#O_']:XW_#&UH1H,3#[A$<8ZB`E5UD7[/HBTF\YQ_$X]'C^5E M4L15984J[Z96Z`'7>TRZ?F$J3]5;].7-Q8+5A.KQ$]ILFF,IW%#XJF&%5O4!8S%_?(L@IZ6UTGT MF*1)DPC=5?+W'<[NT!8_T^GJ658FJR3=4ZX7:;0O^M>]W';"W/F,.C%?U[0W M-E,YKE&/#V[M2_*J8-?N-D^>B>ENTRBN['=84JINPMH7\*00@W!;SP),88S`>[6S!*J2C2SOW,JAZLDB@]=1Z/DTW4-@X=8F MWS:,[?`-`=4C6%`=Y'8Z<<3\&T\F$8IJ#0^K+<%>S-@`]SS&,P0^R(:C(Y_7 MBQ;TI\:^K8LK\A5'I?QY5*`5S8I%65'9N;)4L[UVA\ABHTA*U#Q67QOM#L5X MDR6,(T!'T@>7:2:2[KE;NAT-)=^=O*N'2T)3YR9-Z-VGB$?_C+(856>T)BXK M8:GCAUR6GM%;%) M1HN,DIG#!-^]43JC^QFTW)DY.>[88S7N1])RSP^W*^?[S>Q<3#'P<28?#??L M\9F19XDL-)I3](2>/GYA%H&M%Z\W^[(HHVPUW(F6MNO?"1RV"P1Q,@VU$,5@ M>L@E5XZ`NRJ:?LB<3Y>T,?./=_-'S4!'R[A13K"H84/$Y:5SX`BVCL_B>N[` M2-33)1]<5X:2AX(]/7OH`1(LZ_!(4I@S/)&>]8\_XKR9WNK@E,M#`:P,'C-` MK,PRUF'+$'C:L@^SI)9(W?;F)N]RF#$?!11S^,P`R1`+64"!?3Q*!9R2L^"(]"OS6'AJ:^%H`I@!(NJ M0D8AP=;$1C;CJE#J"=AA'NX+=:[V>'5@W"%4@6U#.`>8LFQ@'Y:-E-/-BUG! ML/IZ?$9?JM_HK+,&M`HSTQ9MV'@46L+Z#+0E*.AWKS3J,]VCF+04O-]MA:<" MA`$\9P!M5BMXP*. MQYR-P-H#-39JNX0*.[4'PI`@J&(#ZWNU!RFG/2WXRBV@S5K#\UL)$Y4/_^Q. M<&&VL?]A%Y[A!KS]T'E0[S,NT?TNR?!ZW7JA401>!7(6;$'D(0%6W1[Z4`7) M.JR^0DV2::S0O%[645GR/+P2+>_!"3&M>[L(7X!G-N)IZLN;[6K#QGJH5N%% M=I`PYFNTDO?676"A]V9,`7GI6$3#0PJ;QA_@"'5J`0;RU)\,-RQ9;;QP9/!@ MX])L\A>@AY\_F)'X;SJW./)>0_/;)`#_T;<.F[E/(>V=>Y+*G5*YQ@8W2YG,'87D94]RV9-\Q7N2?B^6 MG6PN+7LFOL'`P9Z)3P9:=DQX.R;5>BJ.8G>[&GB[3>J:/6?9BBP[Z4L_*(O) M.H$^<)7B8I\CR?=?BT=_+T2-A[.`!^KG`P'#.>E$_UUF,R8Z%FLQ<1X.]&"" M+9F-MUI6Z50GI"AVQMZ='J>!:K5$JD`BU7W\A%;[%-VL[P@:B)L^D>Y>HF>4 MXAWM_1DMQ+:I/YU$"=K;!TQ6LVN<;S_BO$JL+82K'NL"^I,_BP+"CWZCF=MV M9+394=VHF3K>3CDHMH_2T]MO'XG9HO2_B4D^126].2';6-'D,@A8BES\LMKE M'EUE]RC&V8IV5\54'%*(?0:D'@00/3!@(R-Q@X-29[H3)T@G=!W_&>6/V/UV M*E_)SV3^]?`%I<_H$VGSQ-LH46<`1O60P;RQ+3'8E`@?=N6PAZ=>_]83I%]E M9(V`3MN35!(%#G\/$$#1P[*0PC?-A;DA(!J8]NR,$0?."QE/K&<"CF\*)+;] M4"))][Q.?V[)R9ZX3F*4%>B.3)&S/>+G2HC:M3,CV.U\Q0DG)0*@K!HZ>KD0 M;/Z.,A]X:351BHJFA[]AO"H^H_+#USC=TY+&OV'R!R! MG;\\D-X)9M)6>?=FG99XAVAWVGOA+-XJ;WMV;_-V'JKL8A./:WQ.=+.B0WM% M8JGOTZ]<+/DD?HG2\N5LDZ,ZKP7E6_;G7X&B[S\BBI"]@@%>K&,H^U@_]:R# M=5&/@D6POI6N)>GH-EG;^Z9<&Z6\@,!LS.\>W((ZK=R;!78S6$/WRE[W'R$EO8C=CS MC&.CV:)8:(V)0-KO@^XVK>C,S$6"M/V4'OE!BT+^N;7N`4YEAC?^+F M8^SX3#KZEA2PNGY84")?2H0"DFO6]2@#C+A+MD:/.Z?)UL<7R\DHW*$RR2O+ MJZ1:JW(8)EK#.3B;4=(:)1FJ\F/SY'%/.TL?<[_`1=F\W/YO[I-62K0]ZP!I MG49X'W-N21?K#E8?O5L"Q?S8TW.4 M$<26"M?13-GU;*C/+O1@9ZY"VA$-UPB7*ZB?%5&4>IV2E57 M/+Q97S;F?(B^GA4%*@M`8`/3,D(:@-;E!*K;I]L<[U!>OM"O;$E@2VM$5`L` M_BQ*D<%P*@5FX$6(@D,!6S"3(!Q).]*;2($[<"CPK;X/Y,4V\T#5&Z)H1"_0 M7>.BN(CR_(6L6K^0F,0[#=3@($.UB,.,8`TVU&BX%O7@".R?9X)L\H\+\O^D M["AZV,&!HAO&189P&9<9H5S)8*,A7=:+P^N-H:*]/JL@6H*7H``*YO4>#H5S MQ$+TP68356%J,5-RKPX'1&+0Q?D&>ETGT6.25D_O?4;@>3&;2A94^U2A05+- M#&9@E,K2?C84EU'J'0SI"WSUR*@1/USDL4107&#O-0)0F$NW'JYCJ"]`VYK<5D0[_8,^'J` M/G8ZFP4#D;`OW6"7(,R(]2'*LR3;%(<7"FS^NLL0IU:B%,+;;,(:6.'LB-_`.;>AXFYWW)U`E>OQDS M!=2+F,T%_F"#C>,'(O$-Z,/<9^,HW2@WB`%J4)=Q@6&1&W[E%*>&Z(>6T&F00]UH%""VQIL9@&K!7WC#W M#3[/J/:)6OV#?EPFP>&'HZ4A>$Y3M!Y4#>*TMO>&W44:%<5Q8^DFOZ.'VF0&D^35,-VB/,']/!QU MPO9;=T!"YYXJ&RIL8`B.^W)$'E^N`XK2O7\[SG/J7:4^)5FRW6\_X:Q\2E]N MHQ?ZP[ZW*-.U\06C"P9>&F;01!=,T@%<;]^^]1%?9ZM54F?8-%YRAV*4/*.5 M^)5.;29\Y(&8!`I#=0-9P21(;-#W!TZ'/<4#/JE[&R6KJ^PBVB5DX4?KBY4T3MQ9EZV&3=FZ?881V"+XQH3'4/L=N94V!7OYCJ@^OT M%#J>GYYJ2O++IX$I!Q6Q`)0AX5K=%/JP!G33(W":'52\)"OX_)K$`N,M"(R.Z)/<%9^=C7(S@SOV(G,]Q10XJ0K$0/G:`,Z4/#KXY91IB. M#"6>4*M\$.0G:ND[/C2!>XOW@@?WY"1B;/9(`H:C2'EK".P)T;^TX27F/D7E MGM[GO(Q*_OLA,@(AWKH$X:)-H+@MK'5%!)T0V%7L8Q0CA:@V;"Y$6+MYN/CB M*FT+76T!09>>Z:IU2-DFLX+ZZCO_T$R?@1!_8@;A(E+!,+8P*A89=,)85]'? MLVB+R<3VWVA%=XZI5Q(;;I/]5O2FG#('(6XE',(%KHII;"%7(O.T5E%&KR?S MQH-KWD8O$5V.[7,Z?ARHBAMSKL+U&X<$0)#"^ECCL3]\QY6S6CP!57L?ZC9/ M8G2H:#5D&A2H;1K0`/F&W="]+^6);U`+@1_8%C=F M3#;ESVH[FX$_T`\I:*;=:2F<43MS7OZR,2YY'6>)ZL-^HQ+=).A3XBFT_:` M(6O6OJC%;.89$!A#C,%:@F!PDG"\;L7D[.B$4XJ$@O3Q+%L]?,$00/!:LW$Q M;!TB/"0ZFZ-D*,!9L2\I7!Y(.U#H8#1D@Z33,$1\\#4UAT:'MZ,$'#DF8+$# M�"CQ;CA0E&?`@R\:`*> M=(;-O`,-/S1)=`0"9AB)AGP/8`DU;ZEW85N('&%;\2WZ`#$$T58;2!SFH9Y1 M,38OA1\Q:7OYSK$WGS+9IK!X_UCE@\:1)-E%MOI9S*LT>HF^R/*$SKUIAGHL,NB9SAHCT#%`""UZR'A&&S4"`@45!O M[(=,VYFDWGP1EE,&3TX9[!V"WZ,LP?DUW6+)^6?@_%;M(W!6*^\&E'/^+=50 M>=^6R[:U_^_PJ6':K^J45+A_SVTW>%AXT"Z`D8=JJ;UGSV`<=.9#`^=&[TJO MYN;T6;;ZC+.X^8_XTILF%R;D%+@X!Z2NWC9NERG*5KAVYM-*93E!\O8$R8N% MBQ`?_(:"Q8LWB."N2SAK%Q4,]'GSEBX>C?IMGFRK/@FG-YQ6O?$>M/)JL/G3 M&K%V@+$>3F@&+/M#[>ZT%T=QNASWNM"65E>\67],\J*\(]^!A$QIFX>B8.>] M`'JA183TSGU5^RP,;A9;1U]"B8>3KB`7+ET]ZX(D2=PH!P(IAT8(S`%-N&`4 MJV\+@`,IVF]G^P>ZI3"P[X6!PWPKKJO8Q[Q:B<4O-VN=*"P M4:P5%A8(#+J(-=U_>FAV3,]?#DXHV2Z$$3$.F$1$(:%1R0#Z&)2)\)+E MM&0Y+5E.2Y;3DMFP9#8LE[J].SNW!0G$ZA.7J#Z?H72^5T[AU.,J98WPP\ MGV-+[%PYE4NROT'GM_&U$S``YA8E6OSD-#H5!4)4`=IQ^H+K!M$>GK2IE;M# M&?H2I70-R8U5/A"U9`>=V%;I!L$ MPK:LC^^P;5A`E*MK`C4F]Z`/&RN=B"I)7AGD4G#Q6=24!:5!T^"0)%;6$$@# MYD&O"GK1]N.^W.>'FZ?->4!QN9<],:')I8<^92XA`=/,1/J8598[F\.?YG0A MH7.(7:/IS?HV3[(XV47I57:'4]*!S7^C*/^(][SM%QLL!0='ZBS=HQYV5L0Y M73*TH6!WA]\GWA&4>E^"3A;15;TJL&K9/3H\+?E'P_,5.0C+BLX\I.G,J_R` M/'S!MAWDQ-&6>U".K\DY!A9TYQJT*V'O7JAH_AE]+1^^H/09?<)9^20Z_#;F M:>(<0YYS=P^)%:=UD&%G7L-:6OP(LQX3O96T/X\VZZZ.U1?82H\\*W9+8]W= M?Q1:.3_8DX*]$'7O$#UQ)VK2^Q]%'*7TRVC@!D)^&A[!X?=:G`-B3C=^PNG9 M:_A87&5DZDC5YY1T`L+H+YF\#<#_:N"NB\` M-]AKQ32A*`Q87V5T7]E*@!\PTHWP+4:O"/=\`SJ,\:TN!9VN`/^HT3UD._.= M`2?M&4^+TZMR"*X)7ZQF'0IZ$X.J?YD4<8H+ M$JXEGB%NS(@;K,;+Y=Y)_%(P3C8N*K!%0.\IV'D"T7G$\_7:=%AOO'45$MRT MYC<4>F58MZRE2MI`3?^&=\+IZFJ[R_%S=26)W@OFUZV'4;1KV,LH/$.*X$5W)=U!D&$\ M[BX3$O3I!V?E('[P%D(#NY\<%.1T]-<`'5!,T`NWMF[LS;;#$W7U&A:MKK+# M;P"HU&4I`*TZ2^>8MKYKP?$!0VL#L]S*?5>*Y^`_%I[7(8V](E%USX' M,ZB]C%IK,K2V(,/,N+7MIF..QX1^:UF-QI%_#?+3J9#AK)+P:(NM?CJ\K^F/ M4_FG!:L[5VHTTQ6I]4%3&OQFM'&!7O/JPJFLSF]J6I M.4`7,NT)&=&CO;NVZ;,_Z]SY]-&;9W5AE&\,(Q\U\KW%IX86],Y7`D\"/RC9 MKBPK03RK*0??W::O`LT"ZSC`;KG#CV0 M\3HGTOX"Z3IH+52VU=IY/%!+P)5K;)2$RV1_V#I^&_;-FW+QX?%5O8^?T&J? MHIOUZ1MQLVY_9:IT4YESZ[+IF4>=34#AP-!&VG%"7:Z]LR-DCN\NF^[? MH6>4[5%QB>I(7!.&$8)1Z];J@"MI`,%5] M?1#0`1A.6:\3S@6DU]);XV!*,$RO>;?)YX%3GF'&!^KU'*X%BKQ0"(JG9+3"8?'E#=W2"SM:.=%7A=?B&#=H_RYR1&]_O=#N=T[_43 MT8PL3Z(L;FLM>2S4C-U@IUR7G><@%STV:L6"6M!GO4FJVYN@DT?N&YVOB<)9 M`48_E*R_*20E"Q;-BA:QA%JYU*"3C^\M!FPC7AP40:*'K]%-(:`IQ+"9($HIX%7KIYY1HU!0J]^.HTP MS3?0++TF7KC,\ET"!J=OYR^M+YEV](!R$=M)SF46<4716",$&7D/YA!QBL=X M%T4.H\[1L#?K"[S=H:RH=+Q#*5U"5%LH]T\$>T>=;*I3DV:+IU]B?)5]=/B[#E*4III]1'GOQ$:\>4&)[+; MI8BGD^T^A-I!,'8[:KRH;*3!+@3CR2/Z\_6YIEPK[\@GG MU`B_TQK%K:!XFT99J@=A:XE!59&DM+S2NM2G(U*TTFT8NOPX2O])R\0JA'W;`@E=AZJQH(4-C0D M)QA9[FX[.D&[J5T7E95C[<`IKC(RBT3WQ+1UAGEC*D'U,0!%#_Y""M\T%Q8* M`M'`M/>F-!!D/+&>"3AN*Y#8=D&))!\^]+^A#.51>I:MSE;;)$OH+*=,GE$3 M'H1E()1H>Y@"TOJ*+7Y]!QVCJ*%L6,@!*/-PF<;"UJL#I-X1&Y%Q>R):7J)G ME.(=-0H$IPJ4/92"*,/#J+I!3!$*DGC(KPL3G_G-=A43;&Z.**GOMV-(/@8*H;MUD.M M9*>EXPJSY]Q"88M_CS-N(;NX4,NP+]W:-(KP7&]$26-&!F_.$,?\"(\5"U1. M+$?0;S3O'SZ/XM:!'RWIU?R$1L[F!N6?*-D\D<72V3/*HV.#FN2=R-,==XD5 M$IQU*>38`?G`]\.''V-O/\X(;#$(-I?1QG4FF>):ZZ#0>=\Q^G#%ZR"TT%S,4Y;S5\I3GD&\P*GK_:V,!U?QBRB]6:YB_F*[V*VGI@J M>&],F5R[5.:O>,-2@;_SN#K]94I=ZSN_-ZG0<0]2K>DWY7.T%=UM9#7I0;W; MQ+DRPCL;[$8494 M)>HV"J"B'H3%7%!-Z,*&^6J:"O9'S[$T0Q9_M+;P_O&ZI_71B^9N_.+[@[ M+#?U_%XNX"70P:8O:,]>AS%H9UZ-\;RQ;MWT4WJ(CXRNK"2F=K$GH_H7S#_G".+JSS2O1XPMS[F3U7P!./C=(VE(I&I_>@Q]-D M#CM6AT=6UL]QM&Q:+9M6RZ;5LFD5_*:56CA.75>RI@J**U8/6_0K4[=;.-/D M4_0UV>ZW0EV8;7K:]-HX]U>6_3%,)8X#M3BVO:''2?<0US6B/R69'`>L-GT< M=-MXCP.!2HHXZ'(*.K()-O"'M7$84+U3&?V^8/ M#SA3[N&T^A"J?R[[HO-SC65?--!)D[;N'Z,D_R-*]^BL*/;;>M>*OF*!RB>\ MPBG>O$@V2B:4;,N=522[]W>K^[/N1FW4S=I)U=+]8'ORQN')`+]AO*):?L89 MZKZ#43P0BQ5$6VH]J/_KL>,ZM2J[V7NJD7TG=C_5OC8^]FV? M8[*""'T%*B[1ZB/.UR@I]SFZB\K^-OC48JV<;:J(#=@V@-JV\GA MRIN?F*HH?8P6/P;ZO-_Q=$-LI$<5(]%Z>FI%X&P*!)5TLR/PM063R0?1;1B9 M0MT9EE4S#+%_X)2P29/RA8;8YBAIBB4_J`-CKOPE'7C5T<;%('L4?292_SB= M"?0U[2EL59]I.@Q(W0XX"$B'#BP!:>)!?CT!Z:#^,2"%^GRZ35O=)<5?'W.$ MKC*B&RK*B>='`/%C!B.A^"4433K`,PQ$0N7#?QI@5#---R4"B)\\!BW3(2<# M_%IB4&\J-*?:V(9SQLOD.5FA;,4XQYI<[A3+L*[<)=Q,,Z0SC#-LK1W5!/0X MP'07I>ZV?-SM]2QA9KIAG7&@Z>L]PQ+\%J=\KA92KE902Y"9:DAG&&+86L^D M:C\L>9&:I#)A;7=P&HYE$8;YLV(1'D4(S>Q7@TQ:!>M+/5RM]R8YM>)>G_)L M7[63*BXQ1I`UCMMZO(SPQG_-5@/.'9DSJ2<>'?H>I999M&;RUB79]6;O9^O. M?=G&I-N9)POGSL2/0]\*-`IO2J<+UB6-\U7V]@3!N1_;.`AP_D5F[N?KW&3S MI+3?J3[7=Y]1>9617Z!K7!2W**\L=KB\C]?$=DD<9<0"Z9X8@MGZ$I51DA;. MJ@-^B'+ZI/JQ/Y+KK++FO0C!;^XL$/>[5`W2V7&0@'ISJ"3J#ZB&)= M&W`"$T]@._!(!06===`)`V?/Q/MII8X'?(&W6YQ5+_\\X90H6#3Z2ES2F%\/ MM`;\@H*S+;L9`-V@"T&?B_^)DLT35><9Y='I7>S*3L7-OBQ*\M4DQFNT/GUQ MJROU$G^PR[SG'+:8!^4IHUC4P&UL]2?H\YA*N>293,3C?9Z4"2H^K-=DPGV3 M59_+OAUORB=NN4@35H,2SCJLG'N#^;<`6S4GQSFTN]GV'KWN[0O2+5R=;D8I M=9@$$^*7OW_[]O0M"K7D#]RLE86,YV$=+MJSKX;+O'S'S(ACNHURSX*>H2F; MS-;BQ-:BY/4ZAM)R?&+7./8-\#GY0=US:-_AG1'-"25X[;`L>>;QAQG+'_V+/T M9#YFU&6`'[Z?M1\.\ZU;=<]-W!'$6,N MPN\FX'/SLX7=,W^?1QR0#CJ>W MQ=RWE@A[GTC'CETNGCV5PJ>7Q,ZR,ED-C_Z_QNF>#.5'XA/TWO.^'O*;M6I( M&$\0]ZUJ>X*""D*C6]H@>HW1MZ"SM$X&D20U5\_UP9U,BQO7DQ2Y!>HN)C:S MXA.*'9C#]SXI"YR4Z'&UCN+'J%@G95[NZ+@ZFP%4N6XD*-49"P_15WHOZ0*3 M<)7MR>#<[,@:K-J+;WYUAV*[V'@-C=ZDK]_Q=B\*&FG\\='M(P[ M?9A2O`GS!A%$_RIM]VSUSWU1BH[+3%B!HI.,U1P]RZ)QQ_/2G,MZ(@ M2G_$.4HV6:?%94((*;(2NO^J[5E0UAJ>)F?]VCU/T?A^>:*\\T?/#/-]`(@1 M[LEH(+)^NB;=2(_MD,FW3L92PQ/Y+%^[!P*-[9?G\3M]6*^_"7.K"J+\9TSW M`?:DV6.*:(&/K."5H3%EI^%I;':OW#/H>$*'WQ1#.:K[++1CO2Z*PH4%D<"[N=I2G^$F6QR9Q/0XJ&#RI)>>W. MJ3\D?GFMDA['^628*<=P$QL?51J?1KY&#P,8TK7SL+MX>`5'8YWEQ?5[0)PX M*S\BHF24TKVG(2Z>QP<<-R%GC@R;E_/I]!WXXYZG*Z"B%) MHP%0#&]G\BFQ("`TWQK-N&;N9;-;CCX6G`Q!3G<5DP+UN;3S`'6X M^`-P>XC%MJPJ`[UQEX\Y?SI=#3S-CZ.R^3:=/<:\#TO(FW'C^-MHMI_$!6WV M/O"--XYAU>9R:A.SU^,40BNY07J_2X?[]4'NCG$,`$P65Z2&?1P\3`EW\@70 M2P2?-,S/+OV;HR?'J'K;QJ/(@+F6KHS7Z8!61L0'-]559!Z;S%8N;QAR@[EG M`%NJZ M@ZX;+/#W&O9ZJ=F_UHC/T(9\5E:>8E[Q,IXF%Y@_>'SESHEWF%VTF]179GN] MCJ.OPHTZ#0XP=_'TWIP35]&_+3>IFXQ_1\Y=S:@".2P/]:]]4KY<9<0>J"BO MBF*/5C>)1'$`D6V0P-#E.X6GB=/#52ZU$^A",'%;=>O<#AL%S2X9'I; M!!=#E.Y*W1-P-6E!0F`QV_0+['?;!`THD;X6P=03/!?K7GJC^X9G\ M(8&@I'7_*\IK[9.VPFFYM+U<8_;$VX%3R<8.JZO-<1J.I,XL@2_!/Z<@:]3Z M#1882@;-Q2!I-7>W.$NCHKA9-Y_;F_R.OBMS?*#F6(6=/CB(5N_^#/GZYL_#E&#Q[,CS'&/7>HL'LV[` MMC"'8[[8R.9NM.3A7)\]SY/5!GW&)2INTRBN'AP^VR#./J8*2?MBK)3$M[%G M;VMJJ`]?^YZV-6%B&C3\:!,-MWGR')4(B@1`\S8*A,T#0@!<;>W1%XHXO/AM M<^3O$)T-HT\HWZ"_IV+-7B?G)MU]ET7PH<[9/G):7.VY2Z)3%EZ+=N$U."G.8M:2E+ M6HIO:2D?HR2G-8!070Z(WNM(HLKGT[LJ_/1B4?2L6^/KVT3$]X[C`EWM(:?8((X^'W/RUJ_?W7NP+.-8]RV MNM7?D+!Q)M%68[^M[HH4MRA/\"J)&16QE&C:IQ5RFKD";A@/L9X=IP7B=3M) M!=C=P[LC?E2MYO>WN,H^X17J5XY2I(+!^T2U`%QJ2W\A?NJP=O%0'S:86`K2 MJ^=QB59_X)08B!CU15`*49V!8"(O8_"J/,;8P@Z=1Z?OIPR+F?G1`\JW&M[3 M)E/PF9IL\12Y-3WWC[K'IXRSF7G%9?*>TVW MYT$?_K'4O$N*OS[F"!WVI!6]1T0.\!XV^>(]<.MZZCWLGH=];83>G[G-$^Z+ M.<,&K.M038-7B7&NA3Q`<;MOIXWV`'%:[><*\X08+5C;].P-KTVSEV/97\,4XGC*"V.;4SW.!EM[UL:TB23#RFK37](NVV\'U*! M2HI#VN7D4;;M\'BK?_:EK'X_K:G#Q8,,B28SD'Z8JG('!;WI!7[`6)&:G<@I MIW8.#%4]Q\\@4+CH">S\!(D`G/NC[I+&U\_;`L?)/G&7-GXT]?G+P<8O5=$2 M08H"B(:W=F73N%_1BQ%60>KW##\6*'^F,+K*=ONR6RRXKYDPWWXRN;QQ&$^N M\W`)PR^YJ8='.R,-Q<;GB&--A^[-BK(R\D+ M/ENM$LH\2FFLOLIH?]#J-D]P_H#/]P616107>/M($$C;L;*$=7FT_"M6PH<9@DP'.-;3W7 MR?&W@2J-DJ1?;:T^?$5YG`P>$S1AT?8D91:OPVW,+.O"1Y1[?/CZ>.,0-X]I MLJEW>'!U[[Y1B:$)RQDTR-N.H$3^.IQ`WZ(N'$"IMX?TL>G!;WG5V)B/+HW_ M3,JG@=6*KMF*KI&/T:+B)5LVCB&+MVZT*VOV_CKE6$WLW".K=KALHWP';5?= M"?V0+;'`5-8_>`^N+-'`PV@P&*U9Q@/ES>0Z'-R745Z&&A`XAJDF4](]Y3%D M60H'$EE+.+`X5H$%`XEJ\[B):\#ZR/BPX5$E)+L?8JE;]ZK*. M+Y:MHRC=1FN';Y+8N,(7V*U;&27_[BV?\I4X!-AX3F`NZIT' M%ZI:_3S^\[\2E)-!?GJY1L\HA>$70,R'L)#XU:`8;D)'0!9VT(,Z.BUM&9,U8A[6(82SP++PLTH+3..B&?F%A*TD_.XYN3-7?N0KG1;7G[:NLMMWBV? MYARLF1&LQ(J<$G#P,*#T!ZZ`.:WD!$!L%GFY$IY\V5;\0*ZG@"N&LQEEZ$EY M`$`HX.$3'"&34PDBH=:28U/0&1D\!9WP":CU`5:EU7OA37\`!0^$+`I_(*<$ M'!;RI`:1X0S2`R;<6)*#KI[+TNR=,BS?*%>7Y:(.G^`\*5_^_NW; MTRSI;9#?G&-I1'%*-C`UJ$[6Y2]-;]3]R\7_P^\"#$X;(P@:L1' M(>80I,:SN$>/0PQ"8IC;]O?Q$UKM4W2S5LVV.J57R5QQ%!G]!W7MR@C.^<:T ML:'76>[:'&8@25G@5;2.R2(K=;?!=I617B%Z#?PCP=X%SLHDVQ.SW^Q07I>P M.D=KG*.ZW4/TE0Q2DE5KP<-CWF0(NUSJPI>?4/F$R6^>29/J[$@RPW'8DUX< M<=(39]%?0]M+\H^B3&)[(]GG:#XB)X[.X[A+9.,QAH7S,7"@9_L;8Z1?T.?8 M&II_)/]--KR47W.&Y@Y\9+CXK^5!F8W['M4+>ODUH=W=3[W<3[F6@.)^V&<3 M@?3MH9T6C\LH]2-D$0N`+QD#*)@A@4/AB0N+]7'C:FHWC05Z.'*-,2XAN]SE M>>=X;\<;+W6KN6R#&D(BU]VG[6.M$`4R@(U8PA,T#ZG/W M-0:`[D'=S?IW6A(`;[+DWVA%^GJ.,K0FH_3A*RU]2LL&;/&>?'MN45Y&":V! M^H`_?(VV258UOT/E/L^*.YRF9,GY)UN]?$*(;G%1O8#;W](8 M3T#[`3_+`IQ[UV3N@B<8(8XSCJWC\7%`R[KY]7*SGG(7]'WJK!S3>Z4BS/U7 M(&+Q8+NC%*8/"[1S5`7#JA>WGB.ASPX00FKB??E$]WF&UQ`GD&3NTW))BVN/ M,F9A>KA(8Y0ZM]G$5R#K&N(YV!;I9G^UV:1+3#+U[,IS[DOSH.MDF M]=#RCAQ'E-1;'(\BZ54%A>G&S&%0&%5)^\_IN`\*:HZMYIR+@PELYZ^3'('^ M4[`/7%L!._>1Z07N`+A#'WWV"?#6GG!V>6CE[D+DZSVH.EV,J?O72Z,X)"B? M9:LFV5'QMI415^[]*DVNSJ.3]A_6:Q330DM'U>^B M$C&>R(/[B#Y+KH/HL`S7.XP-:,LU=#H2=.[X2?7+IN]$9];-2D67T.+&]09% M;N$Z@HG9;/F`8A^"+L]]TIJW;7.:SBMZ@"Y#KA.H,PS7#PR-9\L5U+MA;_?> MY4)NR3AT$(K(E#M9)W&4E1=/4;8A4Q#>$5-QAZ("9P1Z+[>X*&B]VGIOXH!8 M`L)5TYH7I\:5U@]B8TD++L)-8G;#\#=6'P$E`=^'6>"28Y\ZC^-P(GPX$%;; M"A;S@&T/\WB$YCTF)C+S"47)LR]^F10X<3E)>"9*X?Q%89(@I1A,$@04#N\E M-;WZ+2?Q5J9LIQ%/OZ:1![%`/D08J"37V;DBNO>+NJRUY_1^W+1ME*$ULRJ# MW"%:DHY;]%].P$,2@R!85,F4MX0PAACE5(]?:[1E:!.5R/GY]U&UCTF6%&0A M_1O&*RG6F(UY..LU#A9C(J4MX:LG(NBMZJ-2?^+\KZOL-LH.;K,Z[>L/B\TSRXIG_-;3KEA#<(N2"S M34P>6ES0-(Q9C(`+G4.\B-WMI%[C;$-,L>V]?-D8^RQ;?<99W/Q''$<,./5\ M28N3N[CSA//R@727]E$:982-^S&%T]AY!#$9:JQH#-X#F^I=Z,07CN@Y1!,< MQ:F[>%+=>&V*^F4;6I!F7Q(H?4JR9+O?WM%Q36^CE^J* M_T><'_MLH+VS@.$ M8,2PNL8&W]=\G;Y)"5RY^B0CSLV-@L',US1Q])"2B)/V4GVD'1-/C%/ M"*T^161MG9V1CQBF1'SL@`C::)$0!(0/%=6U$2$1,D8T^1S5Z:OW<4+@AC[B M?;:J?L1'`9"DC0,I24!(4%-?&PM2,:>IH$?I;_A9Y1G M=+K*1X0"6;<4'X`L(&2HFT$;'2!106?KM&YK9\1:+W\F*W2'GE&V1^4LG1>J> MY<#4SL.!3?1@4_-QXH>%/K87.."^\3Y)\QDFZ0;!-"/"ZH;1[-!2S*[[>^R_ M9'-8UKP?7;G-W:--I@F['HJESP\/FCSR'1R/N]AAO\DV4)?^N M5+K`64%6;O5\_2Q;M0?H9OTQRSI]@[QY;I5WSZLL\;:W!CDCT]AH M@S[AK'Q*7RZBXNE\G_>W,@$MVRL-7DOG@'=!M/-#M8GQQL:Y8M^" MOISU&954O]LTYL/+[P5:766GDU!:5:VJ'\5Z^Y-W'&6%:?_,RI#I?'W( MJKFG1748S3W)3.'8-6::%;!U?[^8U]I?2#'B-%95 M7Q5#)YF=_5R>K$,8?Q/F.WW519,GG*ZNMKL# M'0`*Y1U!^,N/[W\.$XB?(C)&&!Y/: MF_4ZB1$,0L*V_4TS=MM080-1W0Y@.)*"SD?FFN"F?$(YM8/X(ZI,#UU)#>E# M!:BNB>R`5D%ZT(^WW^-U^84,(5'Q\,]+](Q27"E[@0O);%"9OK_PA=.'"F1= M$]D!LH+TXRPRT"GD`\9I<9D@^GC9)S)3%B-7TKJ'4V[K4%$)4]\.!KFRCHC[ M-=1E"]<2UY(;,G!"Z*?_FGI]>)VO> M(84")33HM"D#!;VZ5:S@&22V@>I;]=WE9Y0_8H^_CZ+'C&!$4(CZ\MB1970J MO(%D"9C=IY&"72;T.+8W%6M8J6FNAI&7;L4/FZ(A["=/=;CPAL]I#0%@"@OD(\[-6)16#A!W M`O0];PN?NZ%YNRI3V/G:\YH8ZF;FA2R+UFR):*?8^)`Y[:[<\I*P""# MG<@RV^?GXOBQV#D+,LN.VK*C)MM14_.MU'4V\K(--](V7%@X6/;N;.S=A37F MQROC@SVC?NXCMV$_R9'1T.$LN!F,^Y),?ZX3,C=:-1D3]!>TO#AW\@NF',QY M`93.'40PGMC$"KQ=L8&X[AP6($;7Q3Q)#CA:0'BSEMF(YV&^W)+E]-I@#[7# M4+)3:B7D>FDU:I^>Q3'>9V5QAV*4/%-(-,_(\A)/=7CTLTO5>/CCC!!$8#NV MDGFOH"N=7%&U+MC;`7)3,F"+LVJ6DD"&O33$?]''M,!8"VP(/*/PI=!3> M1OE-7IEF5=55OD5YI:T(%&1N;P M.1YVU^`9QQH<@.;Q,]\8C`%LPT:\Y"9))[H/[2@(GT.N<;$J\"9Q]W!$\R)M M\9'@Y@-1(\^B]/3Z<;:ZQMGF.GE&J[.B0&5Q+LFZ'BR6+E="-4T3JP-QA, MF')?9M!CZAS_EJR"K4=,Z65AG?YVO\RZ_0P^_^LWA#=YM'M*XB@5I*]+V_,R MO8;M9XASJ'5&![*@(\$FV:,-5>@.[6C)OFPCRTZ4-._CE-O.AE-,?]A,Z>OT('*1MKQ,^PR9MSX8IJ[V&SM7BC&KR]J?W;RL]Z$_^414L M;XM@7FJ#-&UZ+V[JBX,)!@$KJ2OVFZ$8ZCAB]E[,W0L4O]G@Y^^KI-C\A3K% M^\-_*(K>M_RA^?$_?K_OH6;XB\9H[5^$@0BN*CKCWV;6C/8O;]^&>>+^84]O MTPMOPK*:]$)=MTD8D`"HIP,.-ML33,),0_],I@]/9V0:0)05@H7?L`<95L.P M@"-5U00^+.;V+S*X/"3D+KNP^I1+=DC8E]69_O)E6)G9NMW*+W*'>_FGE45_ M'7*5K7&^K30^?VE^"=O\4^;$W?%3X.1ZC<+JH^SD0X54LL!FD[H/)0:@&`89 M%4-)]X3`'6)$(DE'/"AC?(RKY_N"=*PHFIX7D,U($0UO0Y)-,QL`*IAF).2) M>^!!F>5E1U%I1U'W*VEE&U%!N#_(@FS]0;;[[&_Q?<@VQ"?)2B#;W*/\.8DY MKT_"&K>W^02-?<$]9W,/JJ88S[TM/0%3(YQRQO436E6+#2094E&[]FBRVWD^ MD`#EE,:0S<^#.1-]B_%F_1O&*WJ2AMN^[G=P MW=WR\&/%/7WF.3/YY?SE=#YPEJ.HSGV1W^XPYLC./]?CZ-[I%?8R[-G.8$_# MJ!--&'FO_KJG%Y/%05K8^)F=NX9O$>8V&RZ7?`!]G^P\;5P.6%=YJNN%(;?.E:@ ME)C!SUO&2A%#V18FT0$B;!:WB#-W[Q7=HRS!.;VK0"RR_8Q+5#2U@,^RU6>< MQRI?[,M_')6EPB-CI^T`#^$:)#_)";RI][I*ZE*#AI#>_7(1>)`EG[:DPE]I+E7(+:%0ORJ>-R+8H`"H#K5^ZU(&V`TR-FGS:R.S( M`D#SQS"A^>I+ZZJ"TKRH+A22(DD`0/Y-&9">E`E:2NU:AN=XWW.9-`!,?Y@3 M3%]SZ5T;2!WQ`R\5!\#J3U:PZOM&RK*#XO(*':MC"D`;D,,#L'POTKSW1ZL-SE?`I"2V2YGW?X39W%TYZ79*&#UE[ MBA0?9Z&%UO7F!@".J$P+X(@(_HZF\^HN[C.0_HSR/J-6SU5VR>2J+;FR5 M.+DB=<\!P-3V[@>>4HD.PEO36&&FI2YY^S:A$KGS&*`ZN-C82)P(`>S(\;ZB M4@>T[Q'YL`'Y,4KRZK&RNG@D+2>91(])FI0)O:@94?.L;K([1,^^:?Y,=1"> M'_Y['A5)0>DKBS^@^"E+2)2%I1Q/*KL7.2:2':(+NAP><_^=N/=!/V/>2HNE M*Z3SEXLT*N2S5!@5/].9316RJZB9Q![(I7(/Z01S@.=@`7_\-N>UO12!J\Y/ M#&D5?C,"N[891W,#E1X=CH^#7OPM:[]IUGX2D<*%GRIM>]4'IPTQKIB8Q])Z M#RX=LC\\ZDY2\QOZQV-4(/*3_Q]02P,$%`````@`Y'8,1RA;>T32%P``4!D! M`!$`'`!E:W-O+3(P,34P-C,P+GAS9%54"0`#BY;+58N6RU5U>`L``00E#@`` M!#D!``#M75]SV[:R?[\S]SOP^N6F,U7D/TG:9)IS1K:3',\XL<=VG[QD?#H\>OOV[5`_/:A(1=)$>'QX M>#3\]?/EK6YV34S5I5/!G"XS$2*W)XFLA5!9/X];!X M6)%R/&EM^,U0/:T(*:,TGS?3)I(/Y3+#0T4T4%28DWA5SUUIHP*>`HBMO7H[ MY"Q5M0HRDV72(:)-B3ZD'<2_7AKPXC\$J]%"P5@-4!*+ES&;JRI'KP_?G!Q6 M%6*64\F7=?$+'+^FXA2IE$4A'ILJHTRPB=L+)(%<)`?E>-YAL\B?1$ M>P?#Y/V!(/,L!0!UV4R/7'CUH'K?;QG'+Y5T*A(8)QTHZV&DJ@C%MN[:Y?K% M51.(QU8KEB)0C;`,8JP9-MN5)5""5]9BI% MXVV94E5P^KS\0#MWBH,(_OAZ<]$Y>W6G-%<)PFJQ)4G)I/ZY:KEJ>XW)/]0: M%@VB!2]&>,)IBJKL)? M@J4DT9;1*4IA%8QN9QA+$0#H`B#;0"!S0'"R"P31BVO$%?T,2Z+$]$.`I!T2 MP5@-$OC=#W9$K5_BM&:BZ,8KUU)'0:7:NI$BN+KS"K MA"3*G,)A?K2")^<,,2X-X*J2;M!.-D$#I])GK#;"_,?H:C+!'-``$*[4^LVC M&YQJ!7;'$14H#FM()RJ3Q=Q`!'YUH_%J$XV/B/#H&TIS``5!(2P:0>+M^SEN M[N:X0]ZO-^5]CM6(!P?J#5Y@F@>-TRYIE!J25C^Z)?UF4])*U_-<"?J2H#%) M">SN@ZS;9$W-?1KMWJ0='?ZT*>LO3*V=T35:HG&*@Y1;;4P4FV-:_^R6],^6 MI5ELK,HE\PQE1*(TNE2J.PSO=L'?&U*_[Q;YT>&FR/^-N+)%PIK8+EXQCC.$ M#!F7!=V"MG91MY+%?PS`^PJ;V7FFMK6%17^=*EM0#_C1/>))0*(5"2*/#!C@ M5S<&UI;J@JH&<72''H(^Z7#=H-CTVZA?W6*V-D%J>,^)U*9VHSA`/IDN[BD],]9XX9&YM M>V[Q5#LCUX5AE/OXR;)F1UFW@7[\5WC*HA=5>3ANZ7`6R)JWH-M9=N+A+HA> MW,$>*PB]RV\@:XX#E]!]/`=![!XN!%GS(;C$WNU$"`+W\B;(#7>"2^A;^1," M!F['@@G`O4/Z[:Z%(&E/'X.TG`PNF>_N90B@^.W'Y.:&S`7)-CNR`(+'UJPV M*Q*7^'TV9T'L;K'7SDR$X]#DY\-#2_O?8DH8#XFL1V].,<2D31HE2YE+A@?S^.ZNZTJ M;5&X%N,[U&?VN`#O+A53K,/\A@-4)UBJ^D9^UX'[2"BB,4%I-!("E\$JYKE8636)D#1: M#,#Z`AN3G%B@%H7=@-J'">V`KN?PV0S1J8*-T.@K96.!^4+OS"]HELLP'SUA MDW7`7&:1?0;1"E6P;5P!CF9XHTON#=&-"R4HQD.076<,:2V$U"5DR^ED"#D, M:+>T!:LM`,5OA\RM$[2:S,T%W'@0M+L'',I0I@8:^J<##.L\[;I()[(L+.(_ M M1KN'\`4#/^1D6H-@7>@`PMI!KX`HSH&N,J#V@,C+;1:,QR^4&[54N=>):0JL@F$KN7)4+69ZD?60< MDRG5<<0D7B<3%`\ M1D+965QFQ)I.C20.G*P=:OO,6C^)/CS`-0$/LBQ=P@$I1+/DDJGU[2-.,$>IV?(-DCB2#.8H3-':\7<8*YYC M16(F$\03B9`U2.K/'*/#V@BWCPX]+-08B`L=>X>5QN5@Q)0C@\;ED7B5T&QU ME1-J-I^F!L`]`>=LC#!2UN%X$V[SB0-L:S_=#O8-CAF-%4J%80K1*WA***WN MS7W0!FFI!N#Q5\I5E2DE_RD!+Q5'@-@'8EZ[2LH=5TE_/CRQ]NG5I+M&X%,, MN00]I9[4Q>Z:0B?6MKQ=[F'<>]PFK9F=+L?MJZ.&6R[K&Z7!Y-PNHP\6,8KK ML9)&H6,B6!NV\B9UF1-X=:JA)L6MY'DL@>H%9`$J'W8$.0?\?&(?S93"HCN3 ML,++6OMO\['`?^80C/YA$3*@=HNZ%EV*79/CE7WQ<5/8881[I'LPI>YPOKXZ M="0I#P+?ZCY$TGP?P@7"L0W"4N!*VSJ)T0O,$96E9?U8"OST6GG"13K.,B`K`[`9MEZC^) M-H*.&AZZ('Z*+PU$+ZXY68!/]CI%<7$YL5X5?H##=J2>)84F?L`\)B+@OQO^ MF&1-R!?%+LRMT\J=,(D#H.JT(7&I89NH&&>>@TR;67D(U3,D7%2I731"UB M"43GDG5T;D!N*^3B1NBZ4[@#=I9]^<3812_.E%2CXP!BNP\,Q;4#_N)W-W`_ M-WC".I.>AKGD/*>J'5,Y#TX<6KJHEH]V M1U!;JY71V0%2OR^7U2.<'%EE7QTUG'YV?KTLH.#K>OV"91%R#-'^UYCK^XK5 MB&<3G2!/B;=,C]=(W>:K?<*FNT?'JP8'8UG"G&*X(;G#&NG6[&'=^`ER=> M4PNNJ0=:#6GY'6A]PFS*4393BCG`M!U,D\5\(Y.CRS7=L'BV9@8,\G=?#*M? M!G--CX;HS/H-L"!R/WNC?M=!V7-%*,WJHH-E4S@K=`%W9*>R];AL$3!\'(9M MYJ%OO6Y%^+9AC^ES@>;_P0S]9?@@DG'QZ>Z%>!*^4@$FKUGZ-+%NO&.JK`KT%5;P!%@Z/C MPX-#7TZ(;9WFO]"SY=YMF!J@*\^;7_.S>;>3/D>.+]4DT-;WPS.#P> M'/^TXWL3R8=283JDC`YH/L>/+H[NW7EJ?H!#12: MB.(IQ&7Z=23EO%;K23IR,H2H#$3CK:=$56^G*6&W^2MHB&WZD.X^%P6.7T[9 M8JBOF/#E$$+:!X='JJ'6#K36JWX,UHWLV)L$$VCQU38]J>K`'X-U9?\>3)`8 M:Z'F8C!%*(/67OOTH+'B$*=25"6#=5-6?W!:!)E#A]X?C!:8HRG^S*B\FS.JED6^O)!X#@N)ZGX^%I+('#K_B;,\JTB) M(CF(*$EU?K3W!VIE5>1(47,4R_<'$Y3"$E$0CU$*P_S]03(B5?>=G9/%/Z[0G;-">#T`^?>BIL*2]]=6]A?67S!]YI,["(&HW+O)%`?U@9WFP_*>:\F MO7H#:(?OW/%BB@E%I"8=(+$NN(&ZIEISDIJP9&HS][V')884^:.X[<-WEN+V MK=`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`JH]'AI,;M5K?[QS&+MI`"+F4I]=+NZ,3$J M7V`RZT7>M^WC!SI5>UN=1_$6\P6)L>VUZ*#I'6APP4+?KU@IRC+#,DX^,CX2 M-SC)XV)'5"83-!C=I?)?N@M(\'CG38#B`/3.C.#)AP<][GZ!J70KVTR?1QT?>?+Q4]O^?C$%IA3**C4XP*KM=`>?"["WG%VJ>:% M6N9*E6"[]!L?]X\+%O\QPSCYC.`:YTBUR.`V@,U.-UWO^/J,?F>\,KOLLZ.F MI_WC`2POF=U?66IS+SN?XP MFY']O,EKZB;=%^Z:M]@^Q'O#88,!ZR;M(7?:]KDI/IK9&*W83M+#8PGH+(>3 M;0@\:0"HX6G_,&%+E,KE=1%[CJ;F1KCA6=G_WD2KWZ(4BW+0?&(L$5^P_/`0 MISFDSUQO(329'0.\0^7>`7B+*6'\$D/BZ88H9_MA_SB`(,=3R/AF)GP;@>=E MJNE.EVN2,CI(IXY;.6J,E'^0)BXN/#433.`"^4W=?_Z7O*UWTV17IHO8U!N< MY3R>P<,+6V<_1^,U!VD?@F!O\W%:[.#QXW3.X]KIW>2%F&6X,@$?J2N_?+_N MNL6]%W7O>"R^^`W!,X3&)(/(D")$L8S9OJ`QAX`B-7S+D:SCT\T0BUU;V!N_ M+W!<`MVEK?Z)R.F\[/I'DMFJL?ZJW8SA4T:6KHQJ/BZ2M M%?\F@Z9BJ&+1^XIQ0\7>#0:?6+WJDW!G3,AUJ,0M@P^KRO(%6P7_^32X-YK: M5`-%`-`E0_2.%=\IW]0H7M3[,W%,=NJ*KQK\-=8:E,K.+>R/D+ZI/]56!K:- M:M"/:`+ATNJO;T39*99-YT7=.YO.6`"+J\#(<6'8MT+_.3W=EM.6"KWCM'ZK MJ,H<`L[1>(;;KQ_9A.94)53B*>;?>=DKUPU474$^U3I-&23V$/ M^QM\775[9^#4Q^;:("F[?(-C3!8X:738[E"W=YZJ,DUQF?%G=[?2:(&([M]' MQC\!]_KRTQU^D*?IQJ;I+WME36/*JOQ[2QPF#9RHJ\EANZL:'O9.[UNQPT@K35&=`HPF$DZMX/CT"8=JQSMZ M)\_*$:.=P3?`8%,D1R=5[Y2:W=NFZ(9.JGW@J3$FQ4'7.[Y65\.JO#=U1W%3>GF.()`95;G'&)>JC6<0:4?+?W>AWF(IBV8$I$U0%<'GFX_5%/W,$IQZL;.W8JOR=QK?%/=QA'K5ZZ=$RC<3 M6Q-HC&BR7>ZQ1[?4NTW*-2]CK#ORK;50](X7'<@_`<=/V=5+@L9J$R"7=ZP8 ML`9;/L3[8RRL3RN*4XP8C,Q$6^]WK/INP!F;CPFU0SBVK;H_8OG":'6IU[X_ M9C_;PQ']-6/T!L_9`N)LUE]\9?0C1K)^P/D4C>V-76FQ6#*O1I/);65`VD:U M?\V]D8[OV%=5#S[.J_:C MH"8BRY?AP-;8_R[$/MW;^&$,!/7JN;=WZWUVXKF6NT1PX2U%>SQ[[U[][?X#I M"J3?W#16L=*>/.5W'7:6CZM^[[P4;5WUO<\#YD)'ZH7=FMN?8;0E MOW9HR./DU]9>#X=9ZE7IGL%4=5'W7AP8"_'?KZ-XF+ZY_E5ZZ M<#O'J'YX5=W`KHQ)"A]*3;$0IT@0[ZA@O[9Z-P=TY\?N**AQ`Q0````(`.1V#$>] MX])L)AT!`/K<$``1`!@```````$```"D@0````!E:W-O+3(P,34P-C,P+GAM M;%54!0`#BY;+575X"P`!!"4.```$.0$``%!+`0(>`Q0````(`.1V#$=_D@GI M`!@``-IP`0`5`!@```````$```"D@7$=`0!E:W-O+3(P,34P-C,P7V-A;"YX M;6Q55`4``XN6RU5U>`L``00E#@``!#D!``!02P$"'@,4````"`#D=@Q'\6W] M*]=@``"Z.0<`%0`8```````!````I('`-0$`96MS;RTR,#$U,#8S,%]D968N M>&UL550%``.+ELM5=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`Y'8,1V@7 M>C=>-`$`'(D5`!4`&````````0```*2!YI8!`&5K`Q0````(`.1V#$=P MX"ZI#9(``%<]"P`5`!@```````$```"D@9/+`@!E:W-O+3(P,34P-C,P7W!R M92YX;6Q55`4``XN6RU5U>`L``00E#@``!#D!``!02P$"'@,4````"`#D=@Q' M*%M[1-(7``!0&0$`$0`8```````!````I('O70,`96MS;RTR,#$U,#8S,"YX M`L``00E#@``!#D!``!02P4&``````8`!@`:`@``#'8# #```` ` end XML 47 R1.htm IDEA: XBRL DOCUMENT v3.2.0.727
Document and Entity Information - shares
 6 Months Ended
Jun. 30, 2015
Aug. 03, 2015
Document and Entity Information [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Entity Registrant Name EKSO BIONICS HOLDINGS, INC.  
Entity Central Index Key 0001549084  
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2015  
Document Period End Date Jun. 30, 2015  
Current Fiscal Year End Date --12-31  
Entity Filer Category Non-accelerated Filer  
Entity Common Stock, Shares Outstanding   102,139,765

XML 48 R18.htm IDEA: XBRL DOCUMENT v3.2.0.727
Net Income (Loss) Per Share
 6 Months Ended
Jun. 30, 2015
Net Income (Loss) Per Share [Abstract]  
Net Income (Loss) Per Share

13. Net Income (Loss) Per Share

 

The following table sets forth the computation of basic and diluted net income (loss) per share:

 

  Three months ended June 30,
   Six months ended June 30,
  2015     2014   2015   2014
Numerator:               
Net income (loss)  



 





Basic   $ (5,645 )   $ 56,128     $ (9,760 )   $ (25,638 )
Adjustment for change in fair value of warrant liability      -       (60,458 )     -       -  
Diluted    $ (5,645 )   $ (4,330 )   $ (9,760 )   $ (25,638 )
                                 
Denominator:                        
Weighted-average common shares outstanding used in computing basic and diluted net income (loss) per share


                   
Basic     102,094,158       78,497,558       101,944,359       72,688,073  
Dilutive effect of warrants      -       9,593,643       -       -  
Dilutive effect of stock options     -       6,681,210       -       -  
Diluted     102,094,158       94,772,411       101,944,359       72,688,073  
Net income (loss) per share, basic     (0.06 )     0.72     (0.10 )      (0.35 )
Net loss per share, diluted     (0.06 )     (0.05 )     (0.10 )     (0.35 )

 

The following table sets forth potential shares of common stock that are not included in the calculation of diluted net loss per share because to do so would be anti-dilutive as of the end of each period presented:

 

  Three months ended June 30,
   Six months ended June 30,  
  2015     2014   2015     2014  
Options to purchase common stock     13,227,092       -   13,227,092       7,073,652  
Warrants to purchase common stock     13,747,161       -   13,747,161       14,546,085  
Total common stock equivalents     26,974,253       -       26,974,253       21,619,737  
XML 49 R4.htm IDEA: XBRL DOCUMENT v3.2.0.727
Condensed Consolidated Statement of Operations - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Revenue        
Medical devices $ 1,048 $ 690 $ 2,033 $ 1,217
Engineering services 1,066 507 1,770 1,042
Total revenue 2,114 1,197 3,803 2,259
Cost of revenue        
Cost of medical devices 970 502 1,768 832
Cost of engineering services 642 650 1,130 902
Total cost of revenue 1,612 1,152 2,898 1,734
Gross profit 502 45 905 525
Operating expenses        
Sales and marketing 2,523 1,849 4,374 3,380
Research and development 1,742 699 2,725 1,468
General and administrative 1,872 1,809 3,534 3,880
Total operating expenses 6,137 4,357 10,633 8,728
Loss from operations (5,635) (4,312) (9,728) (8,203)
Other income (expense)        
Interest expense $ (3) (3) $ (6) (430)
Gain (loss) on warrant liability   60,458   (16,979)
Interest income $ 3 2 $ 7 3
Other expense, net (10) (17) (33) (29)
Total other income (expense), net (10) 60,440 (32) (17,435)
Net income (loss) $ (5,645) $ 56,128 $ (9,760) $ (25,638)
Basic net income (loss) per share $ (0.06) $ 0.72 $ (0.10) $ (0.35)
Weighted-average shares used in computing basic per share amounts 102,094,158 78,497,558 101,944,359 72,688,073
Diluted net income (loss) per share $ (0.06) $ (0.05) $ (0.10) $ (0.35)
Weighted-average shares used in computing diluted per share amounts 102,094,158 94,772,411 101,944,359 72,688,073
XML 50 R12.htm IDEA: XBRL DOCUMENT v3.2.0.727
Operating and Capital Leases
 6 Months Ended
Jun. 30, 2015
Operating and Capital Leases [Abstract]  
Operating and Capital Leases

7. Operating and Capital Leases

 

On November 29, 2011, the Company entered into an operating lease agreement for its headquarters and manufacturing facility in Richmond, California. The lease term commenced in March 2012 and expires in May 2017. The lease provides the Company with one option to renew for five additional years. The Company also leases nominal office equipment.

 

Future minimum operating lease payments are as follows as of June 30, 2015:

 

2015 (remainder of year)   $ 188  
2016     375  
2017     157  
Total   $ 720  

 

The Company also has a capital lease for the purchase of machinery and equipment with a balance of $11 and $13 as of June 30, 2015, and December 31, 2014, respectively, which is classified as a component of Notes payable, non-current (see Note 6, Notes Payable).

 

Rent expense under the Company's operating leases was $86 and $86 for the three month periods ended June 30, 2015, and 2014, respectively and was $172 and $171 for the six month period ended June 30, 2015, and 2014, respectively.
XML 51 R11.htm IDEA: XBRL DOCUMENT v3.2.0.727
Notes Payable
 6 Months Ended
Jun. 30, 2015
Notes Payable [Abstract]  
Notes Payable

6. Notes Payable

 

In 2012, the Company entered into a note agreement in connection with its lease agreement for our Richmond, California facility. The note, for an aggregate principal of $200, with an interest rate of 7%, minimum monthly payments of $4, and a May 31, 2017, maturity, was used to fund leasehold improvements. In addition, the Company has a long-term capital lease obligation of $11 (see Note 7, Operating and Capital Leases).

 

Future obligations under these debt instruments as of June 30, 2015 are as follows:

 

        Leasehold     
       
        Improvement     Capital        
        Note     Lease     Total  
2015 (remainder)
  $ 24     $ 3     $ 27  
2016
    48       5       53  
2017
    19       4       23  
Total minimum payments
    91       12       103  
Less: interest

    (6 )     (1 )     (7 )
Present value minimum payments
    85       11       96  
Less: current portion
    (43 )     -
    (43 )
Long-term portion of notes payable
  $ 42     $ 11     $ 53  


XML 52 R23.htm IDEA: XBRL DOCUMENT v3.2.0.727
Notes Payable (Tables)
 6 Months Ended
Jun. 30, 2015
Notes Payable [Abstract]  
Schedule of future obligations under debt instruments
        Leasehold     
       
        Improvement     Capital        
        Note     Lease     Total  
2015 (remainder)
  $ 24     $ 3     $ 27  
2016
    48       5       53  
2017
    19       4       23  
Total minimum payments
    91       12       103  
Less: interest

    (6 )     (1 )     (7 )
Present value minimum payments
    85       11       96  
Less: current portion
    (43 )     -
    (43 )
Long-term portion of notes payable
  $ 42     $ 11     $ 53  
XML 53 R19.htm IDEA: XBRL DOCUMENT v3.2.0.727
Segment Disclosures
 6 Months Ended
Jun. 30, 2015
Segment Disclosures [Abstract]  
Segment Disclosures

14. Segment Disclosures

 

The Company has two reportable segments, Engineering Services and Medical. Engineering Services generates revenue principally from collaborative research and development service arrangements, technology license agreements, and government grants where the Company uses its robotics domain knowledge in bionic exoskeletons to bid on and procure contracts and grants from entities such as such as the National Science Foundation and the Defense Advanced Research Projects Agency. The Medical segment designs, engineers, and manufactures exoskeletons for applications in the medical and military markets.

 

The Company evaluates performance and allocates resources based on segment gross profit margin. The reportable segments are each managed separately because they serve distinct markets, and one segment provides a service and the other manufactures and distributes a unique product. The Company does not consider net assets as a segment measure and, accordingly, assets are not allocated.

 

Segment reporting information is as follows:

 

Engineering   Medical           
Services   Devices     Total  
Three months ended June 30, 2015                      
Revenue   $ 1,066     $ 1,048     $ 2,114  
Cost of revenue     642       970       1,612  
Gross profit   $ 424     $  78     $ 502  
             
Three months ended June 30, 2014            
Revenue    $ 507 $ 690 $ 1,197  
Cost of revenue      650 502 1,152  
Gross profit (loss)   $ (143 ) $ 188 $ 45  
             
Six months ended June 30, 2015                    
Revenue $ 1,770     $ 2,033     $ 3,803  
Cost of revenue     1,130       1,768       2,898  
Gross profit   $ 640     $ 265     $ 905  
                         
Six months ended June 30, 2014                        
Revenue   $ 1,042     $ 1,217     $ 2,259  
Cost of revenue     902       832       1,734  
Gross profit   $ 140     $ 385     $ 525  

 

Geographic information for revenue based on location of customer is as follows:

 

 

Three Months Ended

June 30,

  

Six Months Ended

June 30,

  
  2015
     2014
   2015     2014  
                         
North America   $ 1,622     $ 941   $ 2,894     $ 1,831  
Europe, Middle East, Asia   492       256     909       428  
    $ 2,114    

$

 1,197     $ 3,803     $ 2,259  
XML 54 R15.htm IDEA: XBRL DOCUMENT v3.2.0.727
Stock-based Compensation Plans and Awards
 6 Months Ended
Jun. 30, 2015
Stock-based Compensation Plans and Awards [Abstract]  
Stock-based Compensation Plans and Awards

10. Stock-based Compensation Plans and Awards

 

In January 2014, and prior to the Merger, the Board of Directors and a majority of the stockholders adopted the 2014 Plan that allowed for the issuance of 14,410,000 shares of common stock. Options previously issued under the Ekso Bionics 2007 Equity Incentive Plan were converted into options to purchase an aggregate of 7,602,408 shares of the Company's common stock under the 2014 Plan. On June 10, 2015, the 2014 Plan was amended and restated by the stockholders to increase the maximum number of shares by 11,590,000 shares to an aggregate of 26,000,000 shares of common stock available for issuance under the 2014 Plan. As of June 30, 2015, there were 11,767,633 shares available for future awards.


Under the terms of the 2014 Plan, the Board of Directors may award stock, options, or similar rights having either a fixed or variable price related to the fair market value of the shares and with an exercise or conversion privilege related to the passage of time, the occurrence of one or more events, or the satisfaction of performance criteria or other conditions, or any other security with the value derived from the value of the shares. Such awards include stock options, restricted stock, restricted stock units, stock appreciation rights and dividend equivalent rights.

 

The Board of Directors may grant stock options under the 2014 Plan at a price of not less than 100% of the fair market value of our common stock on the date the option is granted. Incentive stock options granted to employees who, on the date of grant, own stock representing more than 10% of the voting power of all of our classes of stock, are granted at an exercise price of not less than 110% of the fair market value of our common stock. The maximum term of incentive stock options granted to employees who, on the date of grant, own stock possessing more than 10% of the voting power of all our classes of stock, may not exceed five years. The maximum term of an incentive stock option granted to any other participant may not exceed ten years. Subject to the limitations discussed above, the Board of Directors determines the term and exercise or purchase price of other awards granted under the 2014 Plan. The Board of Directors also determines the terms and conditions of awards, including the vesting schedule and any forfeiture provisions. Options granted under the 2014 Plan may vest upon the passage of time, generally four years, or upon the attainment of certain performance criteria established by the Board of Directors. We may from time to time grant options to purchase common stock to non-employees for advisory and consulting services. Pursuant to ASC 505-50, Equity-Based Payments to Non-Employees, we periodically re-measure the fair value of these stock options using the Black-Scholes option pricing model and recognize expense ratably over the vesting period of each stock option award. Upon exercise of an option, it is the Company's policy to issue new shares of common stock.


The following table summarizes information about the Company's stock options outstanding at June 30, 2015, and activity during the six-month period then ended:

 

    Weighted-        
    Average           
Weighted-     Remaining     Aggregate
Stock Average     Contractual     Intrinsic
    Awards     Exercise Price     Life (Years)     Value
Balance as of December 31, 2014     10,791,081     $ 0.79                  
Options granted     3,184,000     $ 1.40                  
Options exercised     (697,356 )   $ 0.55                  
Options forfeited     (40,507 )   $ 0.57                  
Options cancelled     (10,126 )    $ 1.74                  
Balance as of June 30, 2015     13,227,092     $ 0.96       7.86     $ 4,197  
Vested and expected to vest at June 30, 2015     12,118,042     $ 0.92       7.71     $ 4,131  
Exercisable as of June 30, 2015     5,970,959     $ 0.60       6.23     $ 3,451  

 

Of the 697,356 shares exercised, 535,404 were on a cashless basis for which the Company did not receive any proceeds, but instead withheld 243,647 shares from the option holders exercising such award to cover the exercise amount.


As of June 30, 2015, total unrecognized compensation cost related to unvested stock options was $5,386. This amount is expected to be recognized as stock-based compensation expense in the Company's Condensed Consolidated Statements of Operations over the remaining weighted average vesting period of 3.09 years.

 

The per-share fair value of each stock option was determined on the date of grant using the Black-Scholes option pricing model using the following assumptions:

 

  Three months ended June 30,
 Six months ended June 30,
  2015     2014
 2015
2014
           
         
Dividend yield     —       — —       —  
Risk-free interest rate     1.44% - 2.34%        1.90% - 2.61%
  1.41% - 2.34%       1.74% - 2.67%  
Expected term (in years)     6-10        6-8
  6-10       6-10  
Volatility     73% - 74%        66%     73% - 74%       66%  

 

Total stock-based compensation expense related to options granted to employees and non-employees was included in the Condensed Consolidated Statements of Operations as follows:

 

  Three months ended June 30,   Six months ended June 30,  
  2015 2014   2015     2014       
Sales and marketing $ 161 $ 150   $ 292     $ 251  
Research and development 108 21     162       90  
General and administrative 174 155       337       352  
  $ 443
$ 326     $ 791     $ 693  
XML 55 R13.htm IDEA: XBRL DOCUMENT v3.2.0.727
Capitalization and Equity Structure
 6 Months Ended
Jun. 30, 2015
Capitalization and Equity Structure [Abstract]  
Capitalization and Equity Structure

8. Capitalization and Equity Structure

 

The Company's authorized capital stock at June 30, 2015, consisted of 500,000,000 shares of common stock and 10,000,000 shares of preferred stock. At June 30, 2015, 102,123,767 shares of common stock were issued and outstanding, and no shares of preferred stock were issued and outstanding.

 
XML 56 R14.htm IDEA: XBRL DOCUMENT v3.2.0.727
Warrants
 6 Months Ended
Jun. 30, 2015
Warrants [Abstract]  
Warrants

9. Warrants

 

As discussed in Note 3, The Merger, Offering and Other Related Transactions, the Company issued during the Merger and PPO, warrants to purchase a total of 36,055,000 shares of common stock of which 30,300,000 were at an exercise price of $2.00 per share, and the balance at $1.00 per share. These warrants contained “weighted average” anti-dilution protection in the event that we issued common stock or securities convertible into or exercisable for shares of common stock at a price lower than the subject warrant's exercise price, subject to certain customary exceptions, as well as customary provisions for adjustment in the event of stock splits, subdivision or combination, mergers, etc.


Due to the market price of the Company's common stock price exceeding the exercise price of the then outstanding warrants, the Company recorded a non-cash charge of $77,437 during the period ended March 31, 2014. As the market price of our common stock declined during the three months ended June 30, 2014, but still exceeded the exercise price of outstanding warrants, the Company recorded a non-cash benefit of $60,458 for the period.

 

The factors utilized in re-valuing the warrants were as follows as of June 30, 2014:

 

Dividend yield    
–     
Risk-free interest rate     0.69% - 1.45%  
Share price at final valuation     1.47  
Expected term (in years)     2.55- 4.55  
Volatility       70-75%  
Periodic rate       0.18% - 0.66%  
Periods in the model       10  

 

These warrants were amended in November 2014 to remove the price-based anti-dilution provision, among other things. Accordingly, the warrants are no longer recorded as a liability.

 

Warrant activity for the six month period ended June 30, 2015 is as follows:

 

Balance   Exercise     Term           Balance
  
Name December 31, 2014   Price     (Years)     Exercised     June 30, 2015  
Placement agent warrants 3,030,000     $ 1.00       5       (48,700 )     2,981,300  
Bridge warrants     2,600,000     $ 1.00       3               2,600,000  
PPO warrants     7,544,500     $ 2.00       5               7,544,500  
Pre-Merger/PPO warrants     621,361     $ 1.38       various               621,361  
Total     13,795,861                       (48,700 )     13,747,161  

 
XML 57 R16.htm IDEA: XBRL DOCUMENT v3.2.0.727
Income Taxes
 6 Months Ended
Jun. 30, 2015
Income Taxes [Abstract]  
Income Taxes

11. Income Taxes

 

There were no material changes to the unrecognized tax benefits in the three months ended June 30, 2015, and the Company does not expect significant changes to unrecognized tax benefits through the end of the fiscal year. Because of the Company's history of tax losses, all years remain open to tax audit.

 
XML 58 R34.htm IDEA: XBRL DOCUMENT v3.2.0.727
The Merger, Offering and Other Related Transactions (2014 Equity Incentive Plan, Narrative) (Details) - shares
 6 Months Ended
Jun. 10, 2015
Jun. 30, 2015
Jan. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of equity incentive shares authorized   14,410,000  
Equity Incentive Plan 2014 [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of equity incentive shares authorized   26,000,000 14,410,000
Options granted   3,184,000  
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized 11,590,000    
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant   11,767,633  
Conversion [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Options granted   7,602,408  
Merger [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Options granted   2,300,000  
XML 59 R51.htm IDEA: XBRL DOCUMENT v3.2.0.727
Net Income (Loss) Per Share (Schedule of Antidilutive Securities) (Details) - shares
 3 Months Ended 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities 26,974,253   26,974,253 21,619,737
Options to purchase common stock [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities 13,227,092   13,227,092 7,073,652
Warrants to purchase common stock [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities 13,747,161   13,747,161 14,546,085
XML 60 R21.htm IDEA: XBRL DOCUMENT v3.2.0.727
Deferred Revenues (Tables)
 6 Months Ended
Jun. 30, 2015
Deferred Revenues [Abstract]  
Schedule of Customer Deposits, Advances, Deferred Revenues, and Deferred Unit Costs
June 30,     December 31,       
2015     2014        
Customer deposits and advances $ 353     $ 105  
Deferred Ekso medical device revenues   6,048       5,327  
Deferred service and leasing revenues     2,123       1,875  
Customer advances and deferred revenues     8,524       7,307  
Less current portion     (4,032 )     (3,412 )
Customer advances and deferred revenues, non-current   $ 4,492     $ 3,895  
Deferred Ekso medical device costs   $ 4,391     $ 3,568  
Less current portion     (1,876 )     (1,551 )
Deferred cost of revenue, non-current   $ 2,515     $ 2,017  
XML 61 R26.htm IDEA: XBRL DOCUMENT v3.2.0.727
Stock-based Compensation Plans and Awards (Tables)
 6 Months Ended
Jun. 30, 2015
Stock-based Compensation Plans and Awards [Abstract]  
Summary of Stock Option Activity
    Weighted-        
    Average           
Weighted-     Remaining     Aggregate
Stock Average     Contractual     Intrinsic
    Awards     Exercise Price     Life (Years)     Value
Balance as of December 31, 2014     10,791,081     $ 0.79                  
Options granted     3,184,000     $ 1.40                  
Options exercised     (697,356 )   $ 0.55                  
Options forfeited     (40,507 )   $ 0.57                  
Options cancelled     (10,126 )    $ 1.74                  
Balance as of June 30, 2015     13,227,092     $ 0.96       7.86     $ 4,197  
Vested and expected to vest at June 30, 2015     12,118,042     $ 0.92       7.71     $ 4,131  
Exercisable as of June 30, 2015     5,970,959     $ 0.60       6.23     $ 3,451  
Schedule of Fair Value Calculation Assumptions
  Three months ended June 30,
 Six months ended June 30,
  2015     2014
 2015
2014
           
         
Dividend yield     —       — —       —  
Risk-free interest rate     1.44% - 2.34%        1.90% - 2.61%
  1.41% - 2.34%       1.74% - 2.67%  
Expected term (in years)     6-10        6-8
  6-10       6-10  
Volatility     73% - 74%        66%     73% - 74%       66%  

 
Allocation of Stock Option Compensation Expense
  Three months ended June 30,   Six months ended June 30,  
  2015 2014   2015     2014       
Sales and marketing $ 161 $ 150   $ 292     $ 251  
Research and development 108 21     162       90  
General and administrative 174 155       337       352  
  $ 443
$ 326     $ 791     $ 693  
XML 62 R49.htm IDEA: XBRL DOCUMENT v3.2.0.727
Commitments and Contingencies (Details) - Jun. 30, 2015 - Royalty Agreement Terms [Member] - USD ($)
$ in Thousands
Total
Future minimum annual royalties  
2016 $ 50
Net sales [Member]  
Research and Development Arrangement, Contract to Perform for Others [Line Items]  
Royalty percentage 1.00%
License fees [Member]  
Research and Development Arrangement, Contract to Perform for Others [Line Items]  
Royalty percentage 21.00%
Sub-licensee net sales [Member]  
Research and Development Arrangement, Contract to Perform for Others [Line Items]  
Royalty percentage 1.00%
XML 63 R41.htm IDEA: XBRL DOCUMENT v3.2.0.727
Warrants (Narrative) (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Mar. 31, 2014
Jun. 30, 2015
Jun. 30, 2014
Oct. 31, 2014
Class of Stock [Line Items]            
Warrant Shares Issued 36,055,000     36,055,000   30,300,000
Gain (loss) on warrant liability   $ 60,458,000     $ (16,979,000)  
Warrants [Member]            
Class of Stock [Line Items]            
Exercise price           $ 2.00
Offer To Amend And Exercise [Member]            
Class of Stock [Line Items]            
Gain (loss) on warrant liability   $ 60,458 $ (77,437,000)      
Offer To Amend And Exercise [Member] | Warrants [Member]            
Class of Stock [Line Items]            
Exercise price           $ 1.00
XML 64 R5.htm IDEA: XBRL DOCUMENT v3.2.0.727
Condensed Consolidated Statement of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Operating activities:    
Net loss $ (9,760) $ (25,638)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization $ 419 333
Inventory allowance expense   21
Amortization of deferred rent $ (19) (18)
Amortization of debt discounts   198
Stock-based compensation expense $ 791 693
Loss on increase in fair value of warrant liability   16,979
Changes in operating assets and liabilities:    
Accounts receivable $ (845) (944)
Inventories (478) (573)
Prepaid expense and other assets (85) (47)
Deferred cost of revenue (823) (917)
Accounts payable 1,523 (272)
Accrued liabilities (402) (166)
Deferred revenues 1,217 1,746
Net cash used in operating activities (8,462) (8,605)
Investing activities:    
Acquisition of property and equipment, net (559) (675)
Net cash used in investing activities (559) (675)
Financing activities:    
Principal payments on notes payable (22) (2,544)
Proceeds from exercise of stock options 56 $ 23
Proceeds from exercise of common stock warrants $ 48  
Proceeds from issuance of common stock, net of issuance costs   $ 21,961
Net cash provided by financing activities $ 82 19,440
Net increase (decrease) in cash (8,939) 10,160
Cash at beginning of the period 25,190 805
Cash at end of the period $ 16,251 $ 10,965
XML 65 R10.htm IDEA: XBRL DOCUMENT v3.2.0.727
Accrued Liabilities
 6 Months Ended
Jun. 30, 2015
Accrued Liabilities [Abstract]  
Accrued Liabilities

5. Accrued Liabilities

 

Accrued liabilities consist of the following:

 

June 30,     December 31,       
2015     2014      
Salaries, benefits and related expenses $ 1,516     $ 1,847  
Professional fees   273       184  
Warranty expense     91       126  
Taxes     42       46  
Royalties     -       50  
Travel     48       76  
All other     6       49  
Total   $ 1,976     $ 2,378  

 
XML 66 R27.htm IDEA: XBRL DOCUMENT v3.2.0.727
Net Income (Loss) Per Share (Tables)
 6 Months Ended
Jun. 30, 2015
Net Income (Loss) Per Share [Abstract]  
Schedule of basic and diluted net income (loss) per share
  Three months ended June 30,
   Six months ended June 30,
  2015     2014   2015   2014
Numerator:               
Net income (loss)  



 





Basic   $ (5,645 )   $ 56,128     $ (9,760 )   $ (25,638 )
Adjustment for change in fair value of warrant liability      -       (60,458 )     -       -  
Diluted    $ (5,645 )   $ (4,330 )   $ (9,760 )   $ (25,638 )
                                 
Denominator:                        
Weighted-average common shares outstanding used in computing basic and diluted net income (loss) per share


                   
Basic     102,094,158       78,497,558       101,944,359       72,688,073  
Dilutive effect of warrants      -       9,593,643       -       -  
Dilutive effect of stock options     -       6,681,210       -       -  
Diluted     102,094,158       94,772,411       101,944,359       72,688,073  
Net income (loss) per share, basic     (0.06 )     0.72     (0.10 )      (0.35 )
Net loss per share, diluted     (0.06 )     (0.05 )     (0.10 )     (0.35 )
Schedule of Antidilutive Securities
  Three months ended June 30,
   Six months ended June 30,  
  2015     2014   2015     2014  
Options to purchase common stock     13,227,092       -   13,227,092       7,073,652  
Warrants to purchase common stock     13,747,161       -   13,747,161       14,546,085  
Total common stock equivalents     26,974,253       -       26,974,253       21,619,737  
XML 67 FilingSummary.xml IDEA: XBRL DOCUMENT 3.2.0.727 html 127 226 1 false 46 0 false 6 false false R1.htm 001 - Document - Document and Entity Information Sheet http://www.eksobionics.com/role/ekso-daei Document and Entity Information Cover 1 false false R2.htm 002 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.eksobionics.com/role/ekso-ccbs Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.eksobionics.com/role/ekso-ccbsp Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 004 - Statement - Condensed Consolidated Statement of Operations Sheet http://www.eksobionics.com/role/ekso-ccsoo Condensed Consolidated Statement of Operations Statements 4 false false R5.htm 005 - Statement - Condensed Consolidated Statement of Cash Flows Sheet http://www.eksobionics.com/role/ekso-ccsocf Condensed Consolidated Statement of Cash Flows Statements 5 false false R6.htm 101 - Disclosure - Organization Sheet http://www.eksobionics.com/role/ekso-o Organization Notes 6 false false R7.htm 102 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies and Estimates Sheet http://www.eksobionics.com/role/ekso-bopasosapae Basis of Presentation and Summary of Significant Accounting Policies and Estimates Notes 7 false false R8.htm 103 - Disclosure - The Merger, Offering and Other Related Transactions Sheet http://www.eksobionics.com/role/ekso-tmoaort The Merger, Offering and Other Related Transactions Notes 8 false false R9.htm 105 - Disclosure - Deferred Revenues Sheet http://www.eksobionics.com/role/ekso-dr Deferred Revenues Notes 9 false false R10.htm 106 - Disclosure - Accrued Liabilities Sheet http://www.eksobionics.com/role/ekso-al Accrued Liabilities Notes 10 false false R11.htm 107 - Disclosure - Notes Payable Notes http://www.eksobionics.com/role/ekso-np Notes Payable Notes 11 false false R12.htm 108 - Disclosure - Operating and Capital Leases Sheet http://www.eksobionics.com/role/ekso-oacl Operating and Capital Leases Notes 12 false false R13.htm 109 - Disclosure - Capitalization and Equity Structure Sheet http://www.eksobionics.com/role/Disclosure-CapitalizationandEquityStructure Capitalization and Equity Structure Notes 13 false false R14.htm 110 - Disclosure - Warrants Sheet http://www.eksobionics.com/role/ekso-w Warrants Notes 14 false false R15.htm 111 - Disclosure - Stock-based Compensation Plans and Awards Sheet http://www.eksobionics.com/role/ekso-sbcpaa Stock-based Compensation Plans and Awards Notes 15 false false R16.htm 112 - Disclosure - Income Taxes Sheet http://www.eksobionics.com/role/ekso-it1 Income Taxes Notes 16 false false R17.htm 113 - Disclosure - Commitments and Contingencies Sheet http://www.eksobionics.com/role/ekso-cac Commitments and Contingencies Notes 17 false false R18.htm 114 - Disclosure - Net Income (Loss) Per Share Sheet http://www.eksobionics.com/role/ekso-nilps Net Income (Loss) Per Share Notes 18 false false R19.htm 115 - Disclosure - Segment Disclosures Sheet http://www.eksobionics.com/role/ekso-sd Segment Disclosures Notes 19 false false R20.htm 202 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies and Estimates (Policies) Sheet http://www.eksobionics.com/role/ekso-bopasosapaep Basis of Presentation and Summary of Significant Accounting Policies and Estimates (Policies) Policies http://www.eksobionics.com/role/ekso-bopasosapae 20 false false R21.htm 305 - Disclosure - Deferred Revenues (Tables) Sheet http://www.eksobionics.com/role/ekso-drt Deferred Revenues (Tables) Tables http://www.eksobionics.com/role/ekso-dr 21 false false R22.htm 306 - Disclosure - Accrued Liabilities (Tables) Sheet http://www.eksobionics.com/role/ekso-alt Accrued Liabilities (Tables) Tables http://www.eksobionics.com/role/ekso-al 22 false false R23.htm 307 - Disclosure - Notes Payable (Tables) Notes http://www.eksobionics.com/role/ekso-npt Notes Payable (Tables) Tables http://www.eksobionics.com/role/ekso-np 23 false false R24.htm 308 - Disclosure - Operating and Capital Leases (Tables) Sheet http://www.eksobionics.com/role/ekso-oaclt Operating and Capital Leases (Tables) Tables http://www.eksobionics.com/role/ekso-oacl 24 false false R25.htm 310 - Disclosure - Warrants (Tables) Sheet http://www.eksobionics.com/role/ekso-wt Warrants (Tables) Tables http://www.eksobionics.com/role/ekso-w 25 false false R26.htm 311 - Disclosure - Stock-based Compensation Plans and Awards (Tables) Sheet http://www.eksobionics.com/role/ekso-sbcpaat Stock-based Compensation Plans and Awards (Tables) Tables http://www.eksobionics.com/role/ekso-sbcpaa 26 false false R27.htm 314 - Disclosure - Net Income (Loss) Per Share (Tables) Sheet http://www.eksobionics.com/role/ekso-nilpst Net Income (Loss) Per Share (Tables) Tables http://www.eksobionics.com/role/ekso-nilps 27 false false R28.htm 315 - Disclosure - Segment Disclosures (Tables) Sheet http://www.eksobionics.com/role/ekso-sdt Segment Disclosures (Tables) Tables http://www.eksobionics.com/role/ekso-sd 28 false false R29.htm 40101 - Disclosure - Organization (Details) Sheet http://www.eksobionics.com/role/ekso-od Organization (Details) Details http://www.eksobionics.com/role/ekso-o 29 false false R30.htm 40201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies and Estimates (Details) Sheet http://www.eksobionics.com/role/ekso-bopasosapaed Basis of Presentation and Summary of Significant Accounting Policies and Estimates (Details) Details http://www.eksobionics.com/role/ekso-bopasosapaep 30 false false R31.htm 40301 - Disclosure - The Merger, Offering and Other Related Transactions (Merger, Narrative) (Details) Sheet http://www.eksobionics.com/role/ekso-tmoaortmnd The Merger, Offering and Other Related Transactions (Merger, Narrative) (Details) Details http://www.eksobionics.com/role/ekso-tmoaort 31 false false R32.htm 40302 - Disclosure - The Merger, Offering and Other Related Transactions (Repayment of 2013 Bridge Note, Narrative) (Details) Sheet http://www.eksobionics.com/role/ekso-tmoaortrobnnd The Merger, Offering and Other Related Transactions (Repayment of 2013 Bridge Note, Narrative) (Details) Details http://www.eksobionics.com/role/ekso-tmoaort 32 false false R33.htm 40303 - Disclosure - The Merger, Offering and Other Related Transactions (Private Placement Offering and Offer to Amend and Exercise, Narrative) (Details) Sheet http://www.eksobionics.com/role/ekso-tmoaortppoaotaaend The Merger, Offering and Other Related Transactions (Private Placement Offering and Offer to Amend and Exercise, Narrative) (Details) Details http://www.eksobionics.com/role/ekso-tmoaort 33 false false R34.htm 40304 - Disclosure - The Merger, Offering and Other Related Transactions (2014 Equity Incentive Plan, Narrative) (Details) Sheet http://www.eksobionics.com/role/ekso-tmoaorteipnd The Merger, Offering and Other Related Transactions (2014 Equity Incentive Plan, Narrative) (Details) Details http://www.eksobionics.com/role/ekso-tmoaort 34 false false R35.htm 40501 - Disclosure - Deferred Revenues (Details) Sheet http://www.eksobionics.com/role/Disclosure-DeferredRevenuesDetails Deferred Revenues (Details) Details http://www.eksobionics.com/role/ekso-drt 35 false false R36.htm 40601 - Disclosure - Accrued Liabilities (Details) Sheet http://www.eksobionics.com/role/Disclosure-AccruedLiabilitiesDetails Accrued Liabilities (Details) Details http://www.eksobionics.com/role/ekso-alt 36 false false R37.htm 40701 - Disclosure - Notes Payable (Narrative) (Details) Notes http://www.eksobionics.com/role/ekso-npnd Notes Payable (Narrative) (Details) Details http://www.eksobionics.com/role/ekso-npt 37 false false R38.htm 40702 - Disclosure - Notes Payable (Schedule of future obligations under debt instruments) (Details) Notes http://www.eksobionics.com/role/ekso-npsofoudid Notes Payable (Schedule of future obligations under debt instruments) (Details) Details http://www.eksobionics.com/role/ekso-npt 38 false false R39.htm 40801 - Disclosure - Operating and Capital Leases (Details) Sheet http://www.eksobionics.com/role/ekso-oacld Operating and Capital Leases (Details) Details http://www.eksobionics.com/role/ekso-oaclt 39 false false R40.htm 40901 - Disclosure - Capitalization and Equity Structure (Details) Sheet http://www.eksobionics.com/role/Disclosure-CapitalizationandEquityStructureDetails Capitalization and Equity Structure (Details) Details http://www.eksobionics.com/role/Disclosure-CapitalizationandEquityStructure 40 false false R41.htm 41001 - Disclosure - Warrants (Narrative) (Details) Sheet http://www.eksobionics.com/role/ekso-wnd Warrants (Narrative) (Details) Details http://www.eksobionics.com/role/ekso-wt 41 false false R42.htm 41002 - Disclosure - Warrants (Schedule of Assumption Used in Valuation) (Details) Sheet http://www.eksobionics.com/role/ekso-wsoauivd Warrants (Schedule of Assumption Used in Valuation) (Details) Details http://www.eksobionics.com/role/ekso-wt 42 false false R43.htm 41003 - Disclosure - Warrants (Schedule of Warrants Outstanding) (Details) Sheet http://www.eksobionics.com/role/ekso-wsowod Warrants (Schedule of Warrants Outstanding) (Details) Details http://www.eksobionics.com/role/ekso-wt 43 false false R44.htm 41101 - Disclosure - Stock-based Compensation Plans and Awards (Narrative) (Details) Sheet http://www.eksobionics.com/role/ekso-sbcpaand Stock-based Compensation Plans and Awards (Narrative) (Details) Details http://www.eksobionics.com/role/ekso-sbcpaat 44 false false R45.htm 41102 - Disclosure - Stock-based Compensation Plans and Awards (Summary of Stock Option Activity) (Details) Sheet http://www.eksobionics.com/role/ekso-sbcpaasosoad Stock-based Compensation Plans and Awards (Summary of Stock Option Activity) (Details) Details http://www.eksobionics.com/role/ekso-sbcpaat 45 false false R46.htm 41103 - Disclosure - Stock-based Compensation Plans and Awards (Schedule of Fair Value Calculation Assumptions) (Details) Sheet http://www.eksobionics.com/role/ekso-sbcpaasofvcad Stock-based Compensation Plans and Awards (Schedule of Fair Value Calculation Assumptions) (Details) Details http://www.eksobionics.com/role/ekso-sbcpaat 46 false false R47.htm 41104 - Disclosure - Stock-based Compensation Plans and Awards (Schedule of Stock-based Compensation Expense) (Details) Sheet http://www.eksobionics.com/role/ekso-sbcpaasosbced Stock-based Compensation Plans and Awards (Schedule of Stock-based Compensation Expense) (Details) Details http://www.eksobionics.com/role/ekso-sbcpaat 47 false false R48.htm 41201 - Disclosure - Income Taxes (Details) Sheet http://www.eksobionics.com/role/ekso-itd Income Taxes (Details) Details http://www.eksobionics.com/role/ekso-it1 48 false false R49.htm 41301 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.eksobionics.com/role/ekso-cacd Commitments and Contingencies (Details) Details http://www.eksobionics.com/role/ekso-cac 49 false false R50.htm 41401 - Disclosure - Net Income (Loss) Per Share (Schedule of Basic and Diluted Net Income (Loss) Per Share) (Details) Sheet http://www.eksobionics.com/role/Disclosure-NetIncomeLossPerShareScheduleofBasicandDilutedNetIncomeLossPerShareDetails Net Income (Loss) Per Share (Schedule of Basic and Diluted Net Income (Loss) Per Share) (Details) Details http://www.eksobionics.com/role/ekso-nilpst 50 false false R51.htm 41402 - Disclosure - Net Income (Loss) Per Share (Schedule of Antidilutive Securities) (Details) Sheet http://www.eksobionics.com/role/Disclosure-NetIncomeLossPerShareScheduleofAntidilutiveSecuritiesDetails Net Income (Loss) Per Share (Schedule of Antidilutive Securities) (Details) Details http://www.eksobionics.com/role/ekso-nilpst 51 false false R52.htm 41501 - Disclosure - Segment Disclosures (Schedule of Segment Reporting Information) (Details) Sheet http://www.eksobionics.com/role/ekso-sdsosrid Segment Disclosures (Schedule of Segment Reporting Information) (Details) Details http://www.eksobionics.com/role/ekso-sdt 52 false false R53.htm 41502 - Disclosure - Segment Disclosures (Schedule of Geographic Information) (Details) Sheet http://www.eksobionics.com/role/ekso-sdsogid Segment Disclosures (Schedule of Geographic Information) (Details) Details http://www.eksobionics.com/role/ekso-sdt 53 false false All Reports Book All Reports The statement of equity, ''Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit)'', has no durations with matching beginning and ending instants. In ''Condensed Consolidated Balance Sheets'', column(s) 3, 4 are contained in other reports, so were removed by flow through suppression. In ''Condensed Consolidated Statement of Cash Flows'', column(s) 1, 2 are contained in other reports, so were removed by flow through suppression. ekso-20150630.xml ekso-20150630_cal.xml ekso-20150630_def.xml ekso-20150630_lab.xml ekso-20150630_pre.xml ekso-20150630.xsd true true XML 68 R38.htm IDEA: XBRL DOCUMENT v3.2.0.727
Notes Payable (Schedule of future obligations under debt instruments) (Details) - USD ($)
$ in Thousands
Jun. 30, 2015
Dec. 31, 2014
Future obligations under debt instruments    
2015 (remainder) $ 27  
2016 53  
2017 23  
Total minimum payments 103  
Less: interest (7)  
Present value minimum payments 96  
Less: current portion (43) $ (41)
Long-term portion of notes payable 53 $ 77
Capital Lease [Member]    
Future obligations under debt instruments    
2015 (remainder) 3  
2016 5  
2017 4  
Total minimum payments 12  
Less: interest (1)  
Present value minimum payments $ 11  
Less: current portion    
Long-term portion of notes payable $ 11  
Leasehold Improvement Note [Member]    
Future obligations under debt instruments    
2015 (remainder) 24  
2016 48  
2017 19  
Total minimum payments 91  
Less: interest (6)  
Present value minimum payments 85  
Less: current portion (43)  
Long-term portion of notes payable $ 42  
XML 69 R20.htm IDEA: XBRL DOCUMENT v3.2.0.727
Basis of Presentation and Summary of Significant Accounting Policies and Estimates (Policies)
 6 Months Ended
Jun. 30, 2015
Basis of Presentation and Summary of Significant Accounting Policies and Estimates [Abstract]  
Basis of Presentation

Basis of Presentation

 

These unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”), for the presentation of interim financial information. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed, or omitted, pursuant to such rules and regulations. The condensed consolidated balance sheet at December 31, 2014, has been derived from the audited consolidated financial statements at that date but does not include all disclosures required for the annual financial statements and should be read in conjunction with our audited consolidated financial statements and notes thereto included as part of our Annual Report on Form 10-K for the year ended December 31, 2014.

 

In management's opinion, the condensed consolidated financial statements reflect all adjustments (including reclassifications and normal recurring adjustments) necessary to present fairly the financial position at June 30, 2015, and results of operations and cash flows for all periods presented. The interim results presented are not necessarily indicative of results that can be expected for a full year. The condensed consolidated financial statements include the accounts of the Company and our wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates

Use of Estimates

 

The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet, and the reported amounts of revenues and expenses during the reporting period. For the Company, these estimates include, but are not limited to: revenue recognition, deferred revenue and the deferral of the associated costs, useful lives assigned to long-lived assets, realizability of deferred tax assets, the valuation of options and warrants, and contingencies. Actual results could differ from those estimates.
Concentration of Credit Risk and Other Risks and Uncertainties

Concentration of Credit Risk and Other Risks and Uncertainties

 

Financial instruments that potentially subject us to concentrations of credit risk consist principally of cash and accounts receivable. We maintain our cash accounts in excess of federally insured limits. However, we believe we are not exposed to significant credit risk due to the financial position of the depository institutions in which these deposits are held.  We extend credit to customers in the normal course of business and perform ongoing credit evaluations of our customers. Concentrations of credit risk with respect to accounts receivable exist to the full extent of amounts presented in the consolidated financial statements. We do not require collateral from our customers to secure accounts receivable.


Accounts receivable are derived from the sale of products shipped and services performed for customers located in the U.S. and throughout the world. Invoices are aged based on contractual terms with the customer. We review accounts receivable for collectability and provide an allowance for credit losses, as needed. We have not experienced any material losses related to accounts receivable as of June 30, 2015 and December 31, 2014. Many of the sales contracts with customers outside of the U.S. are settled in a foreign currency other than the U.S. dollar. We do not enter into any foreign currency hedging agreements and are susceptible to gains and losses from foreign currency fluctuations. To date, we have not experienced significant gains or losses upon settling foreign currency denominated accounts receivable.

 

As of June 30, 2015, we had two customers with accounts receivable balances totaling 10% or more of our total accounts receivable (26% and 10%), compared with two customers as of December 31, 2014 (22% and 11%).

 

In the three months ended June 30, 2015, we had one customer with sales comprising of 10% or more of our total customer sales (32%), compared with two customers in the three months ended June 30, 2014 (15% and 12%). In the six months ended June 30, 2015, we had two customers with sales comprising of 10% or more of our total customer sales (27%, and 11%), compared with one customer in the six months ended June 30, 2014 (17%).
Common Stock Warrants

Common Stock Warrants

 

We accounted for the common stock warrants issued in connection with our Merger and related private placement offering (see Note 3, The Merger, Offering and Other Related Transactions) in accordance with the guidance in Accounting Standards Codification (“ASC”) 815-40. Under ASC 815-40, the warrants did not meet the criteria for equity treatment and were recorded as a liability. The warrants initially had an anti-dilution clause that allowed for a decrease in the exercise price of the warrants if the Company issued additional shares of common stock without consideration or for consideration per share less than the exercise price of such warrants. Accordingly, we classified the warrant instruments as liabilities at their fair value at the date of issuance and re-measured the warrants at each balance sheet date. Changes in the fair value were recognized as a gain (loss) on warrant liability in our Condensed Consolidated Statement of Operations. These warrants were amended in November 2014 to remove the price-based anti-dilution provision, among other things. Accordingly, the warrants are no longer recorded as a liability.
Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

In July 2015, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) 2015-11 Simplifying the Measurement of Inventory. Under ASU 2015-11, inventory is to be measured at the lower of cost and net realizable value (“NRV”). NRV is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.


The updated guidance is effective for annual reporting periods beginning on or after December 15, 2016, and interim periods therein. Early adoption is permitted. Management is in the process of assessing the impact of ASU 2015-11 on the Company's consolidated financial statements.

#RN+L?[R: M>"^M=.^-@WIBXN[UOV^NUX5B*]4=F&F,]V#H@^K6=!JO%[Y?J8<;=<`GB96, M/8F5,V[XU!^TWHJW[;];J6%GU+"E-30V_6M(O]B""W+N+>,U>9F5>D^@B$)X M@LKM7B^!%Y58J:J;[L_Z(JCF>./[))QXOU+)I/9SK)9G:K>/=KR67R`AA7%1 M"PS(F@>1[:#LYI_$L^&@VRE2\-SCL9Q@[08AK3=1Z:/N3H=0?VY\,I=[7_F0H M];7V)T.I9[4_&4K]J/W)4.HU[4^&4A]I?S)*\8C$`I:(N$09!$PMR\7<4OP[ M3AD$4!/@Q:&MLDA`GYC997&_'&0Q9?NK`:4*V%>P2IE0CE(&8T1:$6M*IOK, MPTV*)=#`S$=F6$N&22.`A')IL)GKV:4,16B;>-I'9DY8R0:J5#H,W63^F8DR MX)>8CJ`\>&9JY8M"0$19$U5HFZCGSM'>ZN78IP6=V%8I#+"HNCEK=WB\GJ`L M7/+&,PQ6'OS'TE2?PY<2N>/(I03N.'(I<3N.7$K8+B;E)0ZW3T!YH^X34-[@ M^P24)P/"U)0H`SX!YUD[[BO^@NT8I_MRU.,Q>!O2]/C,I MG@!6RN%]8E]OV91BEE#<`S:SZ7).<#M3&3QY8VG/Y*$DWSH$+S$8QU4/MY7J MIE>*0B0(*-$`AR249X)#$LHSPB$)I4S%-\QQ<,W_DZ+H:,Q,M5,F@GMO[)8U M%]Q3PQ-AGC+0WU*WE%Y'5N^];CMEVCXY)>78()X][*?RX@P1+TKI?@1?BOE= MG8G+9H)/13F\X.?>RO*)?GI>,MO0S2]E@+^W\&P7TQ02$4U!>#1;/@6YMJ7V M@U@G;=GS;K&<4THS&W];&ANN)J#XS^4-PU5YGWHY_K5>C@QYC2K[2"+BS\80:'@YFY1%Q3_%<:'G&&!P-S$%=SE/_91R2")!02FKK@0% MI:RXN/R#:XBFJ)Q12%!0RB@D*"AQ%$0"*25;^@\EH<1Q"$BHP$"4$@OW2;`, MRYYZ1JG"$-!0IC0$-)0I#I;A+4RGY*'@))0[$IR$"@Q$N7K)22CE&Y4@`3.W ME"F+'+]$0>3X)4HAQR]1!#E^V?)7RG'3&'XI9TYC^*4^G.TKU#`L2]6'_N0I_U4/M#SV\J2F><"'>R6"_+#*&9FV$_.C1>Z7=*+X M;/B@%;3_,]YS3>[GRH^?#]I)"#4?(N"1VK0V M@UX*BM*L-8/^"HJJA5H,8B"#4-N+X0J$JG!3#.)"!J&V%R,9A-+L0,-0N]]2 M^XMRS1N&FAV&P'.P'\/.&HKRCG37()1;$;FA)5<33*FK6'@E%C<#)Y^-\\&23\OYB$;V_*S6\\N8G]4"9Z>H[R\RK!;5P&\V\6KAL,Z\6*]O,J\7* M-O-JL;+-O%JL;#.O%"O#S*O%V6CFU<)EFWFU6-EF7JUH9)MYI;GRLLR\6J`, M,Z\6:*.95PNWT M+5RVF5>+E6WFU8I&MIE7>G=/EIE7"Y1AYM4";33S:N$VFGFU<-EF7BU6MIE7 MBY5MYM5B99MYM5C99EXI5H:95XNST5P:A-+3GT9A%*7NA=.C=R[V6J%V*,-P*O_>5T`X-8:3T[HZAI#3PB&& MD)-G%$/(,YP:@\D[G!J#*B*F:D6.X=1,K<@QG)JI%3F&4].U(J=P MJDPK<@JGRK0BIW"J3"N*6C04$$[-U(H'9I/\2Y^2F]_]__]+S37Y"TT3>CCI9^D7!0Z@R;_/RS@BA*V]32FIM9T]/^P MR];*RXEE2%[Z35O.W'JZ?&9.\OG29_3E:+3R@MK`I9,:[F5+ M-TG_O+=T2?A75,RFS06U9[J)Q22/FV-^@_GE>:O5:LC&,[!,7S"'?&1/Y).UH.99PV&V/OW^__RA MC8W/^O#R$LOH[9+PXJ_/_$[P+O)_`H*)R[ZZP`=]!F]_\QQ7GSY_3R(B2;N# MI>(4DF]62/RF002-H799,$T?4(- MHK%'?<*(0T&P"0@"L9G#J#V9(Q2^&K MJ$T*]8!)UH+90.+2M+X_UAY\`OZ; M'B-3VUIPF7OW!4RK5)QAP#0\>&X2ZO)P+I*/$H,2AB*Z*'/]!%Q;(#QGKA@$8`"]$&^%C MI-BB!X!C.%8J0(,_M9D!,P^T94(=U[*?_5;Y7:U378A^V/+$@IF.B[7@T=.< M@6+J+A?=A66[O.]08[5@R`X'9A.?#TASG(2`;"6"HYL:SA3PN`_V_K@DOP!B MWZ[(BC#-:>.,-M9T=/$,AVQJ&8;U!`)\N5U?L0`2`'/S"O4-\:!![GD?2,@5 MG,:EC(VUK^F/B1\!G*8[2X,"K\8&>'"BE:@0E^W79]>>[5CVG87J:<>*<(^( M3)AA^,[%ZS/P:O&W(RXSX;]]I#%JGXU.CD&7#C`Y^"L812QV24SN-_G/'JFM M4^1'XND3PV7-RD/'M9D[F:\^]8<310,O.F_.975#>7$YQTW@N.W+BRM8+L0& MIFS-!8A1ZT\!^YL&FW+=:2^_!MSSF6,'/0>%=M$B!B9:^$]Q7KM:0@A3Y??[ M,R#\R:;+UV?BOY''[&J)YE:*R9M?[>[WQ!]'%*JOD98`;RUS%OK2WT6_9=`P MKC#\YNNSSAJU`1GQ"0M=?V9O&HG-I/W5,V%9V&IL06%.S%G1OJ.EX?#1BY6(*9W[EVC+.U&5-JQOQIT%]# MD_]J\?\1\&:(8QFZ1OZ@XT6.L"9S-_>CTVKWC]O65(&&@HO=`'V] M%BC"Q5(0\I'Q?A]>!Q2U-Q.4`7D86W!1\97X_WQ/TH;J::Z[K(G+(;ZV0?G: MA?P_;DF_C:N:7<=U+YH[V_$\6.>2;K]+UE>^N8Q(GXO&80Q?T=G#A;4XJHY= MG@L27HG:["#/[59_6VE6+R5[D)XN.`J\_`,GEF1X318[#H)J6W-Y?:61J\E) M&;+@4YLM8DU\;(-G(E[4#SV&734[=TN_;L('C5;OHB`C7A!'#P#9$&(NS&`7 MQ*D'VA4Z25:33?$U4N-B6/0JZ1271M=K6Z82.P]4+8Y.QE4M M>9ETT>AW>O4RJ5XF%;],&C:ZK7J9E.LRZ6?<=CKQ;-Q537!6Q'WI]6*HREY9 MO1A*S$^O>HU6MU/4:NB`SPD;.O5MO4JJGJ!5;HZL)IMB^OBJV^BU.[E,V@?H MWKK4[JR-Q[5Z:D#7S:8_L:L2WCRM1,K.H\[Y!6X$URP/]V2G[CY*E885A[B= MZCKGL2\AISYMMV[K-7JCPJ;%5+.>EQDM?.5](E)<64\16+3-W"1AX18+R6[C M8E1^Z.ZD%Y*9&Q[P--$!`;TJ.*[Y.?[5V0RWR[*KU^B.VJ5/+THD(\=PX,N5 MW()71=M+;K?1'UR4/A<<_V>>T;%MEAX@(+T^^W*1\.4A+RJNB!926602V3LV/V\DI;N MQ[,RJB:#$I-QI]%O]T]C158A4FJEK.ZBKYH,BBMEI]%JE[^#1<5B,_B)N7%B MKQ,)>+;Y]9?O/*Z*S3[>));A/9\HE-7Y]=#X>CSD7[[`#%"&?I&,C`D==-7G8.HSD%TI,D[ZAQ$5<[)4><@VDAP ME8O5.8CJ'$2UO:MS$!UJ%.L<1'4.HCH'49V#J,Y!5.<@JE!27^[=G1&,3?4$-Y_59LWOV M0[L/_6^U(F(WXNU-7E^6$ZFU@;R+WO`0\JXF$]MCVIUM36'=#DMU:KQG$MH& M>["N,^PF2,O&VH^NX7X\VYLN**1Y$_V#EVG8SN*%#"53<=6IQ0Z2GFJD[C52=QJ*UFM)&YEF](Z967E$ZC=4P.< M;/!QH[Z/F^Z)W M`G)7;<=_`USP`8OX+OO^EK@*#DUQVTNJ=<"C/MUQ%*<[7JAXMCN#(Y;.`J+8 M6.>!?JWS:%7$+R&]H@YCUPYQQ3A5KN#U"C*41^P/'SC-?[*>J1%N,:H=W?*5 M8"='MUG[N;5T5E4Z^ZTC%LZBW%R;/C*C]G,KX6Z0^DZ-VL\M0_"&M9^[FY][ M8)3WRC"(A0<+MC:\1W"&]@334Q[30=D"TL568!M)A?:.U"I7JUS>*M<;';'& M*5_";+.7Y<%RZ?;KF>KE4JI.NLMC2]K:;HR*RZ=4)VVMI3@/*>XTNL.M,^R5 M)<,')#8HY=SL>C8%M2>_DZ?*[R=SIGD&NYVN-_N`:.LGQGNM`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`U M-BQ0S\AWVP,,I%/")D>VF]HUOWVY894R=[#/\K8MM_;I3,XF89]U:$\^+Z:3 M@";^@^G`$*%V75/;?M;-V=4"`=&)D[BAX_OSWYHG;>&:11FX0IZV1?'6JGDF[$; M(&5N/*_9SH%TA=;?QF/?&FR=EU&ZMO5\:P/9XJG4?&MYYL6#YL?XQ^"<<)4@ MOD[P(-LX#!4NBZ$F-4M?CJ`?3-)IM3L-XLX9N;862VH^$YX-A6E$-UV+4&(" M:PB=@6._X%;91`DQV02]/O*DNW.B@TP;.'O'BDTMFUB>33[ID_G",K4&N08" MX*FI4S*E$XQ./I^3!\!%@`:O0$UH`9H`EY*19;"T(-:4_#$1TFTE]R$V!!E0 M6_>UE-C8`M1+[,E)5/I3@RR$QI"%4!D2+&O6`'LK<-34@#$W]!G3>2$'A]"8 M6!\]`S'4(9X##`3V33THRGDSMPQ@Z6)I6X^<0\XY`>YC]!@9F1R!.;1`B0'F MN@G]69")\)!\)ENAT\T);;?)*P>6A"C"!`A!6MD"";U=,N`#F%5.L.]F$>%G M\1Z)8M^>G[J8"ZP[BVM`TLC&/G0H2EX9SPFY=7_/1+779^`7 M_>F0M)&RC&B9W^)24D`E$CB5U,KF"OME5Y,DH?HYL$(K>#NESUIOML36#F3- MV/[NQ'J=`YWY;$:I57@O%?X0N0\O6W6CQGVOYG39\>)T.MBI$NP6:6,B:S6* M7G#3N9F&U0TU;PP*BWAI2DV)_.!"87?)V=Q194*:)U09#.>>5[78<.(R^`'Z0P+X` MGKP\;F_OMM6\/EBR.]M;5S7<+MX9XJO"\*MO\+7W9;M'AR16/1K7H7U`ML.C MZ21IMUZ"@_0S86[*"7B^/R:^V-^0UC_<6 MY.WC1`#2?@FN(1D=D.'BR)RF MB7^P`DV>;IF5\YWJ>2:<9WJYK,;KV3S.Y>U3+>\2\*C7`"6+=*&^TYK)[9SW M0Z,;[M_W#2YN*C?Y09-E[*#)=BP0[:JRP5FM[=3$@>+$&Y$E`-K]D^_^[:=^ M.=P^:I3"7X41Z)-G]P[>9LWMPX5[AX^IJMB]5Y(K\2OO4X`Q`[K<1%'RA*CD M-.7**7L\GW,[]:^AN[4_X8#<>JX#8X5LCKAT:OVBU\:QM>!KT?DYAE;YV M;+4S6#E;NPDR26"4/"Q*\7$[C2=]2*80BPB6'3G/Z[!H?73I!9][J(\NU4>7 M3NV8PPM3X?KHTAIJ?73IU'2Z/KI4'UW*#ZH^NO02.%X?75JK6A]=JH_JU$>7 MZJ-+LLZ<\BZ3^NC2B?2Q/KI4[RDI_0-\?72I/KITDKRNCRZ]3/>H/KIT*IVL MCRY5P56JMRW*MBW61Y=R9W)]=*D(0:Z/+M5>4WUTZ80Z61]=JH[O5,\S]=&E M^NC2:3*[/KI4'UTZLM,=]=&E(ME='UTJ5+BK>W0I.H*SZZ&:E9L`P>=E#/?> MX9UX>(IG)NZ,"F]T$IZ(&-AF=RI'="(RG+*P=G2'WU!R->3&7G2'_9U[ MD8#?EWJ\GGF%_KUN".X/]Z0_)&"O'D142ZZ@W'SK;*>U#]7IE^;&;C_^:)F3 ME6M+AY)+*#=S-OWZ8BG:WL3)KNV]:&T@KGL(<;SO/D1;_3Q7MT,Z_,3=Y?*T78B8C5(YA(Q&`#5_8D`M[H-N?86^JR=D1#VJE* MW%[3;/6;W?8*V$I+2:SW5+=_Q7CH%1A\UP'"?M;I&&]?A!GI!JJ#S&NWYB>& M8X9S@:G!`-K!SS+7<+ZQH91]9\]4ENG>#PT\?2)H4^R\M!Q;>9.YJM/ M]?\P<;CT>V+H)FO.975%3Z&C+N\H3+;$YAUM$%><0'7$<69_O3/`P((H*&$+1"B"JZ1-IV?C'DX!$;_L_H?+4SS!_37I M!29D)<9G7NBM_JAKS-3(L\X,;5M',4G,NM1)!&V7:.N.G4U!V]CW%0]VQ[AP M<'QA)UI%R*&)8L15"`\C1*$%7P#[6#!X)L2V7VP_#^)_VKFVS<&+'6'CYTVV M(V$SJV(KI\3?@H5]"0M7BLBXO*E(]'C_-C)'MMA(V8X:(4SUL/6G'OLB,1K;.!X-2HI$5-++5^`PMS*Q# M8&GNSAE96!HS:FM;.Z:U8UIPX+*U/@S'J`=[79X0;10K9!O8%A!%X_Q;SL1:0/L33@.YH?9D MCF1V>-,,;01SQ)MG?#Z,U\<$^[H&[^,]>M+=.;%,!EWAY_B@7S:>Z>`=B,^F M4_TQ&0X@.*%A'9`4_G5)8`4-@V9:`ACF06O!/[I;TRE^A&?_X^E+Y-)Y?'!/ M4Z;$J8$P,]>JP`0Y)PAN4:`.<-TPK"<'_[2FY*\>#$RWQ26Q?UD)]4,#-T'+ M"H;/LQW+OK/TE;W5"5=C\R;LP^_L$8[3\6S2[LLV:0=>86X[K'=<"PE2+[JQ MK-R15$3IN:-GUC3Z&^U!UHG\O6C9*J!]0VKJK>(W^0NY@H#'?IEJFY([KQ'="0?!5@Y;OY?XFA42O*/X]"6`[ITD&JU^Y(M M?\7.&65.%+N+='1URW$J2>?\HB5/R["=5*WH2CM5J_)PG'+JTU::,NQ(HLP5 MU91=XL>R7Z>V@%^+:PP*=NAVCCZ5Q(G:Q>J"A4F8^-=X"NY%[*^**1=LYU(-"+21`3I1MY; M]DI6DI1$"Q?2_!VE)5JH8WQUC*^.\=4QOCK&5\?XZAA?'>.K8WQUC*^.\551 M2>H87QWC2UG0*EFAQC9.!ILJ,1DBWU6)\:+,G7>K.2`KO?,NN@5QEMOF#UC=H/<3J?,#G8EWKIS9I-/ MS*"8V.`!6.G0"<\H&F\GOK=-=QP/BFIBJYT;-LR;N[N[;9`G?TAPVUL8NZ7P MR^6[U1(;X+J#1JO?;X`X)8-8#M^/BJ5Q;YYE`CM1:.&W"*LFVF@UNJW6>AM/ MS.:Y::A)F+_SV$]8LQH>[IROU@5M$S2("!EV,X@M0XO)`%QZ9;YY#U!#CJ"B MP?(?^.>+3F_XO8BJ8'`83"6=!4'%W@4&^UR]J>F&QW<1+FT88#XXP0$7]H@Q M47<.)#VQ8&22#`-*<#\YWW*.\-P_<5:XW0A+`.`$X($!!,079@%J/T/A"5L*B/:J@-/.B?X`(0+"AUEH;N.AP5S!>OB?V$WHQUDV_V;I`%%UDH MQ-Q)16*=.:)B$F?@/3\21>TOS(W4(!E!3XRX*(/#P[1`U=?U2,3"&;`XMN\\ MD/?D/E^;3="5`$$7GSFH,R=@'&`DUA1R.&STNBM.#SS'G MY,J1=MGR[&1'-38QN$[&&N;A?1$^EX7S>PTR]O",B0[2*EC$M!0.[<>8,3/9 M5'?7.#-H-7K]9,@I^E#&N7%>CI"5]AT1]WU;MD,\3$3Q'S$GVJR)N9'93.HTS%7*I5>G8:Y3XQ7I@=6I M\=;,9IV&N4[#7&>[J_W#D_8/M[:&=1KF8W$=ZS3,%3*5M:]9MC$]"E^S3L-\ M=)^AZS3,U;.V)V%<*VQ+*QFX?,EIF$]VPYNSMI]M(38HZO%,JZUV3Z0=7<`C ML3L0/Q(UQQ2WC:]M+!;[9!O0EF7.B,5WA;MS&%/GG%Q-<'LB_(U9+1+;Z?#; MDVD1`^I`^6@;(V:Y,/Q4U\\O(!^I?PB!X-;Y1TP\NTL.!DP1$FU)K$Q"TIAE M.-']A*-^2C8!I9L%]XK\I9G_?7?P[=;QF@\,'M1=9Y4%'4G/I]0OPN3^WQL M^:X[AO/EP&ZAEKVV=.V?7F"+GGX$KW]?V=IHR?)W%P[AS4[RN):FKR),4]-X M\7->80/'+PDJ>K!46O!Z3-N#/HA%]K%760SA(_G^*Y3?+(![F=8![0V1V1BDOE MN'J"!/_N-EK=]30BN3%)24+'_<]0*82N4X;N)&=K"6-J$7HK`4I=V+*M4FO>A>-86%F29W%5Y4KNY:R(J2LTQA=M#%9VQ%9K:IO M?'YCZ]HLVI-Q0'B](.FNJN1*I'4@22N8YZ*IB#S)!X!L=^J@B/SKE4R4JS)# M=&%+A%KJ*L:I@K>=K@5!:K%[D6)WL+TKG,K*LK(6NMJ_*YJGE?[T(3YWW-W6 MBQ3U0CQL]'N]1O\DA/C$3.BI+U+6LN;74ELMS:K&KFMC5 MMR,?P2#5PET+=^V8;N.85NTNC!=R`7@9(E_(/=[M;F,XZC'WOR/D+[S*_63.-,]@M].@\JWG.C"^R*H'[%M8B^C:Z[,'.NM<##&YA8DC M\(E-7Y]=#X>CSD7[[`HQ2UF=$%6IE\W;K!.BU@FS7EPF MA-,_;%M+7?6DKH(;D.N$J+78U<=8JD5D+72U?W=TN8;JA*C'N4@YI819)V9" M3WV14B=$K:+4O81%2IT0]66*7;U(J87N^(2N]N^.Y%-*G1"USCM59]^IES]U M0M2JD'04?*L3HM9B5^>,/()!JH6[%N[:,=W&,:T3HJI5E3HA:IT0]:5,>760 MMO8>*D1DG1"UEL$Z7V2=$+46\%K`7W9"5#]%Z0[Y1D664L]ISBA=7EX;U''" M6KS;Q;-W5F7--#8-I;Y[#UD5!)TI>>B%)7CHCUFJO+EKM3B?6JU_NW]XQF_UV3W[83CL=8<)>ZH^ZQDSM$W591&)W ME<1V=]3JQTB\\Y"=7QW]TM0-,)>V!S^_VPS[27>^O+<9^X">/'/<)&Q/!CM8 M@XU8TSO[H06C.!C)^)*->BBM?1FMPXVTMGO]0VGELLPE,J)F(*/F8DLUZ`TC MDJ+&MYF3.($P2^VI<^T+WPG9 M!+475:MF?4OM:@T&*JER/I@WEL:,B*XUV[UJ&#^X;+'F#;1;&ZD*H+:8'&,^ M7D38JL7&>7#0WMI1V3`/QB`5SM[=UJK!1ZK[HV)G;SXP*?67NDUQD,08172O M&G_.;2#JKO]/?Z2W:G`S`7XZO@AYU=#[R!O'N0=N:RN;-A]K7PE[N+H'[#)MDM=+M]/8KZ]81V4$MM?7!6`> MMA"N0:?=';3+L2'M]14`$+WM"J![D?]B1LKJU8EDC>KB6"VE;VT^P5M)MECX MMKO#4?]B=PIW,8+MM6E#7)E2OA%LKTT,6\9#@&V]87O_@8WNI;F=7EN+)3,= M;K`^,7`0F79M.:[#H=]0Z-T=?<;UHK-V&TVWO3:_Y'@;S<$7^B1.&.$J6)\^ M1]&_,0_]M<[)O0M=;(ZQYR3.'')G4-,AP$]R]41M36S&&X>AP64QI*9>2)0C MZ`>3_)6:'K6?>2;U!F?"$B8WF[@6<>>,B-WS#?[W&PNX0ZPI>:O;L.ZP;,$T M"G"_63:L/O`=%G20TW/+T!@6T:PER!Y_@2"0#%]X@!=K2%Y]S\>]N&#B1\8]4T?B8P!C+;Q_^ M7'KV9`XB!9P@=#:SV0P7,"OT#QN#5J?1:UVDD8\$H4A2\_D;)]&9&,4A\\XC M6;F%`<2DOFT_J6]CA;BG%N9V%T8!1F,4E!_ M"?GL,GL1"F_(]%1+L:#/@E]B'!N!$L$?-G%TF"BH+3XB.61.'W$Z93J.%=B7 MJ?X51!;*\7O'!9 M]`(;%MV$(0%[!7;4MA:QQXG>P_SG3>:^R**>&Y[FZW\T%&@>@+/8;W^45I]P M%P8O7A/*N`03.]'%-.H/'G)9\\/)A(%-!6*`&?[K\U.?4A_2Q7^&+ER2Y3*[ M17!F]"4RTLQO#I-Q"(41NL*\3!J3$63$%BI,3WS/>["'O(^#+NQGO962V MEA0_VNM+E/X,$EQF2BFX]\:_@18%EMB`N<*E@JD:K'<\!QUZ.K8>6>KDHS$D M73?1&_&G+FZGXK-`Z,F%@B.H]RUFT#.IHY&B]+"PLV38PDA&9I[SE,,T?,N, M`\K'%LPO_NWXG_B%PPVEC"O,C>B%+VWK4JZ5#=Q79 M>$X^,TZRF-R`/"X(^%]A3V7.>,+.P0O3,IN1UJ$'1S7@F07K'G\D',\0C&;V M(PP_P-YY-OJ67.ZN[J])O]5O]L&+1`[HV'NQ7FCRI30)UM)8^B.@O0O0.,-X M^08XG<@(_O&!,]=FS05XVY[-(JL3G[J=52/B.8%@O#$H+&;O)^"[HXH+[4/) M%68"OU8(?W]BS4S]/^"1?,4%+_@U%)D.JOGH"T8@8H(R1&84'(6$6G/A/">_ MX"!'.L,-@2@!`ZC`^Z))Q#1'\'EN>N\+,I"18L;`33'PK:QQN)<#;?$1G40.?44A- MY!`Y^M!X_L,)YON$NX`#IA.Y%!D?Q3P&KMCP!M,4QG_687D&W M].9XS6A%*#WNCN^^"5UAPPJN_5V!CK,/$3]SE61:LR1Z2F1%A48A1D;9!+4[ M4J]B_^.7M?&M.UX;7ZG:7X'*P%+UY=F_"HU!!4WO-A35-OA4;;`""=O`FLCG MJ\WU+GS[Q!94-Z%\S;>=^'85?"W/08E>K(^:_[#Q+4:U&4T7:]][JXW!+ER[ MAM9L.G&]'3+FU)Q#Q`_`.-UT],D+,*/*4S\4.[`'Y+O=:'6B79VELN5E63*,>C-T&@Q\"S)Q?^A\HWU.";12C?*O"631C?@]QM\T_U`*IS# M7PU&PT:W/RAL'E?C%65]EC@)>WKRSF/KO-^OG:7F>%23I*/A6NP2U"%:(R%H$*Q;/W-TA3)YJ221M/&+'<\O+ M>\MP/@NY5YBTNXU.9]AHC3JE'U9XT2;Y!41%1\5MXJ@=@PKSK61!')Y?U()8 M=4$\>7/8:[1')_&5J-*Q4W%2G3FN?X<4\V\=QKSN_!Z!U?SCM2M[Q*YLI]%N M7S1:O=J5K6UWSJYL42)6>Q"5YEOIKNRPJ$06M2#6YC#=E>V>A!A6*^#J)Q_C M][[40=>3\E3[C=&PU1CURT\04UOF4[;,K?/!B1V`KR!)1\&WD@5Q<-[IUH)8 M<4$\>7/8;?3ZI^6H!C_128R]3MQ`F/7KU&ZP#H8[0`A"S,*[6QW!U7WA(:I_ M!2$O[5]KV#WO\O^!Y]WKM4?+8),Y!]KK*D6#N2YXH(ZXOC'V7'9WHF4OY]1T M+@GU7$O.@.0^X6CGL&M#1;R?$ULSV9I@"H`G7;.>H/TV_`FN<406;PB('W_1 MH2ULT'%MZPMK^BG!^/OP:DO=1/(3CO/4L*CK8XN-R^+NY^!@OW^K:I@]H9&X MN+??[3=ZK5Y2:4/1>F(VPTNH*9E09\YORAY31Q?WY$(_)_/X3:1`ID;P!F>; M31C>_XS/EK:%USG#J(\]%^AW7$8U?DO]G!G)6YX[O6YCT!LF:`G(#^^O]Z^= MG5L&K"_";NEX/V]XB3U^?IB$M]B&M]+2!2PFW?-U`U6<\A1_M>S5^M*V`?QQ MJ4$\,[P#&"\Z7N`MP.*2V8GEX"@:U/^6XYF/XB-/\J;9)U@W_S$A38WNQ2#! M7[P`&^1%L!ZO`8Y_(AHS$J.`^A?9-L?\VN0$0<$5Q;JY7A+[Z7 MG--\[\)_Q*W+T/O;);/]:\%#J;"#ZV?(DW^!#Z'B"@K)M]M=9Y6_@6K79OU&JW!X'W5NQMQ82W"?X."X=*YMEF MUSH@?+CB=JV.05@(70=S)A'-V(M-[GD.G4A&`P//!D__Q!V99"%?;M>/!R6+ M)3W0>,%8AOW!OEQ\F-N,$7X;NB.N0`]GTDUL3_[K?P)[,:)9P&U%M1X_:CG9VX^*8+^J";VGC8].F2@W]273BR.0W8E9X MK\S+F_!#YG77K7DYD__^8]BO@`Z4YJFII/U@62_-7^SF:0**XT5:]X8;ATB! MU[=:UK66R2`)_YRSZQ6SV[6Z,?7,EB[GYM%/3IQ;?-"J.U!WH.Y`W8$=.I`Q MC]8,378@PP\]`NKWBX/4,K!+!_9S\J+.R/ZJ5`?5NG9E'!7<:DC>ZH^ZQDR- M/.O,T+8=@KP683O+PG$20B2KD+4=7KL0VF]+""VEPA<];-_93[KSI3G% M[1M\>Q4FH["IR_:3R'57O3!EJ!+T@4Y#3*_:Y[WDGN,_D6:2W.!%Y[R[4K)J MW:K).2)R$C(X:FTK@X/VB@PJUN7-@<#*S1+[SMZKH`JF\Y2P2?;TOHNM:J_* M2?+UZ)53DP/ M2%]62K*4PDAXX&F/-B89BB4^"C(=\3PUXA%;+`WKF0$]>..%:9G-Z`DFN]'- MB>%A0H$P5]%N&8JHXR>VJ5/9'&\JFU%5,]FHM.!%'L38;6HIXYSY=M_K2LU) M<]*#OJNHEW8$>7``"XVL%#99PT_V:-\7JTU2M6.K)R*E)63/.2X&G;#M/B2/ MR,XY*/9BXC;].6[`$Q>3G7--G)01.)JYO*-J+B_*,JBB=T4`7@K510M:3K:E M##9LV[/^7E9HV[\4^G25W1)X3PT_.K6@]A>&N:SST[B.]'1.`8-&NVYLCZI(3N1>../S&0V-;C_ M1[6%;NJ.B[O9'O?,ME-H(K12KJ0X^AXH=(N'O1<=+:T%L&P![/=?9)"W$O[4 M_M]&JS63'^1\'<"$`CRU;G=XZF&X?0W?$8A@K8:GHH;]D_\85-SY]Z.;K//S MTSKG%]MX:IKEX4F>@YS-C=S,:3]`2?U6YZ+V>MT-NK\Y]XX2N3N%8:G%\5!Q M['8&]8JI8JX:R`\>\93(QW:>RHK'UD[U[:JQ&2$G+BCTUX:CD]^]4"^;:ET\ M"ETOBP?D?(A^)7__Y3O/:S6ZGU[&,"9]$HH1K MRW&=^SFUV1M,JG!'GWE>@P=@WAO#FGSYX?>_(^0O06.\(,^^$&_JRK:I.>,) M$=X\1T7\MJZ>J*V]^[K419*$.V;KED9T[?79`YUUVT,\/F#B8'UBT]=GU\.+ M5J<]./OAKO_/J!/*<'/OSH6L.T/H3KM54'_>;&[VS6JS_%^_,@>/&XB&VU&7 M1I(NM=K0I=YJCQ1!KW1J,F>:9X#XRC'N,27(K&HC-`@?B.9+$GJCHDID185&(?588_$$M:-3J&KNI*V-;]WQVOA*U?X*5(;. MV,NS?Q4:@PJ:WFTHJFWPJ=I@!1*V@361SU>;ZUWX]HDMJ&X&F1=JOFW+MZO9 MS&:SX*)6M4KT8GW4_(>-!]!J,YHNUK[W5AN#7;AV#:W9=.)ZU*@YMQ/G/@#C M=-/1)R_`C.X^E)5:@N28AXY_%W'*9\O+Y/Z[K\R>Z$YLR7YGZY/MYX!Z.)0. MQ\_Z-#84K_X9W9):#T;A@_$K-;R<-4'93+7KN=L=-T.)+Y6]"_]#Y1MJ4'/" M\!H(:TK>L@E;C)E-NNT&"=/"*MF$Y7\A_9-TGTE.AZ\/Q,S],'OTW3@@T8CV M&L'3QG#4;K0N9#O[BMU`M!P*9O#W":O"#L@X%*4'U91YVM] M%NPVVA>]!JXYBID*%1Q-V(:KN6?+*L*75W-XH3+NF,3;/^_5+ M7N%45I:5M=#50E<0D95.I[?)?63^UX+:@50XA[\:C(:-;E]V7+W*7E'69XF3 ML*PIT^O8HUK7L==J M]%NRU)=5=HEJS_$$/,?BA*Z>Q"O%J7H2KX6N%KIC8^51AQTGN-G0,';P'7-Q M\/).4YVK.I25.)J\:K<:;6DRSKPV>$2;\#)<4.7;GH_!Q&S)G0I[GNUSZ54L M1V>/3UC(:I?@V%A909*.@F^U");ME2J]3"%YJN6OGLE(M\5/M/2/V/'<,L5M M&O#GL-=JCD_A*5.G8J3BISAR7:?QN8_9UR2;XP[5@_!R74+=V94_&E>TT MVNV+1JM7N[*U[<[9E2U*Q&H/HM)\*]V5'1:5R*(6Q-HESKH>E*>:K\Q&K8:HW[Y"6)JRWS*EKEU/CBQ`_`5).DH^%:R(`[..[+[ M&X^8H14DJ3:'&Y/1]/JGY:@&/W>_*C1V9^/!-RMNOJDQ?M5CO#U,(BJNB'0< M;R&>I=W:V"[VUL;$C_IVQHS;&)NOST2FW+,T7<^N=<""RMCF9F`H!*-EF3.)OL=>;#)8.70BN3YJ!L,-2Z/X MFBA9R)?;]0W3R6+!9Q]_Q14K&,LY/-B7BP]SFS&R@()SAS!38UJX;-[$UK1< MP]42$W*H=$BFMT+325_LV_-[_>M^`WLRHUG"_0RU'3UJ.]K9C8MC_".,+HZ/ M39LJ-?0GT8DCD]^(66&F_9NE^YMU^K&P_A;NIR;1S\Y<6X1 MXJL[4'>@[D#=@1TZD#&/U@Q-N;)[W0\]`NKWBX/4,K!+!_9S\J+.R/ZJ5`?5 MNG9E')[8:DC>ZH^ZQDR-/.O,T+8=@KP683O+PG$20B2KD+5OWKL0VF]+""V< MZDJSM";NI(1QTS2NRH`JX?!.5Q/*AB.8F_C>D]08:U$#5=CD=,3SP:GPJ);= MG,>EPJFOM^_L)]WYTISB]@V^O0J/Y]K49?M)9$K.SR*4H4K0!SH-,;UJG_=Z M":+^1)I)"*B?B+1 MTG=A$AIF+\@KW23/C-K.MT>@Y]6%5N=D#!(4-1/*EO0^JM:)FIPC(F<[B;O8 M*SY1^[!%3.QJ)_(=S,ZQSM^5F$>.ABNU1%=_[(K+&'.`COQJ&=35#=U]/@+U MK"ZTNOE^V,UY%\@Z1KP/[ZI)6+9:&]3-RF/\<->.)BLG/VAY,R`D5%6095]*X(P$NANFA!R\FVE,&& M;7O6W\L*;?N70I^NLIOT[JD!#>&=<0MJ?V$N-)&/5N;2V,;N_3%_ETDD^%Z+ MV6Y%'FD/9(FZCX/Y]4@F1K(ONX(BMY$LW>O:P>KO<9$+)M\G_C\'I,-7(U'E MIO/?3OPZTJOZ]OI&M--`;;AQIWQ)+8?"6OP+%G_IA1U"*9U;9,3N`K#+WU9WH:!R#!HWV7%F?U)"=2+SQ1V8RFQK<_Z/: M0C=UQ[6IJS_NF?^FT-1DI5P2_>Z%>-M6Z>!2Z M.!AM\I^.7ABZAG1V$1?4,-Y??;AX_NS']J]'C^F M'^.%:B(%#]@7QU+5]K5E@A(YG/]WP'3[SJ!FQ(O>:GZ(BU:GU=[,B^&@U>FU M+O[R7>ZT2L1BO!EIO(ITY]F3.3R$=B<@NU![89D\>0?((AY3B7C2E_"DW8OQ M!-IB<8YT0#;.U^0B%RJ+Y\9`QHW^)FZTR^+&/E+HIV^Y]5P')B$TT4(N(R8, M)4SH;*$F[1:X>JV+M@*3D49D;CSXS'.=,.T*=)+.V+NOP'/='XR(,Q>;.//+ M_5L8+0ZZ(B6M\^$H%\9D4:Z673]"0=?Y8(KY[$?;JH7V$;FJ(/CN,Q[:UG@^")!L2PQA-# M!6U$3DBWO:=P#$;#;G\0Z_S.-"@>^J#='4=_+3'5]J/?.N_W%8[^3AU0:S[> M6_:4Z2Y,H"%XQ*%5-W5;">FU^JVA.N,AH5&Q!$D0MI.AC^^+G6;UY%(D=DO=^NS/M-<";+`HT4ZM?^WN\^"[.-H)_8@NHF M/(M1XX'9BT[$NA3O^(>[X3_;K9MVZZV"!>3^=.8F5Q\`1S<=?8+) M0B-)ZDF]X15)BDM0LPLS?7LT5+I02*53+3M^90X.@:D%-T8]6/@HW0+UI-[R M-A:HTVY?M'H*+="VM!?-L:WL54_J=6]MKPIE8W%F+(46'Q%CY5M:C7;$Z!3G M':W;Q4U[H-"XJ:.^$)&-T74UF]EL1EV69A.E_OU&F]AM*[6)>_=#M9,?XJT: M1ZF+OX5Q[,/L,>HK#,&MT9@;"[:S=E+/?EMK-U`H0UM2KM:L'62_I"X_VJ_! M/SLWG:Y"^Z7&4*DA(*G`,79LX^>O6B)03(DERH70)$.V^B[[$;^U<]+L7@P1O"J&Y(#:)E?M[R_8? M8;E(EOHR3[\]`M7J_K-]TWE;`$^D!"JRU>^I;G.AC-V!$,R<;_5'76.F]@GF MRH@?:[Z]N*)@]0/C5T>_-'7C]9EK>_#SN]+HE5ZIT"F3WD^Z\^6]S=`J,)CH M7:3W!BSGPEM$9*]YI'(V1WK:PUFPU>ZI^'BY(]5%\XI^3?)JS?'=[B[1 M0$54ERU7:]ZG7!W6Y&JGR.F)R-6:0[H=KSH#%=]S#I>K?7R7+/N:]#G[TDT6 M'>YS*G"B-A)2?(>E>R?`.[IKMTZTQS)?L=,[W2$>R)R]3K_4(5;M)477L,KF MA\&6[MWJSJ!N3A8OD^HDM_RMJTR3$X`MF4[D&`YDP57U$.J,.HEUT':8 MA]$IBTWB#K=,.E?6LD70*0O_=38L+-N#XODIB[]U1METCEJ%DRF+AG4WQ3"Z MP\+IE+D!W?8&.OO%#_O:[+UJV"1TXF[0HNEE MW9K7U)D;S'&@>3V*+PU3XB6;P]NPCFOU@AWJA]*3'(,/YL1:L`?Z]:WN3`S+ M@2EL_?+%8EXEGB/&/=ON;,X;!41B3?F?4Y!LZ,DSH_8Y><,FU`.CXK_SL;]QR%QW7,M^ MYB^@45`%!]E+#5'3(38/XA,+#`3G!A2BGJ:[YY40F?7C35F:G;0!O\0X"N7? M^/P4A@6:L1F8R;=,_#2,-'0'QX8L8CNQ&F)*1HW;MJ]WH;%BG]I+.Z/>PJN8N%[O*-D%>FAJW` M/,S,B6YQ"#S:`N MN"/@CSCHM/$ZUE(W056Q,:"/BN"):`Z\8,OP7/^MXTWF06WRI,-DC@[&G#XR M0B,GAVIX6A.P10\)*IJTAYAT,Y.+H&[&95N?H%0U4&;%W1+\ M*OBQ);;.K]XT0>@,?&MA:9_F.A1?VA9^UR53RR9+$2X,/?4`&-_-+)!OD[@6VA,R$/20((C8\%X_8^GV[CXP8+/B75<.[&,^Q.: M0).Y@OGX`R1&\T!5,=SUE-R@=F14!87''&1'[`2NN1$2[D-?4-8(*/IM\2^<11U-Q(> M'`')"/*1@(%?>@;NJ5CX'PNH:8(SZ2N`C@($4X.-DS\ND''=RSN*2CGU\)25 M6%PVD-@_QCO;;R4S883T+(%LOI0]=54*#3L?F_>6I7'6O;6]&;F*Y5\'VW)M M`$-@*F8OQ[=Z2#@H[V"-17Y\`+D;6ZX^`9MB.5^8P5Q@#IJA,6.F?TTF'MWU M91X62O#K'GT7$&CX/S`2E>\#Z;=;K[Y\"\VP!=!Q9V&\2"-!1)&\`P,DIB28 MGG"C*OAS\._W;&Q[U'Y&.8>5P:TI(CZ=`8_X]+B5B)BU>5A?^85[P^_?O[T* M?EQ\_RVJ&:S\)TP$D#`P$3A\E.>I\?6>3+`_/+[`WZ/:19V)6"1ZX7"2;R>N MA9N2.^T8U03PR1+MG3/W01UOL<"^8IO"[PS`H(`,!'NIFU!\`2\\'C![LG5N M&GQ+1G&%@,,Y9H;.\!D%7WBN.UE]HLNEH8O)`-L()$%T"2>0[.I/,.X:PU`; M=VFYK"!)OB1\:/BNAC_I.(+A@;X)COO28J+H,5P1@JW\'P_$PWB.N(<-\.U] MHEM/&)8 M=WK!<(JPHUAM+'0'D[3@U#KQ;)N33#QP]FT`>-2!;>/G`'1E,@9_SM3X9#WA MJSN/1??01B,A4TC1/@8L?T$F&JC9APDKI#M@(SM58#Y#!,_"[@-6+)8@BIKG" M;H$?\27&/ZZ#C.N0H--`E_R*" MEBXNOB45@[BJ%8$F,`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`^^_/:_)A/&IM.]O/=-S:D@MGXI5D2-]WF=CDUQ*N^\VXO MJNJ6ZY9/0F(/NR=/%?*6]Q7F`9U3IY7-BV7(2GG$G_3(%"'QU>C=\0S=KI=T M[A^&/90_B6.@[5R6*Q]7/Y7O9W/V7F65=3UXQJ>S@V-_*_>U*X;:S9TII;$3 M8.X1">JA5F:O.YWSFN_V(J8\'NU^^[=JW5!Q/WM%96PWLFIQVZBG^8:MUCN] MR9L)MF!U]O8&5ZTRI@:;Y&*0U=.:\PRBGN`_YD.G1(GW(7WK;I!7_<:@UR?K MO:G^$.3CGM>R?3*RW1\TVIV+HY3MHY.9X@,FN[@KA_=WSY#"UJI4J/>6]YPR M:@P'K?WT[C"IX*X4\?\I6D0*F9_$^J52,EZK?JWZH>IWP)_L[CGGOAS=KV0\ M/<$%Y>IPI6&R&YZ[`;-;B.R_F#YB2G6;//++-:TI>:)X=8)+#)V.^0T(17I" M5?7/2MAZ6AU6;%PVE,V=[:UCL^BU2'5&L?I4E2](M9JI4;-7@U:CUR]\X5^I MR-6)KMS+%L+RUTM%KQ#*YGCNLVLU5AT5D+( M:ETN5Y>[YUW^OU:[W^NU1\&\6FOV@9K=:P!/:\VNE&97\8MO)>1:S21?R4_( ME>#O#G:CWK62FPVJ=ZV?E-OORE],5;-)6)UJ-JP%-N>4!)1 M*E'YTV5@354M;"F,J^ MF&R.;YEI+72S]'R.)9G@O8C?LV6)J5"QR#_<(2V2"`YT:M1TJ;!P/2`=%:I4]JJ&N5?:85;:2WV.4<^,S MOZ&1:4T*':,S?G?GPC+%79P.L3S7<:F)-!'/81J>C1:W>^*3G2[V5.27A!S8 M-4]?>DO*'-'*T*:J^L']R&)2&2YY!6:%ZE.8QTQ=L6X5EXNR@O.PFIRD)^E" M5Z!WM?;5VE<][:LST^[D]AS/!M+<>Y(_B87G\&RW.HW6J-=HJ\GG<91,KTD\ M2M$=7C1ZHV&C7UG)/1W#=]0>XY%VOS)[]/>>6=J-4:_7Z/9'I>R7/X4C,7E^ M83D>+M1&X62,PK#3&%Q<-%K#;FT3CO\33KY;ZGB.%?V1$6`\F[BQ[+5.OBY2 M!71>#;FE._U[6@DE>5RKR[2:CB*$:-3HC[J-06_/F>9%&HS3<>DJUL<2=_#G M;G8+\9)ED.-:DR_$6KJZ93HO+TBLJ"?E MI[.MEI]=:595:O%8T2]PIT-B^?)6JV8.JCEH#"[:C4Y;2?;(>@:K0D_*_#93 MONB7S_/*?!"JV&"L<3EFK"J]DJJVNME5B854A8Y*R$JM/@>H#VC.<-AI M]-KM>M]#]<@M8.50`6DMG[=5N!BQ4E8S'OXXCIWY%9"H>L=';9AJPU2<[W(4 MIP..)"!QC%M=/J:G7&J(#$TO[P.;HIY4PA)4;6%7;6YM;S=?M#QZ5]O!TL=CIY5,MZ_*#A9MYZIP2VI.&TPP,H,1 MF7A`1JLWG50IS%JU!5P%6%*Y"$K)89+JQ$(J(!RUOARH+WO.TR>A+Z?DRU=` M\,KG[0O\+INMX?F%)PYPRW>R5MWS+O]?J]WO]=JCH+K$4E0HLE`QM:A-3FUR M7G0@0/UJ/_A)@:.QUYK^F/9K&<<5D&3%BC3$@P:Y9[8^_9XLJ#W33>RP2UHY M"#ZT-99HP%@^3LLJ]^5ASN"%85A/>`\8'Q;B,->!A[8[)TO+9::K4R.\1VP: M7BS&T["X<^H2>`/BPW>O&)XF+A=SH6'0U(EG4$S4@A7C=XLEPREDS";4"W MWR7?R(%U,^C2`8J#OX)N"/-H6O:"&OZS1VKK%-F:>/K$A(^0>.BX-G,G\]6G M$6^(H9NL.9?5W<3H!@AQ;.1\?P3]./&_=F_4:K<':.*$P7M]!J_^=!8W4OL% M)3>X.V>^G7U])OZ;^GUZI5C0?.!@"1+X:<.&CJPF7_U3$:ZK<8F M%F=<]%=+5)7Z2';M6DRLTKHITX%->I.0ZTBB44O6E"!GEMSK7_<3^N.5@CTE M7<''LWJ>RD>>*C@/=50$CD(?M0,OLKS3$B?\DQ"@E]KOEZ`XO0HHSDD(R['Z M;IU3]=W"6>$D!_PE"/7^?7P1TMVK1_Z@17SM;J/3&39:H\YN'EO- MZIK0TH5733KX(^;Q_@<#XY2Y+(=A9UN.N0C4J5/M7T M8CM>R\#)FXDAYKQI#/JUE2@M5V\E5J6?_?MM#UY6'1Q7%]JU_8)*$6#Y";45 MNV*P-VRT!^V];)E2R:WTF!X!B547NYHON2V`3U3(A?G`%ED-[Z>AQ=SE?_3PAYIRX^>@U^KU!HW6QYQFA M%VP^\OUH*67L/IE5-OD-*7N-'BR7&LD#.NQ_//V1&@S6U65Z0KMQH<@U=Q6. M"9;T]:1F8<;20:EUBK7;&31&PUZCT^]NT,>CT-1C$LP3ZLHQZUC-PMS-5%:% M9FUVU*XH53LV>SCBQR#8NW8]CR^<1\&H`GP0I:O18AV:8K_V'D_:VZ*C84?$ MFC)%IMHVIOSQJ*W\L5CY=F/0'C6&W6%MY4L+6NZ>/2GX]9?O/*;>>0!6OS&LR9T8T-M$7U'!>GS6[9S]T!GW0C0@_ MUG`2\1-[9*;'W@/GWGUUF6U2X]IS0":8[;QY_I%9,QC3N3ZYLAEU'I`%(>D1 MA<-5"H>CSD7[[`?D!>;'@8+?O--FU+Z_NFIWNKW^\&*$NON-9#R)]&!\Q-NM M\^WX39]"/IW@8W^K]:>MDNML2#44%^M<\A@$!/>!WJUS&FRYYW8E\9]O1#)P M5!IY%0?W]NIG5?7[>5!F((F+O>UYVV3WMW=T%>I^EDKOK<9* M!@5S$PE=)ZF*FQBCK;4X'WJW3IWTTLU#_JF4"G=!LG`JQ?M3<4%D#$_+(K.# MA[%-3HV,?'^U"-7]?$&JLC%!1ZTJ1];/@](L'=C5/'B?$N-.X&/6*RN:X>K]M"7W/U>@=2Y]J13X]16XW+KI[SDBGK,@' MKT5XQW)9B>QT0#PECCF$2:Q*R[GX?XN:KY^Z:@UJI976@%9V'%..AFYKTU$;2)D'F?GHC81!7PY MVW]U>@1F\MCH+2O=B>)/>64E;=G%/U<3)V^W]XR3Y[$"K:A,5XSX2HAJS!0? MF-5`$N%6?2;X&-1Y0QB\/1H6MN`^'M6L`+W*5@(@CT"&3-ZV\W!7%@3MU*7# M47VCRHE9Q2\'NHV+5K=>$-0Q@]I2U)9B@U/>Z=?1Q0,R#T:Y_@Y(Z9?,#7@_ MF3/-,]CM=#5]X1OJ0'U3>ZL;GLNTM+R`%U7,"[@A.5X`_0+S!L:%+I>CGELG MXED](5`--]E08DR M4J7.'90Q+Z5_^V30V_^[2PG]R0M#_DD%ZIGFF&>:'0]QC_&/,(?. MN#"=DO;BR&3AQ77X5(6_5[#P']NX5ZES!^58>PFNTSX)T4YQW(^@3\H5M6!! M+B[[P#YIQQ3R2"X4:0OL(KH57?BC8`%E1&=N-K%K<-NIIT?DJ M-WDSA]]RO&J5^=:[7`RR>EJ+/*.DA.#"DQ;N1/K6W2"O^HU!KU_T&3U[+]LG(=G_0:.][RKR6F;P)+M*-.KR_%3S143`[=IA31HWAH%7*$8W#LU16 M?'[:G'BQ'J^B1RNM-\\QUT`'+RWR61. MS1DCNDFF5+?)(S4\1JPI>:*V3:&,H=.Q;NCN4%7]LQ>="7+CLJ%L[FQO M'9O5R253S20QM9K5:G:XFKT:M!J]?N$+_TI%KDYTY5ZV$):_7BIZA5`VQW.? M7:NQZJB`E.40AJA`KVIC51NKVEB=B+&J]B63>7S4WY.A?KJ=%_`9*1>"2TT; MNA6C*O>-MA(LVV&-6.][J'6Y7%U.N=VKUNP#-;O7`)[6FETIS:[B%]]*R+6: M2;Z2GY`KP=\=[$:]:R4W&U3O6CEE':MM6&5L6+W]IMY^4_IBK)I+Q.I0M6$I MMCVA)*)4HO*GR\":JEK83FY82W,O*S#7E.?[Y2O_U7"I*C#`.2P6*]"K6F5K ME3TQE7TQV1S?,M-:Z&;I^1Q+,L%[$;]GRQ)3H6*1?[A#6B03CK'ETQJXHU:] M:DST^S@YTKGN:'J\AVN3X;^6I3UY77Q7[7$\(!T4J57VJ(:Z5MEC5ME*?H]1 MSHW/_(9&IC4I=(S.&)E8BX5E$@?OR72(Y;F.2TVDB7@.T_!L-)18>BX^&6,R M+P*OB2:V]@+L2K92LF2V:$R17Q)R8-<\?>DM*7-$*T.;JNH']R.+266XY!68 M%:I/81XS=<6Z55PNR@K.P\=^*7N.+G0%>E=K7ZU]U=.^.C/M3F[/\6P@S;TG M^9-8>`[/=JO3:(UZC;::?!Y'R?2:Q*,4W>%%HS<:-OJ5E=S3,7Q'[3$>:?HUN?U3*?OE3.!*3YQ>6X^%";11.QB@,.XW!Q46C->S6-N'X M/^'DNZ6.YUC1'QD!QK.)&\M>Z^3K(E5`Y]606[K3OZ>54)+'M;I,J^DH0HA& MC?ZHVQCT]IQI7J3!.!V7KF)]+'$'?^YFMQ"?K`+C6=1BK`)=K=6S5L_C4,_3 M_Y@G608YKC7Y0JREJUNF\_*"Q(IZ4GXZVVKYV95F5:46CQ7]`GB<6/JJBNN?RQ5W1%_6TZTA.\V/1;A-'!1+*5FWQ6`&6;&^G M"MV17I582%7HJ(2LU.IS@/J`Y@R'G4:OW:[W/52/W`)6#A60UO)Y6X6+$2ME M->/AC^/8F5\!B:IW?-2&J39,Q?DN1W$ZX$@"$L>XU>5C>LJEALC0]/(^L"GJ M224L0=46=M7FUO9V\U7KO#6HZ#=U1?>?O;S=+K5N5IA;V^MFZWS8J89JGOQ4 M6;W/LO7RIEI?9BME4^,A&9C!]]T5=_BB)[I/HU(?:K^M;L"FMH/'HW>U'2Q] M/'9:R73[JNQ@T7:N"K>DYK3!!",S&)&)!V2T>M-)E<*L55O`58`EE8N@E!PF MJ4XLI`+"4>O+@?JRYSQ]$OIR2KY\!02O?-Z^P.^RV1J>7WCB`+=\)VO5/>_R M_[7:_5ZO/0JJ2RQ%A2(+%5.+VN34)N=%!P+4K_:#GQ0X&GNMZ8_KO_[RG>)X6E,>P^R=\VOQJ*88F0=,VR?Z-KK MLP:3-JWU]=M3O=7G]X M,4)9^4:BB$1F)F,!$&QO8E#'`1S/=BS[SM(!VH['2)`-9,(,PQ_\UV>M,_X; M!SOX[4/[L@Q";-"E\_^S=ZW-;2)9^_M6[7_H4NW4)%78`PC=DG&J'#N3S>XD MSD:>VGH_8FA)3!!HN-CQ_OKW-"`+)"0AQ*6!,U691$AT]SG]G*?/.7V#7EW_ M:VWWH158MK-4S>C9H^H8*DNK))X^T7`H2#QT/8=ZVF+[Z08_Q#0L>K%(>_<8 M,PG$I8XQ>TN6JC,WK&C88<-U^)^D3$1)&C(DA[B^ZL%7/_7B6,R7>SHRJO4B M<[KJA7_OG8;<^MFZ^/4X&C8AV%1WE"N+)W@H"WK/MN8I=!_[XA@S%2AC(I#4 M*(-]3=L0F96`,5E7O>%ILUX;Q=TO'$K)$GZX<`FU@'K(OWR+DKXH'%/Q@?O< M$%$\R4A.%2T&JWUBIMG`,;M)X'J#:&8E.T90LDJFQH]\H&\N"G(BO8`Y$ARG MRL$3A^.07$1^(!ASYLX*0\S?>'<5+=8M/[\(SIHEGDY7O:`O5I6`% M2PA>27`(]5%P9&I#ZNJ(8U(F^[*R:C,ENG]079'DDB!/Y-(\- M58T-K1V\Q9SZW6`=Y]__55YASE"0;[JQJ#\\YZU&XWKS2 M6<$1`ZVGB1$[VD08#I`E:CN2E8NH]+_1-:9GAU5GY]5#Z\H>4!548?WG)A?L MGG5$+\EP<:2,!&DHY>*R0I'+=9\VH(F\PP[U4EH`W%*0EQ#TYDG2%^??GE+] M2YM3S43(3.A?_G&HVI2B*OK](1.TT*5,3Q5W]BN=S?[:-NZ>VWI4^H\&AIUI[:I;UHAYU&`U$\J8']%IS>HGT,M MTF@XSM6@CX[MNE\=>V;$.D;)H9*ADM1(K.`M.-#YDEI0#J-A0.ZMX6JF[?II M1S--!A4>S;2*OQ-2`-GZO1`^$,@T?G(1.YS+(V*2$?_T7<^8/9=`2&:T5UE2 M+@,N"3Z0E\>1?LE&K^[F9[LS]`R*4)4UIOWB\H87RN6L]DH;K$ M>[*)$YA&<`J8&W8FM/&#!6VCT%!K3M;F3%1+)Y^ISKRNR_1?S*E%'=6#?SDA M1Y(5_$`S5JH)%C&#)H8GAH'/I+(1!W[F4M71%D'9.KQCVJL`3VY8)`D6@,YI MU"R/:@L+AN#Y,S'A6\N%'\P=NOZ:%3*WP3.T@C+FX=K1IP5U*/%BHOLNM-"` MKQP;?`Q#<\&O6ZJ&1;Z#FV!2?4X)?'B`$<_0"/UAN]^I2;UH>]^#H1/;"NI: M.3:,F#0@#4?5O%!%4;6!M-",8$`EKL^$W/S-FO,E&%15DTPU@UH@[&_,QP@> M!@6QW]S262#FM?ZHPD]T\FVM,6"[/RFK\QJTKCU?$M:Y4?>L>Q)4Z@*B0#4T MZJY(2P`5?P8M9O::E'!F.T1=K4"]:KBC$33!&K*,2@[>-DS#4YUGAN'OU',O MVV`;[;5T^JB:?F"5*^K,V*%Y#&RL(\$L;2VR5]?V'6;##ZI+`X2O,31W@OL, MPE$[E"4$6PIS@+U20E6`)U2BSJ$@EZY41@E@_P]44\'T&)R>`P.G1#=`?DOS MUD@*T6E;+R6R>A\-G;'/AA,BV[#A?TX2R@&-0)F.\>![P4O@1?P5\)"M^YH7 M-GRM&-UF&K4]9L`N5.*`>CVP3ILI+5&]9)MHK'P+[SA:P_$6;MXP%@!R`,>-8*.G,&@8S^Y;QHF6L8^201[ MF8_\C-K7AB,]HVA]//AI]WC/X$#/(\>;QD/I>L].R[BW+W'4\=["BXP!"CKJ M)B7?E_7PCSIECCF[ITK?QAYM@$Q;U'FZ<`5`],`I..4*'T4!*9+SI:#.(0(% M1H%1X,H%YNAPW`8,G74Y>"=MO:A30>MT9PO=)G0%NPSL6]I67)\]4K93N*X! M/-@-A0BH9NO;$9>ITEUP^Z]/(2_G%"?4=#(@SI2OG&7@6_?-E=F@7)>T-5M% M19ISR=<(\RQ)=_JL6GOA1M1V=RH:8O/ZK')#[*C&RT^\Y;R#E$1K>%-.RRCJ M-O2JW97LPO^C%C/)MYF52((X'%9U#&B>UG,YT'#07,1V%FPK8\0V8KM0<1IE M`K(@24J'3:!Y*;C#?A7;"43LVW)8M=U M.@_O&4;^]9)@%$7N'Q+BS!`&"`,N!_;BTWJ'1M6\NU@ M4G(Y:ORG`QLS"M>LGB*#4`[:C5V#78,Q94MBRFBK!8:6IX>6=>6IBE@)NI5+ M&M6?2\*(I+L`'$X:LH0*`=A.`$J"-&D(!_+M%I6XQB:GG%M['JJ8*^1C60X_ MJ]GJ3L%SK9VMD7#`P4C8U.BXWIY&+.^$%3Q-42.6$F?#A==?38_POD^(N*.5?94FN>R4I_?JI[IA1O.Y,/H9__*#)G>M> MC#E8EXT)T,:@!PWN3(-3!LVP-[[]?/ZRO6U,[^:KM>G+/QJ6K^G2RASL&FZ[ MAN_QHNB\4(4#Z-3X<=(5!?E,I#[7N,85\CQDOSATQ;@T@_/FP:QSX-+E<%ORNA(#M@%[8$^#7!PV`7R4BFNY7K%>2X"R"B+]%/)#E.@&Q+] M>4OV^;M/"\.C%^PR>U!!>-E8:AN+TFUU><%<$LLEB)S,HPNC>DYC)(,`?15W M][G#:3MD0DMNH27+@MBO91:Z*:AOHTQHR2VTY+XP%M&2:\V<'@/.KM=?96"T MO4.CE,"`PT"O`IQGG48O=BUN4U1=/LFV7O_)X$OJ\Q9\<8W%+LB(U(;4UDS] M;^65AK6LT&RJV7=!1J0VI+9FZC^9:!M/D-JJF)4[=ZZR@KFY\Z\M.2($9UQ2 M;9+Q/%[)O9B^*QG-MJ@W0<]#A;.0F@,+;HT@2$5(15RK-^DI#FO9-,6U!;=& M$*0BI"*NU9N@HHF(5%3%-/)V,9Z]BN+0`SILV"+M+LA8!.Q3]=24]`VOJBA_ MC7NK.B^CK:8*%BGE(AARWX1J63]CKT6/T,[;`16^5(%VCG;>6G"C*M#.*YY+ M.V*]U6[_3[G?*]=FUI98$U?Q<6%IEV.R567YG&JWQ*&8`^E:W'%H%F@6:!9H M%MSY?6W>\G36&0C=BE7/F5FL3BV\3O[5MEY>5&JY+J%9BTHK\1/X%AS9H8OL M($NUW+:'[(#LP)]M(#LDV$$6Y,$$V8&[8^(JV'Y2Q4D0S6HZZ+?4J).'C,(7*39ZMF=ANF]+F@^.13P=I`"WY30!1F1]I#V6JCY!.WU MQYSME.:;$KH@(](>TEX+-9^@O8&,M)<]([#^J$+WQ;[6C<=]GU;Q=H9UDZVU M)4+X0"!3ZABSMV2I.G/#8FKRB%BMT*NXF&H9M@6_==;3XP`IE^H$'IJV%GYKSX@&#;*7U"&&2U07?F^:]I/[ M9J]2&MN;[-\)3,('HIFJZU[U;GS'M9VOMF%YU(GGJQC"U^V+.`RLT517+E2_ M_M>Z32&K64SW9O3L474,E>DH\?2)AFNP$@]=SZ&>MMA^NA&4F(9%+Q9I[Q[3 MFD#>X MG92R,?/ELD%H;R_BQJM>^'?O"#6?-CRNAZX#]10Y\D!OV]8\!;JQ+TI)+,;) M2*,,[P6?2YS5VK3?MYVD\F=K@S7OKS<%'BD.<-T%.95K(SUQ_J".,\D/ MF71N,RZD4]A^_-#6R5[#/>KM5-C>0XRPKYW--IN<]%#^V1"5NR"'ZN%*]VUQ M0=(4OF%E.:^'(8O2X)@^'YQ?$$(H)YI*="@.FDI[3"6_(RSWSA6U'O\WQ5HK MUGF6,:=@5'$@=6T6U6G9^3&Q.'%4;6Y'QZVRYO.:-G[Q$*EE.4:GW;U0I".Z MSA4$^9`2O,*:,H:IXK2J,[LC*<*V19W934DS^9B98-L)3:#TW96^05:`[C]7 MV\GBD4/1ZOL"L>MBH[7K)75`XM*3?>4'/*RP?Y3BJD46L2U-5E]LK58B"4,Y MY_;Q\_2>J:6EKC9O3YLR+Y&N'V\31:H#;:5;><:!K-K=`5EZJUVK\DN4.`%C M61A/.-L&7ZKL=6W[X4HF-.3V&;(DC/LY1Z0V&_+9L4@@6"F1R$X?'G)"^I?] MX#]1&BB*-%F__L%W[!45R&=#UTU*/JBN)Y!KUTB).8IV3E+\ZO.W=[:LLW\1YUSYG-G]#K/T-4I+FJY?NE$Y.S$;@ZP<.*8U!K<(T4@1:1Y MG/(8*:*"F;/\T6D#:+)I[2W\.)53_/KBIO)JDN(D_[R8/+DDYZB]P0WP9R/I,&E2DG-JX__?J+ M[U[,577U9DKG2VIYWRB#``A]:[B::;N^0^]!;^]-6_O^[N]_(^37EQ>T!=5] MD][-ME_]M#FA\/US].5+(<30KWKWZKP_&;(5W1;KE6]T=M6[&8TF\ECJO6/M M8Z?WP0]__J#/56=Z?2W)?64P&D\8:G].T3%)VS$8<\,[?!K@>)!R&"`7Q_^5 M>MY.`X]#./M*'T;>[0!,A6ZL24G1&O;SO^9ZHRX4B3G M2T&=0P0*C`*CP)4+7/Z1'>C@G>_@Y9_NKUA!4^H\&AIU6^@VH2O896#?TK;B M^NR1LIW"=0W@][:7&A9U%`%5KLC:<9F2QV)DO"9HKQH/[R0*+TE8VL'!Z90= MG$[6)Y.3EZ,F3\VR%RI?EM7M!1T.44Z#SCG\HZ$J*M*N!&UW9V*AMB\/JO<$#NJ\>K.RCUQ4ROY%MTE6(:5U^.NG+74M@(SR;WF M51SFW&1:C7:Y'&@X:"YB.PNVE5IVAW$'%L1V,U97%FX"9VP]XKH3RO&0>$C! M'?:K;FS78]).J0B?>%1Y,@U,&S;`WOOU\_K*];4SOYJNUZXQA7R/&2_.'3%N#2#\^9R6]L5Y+@+(*(OT4\D.4Z`;$OUY M2_;YNT\+PZ,7[#)[4$%XV5AJ&XO2;75YP5P2RR6(G,RC"Z-Z3F,D@P!]%7?W MN<-I.V1"2VZA)`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`^G?'?;Z8ZW]2YPVZCB3R6 M>N]F4`/]]9>=-S<%WOB.PQX:+HS]_T=5YX.EWZH>W92]0U]1V1<7DGS1E\+2 M]Q6SJ>C6UGQ6_5?J&+:^4\L./46UL.NP+\3A15\,*THM9E/+!\LSO.??#),Z M-_#%W':>7^J0=B@GJN.+;5VH,'K"2_".3H+7P^I2RMNN[!N=&Z[G@'_R15UN M)))V^"6J[<._IW?D_:>[+Y]NIN2?=[_??OKR<2J03U]N+N-U)HO=KO0&5."H MYB=+IS_^36,R[G!,5"O`2QHH$W&LQ"O9*F:WMS8=^AL\<3?U[+!*K+^2/;55 MQ+XZP@[=JF6'0*):_B.GU1$K8K>6^^=5K'-VZ"$J6!(O_I,LFKV7M'PPR$^6 M9B_I[T#%UX^J83)'Y]Z^L9=+VYIZX)0L8`BBCOM>=0UM4^DV,XP'#$L1_^_$&? MJ\[T^EJ2^\I@-&8T*OZ.!\_R]P'8EJZ224F4P]Q]<\D#=P11]>W-E5*4W9 MP#?<+2@`8*]5Z_MDEJN\M;`?<>YUHH6Z@5M;9JI_O"2 M7._4)8FR`,@11L/1ON*?J`/6Z[H^E,.JLGW/A9"014I"\,"R]]=YZ.W+BCIB M"P.K@Y%05B,-;9M^=^TWUQ"_JW/Z&1J],)]O5'?QWG>LC17O&<4/NV(#,71W M#]20I)?WOFM8U'5OJ:LYQHJ9'3CFC(?VUQ'(:$E1Z9Y%_J9:O@CO*&(^=\@*\19[`RLWG"_O)8ESE/[B@*O8; MT.('L#GR'E1J:"[Y)Y`!D!74"T/_);'`(]3#7UQKH%_7"'1_8SLK@2RI,X=O MGPQO$?2`87EVHK2HD%<>C`V1,I31V\_L-6?]>?SV]67:2T^J2]A[0$./QB,T M"6S66=G.9H1]H!IS@W/+=@VX(<`4OAFLW?<6!M0(;K"K:JP.X>#+.G`D])UA M,:8W/+8&@UX$"G&(O:)A,^''*M,:&Q^8+`]KO&ZU+"J3";4N-!1^4]*^5Y@, M*__!-#3@(F@].^)'"X?A2X`.#9*)!@,&8W;2!UA!N6$7".1N!J,7TRVK^@YJ M=,@W:@:AR?U&$^YEF)(,BMG358:U[AZFCPT&95$((A M])+\%_H/1DPM#.I`A`55];_@38\Z84'?#&T!H[,N@)-E&C/;L0RUT*'TB#W5 M8L0`3=\-Y0?%N12<#H]!P@[T"!@!KG&#GK:"A6F!UF>&I5J:$;A:\("%%%`S M>P&4N8P9H+=QU3962`)/)JCC$.Y?L00I=:"GOEM@<`R`7[\`GG3RT;']5?BK MUR$=@%7H@'W-B]@A^I!NK@93$Z#(]%EU^\PCT;3?/?T2+&P&XI%YR!$4``U5 M1(H*8?XV30=KL5(5<,A6MQ6R@DC02588^HDIE<;+.:KY_>5?DC\L,V@:L]@G M`_#!E*LQ%$#=IDETT+#J$'5I^P""2*U[\90&G,`L@Y_;O@OBN*VWN8B*5&(" M!3$LZ?21FHR!@^Z$DOV9&H1R#L/$PH@_M(B6N+9XK4\46V__W- MS"[%MZ66I"DY3=T/1:*(G&=G9Y^=MUUAU00C`3)15/6G:!6E:$7XRI_I%5<8"@)0@L*G$[>L1A%`F6Z(&&RBIE[GVY@ M$=YM<.(\!JR):1VL:PBT%9CI!D3@B+<1_(^%8%I/N'[\M0\&@/\Q@AL7L\+7"`J^8_ZI&(XA[J68D_A74S\*[=#/% MN_UV&,'OA9W#[A7_/9E`&`EN%4;.+(2A MH!*1J?:^ET'LQSW'D&5Q%$1W6!*FKR`MO")&'GMOUG\]`/.P(,;W$]<>`14"FMWZZ?TC@196[`L##XF3V/_-`DB MUTM@H<;P)USS/H;K:["?AXT/JH?'_3N^A(((UC150Z>P]S'&%>6&]P'C\FD' MH\\"^*X8J]#OY"$"/7+QP,:P5H&$=W'D93#$/:YN?!`4=#P7$7]=44V]REQM!*C7NNL!^4%JPJ66B\^+BP7]ATEK0W<.-P^(UH`0 MZ\&!^&P/;HJ+0ZM\^L#X10;YA[`^@.ZIC$[E]W+X#0#T28_8L8L MZC03AZ9SBE70'<.WA:Q1ON<"'GPO>H#WZ_]`F_(*6/0B`+^Z]^%=^$*^MO+> M"?IW6`^[P`6=^B'"K[1(W,+:285L'GH"10A/'F)#CQ8TL)J_/I@Z=T?)R_GI M=^`?C%X.-"?VTB3S4\Y?\!`P!4N:G,&13IL<`&N0Y]THEJ$E.X.AQ6R+ZVH' MDH*G!,3"N@*Y]^3@(227$S(N3\K7T4N(2HC2>/^#B'0GMQFQ,T[D;`7HB>#` MM?4!,(Z9^`K=1XBK@&Q"`+J.LW2]8238I1?#6]$YB$60N\.2Z`E6"O@*>(56"(ZXT/VP7$P$_\^8U_2R1%<>R!?E>11T/",&Z/L5<" M84,4)WE`)B:'E.V'0'7TG93M@._?N6C%3[,=ZI#AGI7BDUX,_@@]'##T@6,& M]K'F[E+N.A"C;[-DG:$3>IN%%$5>3*[].`%3@Z5(`!/4#=#;3GCLI&ZN8A^B M&7A%%21NOO`"ZB#!O\)\9A"YAX5-E?>G[[G3M7,3/A$8JB0PW;@]_S`5]"[D M@]D`YWN$BD#QI<7([X89R['X8#4;QH+UQO6Y5^CAA,6@A6TDU$)`0+\!-RUX MV2UJ;`M!/;C<%\W&EE<"?2505DQ2Q3A6\9M7.WFU$]E&RTIA8R+ZD2:X329% M[A+"R83OLI5(81(4829QOT@Z@M_ZA$E<=H=IO&3",)])@0];;T+RT6DS!E+$ MCCZQIU/T=MBXDG*3O<+L.*02+2G622FI)A-68,J.,9#+Y M#%L0.NDW1;H5:]RY'X`/O&>(E[\8$YBWF(![.39_*1^P/-%L\ZZ#0PVC^"*M57Q+S1W/DYO@!S&>)H#ED?$Z=@F^*#]0\(O. M$Z]_,PR(X9&UFVR0FQ[$VBL5*^#M:WHGVW'7K]0=`/+$0@>7&;NQJS*!Y6;T MYEQDDD1KGS1$U!&SO1MDAQ&O@1,@U@<*!/RD4/+M0.4\^X%RD-YB?Y6E55$! M^<:DX_4ZVV9\&K@;FX*G=K"I2TH"UUH)2'$>^97-I_'[?ROW=2_UJ6GI%;KX MYA-HU8X0FE-7JDGXM*(LW9K.S:JRB@%0<2OFZZ7RU-R0J3J._9FFU7 MX,HO=%X-O9B\SP[IO.38SV.8/%S-[98J,M59G1K6O`4GVB8.&6RSM#!:T2^G MEF:VO`JS0$JPQC=O3^]\,MNVC8ATXV07I?`W]&`.N47` M&'.1;IYA1%E']X*RL:]8@!D&&&Q*A)UDA\H`H('7K'G]:,NP(QG=KT,1*5H% ME#/E"6>QK0$_1SS#B:5='#_8K%6QV?,X,*\1U6M$)8FH*@N?7`**.O+FQ9A1 M&PFQNJS@2E#'VLOK(=PQQDB$5#6'?PK@CCG&O*Y@-U!HS\!X`7 M4CU"]'Q4B@.X4OT05F#*A7[O_T!["3(?C`=7\%1*&"*1Y^_Y`BW:S<&5C':% MIRA253&O2%;B0Y$>C-F&YT6YM\5%3`%)`25GIFG5NY7ZIR6?5WAR29[ZPS)H M&QBDK4W$&_@`\#`08@,H4(T,O\J8+-5Y/G,JU;M.`4?"C4@Y0)8$**[ M_V74DE+E19I@80T5OQ4/TZ$L>(6@0IH+GK?,L&R<.Z8/C"+;D)R`V,7R?1[3 M'GIHX$^!B-)Y^,I[?##7N(MY+I?Q!N-(M/`D.`6KM!#.D]QNC-$Q75^T%A/) MU2^@A;!Z)NE#A%AN<48%0X.YTM$04ETQ-"&T\+9Q@\O0K\D"+P^"\FGQ@ZQL M;CAH^$9*[V2/?L(+@1[-W@^?H4*WH7DP]\6+CC MBP(%5R#LA`FR@=P"$NRU@#T1HQ1LSX#!(7^L6`$'S8!YV9HO>NPLBQF]"'O8 MP*?!GBC0,&H.VV60PGS,U923&NTNPAV6]M$/0%?!`U?&YUT!>^ZUR"@$<^)A MPJL518\)3#D,(BBYLV=U.=LW[V9?<__NX/JQ0C"G,.7#_.0G]Q^!3_"9.Z8? M^HCG]5,^2U-WEN53=A]AU9=;G>??O=4N\-1*%SE#$-5/`A$B0XEH/@31T,,I M\_K!(3R<8FG'&\0A>*X=7'O6X93!V%L.(QT_6./8EC8>]O=$JWOV^<#!5]0I M<1/2EZ_<.$3VAWG[C,<4>%?G80#U*R)@G#LS\EF&BZ^:6S#6Y*8X>54ELT=RW:K;# M7U"&K^&!Q;GF&+JY+.#WDC\*].8&5S,;*71[:3BV.1+R#T4Z1TP3/729\ARS MF$#PSV[([\#[`KYP+[PX;KJ0[8'2*3A.(*-@J>]IW73JF,[",A:%2I^!Y02# M:CG/>Q(%TV>4G?SH/N&7+Q'-G<@6'"#)-KY3S7E'2+)SPNJIMZRE/M>UGE-_ M%-+IAMARJ+BOUEL(0]!R@S<*^;*-;DRR;4,P$OSZ/M>1'`S;GANZ_L+HC99[ M&)3*UQT#UJLS$ORZ)UG=TPS9GE9WY?)':[';3+O0K`*E5%`O+%UBLQ8LVH4] M?Q:4NH]ER#:F<10C]::4>&2Q4T?E(!YS;#PM5TMTQ%,F\$YXA@;-AC144MQ_ M-)N;UF+$B/]9P9XAW40:(SA5L&=(C]2?4H'2^1_#+S.D<=/\)9T@4[I)](U3=!DWI=3_SKF2SZ$M^EV'J>\TU^\@/,E[' MT18K,AG/XM[U?&'WZ[!%5C,Y[;FE#:V48"==*S2;:J_ MQSLR*FGTXW29`=NP=4O_,\V`-*SJSR@CHU*F#%MF8&XYMC$W%W^F&5"F%[O- M0-O5>Z8L++(5Z4M=LZSGW_IGR;)WMNI^'=5,>EUX M:LD85S4']O(9`H?47\S:);>];UBU9+1F*P(!4^MQOV^K9"GA*6Z4M1SM^9)M M&=^I*D6Z[HQZJ;%ARZA/I7G+/-DBMZ4DJ)B/NOV-B4=91)#.DCD>Z=@RVE/- MT$PW%L-)P);RG.J^[>4S:,=6)NQES/K,>YUM&=?9BAN.=6O^_!O-#5M*>`J: M=8P1KG6VI82W5&C:&6',2ZF#YRB\++./:WG(BZ!/S<*$G.I29WFNZ/PV\][C"7T6>I_*ERTOE1XC;TA2>.'GPZO,?Y\= M+_9@7<>,?1#=DXCW5S_TM]FV@*W,E-?[O@S,UVNZ891,YDRHSZTK][&J*Z5[ M+-?5?'%677'4+VU7REZM%KMRM+^>72FWYA:[*J>V7M"N5FJIJS[\^CN+MT5G MZE+F0P#;OOUH_:17UV;15JZNA4UM1D66=5TPOJ M1]I4/_^J]7,9!!'=MRJ7?,4/T!1#E#F=2V4(78UCN\E\'DZ9P[=4Y8YK::YS MX)0Y6TM%=*YKR[/CE+H]JEC^_-,N]CMQ<^O9.,OI*4KWEA)@9N/7ZSH5L(Y5.',1?4`,26@? M*WBH,>3Y[@J,0<6\8X7FDI2>4(8IW:#>`[58MK%=0?T!"ZU)>&,PC0)W&B&[[XOCC/W<`TB"SMFH4< ME34(UC#Z=(:B^HD?+3I5TKW!^7-A#:$'[5E[5?$NT%[2:_ MW^TJ/_!_`#.$:BU]467[QOL[BQ_"MP8`'"2^:(HN``SAW9EI+4PY@D)$#PQ# M.'AF+&J=/$H,>7ZX;I"2^PW4.JB2;^W5'>4.\DJ[RRUB?@]OF$!.N;FM=ZJ; MTFL*^IZ4[RAJ"%E*CL0?E5;7?7ZS$+>*7&$%IB%$69\$N8R^2(;PXGP`DM^B M,*JNE89E#OI=5;UVYKM-3&\T0TAR5ONU]XYHZ#Q,!TB#:+.FH..RAN$:Y,YJ MAC$<6>6PS0&(^NQ]_WL;.LD=PJF*2U?Z7U!C-LZ]@_.R<,J_TRZ_H*825(QY M98[9./U.B"P5HL6@*W-^P9O=P#7[1`>7ZD:J/K,N=>6K5"<5T0N%]%2AHH]. MM_6^*+IMC8T3ZC0]1Q*]6KXS#MH6^U5S%@?\C_A_^^G]02P,$%``` M``@`Y'8,1W^2">D`&```VG`!`!4`'`!E:W-O+3(P,34P-C,P7V-A;"YX;6Q5 M5`D``XN6RU6+ELM5=7@+``$$)0X```0Y`0``[5U+<]PXDKYOQ/P'K>:ZLJ3V M=.]V1WLGY)+M4(1L*61W]^QI`D6B)*Q91"V(DJSY]0NP6"42Q",!D@5([HL? M4F8B,_$AD4CB\>O?ORV+@WO,*D++-X>GKTX.#W"9T9R4MV\.U]41JC)"#@\J MCLH<%;3$;PX?<77X]__^R[_]^N]'1S.&$BTB;]6="X4(5GU*J/+8TES+']XE&7S2JA<2^"/*P&JBBQ7 M!=[^[([AQ9O#FO2'D],?3WYZ?2(;_FN+^7@$)2I*!VA1KL4*XK*C\,UR9CHP1/,,KFJ-%1E>\&."AKI1QU"(E&W=E:*%AR*RH5&BTX=S31[+DHQ?PI9#^**&,P1T>B6-,E M206@:@]0D$TVF#82VVCM2DH+K*TDPXY8,Z'2T3K">&,QR^BZY-4U>D3S`CL& MI958'9T&XOC(MO04]316#_1^`VVTFP0GB_NS,O_,:?;UCA9"P^K=_ZT)?W2/ M`BN;>4P8V*(Y`FPZV%BW>9%'A;WGJ(?)SO&A;:H]6G1-)#M2W(/"C?_$L*#K M=N=4Y^SV=@_KI*75PS=RH5CB_!UB)2EO*Q'!UTMI'\Y%HDTR8IHPX8P*'B", M\6$""Q+>3M"CQQXF((VD!:I/E&-8VF6A5&"CI8R/$UC"Y38S)-O22FV0\$,: M2%#JL)]HF5GQX*0WU#XT]$EAPU8,<=GJ->-8A*:%C+,\)](D5%PCDE^4,[0B M'!6FY9F=6EV?F:CC8P(VK\#,#9E,C)+30L<7O%Q1AMCCQH(98NQ1S'UG2[F\ MO"BS8BVW2UQ35G<>YXS,UUS&P2]40IZ67/2(T.KVHN2887.!=;J&%$Q.T5!\ M.(>LK"9W^?"5V10JIC7`.E5T>XYF([5]BD@H2W,6?`$V>A9^]1(;$+Q.`P3] MC\W.(JF=OE\G-=''QP2X5`HR.;!::I*=%DYF=+DD?"DTDZ%S)L*;"&VXS,QE M(0"'@A4K1U)H`4]T<"<,G[&L;:6%IDM:WG[!;-E>OIJJBQ92MGJ1W9*,:2CC]S\L&KC-#,G2M5(3C:'F7-6V MCQF:G"HR&A_\F,9HF*'J3A93Q%^R#^]149=7^/9S@'7QZL.KKFAAO*E@PY*( MA'C!,V,%-I$6LI[RJ)+/Q-^$>^R,,+,8TU@=2WSX@/='."T.W"*ADYL64,1, ML4(D?_=MAH0?40(.GG]+`TXR6 M]YAQ(A;VYWC.WR/"Z@#Y=/K0_$4'S-DKT`(XX^,)MK3V=T/(.AO42EK(:F'? M.9=9:17T&&CCX\6<&$/,@R;(!EF6OO_U6'7)I?C_/HX!R]LYX@6VBE\M/E": MUV48S.Y)AJO/].EX>2^>N1AZ8[Y2"V0HS4&=5C#$&Z"0*-5,_XLPM M=..Q(CFM_?8?F#SZS^C">%I#0Z'T?H M==U`H7;I`=P2V3E;IHI*"[&=2RL,O:RE44^%=&GB9C]B@I:?6A&O-WY*K9JE M@2T-Q]?(+MBA022TK@R?2^.@PY?^&)8+!2L,7 MZ:YLTUKA269:<6&S`M^NSZUU#I5(6^9X(HK?[2%5#H.1PXL<3X(!!]827$.# MZWI>RVF;U+Z?^B$SS768,WOR77SI!*9U[O$#+H6.A>C$LWQ)2E)Q5F_*LN<; M0"ZUI.;BBH\1T-K$S_J`U8FS@41#$3![=ZW>@W)XC5!((-KSW9%5?21M8\$V MUS3F]'9RS9V2>O($!D,B$TM_U_($T[!L?'$3N[WVZ4Q4Q-TIEBW@[I;0;YJ\Q(S07SF,85?@< M;_XVU=D"1(#..)A$Q-RG(%6\9O2>B-Y^^_A;A85^[TF)RDQ.A)E8IVYV<=97 M;JS%SYH)E):6C0TC".WOA!@D-'Y\"4(5G!H?I2'H'@-HD\4?X2'U,04XPUJX'J-`]1M1N M.JT1*LS+,,ZK]\+]%U6UEN]57BVNZQ/(^+I`&5[:3@[Y,/>O7@$Q)PM&W^F" M#G2<%TR!RBG7OX"42@O`!OLW]`A(-E[XHH>.X$"OF`%4L!,S/!2#;!AZ0:N)L&"QE]4$6+6T M:OK;;U";PDU=]''L^M-0&G;^=2CC8W+\_-?MDJG38*T&B7V);N=`@%M'7>26 ME#>UVT>G37*]+RV=)JW5WG6:2'1KZUD/#K%LI!4Q?H)RTEO`I]`GB[XA*1/0 M/9-G2&8]$MVK-%$^%%:?VTL^!%8MK0_7-WC5I-]7"\!DY2+OG98RD<>'Z/B3 M%=`Y4T]69C42^[[]YZ:)R3+UX9LJQLO9O3==1,V@U&)$/8*>+BB&5J<,;*Z: M5(\M67".68FR.VOO]:>>.HG%S78ZJ-S=!,CS#1R63+_'D2PH1UIIVEVTS\5F M3Y.Q;O"M]P9)?)W\]/JD1I?\R5.LWD7HYHYVG+^G[$R,BGR=28VO%LW^705Q M`Z4T+@Z6DBPR`^;R<5PYU>P>K%U:=U#OY6J8YXU#B!NFSB&5ME.[-E7_T;M] M[?;F?UC\IO[O69D[%CKC"`7NEX`*31;6$^RC"')TK/T54&73&C@?$"GE@+XJ MY8D@:4?KPZ]K0X`?LWI8%LB<+.`'Q/$@QTT=X*%*]:\BC;L4VU7:9'J^'9'U M*ZR.2H&%PU`DT'(D"]`A$1GLHLG#K4V3Q*`H*Q^ED/WX!Q.==4X?3%MYS82: M0\\J8;)X&[2MP>&0Z7BYJ M=E><=+.C3UHX/5M2QLF_T*;FL'L5_0ZQ6^,]3B`>]5%'.T^RV!P0)7W<-'7` M=.C28/*_TL!D>Q#5@^9J51OT[AMF&:FPZ1YU,)\E=AKXDL7G2+$3XJY]QDZ# M/FGA5!U4+>B^G#VJMX0UA?(C8#G#9]51RBTA:WJ6S.[&N]K>X3X_($Q..$ M:H?G^\"HV4W[!V='ERTJ_Y8L*IOGA+>U4^VSPF"X^@ASXA@F[/L`>(!C]X]\ MF)+;(?%CLD,"]KD(S.<$^G?QV(1SG*/FO^J!SM-$OKYK-69KG+?>G_?!JH$5`M<>ZW>#6+O3HH"VI](6 MMXE\^33/"?I#3MY\X%3@11YD"G57O%1`/:QTFLBWIM8@TIRJ-J`4QJ1`U,7T M$O'IY:BIP>E29GOQRXDN28UUV3RI*,FCW36_VT9K?KQ'1V+:]:QYIB>&,?4; M@2YS.D0F@QJB^$-7VPNZ#=DZL_0#KRU2N[6Z$976Q;,[[6[0PT?$,2.H8Z8!`+5L+@J[,1+$@0WUMFWQ&G=U;EDPN!A,J-`P) M0<,5%%SF!@8(C=C$+I9\.B9"V5=9=J49=D\-6F+C29\N<4*H<`<,FZ'!$4,1 MFM9UCSLMW\MG3.]P7C\9[`*$EM@$"(7X60'"9F@P(!2AEMNK8B7A*X3+BLH_ MXZ7BQBN\S:DYA*6_1]?"$G.#LEXM6RH/8X(Z()E4']2K--`-^D%L:U+99&QM M*JWT\"S+UDMI+,[;;\&(?Q?UUD'YG'5KFZKO\PICB^]O(QU)_/.#]$2N'0;^ M\92R)@#'H?`=%BIU[)&YS1,B/%9FEPQM]C`3A4?.:(KV4IK$/LY;\@R2#' M>DJ.'U8#`$:G=*\^/,*U;$>W4;1+,J+[><]H2J45(R!A3_QPQG!. MY&'&"HNNOQLP@9J%!'C0#L1H>$"&8C#JOAB_P31*G!TEOJ:`R7W&U63B:7K[>+2#3V8[\ACM MI6BY:%6`_&*I2PHLHIJEQ,?P\+@*]-'8T=7<;%KXA(RNIBS9H3@GB_HE"DY0 M,2#L0D4'!&.WZ/CPGCY$>SIXWX';K5Y:;T@:1GO@"!DH#1;>G\,X&![F1\%Y M>+A_;CB&C$W/'&4,D0%A/N7L9?KP/BB[F2ZL.[.?1)X(-(SF3U1^))7/&\X+ M;+]K,T`"+&SK)<3']/!0#?#-V.%9WV1:6(2,*P]@#A47$(I3A>ST83@8TM.% M8"OD$WDDT%F9#"TMAY:44T#KF*7DO960=W+#HFB*N!T>2X-P&1Y14\<=9.S,[E!Y MV[IQ21!M+@K='<,_*PKZ(!^<&Q!Q`UH)",9>K<3'^_1Q.MSM^P[A7IJF]=2A M(3@,'UCC"8;-"<]L^`R?+L8>'N$S213XUR<%)*A/?GI]4D-:_L2DXF\EPZ@@ M_\+YTQ/AS9-0"GX'2FE<'"SE62!S'!]YPS"XV?X+B8$+1@/H('.$)P)'$MF& MXV"1\;$9EG1,X-`Q,HQQU+*\_AGS_!;'E.>(Y1RAB`>W>C-2ZSY,\QTR0"XE M+W%R1IKY7NOA+\#EFZ2OYH#V/QW!0_I`XM"@G9/YM)S6`8>>YKO[;66( MFXD`][B@[$$$$5-Q*4"""Y@V"2\#F6`?C0]-6]-I[57LJ;[[_M!1VW$N(5"* M"Z,N*2\#IUZ^&A^KKN;3VF057J<)+\0\DTK+&%@,+*D,P9^E=J)]#BY"LB]? M>"]HM6;X2'GRH#K'')&BBI[XUX\KS]9,[HT4N=`GL:K:_, M&VQOB6MI;#:F-++=G:49V_`7P)W-Z,:Q\JIW6K.$_3T:V.LSCK=FXEDU`PUP M/;'=QIE^*,>$OMI'&J!;+;4COF'5X5N5FB;0VT/6(^)[!/F4P!`>!T/`X1\. M5;`DMM9K(`W.$8ST]BABS@F>1R`QVCLTEK0%IW4K62O1[;]#%SO5[6MD#WA. M^OZERR;Z>'N#EJN"/F)\@^N[A\&V@_G4_3MNOOA#V=VQ--P3^L%M;+*S@\;= M5%K90V/5-:,+7%7"8E2\Q\!AY6#2CRTCTS,#E9&M#"O#(`L3/$RAV MFX?CI"??LNTZUC;!#5^BQ/BYVM;AFI,S("A4W>(F( M``&[6KPGE4#+_V#$`$X;(M;BSC"Q\>.()Y[H9$[5AQ^8>IW'YP>KE59=".8! MAZ47I33MRP,=%%5\&PF*/O!&7LK@&=WA4PRE,91,JT(VIG5"+]/&AJF:F7!P M;9KY!Z^R#919D5:['"NRBWOS'@9PR1"MZ&B4P? MGR.ZS`^UPQK>9@\GB6Q$KLL)%&413QH^'6TQN_3D_J9)-5A.6(QH MRWGQR+;Y;:^(5A1):W$.-T"N>\;!D.>2;[&[/,=8OAS=H?S=8'IXBVJ2(;*_)P4:XYS+77L'<`=I<[NA2XR MW?]"9W2YE!>DT^SK'2V$_ZO&"E,!(%2.6B7PEQ.O+@+6M4;"8,]UI`3[K9$2 M/Z*%0X:.Y3W#PM=7L7:$\U9(7]Q95T(]NN+U!M68!URDA>0>?\994[W=G M]R)KN<6?ULNY7#DVUM=V5%=K7G$QR0OC#+@/E*)`WEM*S&M!&9:9'"H:Y-3* MG7'.R'S-&TRAHKBJ>[@Z*_-F:[3E(NBA$OL7@89+C!]'0B%%I_"I/IAXJJA< M%1JNVG:O]&F2$05D6OTS$35QWBR)SJ1QM]AQ5_I(@D-&BD/P]S-@?#P<9]PX M--QN"4YS^!B&UL550)``.+ELM5BY;+575X"P`!!"4.```$.0$``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`TJS) M)@YJ2V+Z@-BL,W2U_S4?T8#&]"$M,F:&DV\3!M2C,'TX#)4M/.^6YN/ID[`T MH"RI*)TXHAV-Z4/*Z@E?:]-Y^B#*=6T^B$WGZ8.8`EM+@$V9(4V3=#W!'O=) M6%@BR(25@5@9PBTS3]M%QGPL0R+3!U6O:$++>C4!,GT2U@94TMMB^IAV5*P- M:[UF_Z].)BU5(E+6!DBR]?2A;8E,&M1I5J4YK9J2O#[=.H;7Y($4#:E.29UD M>64R2@S5Z7-93)G#8OK<;>DPOX\VBPEN6I_$]`'1),W-Q[+M;6%UF["XV1D` MVR(TV027_IF`E<%\F^"#[;I;6&!OTW623-";9P*V!M/ZE\G4`>V(V!O4W4-J M851;*A;GZC:=XB,-J=CP("=$KC:=;:U?7TA]7K`?R`6MJBM2WMPG)6D/(!9- M3NC=45%GBRQOZNR!W)"T*;,ZL[7(36-M)XA8E1.6H&<"=@:SG#B6Y7@H"W*7 M%5E[7G3!_N>`-/E>,^?L62G:D6@%HCLV.T8Y30?4\_:8BI;#D??C\7=)==N% MSYOJ]3))UF];B=Z2O*YV?^ED?/WN_?9W)*\ M.]A4-*RSNA46:OC6NWA?D]OG3R\3;=!()M:VT5"D9V@:<(H=_^C2P5W]_):?[JJ;\KT-ZW:=B0_[A%2T7I/S'#^_93]U!S=];$T06 M__BA+AOR_$=:U$PM/N8=+:9]9-G^PR,8KI-B28Z^9S*(<[^/(-#[W:\,GP=G MF"(IABU$G%=:P;'T3'B(:GZ:*6;T0B0_T>H#6$0#@=Z[)*\XQ7;X:3\S M\5;-"ORXPC:CSSMJ8_,#BX[0!1]W-#R*&[_\`V^:]S^QF([I1YXT*HV>(T"@ M>KJ%"?`'\E-S6YT7%MCF8';.B]0C( MTM;>U'DX(F@##;0$I72XE59]#*HCC5`3)1SZZ@A1CG][?4&+94W*52OE5\8, MV&E#34>($3<-1LC3@3NH$'/86"'HZ2#5U>4&'?PZ5%,\H:Z(./0514$Y@NW, M'TF9M?I]S99G0!%DS4;8X)L%(1@(?GE#0#A_H)=^":HADA#L8\I]H`,4(P#Y M37-;D;\:MNQ\?&@7--CH*UJ/X^VRUB%)"RJ`LKU:8G_JH/I85%].\?Y%S&=P M'J&D'X&J7)5LWELM!T,@DE;PG>#+2R'BSIL'X&'FS.-@8KK3=&"U\.[>>KL+"4[Q(J`6&]WGE9".`P]#-.DZJ MK+I9ER197!9]._E>@A+=[N!)`]3=+::,#R+0,V#G=`+!CL/@3V\^!.@0#^4Z M+YC*D:IN1>D.3Q=7;$-"NF(\[=\VA_*;]"(4,DT(@EC5(Q@)>B?,DAT\&PV` M0_C?WOS\JU6(B_//MX;_HCTE+X5KJ:+5=NJDK4);1W'B:*ZB*J+\?AZYB`85 M`<&%U4T"(2K*O`^BB"!Y2AEYJDWC:P7Z6+"O\/C/;$&V-U`_)_^BY4E3U71% M2LZ*CI8;S=ZCM07=V]^V87M'Z?*.&^OQXV"TU?'C-5G3LLZ*YFMB@["+O11<\=,[9$QHAY`@'ALGBR.+/NQD*#!S`RAMR6;9\0V_B?4E6 M[$,/A@1&I93M1\("[=T?NP*?B.J+*-0WGD5?M=2D9SULE;C#%VUY,$(6GY-6 MDX^8QT+;3G+/&-6A[R0K.KCUE]4?@1K(*42#E-63`XUC$?9AHLT%@VH85'$X M>/I@AM<%I(.(("_"FG67GCDXM^_`F<-$\XX[;K!NX&V&EB4&_DMW*R');]*L MO91P1IMB*A+?N^N"8582.X MORKIOTA:5T=+AO)'.78,NO:@9J=T-6:%JW20A<=,'UD4!'W\2;_:#C@W@QL.SZ6$+?U M<-$!];&HGI2P!HDX]94)YA#!IOY)TI,\J:K+NVX)PRB,K+U,6?CVWF3N#P74 M$GG#D92BAA[U0_IMJ(9LL&*,6?25`B#M(R)]0\J,5$?U-RKUW:"\#WVPK@"]&)@@MAP_/K)7WH\HG`JNH!3;/7V/:$!2UX1:2FTHK/HT6\!I9H M9DB%4HU,QXW5K%"&([TW$ZAP:TPG3TI6<%$MO+3<=DILU%>-<*)CC:4L2X<[4Q<#'SM#5Q8LO7=G#XL_'FCE-31QO;D_>RU3T# M=;$U13;SK]%,8K`J=+6B!<:=EK3C'&BN7;`N,RR1J9,LHQH!&(X6BVQS%GZ5 M9(OSXB199W62@\!`]1F!1-$G4,#H2&H&'AR'6<^4+05"VSD"_D M6_>+/#:NT9>+DZ/Z!@DA`[&-SBUUV.AF&O@HH]X^Z%.0Q<>D+)@X\$5\N/&X MM+JD<:"K%$HVL^5)03H"E$A@OS&RAA9)TAEGDKC.$=DD6'![1DG&A[^D'`O> M.C.[":>WT9'+?A[4\QME!@LCFJ;&@HF@&1%HC:;)\@*+9\]!_.=8(+Y16LL8 MUR2J8X+W"^5F$V7;9$_`^2_S1U>/%O]JJGISMXA*=M[_3,HR*>J-@,\=1"%7 M"^3Z<=A)Y$)"JN7)T<"H-G&K;$`5`0A'>7@UC'D$.SL MZN7=UG,=(V<"A4'RDB:%D+`T?0ITM\:&S'ATV3SGT4/7!OB[(70ZJSF+VW)=W=Z05XX16=?6D%C,JZ M`4(,Y>!0.LN4S1$VU!@$C^IH#G*ZY6#SYS-:WI#R(4N-SB:E-#1B,@(:(>'7 MQC18CL7(V?&8M'GHXB`.,Q&4"B(Z\9>X88F;"-MQ%QU@AG?>`JG<97TO?P(& MVT_#*&[[180XJ;B6C=^0!8^K:`Y(MEG`^L`2=-0Q;/%!2RZP;0.F`->/X9UJ M8)S:GLCM?]MJ9)U_.^&\6$72X.A83C)$J%J?!Z^+R[L&F7'&Z#6@BHYL[AE^S:?*:@1T M*H+#N^R%6F=:V6_;XZOVF@DIJBY,UGE2N^>LSHOV<;+L@5SE25%=D[^:K,IJ MLMTE;J;PFJ1TN?D44_R2V09CXM',,)B05-+W7#CQHN8;-V\``KU<-2C8VS[@ M>K/."GIW][5D\B8IH+*ZW47[6%3W$-7"4'C3/:T.)QYZ<=VS.DHW2M8F>!E$ MY43=-8)SP^[!0D]?>,NA.B$G'GKA'9NA%X;C\<+0SSR6A\<1>;9U43=.@/4K6O MLEW>?4S*_/$I?VMK)$PU!4=55Q]45*-$O=94S8%MY`#X:B"!(/@LROR-L^6W8)GT?@;LM'%N#:;*$$_;3+GT`+3$?%%2X)5BXLLN5-2_4D3YIJ?./([R"FJ]2D0>R)PMG[$&[4T<9X^?(K M#I05BI)K/$F[R=JE(.L>=*OH8,^VY72"0[V%Z;!Y@JUDR9=$\8>] MS9&E!?#A"*&/IN.'G]:$6#V`U@?@KPX`*!L5-AFDW6"+\&B3;A^>=N@&A]89 MIDL7O%:'P)=&"0_+?%Z()3##A">@648X=CBC)FQF/"O&("BBHD#TOKS^>\7F MI:CO29VE27YX"OCP%+#YN??A*>##JZ:'5TT/KYH>7C45(.5%OFIZ>$$Q@N=@ M#^_@X80[O(-W>`?O\`Z>UHM5FWTXVZIW^6W=WV1.KJJ]\`4K8?N0PB6ZXAF_ M:`61UH6+\]!&9ZXA#/AY<.D.F-?OLWG;#;E MB+J4G>[EGMV4JZ(7MLF/\X>MD?=G-])[LFARTC]'-A(&C+3,PF1LH2PS<1'I ML8Y/ZFC2A7;3EC0#:SN/%/%'M29.Q_&CF``0%W/`T:Y]A3D&]N6^)"L";@>Q MW5!SV._F?*/H`DC4>.+F,&W0D`=77;!#C2#.\7&USNDCZ;^F`#YJJ6P_`C;0 MWNV.!/W1J+ZP&F!\9MA'E)I1X+'&>=9_I7F88UD3;S:M"J@V)G8%B\`.S;3< M2F.QOA9_@; MB,YR]00[^Y^:WI>N^*%JZZJ2!D)K`1I>]1<#`X4*8Z='I0\9ZD0]_(--;4]$L%-*CT:;E+\0=P#?L$]9[&^\1)\%O0^9;=?)G9'HC"TF MBS''UDAZXN%Q;`!Q.Y]P#:(/6[2X@ M/`3W5IW+.Y8MA&<^8V0*TYQ`A0 M+O)=?]3>8_RHOL6 M7)K6@>J)*L03CF4?2#`K4PCMUS85'Y+WLE/%#"\"6]"[#-_6!A+@5V89-'J. M+TIC>L9B-?2GP9(-T6',`_%->._OB%;7#]I>T`=M+^C#'GE!8NGG]X+&?/FG M!X+-RTNS)@L@)^_X\:G8<'=G'G=N+>\C/ZX6]?&O]/#JW"W'OQ?TMB+E0[LJ M=]AK'XXI4M:KRSX>2X8+:\W-5_8=YN/K,W@&X%%DN1Q-OBK*QH]::.]F'VT$ MAQO/.Y>SK$B89$E^7C#GI.F6C\$,`0NW(17I?A-)Q=,"/SMNA)M8DYF%%64N M.<0[8[WQ1Z`Z%N>1"^'.M[KQT>+9%K2+D'+R>U[Q/[/ZGAMZ-1Q[=3T*7&]A MWM'2.%JSQ@MQ`&>!5[06%3P$05[6388=?/&,IOY;*_]>SCZ M`67;DR6.*RNWS'-K)A15!@87@7:-0I+@%@!L"P>,7Y`[CYDE_TX[/$H?U3Z? M7_AJ!W1>M.)VE0)I^94>-Q5;'*OJA*YNV2:CSKB7L2?1ITLC6E`+/2H; M$^G44YHVX`@._$Q=0(D'>$/J>G-/4[D7G8VAI:T.AN%^::?S3Q35ID=#.MWC MKOCUOBN]ZTCEA[SFU?8=KX.BFWZ8?=#QD6#\,^3[KMZ?&&(O:%4QWZ M["H[N5%Y-?]YS0#$_V`:;'[`?3`7"&'Y)]O#-2'[EHJAOI446S(&LIQ!(-D8 MVK>>PLW'<$C]*J7Y\](4C?<:R.6J?;#6S:H[M=R.L]DNP^!612! MUR*;:Y]$B[A1;^5A<],7X.-W4J99)5090Q)]_=`FL8?*,&T:W2/?=+Q\[-A[=6]SV$MOGTN8>UR5CYL"82TC,7\'2U M%9XG>\/OCM>V3'QLC,>(3G5//S=!U@G;6M'VO_ZN@ER5=$W*^O$J9VIY5"Q: M95QCGH?'=QSM?S$=O84CI(/[O2)W37Z1WDW]/M0J;Q<>F4*1!: M)37SOHW18JKN+A9?,QP:3H$%,&ISCK]* MM530X\>OC#=PHU"C)]9B]GN&-R/MV,"@M$9/[(ST>[H/"^M\8LQ"(IT'/=U] MYHY:201<(\B+O4Z*):1^W.\C2/5^]RL#F-$K:"&28X[L79P*\--,,:,7`OJ) M5A^V(AH1P/-SDMZS);1\[&L:^*D1/4:?'NP1B$X",ESG@K6G-W;R2MHS#:.%EM&&P5)QY&V(!'^)HL\U^M MZ2O/P'PZ7<:/Z%W]+2D)DVWWS].V6A+MI#RA50V7R=#N/XX@X?M'HM/'P($V%=*\^JT M?5ZZ6'QF,L'@4K0>`4O:.@I0X62U`2@5)P&8?@L12[,>'4@STCT>'@`%_N8[ M.\"EAKL\/0COQK96Y%V*+`>Q=P!!V-`[#@_FP??PON[GY+LZ0BIJPP78OX<; M(07&KQ4A%=*)X"-?WMUE*<&%Y\"VHX\N:1N%2X*1TX9#`O.)X.;^49HVJR9/ M:K(X)>N2I)LT3/;OG'1?M5@;),?0=0>^4!0#<8'9II, M"Y$$ZR.+0'.D0ES6]Z1LS06\0]3NC_7F^?Z!@!LVV:;S8<.,Z_/6K=K@)_-\ MD57%.OGF,>]\4^-J5V.9,V]B6]+:8P'S_HB@]%V@)2BEPZ1@ M.M((M53"85BR6TY9D.8=75KM4#X@C4_>$,2+Y\2^X6"^)"LXNJ5J#HK:;^X\ M!@%\'JF>2.5#*,LX0*&D'$6F2A/FUD$JG93L[U: M)TI;F>3R[J:FZ9^`OBG;CY-#Y.W]F9?>4$`5DS<W&"L"W<[L+5SH$%"\4PA]Y9C#(:Y(2GA42 MDGH6?[!Q-B6Y8+OIS9NL;7X"^]`_'1 M"W8`3Y4E=!C[P%2O.OT-*3-2)5>L>5?QHK.$PC"]O3+;@`^T^GB"QV MVCAF3XC19!+!VC2TM&=)2HY6K=:@-M%\0%P^=;%==;$4K9*FR;B.5T'W5:<%K'"I-+9#5N'E7CB+YLA3 MKWS'DX'(7X(!0-#'"@<.,]1B'381@-Q_'QIL/ ML">X^9#T#'_S@1%Y\N8#9N(#-*-EMVD'='G75FI,[[E'5S1Z]$&BZA'C[(@VA#&RMWLXG/%0,,7V2E.5C>P2)/WH1=P'MQ[A+))8$E-2.39&PX'`4 MWF7OK99LGT2X+*^SY7V]>^'CJLQ2\O1CM?VU>B\!V"1:XN">+JU@(6EC;DRQ M.HTW!^)?Y@\#;4?S]'3#:5:UO"0O?*E;"UXF$K8.#CYZ\AF%?1#4.0C\&IP= M&TKY>Y%L;O2112L.>E$$^H$KH[!?<&`RE=G.&@GQX0#VV_PVIG/\NO>`%J=- M^P+,%2DSNKBY3TI2;4+E[9;WV32*3(\QD;Y%,B`2'+:LS(:1_3)GRB=]O(-A MY^>>)*DH^[_D;NGOHF0WF<<)FY&VV"2 MQ0D"DT40OR!C:^B(_+K`[\*VM^\5]_Y$3<9AMT$3[\+`U=R$C20"^:O0)IIT MBI1"7)ZA1W$0,A13\I'8OWFM\KQ(F4YD#Z0=&6OTDSRE!M6A[Y,J.C@NVB&> M>6H@'/C%1_DR.+IAYUO;-^4"W=(O@#YQ,"*UC"V?V\`&RXMG.K'"X"-;6F88 M6?QRHB%VD*]F['==KMN&U:=N1WI>;/:L1W9'EZH/(W\W&R9\GEG&+\0KPLX"YN1DYSKK7^J@;- MB&CJ\K/8-M(RZ086>D:IO,0ZN4%=%N)'(;#-!W%.J'D(&U4['XYJS\[\_L4X MVHH86MRQ5DN^D1T+AESZC>*XTP2U9,R4`D80(X[:19%&JR-R4L";_]%Z*X^E*\PD@L)?1P( M"GR:;U1GM\(UAW81:P-ZMR*;G0!V*_S07MHJ]/MZ[7H5DK"<*F@DZ*%:B?H>(=0*_%DEG*(352#"X"$I@ M6)VD70FKRZ:NZJ2KT;U-7'&Q-*FYS[E*0=PC5DYW"Q;Z\^W#VH40-H*:&)WP MMY:FA)^*?Y+V9CQ9'#V0,EF2:])"G_U\0HNZ3-*Z2?*VMLR/D'$)9W0BXQ/" MZ/;:.(4PP<$8KX`F(X)"+6ZG;-#EF"RSHIV_XX212XFL_DN(0_1JYE1#/-@Z MYT!X$08/.2.4QG0'=RG5^[A]F=6%R\5!R M^'->,.KD:_*=5!Q$^V<^4+O^48^XG;W#JAY]T04XL(UDG`ZNEZFGD.+&/E!/ M*=6GHQXIM?BO3#V)MC4/]2-PZPEN/%KC9(T#$A7,SE4U5XKK+TM6\9VHMI#" MY4S,I;\<*:E'D`[.1G]2DD6VJ3=]1\OV+CZ@(\KV(]P`[<.265DW!=D+([_? MNBKJ3TA-I18JDI1?7Y>P?")0J4U-(<8%4"-AFQ%T1FT""YAA"BL]2U`L4+6) MYF2E6\W3B)7S>ZUB("DC5E:G5*CU@X&IHTJ6!A2!>?BX6N?TD9#>#A5\@479 M?@1LH'T(D1%+'YKJ3Y!9Z2.#0?;1KAY-W"("ZXM2I%1XKUAL M0R3$(T!$]X8>LX\7C$7^OYLRJQ99JESQD+W&#IVJ5[AF14]@8P.#9<,#ZPTR M>6G>H@APL!(,^ZC*$`A)P[$>Q<7_R*8,&]?1FS4U5<'$_1)HIER\6V#-L@EA M;H*AD):773"NY$$@^^#P[HE:.J^08MOUB040I)E^8('#VAQ'%N$!9Y;PO11& MG@+X`)ILQN]QN)HW@A\>PDZW#_FV>E)5I*Z^$/EC?_*FW/M^HJ9N=B6HU`(- MF?`9!BBBII@(Q'F&3G/T'&8QI0A4YI+-)7-@BN4%K:J^!9"=@*D[C-0'ZA"@ M$J'ETU- M@[A%7L%D_D^2R"*0@A8\?IY;A`D1B01&*.!H"1XZ#3%P(W1*4?9%HR=FQQ"! M5=&76!]*.CSX1.MW[Q2OZ7I`V.]%25*Z+-K,#.DCV`9O$;+#<^F?1+IF M`A=IEF>=CI[5= ME^X./3"H:B]*[A2W]R9S?RB@SL@;CJ04-?3P"(WRVU`-V<2W+F0L^AH!D/;Q M:-P-*=NH#O,:'TA99\SSO"JWV]YNB/)*V'H]!R^F(WNZ36T&/@R=(K(0*CRS MY[?&]9CX`(UD+0"?&\3VZ0-%W<XW576W^B)\58?WUFPV\=T#G7#KRVXX9Y? M@X\/#$DL)?AN)[8/8MOO[05/*]M^K0<[V&>,P6H&&VP!(^X$9=N.VSD#R_R MTCJ@($I,\#5T)/1\F(LS6JY(>7*?D?91C;2ILP=R>7>7I43\;?4Z]8T%HE-( MW]Y(4`TL:-+GL?'F1YMQ6`D\/E&VT!6M-_2Q8#(^@GJOT:,/#%6/X%"A):(N M))#$!7CXV04@/B?_HN5)PT:T@BP$T*S_Z87-@OO>:F%T/S)$D7_0]LV']U8_ M[;QYQJNV\B3SGWM_TSN!@2@@\Y"%%(+P1(4[VND3,CEKWH1U!*^3GC;D*^W) MQG9O)PW;KA724BS*#N."+$"'\!&'%GH5(4J+((*KE?Q6X"@>B"%R.I*(:5HSP%*VCX&..&$M0`F%2-!=1T8 M2WYNR'\S>F/2\HVCFY0429E1S&TC45O93:-A6X_WWS?#^+VHUB3-[C*R@.M' MJ]IS]]BE[?WE)`F_$]47$DY*ZG,97D-748_@1M[V*/2?25M0NKXLK]NW;0$= M4;87)[&)VH0F2^4`>$6C/X3YK7/=9 MYTMTU5I1(KK.>GEW1\JO](@->W%4+':/G'Y.+8/^6&,=KZETP M')C"GE)@/V=E.H7T!=?JPKNW\B3"Q[^:K'YLGYBA1?NH#,:)@?K('!EQGYC` MA)#:"JA`/J+KS/,[`X?:%@@O+:K:%NY`<[@HM:\7I7YRA:'#/8G]N2<17B+1 M:+T%0QM@V_%#Z^*V_@(02HD3(H(\.S2I=X8$C[J(`,];^\U05X'V(D3%+Q[;RMWM=']RB<&-\ MR'-MNEK1 M0KT5DK8;KSQ\NT`W02J)S'9`.E3]!>=!*-N=+3.XVQK#LTHT M%?L77;<#2?+G2/^OH8%]ETAU568I>?KQ2;+W.A#'TL(`6TTK)CAKSHQ%$*,Y MJZ#[LT_HGB59V;Z/28X6_VJJNETUGF610!359P1%19]`(:91].'QO?H0P/0*$0S:TAK`0H.'"B"_605(-][S MJFK(XI3Y:\7RBI097=S<)R7SW+KX1YLQ8HSK(I[%`-40`6I\M M`X!:'(,*P._?^72*3IE<#TE;1&^G@O);Z6#;<3T6<=O`\*8CF9G3`U-68N/] M$S;\W#1/$U*E2;JN`KAP?K@2"('CB+;%'!5%\+*HOIUA+Q'P&T7LE?3\/>[:N%_E,RB54 M3!5H-JS&+FCF^(*LB;3+;K,BLT/I$AE<0^-GN`% M:DG/0`_W]*4VVXSI\(G@=06$.%TVESG6!MWU`;?M'B_J1/+/!KTALP@>8I`N M\YLDC$URQN_K-J%LEXXA"PN84^+N3QE0"A2@TV?%,,-X`E\>MN_>A7<@(96P M?1Z[VN4,F0!62@"+4P&!V."IF@/+J)2S$X$QO-C854E30A95^^I%JUL)6PLN MRYND#1H+4U[U.W)+M[ICH*#3EMETN4:S$8$LO+>MA0*AB'H]EH(P,H*GB M*,9Z#H;TV%?Y18"3%^R1KXP'=.8"'_?R_G'@Q[V;%?"<#8MM!^K-?N"R[,P1 M$_3X49'OJ-M=6%(%TSW0"5*>?NIVUYH@O^F3VM^>JTBC/2U`(1+U./AJ-1K\ M8TC-.V0J'S*5]SU3^5#JR<`6B_.41BJGS4X9)AI/4349V$J2'R3EXWB."1BI:XQH43I8OJJ%A\ MH059K7/Z2,@-*1^RE%1=W;8D;6?H_V_8?H\9Z7YIVXV2R%8[ZPS&RZ1%!N%: MP=FFT?PXVOZ(?%S_.BZSQ9)\H36IGM3X:"FSFSI=^D%999<`;:B!K(;!6BP3 M'U>[QB9>@0U$\SXNP.:A8@(OHR$>,`PBN+&E61G^8Y+>#]O*-@"VZ$Y[)4!$ M-]P%U/:DF>\TK`V$4X'?8!7PDWMY2]=)1:MDG7A,PF3;NY1]D+*['76=5>J2 M-,H._`9;VL%G?&$X*"@9$VZL$M=A0B;BVU!-L<1YTU(^H\@!1#_^Q,RKDJY) M63^RY9@MQ<6BC=*M5R)[RR?V(SORN?S*C@'4G9,.$U>$#M==6I%.U=V%)FI\ M86%Y+*TI$.JH>@3BPEE(SO%K+V>>E)G4B!ZJQ2"(?&G>,*M.]!`]E,N@U^Q, MS*<#ET:M'$V`&[Q`1IJIR4E[3(KT?I644%UR;#>U2HVZ!301NX'I*9>DFW(B MQMV"4#/Q-X5T#18?JW`#OJ#6R?A%H'J?DW_1\J2I:KHB904HF[SA"%6BAM[$ M^Y*LF$E=Z?1$[LK M"\+;DSOT*J]/HR=V1OQZ@3J?F$Z9![T=F=@[U.$:@6)>)\424C_N]Q&D>K_[ ME0%,&Q&T$,DQQT$63@7X:::8T0L!_42K#UL1C0C@N5OQ..\0OGR&ZS7VW%6] M'%?@0&Q#J:G,.'==X2WESGMV%=\MAIB,K/+8<'5KI`6SRF94QU&8XM0H/ M=-:.=:0PL#\D2P)#P`N MM-+&Y<+:3!X7<8D`34=I2INBKJY)2K*'=D,*&@Y5\Q&*Y,T](TCFG5)M49&> M\Y!?'TE*/K.B2/?XZ.LW:G!\Q/5"'1_U>D5W?"23V/;Q$<\G`J,C];=^K\A= MDU]D=_)7RM`]L8YROV<@QTK@^J8_!1;N7^@PC0"`GY/OZD,F41LN&_5[N(=, MP/BU#IF$=$P_)`MN.;RB*VX;OJ6.$G.RFPTQ\%,"1^X2LFTF2EZ`?SD_O]XO/4Y=* M;=U7%W`*"CAGM`'*V&MT0\&FWRTZU$AEM@T:`2/=:DI^RH?4*YK0LEX5'E]P MJY.ZRX/K/Z0'/6BC:L\5>I6V]UV[J!L*?$8N;2BN+C1HZ+[JL?+3\"6#Y**) M74L9"T$1(!'I")(K#T^U39H@Y4ENY$^U>:YZCU'2^%]JDSAE-Z3,2'64RMYN ME?ME>CW[KAFVI[\7=R5NF9'(RB=V1RZ9)I,(S/]Q4V4%J9A,3".JG<<'EH+" M=!E9,;A+2,(/#4,UM@Q/M?UZ%<7QTS2!N'I"C8B[56,46AD_77# M\H@B,!"'1PU?T*.&MJOJ"=2E.G[L_2]<=3T],M(J>U@R?L]1-(6=ZXTSS?%8 M?O\L.$Q/B*'(;Q8XBZ*`KP!/"Z,@WXVR'4@)[PSNI;^/Y_M1]Y?R0!X<+*B_ MT1/C>`&^LR!D@.D<:M1`6W##P($&'Q\8FKJ[V\3"WQ+-. MH=&6>*811;#2']ZC#N@]ZD"SX�%-K?W:$8^DI@V3M:Q\7D9MB?O_*I[!NKY:HILYO:BFF#D]E>N1_G55&\;:CPK(>.E?+8POM3%FWNF MP5])N3HEM[4B3Q%LR[U"+6P;CIR@MBA:JV3UE\X+?B&J*Z!X>RSB,7P(&Z;M M(PWP^47EK<**R^JBVHK?L1ZW];)9`:T1_X0U*!_>-(XV+$KZ$9C%C0P7-(%W M*+)FXTPSKIGC=X$5&DG1$N$L`K_YD)*-``NM5.=%Q?QQS".?BM8C9$A;!R+M M69*2HU5;2`4E+M\D\7QXRY$L&VH%;37 MIXIQ&G2H!JOG=N?+U"#8&D4$9]KM;#SG<3REY#U/T+-PFS/8;5*?K+;P9'J" M[90AO6!!;FN.IFS=I_'7+3D3BCW_^)TMJEE%KLHL)4\_/BFNM&#V%%H8VZVF M%2R8;A#0='!<2Z=F?3LL]=5R/OE.BZA'NWDU+5N,=')*+#WC@_*3N-)C]T/[5W)\5 M4='W;8=48O9S@?F8T><5,L0.&6*:&6(N"@Q9WV4BSK"-=ID@71\UX`[)=7N97&E7)4T)651G;.Y[M(^\! M[!&<(=*7T]03P'"8-2/\<"=TG^^$(C/`'2+EFJR3QU8^9F0W^[:-*!*LJ)J/ MT")O'BQ>D!*:(D9)'I$&[QLS5T\2=%57N\*L14I.:"6]X8KI,EZBP"[!XD=# M4N-%"L."P]&OP>%H*&ION7V^=MAMOJ%;I%K]P9-@L'^P<#.=`SLW>##\."#^ M%AP0MPIU>7>6%4R3LF)Y5"QT;1NVM]C,J7L'"T$S^2<:/S0W/I'A77#X.U25 M"`''>UY5XKV#;.G-R6QW#KMYO4EYEBYORY^8B]H&AR8=V2:^=' MWY)R<9K4T(U`89N1HS%JX\TY>QH'F%PJ:263R=M-/_',4ZP@0MT;T.QKG(R6 MCXM.$S:6 M$[I:,VU)-M^&+:'+SHX?/SXWV6XTN[G@5BSNWJ\MPMP5X>F$XYONX0NP1TU] M3\OLW]RCP;/SL?4QY'Q<7T:R!E/J;OHE%Y^FBC*\"S.7"#%8Q:=GWI334,GF M`;J:99T^=TO'&GV_+P+;FAZ1-Z?_//#$T0C]P-BNF!GY_M+K9(Z\?^@2F:[[ MC[LR-GT#X"!"]9F42U+"SK^L3=_QY]N$Y?0K9-!R^*6T(BC5;;RF;ZO9?NH" M:^?;Q--/):VL>_]J3K8\4(C3B_9!T9\@9"\4(827BV_2>/!,()C)T73QZ:T/ MG?_@_-T*G8AV3!9\MRL[6BRZSY;DKB():HZV8PH0QQ=MV;4_2<@67D.89\5O M*O8ONMZT[U^QBE>CMU(_)%G>6KLS6G:+WLR!01F[F>*#/+N#(J,_1@Q:K))$ MI<+O?>KP59X47Y(5=+PK:C).>QPTV;NX&S`#[L)NPD$HL<5E.WO`%AAN$S>2 MX,O;0;MP\@4(P1^S]RF*/K,TQB;YT#.4URE2!L;LH;V*6;!&/\DC;:@.@J(Y ML@YN5TC)E%,#XC.\^&]*;@TG.Y&Q:%HNIZ.XV+IMK7\O;>4M-.L M:@,-34E>,TE)69+%-7D@14.J4U(SWZ?REJ,V&D]O=>5<6.[.$;HG=]L(T=/C M72S9Z(X?V^*0<.U-C;[H61GT=9.DBO^T=)KTDA16)?]A.JL.7\1A:^#10+F\ MBN[Y7'J`.,]\*P]NO^AR[0DOR><++:JM4;LAY0.S M:S?->DW+^JA8?&:RL'UK>R4"K#FY.-8P2]-E96V;/)8(T#Z:$YR5 MQ9G3<""GL]F>?UL=$SQN+%K"2;0D+OM>VD`;$V75N;=D_<*KQ#V:$+BH(=P8 MMH7>BAK:,(E:!0ZG6$9EL^JH-) M/[*&H.GTGM33'XPR45;5'!35;^HL\'VD:X9>NCS/0;YF@(FUP2K#37-;D;\: M-OZ/#^HT.$7K<UCHD:>'GOE7MU1)[?.Q;\;&HOIQ")9'P&9PK*.G[*.?X M_-+H90$4=`&:B5]Z[37S65H8N%RB%@EA#@672R"ZH>>#H9ZX1'C'B)GCLKM` MLGLQ<4I?RF3:`*+\I+WY);P0K(4MBS37S>VF!88F_)HU[,/#S#6?%TI9)Q[NP!F;#B[..3,X^Z&AY^A#IPE M*3E:T08X(H2;@^:FWSRXUS@T);03@1:0CP`SH^=NP>Q`L.WXP2AQ6[=04?@0 M5$\TE!O#9^C!I&>%B'(7_?4;Q>RBN6;B772O6?"[:)E(4W?1/%V_7[ABV_JC M8H'\T++6XN_-MP[^LRL$G/KUI>1Y$+P);V\[%'3WRO5U4I.;FOUG<47*M@9) MLL0=76,(@#X&3"`2KT-C%NSX(2B&LZ;MJI<=U@X5OA4TE"P]_8;!6R&Y6).7 M'P'E"%*T^V^B7];WI-S^NU+D\5U#`Y9QE(;V3X]1AQR?@O.WHV.!,Z2K/PCR1OR7#M59N`T>L(' M,N*>P0'-7&Y3FZ7#B4]9>A<'KXU"C<>(4K6.%@0H:0SQ8V".`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`?X)JLMR<@EW?,/2K2;)WDY\47 M9EB_?B/Y`^G.2:#:I-9Y&'T*-`_WA\M684K=3+[T+-N&,.,Z0/:%B,`^2B2% M*S1@^HP3`^$^X=Z&TQ'6^"XE[8A,O3-6F%6[3W(,ZR*DWR_R2)S+#;(@NX3F9D]]-;LC#%7ARD2>,VU:Z` M8L4S;?I,@UG6A^.CEE`WW'N:+\Y7ZY(^=+&TMD*`O'X'KD<_25'5(SPG5%]0 ML](>2!:1K8QR95!8L/.B-5E?O]%)\09=)D8!!SR3_5Q#K4]_8"$';2DBJ,-C M4_*V$I$#+>VSF5%/-VP.FHK\!%'JZD".",K3X&2?I(.3-.OEZ4O86B#'=GC) M@7T1JK.&"4^V]W)V%W)V%VXW,]7F1TJN3]DD"<3.]4GNCW98G%IG.F-ES)PF MA??X;[^:GT0S1$V`JHG[A%Q`=&=(%(XA@K)-_7'#=26`E@#./%64<`4WC?H3 M9/4<7)3\(U3=+\D&OM0]I# MKO7TXZG]SK4^O*!^>$']\(*ZP-E[807V\>6;+)375U=S,BZN'QZH^D[A\>.N MR+M&7KZ\$Q!O%G4*8@J4APP&.?/&-,T3O<+*B0<@8I:[-3VSG1^283K6#/GI M0244Q_3T=EP^V^$)Z3G#.F:J*,U9[2Q<`U.2M*2%=V0W%0U5&Q MV`ZH`I5%V5XLKJB]50$X]`-10O;(VK5:->^E*V#DE: M4$>4[=42>],1U;>"'W##JXF$C^(9MP@UA91M&CR8;B=L,\;(L(W;_0%F0:?!>!9]")Z8;`0@NVKU#>4*+E.%X\WCU=5;]"8("U6<J&C9M)" MRR[/;;"O1'&9%5"28DLWI,AHN1F?O,"2O%6_J)*HE=M/K[;<%"L1=O$8E4\" MZ$9@+X3V$+KYHNZ`V<$*[\&X7"OKI.ZND8Q>=ZD@WQ+39[R6PGU\9%8B/B`U M$QJ_X/+OZ*+8A)VRJC>QV`#8A$E5L^`G],V/R&.&$.<4$1N9,)T@=<%,_HR= M2M_FGHO"8TP^'[I'F/V+29<\)0Z-D%/[V%+"G"_!891>I[Z[@^@4P&Z)_S+4 M4&B\LESTSU8T>0E4YY=(-.?C=V;&LHITCWH]_5AM?ZUD!_"3:&'T3$TK5)S: MG")#^-H9@@#5OP8(ZTV@XQ@1-#I&!(V.(PH:B>69'C0:TXT@)?ZDJ6JZT@T; M(7N-[96J5\"A(SV)S8-'6#Y>RJG/M=%$G=Q,V6(J&/@H?"Y98M;9YI-K.:_B M;DKW==PM`,NMZ<""@EMW827<(LB\/R\>"+,KXJ`OW&ADP\>-`C;9H#SF%EI" M=E84F-F037:_@149=M2P([N.,5L2H?`SVI(1OPB2T$>!6C!+`6P[LBV2MNZS M$U`1::HGI/B(">+4-SHP!W[#^2XXT%PQ6J0LR>*FIBF\NX":$=;5O+-Y5B MR7G&*82DR2FG.`C-D70:'G:LY6%*L>,\$Q/"CHU43!Q\9DK&#`]!NY,!I@>; MHX'+IJ[JI&AK%TM`A.DR0A'<)=0=F('`$\]R4)QX6(5W7C-YVR4U2$XW7J`Q MLK+S0IJCF?9>/P;H7M/5BA;JC9>TW=B1YML%NN52262VWY)3-4;#/(7`+1V^ MH\N"3SQA5Q0)%R15Z50)]W0QMZ))DSWXNYY[EF3E'TG>D*.J(MTR>)$EMUG> M5L_$K2^R)C'EK%H6AD M2URQ'9FF^=EZL^(SB09E?+M@Z>8#.GQ]P1GRJ9 M1/=&Q<:/>7IGKJH:-B]EEXC)1#U^5%RHU>TNW%1@N@C]7 M^]-S6S+M60$\K_[E0'[N-D;AVPW4F,J@7#K4N"/0BNUSOZ#%$[89X7O4QBV(11:)XL8O-WN; MYOWO+Z83P4?>QJ_`CRQL(S[,\1E-U?"8^',"JFIG@",<2/-RDP#O9I:+= M;NENS:7IY_+RM<<<@45PM*=4G.7YVU5"QWLNMI6XPS\_&\OPKG]I;?6M^4!%HYLU] M4F[J*TC4DF\PSJWM-=C_544Z'=[7#<'((K@G"\4AVZ<"#"+8_6X:D>M-M_U' ML.;4><KP1W..$9/F#YFPZV!0^&I[O*OCA4HSZ M4DQT6><5"G\[C,%DORA=9D M5TA`_G*.JFU_LR5O&T#I!LD[.DCY3`HIX^A'<(0@E%-=``3;#6-7HBH$HBGX M'!XVJB"(`U-S568/24VN\B3MO'6UP<'UZ)L=58\`X"(Q/EJR&IL@))<(SM(/ MKU;XMV-1OUIQ*&`<'MI>>@'C%_&PIZ/&?FP!L^1@NK)53]:MO\I%F,7OON[3O!F$DEQC,>09``X5(:";,R6A8C1 MM&%@:LW-L-_?FEW,1A]L.MSA2YJ&"R:<=!/V]#!Y?N?C\N,+D*J!!W1O(400 MO2-`C>X<3`<2GN,SMIJ*_8MV.3I)WM\<^ M*BFJ9`.NLKV^TL[K\>-SDZODL3/DWY)RP?E'HILB5@B+;IA,).SO@DUZ3Q9- M3B[OE&)4,CF@9"#K],>3;X^^BU0CBR"D\T^RN$SV9!$&UX*L#SW^A*AG*3]1 MNJ@VR:!DM<[I(R&[AS2^LGFIDG1K_Y&6SY">U.!ITPO*SN%&KVO=#*@B;)H6 M5;>6S!14"@-F/H\*LZ4Y7I6U,AEG_#;J^E"`DF\1;J43C(9<&]GCVQ@[2QH4!;$VL ME05V.&:N5,#TL49@IJ[RI/B2K*"%5-1D_/3@H(EW8>"'%86-)`)YNZP@G'2* ME$+\5&*/XN")1#&E"+![3?*D;C?B9?W84T:V2^__`KF(V@3&OI<&@2"F"=0, M>4-`;&\:8O#QJ(:L8@<5S7/@PB9#L64@)G__)6 M@S1602O''UB^$E.L*$K'8)RT*B?HXX/N2D:GS`QE#VVR0,$:_23_MJ@._<^L MZ.#VBTL,*S40#MQ5C3XZCJZ/[W]&RQ4I/VYC&8!.@PT'-7K$#=U^9TL1&ZHA MO)48U'`+?`)\6CYJTY)E999=QS&NG=_LK21TF,V<7N%91:V052O]W// M_XRW0N<=/J^M;WZQ68_F\(8R>FOF]@WE\&J9&SNSBA*NL]&WM?'R71`VL'V6 M26W90+95^#*U@:K?M(7FO$C+;GZ2O#]Q)[0"HR.S,[7O)(%,7[:SA/\>03M- M&#%,M7H/]J[`S6%WNU/A(*(RM9JK5?>?/TC5W2?I5AC9&PISL+!5FD[(8F]< MGGDFW9778WOTIO7Y]\!$0C=GW=E(\2AF?3;!\C6#S7(MGA*VK#\PX)$-!JNO M5+!)KLL9N>4M^SZP[R\]\'>^OA,#@RQ6[%F?6<^ M<%.P6:W.:+G]4]M.YE'Y&80KXR`9Q,%*3/QP,9L+6#[.;OP2G-TPGN>MC=R] M/E*=;^-YW;2=%W69,:L;>W+M%CO@V7P\)%"WL>92,59@5^# MLP+;G2E0XTC08J13@Q:^)0'SMH5MQ-)XRZD6S3?%B2#4GQZ]OB*(Z?!7)]\% M!UF)"G=;>:;&Z3VY+.#['`84<,N(F(+;U4#\8=6&'2$]A"_^,%-[95<>J'*R5H.W0?56F+><_QKB8_'4'R_D9;U-"&O>CQ!RPB5&"EYMPXM138W9?2K; MUT!W`;M_DO8Y4;(X>B!ELB3=CZ?,ZITE63EGT-IP%);CU]JCV!L[X.W311#5 M-A603R<,U'I,-I^[N7F:`S"W<$9VLRS^(G9[H_CS?XQHG`!`$C[I+5!5-IG2 M-A>ZG\8^Y2[&_*QM+?E:K/=&W=U^I)`7=Q.I^,25/3(#PSW045/?T[+-Y;&M M\RH^MA1JCG:=C0ACC%KIOM/$H/SB1!&J=/OH];IK=P/ M29:WR55GM.R"X3/O%V7L9MHV\NP.JHS^&#'HL4H2I1+_:'\S:1+*WLCQSZR^ MOR?YXBL]H5?8"@;]^^O6D%OF4]L[1ZD]+5VPY!G897M^DZ M22I:T63Q0W1+/0=46XLZKP&6EN\>87^>E>W<^?&L6\_-'TV^/?H6#7*2YTY= MI)DFV85/9'WHB$<#Z[)+?=G^D18U,YH?\X[)/WZHR++]1P!O"@)W.8'"9.(F MWH71>"!1(9"W"YUZKR-B=&GJVXB!9F:;6(=M\/$Y5'&:5:U03;OCN:WJ,DFM M;]=U>%I.WU3PC#;)[K*IJSHI%EFQ'&4?7I,6R^SO)\S@ME(V2=[6H/QQIOR[ M"2.QG)IG-))(MH=:*F0QH6_ZU[7KW&#FP68:X!3Y7\`R(I^>W>:\>Q/HFN;Y M'2W;CC.M+>8#L;S@F`QDWS^_WV_N]T/'ML),4"2+%TC,/NTL2XW^A-B\:*([ M$2]KS6DG_>2JNJM[4$]5`GW&><%*P*1AP5+3/-I*4_?,K;?^T#=.TFH$\0)BW M4(;-`/DB&7=FA!/Z*G(4#/FBO&I&5J.V4$,7\#2XN)3^5\[YI62KXF]SW;` M\R%`.-'^0UA_5IOR(N/W5@/U2#,4+`A=^:AF]VWB\E]U98QE39L2@^9>=O9Q M\&,T"-MG/YJ#B,1^A'7\,^5#[^,)D-E\Q&"7M.NGRFR+,:&Q?3`@%*V.JTYH MIDZJKP,8\W''H#-3K0F;L3N2U:U?[G,U-QR&[?5<>QC1:KO/%7W:Q]['-=UT M1OBGJ.*S4/I3,]/9+L#)\JFMD%.TIF3FU`[U9XDTM0,2S%2Q@X7-K#$IG?IB M$82?<.+L@^U7[W776=EU\AQK,AJ&_6B3YC`BL0UA>:?3/O8^>J>F,\)9J+_% M9Z'TIV8F[Q3@9-D[%7**UI3,[)VJ/TNDWBDDF*EB!PL;H7?JH>I)L&_Z:4KS M`BR_)#?65>$K7?9N\LX/9;+F_H"1KB;:TO*O:[]`"^*AM*J=03FW-H=]L'O[ MM.>[8C?S\P+LG#PWTX5!T^1N?2^-Y'XP4:X^[1[:(MV)X(S.K_ML=&;=ATGY MS&=(#CNK:9\DTBV47*P7H,Z]L_*-R^7B6-#%F.;++#$94[0FQ:,78A,&>^B; MV)D>WL2]>_?NY5DY7Y;,E[6*V"*YRXI#?;)(G1Z\F`86PN\CX'S&TW!F%Y=:"%2(XY"JCC*C3STTPQHQ=J\Q.MO@**:$10 MA]O>2?[AD?HYI_LLR[J@.5T^SO6TL#YG6Q],AW,D M[HLP_\7?)PHY1]M`J`CL[6.7+ZB;YGWH MB.E$\)&M8GYW['F:/60+Y@M?)[7U0)LNWSDMO)AO)/;=P&C-M0`@OI]=\X^7 M?;;U`90Y!L-A^[VBL8&P_A[2R!#8H[]WST7)-OKNWHKB1Q"!2FC%'J1/1#F( M/@R>8S(+/N`>AC(//X17_O5S\EWM#HO:C-WA89NPW&%@_%KNL)!.!!_9ZA)_ MG55_GI6DO1A!2E+5KMQAB.^<[K"8[\$=GN'[[9T[#,KLI6)\DN=.(VHS^;LN MXF;6AXZHLE67W9,"VS]2!IOO]<>\8_*/'RJR;/_A>R&Y5<_PK<99:T&B& MMDH^(QB^G#7#Q1<+9K&85]A]*,UG$D'Z@^:,3)[5CZ[CK6+.+B*N8\XOQV`X M_8;!6`Y'4L]:/ZG+]&D-P[N?/[SKS,*T^_>0?,\Y4@*;X)KM%DSNV.ZU-?#T M]7R:`N82CU1!`[0O:'/L'@ M!;N\PN$V.\;.:5::X4CWZP?0S MO.0&2ZN/,H1MF<4\WI#G,+5W59P0;?;N_RB"QDSY0DY+F"2Z9J1X!E[SJ&,H MT>!@]')*4->[@F)CLTQ37^0)S_:N@;^#GM$`W)_W/`T@DIUH\,<^XB_Z0DY_ MQL(+#,W[D/?+\TW,)HO3HZ$9#L"#H=D-X&!HYORB+\70C(07&)H?]]S0B`(A M#OT9!'O7"=('7\;!U]P[`X,176!>/KQ$\^+.BT&P=VY>#A[,_%_S99@7M??R M4]#%M=C_)_Z*:YT7;%3DIF8SV4[]1M;4S*/TG-_MUN MO(H*OH2-[39>JI7=W"ZQN.](C>76P=B&Z6`YPC*+`6@?AV<8DJ4VS[>S<7EW M35*Z++)_LY6VJTAY0JNZXO*11KB/LJVT&2A5B&+=PDDZW7>32' MV,YN#<)<^*$39TUH2"P/MF]Z-`<9@P%ZOF%K9]YPA7=FX"4MPF.5E]^"/'-, MF]I/U"_78W&<"/]24*+/O`8";P(@/6=K[1H ME)>]+U3$VN;F%U=K:M[M;X`'<]>D(FR(]VR/=4H>2$[7K4"8';!&SW%Q,DS/ MP/?!^M)/VPKK\(L!=Y](0J,EI?U/2F502"; MI%&V6Y=T`'O@"8+@-KZV&$AWN],9N-@66<6B<"]D>:+%)2HM2"'>]5@;/:*V M;9P[G/[W=^%=N)Q@78X?O[+102]YV:1MS\WHTXYQWMO1@XIO ME;:]>>_3]O#>F54P*C?ZTV;;MHOQ+($Z9&`Z\@B,W4Z>)LDO;_-LV=GLLZQ* MD_P_V4Q\3NJFS&K5PV&&5$:*I$TEK%D[;U4TI+L!_(74'[^G M>=,^!ON)/I"R:&U7UTP8)9Q(95!GT(!*H)%#.[-B%D.>:/B8YT[ME M2;I):.M#B.&IT6/LFT$]'+\`8M6UH":S8MN'>A[7P(="C,<4GJY32JQ%FNQX MQ](]H"+C9*H8EEQDP?!?,A"L)139_+QF641O_A;<\K+G.2".[C\$D0(2'+:" M#U7)'[D+.5@%/8\7=*P*^2A?9-$JFWHGV;E>9&F;"K'=X\CWIE"[_NY3W"[D M_25"L@D[2)"ZCP^^W1PP.+*!UBU87JC[ MF)0%L^U/XG&X'-]_MTQ^?$/>&OD`\LTG"H/+.;?)1)IW;H>)B]QSZ_@4YI_/ M,.E"JVU+&G$>NE4IXL]%GS@=QX]B`D`ZK0..=NTKS#&P+_ M^OM:<*'+)X&MN+@3_.#7W/!.Y"9.V=&*-H7LVHE5VG8=_1WM$-9].YOW.2;; MV9[=[N`C4+M_)FUDN@;=6V&;D1J,VH0`9]B-A82:[+J*B>O"P5,U]D5%JS+S M5[SE9A.@NB9K6K9EB<^+]I0DV>AQ#)0, MQ3^"L%L_.>\+D045)*W&5GCC^U2V:9$EOR$B[^.FVV>RR-(D M/R6*S0#4KK\/$+<+:0N`D$3#^P>IQ1-R77J,N&Z]L*H]W_C(Q"B+)#]IJIJN M2-DNIA>T6%YD#V1Q5%5$_4[:5'+<5713<@%$:S4'CRU_;4X4*'EM0M1-F>N) M>)*4MIX\B9(+(&:CE96PGC#*/0H&?R)T62;K^];48P+!LO:R(##?WK?[WQ\1 M9BL@;R_>%(C:>PP22S\8OSM02@KO$\:%@MQ9?4Q8:)+1UPP/63;[X86)]NC8PJK'KW^48<6%QQYO.`@Q==?+ M^^"61YD43?N!)FG3`#T##=GT?0,4<6<&I"+IFR5]>)NVJ:CE8VL_/NS^1XN- M#SW3L?WS?_U^,\("_\-V=OH_!/B=I>/6_ZH"4MPW_/7=N_">?_S8E'0-O_(H M:C*^HS9H$N"G1LAB[N8+B8H^O\*5E,63MW]O_W.;5(3]Y?\"4$L#!!0````( M`.1V#$=H%WHW7C0!`!R)%0`5`!P`96MS;RTR,#$U,#8S,%]L86(N>&UL550) M``.+ELM5BY;+575X"P`!!"4.```$.0$``.S]>W/;2+8GBOY_(^YWR-OGG)FJ M"+FK+/?LF>X]PQ.R;/=HCLO2M575=X=CH@,BDQ*Z2(`-@++5G_YF)A[$(Q\K M$RN!)*6(O;LL(M>#Q.^WULKW?_^_OV\WY)%F>9PF_^,/K__X\Q\(39;I*D[N M_\ON/`F3G[_"_^? MNRBGA'F1Y.+/__&'AZ+8_>6GG[Y]^_;'[W?9YH]I=O_3^<\_O_FI;OV'JCE_ M&FO:QPEW>WEH/]#_[8UH_?K/?_[S3^)ITS2/90V9VM<__?]^^?AE^4"WT:N6 M@3S^2RX^_)@NHT+\F,;O090M^%^OZF:O^$>O7I^_>O/ZC]_SU1_8KT=(^?ME MZ89^IFO"__OKYRNES3__Q%O\E-![_K8^1G=TPWP6*HJG'7NG>;S=;6C]V4-& MUW)=FRSKJ.*^_9G[]OK?N&__1]?"3RU7-_RCC^Q?';OT>T&3%5W5EKENS2\G M3(OW)#0WNM-E1^N&OX,TZWX=^GN>,G=?_Y>?_^W-S\)9_LG?+QCX&61_29/B M8?-T&>4/;_=94HL*KTM90\LB+KCKVI8_=;WFNCM^9S1/]]F2]JR+__P=X`/D MUUNER_V6,IIRD/:&#%?L#33G-J`I M6%E!/SHAY]P9.><'Y&PKY"2T('N6;M,U6;)F)X*?LHHTBZ,-BP31BG=UF+WU6GQ+%A$V M:2[^&Y$\OD^8^\N(::N_0`"QPH(+J2-091'$+-V+)J&P#[6P`9H;S3Q>\-2M M2*<9X>T(:TB^EDW_]VEC4E\7>4`E3KT$L(->.P%MC@?G>0N75-3>:>:;*BS4\BGPW'I..E9<[*CU77@<[TU5>79OCP=FNO)X1 M$MTJKQ%(1*V\WNYSEBGS_&+YSWV_:OXNDJ8>"B>9%?Y?F>KJXS_M_H M;D,_[;D7U^LO#Q%[SOQDR;(XS(JU"S1TY>TZ#E'Y>&*C?U/$JA#3-T.4P#.U M*!_PFBL7C_B_J-#%"LM*&5G6[J&L3!!V`=Q981S+.(N9741&<),'CX[ M4K^8E`4X-".].'B:[$:M.G&]FHK9O(:ME9&6-E*J(XT^4BHDUQFI59(J*%RO M2:F5-&I?^.R"PJ-D-$XICN<.>L6.Z]IDQ&;U?\7*0UJ.$W)7DSTZ6'AAJPN^ MCI.MJ-V5+T6Z_+VT_&Z?QY'I^,B&6O6/\<$/T7A%+T3K MBKT4)J5T7:FWY$:7LC3!TIP],$INEV-HY?88QSQQ")6/M_TTM(RW6Y9 MS[C,655.X@-=857285!'6R7/2YUY*N!/])MHEH\J?@=:G.K>EI8)@\C`]SFJ MW;836)'CH%-3XR;T&XLC5=1X1M7M$+&.`48%?;?(TFAS#2HS(K9K'IT_ M#J4KDRT;Y\^;%$BU*AXM)JY0#W;G*TZ[/N"SX[R=7SKYY,0J4P_TP*E'$>F! M6H5VQX)E%::\1;MZ[+<83UZY3<2J;V#`P+E>^\7[[@(&?E0!'WJ/:W:7&Q"VQ8/?FSXIW3!L4&VO]PX`'CB;L6`&!L)3;$-XX`X MOAI-E&:MST2[TT6@8?L%+@:1MEZ8K.!OO(!8'`O%\V&@-:TZSC*Z$!KBTK!JL,N-L5NHR=R1PG]OGQ@7HB%D0R-=<>^ MK&E8,U[+\`Y^]I]SDN[X5P^AC+%$8#H"&M+!,I"&_@!98-C'G3Z!FT3!O9@F MJ?#=:DJ:ME4!%-".OPDP:Y@!\8=:I)D.F"W\V0VX71SPGA_`^]P0JI^$\(A0 M'[53\2V]="Z?X,*2"@HBC$9(N*?X=13(-HR5`%6`:NK5^>G64Q:0E)+?&M(R M]IN5R`-`8)3P45X!K6+1H5UDL=;D\J@*+?]@!I5;_N",6G0!S/FJNX"FT5#= MJKY8,'^6P(5481Z!ZZ$6>^L\C@65'%9A9DDL>D)]1*^_`(9!O#3J,5=>;T^V M[@(C4$9W2_A*F&[2(*5Y.-CW4&B!3*+@OE5BM9N&7UYYQ2RDL/*"6LR2RFC+ M4ST%LHL#WD,E]?:Y(1100?E!J%OM5/VFXO?,Z?*/]^GC3RL:L]_U]9_X/WA= M]:=7/[^N;DGZ/]A'?[]@5<**5PH?-M%]#^W*Y]7/(7D^BE=*>^-BODRMFAK# MUHOF3\+_GA?[ZG>2&G_&'HH'[0Y8-;_9,6O@-E&>7Z__%F59E!37V>?X_J%X M_WT7EZ<.EDO*I0OA;`0[J^%@@@BK/6P\Q%P7![1K6O8!4K.XI=FV/)7X6]F2 M'WI7_3.(37MV0$G=7Z%T/0A$07]12%``Q5T9![:(`4ZQ1HXWY,OCJJ;\*#?1 MF!Q:5UOMG@-6#8OF?*$5:?D<;U".VLWAU3S^E!:VLYNI! MEAD0J9_MF/,P`+]V1DG1%'4(ESBTO$\(>D@5A`0W%( M$#*<#SP.1$BG]ZJTXQ_&J[/DBJ7S!DNG#"/]P;4C8812/RJU>R@9M;9<@?2F M`=*W$P:2M@H<"R346J_:LCPXF./7)"[T)[+924K.T3!*HNV@!_J(?^Z&V3!L MN[U)3_?4F_K:D3UOI#P\+802TA)#TFW[=@#L,!&F0;[)/QCT^C@*!&(2!;GM MHT-D!YJ)UF$=838!9D'GD/A`+>JY)29;Z)6OA5T<\':.&_NU%6V?"4PA)Z5X M@:F/H\$,-F^R>$G9`_ZI>SDDTV)?&G6U3$58F>^3ETP])U!XW-%IE8Z($.5/ MQ:/C*:FD.'2)`1I`.T2#MC:GR#`_,V8HQP;FT5EA6Z;U>/&\:8%1S:$28\HJ MKV-WIHIOX`,^/\1="!SRNQ?(=]YT*)#W4#$*:^4!ML:Z4-UV6/W)VF+15>T' M>B4G-05BGD1R>&U`ZT`]&BT?VF->X91AFM32F" MTHE!"9#5W:&$FJ%9[G^,"GJSB9:49RSS0B:81#M;FR3&$P/F$V+F-AHT<,0@ M#UOFM"N5D%VMA67]->557@B)'8B3U.%%REBEE^QQ:VY$HJ9]@*E1:.0E0-6" M-$V"7-[B`7+ZJ@`1=#@5@L$&>IT`L#<.>WR\X.;ZV:!-6SA@H@UED97!AH>E M5@"+X_#V1A;K3AQTVD58F*#SM/@^;^Q=W(-*6$M1^=)\@RCF$D:0EUX6[ILL M@U&U1I5HB:8/)#E6!*I3+ M)T-!M*<=`V:;.&CN[2?(6XE$M`ZRF)D$O-#M!Q[@B[TY06_,XUX%LV$D%!]V M,CQWU`)W._A`K:>;L=ZQ(DU='NG:R6_`:K?#O-!E:!_S1`^Y&?"]+2VI]DTM M_..&(R'4)=K7J;JF1?GF.^"7M5=>QN(?))[NF^H9<`!([UZI#D2.'R'0.Z.L M,()]-U1+L\?[H'I67*#2O??IA%`"O.+)#B6H"?(7FMW33)\<56W:B7'89CR2 M5781$Z+$A`'``XE%^4EX25#YVE+0KRR#;+]M#ZY3@``UX4F56P*`)SH9!(X7 M`?KD9HD!G*0VT(J>T*06;*%PWD#A!%"@35ZV*$!-6A]IE-.'=+.ZVNZR]%%T M)7G'4IW"8!+MA&:2&(]IF$^(R0LB@0-2D#J]5QBF]9(]A<^,3-0\#3(W" M)L_130O2:E(>?Q-0L/8`.7TZ1P0=3JHWV$!/_`![X[!W_IRQIRTB,+&'6F"\ MHW?%59(7F4BKO[#DM=UO?TF3XF'S=!,]\0^EYY[8R+6+#9C<>&[9^(=8>`#- M&F@&T@(K0K:E,-F6TF17B?,29,7,A%!\6&$I=7[-,EY"Y'OL#`G!J*4)V"`" M>GF9PMN10T-2M2154U*W/7V$ZNL63QC%J6%`EM`K&;!5#*CRH0Y%%'T&T-26 M-;Z@Z747#'`=H868;C^,I]56%MYYW!GCM&X0HF1Q(UD<.-P2$]0201O`Z)?P M6BX-!(@;EO+.!U*OFV4[ELHK-NVVT:"@T\^&FDE6^T&-(H"T MVE_S7&%IM=\&!Y9>=M[(#$VP_49E%@&8THTX)4R?#3JM-N;@H!-UB\XUWXY\ MFXIK[BZ2U?OO-%O&N69F$B30+J4-`N.)!O((L7PVV3,P2R^^$(_);4I$`\): MD+I)4*MU8#A([=^4C$A:P1Z%YL4;:B5LMC0&:[SZA:#M%,&F+W;1X(93X.I- MH)>V9G.C4'=>HZZH41<]&]1I:UD\U*$.O%TERW1+;Z/O-/\8)_2JH%OI7**N M7;L>D+<;SQ*=?<3LKS!CH(14:E%^2L3'Y"M_0,23$,"O?9TI^)>7`5W6OH?O M*4&"FK*5!AP`PA/T"4-$GX,=02+)N#BQ[S:ZV_2!I6VCB'E5&U0H=^SZB76U M"3B,2XD>@,6'@6&W^]:4N)6]7!5B15LU6KUAP%OUS=9RM<0/?'JD'V\XW3_6UP\7$:[N(@V8G6:+)PY*VG' M.PY6+VP=*HH,87R6VJP1%9XO6HN4QA7P1^SX7Z]FC MA-#O<5[P=6?+4F>Y`CZ$(2=W:*8X0)$QWEI9+R0-@#4FX)*E$B9!]SF30)\#)Z8`SQ&9O%GW8S%6Y#@-7O+W[[G"[_>)\^_K2B,7L'K__$_\&+SC^]^OGUJS>O1=G) M/OK[Y3[+F`JW:<2^X9WI:*CZ5+)D.B0+M6`ML^5+5TN MJ7)F7DS?F^H;1^:$95]*;"2M1)\O"1`Z4G@TF+`;U;8Z3R^J[P$V&^SZ4.V< M\(S9,+X#A<@&U!44%ZM_[/-"[(FZ32]6*^%'M+F)XM554O7:JC6>Y3V`!P%I M]3A>7:>0'*,.(62,_S:8Y>4H;TQQ9(3RQ<4VW8OK@TB<+#,Q1A`G8NA^R42> M>'$9-4W2?9$7+-3P3_,B7?Y.V(O8;T0)RJDNY/@Y[A&+!5S@6[7$.(B:%`'? M*3;&I$')76T_/ATM!W%+V9%^^..?*'`/XF+%;*.`<`WD*FGF""HE]?W2!\$7 M=JG0$RR_D`KC$0[@U\@CG?%(,W&R[G;+BN8R;=5Y27/)7CN-?:%93'/REC=Z M9#5>S$O!':O-:)8Q::'SA8,J?(7+0=QR_#ZC8G/5+WDQ9-9FQ'FP6QBF(\M>7FG]P*?[; M#?N(]@H#W,IJH-D&`J+Z:=XZ_^087[.AV("^:*2"H*,2/\4/U%N][_/V^RZ. M]7WK$QOX?:,FG\.M,M>)9I>MIIG\JKM6,\P[E`;6$9.2W`KX:J2#4/LJ+\(^ M#FD/F>Y%JJXZ4KWR#GXES947&/D&AZ?;X+KZ[8'1N^7MI*`!O:?-`AS8]Z\= M%'N\:ZUKQ`$C+-6Q*'U.;EG'8_E`R6O2N1CP9/`"O"'-!B^>$F/.+%PDJ]MO M*20_JEHK;H0=M$:]<5#ABY>D*3$&OU:P+]N]#9,'2CY1R9Z'20#E2U?>'JA' MB8(,?2GU#8&3PLK7Y:LR,\Z0&ERQRD%U<=*@`M^=Z@HK]!M2^_H])FJI+7=T MU6D[_&0]'E;`U.T.*U^)O'N,%2B;ZT1`E[Q["<`ZK_PD=X5%UXN#=0>R'M]M M[5`B`<"DXI),%'I!\&00G.86=J=J0*%"?^MZF/$;#WN.EZN[H`]W9_G!V"UK M!QJWE#24Q^].0TS*2#SP$JN[=L`4:8MUAJG$@S"Y('NI*@:H`:!`?4M`B?4I MP.(IJO8MN`"E/Z)Y>E"!ADA+L&#WG-JJ/7::^F:<,%-VE=X<05?)%3/`#I(M M9CQUBX`#F\`134]C3M.,83H-7LI'+<,=5X+W_"V')\T]?=_@\)4JW88@56./ M)P4-<(*$@P,].4XQGN@XD#@<0:PG_HYA+-$%+]#D:($7U,1XN8GR_'I=+?V\ MSC[']P_%^^^[N%QT*#E*PE:LG3A!8N/)8.$=8F*%635P!:)D49Z]P%C3+-!. M,Y+QECFAO"T]XVNU+R__XS]>_?++JW?O2'FU90C#BC;(25W?JHQL`/$>^<)! M*VJFA]H;CU1>"8AF?$MZO2WG.B.B*3FT#>`<%?_8U)<.7M")4UI`#*&7&E"C M""!EI4@+BJOG`$5M5>('BOZKEJMJ*Y)5S2(3,E8L72%/#)-YYKM:Z=ET(5=' MA;92^48S6NTL.[)R10H:``LU8#,SL"T,X=_D(/5?I`RLC06HOD"I6P9=GF!@ MT:$T&8-&CV5)Q\PT1_?V#85<\R6(AU2A&(&`*OX-YAEB,@JR9J`90L/M/UAB[YG>JL M+-G1C+>,[GF5$A4DHX\TV=.\/MV%/8_357EJ2YI0DN_H,E['=$66E2V^.9ZC M,*$'Z3,2Y61%UW'"&MX]"4W,2EP\G9%\OWS@CXN4GU71E=IEZ6J_+,B&7S1S M^#BG]V*93OW)'PD_`S%CWTO89O]FQ1)S--ILGDBT>N21C-#U6GQ+%D0V:2[^ M&Y$\OD^8^TN>YNHO$$)TL2!$Z@I6:7PQB_$/"6X8T_.\5FX;"RPCRZ46]<>D_#R@<]'U;S$%_^"2 M$]&E[;O'H<.PX:/W85@E;",'ZG\@+PNU\6^*'HC5"F.0EI<^R!'U0,>K8&QF'4L_]$:]+Q<%6,<#:[I(\ M.V2Z]4I&(A-UK/@=7=,DIQ>K1SX6O?I,<\I^W(>;+/T'SY%\\]CR25VT.8BW M:SSO+F4 M7I)A(]=)4R`Y!`);^(>9F&!F3;2%:#D,R_&CI,IVI-60?*V;!L%2&[RDSJ]2 MRDJ`?)^.`:$4-[]`#2(@5&24%XQ*7N2$*,7-%N^3^SBA-(N3^R\T>XR7-%=W M:(R-VWE!TW@\S8R>(&8`G2T#J=2BB^L=Y3U8?MU0-4PK!I)96<`_IWD]:DMV M3'H9[\0@K1A/7J8;9B+ETH]\N+6E02+65=V+TT[R,U+0 MY4.2;M+[)[)A3WEMV)Q.S\>?F9+[])%FB=!Q+];_!D!D,_)2.WS("*L4ZK%T M'F2C9@V]%5=4\_S0>DCJIR%U+M"0I`_^H['D&.;;,^SK*+\3/]`^?W4?13L^ MS?Y??J*;(J\_$0FA-=]>??SWBV]1)N8^+[['>0^KVC;53Z%H,XH=6KOC**%2 MK>:!7&(A_A0SZ:P.8I_,#'C]JTI!OVP/W-*V!TS#7OR(>N5#%&>_19L];58, M7RR7_!(_NOJ09A?Y9\IG0F-^:^7G,H'*"AEW+>T*QT7+^`3A[CMB3>3DA"&M M..@4%XNOF1QYY(+E9'6U;8E\>XAY653JR,7!C?PNGN;*Q[K`RKA>RHJGO4A: MA^G[$/8RC4!JB@0;67JSU];+>\?"'=2JR]$\.F]XG<:EB!!K[Z-J)`D3)1=-"7_?-0`R'VIOEW$OE1+-;`OU4A4 M?2G^=WA]J<&KDO>E%&]4VI>JVRKZ4LH7/Z8OE69\.H;9#P+8-*4GHXK%#AY1?S?L8I_M\\T0> MZ&8E>BL/\?T#S0O"0N'OO`=#:S5DE^;BTM@S(?L0K0B_TIZO^B7;*(GNQ>)? M/H2\2Y,\OHLW?#:'9[;#RF,Q),RE,[I+,Y[Y&$#YX[N4\Y/EO%6(4#WC!6?8=0Y?&K"YBDAQ2HXPK&"&PS_VBPZ MK1<^/]*<":NC(DRB'1Y-$N.Q#_,),6`:#1H889!?')[7P\%BE?)N7^1DFR;T MZ8R?4[%CO\I#E%-^4##]OJ/)*B[VU84&>;JEQ0,?ED[7ZW)9Z"XMN+)HPP^N M6,=%=+?AJW"82)(?#KJ(DX)F?%@[3I9,!]<=[7897<;E1@.F6TS/AC#J#,1B MZ@`6&6?UDCWRSHUZU-`/,#4*\3P9M##?[&\IVX24%CQ`3I\H$$&',Z!LL($^ MF@RP-PY[YS+LG3CDM`/)F)!#/1CB8[EUIEI>HJY1=.W:E8F\W7B*Z.PC5B$* M,P8V2*46]9H?L=6)SS/S[4ZT66"UYM5YE.KSZO5[&&%%E'(D2?N!TQ M@I.DI9K14[/2B@M4S@]060869?@ST3![3BB_HQ*9^3'YH6/P;%#!`,4OL7)66* M3K!/F5GAAIN0C9;&0$VDZ&<*-D,"QX(;[I#M+]$_TJP^E$\=H#7-VF%9VFP\ M.S36$4.PW(J!#3*AQ07)X^1^0PG]S@J?)-HTY^V679V(#WSRCJT8(ZC'2$/H MY>C>C8R MQ>@=&Y41!XBP;DV3#DX''=H>C1LZAOT9)'2\L4''(\WN4B=\O''#QYM6^74R M\'B##X\WJ#447<7+:/..&D[>TK7K5%'2=@APUMC'K*/D9DQHEDEU#]BBAQ.V M5I3?9I"?$5H=O5,=>[6-DOTZ6O*)ZYQ57VG^.]W0(DVJDR-VNPTSPMUO+GG8 MEG9+:;YW*LJ>F)KL=QK$F5E:S*3@URMECJ1]GSH3(A&W*E,9<$"AJ,LJE%0/ M@HJMXQ!B*,W<,(+<1XV3>+O?_I;R0'"3?J,9/RP^?T@W*TVPA0IU(J]9"`'\ M4,\P8S+`IHD:1A6+C_$V+L2R'WY?S4:<@,C`$I$ES0J^A>)1"),=EVY=OQ-$ MSQ>,E]3M;4KI91+N;+,J;L]_N0 M[I.5^$A=BP!%VI6(460\KX!>(58A9HL&2ID4+.H&I&I!#DU"8A84$*G+"Y-Q MRB#:8]3\X$,M,2"VQ@&/EQ?/&7KZN@(5?+A=R^OB@69_I>E]%NT>>#=6'<0- M3=O!6]ET/&\,7B`&:[4E`U=4@@OQ@-PW3XAX4V(P+EVW[E1-TN)PUVH(?4/3 MJT]M7I&,(0J1'C.FAQ5J&-;9<(,4#[LEJ-K/0HJV*,C11]=1V,'IH:F4H_?+ M=(8<(<1G5#<;4L+HY)"C[6B-0P[*#*M*N8=95ITI1^R\^2W]!7JN@[0O%W; M:9N/)P3`&\0:3V_-P`J=\*+YE$3\8S']NBL%R*YYMHZ3*%G&R7T(51X$"*GM MRY)Q12/6X\M\8$.M_$QVW('&*\#J,3E`3C0(*0"C0DM?#J*`"[>3_5E,!:YN MHJQXNLVB)(_*D[T3S:9+J$P[-)MEQE,&ZA=BD`:8-!#(J&%1M2"B"6FU(:Q1 M2$P"XR)U>FTR1IED>[0*`86HT1MD;"0">1Q_[AC4QW5D%$X2X?D\G'V,ET@! MHGQ'RAO#)+[YC_1=HVY,:^O0,$TT.P*NR3`"8IL:7!"VM:1A?)L*]S>G&`!W/'H-N4=X1A=@17IP:\IDNT_M$7$MT(ZY9 ME4=V?=MN1%>UQ>"0W@_4"*XT9>2-0G+1^JBZTU:,IJ_HFF898U%U76$(0^C& M-][G"0@@/7;(90:LF!Y/R+%88\012V7L+0_.:J.J?'HZ^#'%UU$(PEDRH=2. MOF9":\D52.<'(&6#\'1"0-*NGQ@+)-1EZ=P*`\,O-+O7'>2B:=9/QX-F.*A7 M6$=.PD,K`*CWA187A'\SOCKQ;I_'"Q#5.9=]3,K/ MP^K@C$"&.\FK,B,.$#GG&\Q/"QK&Q&D/#=QTF3Y%F^+IIMF# M+$V6JD:=5#ELA(!@E67,-"FQ80+O0&1Q^#?9Y^7%PLMHL]SS00F2E>U)>K>) M[\N3Y0,_<2.(5*E\Y2GL!4GQWF_<1_LD$,)-D%+MMO`1 MR;'"R.'38X:!(2?:`@$I'P[4XF=#J0EK/)P?\+`[#3SH$Z$U'E"3X!=^W'[5 M/?UKFJ[R3[1X_WVYV:]8C#Y;U1FAM8I^D^;&D_H:J2`N;1@!S10))S+:VVOKQ85C M(0MJR>%H'ITHO&@1?S:74`@YPNG32)+6)4!EXX"Z=C/20E\?S4`,G`K+P2YZ M">;H`SX_SMNIY`7VYO&0.6"/6TC2)$ZSCS19Z>8>U*TZA:"D%0)!E;8Q"SF9 M$1._AC*+\B\QRY^+QV1%[P+;+:=YF2GPEY=28="Z#_6)X(%;NLC56T-#E!XE M(BJ,A!1>W1%AJ`KL,8&4U8=Z\;.VW(8]-%C6_9+]D7Q*"TK^)^NLG0XX]+G3 M`1RXN>\ARNA;UN-=7:;;'4URD20NLHR]/K&O\NW3HP\A5D$YD[WZV#6 M#Y-X;0HM$SBQN'V@A.9%O!7K@-?-4Y+Q::,?HM;H+U]]P0]J3_=%7D2)Z%RG MI?8?.=7O:"W/-+'$N&0U$MUL^!^//!AP4='\/^>$!>1M$,73A.1-YR*&-%K[ M-]\/_R\!JW(3MZ*=R-_Y@Y6HN;D.(I20MB'2LD3>/I%VN\H:$>8(MT>$0=*R M2&J3Y&"3<*,O,6HJ+CR;*(74)9K`4?P^UD1.!Q"L6"_P0[>:>@DE4\'U^822 M,#K0XM/\,ZVGG%=7FLUH_JR@=(\U5F8,VL;O'D+G5^>DKXBLMKFX2I8991_Q M#0&Y:$:BQRAF5C>BITKNF?:"K/:"N+Q[FC5J>%^WDEGM,][3Y<_+735'W6\U MDP@I;D/9BA.DE=:P8O*1A84PNIAZ]R8/"3@=R%(]:>DG5P'MW#SBR."I+SA? M;)BYIZ?V*YR.G=['Z4.$V$_;?/S"9QR8G0J?<;M;^[M-O&1^48JT_AM#8:<3 M-4XA0NC#^$:87:.1_ICBV2CUDF7CU8Q=?M![_"O)44">XL-,&N/&*.Z'LZ,F M(VZ'9+0G/HDHNADMQAWY$O70^&;H)83".*3:?Y0+^&7^:'>\$N]<$.]5P[PD MR,7OP1%*7Z8'0RC4XOO7A"]3^E+PJ]$_T!7-HLW!JKK$MA!K%](@L?'1PL([ MQ*(89M5`?(B21=F(E*U(U:R=/0.BN0U24M>W*",L0+Q'RW#0B5HE0NV-1R:O M^%ZP";H5QPLZ<6HMB"'TB@IJ%`&DK#KZ]8]?_OBLL:DM=?Q@$[5LN=BF^Z2X M7M]D<;*,=]&F&K?,;VC&G:GGO*^2FVK0AK4<@!Y#5;N\<58UGK0COP5B&>3N MB8';KHKY1`;[`7E+,0H8"3U\3'!7:R*[2M49^?80+Q](G/-%#F3/U)*XM7Y" MK'ZHUT;LN'HN0\M.>[`+9I1H6^($8/QX(^Q02?+`8YJNS% MI>,C)&KE-\8'/V3D%>)%P[]&N%Y:D//U`X3+D_:JI5H%$3I>Z-.'2G`$PBE$ M78VC%Z=C'/'$H_,VCX9Y;((T]D+#/MS"HR'N/'V1+G^_RO,]7;T3:T'+Q0!B MA?9EFO#S45EA>+TN_UW$=QOF174GA)"5SM5C*>W,UX]7BC!E@?7-,.?M$7PR MS5R,-K$H=Z4=5A['0IM8JBSB4Z.%MUD>]+!(5E]!DG--@2Y91D-\Z@=OTMF/ MLLGPA6H0T!P'U:8HZ\O%O]AUO8-60&%O MI=5;D'+X;OY+>SNGW**4C8W%I[V8/Q*5^W;+0E59JG=+_4'A;E_\!USJNY`` M%/'!;:81'OZ&@[1;UOZXYWRAHJ_FH;X`F4_"'0TJGHGY.87LM^&S^F MJOMM??+/3U/E?U8EUQ?FH?9(/[[[_3;!GG]'K]MXCO&BQRVY%\M0;H ML+U,@]_A!K7/$PW(2QT8,8X@T==?&O/8C+P+R%;5>)23J+I5M-Y)1RM=_.]O ME;:`*VX3".'C"48D@X<.AIHLQ@E"H,-DH]\*TZA4`(UKOV^AOA9\GJ!W'YQ& MAKW_86>)S4G'F!7V<='/:DC>F)]4/!B:$=N@90'_C&\L>Z;X=QXQQL;_=&/! MM>Y]*GZ<:NY4Y,*93.=37KP*39HA6=!P;OC=!H#-` MN]QGXGKYX%=8F#!HT:,T`1G>=QQHLNDG!L"&Z89$Y:91F0`;ZFSB=B/W/#$_ M8JP2%_43C$$.;4X[WBBWCPM^]QKP6$88/?'`?>00F0>X6^Q6_]CGA5AE?)M> MK%8QKV'XRN-X=95<1KNXB#;7ZS7E;EVF>9$W1>F7=!,OXV[1TZX1<35W-N`A M:4;8NX#Z'3&WYV$Y9MK8@&-'O7EO10_[&:)&/]DQ`_RC96F"_'!Q9XN8W'QS[>X>&#*2[>JQX=HQT\*:UP+H=)%9E+J M$<+2S1$H%OI[)4XL!N#N",1S:1+^B_V"!TW\51]TD9N*ZY4Z4NLCES5Q*Y6D MK?.%MW:P.S+F(NT]Q/$%UDOX<\G=A-[S)&3H)R!Z-@V%6;_B&I117XAIAZEC M(R9J]Z2]1N)M%J_NZ<;)@"CL3.2`1+]PDC<90_L'\^\BL[^?6;V>$NZ@D$6"0#B/9J'`W+4FA=J;SS`>;7:78I7-B0?*R27;8-9".L5F_H" MT@LZ<4H_B"'TT5^H4020#M:+:L+MR8-46TSY`:FW,JB[/K0>'NX8URW@'*E* M52Y9J<)EK\.W\%16V7EB07(;Q=#RJW^,0C/_WZ_%F@?'7)2Y0%T=9]R)HXP\ M%BHUT>@X:.BM\+/UP0\%AP5B;W<4:;_)=K48TGK3(-@#+R\GYP]^&6ICW&MI M:NN()QJ9MCR94]8+C2`+6>>ET;!0GI!&;VQHQ"S930&B/M<%:A0!IJQ+PI^S'_C90%';=?`#190N`<20A_(?:A8! MC&\,,?/J><5,;6GN!ZBH)7?K#)`O-(MI'G6K?W75;2,G:RP?^,7L?&%K:_"JW'J69B0M'C@@ MV6\KUM'E=+G/Q+P*83KXK$[Z+:'9?_[/[.DNE&7JEBB4]<#?P\P(R"0*]@_S'N69<%73P6A30!EI`LQ"IC"\H!9S@L)HR]-\!,@N#GC/ M6Z%[J3YQ]+FA%S!SX`>]'A;0M&R^=:ZMM)+:VDHAZ8&C6A]]UE8JP[84E>NI M"?IVBMHJZ-)*#T(#T2$(UM-T4IM$@;Z\M&)$.*;:"A^TEK45 M'FP]U59R6_YK*[5='/2>MT+WL=96'M!K5ULAHA>UMGI'[XJK)"\R43&4)_]? MKV^S*%D^4.D:9)A$NY8R28SG(LPGQ-K):-!`/8,\;#+X<`A840F&4.X`\9$Z MO$`9T_22/8;-C434,@9@:A0*>=G"6Y!#$W*X&J1N=9J(T]?U*?WK!D_XU9C;X7"Q_Z;8,9)`$` M)+5\BS(ZJ:5Z5)H+@J@5@L&,,_QX95`?V\,?5V>O'QJ<%J#TQ0`"I'"*`(U^ M]`+`8,L=62SQ?U#%LA-#E3;O8Z!JGCLH=?N7G94XW3")N5G2V?.ISB!7^(!U MM]5AA_+M\/AQS:60^QT_JFAP*V2]QRN$TL,=E(X77$%V%ULK<[V\:E:2S'-; MH\TN8A>EUGD@(IP1ZEM?#KH5R(RL$I-X?S@NMAJZR2XN?6L#"W%2<(-!HXK'?LQW[@AXM'PW*4_8LU MC(NG[LD"])][9H+)2J[040F%4*&Z0UXW$&U/'F MGVQ>KW5B=SVP5PN2@^1SIH+-C.`$9/`Q;P@QZWDJ$>H".B?.^2'VZBST@[A@ MMTI`/SYK'EA,5T[!`]Q!SN4#7>TW]'HM2N*WK+Q87:;;'4UR45==<"_N*??M M[=.AR4WT)-QEL*EJZ8O'*&9?:T,_I-E?N>>W_(];^KUXR_R1'GL]M>W.D.ID MMA'ZU!/_3I@#N-.Y;NK`3^7)@OV]WT0961TF,*I9G:KLCFH-9)UFY)[K"*'F MGIR.Z:PHEXXV3.1#?Y#B)1@-?,4=*)_2Z4`"D1B6KVSQ`"2$B-!%VO9(RR"Y M>^JTJXP28;4>R;_HA"]AF7P5M@DW3H3U$-;$/Y.`9IA'..V0AC1K,96W^),= M4WH>2F0[[T8V=5GU$H2F1_9S#$+XZXX>TLV*T5^]T5O=:K!RJ-<*:9)7:AM[ M[4_?"&26MBNSN.;;H_/R$M6(W-&$KN-E'&WX=FO*OJNX:V";\F5F#U%"7O]< M#WK5O;;'5-P<4#MGJ:E&9;(0$V4[_^YCXNGJX0' MZ_B1WK!WQAK]29TS00+M]&D0&`]RD$>(2=5DSX!\O3AL#R\7(%PRA#P*0T1J M_\YDA-$*]K@S+_)0TZ_9TAC4\:1<-B!-"P&O$F@!!6)TK.D3-QK:<-*YW@1Z M9C>;&P4ZEN^;.';:&-.6`'@8P^U!N_;VK\7NT/SB_CX3UYY?)446)WF\%!N- M+N[R(HN6A;0[/HW)3M_>MTF$&GZ:7P6CC^C=4U.GPK,#B_'S/Y4ETI@BC:UJ M/^S7VEP(L7`J2J9S0%[:(?-KNM^[>_;AQZY*!HU'3.#PO'&(E^O*^/$2-'P# M]>3#AJ2S,D2@D)LC=C`+?X/3"GK/RZZRMR M0ZPO_IJE>3[<0M3=S[CC[TCA1'6`7*Z2?0!3! MG:CT[>B,$41,GH[N@AZ.R*L6(W:/%1#6Q*#<2[#QA_03#C=(4]<^/<2?!/?M M[9Q11W(I>U.BE"7,2Z3P!]%3CA1!S5B(18GY55*>;G&Q9KS_A6;WBJ6#OHUA MSE)HC,T_0&C\)4+H7`)\]3PFJ#8M[U96I[3FY`<6JLM/]DE3E7`,'I5=83FZ49?@!/ M=79=&69*4R\QQ0>R3S*JS-R+-+H73A<2Y.ILP>6)K1 M`'?1^W>:+>.Z$U/W66BED0]!+2D1N#HC:4)#Z*Y`<)+:ODOIDE&U6'_!Z&Q8Q%W^;K#C MCD.Q]+T&E7A.1`/"6@2U*!D36X9%[QCH0EKPKC&`O]S=8&P$R%@1]'_^_,>? M_T1>$?[?_WJZR-(O=4=!EN=2X/9;:E,*#)KK2X%6..0V4IP%J$';!'8,NV%'!` MEZ]2X&!@@E*@:VP$R,I2X,V?>2GP^H\__WRZR+(L!5R0Y;L48.VMQ@4D`H9R MH"W@A21#C_R6!!U[]CQIB:.6!5QOH(6!!#-&DBEQ9B+90=!,LPFQZ;M$Z%D: M@TMUF<#;!![.QV'-NEAP0YNW@J%E8HJ2H6=N%.AXV<#*A7_C9=ZU**<+$2%>.'`0)ER0_?!2\8D\J\>=-"WWG;`9BX'3C'.RB]^T< M?<#G!^L%]ECPT\=N;GCF'-!V'.?@P-1=S-_2#:N9HNSI0[QAR%9V+17M!EW* M03NDKJ3"/E87TG7L2]5=QN9S4CX(I:.H>HF2#J+^?0\[AKWVL@ZA"1IC MIF)8J;_D)QP>&,=JZU&]0B25G>F=_68-,])V2"47KCA?4LZ MXR"$#/OD:[S?< MAP_L9RM/_A&;.YG039K'HI>N^NXYR6H#94>;/]O5BME?O].$RU>'HI6'7H@^ M.RWV61+$58=^R)3ZAZ^L&$$UU"M-3CLHH';,\3V;,B#P3GM;H>BPURI)HY/\ MT&C]D7SNQH'JH-22\%R\4?["^#'8/&K.X_3]<5U"'PG`=V]2ZI^+52:#&H"5 M!NH:H)?FGV@T]S3@D=)<.\YP/#2?>@Q"S+%>1@6]3[,GY="#M-5@Q*'7"FF@ M06H;:WRAKQPRK-"5J4<3Q*>D_CB4,03YBY,,'>C>\'#$H--:-E"@A\+DXP/5 MN(7/$0*CB?%C!!H3H(`_1(U]FP*H)5D=\ MBS<;]L>AO%A6@YV#<83C'48P,PZCWH#R&J'>4)I"J3B.*7H$,*"@]VW:R($P MJ%!/=IS4L,+,$<#'T,),,6#.X06U4X$,,.@=G#@4C!IDJ*L`/LSPPOJQJ#Q^ MUD\]VG"SO]O$RP^;-.JOI=:V&8PT=-H@C3-([&*-,G150\88VA+U"$/Y&1$? MAC*^('M9DM$%]3L=CBVTVLI&%G2O?O)QA2^T8-^"]UWSO\7%`Q-D#R[VQ4.: M,891Q.$%J*7QHPQF2W,5"M#?8/8Q!X"C7JH&HUW$$8C\8(M\8\9X8_XP.I@[ MWJ$%,-LP*@U+:B.4&R:+*%7'\<:1`$8?0"[.$D,0QB):)@BW04HCI&7E)7+@ M`OG$8L>1Q^)CPST,9]5"\ M/LG`A_9%#\<^NLUEPQ\&2(P8`:EV07U)-_$R+OO%EVE>2,@E>\EB;N"AUK``4Z-`Q^M9T8*C MKJY'&.A$*](T.TW(Z8M<1-#A%+P&&^AE+\#>..RQ$KB\1/RGFYOK!GWB'O+\ MY+&GK8LQL3>LD?&Q]\8&>X\TNTO'HN_-:/2]:3I@K>1ZHF![,Q78WDP`MC^! MP/;G$FP)O>>S7N/`]J?18/O3X6JR4\78GZ;"V)\PNT(?HCC[+=KLZ46>[[?E ME87E.M]XR0\_DW6&H#+M[I!99CQOH'XA=HD`)@W$,6I8U'^)LW9)U#0C^UP< M[DL>F;A8.<>7Z.=%)AP/H9L$!DKJ]!YE1#/)]J@6`BQ1.TP@8R,AR3M-O`T1 MC4BK%6FPRMN=+@+U/2=D#.+TGHQ6T/M/((MCH7C>BX\GC#EMCPD;-B1=BQ%G4/HN2!H[$Y8D M'9OCL7DNCZ(G#D3'"L4=B*A5RI?E`UWM-[09>1,F*);E;?D_-+?U> MO&4J?Y>5*P[B[;K%2GP\^QR\1:QD[*P;Z&BC;,'^WF^BC*SB?+E)\WU&N_/- M!\D0"AD73*5CW[.,O!9J>BP.%]>H58^M73Q,\SJH;MZ:QA7D3LB-^8TMEN@!:PZ%4UZUM/B M?\MZ.N;6[8Z-KC7"971&7Q"[+5ICIAODU+*RA:\QZ_/2%5FG&:'1\H%0(4[V MK'T('1,`!%++]R3+8FJI_LUM,X$,]T91O1EG@(E[0$O\B,>'+@)K(#XZ+409 M;N0S35^O&OR-3;6L58504$2\>^>\H@M8)0DM_&R4"M%"'--]F M\>J>?DH+FM]LHJ4XZ.#BGO]/LKK)XL>HH-W/:V]^H3PCR9(_DLIVA3!:Y7@N M(GTKQ%ICO$<&4H\U<.!]5:LPB(N]Y+40B;B4*&'NA"V2I'P!6[+B=]5P_:VV MZSB)DF4@PZY8&$]]8$P6>$:J[D6GX^!< MI6?PK*'QUU)9""/#01)07U8&14&<`G6L$^A5+(9#GIG()_Y["?#;"\%L`1,^ MP5#+])N,EAL!S>6WH6F[K%8V'1\9#%X@EL%J2P8BJP0/96MKKI_<45:FLMJ4 M;(5,"$6HZ4VG-F]$1BB%2(\HTZ,(M7C3V7!#$"^VV"-2/@NR?$*!CK[<&04> MG/)$I1R][-`9^/<707;^+BZ38M M!^MDR1@NU<[+$*GQ[(#[AIBM048-E`'H6-1MR/7AU(ZF&;E-2=DPA#1N@9'4 M\07*N&66[M$L%%2B9G^@N=&(Y#4!$).G#4E]T>`!E#BE!,`.>E4!M#D>F^QWA^NOJ-6-HXN&"@KK7&Q4&"_8^!!JBUE)-Q9`KP.LN-!,^7`_J2;&(6X)1K MUE;1BS)C[0J-AGTB,K\;3:S>28M4XQ M>`G];I/.!`&<&CWV:;0!';4G7!.I5/&V;66DTA9`3$#$N>WPJB6!+`=?3=JM M!V>/@YD3SX:!W/'.2HO9M!=>(D+L2)@YU92?T0]8S6IU$#N25_XIVIY4;.8/ MR9ZS,:O8F*X)4QV_:NBX?J&C#:J.A8ZHY?_`B\J_C*[:#M6GX>B`:H9>#UW2:^%_7*;7K%CQ>HO)$X(2L!'<3;Y9^5^'CN M.WB+6/;963<0WD;9XM"8IS?1O!GKD>:^$$H]%VBE8U^WC-T6:GK,#A?>J&6= MK5T\:/-RSAKJ=V)K'A'H;UZ`;O72YP/Z\/K=41MN_K'/"UY! MY[?I8:7G312OKI++:!<7?-GG,J-13M_MZ6WZ:Q)MTZR(_T57?#GHNSA?IGLN M#>NT3&&ONY''ISV,5=[^?P_4#4)>W34N'O=H?='2S@O6UJIS;H!<):0R<49J M(X19X6U;=LK]&HVE0DV_I!^PN$&:QN;1P\]3!!Y]W?.N'/^AT4[>(C==*LF>(3:PSNUX&'8 MK'<:P0/W;FT69`I*FST9FK,C#4T[MVBKFB+<^ZKW`K%'IK9DNN!5(;BH'S1; MQ/*@M@N:7G!J\R*D=[C*1?H7MTX.'MP+K#4VW(`CKJI60^=4D&.XB'H,=I"N MG%8HQ[]G6F/($4*L/GG])T)/%SSZRZ-'@0?Y'"9S:?`;S8LXN;]>OX^RS5.] M1&9U75YB[3KX"]-J.\1KTCI-/P?VW28>KC4ZA=!A,=A87&QY'4:/##PQE9*#[Y)R@KK7\SYL,7VL'0"A%',[:]!FLST\0XQV\_<;_"WDN$(&AKU&8:ENLF M0GG[O(;V$NAC7NKA2BG[(#N.O-8QU]*<0Q`^C3`Q>;_%Q;_I0X3E6@VW(/$2 M(["P>S)18KHNDZUCL_2A7)R<(5BP7I:(`(\B`K0NHDA;:^N/>)E%N!%@=-\L MO`@00._-M#%:>F;.Y2;:RT^MFXWCOH.7'##&I?'% M).CL%-5I@:47Q]LIQ8@%&,D(+R8A)*H1SJ"DL><6&P/H*H_U/K2XB-+-1HB, M+X$Q!%J]A,8]UIE;T[L=R/C`V*\07(14CBV`3A%3'EB[?(E[<\<]#V,7QQSW M4,<]OA3I\G=QI,+JW3Z+D_L;FL7I2GA[D\6/44%O-M&2\B]XO6:.LB:RH8LQ M>MJC#VYZQN>!,?XCC@$XNF$(QDY:%[_5@31_B-@/*/[%%95'GZS(2J@22TEW M0A_[9U2PIR0JBBR^VQ?1W4;0)>)7T7$K9%>;8=I*.R'TM4>!-T7#D2R\N>CK M1:ACHA1JU]'9`0]TXATX(5<>`[7\S'&B@Z0:*-7"`LW M@5)KBC(5X($/6ID*U5+Z."O5Z>CB5*OZ)XS7:M5@>JIR%>"&%]YH"]:SZO,7 M;CB6KA-P`[5X55G1E=67:?+(<,\JL.LU/T!(5LMBZFV7MCAZQ\<6S.^'6/@B MN64(/"A6%K=\;W\S=JNOA\7<%_][V:CA4N+DLR@GNR@3QPZ$7AZCLB+U!DA9 MO,/0WPM_I\1EU$H;S:$)>,SK<'6-S>IP\V#R025?S<.5OE`5CK(\Y7?[Q/GW\:45C]CY?_XG_@_OWKP6/0[VT=_?587LASA?1IO_ MH%'V@7W2/V<,T++Z>;4M1P4;@`_C@#H.Z.06]0-2/B'\$1'/YN4NY(VF M%C]]CUT:B0-?;+`R79^Z[.Y[Z%3K%8_H5:L43Y[;]=]POGZUTB_Q(UL?>WVWBY3%WL`T,&54=@-@WICB0&QA7'03.[#E[ MV1J/IF#UF'YV/1=V"AWMZ2F+VM6>CK2S=+85KLS=V]:X-0EWG?O;`SH<_C M'\RHJQ%KW",R3*GG;6`VWVRJ#,&R!VW M$$*MAX=[BRUG#GSJA*O1RFTVHAT-3Z?;[0SVQC='H;N@RS;U!66M>QH34NLC M0N$+(R'X.@I.3K")&N3&M!NJP2YYIR8KLVO"M6YH'&;!%\I!P',S$4^_;IT.0F>N(?77R+LLKAO\7%PP/=K&[3R_21 M9K7/Y27=TB[`!/8ZO0.O]A!"WP2_!V:?PJ^[IGCIT_JB;"2F\GDKSMLE;RB, ML47TH'BS5T*:M"V0E@GR]HFTVU5FB+!3=[1(;8K?5B&,-7TM4II["3;^D'[" MX0:I+^?30_QNGF]OYXPZYYJ:)BK1Q>J80;'R$C[\X?:4P\?T>PQNF5K-MH+V M8\E.@O(QVN:!MC6\_0*55M@6`='XL"N`_QG.-H#.VY"N_)>\KYHH_6;R]?W2 M-VH+PG64WXDON<]?W4?1CB/QO_Q$-T5>?R*&45J0K#[^^\5RR8G`QW323;R, M:7YQEQ=9M.R/A,`%JI\!(C`*R'"/QD$;9$<-=H#XHAQT8XGMAGWC>D1#+%/^ MLM]NH^R)/_L2WR?Q.E[R.Y$.RDBM331_GQ?Q-BK87U]K[3,ON;'`36K_9GN4 M,PL>2.B`S\EIF7^F2QH_\E.NI=MPH,WEE)0TQR2DTAM4.LJL@,DX%%[43\CA M42!KJ,$O6\4C$SP4+!J(*3DT-:#L!G,,?2N0,7=DB1M`:VQEIX\MY?`#'KHD MG?_I(S3K<7"/+LM%/8;X+&^LB,[]QJA4DGN"&YD'-N#LZ8D>F%,]."/5H[!H MHWB_2M)H\:`B3%=(39<)\>,U$$M,N0*I$X1WY:-30A`XZ+IA*(B`>\@"GV@! M"[LZ$6-IW!;Q5,T,O?)5(GV*NB#"?)5YV)_9GJ[J^Y;YZ$RRNBX> M:-;ZZ+"SI/H&J@VQ?HWHZ_C11GS4;TC?W$N_8;QOUF7B6).2?DJEDK04G(FA M6J&V_7%KRV2300/:.^F9.Z8*%Y>CAKIXI#%C/7V*L6"*/B"&BU,'A:I8Z0>! M%S)C0.TDZ#QWO951/MWX_CM?7-&/&*9FPYJGUPPK4DFMH]4=?>V@(-$56C2? MD.JC8"@N?W,RDNK>L81DG>92FDR!!E^99VC$'A8\^E\ES";-"T*K'RJJTH%8 MV<9//2UB/A64S'^3S'C00&*S)6P0XF.]2DN$[>R)A\NGJ]OW[\B7VXO;]U\"F9V4_/"I M^B?KX>[0X(`T#R\,-0CUU$+>'`\TOR8Q7_KSI2A7`!W1NU-&#?W;F[UR8E'\ M<_H4;7B!9YR+T+66U%'2UF@)5.,+7E4E-P++HC+9IB/5/`EOKD'[EJ7ITPP+ M60Z52,E3Z>0X\E:/J6PY`XH'S>:STT(0J`X;@Z$08F^K>PV*ONKV\O@K:X_) M'+4_J#%8:@9,&HFT;$`KS$BL>>,J)AE!HF#24$[)I>EQY3,F*ZR-`%A[S'03 MX)@I&K*@47H4MD9ODC1;L-ODF!;19@RZ])L4(?*+6^[#">))M6L/%4_C=\V- MSOPW6;JF.;\M*-I\H,#T;Q"2UP!*(4Q*&3Q#K0;4ML"<4JEH@G:[`>$MPJP. M3(!0$0\&)`7W%,)*`LX)0)]E@\[D6"26%WZT,+BF@94/R-"#%A)(X`NA\_=; MM!3[)$&A7]%8'O('C3&9IO`$-<0/;8`)U1=M0GK](,Q(KGJ_*AKI\:`@3T]( M29HI\>,S0LM,N0*)1^3;+'JD857=(W$##;N.R`DAS.I7M9A/"[#781R+T^KP MU-,%^.UKS$YOVJ4CK-,H&]L+\30!!UP!^M%P>)I[UAI=D-ZV#L?MS1K'BZ81@MV+/W_]S'NZVV M7$-5/XPE2.JQP@SJMT6+0%A>@8(3CK%%2Q-IJSHCC3*Q\+ZM[HS4"L^(4%FN MS6^T!A/M<$DA"X0^:">)D2AFI.'S%(D-K.[_7%([H??<(JB^QW-O.HY7TT(- MRUM^V:)J MC1.L]+X@%15*(X#XH9!='!X0_H2?9%X]"X3]AK<\)#,(%@-FRJ4D1)L#1WY& MJ#2VG`$E\LL!4COV[!6#U/(4(64.]R-!%6(PUA^B!Y&!!6;GDP733@&]*:GWCWU>\'(LOTT53O**K7CB MYSFG"6MXO;X\;(-Z1^^4@T.(J@=$QE"-Q'>\;XD5%E`\@D0/!$.+EA9.&W61 M>$9*9:31QL_9;>DC7&$H`0D1^Y*XAY4P:M"/:'WV3I M8[RBJ[=/O[(O>Y5<[V@6\7MZ+I9%_`A:?>K1E*XT1C.%GS&0?P4/12^>AY8I M`,MPOYQM]/*ST4FIF?S`=?_('W/UI-9/[I[(#[^6EW+_2!HKY&`FO*6X/DFF M3Q%^**W-!D@F#:'_]`.(__H2T]%Y(DDY$-J))5D32Q(62S9,*_^4_YM?BW(!(YS"4%7\\C+W*L_W[(NP_XT8W"[3O,C'#)<: M5+J,@2I53C<$8/A6$XY6JCU!ZJ.K#%B-*XK1PU++&:GU$*$HP,#IBF6W+C>, M(4Z]:(5JQZYQN+SSM9!_K$M^*<@KF.OUFF:\%%F^<`F"C^#9%'Z1P$?([OHC M9.5>RC2Y9YV)+:N1F(KXD?(]!/YG8[TXXSHYB^S,M+,:7G[)B:=NL;\#XE0' MKFLX$[O514G,AU?<"=)X(79LGN94KY^`X3[AXC.`.<^^H#HU8C+F):"&,6N, M_U5"C:R\KKZ4S".+%9%I.0M(8E&ZD8@D:?**;G>;](D>VTSS2<=!O'GHDXR$ MP?ANN_IF2R/2/V?KJ;NF\<)VEVM-I5L)5D-)AY/ MP)7#T"E6ZA#M$N0Z^MSB4Q#DF*T^&GKA@27BKK-ZY#Q=\Y5N6Y9.,*E! M6C5((<4)D&]8*=-D#$)]O8Y%JT$Y1W9&RC;D:_7?\.ZM!@)$0FD;9`WIJY66 MD34`2'I*5&:;H[%9+IKIH?.T$0A((;@8#"4]&*XL5C94)P'DBVJ5'J"'>JNK MBX=B'`*\PG@@H.6";W3XCKJ65QG+!#M`"6I&?PQ,;"*H!5#F MC9,;H9RNY!M&#+'32K@?3X'"."RR\A0I[D)M`D@&4[5HVBDG2@,+VW8`&G+4 M!8`#UH*42)@<'H#M4@,+1'^6>ZI/%C=+>AA@M^7'1(,I:%#C3>6_N-E[]L3,.H#]>X M:)J+">M:@-02Y"`2VFU#3F"31@97S,K"`UB7/$H$#7T_G2)K#Y`Y4!UE7L(] M:\$]JK4\7\"#,N)4D)\W/[9./;]>\[.OWL6YX!E4'EE3EMM6EZQ?>$^5>VU&(5"`8,G-,B1T^XKJB);Y/C;8)X+S$X#GBR:)^D M!8MFN^B)CWBP#P+?]]N=FO MZ.H#^Y7Y=-"^J#Q_'V4)\SN_H9F8,/H8)_2JH%MEDD!6WT\H:.IQ@@'RMT5* M5'A>`6(+EK%%6Q,YJ"*U+L)#`&EIXZ&JUL+(,A7KI,(I:$L,L8FQ3"R M^:'=(`8BF9'$R],DMI^*`-.YZ1@N*HT7CL_.<7.E$SS+`ZR@/D5;^B[=1K'R M6""@&*CB:8MY#'A#[WQ6*!UKKG&II405;`#C@A)8,+8? MQ*$LUD!R;FZ"`\S;)[F"B^^QIPX/Q")N'TAO,83J"?*;!-%3,CCJO;32VE?6 M6E_YXZ"C'BY[L`LI"\HB5U8ZR^C%EE6<.)H(?['EL^]^8GE7-V[4KG6'$)^[ MWS.(2-RXY#WF5I:P>K)GI%1X$N&X1P#LP"OE%W*(+6V@!]/PZ!OBR%3+LXEX M/!B3RAM-+XRTA](1H:0\I\75=A?%&3^'Q[#T3MNX7VXH&N,$(*TG2`6! MR@8@,LA%%^)SL=4A<"AP$3I4(2:DT/'S\)26W*%4?B/+,#AOAM M2Z<$(',P'P6A^<.M\7I(:2-9>$6_44UJ&3&<6EZ#V!4IPV>`-PW*WY<<[N#; M_3J-%>#V^_[]Q4/K6^SZ0A44COG]P\(<&`$!A+4/+-#^QD_/Y%M,6%;:9\IC M7$SMI<%.VAX1]QI_,$.@W`R4!#+IB@UGA#\DXBDY/`Z))+I7KN"+&25RXDCD M5!R:`5@>8ZO*V@B$\8C[H3DG6ZY]@"CDNEM`N.-ZGT&$$D, MIR#)VDCC"O)1+C*[F%'&ZA2BCD13K85U@I#T12E0"SP!J-U6A6"/K]UC?+(\ M@:U[&``C&$P((03T4"C=(JVN@CG9'B.7[$?` M0$?T5.]6SP:K\;V>C($;4R#'8\=49LD10N*BN4[X_,OI(,49I`'W#?B`6,\6RG><$6V/F\0O< M>7-3%J_NZ<]O"%?]*]YP(M>D`H@G\0A+Z>"$'/L MM,:()!XBH>3#$K.\5%R/F?6W.=Q0O/\8EG> MFLTO<&#_*IZN$A9<:%[DY4HVKO)^AD93C M$!3UFR)5`U@^`2(`CJE%K8>T%)V14A6I=5478),T([6V,U+JX[5_J3&0.(-+ M@&%T\D&P041#,2*)@Z='8#_5&YYK4S%9W,4D_B9Q^?;CA-S5Y(X.NE]HZ@*N MHR3JO(,#U5>X3+=W<2+&A4RK^"$BBI)$+H(:IW1>X98/"DOP4")5L+A]H.07 MFMW3[(Q#1LF*7!2OFV):>T?E`@+;L#/"`/A`)(\E5A M!Y!0&U%0FIP2<5/5GEV#XZ`G)FV>*_A[VC^3*+=]RQBV15S2BU M9^J,"PB<%2ER@XTB5/[:?P/$1/TGG<0E7\-;B.".1F68 M<$:V*G3`%:H#RA&PQ&ONLW3#!UUXGKS.[J.DN@_@A0&0M0ZS<""(5-OJ\1UV MK4'3*TS8//0A%?8U"*+QU-MPB-RFT\"(3-4A1;8:MO8%!YP3@1""#(V8(0@8 M))$H`0V7S`UAKWD-8!H+RV+/C/V`WW,"-3B=^8'UK&GKDB\JI-DNRHHG?@BX MYK!L7=->2I(W16&OS@N<=*.P8":D5'#1_K0ZNSZ@,YRU+W7`)P`$^MR1B0R9 M`@+,A*R(=C'?TDBCG%[?;>+[<@1?N[H5)-/GB5X&AS`0OY"88S`%H)!6PZ)Z M3,1STFH0V"(W&!:&]+*`T(!G.ED)X>9&GI?ZRFQQ)`3%YKD."$\?>,;R"!-Z M\Q9#U(#6`X6_MMR/HDX],]K&NB8<^9A2XLZ'9R10[.@B2F!")2< M2G0!Z7F0!U-T>F!.F25Z5A$0VLX6&X'1=9J1'?M9'O@?Z9ILH^4#ZR)F3Z([ M3O^YCW?;9X%9UZ0R"K7!))?\P[[89_27.(FW^^U-],1?>EZOZ;M*RD/0KY+Z M"2#ON*K4I"1[E>A!P?5;X2MY?N5%KXF MN'X<7JQQAK(V#(TDB"X^V:K6AZXCI!TP3?^Y)%Y"[_EXLUVB=G+)+P-Y>O]( M\_POC$YEFQ#Y^6`6D,+\H3;`I'117$99]A0G]^*$;JNDI)`%):6!K$<^*_STF92& M)EUIW->D2TI10>K&Y1T((?-:A1X@K_7@@[&ZIP/*ZAFQ:Y>+=C2+T]7[!-1' M@UI'`O(A'Q6$,C2G:U(\4%*Z_'QPZYB/<)"+=KH.S)K5D3LE$+X4459@H1=V M%@]45X/>.WH?)_Q6RV>+8=.)/EXQ/#S[QR>&WTS6%Y!9QD+OFQ*]SPBB;^:$ MZ)O@ROX;$:*NDF7&!]?>T?*_=D-26A6PD2F%"I]]>ZW77L>I5):=._ARA=I1 M*R%":AGR0RWU8\BAP(`TZ$``!*_`T0"I*O"@0"BH]W([B+4#N/#GW8I/M"!Q M`_%5#7$^6[H,/.OYA+KKT)<'L,\^$/9ADW[C"TK8/Z^21YKS`YF9\Q_B)$J6 M_-_+(GX45]D?=GH83CO"4BO)G./4HL45C&^'EV%'>@,+.Z.,E)F8JR@7,O*_ M&BTB0S=ZR$%19W]B8,(E;1[FU=/\M:H`&:.K7W6XZ<():6.^!U)]X>@"(&8Y M:5X(,1Z4JF?\Z&;Q\(S4PD1(M]KD3:-0YO='`708JQ#P/@A/+CHE,>G8Z..G M#'#VQ!./>,)OZ++CC5Z(,41`@-3`FZATLN[GKA!W7WS1X[Q%CYL7>L@Q$"(] MYKS_1.IQXS47A?1IL-7;U]>A\M'[IM;9+!M"4D[(;Z7$"P_A8#HB)H8PNO:E2)>_?S1< MD*!M*R\A^FTQ8X[<#]14/S`!#@@]R4-*%@\"/'I>_W)55-5B04&^KHR24`;H MS%R]OTNW49S8U.5="4C%74OX2]1=GSQ6R8TAQXQ:R:LK6_*U;!(6F[0(@*4_ M*6Q`::V4!"8L!=9F9IGNC$Y3>PC#,$_K-/GCD5WP]J5I?T!,YP1)Y76<>--0ZUS=&55WVV6L2:),^A]UX&-$>-, M1S7_ZH#OL5U;`W%&=FO[VD=W:L-DI.5.T)3?9_6(/[8D=#?<%3P/[_X4PAREU"O_ MS/O3D'DO-(.AY5AH]J?0QJF`,Y$&(<@HDZ>Y28-G'L>(G&8K52ITH\*ASF": M0`&CN^6$U+7FF-* M:BO133NTV@7%,3,\8&E)#2Q08FJ)`U/3])#T=WXCQ/!X?/*!]_"'`5$@Z#98 M/@J$?H>[VX8\'L4(,8T`Q*,8C\8!HM.(\C@@>AT3;AN:;-"W;Q0!@F^>#P2= M!E?'07#60Q-ESMU&=QOE$8E&`4B)7`GX8U['(X]E<6W'D62EN&Y\1K0(JZ>I M>_!D`OP\B7WVT,1,Z"76E)VV_V,,/-S M8H?!WBB\B1/_>XA;=G[A'SZE!26OST,YC189>^8>)1+ZYMUTI_;K@!]^QC2=/NVBPR5?8I]?Z^+WA-G2[L1H M*XV&7!GA;5S2/4.I3S2O&T95=K-Y6R8`!?>JKV!$7N` MU!4;@TA>0N3__/F//__\FNRBC#SR%O]._LO//Y_]7/Y_O50_VA$J=A1?NXUW3P=.[A!U:(=O&>O M^"IGRNV+90PR!W99:W5\[[;&IK/,%_1HWS-BQ>F.;"_VE\^"#?[2]ZRCB088 M&JZTI;24F0Y)OO/#P)8SI(;9HA.X3PM3-A'8"55AQ>.+)J5#8_)0PA27VQ)^ MTR5-\[AAR(%1+7AJGR:%!H+22O'XSM928,9+K(`D@V)1`FR9\]^R-0IPR MC$7BI@[?@*L+)E.7C#+[0M4T1P%#5"1D=5(-XTA%5IT!)W?K#Z3A]: MNRBH'::39O"([!A:\^>#5IL$@XK74!+.+V),SIQ>NNW4R:1NA\W&KGWT1-&H MMR)8)=5)`N1K^6E`4V+R5ZBCB_1M:ZA1MM<2P2\P?`?EEA4'A(A;/&G&ITPO M3@@?-L$3C!"\#68#S9[NR)+:<4')>3K MD(_.I:>//?L!.F?T^2@,AD:\UPARDR,1V*L<3A9M%F7$6+3-7%SL:))'19PF M%\GJ,RWBC/)%@#9K;6TU#$L/N`8L7MKZC%:86!@&416L;_%^N]ND3Y22MS2A MZ[@@-TQ[B"MKK?$DH[8C*"4\AVJ2TMX9V=/&@#3A"W^OU^_HFF897=U&WR_R MG!8Y@/U@60GO`;)HC`?[B<=UB$D8R\V:%H=F_)B`NB%A+4G9-$BNP]$C9;DM M^&3\-NJ0,SLH[/KJS@`M(X&8=W`:X!8,N)%X_)?G`U=(-\<;8.>>*MIE]('E MR_B17B7+=$MOTDV\?"K_%[!)VDI(@:.>D#!+6W7`4VCH?N:DAN@.^??OB8YGDX M9W=,!&50^O(+YM"2V"=:7*]9JH7GK;Z$.54=)'P1N>^3MX34,N3$TD9>2DM2 MTO*,L&:\E\0:GI&+HLCBNWU1'QQV$V6L4`J6N@-X0-BJP!2`GK4DB)'3`7&J M)-*Q-PJ1PU2Q85@\39BYY`$GH,T>[?<,6N__N8]W?%S/M,9-UUH2Y:6MT8BE M\04ONLN-P'@DDUW4#TCS)+S5*]K7+*61&1HK/*EC.BZJC, M'Y4GC_`3OGJP\N-DJ8.-:6\,.QH4^>.-8QY,"QEKR:8_QQJ`R3O'TSPY20,3+L M(`E@F`9G,S+L,J.KN.#_@C)L*&%B6%O"#\.&/GEB6,>0`\-:\A*&G9'R>?5' M^',99FB8Z:?$DY%^!TD`_:8$H:=^BM[>*#26_94V'M-U&XRB"W-=L/Z+^+/L MTOS*VF<%*QF*@$Y:Q84DH$^#`\JP^C8?3??G&@5,.>$C]KVY1H\\982/=O?E MJL5E%5>`E^2:W[R97RJT&,GU47,Q+AQA1B,:D09'!N]@O%>@[=T(Q_ M$-W3UU#&2$1,O.F(^&&/Q"M/'.I:N=M/J9OS6E2IJO$T%4)>WI&C@W('(T.58")FHXX:+9&C\=)B9FGFW@E7(/N M6C&+#`FI$<$BH]$K-"+J+(%(J%:PZ#P]BFD:,QID%(1B2$(_I:B4>G,BSU<= MIC)[X6#[_;T M*OE"V0^_^@\:J5<#PT6'&0`@BL5'L)=H&0%B$41+LZ)%JQ4Y-#LCK"&)$U(V M);QM,%R%PT;&65O029AK5"%E<$B0]95*8(9QL,M3"P]+SP67D)SB"9F(!X(! MC/DZ&`QH&@F=YP*=__9LT&D^,,P;.N<]0$SBX((R0 MDQ9(7:33XH_39M\]5DM:XX[TUNA4UE"EC"B>2"T5X!E$;M"#10DPAD'A0JT- M&#E"(\-T=9C!!W16\.KLPYY]1LDV3N+M?DNB).$,R=*G:!/4.LQ9\.]6SGED M0*`#"9_H]^+V&]T\TE]8FP?-[(ZE`O"@PE"!YUI8Y;'O`0:)W3'%\$"=:;"! M"Y!2@I0B`8<(/;8L:F@#/N%U=%^1334].\8G'I&0FL<$>S4Z\:?GB.`1(Q68 M&)Y@U&)@:[K#[\N+R7B[V%98"W;?C# M+:1T0D?NW#W_KG?E!2%7>;ZWR"Y2(5-JZ0GYH:_4,T])I6_+@:]=%?)T4K8A M9:-`.2D'A)F0.B`9N=@1!A!Q>@!.DSR&)L`Q2>/1?O,,`J-`>0$ M41+GUP79L?;!1(4RL\^S5`'KYK`$-3&.^ M(1UF>FMGX%]W:>*>Y\R:H`E/I\EO6#!_!\\I4.O`B/B@T:M/BIV.%]DST>-) MCP!$PL,*&-[@Z*+6:!%F0N3*M+G4X(<7T@S[AKUAQ!=FC,N\GKD19BXV7&4` MDH+F6.03Z4&^>E" M$4U;-??:;;$9-_0#G6<=$U;L:DEV.,4_#Y=(DE>KHX\2"1K2'&2T5)D&.+X+ MMIXE1P0=BJZ3QI!-T62-HE`*'^[1ARC.?HLV>WJXFEVSU!HJJ0_"=#;Z^OWF(T[)FQQT,ZZ-+F/$TJS.+DG^0F@`IAJH;B8>6Q8 M%8*-YUA!!<&=(_0#>J`>^NXL69Y)951CZCP%>/(4&"P6M0CX?"F3`IO*9'*0 M3MS?LCXK"J#HV/I?&*`/TTA(&AH!$/[$;8',T)$5LKT'Y/!!HCOK(&)PU*_#I[ZN$%>;[+6U.8>'S MXI_VW+?K]?M_[N/BZ=!$-=CLKJB7.UP4H9#8_1O@9!@G^V:&.ZA=B/6SAT_. M2$OLC)2"O-PK15LM`ZGX1H!Q$"Y&`[L?/^P5#D/*$9'$2_)S=,,'6WB*/#`B MP!-@YB6#,9W.0X>`DN['.*%7!=W",NN@M39]MEI[H/_`%Q^)L&W$EK\'V7Y* M(U_Y,R(>!E+0FMZS@8PJ8.CYUDB92#41DB;(%EU;SI#B8CE MJ5RU\6"*,M;6'Y_D8F7OW[J4>N&.&A0AU,VZ>3U0; MV]^+9*D26@4'>'.2(^3L0XO-S4IVRAQ"R/P4L*M@\=*LR]U,UDH77\)\7'!,MH&C,N0*GO(#H%9%@NAH%BP],2&*%ZBM4O MC2$G?+!N\"]1L<_X\O+B5(!BMYX%#)2Y.YJ'4Q,-!W+H&TNRJ:PQ&B?4GN!E M5:D-&"$DHHM/8A+_)GJ*^"1H:$=H&%ZOE"%&.,@X,A22\P0`GP!V6AWJY<]\ M9YAN-,9*'KJO:BCO=Z>(RE_/NZ@D9D=L!QEH,^R9:BUE$`+A,-8.4_`=(098 MZG.?1H_%[H^YD>UQ5`5N'Q'DO15F*Q9>PUKS.!66W31E`J`]8]'R&W^+)\H*O]1AS[_C%-[E_Q#A#IY9>*VTVX^EU:;O9UHJLU]"X!& M&71Z+=P-`0`TV4\TN&P/4*MQF%J8!]'SK/T:LW5`JX[5=]LMJ^W$)H#!XJXX MX6N[$KH4QQ)]BXL'T&8"ELC*S6K/C0SCY]M&TV&Z)5Q3;CPPF$>DQ'D5[Y=- MXV<'XM&KK<:#>.XA[H-';Z,\SK^P`!>MKI/?HBSF92;KD%'8N)U97-LITHE[ MZ"F9O?71?=):M>U3:90-A^Q$8U*V)BS#U>WYF%T@1P);P\G0^P(#4M\E4ZLQ M]=."@?0$<^8&XWC8YI5<">96P)(60%Z;M;3R'C@.\-='WM*;M26W3MLP<_'6?+Q0M">U`*DD0J0_ M!%0&_L-QJ:>_1H^)_P%!>X+\9;*.B'&>P:Z2N(BC#:D/65H%6H7YA;)E+O,# MYH"RV<7W&'947KNA-C^5#3VPM>V!CXQ3Z;>EG1`;GHC'/PYR.JGS(@U$DKQT M/5^X@(D84H#,ME2UG2(EM\^WUFZ>% M(E"5,@9'`54@EU&6/<7)?3DZ#5NO*171+]'LB?A8NR;URLM"S+XEZV5I706+ M[L*8,_+7+,W#/'U>_N9-B\]T>-$7-%U1XP*SJ5$VQ7GP0X/CX,9C]_6^R(LH M6?$S5W=9G"SC74@Q'!=PM@L<1T#.TSZGGI$I=CQ)3(Z$77GR+X=:M"'I`8`G M"SN['5*C8!?.E+)TC2][[TO@G#)`WGXO2"T_U8KYKK^3[05IS*(LDZ^TP?>" M"($@V0S`E,OZ>2DL#2Q7ZW%:/3\/LJ>]!D=J'1'BO9T@N^<)8XQM(*.![*M^ MTEB[/3C,\2X94GF!^/A%&LW-(O3 M5;RL)L9`!9I"1EN4#60\<%SAEX_B:VC*EL!]#<,BJVX1\JH'%10,!-4C2$_) MGJR)AC,`;X+:2&9Q)`)Y#=1`;G?JD+.L=<:!+J"Q_E^3:)NRK/0ONGI7[7<& MQ7R-G#;N2^4\4%#CGX_X+S=GRT"9EF$>:+4B[P+>HZZ#B(&<9G3IZ2F1-U%T M1F!.D!]45A$0RO-$&Y(KCM>0ST[`Q:5EXL!!9D`)I#[&C"^N`V4.F8`V970% M/%!2YI&/)-&S8\N]CO@P+33GR;T+=!FI],4;"*&^@%>H*Y;'0L@SBKN`**&Q_R.@_]S19/EVO789\S.+:D*X3]\`_L[<^ MPKW6JBTE-?!0'J"!&,PCH=MV1@4 M6=?-GQN2+;.4#RP'E,$^15OZ+MU&<0+*6,/FV@S5;NZ!OD-O?&2@CA5;5K:$ MAQF&/R1?R\-M=7>:WF/E+@ MP!LO55S;BG5F.PA+JC3V,+A3U+0OVY2Y5/`PY*E&S)B7I@+4%#54UY@[LD2- MU*RBC4X23[:5CP.B`JILKA*&*)H7_)R-+P7[GQ6KPI;L070/&V*%*-!&;KT" M#]2#>.PCNAOLVK)2JVZ8`>KFXORE,U)*D(-(B#0&8.P;T9;)RQ>F/2VDU9J<8B6MT0%47)__87&1 M)'M6:75PS0=:DY3]-Z-+&C^&M?]Y0JC;K:;U!O5PUM-*)N]O,KJ-]]M/U'FE MU5"#[9JKMH9I%KD,?9YH'5;',,)ZEY8^V-HL\D,E\N,985(AQ@48QNP7QRB! MJH\+6DT.RV7F1/LDE^28/4`%?KGD*Z/11@`]VNU8VHOYK2T!G1X]);K'+P)# MPO?LHQ@WZ29>/D'.<%*TE&2R04LT#BM\P,M,0P,P(O;E1*8Y(^7'Y&OUWR#/ M;%*]5RF_]""0L:@G(6?+9(CQUF^7V7&"SF$K:WEW1:]D">A,F3'``05@%^C, M'E!A/1[^V6>&#?I+G,3;/>RN=Q>%SL/&0X43#T:HOM'4P\H2/S!'*`;J[8>= MQ>=$*#DCE9IPPL1(_(X8W3!PPGVLHZ]XS-A'<#R;>6A;ZHY/PHD%T]5[/.JQ M[RDHA#@V[I-$,U*`,4RE51@?/][GI(M7<7+:$-6 M])$?=+9\'@`%)Q%,B`:1,C[31YKLZ>%(_8L[UL6+EJ:48913I`R-'"IAC?[A MI@R=.3A/U5H.+*W:Y.1K_3"8V2LH,I3\A()*Q4ZEO)J=<#Q.S\T/<1*QGUT$ MD$/8T*U\`LHIN*F10^6FT3]<;NK,P;FIUG+@9M6F+.O.R*%94$N7H"!1TA2* M+Q5-E?)JFLX.3:^#"'JK"!@5"\KILCR&),[SO8!I@,6=#U2"BSM,7`91W%VF MVQU-J.BY.V_!EI-)R12D=8L64$>#4]RI&$4'J!'1S*OZ=;1'9]LXPFZ^8RL]F(#!XVRS1/)"[[:*MT)]M'O-%O&>3"S MX2$QRV(09TYN!5(9L((%,BL`F0'P,=;J<63??NBT/V+?[MJ%QL3V.],/A-H, M>1J&-WT@P',*J"U80J$S8LX[4'SO8E8.(IV1)$U>'3TN[`;##<@()]I!>SC# MIH#93X_33?[G.)WGDH9Q,=#"7_).09-$#K-"L(D@CWCQMF5.8EGP5K<.+6K$6^5H`N)=3,-?JN@"`HB%[0[LUP`(EEH0%WB9@5F%+V@!N&>BX M=UB;;#X8"BH(79V/?P@0U$//Z_-M#Y4RJAE2]="*?`WPK"DP5.#+]>$G49D4 M6"S8GQZBGGMC6K,86.WTS.K]),\!EA8]-4Q@AM1K@V4.6)KP0SBO"<"%04.R M!,D5,#'L.&`$O!\4>-U7V[9A#0=Q).`^+](MS4BT>N3K_W-Q!L/J,-H5<$P% MX\0V6AJ1$D0<;(YRJ-=EQC0W;ZDS2)E._.E+^3D!1>Z;I[-]!L8Z4%3Q?DV%DMUB MT:Z0L6B:`C]3#&BX+1D="+>GE,LB.]#5HN.P9%M[6Z()?=5H3[W?=:,28\Z( M.HJUHR.Q!%T_ZHBE,->0?HP3>E70K?VBA($D>'ZS)>EY>G/@H^_9S;;!,9.; M!SWZE0E?>4,B6H8Y8Z(%C,54IPIM\)G.1H/-1*<:JK.1]^U3RS_G24^H%CVI MS5I\$!SJNQ>R`XQ;$]^H4](SN'OJ+B#O3*.*1=&A3Z:"(6@*$Y98-H0,DS9C M^`B3%%-T7D`^H+-#G-JT?*"K_49#H137_P&C2G]`]$W,2 MS<>_)G$1XGFS4W/&MF?EG34A#8-9[-50M->G58^+YA7^>$F5SOLS^M*2]!?N MQ@S5&SQ7BQV:3?.-'"(I'T79NGHQV60L"FG?WB:)KKA48L;ZC6-#20"GT] M@S5J[%L<>AZ1S/&_.3^8YKGEU&6/:W3[%N4K4R3'!8:3$%9I\$/ MQ\P^>PKA6L,.1-3HDP?\1H!P"=(1"92\`("9.0U&J9'H:DT`_H<$]6FRC,$^ M*N;K=79I`_(-!_GR!>3V^4#8W&':*#0:<\*_)_EU+=C'A&:L%`PP80>N;0885A8_#0:P,$D!#) M,$V^!/B`S@J>-W]-]OS^A<__*=KN_OV=Z-$MA42H&7,BZ-MG3L_@#RN#-B-' MS<`1-&NJ)4V94B;I)R"H??24$:4&'?@NT2//?,8T#S_2PNGT?/"J7W^04+JW'DF3OC!PDF1Q7=[[AB_ M'YTO-OI,E^E]$O^+KM29!BX[S#4062P.P_U$RS<@DR#R`C0MJF:DW8[PAF=B MX1@YM`V&S1;8D?'9&GH2/IMU2!D=%G+]71H`M(T$8IZ#WF]WF_2)9F39:AI. MQ\@[9"%)R!MH9TY$NXPN8Y$:E?EFV&205MI-D#@XM(J5)#J:(31J"2S:?X7" M$,D+DA!!^1J':#\TE8':Z\OV-`S5,V#WULO%`*T?A2_2BK9\X^._CAH(@,`' MA<+,82R+'YD;C[2\7CB.-E=)7F3[SGV",V\]$/`'DD!;?AG3I*2M,AEVVB+37.(' M=F+KFK!A:ENRG:0:0H;&0]E;U;!-#0(UH]J96,.;B3#C.0'T+3F"IQW,-Z>' M'8MX;(^>0&)K_IX%^M6*KEH?&8.L3D@9;>5"R!32>88=?Q6V;+@D5=&*R*R' M4+<@K4_)UYMT$R^?0CQ$`801#?\`V%+34":LX^-LF/0NQJA*I^%G%2A.X>0"@NHOB12U%#F(L M2PE!PL*"$"6U+&'"1$CS,X`JP:19$?-C@`Y*`HD@8T`[C"OC*3"(-0XJ M)1'HN`CE:V;;U14_W.+)]6+UCWU>B-/SUFE&E@_\T!D2)V0=Q1EYC#9[<8K0 MMT![7;.SQYRK9^//S'F]/K/H>LT*N!U-VX>C=9#M1VI%BE,HWPVK!ACK#"1DC;.Q:!WRQP\Z:ZD@E8[R[+*SLB)X M=K(<%;$MDP>3,,<:.TRZ+="1#23Y<;P2?OS!1'$/+>>L6X#C/Y MZJ_RB)^+D';K!LH\0'D1%O>.H^BX:_M^<9<76;14'D:$HM2UY%`HG3;`:;_9 MQ`6'RA?$J"8W`0]IY&LM=&QUA1["[L$-0@WGR"95/B*PP2@W851+MS0OXN5E MND^*[$F_?D_7MA^#Y&UQ0HO.#Z2(H3`!"`12R47]<;E[!L23R4CX-#5\_!342DN...+%[P>ZHEFT.4'HF.O1$>"9MW;?G.RB)WY%R"F"RQRO4>`U=^3^P'Y" MR]AM%!E&;XT(%KN,7J%%<)TE$+'4"D04YZ@./XZ;42`C&Q0[$K(I1:5TFQ-Q MOB*ZWN`XZ/&H_IDN:?P85$!'1ADDJ"/A;-;`_GZ?I3NJ'>^0->D%[FX3%-K( MK.($YIYF,QLZ`HORK\#ZG=)W-`"\YDWVX=UN.H2SY_?M)2P.#-B]>'&`Q6F\ M>F-L@[_\>6-7;T5.N8#>M+X%*-6/<"8I'!+`?$.*@T9C`(88="QDBT:KC0[! M;GB`(F1(,BMH#5BGEY80,01,^HG5`)NCP5F?.:\T6E#T!SZD4$8 M5((0ZS@ODI58Z:D\^0XH94@0`RDO9%3XYB=!#(W9<["O0YH@ROT&XI;4LEF8 MI%0!PTA*/:),E.Q)FRDY"Q0GR0LRFZ,Q*<\+9^2N0>7J.:#2.E6,Q27:U8TF M.WXN<(18'8_-\S\LWO9Q2)(CJ6+0H&FZR!$=FG->ZMCWS;:#:]NU]=V!F*@[ M.ZXCJ^W"!KBMP?S2C21S[:=:=`XF@]8DU&&FZCV&2IOMJ876/2ZT#K'!\`F>Z M#N"8;A\/O>4OQHOHN`K`&Q&`CZ&:ML226Z<.B":_';@INVUC.FN\B_9)C:5J M'.&$(.74&8-"*J2.E]VPL=UPL=^QN4F&A\<,"VN'@X,>!+8>RW`;]`6/7$P" MI$ER^[A!W=9@[KO6,-E197A7;%EG>5MT>:F[SQD_2M=H%:2B`PQ_2C,;W2:?%NY@)\LU) M<;09D96AJAVRM%GU9!$(^BVGR^(`CW`"D]&019:O=`W:M?6=\7[!,IC=K:@< M<`J$E@QS"8LF$VYA\HCX.UM%`7)L&B*+(W?*-B_4LX7-T9$O^)KE2\$^NDA6 M'YD;FZ:=\IHC#)4.-8I:Y62QS?2MIJM)-)[@A#"E`8L:1.@0:ZN%EE;[4"ZS M0(&R4[P#$L0ERJE4NT6W@&DW6RFA=<@O_\JCJCFOBNC[F9B%3==D79W?QSXC M5&A_X9<),\$S+/BZX5.:K.AJOQ07%;W_S@^H[9,=2YU#O2!7-UG0TGV;Z>H$ MA14X!18M@EJ!R4N862F;DP6[[MN8!-"IY; M.=B7Y9_/&>0HN1,/Y@'FR)D'R?WUSN:"7]SZ;[..4:C^QMJ;/W&3EH(P=U9ZKT'MYJ8&0^``/A6,+!XJ.U%6C@/')& M3UA1N/DV&;5Y#5)16HSD5SW.'^YH0M=Q\2-9E=/*J_*P^N*!DJBZ$H()[<3> MD+LG$NUVFR<>`GB#O(B*/4N.3\TD07RPD(F)A)3L,LK_K)Z4^[F:>C^Z#WI0 M+KSHX%@_A1,?`JRX5,7A9YI3!J$'E!&*OK)1(Q4'93/TTOK?9(Z1BY8/V)VU M1K7C2$8M?]1C&@.TCNSV*=`_KO-7*QW;"0R"30&,?71<\44K<2O)?XJVNW]_ M5U'FA1\R%`3)D."3]^4#PRQK\(ZR6I;YSAI=Y#DM\M^BS;ZL0S:;]%N4##CL MV8I#NK>R,EGDH)HUNTB@_GC#J M0A^G^.K.4Y>P:V'-+1X??4"8K<:Q]7'RR,"KH@/C'QMV1R_LQ@7>B?`[P$), M-A(T>FIJ].S3Y,/1<\TA(8\EV\\$A1RAM-`:,52+-A8[9KAU0;WLCTS\ASAC#BY,`;0`2:WWEQ&\:&<[_I23X!U&H\860!J=AA- M,&J>K,,`_([3C1J8'<+I#YCL6(P.1`6I=)%&65\HY`CFAGJG;H(=I5PZ!@8+ M;IV!H^'K;)UZB%^3$%<5@9D;TPT1I(1\;%>>N5[6Z3/E'ZA6:/ M\9+6)[+3U66ZY85L,VZP%/^Z7O.O=I_$_Z*K&YK%*6N7%_G'.*%7!=TJ>^Q^ MK/3K&&PK.#'2SW='JF_0G0.$3&2;BUHAJ326Y\F^NN,Z25OI&3FHY7O3#XI) MJ9D(U>0K5TZ$]E!6GWHBT#`0>V7J("3C6I.$9\\A889`7:3+WZ]WW-M?Z/:. M9J:0JVJO"I[#]KAA4.4/D[4D<3SR6;?FACE91FST@Y@]AN)3JCK&5!GFC1ZJN>U9W5=9J1E@>!!>QI MV>_6D?45A9SZN6C..':#GW;?FUR0[C+0MVR%NR=2<\=O4 MZGB6O<2S$.(9O#?V+"):^%,T+E^UU7<9-7aNJ$KYK.^Q<)?N=`B_8>R[/ MF)`ZGDQ7GK='B$-9USHICZ=+7IHP,EG&:OLP8:(ZUBAV7(7VP/-`PIFYK'X) M/-,C^AF&GB!*X\]T$[&O\#&.[N(-*]EI?KG/^!TWAK+6**Q4,S(AJ0ND6( M:SPM\3-DM!,`!ZR&:9%PVQ'!$_+[GWOFX57"T@XK>:_R?$]7UQG_+[^PXI:9 M?Y=NHSA1$=Q2O,]PL#@.Q2V]1>(XW"J`Y%!EB[(EJ9N2LBUAA*];GQ'>GGPM M)4*AO"VBAIQWP^2`]$`U$M:[HCH4VK]]XDY>?(^5>=U2W(KV;?$):#_T=@K: M=ZR.I7U+V8#V)<7YLZ,@N`0[E@17HL^.X`T ME5)WT!:1IPH_,$DY-`%E8%^RIEOS>9#95/5J%8QS26=DU M,]%"W8*W%4<[4M)J?4;J]N0@$-`)#P[0&E#9&9Y]?L,5#4D?,,2]C,I:FL?$ M.A^G/7SR''%L')R=!LFS#M M'T#=/H^!_[G/LCBY?QOE<5X/0C\)7:8$Z,.6*E?BVL*-.3Y^!^0,C.RB10!# MM=S*ZV>DI9E\8ZI)6S.>\KYI1*5?B(,G#7SKD^EWL`BJ!>.J8.M1THK MHS*F34T`?RX1Q*[`*?<;O$]6%D4.NK.KV--N*8X:@@[^BRW.'ZYO49 M87GV3R^A`!^3)Q@,T';2^_'.:A=^&0Z^%%%6S!408+OX?=G6!80W+P$!'Y6G M&!#F//=`UV&]I=G6852S+68QEEF*>1_>:7OG?]RRLC9N!$)V`S83(G+R8<;&Z'AH\KJX`6'Q#$`X:@31#89AC!:^?6HR MU^4FRG/-T@^0C"H[R&5PB:CS"SDO*$Q9,$^J87$8BA(?!K5\`_;^U=0#P$;) M.IFLAG(@M(51D;V+'^,535:.\\TR<8L*K2ON/2_*O/5?L?6LCDN/'67F"JYN M?B1SS%(X6653#2!MIYAN5L\-O:-J0AS\ MAE$CEA?G723M'4K5:,GJ.FG&05B#3RG?A=T:%FENV[NERX>YK=\1`60 MZ7R9U&1'?)/HX. MP>\4?@IINSQO+CEX@IY4"-=-A/)GD%^&;)TTT:B"Q909I_%AVM1SE+'*>P_= MK^>!!"UQ,LCR@:[V+-RD:Q(UO5@&>+HB<4(>:QTO(6AZ;#_#(!3&2(GE&A+% M$A*QK=0X"^?#%M+:>X.M69?*@7Z'>=?>FUSTMS9.;WGLVGO=TONS\FP*%L@# M.4S*+\_0UMC9T!IKA9W6)MX*NZ.-(GZ+3'1/9PHGXJ9G'E`>1=^7E9'?HBR+ M6->7Q-6!-0F+,MD]S40'.-\S6RSQLWASZ=:_S"'@&4F[+I!,LT=!9M-`UX`*J;!!9X.%EFE-]L&B=D+AW\*IC,,2^I^07"7(8J^OG MY)W/MGF_`UHM2X%%3'\4]-UE5=/>N<_PX/&?4X=7_ M+2L`\G5YE3HMSY'<[UBIE3?-^.[S#O;XL2#$YB+J3^&=B729'2<:OFB*A!,M&[QH_KVILE#T''EDBD2 MQQ19(L24$'#\GS[82R/[&2DUBDC>TEE'?+%P2%/$"\TG&M\G"N931F[/83JT MF%P?!_`YSG__D%%:WS5D>3Z,3AQP/HQ MFO#FA^NZPCX@1HLGT!$;`$3JPH=.#>R`C0`P/=D!,4KC>.#F\QC\\U=K#N.X MAG'V#&'L=%(,+I##&.IO][F;K/N+.$+98EF(2A2PP&,HZFW^5.6EOT47$HMN M$YD#1:J%$)V!DZ]EX]"J90AP0%.+!MA!I@C[*F"3?3."=K*M*E+#..@5B>C9 MHM1I*AL'IV'DG'=QOMRDW,?\XBXOLFA9F'*-1D258Z0BN#35>(6<4^26+-@H M4Z`:>R=?ZR:A<5('`S47S>!1,E`BJF$>!'*SG!C=>KNL#.5;\I9/L'.C39+J MTZ/5DMAG2)M\1#])6F/0ZCQII9Y%>VEK\RC4LZ6-&-&=,`T$F)*A:@W:TZ;! MZ)R%K\T__V=,,_92'IX^TD?V;D&4!0BK6:L5QB8NP%-T[NIM6M%7IZK3/VN> MA\I@"&1T)(9#3L-CC1(ME6T@.P.;]1,<8D9CL&ZTNVRT?S9^]ZIW52#P;5<5 M0_S9Q0T_OG\?Y,CET5V+H.?-BW9?Y.ZI=<%K=:M&V2RTR.F=8^J@.Q&]E?': MEWU-J)\LLLP[)@(^2EEE<5D+\1$X,!I,6Y-1J:E,T79.F)6DU M/2-E8_*U^F^X200$*#6E+?"H)+9.AX;@H<#9;[(Q6D;"=2_YJ)#]?-`+3TP> M\!M&HFI7(,,A-]B8E(T.R-HAM0Y_ZS%,?GM<3:0Q[;@P0ZE1L[ZH%1A:`]MA M#M!8`0ZVF@.(6]"B#I4NX.H.,/SG#1?-!)MUD%!(`D+#0-);0%#XZ"\,#`VZ MD;^O1WFV4FL".GB6JQ`#XK8>;A!&]S3`>&S"Z@SL+4\O$?-H;V"K@=42*K;* M)'!9JO8)F9U20Q:LE,AWV%@^/R.B!7D3ZI))#0;4_#,"1\F[H:2&;W.@S6]G M4&%O%.S$/4'Q?1*OXR4_051VHM[S`"&\QS<2AF'T[EI^O;8.^*^M`_YK[Q1\ M/57`?STRX+\V!_S71\"U/@9`7),#!\*TUS9,FPQMDP7\UZ,#_D'#XO^[3PNZ M(C=9O*0Y/];\8EG$CY3\$F6_\UW[ZS0C5RM6J+*1]E"6LVT?4Q9OM^;Y/1V0_QQ@?S[Q7D M73-:MR>_!$+CC=^;:,H+O3Z*"[UJXWQDIC8?6.*9C.*^;YP`1QG(9+`7/[S? M1G$Z@>X8;G4V>!]0Q..#!)! M[NCV8,IC[/:UB=?#KQ!>#'?;K8YIV&\L#WB7HP^6>0WMMAOS$4WZ#?%'$$'\ M#B)@.SI/*!'K!_;;;90]\=&`GGN] M*[?UA9HO>3A50E78V4GW:S6H-$[PM/,5J:("&P5$-J"NQ6$O>[OJ:86J0^-` MPI,EC(81QPF'@Q`"TR*)"B$"V4]BM["-ANCFM(9F/'X37(*=",'F-.@9PY)D MY1?%YU8H3@NF$`W%YZ@H/O_#XI;[UT8OV=9]T:@@-"_B;<2W*AQFGYX9O,_G MAO?YG+58FM'X/KED-23?+7V;14D>+<4%2Q?)2ORY$:5C=6Z*<=AMK+Y^O>:N M#R=DC/T^2#7="#<`T<19^Z(2);4L:0N+F>JV>/BG=HV&[S`,(3%B$)9<]4H" MU;&2S$^].][],Z=%"^-8@.8) MC[?B6,XK+.]J+//:DCY')!N3FE\LSYNN:$*S:,,2ZL5J&R0+5)<.Q<\/O6,3 MT2C\SIN4,M:C8CVI=:P<11NVZ">8=@L<+@YM(B6+CF(`G5KM%^(/4OX5"#N+-7@\(65^]Q`J>#=3/=K)4N:@G2 MB)"#3/BW;CDC<,#QD5CNAP%;=<-8<22L\%+`.SF!3P^>LOY6'\MP51[+$"?D M,DT2*F9ZRX-J&G6!+!2=CQ3&[#@]+0+(LWP6Y3I[%^>[-(\VU^N/:7+_D75: M5A=Y3@O@0KLQJJ3YUE858G1Q^Q:8>=?:`VAPL52\.$B1-".UG-CHQ21?"5%2 MRAY+-G;$J"+XC$*\//S8J52%H*/AC\<,[>"('R+Q3-VFDH0^+Q2QRM%SD&3> M7)TLTRW]4D2%.$#I([?$2KR+[['J=$Z`1#_SZB1P`H39)Z0\JC4$8+E&?E$^ M),U34C\F7WF#4-(=X/T/*0L&S8"7:DD)_2R0-C7'^)JC#^R79/VH(D[VK(:_ MWM&L7"O[EJ[3C);M;J/O-/\E3M(L+IZN$I:9:%Y<)*NN%KY0J7CZA18/*7OR MR)J(>STO[OC.114C)\G3BARQYQ!2YZ3)O5(E>M>(BC(1$OQ6J0=;6'B^G8I0EO6BYLIZ^*Z#O9,*TOL2Z$6&?N&3_3:!=`O]SJ M^];LPZO]^QK'U_`'C7-EDOYWFJVF;CGB):`W^JUKW&XA6^LYVF@]0#%&U%50 M`R%V-DD4(P:&P[=0*K"./UZ)UZZ(7LBCQT3@]`F@%&@&-4%#?,K6^J%Y+QT] MI2]>AN0=AIR&L@N&CA5?6KWBF3)/-_%*G!YU&)IG79E6X@QS_$8-`M/XO-4X MR$#*."ZOA-G4I&(D/YQ0!2*65D)*+H4$(L&T/F&23&4(2C2Y?%V?BH@;*)7T MKUU!)PA6Y)222JIH!0-8T%W7ZE09O)YK3^'XCFNC<*XZNO>-9NNV'OSP4CS7 MZD=V6BLU(8604?C%J+KEG$`HN>O3NC`J[E!X%DIWM>V.3\*U3EU[(8T.#D'3 M)H!^*G/G8E\\B)%WXRHR56-5(=UKC%M#2SU!+I_[-BPJYZYHJV@FS9,`UXDI MW["Z9M8A0EDN=X0TE;(>04$7R:[S6?.O!9M_#=CQK5R8O=`?X7A0"Q0"6>,5 M4E">EO1S+G((9VG#K$L:CB_\>3G)86K_@XJ#S3&C592+RU!6<)TOP6E>C#_S M\!1`MW6P9^1=NHUB_8BT00:V"ZJ6\;D/JNN7UYU0C2GGO5"5!MUNJ+))4/U< M$Q:@.Z*D$#+,NW9EP;NB%,B;8<"H>WUC>0GH5?*.KFF6T17OM8M]D_Q&H7(_ MUV:3?HN2`1GP%:L&HD8HQAVT&OT-D0>XQOAC,1CF;J8]<-;5-K0A=IE)%&6T@1"`7NZE$Y+"HI1_"<#6A&^XZ?IA[GH4:[-05?>:_E0,O' MAH+1"P5=0'14)`R@6\"\JPY9?4L3NHX+63](\4VAZ\G0#*B*%00#N-$0[1LC M%R\8?ED$Q?'FVL5,?6CX#Y6^'\_DH]SM0>Q>!13NXCL\CJC#*S8/E4%VM"%- ML#T]KONM@'#L]3*[SKF,UW%`R71-MWS,3XF MM-OS=>QW3R3:[39//#+P!GD1%7N62)_(FJ[$>>Z'T6'"W!+I?9=1_F?UY`>^ M@Y?%F`NA^R5,$*LTNY++KG[R&R`GJ6S&1"Q]S1%T'+`FM1L_P63S MBR2/,ZAR6\Z0XAGMEMMO)[330I)KK`=C*8PHW*RN`\R>J9L;5W]ZF#-3>^-K M!:CU3)E$6+$*-,#Y,D8A^5B_` M*V][$BW/KM8I:%/K\)Q\#>_X:0@,(#L4P<=):T1!>Q2GA)S?T0.5P7'8:_7P M;T-;G86),WA1-!II891'-+^)XI4IG'=;J2)XW0J705W;R'&Z46Y!CTJFNT>< M?Q08*7HO3,M8[3$! M#X=`5(01]+JCAM?%`\TN5O_80S8G@:5AR[2&TCX7>:A\];K@2F+4>97&0)=N MZ91H3%JM`^,B$$?0Q1<&(`+75_2U@!=1S(OD*=KD`S>(&<7IRO!5,*M_'$$MWJ97KN:?):WB"N-GQ6=^.^M]?>C+-KS@6BHT5=STBW7.*,1`6I5)-&=V>!)E,?6!!# MI0VTA$5A)[#,=;,%+H9/)PA,V1$'$T4`N*DB*.-74D%U08KGLS:?$9(Z'?Q6A`!G'`.=D;=B_?L MCV41/])^@3*H>>JC#?OMVOH"73KNB&!HW+.D!#"^F;2"(UG8')NRW@#YXHUL M@1['.C\_7"N`R1@28E9G'UQF=!47^6>:4_;6'^SRN%H>EKEE\C[CB-I?K]E9 M:M8Y1$BT661@_J`4/R.U_%%D7`W6H#'$"%=@S!CJ`4>)^1$_9:Y46$>$/L^' MG_]3M-W]^[L*UL\/Q*ZI#Q7&8:CV6S M`XNGPBLP^?RY1&Q"[_GM:@CI!ROMB!V)#)++\L_3Q^+XW.*`QA!SB3@E\2)9 M\4,2-TT;:IE93%I@>4:MQ2>+3;Y[S4$:X\ZT5NK4S=H*(7&/O1#K'/P>=#@P M0@\:'(`8!@8*E39PV`B+#%/VKK0^H+."I[X2_`5?II=0<=?INC6?2455][Q) MX)HOO=$@Q%SZB5^BN]JS'L#=AE93HW9Y5*#($`;2ITR,2ONHD.<)D7W^J@7MZHB: ML`M!;]AVS7WHZ)X[YV4TRND[6O[W*KE8+L4Q>\QQ&C]&S$]UL@.+#K,<0!2+ M]&`OT?(:Q"*(W69%B[H5^:%N]R,_8[IN2@YM@^$Y'#8R@MN"3L)KHPHIH4." MK+^A29AI'/3RI-0`-7MV0(6D($]0#33IW$1/3AFG)P=.-XV<9^+V_/.=:`[F MQO"TUF),,57#T&G;!XD%9^7X@M.UDK?AZL30]-7C`5A%P&@GD>R>"QQ'Y`]W M0(:7.;(]*VWBZ(YULHI8-\<%%H7DCX&H/YXJO/281886'4G:5Z3));PI:;4- MF+\JV,`HK`<=B,,]%4`:SP?9Z;*+S#`.=JL<(V"Z>7XP=4LV*$`-+.74=SY= M/D39O46^4<@9D\U`SA-M%?[Y2C-#_[YSB$'& MYD1=$IE5!(QV,DB5.8*O:<;C<43J<$=D8*FCNM(LN;^,=G$1;\J80F96;.9Y9'( M&!-<1\83VR5^^4IC75,N5&YK4"6K5IM0&2O#`H"D:@B96=F2A1!Q8N1--I#6 MMSD2A.4!R<\`;PYYP!UQ@47[FXSRBW'JWEBU7/HB697G\(MB`9P&;)09\P-, MF2?ZVGP37QD%Z(,+RT&J53FH$FZ.*.:E9'6GBQ`,-5!8H1,001S0;@XL$*60 MB!,\>R;+BF!G?!&)Y]&:,[3%F51P)GKAC!(90;)F_@3.[\6)-I?I=ILF7QXB M1M*+HLCBNWW!UP[>II?19G.]XUNAG,U4GM+$)]*Y4E)I%=&LUAM0)!N) M:GDX0Z&*-**Y:5:$M6/EG]TX["/-[E+P2.P(C[Q24\L*H-5-],0;7W#/[ZGAUE4DQ2[5@T'Q=$$,]`TGK"5,_B#%,;V9 M<96%:/GJCBLGE7;25G]$X1"&?[>H:,,MI]"H->`8(8^#MW/6(&;'IJ"PHB+) M"WX]8%JFN!<>VB#IJ)@X<\E24.9N83H%3-IJ4$ST6B%%&*EMK#3?5PXA?%=F M47\0VLE:\G M[!J`H[XM=\!]^>E9.7\=%OIE;U/)`/6K5W&@):'FP20X\383++?D!)E.#HW+ MG)'J45@44;Q?)4NT>%#1I"ND9LJ$ M^/':AY&8<@52N3'OKA`3SU%U7$A<-3TE*(%CKAN8T+L]/?6PWH_].*K2F#.@ MS@_'SIPDCJ`](T<";2S<+P* M#>:M-Z0!]^`]J@$=KW0P]O*V/>?1RH#=:Q<;`J/\@8AUJ.LT"S;001%@D1Q- M&)BY"U)N#GFZ23?Q\NF6?B_>,G._*X.9OOD@L*F:(\%>[PU6P%-:@;!`(=SL M;GHZ(^4S\K7Z+V]$1*M@]H`;WKJ$*B"<#$DC%Y,1:!9D>0JN&F/N$.MMH1-W M9)T:G@!A>"RBP@C/?\W27+T<3M9(%8JK1K@TZ5A&#KNU;@LFE"+M$"L^"0S] MW=>EQKSLM2IQ+AIKT.WO]5O&QK2(-A:Q\6#"%@?BIL#]G3!XS`B`QSH0!L*( M:[]%F[VX..DSS6GVJ#GVP22@BG<2`5SP*SU"CH,R.Q9<&(H?XB-I'I+Z:6!, M4;]V-6M,4%'R9R"HX=+T\/(V9:DU.`9I/`)_I'G^%];MKQ&7E<].$6;P0#T* M:&$$\`]Q$NTL2IP]QKCLDKJ"7+`[MNPH%!7M%W(UD^(>!1F M82M_S6H&Z6"AY$Y'2,.;Z6#D=W!@:,H53SP<-S"ZYY^<$G[@T=<)06%$W7=Q MOMRD^3ZCX!%;C8@J`DM%<`FD\0HY&LLM67!(IJ!50A\>DZ_ACN#J4*`FF!D[ M2I))1#54FP=Q?@.WRN`XZ`5Z0!HVS.#1?#30PHCLGZAZ`>"PB2IRBR:XO&E9 M18[,I68+.G"!=DW\*;B)C?8K4N-]^"*5Z&9--6CV\[K]AL7:@-U[/X))+?"[ MA\P?>B'&.UZ, M$N9!'/3[+8P^>1O"L;RG12W?+B8#O'O%_-8AO6GP[2I*25!/6HFO.8J1-/N= M'ZF:+JEYW92TL;(HZ39&SCPR3["+DYX-F\33$6T7XOQ)>3ZW>!;FO)3\/6N2 MD`87ZC34%M*EHLEPY+F*&9AR!12O9FH<[;+TGGWEDT*012GC@J$P2IK/T;=? M(H:A.-H8XZZLK2KL=MOBLD7F!W+0[9FPH$A'LAURV0/2/`DSX$I?L)HM&CPH MJ=*6T3!E*OCXC;4#2XXXXI&6PV=;?W`ZN($'60?DS!YB\X*?D5>>7U'O(=-$ M65US2:"5-T61B/OH1$B2_J6,6-M M2S>4"(W(HOZ;?"T_"6C83?*^%*!7O%8V/'A"T0ZED,_DE^ M$E@`ACTH&N8-<7F^YY-*U^LO_%2YUN42']+L"\T>XR7-K[/+311OE3U^%QW] M`&FG`X<_+GXCA5=+TP#266EAYJC(XB7_NOKAA34\%Y<7W/%7E?$'+USHOOK` MV#!O^DV3>P;S[67*NM)9$=]M*#^UMSHTE-4-G]B;K?[0K[T;H:F??ETTX404 M]^^`E'Z='``$$@>]BU9C(HYR#FWAWQC(#4/*:/P.`HJ]1DE`02##].&$NWC+ MC%U\CU6#7;JFBH#0;8K*>)D7N)3N68!SMB.XX)^^XA\+2IX1_H01DST+C)32 M]ZIDG08%*EJU1=2\T6)F/F*\2[=1K-H"I&]L($?=V`L]NI[X(4ACPYXBE:B" M).730&G2>\=&HD@Q8:)**60FBP)#4XX*L2*9)3=6)A?11G_-I+;M8&1'VA:I M.ZKQ`VMT1FX"TI.422ZD@RB!74FI?[^2KJ$9#L.NGT1&UKF;&#V>ABM4EAQA M))9)8$87%T.KY<*+L2G MX1]:KWV[YR)6>]W44%?ZV*JHJDLI@Z:XC%#X05B3!U:`!*B+UC&5'+XF/#/`Z*% MZHW*::%__U)2]$04I)@.+?[BJ,R0&VQX'&U!9G5"D(%%4B?0S!])^<6\5]M= MECZ6,VC:Q>,`"5E<54G@$4;O$V*451H"LD8AOV@>DKCU-+#UQY#7+V<4"#-2 M6LDE%>R:"VC^`K3&WBC$_?VU`G,G#CE8+$<`W?R1/;]>E^LDX.05'0\"FOR1A MM(H`TG+%6SV/P7=?7$:[N(@VU9S&Z4,3ECJ0P1E"&JG?NFEIFKZU/&4,6V.2 M4>4+:GJ0&`'S;2"KY5AX2\,,KUQ%,@-&%,3J2RGI9`35E!1*5C2[Y#]E4I0= M_\]Q_KNAEPV0&=!)*X-$*H!?6-32FX(03*=A43XFG>>$-PBN_P/!@H1G<`@- MV::1E7%N9N1YJJM,%D="L.R`"Q">/N(`I1,>YN8MF>+H+M[$14SS:O&P*L@K M&_8CNZ0A#JF4'B#%<)E^`&N&8HO69V>D^C00MJA?XY`BIE<^8,5`0$*%Z>#A MY4YEA1D7G/"0>LNMDFJI/MDS%K_X+]EW96H?]@ZU:,@U*.BM MVX0Q[7L/)5!]B.*,7V!/+U;_V)>G>)ICET9('QA#]#MUO^Y@O=SP[1-JO*$ZE#25Y-9 MP?=ZV@D#>CW>;ONT\]1?+\CQ#E"@*F6OJ+TZ.-ST!<$0J!*UOCL4I@16E\Z, M8=])RV0:"\R]A!7>>+]'M#KUG_#P&DI"DF9-QWZ48_]IHHISVOX22F&IZA\% MQU,]'*P+QY'EHGV9.!$$?<^(J(V.QZ)T[D1@,N]T<>BS0.CH+HT]1F<_*_FV M.B7OEZC89\+/SW07/95'/*]OLCA9QKMHVY`A/8"=0.AL8G%-YT,`/XJMU\-V7C19^ZW>EAW!%A&L* M)-)@@%EZ\"4210;Q:81J^2&:1TP\/_VYL0[Y92#/YRS8_[<7_I@P$3R#CK(R MN&5.*(^UQ=")5!M4.F>-49WO-6]U4+OB+SB5%E#J`Z'JN`-<%])H$4[&%*P` M)W3C1;A@"!A4E7#PR#,3JSKAO[[0R(R+(R!2,+7"1;*JSE$0YP-[%G M5/5-/M'OQ>TWNGFDOZ1)\:"[6P7=AJ:60+"!'MK0OC=^K8'AFEW$&V^Q5XL, MSP`A+:7:ZH2K)J5N4BH/+ZSBD48;9K&YJ0NZHVWI@_!)A@#OU0Z.AQ/'@JH: M^B\OM!V/JQ,@;C#5E*$._$SYI48KFEVO/\3Y,MKP>G#\X(M6K?OXBT+MU#U` M[;>;?!1&Y0UJ]T]NQ&4LAC^H=/'/2VUB5":\T#D*Y6/ZDA#^C.A,2M6/ZD^& MS,RYAV?43OFG:%V6D!^R^O&/+SR#XN5HF!9,N:$NG(P#4C9S/YAFG(9P;,Q, MV(6S__93#N18>8?5?[,P:CF<`YQX"GG""95'CMU#9\:Z]0_AYER[B$ZLUW%Q&6FT)R0V'T$1=I4L-_M5G-Q7AU(=OIQILR&R>J>B"Z)^ MPH`*_[93%ED@K[#B)L"895'5:&S.-3SH#&_[)#8K',.N->_<@JW9C&N0/3IF MSU@B`9V;CN*\)/JP+_C^YO0@1_9BB'?%.1\GK.5>I,X7XKH"[6BI>P1U$:S( M^Y9.,#1U,.)Q8(H;":[K>?CFX0U*"=^F[6TRDSX'I+ZEQQ2*K;GCM0,[X*C/ MSNNWU&_7-=!8$/P@5.7BU$&A&H#ZMQ?V8F#K)/@;3(%EM>@<5$TY:L3:XN4E M-CI^IYFW=SE40+;Z<;9VA5C8N,(8;S^*5F M"($X_K9Q(5,GF#I`7=*,&D`9-3`R:2=GCH$,Q+Z(W%$#`"'''@9*O\&U M/S`IA/T<208WC87EP_%DVSB)M_LMJ2/I<\(M4H_7%;G!9*9;^KUXRVS]#DA$ M@[::O--JB\[1@1_X6:5MPHYX!\E^SOC*'Q'Q+,#I^N'+U3)+A04=C1H9/6LF M@8[W/DW7DB.&>*S^0I,XSHKM-@`MG7>%C%8=M`11,E'W[5/5< MC!>P@(0T<5(HW.L=8\-B M(]"C;D*A$>Z,D6J9*4&`RJJM474#)H(,5X3Q\"0&W1XF"_!LZO!DZ3) MJQ-##SA4V^-'$E@1$73N<7IN8,@10>?MHGV79GPNB-?G21M6)X.D@E;*X'"(8!/..E;;\A,))W\ MHGDH5F30^C'Y6C8(9-P6\OX'E(*#IL\KC>207C9(FY)C_TBSRWU>I%N6ZR^^ MQZIQ,'7#`:. &(I/(`BS\2_1#:#,06]9_D*_\[&'(HWZ"$$X:W/:1"7T#& M`",RI@3^=[XFQY!.)&T&<.^T04*ZQ"X6R+NJ(?AN2RRJ/X,+_+(W)8&U^H4. M$=UJ*P.S[KU/B.-R;9D>Q[(V?1QWV^#@6&87"<<]U0`<=R06U9^AX5CZIH8X MUKS0`8[;;24XUK[WZ7#\B772'BY88HB7D1;,ZH8]1,L:HL!:[0$.MJ7ZS0"7 MB"W$9Z3Z,#"L:U[D`/#&E]Y'_5!@"/T)`>)EV$UAQ@4IY9#;J6+%.-3FAI99 MYR\^15MZO>Z4U.]2?D"O*FR:VO>CI[H]#D=,_B#%4HT9`%&4TJTN7OE)*$0Q MON8A7X#(&)!&)2?A#AA,$Q*(%I=1_G"3I8_QBJ[>/OV:T]55\B%.HF09)_<7 MRR)^A)Q0Z*ZH3SD'13A<=/X&2"1UL0]@K[W:!9,A7(C44N3NB?S`!4F<_$@: M67(0#F[UZ@A`#H/#6'`/HH:U0DDX.1ZB^"G\W-SPP1AQ!%]#BJAY'LB:VGFI M8*X[9R'#O'4K+:Z2):L`/J9Y?O$8Q1L^SWB;7J;;;9I\*=+E[P_I9L6(\#;* MXZ4ZY[IH&29<.RU80<3%=[14:VD<%#6L=(HD6TJ0'[C,CZ21XO@NY4A;\(P( MT6""BA/X9!%E!(HEP<1&FS22A$\'7PG5V@=T7H@Q&,K/K"V9L>',>-Z(AR30 M23&/MK+*UJ[5HJM'FMVE/G`/6Y%EKU7@GN.=O5C6TV)OB8GO]@4E2?U@1S.2 M/T09?Y[*RT3-Q3.GY/W5I>3"/&4QJ MK4[E925\;&&E#\01@46.:??`4ND;$UIFIH>7@XC8N+^R*(?,BC''ZQO;A\6>:QWV? MF?KTM@LT'+6/Z>.'N%YC)';'=X#@JS?<]")TAT)AV,PS4#)O/%)-5`;[+4\: M:1;.JHY@"(,_EF54A4BN",)EDIA(PE@I3X[,);?S.M(`MP7YWX+ MU(1I)*'1<^0C";;`AG9MW`@#[-@`E8,[-L=$Q"D7?MJXY)N1O%ZX;(\BI"\$ MLX++45`,$;Z)PSHZ4OT']D)3-()-AX,@''OR/B;J,<]:SFGP!\?&^ M>KL11L/+][.`W5<=WK-@^_K/CV-#!10'5HN^33B8><$V<-[:;>L]0)'S&K)I M=A0#OL'4:\4PMM[KU+JL"0MQ*M<5D",6HXS;>J]1.&;)R>Q$F7($UN2&#\;P MZN9*LD0KG$G:&:F`N!8+DPQ',A'KEG8!BIPG7*>))H!O,/7$*D;:U:EUF4`] MEK0+`>2(T:YQ:5>C<,R8UNQ$F7GB$R?MZA4O#J0XEK0[$140IS$QR1!BVI4< MT#-^_9.E4N<#Z*9?=F'YS:8^F`Y[_1/4A,N!=<>X_LD6V"-.[\);_P14/N9, MKV")..5.*AN7?#.RLY-JU^+D6G)*W@OE\%=$S42ZF4N,;Q?+9;KG;MVS+Y"P M?RZIN('S)MW$RZ?R?V_I]^(M<^-W95'AIF901MBJ08I7;MYCE0K6UB&AR%(I M"SW?R$&$=&7.2-F>?*W^RP6)D`RF(^^(0$GP&87E8;"Q4R<++T?!"D_==PZB\3@#]:=-6HSD`M)5-*+]J-FC5?U-)3%',97+KFC!(:2`?E4[;G361B!,#.<6#S0CM/S@C)\Y>7K``MR!,QY:*RZ89QW5(?%UE'?!BU+N'H!HKB; M\D5+DE2B9Z02%O<=M\1)2SZX2[)&(E8633`X(`DU3FJED>@86>4K1;H[XX]> MXIQ)NJ991E?D_>]Y2K9T%2^C#5E1KH5D])$F>[ZJX(5-!K0$RZ>9$W]!\YOH MB>_U$*5<]>_D;*BKMN%!SS M8-&^/!+ZZXF?6(EI8_@$H-4*)Y((&_HLP: MZ[TR+#QHPS!M`64]ACV\;>^EE4--)8Z!K#C-9]`V:7+_BIG>DF6494]B&?26 M+P$Z5D!855-Z2'BIG_PYHM M`IED4E1EVT.S,U(U)%7+$`="H+"1<]`.=%)F&E0H&!L.9/V5`!##.-BMQU]( MUK0C'"LD/UQL\%PP"ZLNO*!V_JG\@X.?*##;M!KJ09OG<#4?C63!,M?&)DBD!=FW$!BS((1V2Y9X%X M&V@,M@2-;7P%PF;6V'F]7L=+^OZ?^WAG7-RL;=N+H(JV*`31^H$31U4FS.R0 M2R[*CTGS>6#S\OI7.^`&!`E]@JO:DB.">(C]L,^2N-AG5`R. MI26BZ`DCRAAPQV!JWK"[H\EM]/T_:*0,ML,6_1#;;H'#CZ%-I'#:40R@0*L] M/SPOPO\,!-R2ES.$M/(-#F!\:"D!K\_7["?X]?1;O>_JI+2$%.R-/QWM M&S>'+N`[GSM,E1OVJJUZIC,^C>V'(4S5'@OI>G_0PIO2#`C\"NG6D8'UL^!. MT32_8X< MD*&V+>@(4]D*Y:7`&2E%2"5#:B'"I/@,U_>"W'ZCFT?6(DV*A]`H;8<_-=]= M<*P,!2!EFC@1+A_L4A%X,X&#$]C4X&F,1\SGC&]XLIL$X<>0)J%C0'9:W!*E MKVZ]G>^3IDJWL26@3MMD^2'.^:$L8A3SEX@UC(NG<(>H+!'I&EILA[-@VIQ# MR[P<\3L@9N$#.EG**5E!CGI%^J$[N.$JFA7J@5SS,A<1L)(L&A6"3[.?Z3:* MDQ7-KM=EB-7/%(_3YY!Z%?HF"S#:[S-=.E:Y@1-KY-KA*9JOXJ\TD'3=SM7' M$X[TP'4*3!`NN`0HJ5ZW4!4DO6;+Y&IO//*L[AR3'[(VB?B*A$!.D`Z)/B@9 MWC>!@L_ZK$*Y2FZ_I=Q9XP2>K1ZW#G9;SY3=AZ'_DW:R.^;1>@XMK399G$F2 M."%,5B3OXQJ/E@#1M3NAQ+1C=^*@S[E#,3\]YNQ?][SPP),J"__;"^2Q^M"H MH`\CHY:W"7Q,PK_/+3"5_(Z MU413OGLED0X2&JI,`12_JV%Z=IP0P^.T^*'$MK]JZV''`@8>>RTA$T;\ MU$?[,(,Q/DWD'SKIN^.!+-73VWUZ0CSEXAHK] M0'(LZXA>\O-5UVGV+3P`/,6.W<:K=I$ M`(.R=I[D`Q&=MF?DT)KPYJ&%!R":-$'!"H_J0*!7HZ-_4(CVG.8`QO&@+M$9IVZO%-[JO0TDK7Z%!0Z M(UTXZ,PY&Y9YA]?$N6)T=H#F@U-$W(@X;X.Y0&*Y:3T"LTIQ5LT--#FOFVMI MFGAIT.`[3+UVKNT`YJJ@@UZ7]7-<^BA'`R6@'+&@2(5PYS&1@\8Q2XH"H,O, M:^FZ?GCA334H^%]?"("\I@Z7`O-FW>P^2N)_B>[<99KDZ29>B3\NDE5U$8_X MDR^M%T?$1YLO[!,JOHAI:#AA^..7?5_D.2WR3PP'^C.A=&W[X4G>%B?!\%O[9H=\!0!AP#^9C(1/4^/&3Q6LM.0(('%T MJ8!0))Z<#FS,5>D(X,Q;67*/RM7/+!E`SY0&"_(:)<,^X]2^($9[J1$@M22R%:-: M3P*[U-7TEN5T,L)"RJ*AE((^4^/(7\A6V'(&5!.D3PL]L"@\`C]H%[>K]%O= MX0X_KU9CS1U#YW]87&PVY!1Q9+KI7-RHNRS*AJ#%T:-PK) MLKE&"(]*1L\0<[O.%I!-:A55IF\W:+;QOP^OD#8C0LXY*)*DQ%,**_@W+P+] M;.'RLWLZ$?Q+8=:ZJUS;@@_[]]N'?:SW$NPD(4\([7>V7 M17Z1K+[0[#%>TOQ=RD\95`+=T'X`>65[)/`;_,&B@=H,A!`JZ47]2`Q-UP_) MU_)Q,"PQO7,)7V`P&3)'(2?C$!19$[*I7/C4+`)([KEW1;K\_2K/]^P3>IGF MA6HYKZ5TGVE0:1S>V?F*Q$*P40`G@;H65H(@X`%"E#08@@!Z:]/Y5N;[E!8T_TR7E%5&=QO5;!!4 MS)3E!F)^:*_PSE-&&UISX'5?B31[B4;DT"I0%JO`8>:N'E9&OO;$`2R=!Y!3 M91^9V?'8%#OYV4/PX\OJM?OX9I)LRH:3:0U+%L!J!Y+O%5%D=AKAW:UVDFF2ZI MH_UI@L\BRH^#W[PQGB9YN<-?K$^[80YEM&#]#>[M6YK0=5SD[^)\N4GS?49O MZ??B+7/G=U4"&*FNGQV$P>N2W0M)I*L*Y[X=.C5[]<6]I(@6#Q&M'SKY]FNFB6T7(9W$V476?B%+75;]%F M3V]H]N4ARI13[U;"@WT*,&&D30LVGF+M8`#:A&QG`*E:-.W*:9(MET4?H%25*>E-A]5+3WPMN.# MCTQ3&[`E8BDWS"'B\S,QQ4-7(3*L^U8-=))!0,^<,FL::.(9+Q,$]8,=)^`8 MP_7_^?,??_[Y]2%J_SMY_?/9SS^+_R^C=TZB??&09O&_F%14D/^U3RAY\_,9 MX5%`C.R^H\MR?^^;U^+3/_T[25+6*!;8%$W2?9$7[!]BSQA(QQEAIG=T6<2/ M=/-T&@"W3`YPB`<4]D4:RLNP!(K^,@%M$N@*>."VS",?*:%GQY;@'?%A@B@? M!YP@I"_>0",-6/1<:@N:*#4IP";((0-S8Y`FUO+N1:A.UW6&B$\69)8AVQ5F M:,?&:4SX.3G.8'`4U,X-Q0 MU!84"DD/?-3ZZ*/$4!FTI:5M)*-9C8.S-D M)RA:U'91L,O+F#98=X>?/NAQ2WRP6E8X>'#U5//(;4U1_*@MXT#VO!UPJQ)H M\X+ASNN=&L.!5T[P07BSN'T-Y6_XU>SM9-64Z\"^1AFTKJIF`8Z&XU8CIF!` M.G`=-+(:#*3GJK;9V+ZBR%[/#<\8%=A(1`"3I=)BA'H M#*?+7;IV?5C;8E&K2*0`Q4I'RAM');[Y*U>ZQMRHV=:A+%A:C<*EHPP6(#ZJ M\02A8TL:QL?)@3A9V=*W.1J1TL(E?2Y@=*I=QL#1:_72MC-=^=*W.AZ2P`+F M^:#4I889A=)PJAC#A4[JIMIZ!?EJ)[47/BH3JTN>)(+]>;K@KGO2O%0#=8`7 M/PU%3!0)X`HHNHOB^B;M>@O_19[3PG"#M87DD#-F22P*07U$8Q3`((A@1CV+ MJA&I;]8['#A3-@SL,FP;P,CX:(DV"3U-&J1L#0>JOGH#(+LHF!5'IU6HK2[, M+"\_*^_27%:O(1(RSP.UD*Z"%]S.?;$F/S/OICXRSW2_IJ;Q\)I-:6.LVS8U MGF"E$(4-T-V;,M%%]3EI'@17FFE?L.Q"3C,@ACR2"4FOYYP:0)X"N]*4*Y+* M\/T4KO(/['?[6Y1E45*\_TZS98I MA!L,C@->&<[;T/M6MLC%Y5=\X+XNTD\5@H`XCP5"Q"%ZC1%?X_,&DR.!>-X' M(JT><0SRRT?3I!I3K!%ZLH`TC\FC`7+>T?B#8_6AW]?K[N#H8;FF^)/U8JNO M`"E3W)5J"AD7I>B<=_]F^,60DR]VP<+!1"^8-#="L&`R6"=Q4%-_PL>C_A9L MF!F!:VT@<77:"R5ZX/94?*0^]%HJ-+O@DY+#3C%B67K3GY76\*D7-Q4)0V MPB%=IA0D1:W*V_E)&LRP2&N9"+^5!%!N*"0TM<1``CU`*7S"KP*&ANPB2E^^ M%RS:BW;X\_`8KWK[6CKK(:-C:D]23\/)<>8]R\GLC0*'%.OM`L9AVL MMQTPOLWBU7UUW_!I@M(J@8R!I9?1D;X-_X,C,HOCH'G^A\5?LS3/^37UHM&) M`LUFW&,4T((;]CJ>(LF5XS#1`!=;;T,$,U)_H*`#V&>:!Z'0=]*%9#*P."QE:_NAU M/?,<(.K6Z1T-TF`ZKZ((I;Q`.E$UER31+K-T7DI\P8_8?2LV%&O(]RC MFWA&JH?AD4WZKK44TZ!#1ZNVF)Y,$^+)>W0?&','EKY+F@B8[:K?]R@'2<=! MT2K&NX'12X^T8\!_=W1@;@0@64?T2@7!DX.736_4$5[!]4/7_;6*EK/L%),BT#HU%=7"7R*:T8$ M3SJO+#&-!67C./P;\SC\T11`_H#O/.N+`WTOA9/&G/\RRF`<#?Z#99"[*G[O MGF/\MBK"/,`XO`*M%?.Z2RJL*C6C%E#)IM'BD?Q&WWT6<3KCKC%`K5-3ULE/ M,1%B(0<(,_"`D0**8%C`4&J#1H[`J#!A-:CW`9T3XF+'*'_HUH;/&_*.Q9X_ MT`\@<0T!`__\YK^V.7=V'[1H;VU3GU\/U!.DV44;ABRBHMDQ5>8[8!3LD`-NA1CTH#/:9C/'M*.T;`EO0WZ^JFH6C]<"YP1 M(5+N06ZD`N0\$&-Z]EL!51L%])H,\2`TM/O/90#[J+`?YK><">0<^;M*1B"> M/F_$VV4^CY@/)AN*4RO?T5V:QZ!#/Z3M-9FNUQZ=Z5)_\+-8WXP=>;O2/:*6 MYPG73\/CI?R-:UFH`XF.<1TY/;\FQ97W?#&T-@)@/!=\H4)V]20G7_G#8`Y;U;Q8&5E,,)"P9"`B)8@9-),SHSK5Y.EBN9R$^5Y MO([IRG2O@I6TG#]F:4Q*07U%91G`*)AX1ETU%^N#P9Y(U32X.Q;LP*/BJ"7Z M%+0U:5$R.2SX^BJPP+;1<,R+KP;!U=FNSPNXD+K,*W3GKMGD/?Y;^KUXN]&N MCP$*#O.141"+RT`/T;*0V1Z(N"8UB][H<'=PF'R]%1O/>'LB!,*I#:&0D9'9 M#FX2%AL42`D<"E1]91R(60S,BD[^\H&N]MWYC2YTQ8J9YP!62-+Q`-2COE\\J?SVS6F)V!+<'VDP,+V=]A$1P MUSO9`@M.>`,VP;3OZ[$@_]SPGK;PE%I'Q#DO0TLH/U\0N]>>B#`.LQ*]23?Q M\LEYZ$,A#LUD`W&_3%=XZSF/#:V.H'=?F2F+E>W)U^J_QS-"HD(6/`KHL0D. M`3TU%A%@7G1/F\9DQO%@7BV>DXR?/#<4NZ3\LKKOG^=DU3(W@KZ-%@5KRWV"7^MFH>>B`4;@]%7`"\S:6MZ"KDID!L#2 M7W.ZWF\^QFO-J;Q022A3VY)^N3KTT3-;.P9'\+6EQU10EDT);QLX:R6(@?-6 M"3;6R<>AEH00S%A/C M*L#!Y\4;#383XVJT!L#?3]2Z_]82@3)6B/BE:LLKSQPM+8T@)U=@8N6GX->H MM&$`)^$0/&#V,5$+VDT#N6F'_&J#X[`W&-JC!]B%OS3*&7;NA9LU\##/(E8; ML3J!N$B+:#,2>N!3AW4JGB7T`&<*8T%OYO.#Y8Z)NR1MZXR.$+32J(3\LJ_C MF>=JH[8U@GBE"E/%(5H%SL`N).`#X+35Q\'D6"RJ*Y!3 MQI][`>*$P##'BS[&";TJZ-8Z&PP$H1FA)>B7D@,//6>&MKT1C#RH,6WYX2V) M:!KZ.-$0+'"NJH`&9FNCP(*Q:I`&P-EW<;[6+$:G:X#I[+T(JX6W5@#Q&IX)VGA]8U2@/: M03I\(W*$`G:#-NT4Z)QY9^=GNJ3Q(S\R(H?M?S$+]-&K$<"!L]$C)'SK[``` MKQ9?M)Z%OT\%@(`A6Z"H&=!'*2CATWQ(\U*'&\R-@1ROL?G]N.30Y!3!9:R9 M<>`U;SU,^<\:;^*(WV%PO?XUR=@G]TG\+[JZC;Z_I0E=QT7^_OMRLU_%R?W% M-MTG17[#BGU6%+(/;M/WWZ-MG(CFGVFQSY+\<[K9?$BS;U&FNKQF*K/#;.+9 M+%:DF.370R0RA`Y6.*QH;8EQ"IK MY"NW1RJ#X:3K:8@JB\M3A@A);/=J7IHA7H)3YN?VI4F*!TKN MZ'VS5\8J##OS5ZI/S>8\[.4' M+@B#\`84M],`/,22\Z-AR2Q4 M#);B/B(OEX5ZYS69?;1:*FM4HBM"/X:V2!8,#RB!5<`"GFL-21GY^9G M]J$=+=L2,$:6$C[)V/;)*P\K0\X4%/)J]IT1WB!HVG5>/Y1Q$LP`R<8EP3R; M!FA35G2-O5&(XQ7;5<(\H7E!LI-%F&L19HVQ$(NL:FSR>MWZS"ZPZS3``KU< M@T\^ZGSVF@@4AIUI*M6G2Q3U;&NZ;G\>-+&U`(,2'8!2(.UEFL!A(`RH3YF* ME/91,2\V-41/?$%]3K;1*NQ4Y0W1KJD,'=,AIKIWUGV6M@1P^LI[*=GVR>_4 MU<@^RSM3G^5=Z!5EY_6#9ZR<^RSO;.K):8`V9:)H[(U"'$\$[_:4K$X67*XQ MWAI>(<9PW38?LP2P.X*X%-^H;TJ8BP/L'UU:`C4=J27CE M-/?F)/G\T-NG]A-[RFD4`)<;R!1XG8%5>^QWL8'4KONTJT1=C[U'P%@=?,"3 MK48(0F=:AXK@$ZT`&,_#=O!J/O`2/F_K]GPOUG-BH-X;+.HIK4`HIQ!>')[P M&2'QC%0/0R&8X5U+B`5"QY!0Q.(TQ=V"5:SVK9QQ9.4WB-"-) M&LZH'!:N`.-Q8Y&%=JZZT@#L3/4_E]A*Z#W/)"/0!3M172.^N,GB9!GOH@TY M!+!$X"OGGYQB`#.>IHX`M#E/46=.,0`_1#F]N,\HY>Y=\IE%FNUXS?(IVNIO M7+*6']8)4'DL,MKYBU9)@,V".`K4MFA_3OB#X+K+MOB14=<)@A(FP_1(J>V( MXBF9GE/V8AXNDM4[^D@WJ3@)\?WW'4UR==$/D!DP6BN#Q&*`7UC,U9N"L%6G M85$_%EO@6PU(U2(4GD*0(.$F'$!#/FID91R<&7>>^@HFBR,!6/8:6A!<'9J< M+O0`_0<\\,T\IR_S["++^$&-9:)*Q%#4;7I#LW6:;3^DV77QP.#Y]HE?)ZB= MBD34#4HCUKH]TM[Q>_I,2_8NN48/6TOJ--?2=$9J79QAE3;"_H>4^NK[0X.: M3L6D`#"(C6,8+-19VH"&Q+$$GCYPZH_EEC92A#+^HW[/V4M(RYOC<2RAEI"!#8)BD@"S MB`1?8X]B`[6(U%#X*$+G1^-)+'BJ\0+G1_037?"^Y>QA\Z/ER3`(AE""9I`' MS2"B'S-BJKB%&#`_Z@ZU\<#='V<8.ZJ M,3AR`J'28YS'.H9+8.`8LIMND`+0:LJA^LWL)AZF1N_T,V`MNR@PUHU+/`^0 MCIL9&P'3`(8>`(=3X0`QH[`5H/2 M&@V6])T:JM-G&:>!;KVF8QO]]H76<>EF!%YG3C?\4@JZ>A]E_&J*W)!A=(T' M247>&(F<.D^P4H?"!H1Y4M'%Q7*YW^[+[6WOZ#I>QN&Q3/N*)<0"0&+())F0 MC#P@",W'EM;[K%XGD#EJ00.+9()>&*7VT`^[I/;LF291LZC;D+H1^4%"Q!_# M)*`&*48R&E%F(N90@9FD,R+44ST&,HL!55Z-M9&Y*C]^#L`$5%\^H(FXM/U]XFC??>8'GO!OR'FFRIY_+R^WX80'0.^R!N+#.WEB436'I.= M:G]0$X?4#)B$$NF&>ASCI'W:$GL:%-\T;US%,R-(%.P:RBE9-3VN?$9[A;41 M`&M%]]-#$S1:C\)3*-'Y_7>&I23:7.[S(MV*[5!_I>E]%NT>XN5%1J/\EA\; M`NP0C-&HCO#V&K&YZOJ=T+.$@R-6-+?6W\TTM3AIY,G=$SEH($(%^2J4!-M3 M&85B79P920U-'++5K(U4Q\X_QH]T=9'GM`#L(!FG3EX>.*C#C%7. MWP:U,'#Q`AR<[)77)4&NK`GX@!`7?R7D2:D@R'T?(S&KBEIC6:`(6-9JE=%J M/*^F#U3&8[[ES12!!?T8;[EUW$!@>4QW3^A`W/`.X5:\.R7!P(=L=YNK">$9 M#SXKV*X1>V"$.MKC``=HZ6:`VYO:;8U+%PW2\@CGEP"DP`ZGU!CH<(0F`]2^29*-D^) M>!S:JG;`^U<1"``:!9=DDDIB@9`V'<>^/$09O8MRNKI,MYSR8LA0?)I?[(N' M-(O_15>_)BN:?2G2Y>_7.['*@$$I?_^=9LLXIS=9O*2?^7;_ZA,^?%6VR_]& MX_N'@G4462B/F@:ER&L%B4-PJ127, MD[;],U)Z0`XND#WW@0@G2*F="#?.2*V5"+5$N-)\*B;N*F_.2.T/J1SJR8:1 M&4*`_S#U!.&5/+?-Z=HP>;X$X%%?PJH+^`QDXSP M"Z.L;8:S6PY(QFH:)TC+BU,H>1%B`U["0PM4:'G0W2/$!/D?/S&>&ET$M<"R&N^:OPCSRR!=@G+7ND#\<=X?8J+(D\X M$$^[QN<$0W&`G31XI_0WFK.O>)7=Z3!)<@Y M!ZVS\T497@W?I@6K:]<\'CR*A8'INERUGI-'(?82('P!]&1#Q'&6C#2Q29S"(`0/S+Q+&>*363_]C!1KSJ&.2G6WUC:53&I,$4!!]T`%,>^Q! M![5A_&&'(PXU8964,'?GC#GE#L3#P44GN\8YK&#A?8PRC'`18$GI:WJ_(_*6 MWL<)G^NOM@Y,WZ- MV/6Z[`E[[9+)37GI7/5-!90RY;]"2!V>@8=39:^>80^=D#-2VN#+.$HKIY2] M%`3SE(>T=/:33[HF?66&HPD>`5?.$D?GB2)U- M&B[`GWEE0CA+$(YWWNGH%Q6$NGI@]F4"SWLE0%`33>'-[049H?)6_4&%?BNS*+Z]QEA?P42:Q3O:Q@'M"]V MP-!N:PE[ID"`9<>"'Q`-R*D2&]90.!Q(G96?'3<:S#6I)1[P:KF>7D]UEL2* M/2;.FP!QY&@PYF];-(22][[0[#%>TAR6_R2M-7FPTQH=^Q)?\/-BUX@=`=JR M"_&`--FR?A9HWI2]9RU'U,#0,:4EI6?,9$CR,W"GL>4,*3'%G-S'":49'_'* MJT>G!2:K-.P"IWEG9UL^_35-5\`HW&^J"<&'INBLZ7N!'WQ;%NQHT@CVPZYX M$&C,';Q5+4<4&-#1HQ;1Z6,L=?G'SK>0VO7DB.&>'#EL,D%DDX//+:#1U;PF3?& M+FD297'Z:Y+OZ#)>QW3U+N5C^ZHX:VK?C[7J]CBD,?F#%',U9@"<44HOZD=G MI/60?"T?A\(@XSL?L@@(DP&/5'(2+H&1-26;'NAJOZ'7Z^8"OHL\IT5^D:P^ MQM%=O(F+F.:_T"C?9W1UG7RFRWV6B=/0\CB_Y3-MM_1[\9;Y^+N2@1YL#%B+ M:@.)Z1Z^-U9TP'4-$E$P+2YJ=7RUP>$ZXC-2ZA0GG[2TDEHM21/2*"9",_DJ M=!.NG`CMP00Q'[21!#Y_[!P&2T1;L@![XD'`3VV-[N'$T8#7\NUX8(H!41'> M#>9'R'5S%^.(V#YSEZ;^)A=)$:_BS;Z('^D7[J[X"N^_+S?[%5U]8)CAZZ+V MA5@6=;U^'V5\25-^0S.Q+`I>B6$;4I9C>(:0PS'V+X!=F"'Z9Q./TPL,A:6GF0K5NOLF\W()T!+4:.K$T0=P3B=5Q',N@+IB??,#P7,2A MNCE'Y!B4<_+8\4)\3"B>%/5/I)CCJ=ZQ;S,U(K.X(^[VC( M:Z(G$IW4$=/5@"Y*'CU5/?=11[DU!6=%'W2_W4;9DR!M^R;46N*%A38X.BH> M!M*!O$J6Z9:^I>LTH^6_;Z/O[]A_\B)>7B2K#^SS^#ZQ+%!&:556)XY:D>/= MJ.^&79>X.F,3X-QL="J24HS<"1WU7TS+&:GUB*G42M,1E"/C`*Z)@AC,40=` M)^VZZ'?$E/146:7+_,7ZDJW(!!FSD M>HQ291GBIA0YY(WY9MA%B*,O-G'.R40GR-4:RA'E6@=IE)1KN9B:5T)/O<(K MT('E4<#6A#P$PJCCG8MR7;A#(>*\`\/M\Z7:?4:^U*P\ERK/]]OR,^=!XO%& M``/&8XQX&Y$:_\W]#22/\LUM@&J$2>4`<^^LYMX(,/(#.]_1N\*RVK)3HZRGH&J0@Z2=]]@U$=BZ37P#*NW$KX,, M_TMT!L6QZESN"(H62PQJPI43FM7A"*9.%W""YH7G\L#""7R"]%/\>L^DV+_N M-O%]5%;S^V1%,[+B'(F3O,CV/"$$E^FG)H=%MIZ*'H%DW/?K->53XHSU\\T.JF]5S,,^_Y]49W3R3:[39/_-0,WB`O6%)CR>B) MK"DK,*)-VT+&J4@9:AEGDLV_9O M6:0X:5/6)Y;:D$.DTW?!KDILG;")AW:Z.X&P%A4UB.*@D/#+$#>T:@+6&/BK M(Y655EV0.B(^>:XV['WQ1JQ^C2&*"Y%-Q`A=0;>[-.,+Z*OZ@N&[Y%I&-Q$O M*E8U%[ED=.#BYF#QA7B.1<(\U`ND-+A8+K,]'5$-0!6H-TP;%6!OA@9ZC+[1 MV6S7:A.S25UW@W+9^LB2-QAX-!`[OMD%8AY3+0/3D(9 MXOTY@MOFU!*/\`XDV7T0DSZ_Q$F\W6\_TZ2(-M6\?_XAS:YW-&-]^.3^(XUR MZSR(H%M]3N\8W=A'H$SA&6NBN,RNG'2A,I5=5K$'.^>84T MVDBI[@C2-08'=`=QHE%,'05'V-`>NWD:#/9]J.Y(SR:B\F"Y8)?,/>(VK'YA MJSW,CI"O@=0Z_>.$^$&^?._<.WXB$1^CL%N8X*)-O2;!3AOVM*C+=T%?B6#I MA-43R,\KW& MP-H7;]3JUPEW#9%6%9$26G3G_`G++"3GFE\8Y3KG/PNG`LGZU5;2MT^_1/]( MLV83Z=NGSW279KQD^4+O11EC60",56S:A>Z@V,].=.=OZ&DWNHL_#CO2[SH>.:YBG!RQR?A^E5#UMV(Q)_CA'>7Q?@&35;BGV)O M!&^R;_.4KV&L=E0$-RD2`@\M2HLYF1A(*?%VG\<)S?.+Y3_W<1Z+O;QOGUI_ M":^-!82=&F79`%6#',3LO,(44&DG-M4RI"UTQCLXK0]"/0O/$H&: M@..$9760@:G3A19'5LQSD#CK6/'M>I?[+&/_LNR'P,0U1X/KQ=$/'(9XBW_8 MM\&JWD:GT$/0,@HK3G_UI@4AT&]&KTY_D&A&KOYV4;C>/! MNU^;UZT#7.WL&\96YU7[`7(@!?'[[6Z3/E'ZA6:/\9+*+_:XV`A?8G[SV.>F M[+^A69RR=CGT8&H/MM2KAC!M8:^`P/\=T%<& M'=27,Q_-8$1I@0@3H?8,?+!,MS+#&ZDUJS;P;&K7='B,(;/$^H3]LD]_BU?4 MSAAS^`AD-WQT+@!N*R7OR^,47Z*&/\B><-P( M9'3U)DMW-"N>;ACCBHMD]?Z?^WBWK<>"C74B3%Q9]IG$D4,KS%OLHLQHU2;> M&91U2J:Z[1D1K<52IJ9]J'U7(*(TT<@*D^K0HE>CBQ26J)YG8Y4XB.\F8F[> M9A&+7LMJ%4/G"2@&..C2;)^RT(6^#\/Z>^!ODK)QP6Z3!5QS;U"L/+)1/"=M MT6I0K/TXT)CB@E#M'@M7P*NCC85._3X*=_[,LTVXH"ZNU3 M]1`6A:PUJ2_/A&O"OA3/]CN@7X-IX8#5K79@O=T++L1X2MM(Z.3V&PRO>%MM:^>*-7?Z6GEF#___:^_<=M)$GS7TD, M%IANH#S7+O?>WNP"!91?O37PZVQW#P[&8<"2LJIX+9$:DJIVS5]_S"0I46(^ MR0AFD-(/[;:ES(@0&=\7D9&O,X+43D(40T0JF^H"K?PTO]X6#VDF2K._BEL2 M6S?DBII-.5IZ\YUGBSCGG[)XP3^7$.".HQ!$I?J\`44IVH7?\$\&/`O!L;7? M/>"`)AQ2KG;^O-+"]FKJNT0/IL*D*IGZ--J85,>D/K(#,DQ\.ETTCL8+AC"` MH-SM&G)$/@H24H2U+Y]>K:+<<=FIMH>>S+L]H)E89Q,XC2H4>7%@I_\A@4DZ M*@E(-B#+.%H/,-&%Q6T,6#_N:02JU=>"H\R]%&/JY88VO$&@R394U/4ME2AE MV-%'NNYA=!!7,/K7,52]G4$YKDMBUQ^T.@?[9F?G:)Z+ZW+$BH>/VR(OHNH$ MEU=I\LC+$:QPU4]9-];ON?0WD/^**-X[]\[SH#=QZSA8W-W;4[#<-:6)V<86@UKF>RZ=1P< MO8`+A`WO875?^/F.H)WU^`^6^R,\6,;^D*[*`7TN%KL53Q_2@O\]$C^BR#]F MG^/[!Y_=1SWEF;-\'WD8R9;_[T$9&7B9X9V7>4COCB;JSG]F57"2)_(2H3\;V36^PS!A]4I9TWH0-WQ'G:/TS M,20#QIRKG1QM82>!F&93X"^95F[7ZRA[$@06[U>&L>BV3"Q9+@DJE>+R=JIY MYIXQO?NDV(=(%OR9Y[QTQ0=QRQY_Y*M4[@)MU?9>I4F118OB:_J)9P(XXC;> MXJ$D&=>MES`*#/LQARH`WZ0)\XOA=VX.MLMO.^=`=4=[/"MIU:VX>WGM.8@+ MUH@4@*Z%LO(/5HFE.@L!!A'CAE!0&.HY>J@B\]918*B'K3O\DJ;+O/PM']*$ M'Y[1V0]OMAF7 M&AU#K]-U%"=FX!RV4:.E:0,)D4.]H+C8B78&0]UCAX!OU0>T?/[H3>D<7?E" M-=Y=M=6ZM.:]AXL%K2WI[^*$WQ1\G3O&!5-72XQ0=T6)%R8K<6*'1J-_'%$* MVB%*>>8#^R9:,MF4%M;)]A6!?]N/>TH%C9 M$P7$!AMQ,*Q6Z`]AE1P%@O?-V#=ZRTP\',:*7[NWV>"KD&!';U!711JZN^D% M\=EJB-\9RYR&?SH4`W`\E$+1X!>>WF?1YB%>1"N7P8^^O3J8J-I#XE)O#VC@ M4*IQAIZB=P.W"];^DN8PRO#.=7BSNHD&8]U^6F0Y>-:8:%JM1"$C6;Z/LM^Y M`'Q]#X863K8.'3SI.P`!RF81%*(,>EP@I>U^57\GIQUWWQ*[D,3^WA687 MH[KDR&&@I72X;QZ&A+UOGHI/#H@3?;TR<,Q(XC1[ER;WI1^NQ=;3_-4VR[B\ MV.A#^2;J?]AFXGM)Z4043RE`:.YE.U2\\57N`G$_F5=5!WD<0RZ.GI$+Z>C- M_O=S,04##/'5+AUX25.QPS"G'YLJI(66?%+33@GW@W:`@%;HAX3LH7A74+9[ M'<*.6GS5O4(-G/1O6PV85GL=)$9P#*1$3:6EAX=4$CB? MRF*>O[00I*)-AQP/V@#YOT(O%"D>BG9Q]W:/J^J?["4YYU:]*H5CZ]]HUZ5; M;57N;'KQ8SORM8,C7SLX\C6"(U_C.?*UMR-?'SGR-4E'/GY5&D=6OU&U(U^; M'5GWXD=T9-L!C+KS%^4?O_%<#-BK&[Z?ZW"`H.(81J`J8%"(\*N!0`QKF0,' M0"J\)]$T$4(WQ3 M1&`CQ@D"*$]NI+02VG:`:`%KDE,J:KZU]**^LR:_V-U5D[,XJ>>B+UBCG]4& M'-UH,Y'PA(-__\"%R4/>`0W4F!ZA[LR'86JH\#^!&C&*!+ONM\^KSU1%P='/ M9%4_#KH9N^Z7OHWB[+=HM>77>;Y=-S][PQ?EK_PM795B5G'Q]+DC^QP(7?/G8CUG+\S8%8L$8SVZMF M0O<%J[5/)-+!PQRNDC24:L"J2]Z&`-:-<^:4J:?:H=)X%3[4,#`J3:C0&3B3V'3VPZJ?;.;AHAIS8G4*I=:3^=R'8$ M\R"134DU(>):94B8N#91NIMLJMTRGQ+O=5+M,R&%=^V3IB2"J;976NR5PJ+R M[QBIX0`ZTZ=H@WA4 MSSCAZE,$^=HNS41'Z)+'8$.@2A\##`D[ M)AC\!`.70H;8CS@TZ&\61&EDMSRPI=^Z+)!]$V:PMY4=4]\4/9P9X`8G4"P% M-D3I;1#@4.7T&)-6-678SZ!(G2(U;9H^F_32YUF3&E[E9=*T1GLD8%M*668- M=SPNQ([VD'N">IH!O2O(VPP:Z^![/CTB.X/\K1]A";RO4;"[@UK:3V]_4%\N M@%]V/XR5P)?=>YJ#L/#^-/B1YDZA/C^"'E&V=PO=55UGLUMHLL2%OV-H_O\TXOTE*IN)Y,?*>(0?UF,L8C>KIK>IQ>%H$ES":K1YY(8_) M&,SEBT(O$XI9HWGV&X5&KP;._R2I7F.M"K&H`EX MV8M2$XE96L,SH+%P16T@_O2J2B_HTI-*0;OL+)5,/%PX0`M\BM6.8^@95(5& M^"G229$&K:S28F<0]A"YHOQX,G58XAA'7R<1"N6*](T.SB]]<(Y_&++%TC!( MO]S/O=R?$8_A?'-#_.44!VSOXH3?%'P-/C[K"(8:CK4$AR78SB\,/-AJVX/( MF7LU`!=.?!/2F!0W]<7X78>'HU,=F,"X[E M.1=;RBZ3&X=V?:S'.%3GJ/ZCT)VD/J/0@-X>J-ARJ!_4[7?%EEN^2->BVA(E MC*\WJ_2)3Z^F".OF`.46&$/88+W@N+,ZCA?@% M8B&__"GO>1G"E\WQPU]YMGYNC9%P*K1!%$(%,._`_6KH,`QBF0]A`2@\".12 M7LEI2]:2R!J1K"7S@NVDLDILZRX)(9D:"0)BQ<"2X(C4D^AP52:6G27ND1,2 M(`/')0"1TNR`6YR!"^!NZ=]40Z\+.0L$YQ\SQ?K7WR&;D3R%R. MV'$^M]$8^BZA@=[&H'S\VX)WBNWVG M=P1H7RZ`/TEO&"MY3^T!FX-PCMYI\"/-(T#[_`AZ1-D^`G01E62R6DUFF=)L MB0O_"-#)41?MK'[PD4SCW67NH'[T(T#I7NSK\+2F<@1HJ#O,3<:$.0)TMO<% MNV`[P)%[XU]>;C`CQ(%[D^0W6HMY^QA/A^C,1X">^2BL?Y\L(]%.JFTCB,,C M]I,BP':1>UIG+<]R,5L%*VGQ7PQZ#/DM5HS:SU ML)T,O56;U'9-692+$[C^MDTX>_'3!1-IQIF'PKCVB3(1[2DUGWG#9N??Z_@Q M7O)D*>8-QUB@9M*+N3)-K9?>D@W3\R&X%DUC[LAK,Y168*X^VVV=;C3*Q6<3 M#T;><,5=W.'`%*AK.E3ZD1=S3)FD:*6]7E838"N1ZNZXY"GFJZE,84V83,9= M(D:$3J:9P>IWE:!5>[6:P"N["DU$ZAW:9T"E8JLR<(SR15P,PAWMH=M=]?5 MNK76QE4WT>'OL#C4@[>7HM%#@H^UOY_&D$UEWJA+A6NM>'L>*@7SH'(]F#`7 M#RMQB[A(N+Z7&7,Y,&V*(#E$4UL9@"M.<0/!Z&@?*XT$<^A/&;4:T,-"M'D&<7/CK.^P&(5;,`L<@RD/ ML1#B;QMJR>0TF9AD'C_\%Q&G9#$^>#6OU3=SY,(QIX(FSX:3'KE<+Y>Q^$NT M>AWGBU6:RV=PFQ=9M"B01B9..H%''A:=).*9TW.A,7*PF8H?ALP6@&;^>U6L MI8M]:[3]WWD$,C=8@@\H%22TBS^%P<_(-"F!VD]14L/J M*\Z:B9W\B4<"*Y;0"A*\\B;*F%I.@ULN_W353F>V(O,1 MQULLHM5BNZJ2I/2.W8GLYU%F/QN>55.\9RH:U\M/C8HF.7'D>J0I]%#;5^_8 M5PN$#BN^SX?&09\NYA(XK*L:?:@# M.A*YF(!VG>-XJI*K?U26-I7>OEM9B99,#TN6>LFV,) ML@_!;+BRODS>;YJ=:Y]*W.:?TE6\>/)*;ITD.>6J%DF(#.[T&S`S29L!?6G5 M+%>;YS7IFZQ`[KHRV9=5G=FW^O]?^?>"O2P=^'?2BW[+@YTFC^C7D9^`/*/M;!UHGJ\QH MYGRK8PI+@A,?[XIHPI@+MC-GGF6TX20"/KZ%XC7H(6]ON^#'P2=+M23K=<-^ M#6'.E0Q_C`KVMVW"V8N?+IA(NLZ42(T2T>N`)@#&J7ER%ZV4W-=P&B16 M3:'O"6?1)IS%F7`".//)40[!+%A^VCK@[]=DR3,Y]5.E_')FX>53LRK@4Q8O M^&?Q2*Z_Q[E7T@NBR2G'':@),2R`/`/,#':H@7VY?IC>J^9S)K]@\AOV37Q' M>@X?!A*.+`Z)/S?*'J31E:%AP1Z:CMU+,1^W15Y$\K;R4:9"K?J`ISH-^DC4 MUZW/@\94I^G#U9CJ%5$'"R M-B#9B*'_[JKN7"R5!<1R2;L6_4IZ<$\ M$"+\67HX_KSIN8?*'LP,@79"E*S[-54%XR;/MWR)=:"420?4P%VM(VPB;?K= M@0?H&M,0\V2E1HB!>"6859)GN'9Y$\-EKLXVH$]@FU8:]ZW5ZU;KH<2ND,RF^V=DN%>Q/)SJ<"1=JF-1# M>@@-AC;(*7%W=`/.BAN4@DZ,3Y5-1IP``3$U%*WL-O+OS@E*]_5L=K$[-8AM M)%UD9[H8Q6EG21@$<\5>TSS5W`MGVGT4)O2/OS]Y);+[,P;=>:Z MUHJW/*920)G6(<"$.=>MQ"WB#'>E#W5FFS9%^"5[&UFX>).,<$2ZVM(`?'%J M*UQ&1_N8*UI&PWOXZ\&TEGE=!E8A_DL1944(S"-?_V70>X3YUWS!I>N\>"YQ M__,9]W".."?<3_DNKM:O^3N/[Q_$>12//(ON^<'0%'_XYJ(=;U!GUDZ-U5V> M%;D!H,7H42G?:`O>8+%1RVJ]1],+LXLO3IC&C#H>I((8B4Q6H,:G^;#:%,:L M5OO)4-RIC6])\]"88V&23$1QW&RT=Q*C:>LOH,-&)SCRILU((X[2:3+2-$?T MQ0//Y%?RS)SRZQ)'\O_@HW>K)K"1ND%3X)AA?0:A1^`F`S')7Z\79&0MQ%<- M6*.`_="H^''JD<*.+,"HX`IC./[7:H3D^@ER!K$3",QV!B&/65U+30/EB"// ML#B?]-(YS:'@8ZVH\U4_SI4\5!?7^#ZMT#FAM]7![GI`7L1GO$YGMBO\O,$] MUKT08Z\'=#5CM#L?IDYPQ!+8'L;38;KS)3:TN2G4%36$V(G,G(VSP5Z3-H\\ MNTU),=0X,S8>YC0,56^$.W-0*'\^70ZB-TLC/_7?\]?CP$`039C'*(QP7"#( M,R!X@,+@PP*'Z44].F$")P_"0`MW$_2`_#S=4P>["PP^IZO5VS03 M7^*OGE(!\#_I:7MYT&?> M'/1XM+I4?ODZ*OC;*,XPKY7J:05PKNAM!0G>[_GL:&27_L;C!PA?FT#ST4KY M_O1LQ>Y+V80)&Y@P8DX77/7E`?!`-HR0H..;IS7P@>\DF)%DJMSG-Y"C2)%< M-XV>136-W8MFSY:"QNX$C3U*UTWO=F=4R@;37S0[;69#S]VGQFV3SO;ML"!9*M/S$(QX6#`(#7(X-32P1HEK*7E@K7UB(J;U'3! M6KH.QQ]"&[6(A@I-0\0:@1+T\0A#N2G>G"P5(>?9:":'YB1YW$6;.D2FG.2< M"1BSXH&S]1'W%$+BF5S&<.63H)>IIZNO>;[(8IFXE]WE1WAIJD$9?'JJ5$8E M%AB>!)ET5&WC*)2O4@V=?K9T2$%?9Q493%##B`AV:"/$`852%/Z?&I7XI9,] MMG&#&QN*540">